data_1wa7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1wa7 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.38 136.93 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.189 -0.945 . . . . 0.0 109.54 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.448 HG21 HG21 ' A' ' 37' ' ' VAL . 1.8 m -131.51 160.42 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.372 -0.83 . . . . 0.0 108.929 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.43 HG21 ' O ' ' A' ' 33' ' ' GLU . 10.8 p -121.12 137.64 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.965 -1.085 . . . . 0.0 109.295 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -71.04 134.51 47.15 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.445 -0.785 . . . . 0.0 110.108 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.567 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 42.1 mt -98.37 -14.97 19.9 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.587 ' HA ' ' HB3' ' A' ' 31' ' ' LYS . 4.7 m-85 -157.45 155.48 27.47 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.0 Cg_endo -62.42 146.05 95.67 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.58 1.52 . . . . 0.0 110.381 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.759 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 8.8 t80 -76.34 -68.76 0.56 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.222 -0.924 . . . . 0.0 112.04 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.758 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 40.9 t0 122.79 70.94 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -177.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -54.28 94.36 0.02 OUTLIER Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 20' ' ' ASP . 0.6 OUTLIER -105.0 -44.2 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.143 -1.21 . . . . 0.0 107.822 178.552 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.472 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 13.2 m-70 -75.48 156.35 85.24 Favored Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.6 -11.52 26.24 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.026 1.817 . . . . 0.0 111.994 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.69 -16.14 12.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.216 -0.927 . . . . 0.0 110.813 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 18.4 m-20 -57.24 138.89 54.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.839 -1.163 . . . . 0.0 110.422 -178.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.632 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -88.96 119.04 29.13 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.599 ' N ' HD23 ' A' ' 27' ' ' LEU . 4.8 p -77.79 138.03 38.76 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.224 -0.923 . . . . 0.0 110.179 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.759 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 8.1 p90 -143.78 155.24 44.09 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.536 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 7.2 mmtp -111.74 176.76 4.89 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.027 -1.046 . . . . 0.0 109.613 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.587 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -67.52 151.01 48.1 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.08 -1.013 . . . . 0.0 109.142 179.524 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.52 -7.76 3.55 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.749 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 1.1 mt-10 -74.75 144.15 43.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.868 -1.372 . . . . 0.0 109.938 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.482 ' CG ' HD11 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -95.78 138.08 33.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.0 109.406 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.555 ' CE ' HG13 ' A' ' 63' ' ' VAL . 0.9 OUTLIER -136.19 151.95 50.26 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.596 -0.69 . . . . 0.0 109.912 -179.423 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 4.5 ttpm? -105.87 124.27 49.31 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.442 -0.786 . . . . 0.0 109.498 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.448 HG21 HG21 ' A' ' 13' ' ' VAL . 2.0 t -80.98 137.23 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.359 -0.838 . . . . 0.0 108.92 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.1 mt -113.85 -39.48 3.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.113 -0.992 . . . . 0.0 109.688 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -150.82 91.43 1.72 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.939 . . . . 0.0 108.924 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.573 ' HG2' ' CD1' ' A' ' 45' ' ' TRP . 1.6 tm-20 -79.35 115.39 18.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.361 -0.837 . . . . 0.0 109.795 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.598 ' CG ' HD12 ' B' ' 186' ' ' LEU . 68.4 m-70 -79.08 -98.32 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.361 -0.837 . . . . 0.0 109.223 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.474 ' C ' ' HG2' ' A' ' 43' ' ' GLU . . . -143.33 -12.33 0.36 Allowed Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.664 -1.255 . . . . 0.0 110.197 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.533 ' O ' ' HG3' ' B' ' 180' ' ' PRO . 7.1 mm-40 -148.5 -25.57 0.33 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.002 -1.293 . . . . 0.0 110.171 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.767 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 64.9 m95 -135.5 102.85 5.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.947 -1.095 . . . . 0.0 109.568 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.611 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -90.8 141.66 28.57 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.075 -1.015 . . . . 0.0 109.985 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.516 ' HG2' ' C ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -90.5 106.53 18.56 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.13 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.52 -176.73 3.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.171 -0.956 . . . . 0.0 110.173 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 6.9 tttt -124.59 128.87 49.56 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.651 -0.656 . . . . 0.0 109.521 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.591 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -73.37 125.24 27.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.156 -0.965 . . . . 0.0 109.938 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.482 HD11 ' CG ' ' A' ' 34' ' ' LYS . 2.9 mp -71.22 -8.29 52.56 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 tp -53.72 -54.68 34.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.614 -0.679 . . . . 0.0 109.381 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.596 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 2.0 t -161.3 29.47 0.14 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 110.215 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.596 ' CB ' ' O ' ' A' ' 52' ' ' THR . 5.7 mtmt 86.31 44.0 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.403 -0.811 . . . . 0.0 110.585 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.591 ' HB2' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER -87.09 133.13 33.64 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.124 -0.985 . . . . 0.0 108.449 178.421 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -122.58 119.29 30.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.876 -1.14 . . . . 0.0 109.256 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.632 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -158.08 167.76 34.42 Favored Glycine 0 N--CA 1.487 2.092 0 C-N-CA 119.316 -1.421 . . . . 0.0 110.022 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.676 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 10.4 m-85 -73.61 133.03 43.4 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.57 -0.959 . . . . 0.0 110.009 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.516 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 4.0 pt -122.07 139.44 30.43 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.737 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 46.0 Cg_endo -68.6 145.77 65.12 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 121.878 1.719 . . . . 0.0 112.086 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.596 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 38.5 p -75.97 5.02 7.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.409 -0.807 . . . . 0.0 110.635 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.72 -53.1 2.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.912 -1.117 . . . . 0.0 110.613 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.608 ' CD2' ' HA ' ' A' ' 19' ' ' TYR . 4.0 m-85 -51.27 -60.73 2.8 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.116 -0.99 . . . . 0.0 110.788 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.555 HG13 ' CE ' ' A' ' 35' ' ' MET . 3.1 m -78.82 158.55 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 122.094 0.95 . . . . 0.0 111.302 -177.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.4 ' HB1' ' CD1' ' A' ' 16' ' ' LEU . . . -134.61 160.63 37.49 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.422 ' HA ' HG13 ' A' ' 13' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 O-C-N 120.916 -1.115 . . . . 0.0 109.422 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . 0.55 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 121.752 0.787 . . . . 0.0 109.558 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.767 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.9 Cg_endo -70.69 -174.57 1.12 Allowed 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.902 2.401 . . . . 0.0 111.485 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . 0.734 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.1 Cg_endo -92.19 -23.04 0.41 Allowed 'Trans proline' 0 C--O 1.213 -0.726 0 C-N-CA 122.956 2.437 . . . . 0.0 114.347 -177.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . 0.734 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 41.5 mtt180 78.41 95.62 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.001 -1.062 . . . . 0.0 109.197 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 42.4 Cg_endo -66.02 114.44 2.99 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.634 2.223 . . . . 0.0 111.735 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' B' ' 185' ' ' ASN . . . 56.15 50.81 12.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.423 -0.798 . . . . 0.0 109.584 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' B' ' 184' ' ' ALA . 9.5 m-80 60.26 45.82 10.94 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.155 -0.966 . . . . 0.0 109.426 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . 0.598 HD12 ' CG ' ' A' ' 41' ' ' HIS . 49.2 tp -65.36 -78.09 0.05 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.344 -0.848 . . . . 0.0 109.058 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . 0.676 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.485 1.939 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -112.07 137.24 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -0.962 . . . . 0.0 109.536 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.419 HG23 ' CG2' ' A' ' 37' ' ' VAL . 1.1 m -131.1 160.44 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.371 -0.831 . . . . 0.0 108.97 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.92 139.91 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.007 -1.058 . . . . 0.0 109.341 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.515 ' HB3' ' CD1' ' A' ' 29' ' ' PHE . . . -73.36 133.31 43.77 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.448 -0.783 . . . . 0.0 109.989 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.589 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 79.6 mt -99.55 -15.2 18.71 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.589 ' CE1' ' HB2' ' A' ' 16' ' ' LEU . 1.0 OUTLIER -155.96 154.07 26.96 Favored Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.448 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.696 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.6 Cg_endo -63.3 150.13 89.41 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 121.823 1.682 . . . . 0.0 110.276 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.769 ' O ' ' CB ' ' A' ' 20' ' ' ASP . 39.6 t80 -93.32 -33.01 14.07 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.068 -1.453 . . . . 0.0 110.541 -178.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.769 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 29.9 t0 107.57 -53.67 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.431 -0.793 . . . . 0.0 110.446 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.33 79.5 0.76 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.3 mt -97.66 -46.03 12.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.606 ' CD2' ' HD2' ' A' ' 24' ' ' PRO . 3.7 t60 -73.31 146.01 86.15 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.606 ' HD2' ' CD2' ' A' ' 23' ' ' HIS . 43.7 Cg_endo -66.28 -11.47 31.52 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 121.898 1.732 . . . . 0.0 111.342 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -114.1 -18.91 11.56 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.514 -0.741 . . . . 0.0 110.117 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.468 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.6 OUTLIER -57.81 144.23 39.31 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.004 -1.06 . . . . 0.0 109.919 -178.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.663 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.6 OUTLIER -91.23 118.47 30.5 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.178 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.568 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -83.28 145.04 29.32 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.597 -0.69 . . . . 0.0 109.153 179.266 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.746 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 18.7 p90 -148.15 160.75 42.58 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 11.6 mmtt -111.34 172.22 7.01 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.069 -1.02 . . . . 0.0 109.504 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.583 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -66.55 152.2 45.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.201 -0.937 . . . . 0.0 109.392 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 71.84 -8.01 6.6 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 31' ' ' LYS . 1.8 tt0 -76.58 142.05 40.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.018 -1.284 . . . . 0.0 109.785 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.3 138.89 33.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.892 . . . . 0.0 109.204 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.603 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 3.2 mpp? -136.11 152.32 50.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.644 -0.66 . . . . 0.0 109.662 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 3.7 ttpm? -109.62 126.19 53.37 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.48 -0.763 . . . . 0.0 109.503 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.419 ' CG2' HG23 ' A' ' 13' ' ' VAL . 2.2 t -82.13 129.39 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.389 -0.819 . . . . 0.0 109.003 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 mp -102.05 -44.18 5.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.113 -0.992 . . . . 0.0 109.785 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.1 103.51 3.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.164 -0.96 . . . . 0.0 109.085 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.59 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 1.8 tm-20 -81.08 127.31 32.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.357 -0.839 . . . . 0.0 109.656 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.574 ' CG ' HD12 ' B' ' 186' ' ' LEU . 63.9 m-70 -87.57 -105.56 0.07 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.348 -0.845 . . . . 0.0 109.182 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.469 ' O ' ' HG2' ' A' ' 43' ' ' GLU . . . -127.05 -19.83 1.91 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.581 ' HG3' ' CG ' ' B' ' 181' ' ' PRO . 1.1 mm-40 -157.24 -12.8 0.09 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.993 -1.298 . . . . 0.0 110.563 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 1.044 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 50.2 m95 -135.81 101.45 4.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.002 -1.061 . . . . 0.0 108.415 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.62 ' CZ2' ' CB ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -92.05 149.02 21.74 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.146 -0.971 . . . . 0.0 110.566 -178.849 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 4.9 tttt -92.9 107.28 19.1 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.91 -173.68 2.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.248 -0.908 . . . . 0.0 110.003 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 1.1 tttt -126.96 131.16 51.14 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.55 -0.719 . . . . 0.0 109.587 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.603 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 4.9 t -77.25 127.9 33.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.078 -1.014 . . . . 0.0 109.895 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.24 -6.66 44.57 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.239 -0.913 . . . . 0.0 108.55 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.0 tp -54.99 -55.61 28.9 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.345 -0.847 . . . . 0.0 109.228 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.613 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 2.7 t -160.13 28.57 0.17 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.244 -0.91 . . . . 0.0 110.157 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.613 ' HB2' ' O ' ' A' ' 52' ' ' THR . 0.1 OUTLIER 86.32 44.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.52 -0.738 . . . . 0.0 111.065 178.18 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.603 ' HB2' ' CB ' ' A' ' 49' ' ' SER . 1.6 mmpt? -86.61 131.99 34.01 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.15 119.27 30.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.934 -1.104 . . . . 0.0 109.577 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.663 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -159.81 170.5 36.0 Favored Glycine 0 N--CA 1.488 2.13 0 C-N-CA 119.54 -1.314 . . . . 0.0 109.914 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.612 ' CB ' ' HA3' ' B' ' 187' ' ' GLY . 5.2 m-85 -71.77 132.33 44.34 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.56 -0.965 . . . . 0.0 109.804 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.502 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 9.0 pt -121.12 142.55 35.15 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.629 ' HG3' ' CD2' ' B' ' 179' ' ' LEU . 48.6 Cg_endo -70.69 154.45 64.07 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 121.775 1.65 . . . . 0.0 112.226 -178.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.62 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 79.6 p -82.88 6.44 18.44 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -0.903 . . . . 0.0 109.692 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.639 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 9.2 p-10 -106.23 -52.56 2.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.034 -1.041 . . . . 0.0 110.96 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.64 ' CE2' ' CD2' ' B' ' 179' ' ' LEU . 2.9 m-85 -52.1 -61.97 1.93 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.175 -0.953 . . . . 0.0 111.071 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.603 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.7 m -80.48 156.28 4.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 122.034 0.921 . . . . 0.0 111.122 -177.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.411 ' HB1' ' CD1' ' A' ' 16' ' ' LEU . . . -132.83 159.07 40.88 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.063 -1.023 . . . . 0.0 109.479 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . 0.64 ' CD2' ' CE2' ' A' ' 62' ' ' TYR . 41.8 mt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 121.687 0.756 . . . . 0.0 109.957 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 1.044 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 41.4 Cg_endo -67.23 179.6 2.32 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 123.108 2.539 . . . . 0.0 111.269 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . 0.613 ' HD2' ' HB2' ' B' ' 180' ' ' PRO . 55.4 Cg_endo -75.74 -48.79 0.14 Allowed 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.697 2.264 . . . . 0.0 113.527 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . 0.652 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.0 OUTLIER 80.59 81.66 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.07 -1.019 . . . . 0.0 108.879 -178.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . 0.495 ' O ' ' C ' ' B' ' 184' ' ' ALA . 54.6 Cg_endo -74.06 141.64 29.93 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.784 2.323 . . . . 0.0 112.114 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 37.74 62.7 0.87 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.835 . . . . 0.0 109.688 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' B' ' 184' ' ' ALA . 0.4 OUTLIER 43.05 48.14 5.22 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -0.888 . . . . 0.0 109.197 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . 0.611 ' CD2' ' HB2' ' A' ' 44' ' ' TRP . 63.6 tp -64.54 -79.71 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.379 -0.826 . . . . 0.0 109.472 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . 0.612 ' HA3' ' CB ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.481 1.695 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.537 ' N ' ' HB ' ' A' ' 37' ' ' VAL . 9.5 m-20 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.425 0.631 . . . . 0.0 109.929 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 18.8 mm -71.86 133.26 32.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.427 -0.796 . . . . 0.0 109.843 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.485 HG21 HG21 ' A' ' 37' ' ' VAL . 1.7 m -131.65 161.47 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.469 HG22 ' HG3' ' A' ' 34' ' ' LYS . 9.9 p -120.28 138.1 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.854 -1.154 . . . . 0.0 109.475 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.496 ' HA ' HG13 ' A' ' 63' ' ' VAL . . . -71.87 133.9 45.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.44 -0.788 . . . . 0.0 110.225 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.49 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 20.7 mt -98.89 -12.38 20.8 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.587 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 39.9 m-85 -158.57 154.84 24.06 Favored Pre-proline 0 N--CA 1.487 1.386 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.67 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 41.2 Cg_endo -64.68 148.75 90.37 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 121.723 1.615 . . . . 0.0 109.721 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.778 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 51.7 t80 -97.68 177.12 5.59 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 118.188 -1.405 . . . . 0.0 110.388 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.683 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 4.3 t0 -109.8 79.07 1.18 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.673 -0.642 . . . . 0.0 109.655 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.69 86.37 0.01 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.601 ' N ' ' O ' ' A' ' 20' ' ' ASP . 40.7 mt -105.99 -0.5 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.057 -1.261 . . . . 0.0 109.63 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 -120.45 158.37 51.44 Favored Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.01 -18.54 46.21 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.178 1.919 . . . . 0.0 111.844 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -111.77 -13.56 13.69 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.501 -0.749 . . . . 0.0 110.45 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -57.68 139.11 54.56 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.838 -1.164 . . . . 0.0 109.52 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.666 ' CB ' ' HA2' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -96.59 121.53 38.52 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.312 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.65 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -80.25 140.91 36.02 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.369 -0.832 . . . . 0.0 109.796 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.778 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 30.7 p90 -145.62 157.55 43.96 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 108.576 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 2.8 mttm -110.49 173.44 6.33 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.033 -1.042 . . . . 0.0 109.596 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.552 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -66.99 151.75 47.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.198 -0.939 . . . . 0.0 109.32 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.54 -8.09 4.46 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 4.4 tt0 -75.13 143.29 43.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.973 -1.31 . . . . 0.0 109.559 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HG3' HG22 ' A' ' 14' ' ' VAL . 7.2 mtpp -97.21 138.93 33.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 109.799 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.581 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 2.5 mpp? -137.5 153.51 50.02 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 0.5 OUTLIER -106.64 129.19 54.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.454 -0.779 . . . . 0.0 109.287 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.537 ' HB ' ' N ' ' A' ' 11' ' ' ASP . 6.3 t -80.91 124.8 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.046 -1.034 . . . . 0.0 109.041 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 mt -101.62 -43.06 5.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.184 -0.948 . . . . 0.0 109.934 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.538 ' O ' ' CG ' ' A' ' 39' ' ' GLU . 1.2 pt-20 -145.58 97.57 3.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.133 -0.98 . . . . 0.0 109.306 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.592 ' HG3' ' CD1' ' A' ' 45' ' ' TRP . 3.5 tt0 -81.35 116.6 21.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.196 -0.94 . . . . 0.0 109.282 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.595 ' CG ' HD12 ' B' ' 186' ' ' LEU . 23.4 m-70 -85.0 -105.78 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.287 -0.883 . . . . 0.0 109.509 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.24 -16.59 1.71 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.492 ' HB2' ' HD3' ' B' ' 183' ' ' PRO . 16.6 mm-40 -153.92 -17.8 0.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.038 -1.272 . . . . 0.0 110.389 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.837 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 63.5 m95 -135.76 102.57 5.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.964 -1.085 . . . . 0.0 109.342 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.592 ' CD1' ' HG3' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -90.7 142.67 27.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.103 -0.998 . . . . 0.0 110.045 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.9 OUTLIER -91.84 105.77 17.96 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.063 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.81 -175.86 2.92 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.191 -0.943 . . . . 0.0 110.184 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -124.89 129.71 50.93 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.689 -0.632 . . . . 0.0 109.376 -179.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.607 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -74.77 125.83 29.61 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.097 -1.002 . . . . 0.0 109.943 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.27 -7.53 47.61 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.3 tp -53.78 -54.93 31.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.604 -0.685 . . . . 0.0 109.214 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.601 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 0.7 OUTLIER -161.38 29.54 0.13 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.264 -0.898 . . . . 0.0 109.994 179.672 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.601 ' CB ' ' O ' ' A' ' 52' ' ' THR . 5.7 mttp 86.45 44.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.454 -0.779 . . . . 0.0 110.423 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.607 ' HB2' ' HB3' ' A' ' 49' ' ' SER . 0.0 OUTLIER -85.94 132.46 34.07 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.335 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 20.0 pt-20 -122.84 120.32 33.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.933 -1.104 . . . . 0.0 109.103 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.666 ' HA2' ' CB ' ' A' ' 27' ' ' LEU . . . -162.58 165.72 36.33 Favored Glycine 0 N--CA 1.488 2.128 0 C-N-CA 119.105 -1.521 . . . . 0.0 110.253 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.634 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 8.5 m-85 -71.38 132.95 45.57 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.759 -0.847 . . . . 0.0 109.652 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.47 HD13 HG22 ' A' ' 63' ' ' VAL . 7.4 pt -121.91 143.14 37.87 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.734 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 44.2 Cg_endo -67.66 153.77 75.18 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.701 1.601 . . . . 0.0 111.614 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.528 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 65.5 p -82.71 6.77 16.91 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 110.783 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -110.31 -52.86 2.74 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.741 -1.224 . . . . 0.0 110.637 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.587 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 5.1 m-85 -49.08 -63.15 1.19 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.094 -1.004 . . . . 0.0 110.938 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.581 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 3.3 m -78.85 155.01 4.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 122.027 0.918 . . . . 0.0 110.935 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.44 ' HB1' HD22 ' A' ' 16' ' ' LEU . . . -133.14 161.53 34.17 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.3 mttt . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.093 -1.004 . . . . 0.0 109.479 179.895 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . 0.578 ' CD2' ' CE1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.712 0.768 . . . . 0.0 109.622 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.837 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.4 Cg_endo -69.92 -175.0 1.05 Allowed 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.963 2.442 . . . . 0.0 111.457 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . 0.715 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.6 Cg_endo -91.31 -25.31 0.34 Allowed 'Trans proline' 0 C--O 1.213 -0.76 0 C-N-CA 122.856 2.371 . . . . 0.0 114.531 -177.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . 0.715 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 39.4 mtt180 78.71 94.33 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 120.942 -1.098 . . . . 0.0 109.2 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . 0.572 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 46.3 Cg_endo -67.58 118.5 5.64 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.664 2.243 . . . . 0.0 111.75 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . 53.83 57.59 5.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.255 -0.903 . . . . 0.0 109.3 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . 0.434 ' N ' ' ND2' ' B' ' 185' ' ' ASN . 1.1 m120 51.09 50.75 18.43 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.319 -0.863 . . . . 0.0 109.414 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . 0.595 HD12 ' CG ' ' A' ' 41' ' ' HIS . 62.0 tp -71.72 -80.54 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.306 -0.871 . . . . 0.0 109.508 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . 0.634 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.486 1.98 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.439 ' O ' HG22 ' A' ' 37' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.445 HG22 HD11 ' A' ' 12' ' ' ILE . 25.5 mm -100.89 137.0 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.163 -0.96 . . . . 0.0 109.553 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.17 161.76 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.463 -0.773 . . . . 0.0 108.951 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.413 HG11 ' O ' ' A' ' 14' ' ' VAL . 6.7 p -121.23 139.06 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.006 -1.059 . . . . 0.0 109.317 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -71.08 133.68 46.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.364 -0.835 . . . . 0.0 109.697 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.574 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 55.7 mt -99.12 -12.86 20.11 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.575 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 34.3 m-85 -158.35 154.19 23.15 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.677 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 42.0 Cg_endo -64.36 149.07 90.79 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 121.662 1.575 . . . . 0.0 110.055 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.814 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 54.2 t80 -97.86 177.93 5.29 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.324 -1.35 . . . . 0.0 110.405 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.686 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 0.7 OUTLIER -109.01 80.58 1.33 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.498 -0.751 . . . . 0.0 109.303 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.45 94.68 0.05 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 20' ' ' ASP . 18.1 mm -108.19 -42.02 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.303 -1.116 . . . . 0.0 108.807 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -77.45 158.15 79.36 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.89 -13.77 34.78 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.232 1.955 . . . . 0.0 111.811 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.74 -14.35 13.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.258 -0.902 . . . . 0.0 110.525 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.61 138.69 55.02 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.873 -1.142 . . . . 0.0 109.864 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.683 HD23 ' N ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -93.87 120.76 34.56 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.041 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.683 ' N ' HD23 ' A' ' 27' ' ' LEU . 10.1 p -79.92 140.74 36.57 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.365 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.814 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 21.9 p90 -145.94 157.66 43.88 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.14 -0.975 . . . . 0.0 108.535 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -110.81 173.16 6.46 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.153 -0.967 . . . . 0.0 109.51 -179.44 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.564 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 7.8 pttm -67.09 152.02 46.54 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.183 -0.948 . . . . 0.0 109.38 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.42 -8.18 4.26 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -75.5 143.4 42.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.936 -1.332 . . . . 0.0 109.709 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.419 ' HB2' HD11 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -96.61 137.84 35.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 0.0 109.418 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.604 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 2.4 mpp? -135.01 151.79 51.13 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.492 0.663 . . . . 0.0 109.669 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 4.0 mttm -108.95 127.01 53.69 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.426 -0.797 . . . . 0.0 109.407 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 11' ' ' ASP . 0.4 OUTLIER -81.57 143.58 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.397 -0.814 . . . . 0.0 108.958 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.528 HD11 ' N ' ' A' ' 38' ' ' LEU . 7.8 mp -119.69 -40.89 2.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.064 -1.022 . . . . 0.0 109.833 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -140.38 92.13 2.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.16 -0.962 . . . . 0.0 108.96 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.576 ' HG2' ' CG ' ' A' ' 45' ' ' TRP . 1.9 mt-10 -74.09 120.37 19.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.479 -0.763 . . . . 0.0 109.536 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.578 ' CG ' HD12 ' B' ' 186' ' ' LEU . 47.7 m-70 -92.28 -106.49 0.11 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.235 -0.915 . . . . 0.0 109.555 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.36 -16.66 1.17 Allowed Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.179 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.486 ' HG2' ' HD2' ' B' ' 181' ' ' PRO . 0.5 OUTLIER -154.21 -17.04 0.13 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.968 -1.313 . . . . 0.0 110.351 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.812 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 59.8 m95 -136.97 101.73 4.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.038 -1.039 . . . . 0.0 109.155 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.6 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -91.07 139.57 30.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.904 -1.122 . . . . 0.0 109.992 -179.679 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.7 OUTLIER -86.13 107.41 17.84 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -102.26 -177.86 3.53 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.289 -0.882 . . . . 0.0 110.233 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 9.8 tttm -123.45 107.97 12.17 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.605 ' N ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -54.1 127.02 24.95 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.11 -0.994 . . . . 0.0 109.925 -179.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 52' ' ' THR . 3.7 mt -75.84 -11.2 59.93 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.464 ' O ' ' CB ' ' A' ' 52' ' ' THR . 22.4 tp -46.05 -20.89 0.11 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.719 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 0.6 OUTLIER 168.15 -21.47 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.392 -0.817 . . . . 0.0 109.851 179.151 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.719 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 140.55 42.61 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.536 -0.727 . . . . 0.0 109.972 179.629 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.605 ' O ' ' N ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -85.37 134.64 34.08 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.085 -1.01 . . . . 0.0 108.505 178.419 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.5 114.33 20.53 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.047 -1.033 . . . . 0.0 109.359 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.617 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -155.52 168.85 33.29 Favored Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.416 -1.373 . . . . 0.0 109.959 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.643 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 8.9 m-85 -71.41 131.93 44.08 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.574 -0.957 . . . . 0.0 109.656 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.532 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 5.2 pt -120.86 139.63 29.42 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.701 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 46.8 Cg_endo -69.14 158.74 56.59 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 121.671 1.581 . . . . 0.0 111.948 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.515 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 79.5 p -86.44 7.08 27.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.334 -0.853 . . . . 0.0 110.387 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.28 -53.77 2.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.903 -1.123 . . . . 0.0 110.441 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.575 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 2.8 m-85 -47.93 -63.38 1.08 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.133 -0.979 . . . . 0.0 111.115 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.604 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 3.0 m -78.53 155.0 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.929 . . . . 0.0 110.968 -177.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.474 ' CB ' ' CD1' ' A' ' 16' ' ' LEU . . . -134.8 162.67 31.71 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.4 pttm . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.044 -1.035 . . . . 0.0 109.251 179.747 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . 0.605 ' CD2' ' CE1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 121.697 0.76 . . . . 0.0 109.761 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.812 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.7 Cg_endo -69.34 -173.43 0.66 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 123.049 2.499 . . . . 0.0 111.484 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . 0.752 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 53.1 Cg_endo -92.95 -26.5 0.18 Allowed 'Trans proline' 0 C--O 1.213 -0.732 0 C-N-CA 122.95 2.433 . . . . 0.0 114.441 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . 0.752 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 43.3 mtt180 80.99 95.02 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.076 -1.015 . . . . 0.0 109.059 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 49.2 Cg_endo -69.98 135.98 31.29 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.745 2.297 . . . . 0.0 111.865 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 41.61 57.79 2.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 0.0 109.367 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 49.13 48.96 20.31 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.228 -0.92 . . . . 0.0 109.288 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . 0.585 ' CD2' ' HB2' ' A' ' 44' ' ' TRP . 48.4 tp -67.43 -87.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.408 -0.808 . . . . 0.0 109.319 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . 0.643 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.486 2.014 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.5 tp -99.23 138.84 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.164 -0.96 . . . . 0.0 109.451 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.486 ' CG2' HG21 ' A' ' 37' ' ' VAL . 0.8 OUTLIER -131.2 160.36 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.333 -0.855 . . . . 0.0 109.007 -179.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.455 HG21 ' O ' ' A' ' 33' ' ' GLU . 14.0 p -120.5 138.98 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.017 -1.052 . . . . 0.0 109.353 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -72.53 134.81 45.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.411 -0.806 . . . . 0.0 109.842 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.602 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 69.4 mt -99.85 -22.4 15.33 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 16' ' ' LEU . 32.3 m-85 -147.48 153.1 43.41 Favored Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.653 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.7 Cg_endo -63.21 149.67 90.73 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 121.845 1.697 . . . . 0.0 110.089 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.806 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 57.0 t80 -98.81 178.73 4.88 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.268 -1.373 . . . . 0.0 110.524 -177.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.686 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -109.96 80.38 1.31 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.01 95.89 0.06 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 20' ' ' ASP . 75.9 mt -108.8 -42.21 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.117 -1.226 . . . . 0.0 108.86 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.471 ' HB2' ' CG ' ' A' ' 26' ' ' ASP . 88.5 m-70 -76.81 157.87 81.29 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.59 -12.74 33.88 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.129 1.886 . . . . 0.0 111.657 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -112.92 -14.51 13.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.894 . . . . 0.0 110.64 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.471 ' CG ' ' HB2' ' A' ' 23' ' ' HIS . 79.9 m-20 -57.53 139.81 52.42 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.762 -1.212 . . . . 0.0 109.783 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.66 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.4 OUTLIER -95.1 121.53 36.83 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.159 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.539 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -80.07 140.49 36.46 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.448 -0.783 . . . . 0.0 109.491 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.806 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 25.7 p90 -145.39 156.95 44.09 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.163 -0.961 . . . . 0.0 108.676 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -110.64 173.32 6.39 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.151 -0.968 . . . . 0.0 109.596 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.542 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -67.26 151.49 47.41 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.186 -0.946 . . . . 0.0 109.322 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 71.51 -8.19 5.8 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.455 ' O ' HG21 ' A' ' 14' ' ' VAL . 0.9 OUTLIER -75.69 142.93 42.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.934 -1.333 . . . . 0.0 109.839 -179.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.434 ' HB3' HD11 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -97.0 138.94 33.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 109.456 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.597 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 2.5 mpp? -135.49 151.62 50.54 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.577 -0.702 . . . . 0.0 109.82 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 82.4 tttt -105.29 123.24 47.52 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.424 -0.798 . . . . 0.0 109.428 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.486 HG21 ' CG2' ' A' ' 13' ' ' VAL . 2.0 t -81.82 115.96 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.362 -0.836 . . . . 0.0 109.052 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.402 HD13 ' N ' ' A' ' 38' ' ' LEU . 9.3 mp -92.01 -39.65 11.54 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.085 -1.01 . . . . 0.0 109.887 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -142.29 102.65 4.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.102 -0.999 . . . . 0.0 109.06 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.563 ' HG3' ' CG ' ' A' ' 45' ' ' TRP . 1.0 OUTLIER -85.41 118.53 25.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.391 -0.818 . . . . 0.0 109.498 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.605 ' CG ' HD12 ' B' ' 186' ' ' LEU . 68.3 m-70 -89.26 -103.13 0.09 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.287 -0.883 . . . . 0.0 109.367 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.44 ' O ' ' CD ' ' A' ' 43' ' ' GLU . . . -138.71 -13.71 0.71 Allowed Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.426 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.534 ' HG2' ' HD2' ' B' ' 181' ' ' PRO . 0.6 OUTLIER -155.57 -20.95 0.11 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.832 -1.393 . . . . 0.0 110.584 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.798 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 58.9 m95 -136.47 95.27 3.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.874 -1.142 . . . . 0.0 109.047 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.568 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -87.03 141.46 28.65 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.992 -1.067 . . . . 0.0 110.492 -179.184 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.8 OUTLIER -87.1 106.74 18.07 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -104.32 -173.23 2.26 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.287 -0.883 . . . . 0.0 110.179 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 4.3 tttp -127.28 131.37 50.53 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.5 -0.75 . . . . 0.0 109.452 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.65 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 1.3 t -77.17 128.09 33.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.002 -1.061 . . . . 0.0 109.885 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.434 HD11 ' HB3' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -71.87 -7.68 49.87 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 51' ' ' LEU . 9.4 tp -53.7 -55.8 22.95 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.35 -0.844 . . . . 0.0 109.348 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.623 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.4 t -160.69 28.42 0.15 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.229 -0.92 . . . . 0.0 110.149 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.623 ' CB ' ' O ' ' A' ' 52' ' ' THR . 31.0 mtmt 86.8 44.5 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.444 -0.785 . . . . 0.0 111.122 178.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.65 ' HB2' ' CB ' ' A' ' 49' ' ' SER . 0.1 OUTLIER -87.67 131.95 34.27 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 8.9 pt-20 -121.83 120.66 35.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.932 -1.105 . . . . 0.0 109.641 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.66 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -158.37 168.94 34.82 Favored Glycine 0 N--CA 1.487 2.1 0 C-N-CA 119.539 -1.315 . . . . 0.0 109.887 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.755 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 11.5 m-85 -71.27 133.71 46.27 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.546 -0.973 . . . . 0.0 109.884 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.562 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 2.9 pt -122.31 142.37 36.8 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.659 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 47.8 Cg_endo -70.85 159.41 52.69 Favored 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 121.562 1.508 . . . . 0.0 111.818 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.513 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 90.3 p -87.31 7.2 29.78 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 110.073 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.97 -54.86 2.44 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.006 -1.059 . . . . 0.0 110.351 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.539 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 3.5 m-85 -48.6 -63.28 1.13 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.167 -0.958 . . . . 0.0 111.151 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.597 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.9 m -79.8 155.9 4.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.995 0.902 . . . . 0.0 111.133 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.46 ' CB ' HD13 ' A' ' 16' ' ' LEU . . . -132.3 160.47 36.15 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 O-C-N 120.999 -1.063 . . . . 0.0 109.463 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . 0.645 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 121.668 0.747 . . . . 0.0 109.589 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.798 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 39.3 Cg_endo -67.96 -174.48 0.62 Allowed 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 123.042 2.494 . . . . 0.0 112.075 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . 0.617 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.6 Cg_endo -92.78 -29.0 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 123.252 2.635 . . . . 0.0 114.213 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . 0.742 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.1 OUTLIER 84.23 104.95 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.162 -0.961 . . . . 0.0 109.877 -179.323 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . 0.645 ' HG2' ' HB2' ' B' ' 186' ' ' LEU . 44.7 Cg_endo -69.29 124.94 11.79 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 123.022 2.481 . . . . 0.0 111.998 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 40.44 69.27 0.33 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.36 -0.838 . . . . 0.0 109.567 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . 0.454 ' C ' ' O ' ' B' ' 184' ' ' ALA . 0.0 OUTLIER 42.06 47.22 3.83 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.289 -0.882 . . . . 0.0 109.413 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . 0.645 ' HB2' ' HG2' ' B' ' 183' ' ' PRO . 31.6 tp -56.19 -94.81 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . 0.755 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.526 HG22 HD11 ' A' ' 12' ' ' ILE . 21.6 mm -119.03 138.32 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.18 -0.95 . . . . 0.0 109.587 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.461 HG21 ' CG2' ' A' ' 37' ' ' VAL . 0.8 OUTLIER -132.21 161.91 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 p -120.83 140.45 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.936 -1.102 . . . . 0.0 109.463 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.508 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -72.79 133.87 44.69 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.336 -0.853 . . . . 0.0 109.566 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.584 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 84.3 mt -99.88 -15.51 18.35 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 16' ' ' LEU . 3.5 m-85 -156.32 154.71 27.78 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.684 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.2 Cg_endo -63.45 149.05 92.13 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 121.903 1.735 . . . . 0.0 110.448 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.812 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 50.9 t80 -98.46 178.7 4.94 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.438 -1.305 . . . . 0.0 110.367 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.694 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 0.5 OUTLIER -109.66 80.65 1.34 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.631 -0.668 . . . . 0.0 109.291 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.95 94.58 0.05 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 20' ' ' ASP . 17.1 mm -108.28 -41.92 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.089 -1.242 . . . . 0.0 108.902 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.439 ' HB2' ' CG ' ' A' ' 26' ' ' ASP . 20.5 m-70 -77.54 157.75 79.62 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.54 -13.32 35.03 Favored 'Trans proline' 0 C--O 1.213 -0.75 0 C-N-CA 122.271 1.981 . . . . 0.0 111.921 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 1.0 OUTLIER -112.11 -13.9 13.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.253 -0.904 . . . . 0.0 110.673 -179.069 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.439 ' CG ' ' HB2' ' A' ' 23' ' ' HIS . 84.4 m-20 -57.97 139.74 53.77 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.819 -1.176 . . . . 0.0 109.94 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.656 HD23 ' N ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -94.74 120.9 35.71 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.656 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -79.19 140.25 37.77 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.263 -0.898 . . . . 0.0 109.277 179.723 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.812 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 23.5 p90 -145.2 156.8 44.07 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.098 -1.001 . . . . 0.0 108.701 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 5.6 ptmt -110.81 173.24 6.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 109.319 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.565 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -66.59 151.96 46.27 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.983 -1.073 . . . . 0.0 109.482 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 71.76 -7.39 7.2 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.574 ' HB2' ' HG2' ' A' ' 30' ' ' LYS . 5.0 tp10 -76.15 142.62 41.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.892 -1.357 . . . . 0.0 109.944 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.456 ' HD2' HG23 ' A' ' 12' ' ' ILE . 1.4 ttpt -97.28 139.52 33.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.886 . . . . 0.0 109.382 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.563 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 2.0 mpp? -135.1 151.48 50.77 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.441 0.639 . . . . 0.0 109.735 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.615 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -104.39 123.47 47.49 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.546 -0.722 . . . . 0.0 109.163 179.797 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.461 ' CG2' HG21 ' A' ' 13' ' ' VAL . 2.2 t -81.43 114.1 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.29 -0.881 . . . . 0.0 109.088 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 36' ' ' LYS . 6.3 mp -90.23 -44.17 9.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 109.656 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -143.08 97.46 3.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.932 . . . . 0.0 108.921 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.576 ' HG3' ' CD1' ' A' ' 45' ' ' TRP . 3.3 tt0 -83.72 116.67 22.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.34 -0.85 . . . . 0.0 109.588 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.563 ' CG ' HD12 ' B' ' 186' ' ' LEU . 4.0 m-70 -78.27 -95.83 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.319 -0.863 . . . . 0.0 109.228 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.46 ' O ' ' CD ' ' A' ' 43' ' ' GLU . . . -148.38 -13.05 0.13 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.383 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.582 ' HB3' ' HD2' ' B' ' 181' ' ' PRO . 6.5 mm-40 -148.69 -26.38 0.31 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.969 -1.312 . . . . 0.0 110.008 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.921 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 47.8 m95 -134.02 102.26 5.35 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.17 -0.956 . . . . 0.0 108.768 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.636 ' CZ2' ' CB ' ' A' ' 60' ' ' SER . 0.1 OUTLIER -90.02 147.17 23.83 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.092 -1.005 . . . . 0.0 110.398 -179.129 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.577 ' HG3' ' CD1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -96.06 108.2 20.6 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -105.65 -172.89 2.18 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 110.346 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -125.56 127.11 45.86 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.609 -0.682 . . . . 0.0 109.266 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.597 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -70.82 126.06 28.54 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.183 -0.948 . . . . 0.0 109.835 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.449 HD12 ' HG2' ' A' ' 34' ' ' LYS . 1.6 mp -72.18 -7.97 52.14 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.4 tp -54.25 -54.83 34.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.528 -0.733 . . . . 0.0 109.17 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.6 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 1.3 t -161.06 30.08 0.14 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.173 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.6 ' HB2' ' O ' ' A' ' 52' ' ' THR . 38.3 mmtt 85.78 45.49 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.499 -0.751 . . . . 0.0 110.661 178.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 49' ' ' SER . 0.8 OUTLIER -87.05 132.29 33.85 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.137 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.477 ' CG ' ' HE3' ' A' ' 46' ' ' LYS . 15.4 tt0 -121.72 117.35 26.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.876 -1.14 . . . . 0.0 109.57 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.623 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -158.42 168.62 34.78 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.44 -1.362 . . . . 0.0 110.015 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.835 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 12.5 m-85 -73.66 135.15 43.72 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.679 -0.895 . . . . 0.0 110.16 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.448 HD12 ' HB2' ' A' ' 47' ' ' ALA . 7.4 pt -122.39 139.34 30.61 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.581 ' HB2' ' CD ' ' B' ' 180' ' ' PRO . 52.3 Cg_endo -72.6 131.96 18.14 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 121.519 1.479 . . . . 0.0 112.014 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.636 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 53.7 p -62.88 3.68 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.39 -0.819 . . . . 0.0 110.542 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.637 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 6.5 p-10 -98.36 -52.42 3.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.797 -1.189 . . . . 0.0 110.62 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.656 ' CE2' ' CD2' ' B' ' 179' ' ' LEU . 4.0 m-85 -57.28 -59.25 5.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.113 -0.992 . . . . 0.0 111.176 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.563 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 3.2 m -79.78 159.9 4.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 122.024 0.916 . . . . 0.0 111.235 -177.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.499 ' CB ' HD12 ' A' ' 16' ' ' LEU . . . -133.93 157.83 45.01 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.053 -1.029 . . . . 0.0 109.562 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . 0.656 ' CD2' ' CE2' ' A' ' 62' ' ' TYR . 74.5 mt . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 121.483 0.659 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.921 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.8 Cg_endo -67.67 176.91 4.54 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.566 2.178 . . . . 0.0 111.5 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . 0.619 ' O ' ' CB ' ' B' ' 182' ' ' ARG . 56.1 Cg_endo -81.36 -37.57 0.28 Allowed 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.822 2.348 . . . . 0.0 114.029 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . 0.703 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.4 OUTLIER 82.22 98.02 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 120.997 -1.065 . . . . 0.0 109.295 -179.006 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . 0.64 ' HD2' HD21 ' B' ' 186' ' ' LEU . 45.4 Cg_endo -69.61 130.76 20.09 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 123.206 2.604 . . . . 0.0 112.329 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.509 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 35.63 72.89 0.09 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.436 -0.79 . . . . 0.0 109.821 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . 0.464 ' C ' ' O ' ' B' ' 184' ' ' ALA . 0.7 OUTLIER 40.59 45.34 1.96 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.37 -0.831 . . . . 0.0 109.438 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . 0.64 HD21 ' HD2' ' B' ' 183' ' ' PRO . 34.4 tp -54.6 -94.54 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . 0.835 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.486 1.988 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.455 ' O ' HG22 ' A' ' 37' ' ' VAL . 2.6 m-20 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.531 ' CD1' ' HG2' ' A' ' 36' ' ' LYS . 2.5 tp -91.02 138.64 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 0.0 109.663 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.462 HG21 HG21 ' A' ' 37' ' ' VAL . 1.9 m -131.01 160.75 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.407 -0.808 . . . . 0.0 108.908 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 33' ' ' GLU . 9.8 p -120.39 138.62 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.079 -1.013 . . . . 0.0 109.283 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.524 ' HB3' ' CD1' ' A' ' 29' ' ' PHE . . . -71.4 133.35 45.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.41 -0.806 . . . . 0.0 110.101 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.457 ' CD1' ' HB3' ' A' ' 64' ' ' ALA . 14.7 mt -98.59 -15.2 19.57 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.546 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 53.3 m-85 -155.0 153.87 27.99 Favored Pre-proline 0 N--CA 1.486 1.374 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 41.4 Cg_endo -64.48 149.59 89.72 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 121.75 1.633 . . . . 0.0 109.805 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.788 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 59.1 t80 -98.89 179.25 4.7 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.102 -1.439 . . . . 0.0 110.346 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.682 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 73.5 m-20 -110.37 80.78 1.34 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.525 -0.735 . . . . 0.0 109.303 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.82 94.95 0.05 OUTLIER Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 20' ' ' ASP . 69.0 mt -108.74 -41.54 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -1.173 . . . . 0.0 108.895 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.562 ' CD2' ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -78.14 158.81 76.7 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.103 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.562 ' HD2' ' CD2' ' A' ' 23' ' ' HIS . 48.5 Cg_endo -69.67 -13.85 35.51 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.24 1.96 . . . . 0.0 111.91 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 4.4 t70 -112.28 -13.86 13.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 110.799 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.465 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.5 OUTLIER -57.84 139.6 53.75 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.74 -1.225 . . . . 0.0 109.817 -179.282 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.64 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.3 OUTLIER -95.33 121.37 36.91 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.148 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.628 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -79.44 139.98 37.5 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.338 -0.851 . . . . 0.0 109.439 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.788 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 32.6 p90 -145.2 157.09 44.17 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.19 -0.944 . . . . 0.0 108.711 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 1.4 tttt -110.56 172.95 6.56 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.492 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -66.77 151.88 46.59 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.216 -0.927 . . . . 0.0 109.343 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.7 -7.95 4.77 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.447 ' O ' HG21 ' A' ' 14' ' ' VAL . 5.7 tt0 -75.88 143.6 41.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.957 -1.32 . . . . 0.0 109.765 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.446 ' HD2' HD23 ' A' ' 50' ' ' LEU . 1.1 ptpt -96.97 139.63 32.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.307 -0.871 . . . . 0.0 109.398 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.59 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 3.4 mpp? -134.52 150.89 50.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.627 -0.671 . . . . 0.0 109.841 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 30.5 mtpt -102.55 123.08 45.64 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.455 -0.778 . . . . 0.0 109.42 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.462 HG21 HG21 ' A' ' 13' ' ' VAL . 3.1 t -81.14 134.71 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.166 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.4 mt -110.99 -43.3 3.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.144 -0.973 . . . . 0.0 109.703 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -149.2 93.13 2.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.178 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.646 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.1 tt0 -78.24 116.24 18.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.331 -0.855 . . . . 0.0 109.326 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.513 ' HB2' HD22 ' B' ' 186' ' ' LEU . 5.7 m-70 -79.81 -100.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.301 -0.874 . . . . 0.0 109.481 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.06 -11.63 1.04 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.693 -1.242 . . . . 0.0 110.114 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.531 ' O ' ' HG3' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -156.48 -19.15 0.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.061 -1.258 . . . . 0.0 110.594 -179.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.784 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 66.2 m95 -136.49 99.02 3.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.882 -1.136 . . . . 0.0 109.427 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.646 ' CD1' ' CG ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -89.17 142.14 27.91 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.005 -1.059 . . . . 0.0 110.037 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -92.03 107.0 18.89 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.121 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.29 -174.78 2.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.858 . . . . 0.0 110.238 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 27.1 ttmt -124.98 111.4 15.36 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.675 -0.641 . . . . 0.0 109.277 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.627 ' N ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -56.01 126.35 25.52 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.23 -0.919 . . . . 0.0 109.776 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -75.66 -11.25 59.97 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.129 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.474 ' O ' ' CB ' ' A' ' 52' ' ' THR . 1.5 tp -46.19 -20.9 0.12 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.724 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 0.5 OUTLIER 168.02 -21.87 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.009 179.148 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.724 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 140.93 41.89 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.431 -0.793 . . . . 0.0 110.18 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.627 ' O ' ' N ' ' A' ' 49' ' ' SER . 3.6 mtmt -87.22 134.4 33.54 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.046 -1.034 . . . . 0.0 108.375 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.401 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -122.45 119.1 29.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.95 -1.093 . . . . 0.0 109.48 -179.609 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.64 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -159.87 168.92 35.73 Favored Glycine 0 N--CA 1.486 2.027 0 C-N-CA 119.365 -1.398 . . . . 0.0 110.124 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.725 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 10.4 m-85 -72.92 133.66 44.45 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.636 -0.92 . . . . 0.0 109.929 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.483 ' O ' HG13 ' A' ' 58' ' ' ILE . 7.8 pt -121.89 140.8 32.7 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.699 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 48.4 Cg_endo -69.56 140.53 43.67 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 121.676 1.584 . . . . 0.0 111.976 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.612 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 32.6 p -71.43 5.42 2.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.344 -0.847 . . . . 0.0 110.68 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.34 -53.28 2.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.794 -1.192 . . . . 0.0 110.58 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.546 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 3.4 m-85 -50.99 -61.76 2.03 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.09 -1.006 . . . . 0.0 111.012 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.59 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 3.4 m -78.04 156.22 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.948 0.88 . . . . 0.0 111.235 -177.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.457 ' HB3' ' CD1' ' A' ' 16' ' ' LEU . . . -131.22 160.05 36.0 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.456 ' HA ' HG11 ' A' ' 13' ' ' VAL . 9.1 mttt . . . . . 0 N--CA 1.49 1.557 0 O-C-N 120.994 -1.066 . . . . 0.0 109.792 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . 0.602 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.705 0.764 . . . . 0.0 109.628 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.784 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 39.1 Cg_endo -69.58 -176.04 1.31 Allowed 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.111 2.54 . . . . 0.0 111.917 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . 0.623 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 53.7 Cg_endo -90.33 -22.54 0.74 Allowed 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 123.075 2.517 . . . . 0.0 114.697 -177.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . 0.726 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.8 OUTLIER 77.5 91.26 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 120.772 -1.205 . . . . 0.0 109.237 -179.331 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . 0.525 ' HD2' HD21 ' B' ' 186' ' ' LEU . 50.7 Cg_endo -70.79 134.99 26.98 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.907 2.404 . . . . 0.0 112.029 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 39.27 64.81 0.76 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.328 -0.858 . . . . 0.0 109.625 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . 0.428 ' C ' ' O ' ' B' ' 184' ' ' ALA . 3.1 m-80 43.86 49.73 7.01 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.34 -0.85 . . . . 0.0 109.476 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . 0.573 ' CG ' ' HB2' ' A' ' 44' ' ' TRP . 35.3 tp -66.32 -87.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.321 -0.862 . . . . 0.0 109.34 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . 0.725 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.486 1.979 0 N-CA-C 108.816 -1.713 . . . . 0.0 108.816 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.444 HD13 ' HA ' ' A' ' 36' ' ' LYS . 2.6 tp -111.99 137.08 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 109.529 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.4 m -132.83 161.79 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.385 -0.822 . . . . 0.0 109.161 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.7 p -120.26 138.84 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.97 -1.081 . . . . 0.0 109.219 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -71.64 133.65 45.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.327 -0.858 . . . . 0.0 109.896 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.571 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 25.4 mt -99.09 -12.1 20.83 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.576 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 39.5 m-85 -158.63 155.07 24.4 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.658 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 42.2 Cg_endo -64.71 149.04 90.35 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 121.761 1.641 . . . . 0.0 109.887 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.807 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 59.9 t80 -98.82 178.86 4.84 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 118.373 -1.331 . . . . 0.0 110.415 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.671 ' OD1' ' CZ ' ' A' ' 19' ' ' TYR . 6.2 p30 -110.21 80.29 1.3 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.584 -0.698 . . . . 0.0 109.522 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.61 95.86 0.05 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 20' ' ' ASP . 0.5 OUTLIER -108.96 -41.78 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.243 -1.151 . . . . 0.0 108.859 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -77.72 159.41 76.69 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.33 -13.79 33.62 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.195 1.93 . . . . 0.0 111.804 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -112.37 -14.29 13.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.143 -0.973 . . . . 0.0 110.758 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.434 ' OD2' ' NH2' ' B' ' 182' ' ' ARG . 2.1 m-20 -57.32 139.06 53.99 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.825 -1.172 . . . . 0.0 109.646 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.651 HD23 ' N ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -94.66 121.26 36.05 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.113 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.651 ' N ' HD23 ' A' ' 27' ' ' LEU . 55.9 p -80.26 140.59 36.15 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.265 -0.897 . . . . 0.0 109.427 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.807 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 23.4 p90 -146.06 157.87 43.86 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.145 -0.972 . . . . 0.0 108.875 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -111.07 168.06 9.78 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.122 -0.987 . . . . 0.0 109.453 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.549 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -62.23 153.63 29.92 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.135 -0.978 . . . . 0.0 109.628 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.69 -8.11 3.5 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 5.2 tt0 -75.65 142.61 42.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.979 -1.307 . . . . 0.0 109.912 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -96.2 139.28 32.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.227 -0.921 . . . . 0.0 109.312 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.6 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 2.6 mpp? -135.28 151.44 50.57 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.606 -0.684 . . . . 0.0 109.919 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 5.8 tppp? -105.07 124.13 49.0 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.533 -0.729 . . . . 0.0 109.186 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.7 t -81.03 132.73 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.855 . . . . 0.0 109.291 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.7 mt -107.7 -47.43 3.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.152 -0.968 . . . . 0.0 109.63 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -142.42 97.47 3.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.943 . . . . 0.0 108.936 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.594 ' HG2' ' CD1' ' A' ' 45' ' ' TRP . 2.3 tm-20 -84.17 116.66 23.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.359 -0.838 . . . . 0.0 109.653 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.575 ' CG ' HD12 ' B' ' 186' ' ' LEU . 7.1 m-70 -80.58 -98.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.433 -0.792 . . . . 0.0 109.458 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.26 -11.36 0.67 Allowed Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.32 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.547 ' O ' ' HG3' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -156.85 -18.78 0.09 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.879 -1.365 . . . . 0.0 110.413 -179.692 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.844 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 67.2 m95 -135.78 96.17 3.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.902 -1.124 . . . . 0.0 109.124 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.622 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -88.21 145.27 25.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.022 -1.049 . . . . 0.0 110.119 -179.253 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.6 OUTLIER -93.7 107.43 19.31 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.219 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -104.55 -173.96 2.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.296 -0.878 . . . . 0.0 110.094 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 2.7 ttpm? -125.46 126.84 45.56 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.59 -0.694 . . . . 0.0 109.459 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.602 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -70.92 126.5 29.74 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.111 -0.993 . . . . 0.0 110.03 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.24 -7.47 49.52 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.8 tp -54.49 -55.05 33.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.503 -0.748 . . . . 0.0 109.253 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.5 t -161.16 29.69 0.14 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.122 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.587 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 86.36 45.85 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.482 -0.761 . . . . 0.0 110.671 178.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.602 ' HB2' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER -86.94 132.3 33.84 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.068 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.465 ' HG2' ' CE ' ' A' ' 46' ' ' LYS . 20.2 tt0 -121.59 116.38 24.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.942 -1.099 . . . . 0.0 109.353 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.607 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -157.13 169.26 34.19 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 119.385 -1.388 . . . . 0.0 110.032 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.7 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 11.0 m-85 -73.55 133.91 43.67 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.625 -0.926 . . . . 0.0 109.958 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 45' ' ' TRP . 2.6 pt -121.68 142.51 36.04 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.646 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 49.6 Cg_endo -69.93 152.0 68.3 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 121.792 1.661 . . . . 0.0 111.816 -178.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.543 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 66.1 p -80.81 5.67 15.27 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 110.006 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 4.4 p-10 -106.01 -52.48 2.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.997 -1.065 . . . . 0.0 110.941 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.576 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 4.5 m-85 -52.63 -61.28 2.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.099 -1.001 . . . . 0.0 111.263 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.6 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.6 m -79.83 155.49 4.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 122.069 0.938 . . . . 0.0 111.092 -177.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.42 ' HB1' ' CD1' ' A' ' 16' ' ' LEU . . . -133.61 161.05 35.68 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.0 -1.063 . . . . 0.0 109.537 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . 0.662 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 121.755 0.788 . . . . 0.0 109.797 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.844 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 39.5 Cg_endo -68.92 -176.02 1.13 Allowed 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 123.03 2.487 . . . . 0.0 111.991 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . 0.721 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 52.0 Cg_endo -92.74 -20.57 0.49 Allowed 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 123.28 2.653 . . . . 0.0 114.661 -177.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . 0.741 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.0 OUTLIER 78.75 89.9 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 120.873 -1.142 . . . . 0.0 109.175 -179.106 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' B' ' 186' ' ' LEU . 49.1 Cg_endo -70.41 137.43 33.55 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.804 2.336 . . . . 0.0 112.039 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 37.26 60.87 1.0 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.424 -0.797 . . . . 0.0 109.562 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 46.91 47.71 15.44 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.154 -0.966 . . . . 0.0 109.125 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . 0.606 ' CG ' ' HB2' ' A' ' 44' ' ' TRP . 20.5 tp -61.18 -84.93 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.517 -0.739 . . . . 0.0 109.427 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . 0.7 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.486 1.988 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.16 137.55 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.296 -0.877 . . . . 0.0 109.523 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.56 HG23 ' CG2' ' A' ' 37' ' ' VAL . 3.0 m -131.79 161.3 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 0.0 109.279 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 33' ' ' GLU . 9.5 p -120.13 139.99 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.126 -0.984 . . . . 0.0 109.186 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.566 ' HB3' ' CD1' ' A' ' 29' ' ' PHE . . . -73.1 133.06 44.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.475 -0.765 . . . . 0.0 110.122 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.516 ' CD1' ' HB3' ' A' ' 64' ' ' ALA . 8.7 mt -100.1 -14.01 18.75 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.653 ' HA ' ' CG ' ' A' ' 31' ' ' LYS . 34.1 m-85 -155.84 150.47 20.31 Favored Pre-proline 0 N--CA 1.489 1.476 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.68 ' HD3' ' HG3' ' A' ' 31' ' ' LYS . 39.6 Cg_endo -61.09 149.03 91.11 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 121.718 1.612 . . . . 0.0 109.742 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.775 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 60.9 t80 -97.95 178.23 5.18 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.041 -1.464 . . . . 0.0 110.525 -177.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.679 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 30.6 t0 -109.75 80.46 1.32 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.673 -0.642 . . . . 0.0 109.408 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.63 93.22 0.03 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.503 HG12 ' O ' ' A' ' 20' ' ' ASP . 0.6 OUTLIER -107.26 -42.81 6.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.142 -1.21 . . . . 0.0 108.675 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.592 ' CD2' ' NH1' ' B' ' 182' ' ' ARG . 59.0 m-70 -76.86 156.43 82.54 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.97 -13.94 37.61 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.287 1.991 . . . . 0.0 111.998 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -111.71 -13.72 13.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.341 -0.85 . . . . 0.0 110.493 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.487 ' OD2' ' OH ' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -57.97 140.52 52.09 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.827 -1.171 . . . . 0.0 109.989 -179.316 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.696 HD23 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -95.62 122.11 38.03 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.077 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.696 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -80.54 140.48 35.81 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.203 -0.935 . . . . 0.0 109.282 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.775 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 29.9 p90 -146.99 158.27 43.87 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.124 -0.985 . . . . 0.0 109.042 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 16.4 mttp -111.69 174.61 5.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.165 -0.959 . . . . 0.0 109.41 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.68 ' HG3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -66.54 155.88 36.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.875 -1.141 . . . . 0.0 109.428 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 67.71 -6.75 2.51 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' A' ' 31' ' ' LYS . 4.6 tp10 -75.24 140.51 43.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.86 -1.377 . . . . 0.0 109.573 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.9 138.99 32.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.532 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.573 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 3.5 mpp? -135.83 152.14 50.77 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.473 0.654 . . . . 0.0 109.753 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.9 OUTLIER -108.6 126.14 52.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.459 -0.776 . . . . 0.0 109.313 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.56 ' CG2' HG23 ' A' ' 13' ' ' VAL . 3.9 t -82.14 126.31 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.357 -0.839 . . . . 0.0 109.37 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.8 mt -99.33 -46.57 5.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.924 . . . . 0.0 109.429 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.5 90.62 2.58 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.588 ' CG ' ' CG ' ' A' ' 45' ' ' TRP . 1.4 tt0 -76.55 117.67 18.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.4 -0.812 . . . . 0.0 109.965 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.533 ' CD2' HD12 ' B' ' 186' ' ' LEU . 14.2 m-70 -87.34 -98.8 0.08 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.336 -0.853 . . . . 0.0 109.074 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.07 -7.52 0.11 Allowed Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.328 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.533 ' HB2' ' HD3' ' B' ' 183' ' ' PRO . 3.0 mp0 -149.43 -29.52 0.25 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.957 -1.32 . . . . 0.0 110.098 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.8 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 67.7 m95 -137.7 97.32 3.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 109.328 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.588 ' CG ' ' CG ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -88.42 146.64 25.12 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.976 -1.078 . . . . 0.0 110.147 -179.718 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.567 ' HG3' ' CD1' ' A' ' 57' ' ' PHE . 0.7 OUTLIER -93.15 107.07 18.94 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -104.75 -173.39 2.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.211 -0.931 . . . . 0.0 110.045 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -125.73 129.27 49.16 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.57 -0.706 . . . . 0.0 109.664 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.566 ' HB2' ' HB3' ' A' ' 54' ' ' LYS . 1.2 t -74.07 128.08 34.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.0 109.882 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.63 -8.88 57.49 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.3 tp -53.08 -55.11 26.39 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.41 -0.806 . . . . 0.0 109.329 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.596 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.8 t -161.24 29.61 0.14 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.094 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.596 ' CB ' ' O ' ' A' ' 52' ' ' THR . 3.9 mttm 86.59 45.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.356 -0.84 . . . . 0.0 110.607 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.592 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 8.1 tttt -85.79 132.67 34.07 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.52 116.7 24.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.939 -1.101 . . . . 0.0 109.412 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.607 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -157.62 169.09 34.44 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 119.459 -1.353 . . . . 0.0 109.972 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.824 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 6.3 m-85 -72.65 133.76 44.79 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.72 -0.871 . . . . 0.0 109.874 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.45 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 6.5 pt -121.97 143.6 39.13 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.714 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 50.1 Cg_endo -71.41 152.0 60.13 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 121.778 1.652 . . . . 0.0 112.176 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.477 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 28.1 t -80.32 6.26 12.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.314 -0.866 . . . . 0.0 110.81 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.99 -52.51 2.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.795 -1.19 . . . . 0.0 110.709 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.582 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 3.9 m-85 -50.04 -62.59 1.49 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.043 -1.036 . . . . 0.0 110.9 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.573 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 3.1 m -79.14 155.31 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 121.925 0.869 . . . . 0.0 111.086 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.516 ' HB3' ' CD1' ' A' ' 16' ' ' LEU . . . -130.76 159.56 36.94 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.037 -1.04 . . . . 0.0 109.57 -179.916 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . 0.628 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 121.757 0.789 . . . . 0.0 109.778 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.8 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 40.2 Cg_endo -69.13 -172.15 0.48 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.268 2.645 . . . . 0.0 111.652 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . 0.686 ' O ' ' CB ' ' B' ' 182' ' ' ARG . 53.3 Cg_endo -88.54 -40.96 0.05 OUTLIER 'Trans proline' 0 C--O 1.214 -0.721 0 C-N-CA 122.679 2.253 . . . . 0.0 114.025 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . 0.739 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 2.7 ttm180 91.49 92.92 0.03 OUTLIER Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.299 -0.875 . . . . 0.0 109.39 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . 0.533 ' HD3' ' HB2' ' A' ' 43' ' ' GLU . 48.8 Cg_endo -71.99 133.99 22.59 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.996 2.464 . . . . 0.0 112.144 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 36.66 69.81 0.19 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.49 -0.757 . . . . 0.0 109.725 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . 0.453 ' C ' ' O ' ' B' ' 184' ' ' ALA . 2.9 p-10 39.46 45.42 1.27 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.417 -0.802 . . . . 0.0 109.44 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . 0.577 ' CG ' ' HB2' ' A' ' 44' ' ' TRP . 18.1 tp -53.82 -89.0 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.458 -0.776 . . . . 0.0 109.046 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . 0.824 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.488 2.128 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.7 tp -107.9 137.87 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.142 -0.974 . . . . 0.0 109.59 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.431 HG21 HG21 ' A' ' 37' ' ' VAL . 1.5 m -132.0 161.76 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.49 HG21 ' O ' ' A' ' 33' ' ' GLU . 8.0 p -120.94 139.18 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.024 -1.047 . . . . 0.0 109.279 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -71.53 134.55 46.57 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.395 -0.816 . . . . 0.0 109.731 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.651 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 19.2 mt -99.41 -21.72 15.86 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.651 ' CE1' ' HB2' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -148.68 152.55 37.93 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.439 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.656 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 39.8 Cg_endo -62.92 149.63 90.93 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 121.931 1.754 . . . . 0.0 110.185 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.791 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 55.9 t80 -98.84 179.13 4.75 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.153 -1.419 . . . . 0.0 110.432 -177.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.69 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 57.7 m-20 -110.84 79.86 1.25 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.682 -0.636 . . . . 0.0 109.356 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.8 95.15 0.04 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 20' ' ' ASP . 15.2 mm -108.42 -41.97 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -1.13 . . . . 0.0 108.893 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.415 ' CE1' ' NH1' ' B' ' 182' ' ' ARG . 36.2 m80 -77.56 158.88 78.15 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.53 -14.17 36.39 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.284 1.989 . . . . 0.0 111.869 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.0 -13.51 13.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.0 110.416 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.66 138.08 55.76 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.821 -1.174 . . . . 0.0 109.809 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.632 HD23 ' N ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -95.53 121.22 36.99 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.632 ' N ' HD23 ' A' ' 27' ' ' LEU . 3.1 m -79.99 141.3 36.08 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.355 -0.84 . . . . 0.0 109.475 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.791 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 28.3 p90 -145.84 157.54 43.91 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.201 -0.937 . . . . 0.0 108.588 178.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 40.6 mttm -110.65 173.82 6.15 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.087 -1.008 . . . . 0.0 109.585 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.491 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -67.52 151.54 47.19 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.111 -0.993 . . . . 0.0 109.314 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.87 -8.09 4.83 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -75.43 140.46 42.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.928 -1.336 . . . . 0.0 109.788 -179.676 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -93.54 138.66 31.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.862 . . . . 0.0 109.263 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.599 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 1.9 mpp? -135.24 151.66 50.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.622 -0.674 . . . . 0.0 109.796 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -106.16 124.61 49.85 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.469 -0.769 . . . . 0.0 109.62 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.431 HG21 HG21 ' A' ' 13' ' ' VAL . 1.4 t -82.21 132.32 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.34 -0.85 . . . . 0.0 108.846 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.49 ' CD2' ' HD3' ' A' ' 36' ' ' LYS . 3.7 mt -110.37 -42.51 4.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.006 -1.059 . . . . 0.0 109.849 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -138.8 84.47 2.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.178 -0.951 . . . . 0.0 109.215 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.591 ' HG2' ' CD1' ' A' ' 45' ' ' TRP . 1.4 tt0 -67.96 116.14 8.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.861 . . . . 0.0 109.274 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.598 ' CG ' HD12 ' B' ' 186' ' ' LEU . 46.1 m-70 -86.04 -103.32 0.06 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.235 -0.916 . . . . 0.0 109.398 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.435 ' O ' ' HG3' ' A' ' 43' ' ' GLU . . . -136.4 -15.39 0.88 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.304 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.569 ' CG ' ' HD2' ' B' ' 181' ' ' PRO . 1.3 mt-10 -158.0 -20.24 0.08 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.944 -1.327 . . . . 0.0 110.525 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.925 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 57.1 m95 -133.51 93.81 3.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.919 -1.113 . . . . 0.0 108.676 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.63 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -85.85 146.57 26.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.074 -1.016 . . . . 0.0 110.796 -178.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 1.1 ttpt -94.21 105.85 17.83 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.41 -174.05 2.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.32 -0.862 . . . . 0.0 110.125 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.9 mttp -125.72 126.85 45.29 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.542 -0.724 . . . . 0.0 109.496 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.548 ' HB2' ' HB3' ' A' ' 54' ' ' LYS . 1.8 t -70.94 125.62 27.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.136 -0.978 . . . . 0.0 109.875 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.75 -8.69 54.09 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.499 ' C ' ' CD1' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -53.4 -55.27 26.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.508 -0.745 . . . . 0.0 109.352 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.611 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 1.5 t -161.16 30.11 0.14 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.267 -0.896 . . . . 0.0 110.186 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.611 ' HB2' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 85.58 45.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.499 -0.751 . . . . 0.0 110.651 178.547 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.593 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -86.8 132.18 33.91 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.122 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 1.4 pt-20 -121.82 117.56 26.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.89 -1.131 . . . . 0.0 109.455 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.614 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -157.67 168.67 34.38 Favored Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.346 -1.407 . . . . 0.0 110.158 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.72 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 15.5 m-85 -73.54 134.33 43.78 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.686 -0.89 . . . . 0.0 109.954 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.463 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 4.1 pt -122.37 141.16 34.09 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.587 ' HG3' ' CD2' ' B' ' 179' ' ' LEU . 53.4 Cg_endo -72.48 134.43 22.48 Favored 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 121.673 1.582 . . . . 0.0 111.997 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.623 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 24.3 p -65.2 4.69 0.45 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 110.422 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.67 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 5.9 p-10 -102.01 -51.64 3.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.871 -1.143 . . . . 0.0 110.86 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.67 ' N ' ' OD1' ' A' ' 61' ' ' ASN . 3.1 m-85 -55.27 -59.99 4.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.142 -0.974 . . . . 0.0 111.304 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.599 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 4.2 m -78.74 157.61 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 122.054 0.931 . . . . 0.0 111.41 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.506 ' HB3' ' CD1' ' A' ' 16' ' ' LEU . . . -135.63 161.88 34.29 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.509 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.454 0 O-C-N 121.046 -1.033 . . . . 0.0 109.265 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . 0.653 ' CD2' ' CE2' ' A' ' 62' ' ' TYR . 46.2 mt . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 121.527 0.68 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.925 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 39.6 Cg_endo -68.79 176.32 6.16 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.755 2.303 . . . . 0.0 111.648 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . 0.594 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 55.5 Cg_endo -86.82 -26.85 0.82 Allowed 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.885 2.39 . . . . 0.0 114.51 -177.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . 0.715 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.0 OUTLIER 79.41 95.67 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 120.818 -1.176 . . . . 0.0 109.458 -179.213 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . 0.652 ' HG2' ' HB2' ' B' ' 186' ' ' LEU . 48.0 Cg_endo -69.68 131.19 20.83 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 123.064 2.509 . . . . 0.0 112.269 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.506 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 35.64 69.13 0.19 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.448 -0.782 . . . . 0.0 109.874 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . 0.437 ' ND2' ' N ' ' B' ' 185' ' ' ASN . 0.2 OUTLIER 43.34 45.33 5.13 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.377 -0.827 . . . . 0.0 109.537 -179.824 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . 0.652 ' HB2' ' HG2' ' B' ' 183' ' ' PRO . 28.4 tp -55.7 -94.96 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . 0.72 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.484 1.874 0 N-CA-C 107.859 -2.097 . . . . 0.0 107.859 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.441 HD11 HG21 ' A' ' 12' ' ' ILE . 36.0 mm -102.86 133.93 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.195 -0.941 . . . . 0.0 109.366 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.552 ' CG2' ' CG2' ' A' ' 37' ' ' VAL . 1.0 OUTLIER -132.36 159.57 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.508 -0.745 . . . . 0.0 109.171 -179.424 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 p -119.45 135.51 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.878 -1.139 . . . . 0.0 108.95 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.612 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -70.21 131.62 44.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.409 -0.807 . . . . 0.0 110.594 -178.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.606 ' CD1' ' CB ' ' A' ' 64' ' ' ALA . 95.2 mt -98.79 -39.31 8.69 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.441 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 16.4 m-85 -122.33 139.28 30.44 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -63.0 150.61 88.15 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.625 2.217 . . . . 0.0 113.015 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.754 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 25.1 t80 -130.25 115.97 17.72 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.431 ' O ' HD12 ' A' ' 22' ' ' ILE . 0.5 OUTLIER -94.72 119.11 32.8 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 116.294 -2.162 . . . . 0.0 108.922 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -41.92 99.19 0.01 OUTLIER Glycine 0 N--CA 1.487 2.077 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.431 HD12 ' O ' ' A' ' 20' ' ' ASP . 12.9 mm -88.64 -54.03 8.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.597 ' CB ' ' CD ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -66.39 -171.02 0.07 OUTLIER Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 23' ' ' HIS . 52.2 Cg_endo -92.26 -13.48 1.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.54 2.16 . . . . 0.0 112.333 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -117.8 -11.14 10.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 0.0 110.779 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.471 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 99.5 m-20 -57.64 140.4 51.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.001 -1.062 . . . . 0.0 110.413 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.62 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.3 OUTLIER -97.64 126.43 42.94 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.557 ' N ' HD23 ' A' ' 27' ' ' LEU . 9.4 m -81.62 138.02 35.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.149 -0.969 . . . . 0.0 110.693 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.754 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 18.5 p90 -145.84 156.66 43.71 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.508 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -112.09 163.19 14.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.015 -1.053 . . . . 0.0 109.618 -179.368 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.436 ' C ' ' H ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -56.41 151.6 12.87 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.218 -0.926 . . . . 0.0 108.99 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.49 -8.42 3.07 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.519 ' OE2' ' O ' ' A' ' 34' ' ' LYS . 3.2 tm-20 -73.66 144.41 45.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.93 -1.336 . . . . 0.0 109.997 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.519 ' O ' ' OE2' ' A' ' 33' ' ' GLU . 4.0 mtmp? -96.03 135.98 37.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.91 . . . . 0.0 109.336 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.583 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 1.4 mpp? -134.52 150.67 50.8 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.518 -0.739 . . . . 0.0 110.02 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 13.0 tttt -105.74 117.52 34.24 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.529 -0.732 . . . . 0.0 109.182 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.552 ' CG2' ' CG2' ' A' ' 13' ' ' VAL . 2.5 t -76.92 132.42 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.386 -0.821 . . . . 0.0 109.185 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 98.2 mt -103.47 -50.53 3.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.722 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -140.89 103.94 4.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 108.913 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.653 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.2 tm-20 -87.54 119.22 27.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.459 -0.776 . . . . 0.0 109.784 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.583 ' CG ' HD12 ' B' ' 186' ' ' LEU . 3.0 m-70 -83.85 -98.39 0.05 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.379 -0.826 . . . . 0.0 109.206 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 43' ' ' GLU . . . -138.98 -13.1 0.71 Allowed Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.654 -1.26 . . . . 0.0 110.318 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' B' ' 180' ' ' PRO . 12.0 mt-10 -153.24 -16.43 0.15 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.918 -1.343 . . . . 0.0 110.412 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.775 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 65.3 m95 -140.21 100.1 3.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.939 -1.101 . . . . 0.0 109.53 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.662 ' CZ2' ' CB ' ' A' ' 60' ' ' SER . 0.1 OUTLIER -92.51 144.41 25.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.135 -0.978 . . . . 0.0 109.809 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -85.66 108.92 18.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.267 -0.895 . . . . 0.0 108.642 179.234 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.51 -177.87 3.5 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.264 -0.897 . . . . 0.0 110.01 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 8.5 mtpt -125.0 132.02 53.32 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.586 -0.697 . . . . 0.0 109.608 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.628 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 4.4 t -79.87 129.1 34.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.927 . . . . 0.0 109.717 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.457 HD13 ' CB ' ' A' ' 34' ' ' LYS . 19.6 mt -74.14 -5.24 40.56 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.7 tp -55.91 -54.76 40.77 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.334 -0.854 . . . . 0.0 109.132 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.633 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -160.4 27.56 0.16 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.33 -0.857 . . . . 0.0 110.04 179.323 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.633 ' HB2' ' O ' ' A' ' 52' ' ' THR . 5.0 mtpm? 87.2 43.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.586 -0.696 . . . . 0.0 110.805 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.628 ' HB2' ' CB ' ' A' ' 49' ' ' SER . 3.0 mmtp -85.27 132.57 34.24 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -122.63 116.54 23.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.955 -1.091 . . . . 0.0 109.424 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.62 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -152.67 170.62 31.8 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.659 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 5.1 m-85 -73.0 132.05 42.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.449 -1.03 . . . . 0.0 109.52 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.536 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 7.2 pt -121.14 140.17 30.64 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 108.965 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.642 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 49.3 Cg_endo -68.87 153.38 72.87 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.42 2.08 . . . . 0.0 112.022 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.662 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 77.4 p -85.61 6.55 26.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 109.948 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.574 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 3.4 p-10 -105.95 -47.58 3.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.145 -0.972 . . . . 0.0 110.158 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.637 ' CE2' ' CD2' ' B' ' 179' ' ' LEU . 10.4 m-30 -56.76 -59.97 4.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.495 -0.753 . . . . 0.0 110.956 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.583 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 3.1 m -80.11 163.28 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 111.296 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.606 ' CB ' ' CD1' ' A' ' 16' ' ' LEU . . . -137.24 130.59 31.16 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.507 ' O ' ' O ' ' A' ' 64' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.154 -0.966 . . . . 0.0 109.849 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . 0.637 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 121.456 0.646 . . . . 0.0 109.258 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.775 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.4 Cg_endo -67.36 -175.84 0.75 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.872 2.382 . . . . 0.0 111.797 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . 0.747 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 53.5 Cg_endo -91.88 -22.58 0.48 Allowed 'Trans proline' 0 C--O 1.213 -0.775 0 C-N-CA 123.062 2.508 . . . . 0.0 114.709 -177.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . 0.747 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 20.7 mtt180 77.0 93.07 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.892 -1.13 . . . . 0.0 109.063 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' B' ' 186' ' ' LEU . 47.0 Cg_endo -68.38 130.89 22.0 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.666 2.244 . . . . 0.0 111.848 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 43.53 61.82 2.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.367 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 47.18 50.27 14.4 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.267 -0.895 . . . . 0.0 109.274 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . 0.583 HD12 ' CG ' ' A' ' 41' ' ' HIS . 49.9 tp -68.51 -83.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.412 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . 0.659 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.486 1.977 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 tp -106.3 142.13 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.233 -0.917 . . . . 0.0 109.648 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.492 HG23 ' CG2' ' A' ' 37' ' ' VAL . 3.5 m -132.33 162.46 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.443 -0.786 . . . . 0.0 109.175 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.7 p -121.78 138.64 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.123 -0.985 . . . . 0.0 109.209 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -71.2 136.85 48.26 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.469 -0.769 . . . . 0.0 109.829 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.614 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 55.6 mt -98.97 -25.46 14.57 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.614 ' CD1' ' O ' ' A' ' 16' ' ' LEU . 23.1 m-85 -144.66 154.85 56.46 Favored Pre-proline 0 N--CA 1.486 1.373 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.662 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 41.5 Cg_endo -63.99 149.36 90.7 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 121.941 1.761 . . . . 0.0 110.192 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.824 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 58.8 t80 -99.65 178.38 4.87 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 118.01 -1.476 . . . . 0.0 110.552 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.679 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -110.63 80.0 1.26 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.655 -0.653 . . . . 0.0 109.377 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.27 95.26 0.03 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.701 -1.759 . . . . 0.0 108.701 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.417 ' N ' ' O ' ' A' ' 20' ' ' ASP . 28.9 mt -109.89 -40.2 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.14 -1.212 . . . . 0.0 109.167 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -80.18 158.91 71.53 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.88 -14.95 39.84 Favored 'Trans proline' 0 C--O 1.216 -0.586 0 C-N-CA 122.314 2.009 . . . . 0.0 112.159 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -110.61 -11.46 14.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.022 -1.049 . . . . 0.0 110.488 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -59.95 143.2 52.25 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.857 -1.152 . . . . 0.0 109.655 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.697 ' CB ' ' HA2' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -102.42 122.92 45.25 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.647 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -77.35 138.94 39.62 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 109.568 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.824 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 19.8 p90 -143.66 155.4 44.23 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 108.542 178.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.591 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 1.8 ptpt -110.15 173.16 6.45 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.204 -0.935 . . . . 0.0 109.486 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.497 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -66.34 152.48 44.92 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.198 -0.939 . . . . 0.0 109.304 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.47 -7.76 3.49 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.422 ' H ' ' C ' ' A' ' 31' ' ' LYS . 0.5 OUTLIER -74.95 143.67 43.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.843 -1.386 . . . . 0.0 109.564 -179.677 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.42 138.83 33.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.901 . . . . 0.0 109.556 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.544 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 2.1 mpp? -134.86 151.58 51.03 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.594 -0.691 . . . . 0.0 109.657 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 2.6 tttt -104.99 128.82 53.45 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.406 -0.809 . . . . 0.0 109.179 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.492 ' CG2' HG23 ' A' ' 13' ' ' VAL . 1.7 t -81.58 135.11 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.416 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.8 mp -113.43 -41.13 3.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.313 -0.867 . . . . 0.0 109.513 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -149.91 88.38 1.53 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 109.233 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.628 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -74.76 114.49 13.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.378 -0.826 . . . . 0.0 109.438 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.548 ' HB2' ' CD2' ' B' ' 186' ' ' LEU . 3.2 m-70 -80.6 -101.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.518 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.411 ' C ' ' CD ' ' A' ' 43' ' ' GLU . . . -127.28 -14.91 2.59 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.048 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.559 ' CG ' ' HD3' ' B' ' 183' ' ' PRO . 0.0 OUTLIER -165.8 -10.87 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.022 -1.281 . . . . 0.0 110.3 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.822 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 71.2 m95 -131.1 89.2 2.7 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.859 -1.151 . . . . 0.0 108.701 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.628 ' CD1' ' CG ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -83.7 140.97 31.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.798 -1.189 . . . . 0.0 110.312 -179.064 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 4.3 tttt -91.42 103.54 16.16 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -101.92 -177.21 3.35 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.351 -0.843 . . . . 0.0 110.336 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -123.72 109.5 13.77 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.855 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.614 ' OG ' ' CB ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -57.45 129.53 42.25 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.807 -179.606 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.436 ' O ' ' N ' ' A' ' 52' ' ' THR . 0.3 OUTLIER -76.88 -8.61 57.67 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.318 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.472 ' O ' ' HB ' ' A' ' 52' ' ' THR . 55.5 tp -46.55 -22.68 0.3 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.738 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER 169.42 -21.94 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.38 -0.825 . . . . 0.0 110.115 178.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.738 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.1 OUTLIER 140.33 39.23 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.47 -0.769 . . . . 0.0 110.105 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.614 ' CB ' ' OG ' ' A' ' 49' ' ' SER . 0.3 OUTLIER -87.86 135.24 33.48 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -122.43 127.82 50.14 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.914 -1.117 . . . . 0.0 109.274 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.697 ' HA2' ' CB ' ' A' ' 27' ' ' LEU . . . -166.93 168.81 40.51 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.235 -1.46 . . . . 0.0 110.41 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.704 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 14.2 m-85 -71.62 132.89 45.26 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.754 -0.851 . . . . 0.0 109.898 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.513 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 8.1 pt -123.18 129.48 24.92 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.632 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 56.2 Cg_endo -75.1 126.49 9.94 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 121.634 1.556 . . . . 0.0 112.591 -178.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.623 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 32.2 t -55.28 -10.85 0.64 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.522 -0.736 . . . . 0.0 109.997 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.452 ' HB3' ' HD3' ' B' ' 180' ' ' PRO . 5.3 t30 -88.35 0.81 55.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.034 -1.041 . . . . 0.0 110.383 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.604 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -117.08 -41.34 3.02 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.864 -1.148 . . . . 0.0 110.045 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.544 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.5 m -96.62 159.09 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.104 -0.997 . . . . 0.0 110.567 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.403 ' CB ' HD13 ' A' ' 16' ' ' LEU . . . -136.87 161.89 34.77 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.087 -1.008 . . . . 0.0 109.4 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . 0.631 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.711 0.767 . . . . 0.0 109.598 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.822 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.5 Cg_endo -68.79 -176.57 1.26 Allowed 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 123.031 2.487 . . . . 0.0 111.647 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . 0.73 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.6 Cg_endo -89.82 -26.75 0.38 Allowed 'Trans proline' 0 C--O 1.213 -0.739 0 C-N-CA 122.886 2.391 . . . . 0.0 114.937 -177.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . 0.73 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 39.4 mtt180 78.14 91.56 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 120.879 -1.138 . . . . 0.0 109.13 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 50.2 Cg_endo -70.0 135.59 30.27 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.689 2.26 . . . . 0.0 111.787 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 42.38 55.38 4.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.884 . . . . 0.0 109.5 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . 0.52 ' N ' ' ND2' ' B' ' 185' ' ' ASN . 0.7 OUTLIER 51.68 50.54 18.52 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.26 -0.9 . . . . 0.0 109.281 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . 0.675 ' CD2' ' HB2' ' A' ' 44' ' ' TRP . 60.9 tp -70.48 -81.88 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.362 -0.836 . . . . 0.0 109.418 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . 0.704 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.485 1.948 0 N-CA-C 108.924 -1.671 . . . . 0.0 108.924 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.48 HD13 HG22 ' A' ' 12' ' ' ILE . 30.7 mm -107.98 136.8 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.099 -1.0 . . . . 0.0 109.594 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.34 160.68 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.505 -0.747 . . . . 0.0 109.036 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 p -120.66 139.23 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.054 -1.029 . . . . 0.0 109.372 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -71.86 133.3 45.37 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.379 -0.826 . . . . 0.0 109.744 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.584 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 23.4 mt -99.13 -17.25 18.28 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.672 ' HA ' ' CG ' ' A' ' 31' ' ' LYS . 7.2 m-85 -152.62 151.61 27.21 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.685 ' HD3' ' HG3' ' A' ' 31' ' ' LYS . 40.7 Cg_endo -61.53 148.93 91.8 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 121.53 1.487 . . . . 0.0 109.655 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.811 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 36.6 t80 -89.29 -34.3 16.63 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 117.947 -1.501 . . . . 0.0 110.224 -177.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.756 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 30.3 t70 106.84 -53.52 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.26 93.31 0.2 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -109.42 -42.96 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.385 -1.067 . . . . 0.0 108.433 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.5 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 1.9 m80 -74.74 153.35 87.22 Favored Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.79 -9.69 26.71 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.075 1.85 . . . . 0.0 111.417 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.8 -17.4 11.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.368 -0.833 . . . . 0.0 110.545 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.5 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.5 OUTLIER -57.18 141.28 46.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.856 -1.152 . . . . 0.0 109.956 -178.838 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.613 HD23 ' N ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -90.03 119.14 30.12 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.867 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.613 ' N ' HD23 ' A' ' 27' ' ' LEU . 93.9 p -77.08 138.51 39.59 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.333 -0.855 . . . . 0.0 109.734 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.811 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 17.6 p90 -143.68 155.56 44.26 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.238 -0.914 . . . . 0.0 108.772 178.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -112.36 175.47 5.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.242 -0.911 . . . . 0.0 109.434 -179.356 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.685 ' HG3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -66.13 155.8 35.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.95 -1.093 . . . . 0.0 109.423 179.576 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 66.01 -6.94 1.32 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.461 ' H ' ' C ' ' A' ' 31' ' ' LYS . 0.5 OUTLIER -74.79 141.31 44.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.839 -1.389 . . . . 0.0 109.687 -179.602 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -94.87 136.97 34.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.324 -0.86 . . . . 0.0 109.415 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.579 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 1.1 mpp? -137.23 153.1 50.45 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.421 0.629 . . . . 0.0 109.758 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.654 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 13.7 tttm -110.31 123.67 50.24 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.472 -0.768 . . . . 0.0 109.26 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.456 HG22 ' HG3' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -88.71 115.66 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -82.88 -41.09 19.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.196 -0.94 . . . . 0.0 110.038 -179.365 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.54 126.02 11.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.147 -0.971 . . . . 0.0 109.505 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.613 ' HG2' ' CD2' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -95.19 131.44 41.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.451 -0.78 . . . . 0.0 109.406 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.577 ' CD2' HD13 ' B' ' 186' ' ' LEU . 78.5 m-70 -98.72 -122.84 0.14 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.266 -0.896 . . . . 0.0 108.997 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.23 -28.96 21.28 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.569 ' CB ' ' HD2' ' B' ' 181' ' ' PRO . 2.1 tp10 -172.44 5.28 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.039 -1.271 . . . . 0.0 110.672 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 1.01 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 64.4 m95 -136.26 97.29 3.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.834 -1.166 . . . . 0.0 108.372 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.638 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -93.23 145.89 24.1 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.921 -1.112 . . . . 0.0 110.337 -178.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -84.97 107.98 17.36 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.654 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -99.9 -179.62 4.22 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.363 -0.835 . . . . 0.0 109.909 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -122.76 129.97 52.36 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.62 -0.675 . . . . 0.0 109.493 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.526 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -76.75 126.79 31.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.75 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.64 -9.49 58.32 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.8 tp -52.11 -54.8 26.05 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.511 -0.743 . . . . 0.0 109.368 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.621 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.2 t -161.54 28.72 0.13 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.229 -0.92 . . . . 0.0 110.146 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.621 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.5 OUTLIER 87.09 44.33 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.47 -0.769 . . . . 0.0 110.715 178.726 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -85.46 132.64 34.18 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.077 -1.015 . . . . 0.0 108.337 178.517 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -122.4 114.75 21.17 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.859 -1.151 . . . . 0.0 109.483 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.599 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -152.22 171.84 31.49 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.657 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 8.1 m-85 -75.27 132.41 41.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.351 -1.088 . . . . 0.0 109.689 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.545 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 9.2 pt -121.93 137.42 27.3 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 108.605 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.58 ' HB2' ' CD ' ' B' ' 180' ' ' PRO . 50.9 Cg_endo -74.1 137.62 24.18 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.975 1.783 . . . . 0.0 112.763 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.593 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 28.3 t -67.93 4.3 1.23 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.583 -0.698 . . . . 0.0 110.317 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.547 HD21 ' HA ' ' B' ' 179' ' ' LEU . 0.8 OUTLIER -100.91 -55.34 2.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.022 -1.049 . . . . 0.0 110.063 -179.391 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.654 ' CE2' ' CD2' ' B' ' 179' ' ' LEU . 2.4 m-85 -51.81 -60.87 2.67 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.261 -0.899 . . . . 0.0 110.872 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.579 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 4.0 m -78.61 154.8 4.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 122.004 0.906 . . . . 0.0 111.182 -177.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.463 ' CB ' ' CD1' ' A' ' 16' ' ' LEU . . . -130.07 159.55 36.4 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? . . . . . 0 N--CA 1.49 1.527 0 O-C-N 120.974 -1.078 . . . . 0.0 109.552 -179.851 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . 0.654 ' CD2' ' CE2' ' A' ' 62' ' ' TYR . 33.4 mt . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.45 0.643 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 1.01 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 39.1 Cg_endo -70.56 176.12 7.81 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.483 2.122 . . . . 0.0 111.638 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . 0.578 ' O ' ' CB ' ' B' ' 182' ' ' ARG . 55.7 Cg_endo -76.47 -42.63 0.34 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.823 2.349 . . . . 0.0 113.916 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . 0.649 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.0 OUTLIER 78.94 81.44 0.1 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.039 -1.038 . . . . 0.0 108.49 -178.583 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . 0.507 ' HD2' HD21 ' B' ' 186' ' ' LEU . 51.5 Cg_endo -72.95 146.21 41.48 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.939 2.426 . . . . 0.0 112.33 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 36.35 61.93 0.76 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.607 -0.683 . . . . 0.0 109.616 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . 0.486 ' N ' ' ND2' ' B' ' 185' ' ' ASN . 0.7 OUTLIER 42.95 46.2 4.6 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.308 -0.87 . . . . 0.0 109.05 -179.65 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . 0.672 ' CD2' ' HB2' ' A' ' 44' ' ' TRP . 68.0 tp -61.85 -86.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.435 -0.79 . . . . 0.0 109.447 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . 0.657 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.486 1.999 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.44 ' O ' HG12 ' A' ' 37' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.525 HD13 ' CG ' ' A' ' 36' ' ' LYS . 1.0 OUTLIER -101.43 137.79 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.884 . . . . 0.0 109.407 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.413 HG21 HG11 ' A' ' 37' ' ' VAL . 0.8 OUTLIER -130.99 159.93 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.6 p -120.55 138.46 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.981 -1.074 . . . . 0.0 109.482 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -72.29 134.58 45.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.465 -0.772 . . . . 0.0 110.111 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 62' ' ' TYR . 16.5 mt -99.26 -17.81 17.91 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.583 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 43.1 m-85 -152.55 153.87 31.02 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.65 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.6 Cg_endo -63.66 149.64 90.4 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 121.812 1.675 . . . . 0.0 110.042 179.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.804 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 65.7 t80 -97.58 179.14 4.95 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 118.219 -1.392 . . . . 0.0 110.224 -177.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.67 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 9.8 p-10 -110.15 80.93 1.36 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.569 -0.707 . . . . 0.0 109.313 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.5 91.92 0.03 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.466 ' N ' ' O ' ' A' ' 20' ' ' ASP . 67.1 mt -106.67 -43.17 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.265 -1.138 . . . . 0.0 108.765 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.59 ' CE1' ' NH2' ' B' ' 182' ' ' ARG . 41.1 m80 -75.86 156.14 84.59 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.01 -13.27 36.23 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.225 1.95 . . . . 0.0 111.799 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -111.86 -13.99 13.59 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.24 -0.913 . . . . 0.0 110.363 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.74 141.83 47.4 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.825 -1.172 . . . . 0.0 109.798 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.629 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.3 OUTLIER -98.64 124.06 43.2 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.595 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -81.08 140.26 35.2 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.322 -0.861 . . . . 0.0 109.81 -179.704 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.804 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 28.2 p90 -145.79 157.97 43.89 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 10.5 mtmm -111.27 174.03 6.06 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.047 -1.033 . . . . 0.0 109.557 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.539 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -67.38 151.9 46.64 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.186 -0.946 . . . . 0.0 109.314 179.803 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.39 -7.94 4.42 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 3.8 tt0 -75.55 143.43 42.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.917 -1.343 . . . . 0.0 109.838 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -96.3 138.18 34.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 0.0 109.273 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.596 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 1.7 mpp? -135.97 151.82 50.32 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.628 -0.67 . . . . 0.0 109.932 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 7.7 ttpt -109.02 122.37 47.11 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.507 HG22 ' HG3' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -89.93 119.0 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.296 -0.877 . . . . 0.0 108.758 178.832 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.468 HD23 ' HE2' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -89.01 -40.79 12.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.159 -0.963 . . . . 0.0 110.191 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.28 119.42 15.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.049 -1.032 . . . . 0.0 109.268 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.616 ' CG ' ' CG ' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -99.35 122.17 42.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.823 . . . . 0.0 109.453 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.567 ' CG ' HD12 ' B' ' 186' ' ' LEU . 5.2 m-70 -90.25 -103.86 0.1 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.957 . . . . 0.0 109.116 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.69 -14.06 1.55 Allowed Glycine 0 N--CA 1.489 2.174 0 C-N-CA 119.548 -1.31 . . . . 0.0 110.177 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.571 ' CG ' ' HD2' ' B' ' 181' ' ' PRO . 0.3 OUTLIER -158.77 -15.1 0.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.963 -1.316 . . . . 0.0 110.972 -179.506 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.825 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 62.7 m95 -138.92 99.52 3.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.725 -1.234 . . . . 0.0 109.608 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.671 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -93.18 142.98 26.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.881 -1.137 . . . . 0.0 109.511 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.9 OUTLIER -85.91 109.11 18.51 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.29 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.601 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -101.3 -174.62 2.65 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.333 -0.855 . . . . 0.0 109.818 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -126.97 129.39 48.05 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.478 -0.764 . . . . 0.0 109.298 -179.729 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.583 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 7.6 t -74.9 126.75 31.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.064 -1.023 . . . . 0.0 109.795 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.3 -7.43 46.96 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.151 -0.968 . . . . 0.0 108.521 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.67 -55.6 27.96 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.374 -0.829 . . . . 0.0 109.227 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.634 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.1 t -160.62 27.51 0.15 Allowed 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.136 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.634 ' CB ' ' O ' ' A' ' 52' ' ' THR . 5.1 mmtt 87.83 45.17 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.495 -0.753 . . . . 0.0 110.898 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.584 ' HB2' HD22 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -87.0 130.67 34.36 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 177.752 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.503 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 10.1 pt-20 -120.31 117.87 28.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.79 -1.194 . . . . 0.0 109.508 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.629 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -154.77 179.12 31.09 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.725 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 9.3 m-85 -80.07 132.56 35.99 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.454 -1.027 . . . . 0.0 109.954 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.535 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 8.8 pt -120.27 136.61 25.26 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.66 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 55.3 Cg_endo -73.95 135.16 20.8 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 121.827 1.685 . . . . 0.0 112.536 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.608 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 23.1 t -65.97 5.24 0.52 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.512 -0.743 . . . . 0.0 110.565 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.552 ' CG ' ' N ' ' A' ' 62' ' ' TYR . 1.2 p-10 -101.21 -51.81 3.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.765 -1.209 . . . . 0.0 110.458 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.583 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 4.8 m-85 -57.06 -59.01 5.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.117 -0.989 . . . . 0.0 110.947 -178.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.596 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 3.1 m -79.79 156.8 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.988 0.899 . . . . 0.0 111.272 -177.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.54 159.47 38.08 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 O-C-N 120.933 -1.105 . . . . 0.0 109.568 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . 0.631 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 121.687 0.756 . . . . 0.0 109.568 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.825 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.1 Cg_endo -68.68 178.51 3.84 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.903 2.402 . . . . 0.0 111.531 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . 0.729 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.3 Cg_endo -88.21 -21.59 1.54 Allowed 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 122.982 2.455 . . . . 0.0 114.411 -177.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . 0.729 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 24.6 mtt180 76.34 91.25 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.956 -1.09 . . . . 0.0 108.974 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . 0.547 ' HD2' HD21 ' B' ' 186' ' ' LEU . 50.9 Cg_endo -70.68 136.42 30.54 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.84 2.36 . . . . 0.0 112.017 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 41.0 63.73 1.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.834 . . . . 0.0 109.492 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' B' ' 184' ' ' ALA . 0.0 OUTLIER 44.73 48.86 8.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.205 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . 0.588 ' CG ' ' HB2' ' A' ' 44' ' ' TRP . 42.6 tp -67.77 -87.15 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.441 -0.787 . . . . 0.0 109.413 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . 0.725 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.487 2.034 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.487 HG22 HD11 ' A' ' 12' ' ' ILE . 34.4 mm -111.8 136.79 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.119 -0.988 . . . . 0.0 109.729 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.523 HG23 ' CG2' ' A' ' 37' ' ' VAL . 1.3 m -133.09 162.92 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -118.65 139.17 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.84 -1.162 . . . . 0.0 109.069 179.176 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.659 ' O ' ' HA ' ' A' ' 31' ' ' LYS . . . -72.09 95.42 1.63 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.44 -0.788 . . . . 0.0 110.695 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.614 ' CD1' ' CB ' ' A' ' 64' ' ' ALA . 37.3 mt -60.99 -34.08 74.24 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.584 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 29.1 m-85 -134.1 152.95 79.3 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.503 ' HB3' ' HA ' ' A' ' 30' ' ' LYS . 50.8 Cg_endo -70.27 150.9 65.79 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 122.409 2.073 . . . . 0.0 111.677 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.883 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 60.6 t80 -114.44 105.62 13.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.979 -1.075 . . . . 0.0 109.756 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 19' ' ' TYR . 40.3 m-20 -27.49 -37.75 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 19' ' ' TYR . . . 66.74 96.3 0.03 OUTLIER Glycine 0 N--CA 1.496 2.664 0 N-CA-C 106.206 -2.758 . . . . 0.0 106.206 -175.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.6 mt -115.04 -38.18 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.447 -1.031 . . . . 0.0 109.809 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.467 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 0.9 OUTLIER -77.41 151.76 80.87 Favored Pre-proline 0 C--N 1.298 -1.64 0 O-C-N 121.346 -0.846 . . . . 0.0 108.753 179.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.34 -10.17 26.55 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.211 1.941 . . . . 0.0 110.774 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -114.9 -17.22 11.59 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.459 -0.776 . . . . 0.0 110.279 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.467 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -57.51 139.24 53.89 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.888 -1.133 . . . . 0.0 109.91 -178.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.632 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.4 OUTLIER -88.19 115.06 25.41 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.841 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.609 ' N ' HD23 ' A' ' 27' ' ' LEU . 84.6 p -76.3 141.22 41.69 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.369 -0.832 . . . . 0.0 109.404 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.883 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 24.6 p90 -145.81 156.74 43.77 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.31 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.503 ' HA ' ' HB3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -110.21 174.52 5.82 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.198 -0.939 . . . . 0.0 109.321 -179.704 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.659 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -67.4 151.09 48.03 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.093 -1.004 . . . . 0.0 109.315 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 71.38 -7.4 6.4 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -74.77 143.42 44.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.965 -1.314 . . . . 0.0 109.68 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -97.52 139.48 33.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.749 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.529 ' CE ' HG13 ' A' ' 63' ' ' VAL . 3.9 mtm -135.89 152.44 51.02 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.588 0.709 . . . . 0.0 109.744 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 17.2 ttmt -104.81 125.75 51.18 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.523 ' CG2' HG23 ' A' ' 13' ' ' VAL . 2.7 t -75.72 132.18 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.192 -0.943 . . . . 0.0 109.431 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 46' ' ' LYS . 12.3 mt -110.94 -48.54 3.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.199 -0.938 . . . . 0.0 109.649 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 1.8 pt-20 -143.27 91.94 2.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.161 -0.962 . . . . 0.0 109.051 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.59 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 0.8 OUTLIER -78.68 114.89 18.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.697 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.548 ' CG ' HD12 ' B' ' 186' ' ' LEU . 4.2 m-70 -82.47 -101.71 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.372 -0.83 . . . . 0.0 109.113 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -136.33 -12.87 1.05 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.519 ' HB2' ' HD3' ' B' ' 183' ' ' PRO . 0.8 OUTLIER -153.15 -19.76 0.15 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.026 -1.279 . . . . 0.0 110.544 -179.668 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.858 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 66.8 m95 -137.43 99.93 4.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.868 -1.145 . . . . 0.0 109.395 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.623 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -88.22 146.97 25.08 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.133 -0.979 . . . . 0.0 109.851 -179.879 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.527 ' HG3' ' CD1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -93.81 105.67 17.69 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.171 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.79 -177.96 3.52 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.298 -0.876 . . . . 0.0 110.281 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.619 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -123.73 128.07 49.07 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.644 -0.66 . . . . 0.0 109.684 -179.49 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.548 ' HB2' ' HB3' ' A' ' 54' ' ' LYS . 1.1 t -74.45 126.95 31.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.124 -0.985 . . . . 0.0 109.884 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.425 HD21 ' HA ' ' A' ' 50' ' ' LEU . 32.9 mt -72.23 -7.43 49.26 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.5 tp -53.58 -54.92 30.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.529 -0.732 . . . . 0.0 109.287 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.608 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 2.6 t -161.08 29.08 0.14 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.278 -0.889 . . . . 0.0 109.955 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 52' ' ' THR . 12.6 mttm 86.93 45.46 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.552 -0.718 . . . . 0.0 110.585 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.619 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 3.6 tttm -85.17 132.29 34.31 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -123.22 117.01 24.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.929 -1.107 . . . . 0.0 109.17 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.632 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -159.27 166.03 34.55 Favored Glycine 0 N--CA 1.486 1.988 0 C-N-CA 118.966 -1.588 . . . . 0.0 110.55 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.76 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 8.1 m-85 -71.97 134.1 45.74 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.752 -0.852 . . . . 0.0 109.714 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.501 ' CD1' HG23 ' A' ' 63' ' ' VAL . 13.7 pt -123.29 144.53 43.96 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.304 -0.873 . . . . 0.0 108.841 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.604 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 43.2 Cg_endo -67.54 142.92 60.8 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.915 1.743 . . . . 0.0 111.597 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.525 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 32.4 p -74.67 6.05 4.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.189 -0.944 . . . . 0.0 110.737 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.42 ' OD1' ' C ' ' A' ' 61' ' ' ASN . 0.1 OUTLIER -108.41 -51.72 2.86 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.808 -1.183 . . . . 0.0 110.484 -179.208 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.584 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 5.8 m-30 -49.68 -61.26 2.22 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.19 -0.944 . . . . 0.0 111.271 -178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.529 HG13 ' CE ' ' A' ' 35' ' ' MET . 13.3 m -78.32 156.32 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.096 -1.002 . . . . 0.0 111.321 -177.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.614 ' CB ' ' CD1' ' A' ' 16' ' ' LEU . . . -135.74 163.5 30.03 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.464 ' HA ' HG11 ' A' ' 13' ' ' VAL . 3.7 ptpt . . . . . 0 N--CA 1.488 1.469 0 O-C-N 120.977 -1.077 . . . . 0.0 109.373 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . 0.58 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.682 0.753 . . . . 0.0 109.519 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.858 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.3 Cg_endo -69.14 -175.29 0.96 Allowed 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.944 2.429 . . . . 0.0 111.568 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . 0.768 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.1 Cg_endo -90.36 -29.75 0.17 Allowed 'Trans proline' 0 C--O 1.213 -0.742 0 C-N-CA 122.928 2.419 . . . . 0.0 114.471 -177.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . 0.768 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 51.1 mtt180 81.97 95.34 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.227 -0.921 . . . . 0.0 109.212 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . 0.593 ' HG2' ' HB2' ' B' ' 186' ' ' LEU . 43.6 Cg_endo -67.41 128.41 18.24 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.852 2.368 . . . . 0.0 111.806 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 42.47 66.87 0.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.182 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' B' ' 184' ' ' ALA . 0.6 OUTLIER 43.08 43.91 3.96 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.368 -0.833 . . . . 0.0 109.137 -179.465 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . 0.61 ' CD2' ' HB2' ' A' ' 44' ' ' TRP . 59.9 tp -55.67 -93.81 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . 0.76 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.483 1.767 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.452 ' O ' HG22 ' A' ' 37' ' ' VAL . 3.3 m-20 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 35.0 mm -105.27 136.09 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.927 . . . . 0.0 109.655 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 65' ' ' LYS . 1.5 m -132.64 161.79 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 p -120.09 137.75 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.982 -1.074 . . . . 0.0 109.071 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.605 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -69.22 131.77 45.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.395 -0.816 . . . . 0.0 109.976 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.601 ' CD1' ' CB ' ' A' ' 64' ' ' ALA . 62.5 mt -97.77 -30.21 12.92 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.599 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 47.7 m-85 -131.74 143.32 48.63 Favored Pre-proline 0 N--CA 1.486 1.373 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 40.8 Cg_endo -62.34 149.39 90.94 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.692 2.261 . . . . 0.0 112.699 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.797 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 21.6 t80 -129.29 113.3 14.83 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -98.2 118.0 33.85 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 116.75 -1.98 . . . . 0.0 108.546 179.434 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -40.44 90.25 0.01 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.538 ' N ' ' O ' ' A' ' 20' ' ' ASP . 2.4 mp -82.49 0.11 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 121.142 -1.211 . . . . 0.0 107.815 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.563 ' HB3' ' CD ' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -121.66 -172.55 0.24 Allowed Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.372 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.563 ' CD ' ' HB3' ' A' ' 23' ' ' HIS . 52.0 Cg_endo -90.86 -17.89 1.22 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.218 1.945 . . . . 0.0 112.602 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -117.53 -12.09 10.4 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.389 -0.819 . . . . 0.0 111.09 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.465 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 9.5 m-20 -58.52 142.56 48.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.927 -1.108 . . . . 0.0 110.708 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.672 ' CB ' ' HA2' ' A' ' 56' ' ' GLY . 0.1 OUTLIER -98.93 122.68 42.5 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.659 ' N ' HD23 ' A' ' 27' ' ' LEU . 15.9 m -76.92 137.53 39.15 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -0.925 . . . . 0.0 110.655 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.797 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 30.5 p90 -143.75 154.74 43.77 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -111.54 166.04 11.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.979 -1.076 . . . . 0.0 109.656 -179.35 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.436 ' C ' ' H ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -57.23 151.37 15.88 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.248 -0.907 . . . . 0.0 108.792 179.71 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.17 -7.69 3.18 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 9.0 tt0 -73.47 144.41 46.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.931 -1.335 . . . . 0.0 109.798 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.534 ' HB2' ' CD1' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -98.13 139.07 34.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 0.0 109.894 -179.708 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.482 ' HE3' ' HB2' ' A' ' 15' ' ' ALA . 4.6 mtm -134.89 151.08 50.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.578 -0.701 . . . . 0.0 109.662 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.623 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -103.05 121.05 41.77 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.504 -0.748 . . . . 0.0 109.252 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 11' ' ' ASP . 1.8 t -82.7 124.1 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.369 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.2 mt -99.4 -44.88 6.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.137 -0.977 . . . . 0.0 109.608 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -148.25 97.22 2.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.891 . . . . 0.0 109.157 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.637 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -78.72 122.76 26.41 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.38 -0.825 . . . . 0.0 109.618 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.604 ' CG ' HD13 ' B' ' 186' ' ' LEU . 43.4 m-70 -83.01 -101.77 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.342 -0.849 . . . . 0.0 109.223 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.34 -16.28 1.37 Allowed Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.366 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.568 ' CG ' ' HD2' ' B' ' 181' ' ' PRO . 0.0 OUTLIER -158.43 -16.99 0.07 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.913 -1.345 . . . . 0.0 110.755 -179.531 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 1.004 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 64.3 m95 -132.74 94.86 3.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.942 -1.099 . . . . 0.0 108.601 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.637 ' CD1' ' CG ' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -88.47 147.55 24.61 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.028 -1.045 . . . . 0.0 110.096 -179.114 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.7 OUTLIER -94.46 107.39 19.36 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.623 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -105.41 -175.41 2.79 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.273 -0.892 . . . . 0.0 110.23 -179.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -126.18 130.98 52.06 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.667 -0.645 . . . . 0.0 109.905 -179.207 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.596 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -77.06 128.34 34.29 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.157 -0.964 . . . . 0.0 109.698 179.476 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.534 ' CD1' ' HB2' ' A' ' 34' ' ' LYS . 1.2 mp -73.95 -7.21 51.52 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 49.2 tp -53.89 -54.46 38.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.399 -0.813 . . . . 0.0 109.32 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 2.8 t -160.88 29.16 0.15 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.267 -0.896 . . . . 0.0 110.036 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.587 ' CB ' ' O ' ' A' ' 52' ' ' THR . 17.4 mttp 85.91 42.98 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.528 -0.733 . . . . 0.0 110.879 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 49' ' ' SER . 7.4 mmtt -85.41 133.0 34.13 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -123.36 120.8 34.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.976 -1.078 . . . . 0.0 109.332 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.672 ' HA2' ' CB ' ' A' ' 27' ' ' LEU . . . -159.72 166.11 34.81 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.27 -1.443 . . . . 0.0 110.133 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.72 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 9.2 m-85 -70.19 133.3 46.94 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.64 -0.918 . . . . 0.0 109.437 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.48 ' O ' HG13 ' A' ' 58' ' ' ILE . 6.1 pt -121.97 136.68 26.46 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.311 -0.868 . . . . 0.0 108.717 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.597 ' HG3' ' CD2' ' B' ' 179' ' ' LEU . 50.0 Cg_endo -69.39 138.62 39.44 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.269 1.98 . . . . 0.0 112.325 -178.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.55 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 23.6 t -71.46 0.97 7.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 110.202 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.681 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 6.5 p-10 -95.45 -49.66 5.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.964 -1.085 . . . . 0.0 110.233 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.681 ' N ' ' OD1' ' A' ' 61' ' ' ASN . 11.6 m-30 -61.11 -56.94 15.0 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.337 -0.852 . . . . 0.0 111.211 -178.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.558 ' HA ' ' HA ' ' A' ' 15' ' ' ALA . 3.7 m -79.19 157.29 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 122.175 0.988 . . . . 0.0 111.443 -177.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.601 ' CB ' ' CD1' ' A' ' 16' ' ' LEU . . . -138.05 163.0 32.69 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.512 ' HA ' HG11 ' A' ' 13' ' ' VAL . 19.0 ttmm . . . . . 0 N--CA 1.489 1.488 0 O-C-N 121.036 -1.04 . . . . 0.0 109.17 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . 0.645 ' CD2' ' CE2' ' A' ' 62' ' ' TYR . 25.0 mt . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 121.494 0.664 . . . . 0.0 109.689 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 1.004 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.1 Cg_endo -66.29 170.94 11.14 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.508 2.139 . . . . 0.0 111.254 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . 0.576 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 56.1 Cg_endo -79.05 -34.29 1.22 Allowed 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 122.903 2.402 . . . . 0.0 114.154 -177.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . 0.699 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.1 OUTLIER 78.27 84.26 0.09 OUTLIER Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 120.982 -1.074 . . . . 0.0 108.711 -178.865 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . 0.501 ' HD2' HD21 ' B' ' 186' ' ' LEU . 51.1 Cg_endo -71.65 139.27 33.68 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.791 2.328 . . . . 0.0 112.125 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.483 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 38.6 62.23 1.06 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.504 -0.747 . . . . 0.0 109.582 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . 0.484 ' N ' ' ND2' ' B' ' 185' ' ' ASN . 0.6 OUTLIER 44.68 48.58 8.78 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.273 -0.892 . . . . 0.0 109.157 -179.699 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . 0.617 ' CD2' ' HB2' ' A' ' 44' ' ' TRP . 56.2 tp -64.92 -83.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.413 -0.804 . . . . 0.0 109.352 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . 0.72 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.485 1.948 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.45 ' O ' HG12 ' A' ' 37' ' ' VAL . 73.4 m-20 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 19.9 mm -92.4 137.23 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.565 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.1 m -131.44 160.2 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.459 -0.776 . . . . 0.0 109.097 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.2 p -121.64 138.43 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 109.346 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.562 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -70.04 132.03 45.25 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.26 -0.9 . . . . 0.0 109.747 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.587 ' CD1' ' CB ' ' A' ' 64' ' ' ALA . 28.3 mt -98.03 -13.61 20.97 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.57 ' CD1' ' O ' ' A' ' 16' ' ' LEU . 56.2 m-85 -155.46 152.7 25.16 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 42.6 Cg_endo -66.04 149.42 85.98 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 121.554 1.502 . . . . 0.0 109.589 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.832 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 20.6 t80 -102.34 -175.85 2.94 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.176 -1.41 . . . . 0.0 110.535 -178.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.735 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 31.2 m-20 -112.99 85.92 2.27 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.572 -0.705 . . . . 0.0 110.065 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.19 92.03 0.05 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.519 -1.832 . . . . 0.0 108.519 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.519 HG12 ' O ' ' A' ' 20' ' ' ASP . 0.4 OUTLIER -107.75 -42.94 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.262 -1.14 . . . . 0.0 108.767 179.604 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.572 ' CE1' ' NH2' ' B' ' 182' ' ' ARG . 56.3 m80 -76.09 156.93 83.81 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.4 -13.23 35.23 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.156 1.904 . . . . 0.0 111.859 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -112.65 -13.78 13.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 110.462 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.47 ' OD2' ' OH ' ' A' ' 19' ' ' TYR . 43.2 m-20 -57.39 138.9 54.41 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.764 -1.21 . . . . 0.0 109.793 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.641 HD23 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -94.95 121.99 37.14 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.641 ' N ' HD23 ' A' ' 27' ' ' LEU . 1.1 m -78.77 139.25 38.44 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.153 -0.967 . . . . 0.0 109.598 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.832 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 17.5 p90 -146.87 158.1 43.83 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.242 -0.911 . . . . 0.0 108.918 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 mtmm -111.79 174.33 5.93 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.138 -0.976 . . . . 0.0 109.41 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.493 ' HD3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -66.73 153.02 44.32 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.12 -0.988 . . . . 0.0 109.305 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.27 -7.96 4.27 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.419 ' H ' ' C ' ' A' ' 31' ' ' LYS . 3.4 tt0 -74.53 144.03 44.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.918 -1.342 . . . . 0.0 109.615 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.415 ' HD3' HD11 ' A' ' 50' ' ' LEU . 2.6 ptpt -96.67 136.12 37.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.517 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.561 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 1.7 mpp? -137.85 153.69 49.57 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.415 0.626 . . . . 0.0 109.528 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.696 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 2.2 ttpt -110.87 125.42 53.61 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.377 -0.827 . . . . 0.0 109.004 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -87.65 128.43 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.9 . . . . 0.0 108.753 178.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 26.1 mt -88.58 -29.7 19.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 109.945 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -176.99 130.99 0.18 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.147 -0.971 . . . . 0.0 109.834 -179.444 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.642 ' HA ' ' CD1' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -78.53 132.44 37.2 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.441 -0.787 . . . . 0.0 109.162 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.604 ' CB ' HD13 ' B' ' 186' ' ' LEU . 18.7 m-70 -111.57 30.78 6.66 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.223 -0.923 . . . . 0.0 110.543 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.455 ' N ' ' OE2' ' A' ' 40' ' ' GLU . . . 108.73 -47.25 1.06 Allowed Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.516 -1.325 . . . . 0.0 110.744 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.411 ' HB2' ' HD3' ' B' ' 183' ' ' PRO . 0.0 OUTLIER -159.2 -5.9 0.07 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.023 -1.281 . . . . 0.0 110.388 -179.571 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.768 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 65.4 m95 -141.68 99.87 3.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.038 -1.039 . . . . 0.0 109.276 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.679 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -94.68 148.66 22.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.031 -1.043 . . . . 0.0 109.454 -179.621 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 17.7 tttt -88.56 109.11 19.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.256 -0.903 . . . . 0.0 108.973 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.696 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -100.97 178.6 4.62 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.449 -0.782 . . . . 0.0 109.863 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 2.7 mttt -121.1 129.78 53.45 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.647 -0.658 . . . . 0.0 109.588 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.557 ' HB2' ' HB3' ' A' ' 54' ' ' LYS . 1.1 t -77.6 128.41 34.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 110.056 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.415 HD11 ' HD3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -72.92 -9.25 58.5 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 tp -52.32 -54.92 25.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.407 -0.808 . . . . 0.0 109.383 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.611 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 2.6 t -161.5 29.35 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 110.041 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.611 ' CB ' ' O ' ' A' ' 52' ' ' THR . 8.7 mmtm 86.68 44.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.502 -0.749 . . . . 0.0 110.488 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -85.0 133.25 34.26 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.183 -0.948 . . . . 0.0 108.488 178.61 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.93 114.34 20.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.923 -1.111 . . . . 0.0 109.215 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.59 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -152.57 169.21 31.69 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.366 -1.397 . . . . 0.0 109.89 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.699 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 7.7 m-85 -73.4 132.0 42.49 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.546 -0.973 . . . . 0.0 109.57 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.529 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 11.0 pt -121.96 140.98 33.13 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.875 . . . . 0.0 109.069 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.577 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 49.2 Cg_endo -69.54 149.42 68.25 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.176 1.918 . . . . 0.0 112.094 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.523 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 21.2 t -77.57 7.78 5.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.328 -0.857 . . . . 0.0 110.656 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.74 -51.8 2.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.824 -1.173 . . . . 0.0 110.672 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.67 ' CE2' ' HA ' ' A' ' 19' ' ' TYR . 2.6 m-30 -48.96 -52.16 26.32 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.105 -0.997 . . . . 0.0 110.83 -178.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.561 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.7 m -88.91 155.52 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -0.972 . . . . 0.0 111.19 -178.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.587 ' CB ' ' CD1' ' A' ' 16' ' ' LEU . . . -134.09 162.38 32.25 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.497 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 3.2 ptmt . . . . . 0 N--CA 1.49 1.545 0 O-C-N 120.954 -1.091 . . . . 0.0 109.344 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . 0.614 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 121.685 0.755 . . . . 0.0 109.802 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.768 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.4 Cg_endo -68.96 -172.3 0.48 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.068 2.512 . . . . 0.0 111.326 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . 0.814 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 52.7 Cg_endo -91.48 -35.17 0.06 OUTLIER 'Trans proline' 0 C--O 1.212 -0.783 0 C-N-CA 122.788 2.325 . . . . 0.0 114.694 -177.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . 0.814 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 32.4 mtt180 87.83 96.27 0.03 OUTLIER Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.314 -0.866 . . . . 0.0 109.013 -178.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . 0.501 ' HD2' ' CB ' ' B' ' 186' ' ' LEU . 47.4 Cg_endo -68.78 124.56 11.62 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.76 2.306 . . . . 0.0 111.904 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' B' ' 185' ' ' ASN . . . 45.69 67.4 0.74 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.862 . . . . 0.0 109.495 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' B' ' 184' ' ' ALA . 14.9 m-20 43.08 50.5 5.5 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.354 -0.841 . . . . 0.0 109.535 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . 0.604 HD13 ' CB ' ' A' ' 41' ' ' HIS . 47.7 tp -67.6 -83.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.296 -0.877 . . . . 0.0 109.507 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . 0.699 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.485 1.953 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.473 ' CD1' ' CG ' ' A' ' 36' ' ' LYS . 5.2 tp -109.61 136.64 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.183 -0.948 . . . . 0.0 109.46 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.0 m -131.77 160.2 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.35 -0.844 . . . . 0.0 109.186 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.526 ' CG1' ' HG3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -119.64 138.7 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.068 -1.02 . . . . 0.0 109.302 179.121 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -72.14 133.67 45.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.451 -0.781 . . . . 0.0 109.946 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.587 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 7.6 mt -99.79 -8.31 24.35 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 16' ' ' LEU . 27.6 m-85 -162.29 151.94 13.49 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.721 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 39.2 Cg_endo -62.19 149.16 91.58 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 121.733 1.622 . . . . 0.0 110.05 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.829 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 57.0 t80 -98.63 178.23 5.06 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 118.364 -1.335 . . . . 0.0 110.764 -177.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.68 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 6.4 m-20 -109.22 79.95 1.27 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.47 94.44 0.04 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.409 ' N ' ' O ' ' A' ' 20' ' ' ASP . 21.2 mt -107.17 -42.93 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.108 -1.231 . . . . 0.0 108.803 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.516 ' ND1' ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -76.04 152.69 84.47 Favored Pre-proline 0 C--N 1.3 -1.563 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.516 ' HD2' ' ND1' ' A' ' 23' ' ' HIS . 43.9 Cg_endo -66.68 -11.42 31.8 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.299 1.999 . . . . 0.0 111.567 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.87 -14.68 13.49 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.89 . . . . 0.0 110.215 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' B' ' 187' ' ' GLY . 26.4 m-20 -58.07 142.17 47.73 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.883 -1.135 . . . . 0.0 109.784 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.673 HD23 ' N ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -98.55 122.21 41.46 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.673 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -78.03 139.77 39.12 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.327 -0.858 . . . . 0.0 109.449 179.669 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.829 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 24.3 p90 -145.29 156.74 44.0 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.232 -0.917 . . . . 0.0 108.74 178.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.647 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 3.2 tttp -111.18 174.28 5.94 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.172 -0.955 . . . . 0.0 109.539 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.568 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -67.37 151.85 46.72 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.108 -0.995 . . . . 0.0 109.346 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.96 -7.65 4.15 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.429 ' H ' ' C ' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -74.79 141.89 44.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.04 -1.271 . . . . 0.0 109.611 -179.735 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.526 ' HG3' ' CG1' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -95.86 138.61 33.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.89 . . . . 0.0 109.298 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.608 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 3.7 mpp? -133.2 149.63 52.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.53 -0.731 . . . . 0.0 109.88 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 12.2 mtpt -104.78 119.77 39.8 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.463 -0.773 . . . . 0.0 109.256 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -78.05 109.43 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.342 -0.849 . . . . 0.0 108.887 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.427 HD12 ' HE3' ' A' ' 48' ' ' LYS . 7.3 mt -88.15 -40.22 13.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.905 . . . . 0.0 109.991 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -134.99 97.47 3.75 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.032 -1.043 . . . . 0.0 109.158 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.697 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 0.7 OUTLIER -79.89 113.62 18.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.245 -0.91 . . . . 0.0 109.298 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.564 ' CB ' HD12 ' B' ' 186' ' ' LEU . 55.4 m-70 -106.33 -121.1 0.23 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.48 ' HA2' ' HG3' ' B' ' 183' ' ' PRO . . . -85.5 -124.58 1.43 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.509 ' HB3' ' HB2' ' B' ' 180' ' ' PRO . 7.0 mt-10 -78.46 10.33 3.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -1.104 . . . . 0.0 111.102 -178.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.849 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 64.6 m95 -141.1 98.1 3.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.528 -1.357 . . . . 0.0 109.824 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.697 ' HB3' ' HA ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -92.97 145.24 24.52 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.826 -1.171 . . . . 0.0 110.197 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -85.77 108.06 17.91 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.754 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -100.54 -177.16 3.41 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.264 -0.898 . . . . 0.0 109.97 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -123.94 109.03 13.06 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.648 -0.658 . . . . 0.0 109.394 -179.663 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.617 ' N ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -54.77 127.84 30.18 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.167 -0.958 . . . . 0.0 109.861 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 52' ' ' THR . 0.1 OUTLIER -76.76 -11.46 59.84 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.222 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.461 ' O ' ' HB ' ' A' ' 52' ' ' THR . 4.5 tp -46.06 -20.9 0.11 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.722 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 0.5 OUTLIER 168.1 -21.72 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.371 -0.831 . . . . 0.0 109.935 179.123 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.722 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 140.84 42.48 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.528 -0.733 . . . . 0.0 110.046 179.595 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.617 ' O ' ' N ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -85.67 134.36 33.98 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.131 -0.98 . . . . 0.0 108.424 178.4 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -121.67 114.16 20.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.909 -1.12 . . . . 0.0 109.439 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.599 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -152.49 172.46 31.65 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.67 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 6.8 m-85 -74.49 132.17 41.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.431 -1.04 . . . . 0.0 109.859 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.551 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 7.3 pt -121.42 138.24 27.97 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.629 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 48.6 Cg_endo -69.93 163.06 39.81 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 121.64 1.56 . . . . 0.0 112.01 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.564 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 82.8 p -90.89 8.25 35.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.389 -0.819 . . . . 0.0 110.095 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.91 -54.9 2.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.028 -1.045 . . . . 0.0 110.109 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.577 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 2.3 m-85 -47.24 -63.56 1.01 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.201 -0.937 . . . . 0.0 110.648 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.608 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.5 m -78.73 155.77 4.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.945 0.878 . . . . 0.0 110.96 -177.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.419 ' HB3' ' CD1' ' A' ' 16' ' ' LEU . . . -128.46 157.66 40.5 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp . . . . . 0 C--N 1.301 -1.525 0 O-C-N 120.948 -1.095 . . . . 0.0 109.583 -179.674 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . 0.605 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 121.597 0.713 . . . . 0.0 109.481 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.849 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 37.9 Cg_endo -67.24 -174.65 0.54 Allowed 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.922 2.415 . . . . 0.0 111.648 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . 0.76 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.8 Cg_endo -92.62 -23.69 0.33 Allowed 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 123.022 2.482 . . . . 0.0 114.617 -177.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . 0.76 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 27.6 mtt180 76.47 96.73 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.876 -1.14 . . . . 0.0 109.048 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 45.3 Cg_endo -67.0 107.24 1.29 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.6 2.2 . . . . 0.0 111.408 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' B' ' 185' ' ' ASN . . . 60.65 68.56 0.74 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.306 -0.871 . . . . 0.0 108.864 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . 0.458 ' C ' ' O ' ' B' ' 184' ' ' ALA . 2.9 p30 41.15 49.18 3.14 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.46 -0.775 . . . . 0.0 109.468 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . 0.599 ' CD2' ' HB2' ' A' ' 44' ' ' TRP . 64.5 tp -68.67 -75.33 0.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.357 -0.84 . . . . 0.0 109.278 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . 0.67 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.484 1.838 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.407 ' O ' HG22 ' A' ' 37' ' ' VAL . 79.9 m-20 . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.528 ' CD1' ' HG3' ' A' ' 36' ' ' LYS . 24.2 mm -101.82 136.39 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.134 -0.979 . . . . 0.0 109.553 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.467 HG23 HG21 ' A' ' 37' ' ' VAL . 0.8 OUTLIER -132.07 160.69 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.71 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.459 HG11 ' O ' ' A' ' 14' ' ' VAL . 14.8 p -121.24 137.15 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.001 -1.062 . . . . 0.0 109.341 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.584 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -70.44 135.21 48.5 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.414 -0.804 . . . . 0.0 109.886 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.588 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 18.1 mt -97.73 -28.36 13.92 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.659 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 4.3 m-85 -141.27 155.79 67.78 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 39.7 Cg_endo -62.13 145.39 96.41 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 121.692 1.594 . . . . 0.0 110.73 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.72 ' O ' ' CB ' ' A' ' 20' ' ' ASP . 23.7 t80 -70.36 -76.45 0.1 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.448 -0.782 . . . . 0.0 112.102 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.72 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 6.0 m-20 127.03 72.46 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -178.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.57 82.77 0.01 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.189 -1.165 . . . . 0.0 110.189 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.55 ' N ' ' O ' ' A' ' 20' ' ' ASP . 9.4 mm -99.56 0.96 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.979 -1.306 . . . . 0.0 108.226 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.485 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -122.64 152.6 62.14 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.753 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.25 -14.49 34.6 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.838 1.692 . . . . 0.0 111.986 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.73 -19.11 11.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.401 -0.812 . . . . 0.0 110.875 -178.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.485 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.8 OUTLIER -55.72 139.34 45.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.872 -1.142 . . . . 0.0 110.103 -178.773 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.649 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.3 OUTLIER -87.79 117.32 26.55 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.315 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.566 ' N ' HD23 ' A' ' 27' ' ' LEU . 3.8 m -76.87 138.7 39.93 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.331 -0.856 . . . . 0.0 110.216 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.691 ' CE2' ' HB2' ' A' ' 19' ' ' TYR . 10.6 p90 -143.38 154.77 44.07 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 0.8 OUTLIER -111.18 171.28 7.57 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.006 -1.058 . . . . 0.0 109.652 -179.291 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.509 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -63.15 152.19 38.04 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.201 -0.937 . . . . 0.0 109.081 179.792 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 68.02 -7.59 2.32 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.438 ' H ' ' C ' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -74.15 143.4 45.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.827 -1.396 . . . . 0.0 110.009 -179.461 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.406 ' HE2' ' HB2' ' A' ' 34' ' ' LYS . 3.9 mppt? -95.22 137.14 34.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.34 -0.85 . . . . 0.0 109.457 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.571 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -136.13 151.88 50.24 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.611 -0.68 . . . . 0.0 109.813 -179.448 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.528 ' HG3' ' CD1' ' A' ' 12' ' ' ILE . 4.5 ttmt -109.87 126.79 54.21 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.455 -0.778 . . . . 0.0 109.776 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.467 HG21 HG23 ' A' ' 13' ' ' VAL . 1.4 t -82.68 138.28 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.386 -0.821 . . . . 0.0 108.942 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 36' ' ' LYS . 6.3 mp -112.54 -31.0 6.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.07 -1.019 . . . . 0.0 109.927 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.03 96.08 1.2 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.184 -0.948 . . . . 0.0 109.303 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.577 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 1.0 OUTLIER -49.93 130.52 21.9 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.477 -0.764 . . . . 0.0 108.993 179.646 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.594 ' O ' HD22 ' B' ' 186' ' ' LEU . 1.8 m-70 -128.51 102.12 6.48 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.486 ' C ' ' O ' ' A' ' 41' ' ' HIS . . . 41.18 -142.37 0.93 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.612 ' CB ' ' HD2' ' B' ' 181' ' ' PRO . 4.7 mt-10 -77.1 11.04 1.99 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -1.137 . . . . 0.0 110.707 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 1.028 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 64.5 m95 -137.4 100.36 4.21 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.668 -1.27 . . . . 0.0 109.67 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.58 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -94.44 149.27 21.41 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.817 -1.177 . . . . 0.0 110.215 -179.616 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -95.52 110.96 22.96 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.112 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -107.33 -175.3 2.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.177 -0.952 . . . . 0.0 110.297 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 9.9 ttpt -125.14 130.75 52.83 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.646 -0.659 . . . . 0.0 109.595 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.591 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -76.35 128.21 34.4 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 109.735 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.48 -6.11 46.46 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.435 HD22 HG23 ' A' ' 52' ' ' THR . 6.8 tp -55.9 -54.73 41.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.455 -0.778 . . . . 0.0 109.259 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.598 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.3 t -160.45 29.68 0.16 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.143 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.598 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 85.25 43.03 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.466 -0.771 . . . . 0.0 111.09 178.199 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.591 ' HB2' ' CB ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -86.42 132.5 33.93 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.474 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 12.9 pt-20 -122.62 118.91 29.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.937 -1.102 . . . . 0.0 109.387 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.649 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -155.6 166.57 32.85 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.013 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.718 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 7.0 m-85 -71.87 134.97 46.4 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.7 -0.883 . . . . 0.0 109.695 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.517 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 3.0 pt -124.55 144.89 47.53 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.406 -0.809 . . . . 0.0 109.148 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.612 ' HG3' ' CD2' ' B' ' 179' ' ' LEU . 47.1 Cg_endo -69.31 162.67 40.91 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 121.977 1.785 . . . . 0.0 111.393 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.512 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 98.2 p -92.13 8.98 35.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.016 -1.052 . . . . 0.0 110.894 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.575 ' C ' ' OD1' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -112.08 -51.7 2.83 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.765 -1.209 . . . . 0.0 110.153 -179.581 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.659 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 1.3 m-85 -44.66 -62.22 1.28 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.163 -0.961 . . . . 0.0 110.787 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.571 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.9 m -79.64 156.7 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 122.104 0.954 . . . . 0.0 111.486 -177.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.49 ' HB1' ' CD1' ' A' ' 16' ' ' LEU . . . -133.35 161.22 35.1 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.9 tttp . . . . . 0 N--CA 1.489 1.519 0 O-C-N 120.995 -1.066 . . . . 0.0 109.395 179.956 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . 0.64 ' CD2' ' CE2' ' A' ' 62' ' ' TYR . 30.1 mt . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 121.443 0.639 . . . . 0.0 109.657 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 1.028 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.3 Cg_endo -65.92 177.08 3.18 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.781 2.321 . . . . 0.0 111.83 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . 0.617 ' O ' ' CB ' ' B' ' 182' ' ' ARG . 53.9 Cg_endo -73.65 -48.01 0.26 Allowed 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.933 2.422 . . . . 0.0 113.873 -177.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . 0.694 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.0 OUTLIER 84.81 91.78 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.151 -0.968 . . . . 0.0 108.946 -178.724 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . 0.731 ' HD2' HD21 ' B' ' 186' ' ' LEU . 43.9 Cg_endo -69.07 129.66 18.74 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 123.085 2.523 . . . . 0.0 112.326 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 38.21 67.03 0.43 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.477 -0.764 . . . . 0.0 109.464 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . 0.484 ' N ' ' ND2' ' B' ' 185' ' ' ASN . 0.5 OUTLIER 42.93 43.47 3.56 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.357 -0.84 . . . . 0.0 109.026 -179.55 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . 0.731 HD21 ' HD2' ' B' ' 183' ' ' PRO . 42.4 tp -54.27 -94.54 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . 0.718 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 107.474 -2.25 . . . . 0.0 107.474 178.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.435 ' O ' HG22 ' A' ' 37' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.451 HD12 ' HG3' ' A' ' 36' ' ' LYS . 17.6 mm -92.93 136.67 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 109.618 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.515 ' CG1' ' HD3' ' A' ' 65' ' ' LYS . 1.1 m -132.14 161.8 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.6 p -120.97 139.2 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.137 -0.977 . . . . 0.0 109.075 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.525 ' HB3' ' CD1' ' A' ' 29' ' ' PHE . . . -71.05 132.92 45.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.346 -0.846 . . . . 0.0 109.807 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.582 ' CD1' ' CB ' ' A' ' 64' ' ' ALA . 24.4 mt -98.66 -11.97 21.51 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.572 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 54.8 m-85 -159.55 153.69 19.96 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.661 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 42.0 Cg_endo -64.55 149.09 90.49 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 121.672 1.582 . . . . 0.0 109.983 179.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.796 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 56.4 t80 -97.79 178.6 5.09 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 118.303 -1.359 . . . . 0.0 110.265 -177.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.682 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 12.2 m-20 -109.47 80.66 1.34 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.56 -0.713 . . . . 0.0 109.322 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.51 95.38 0.06 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.6 mt -108.5 -42.24 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.157 -1.202 . . . . 0.0 108.896 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.462 ' HB2' ' CG ' ' A' ' 26' ' ' ASP . 3.4 m-70 -76.98 159.6 78.19 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -71.11 -12.12 29.89 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.141 1.894 . . . . 0.0 111.778 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -113.86 -14.94 12.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 110.869 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.462 ' CG ' ' HB2' ' A' ' 23' ' ' HIS . 90.7 m-20 -57.19 139.47 52.54 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.719 -1.238 . . . . 0.0 109.955 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.628 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.4 OUTLIER -93.77 120.86 34.58 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.005 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.551 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -80.68 141.41 34.93 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.351 -0.843 . . . . 0.0 109.595 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.796 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 30.5 p90 -146.05 157.79 43.86 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.181 -0.949 . . . . 0.0 108.599 178.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 6.4 mttt -110.7 173.7 6.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.147 -0.97 . . . . 0.0 109.594 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.537 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -67.43 151.43 47.42 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.141 -0.975 . . . . 0.0 109.314 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.96 -8.25 4.79 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 31' ' ' LYS . 3.1 tt0 -75.84 143.63 41.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.953 -1.322 . . . . 0.0 109.755 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.31 138.95 33.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 109.509 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.576 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 2.5 mpp? -134.91 151.47 50.91 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.564 -0.71 . . . . 0.0 109.761 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 8.3 ttpp -105.15 124.13 49.0 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.507 -0.745 . . . . 0.0 109.53 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 11' ' ' ASP . 2.2 t -81.13 136.97 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.297 -0.877 . . . . 0.0 109.216 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.584 ' CD1' ' N ' ' A' ' 38' ' ' LEU . 7.1 mp -111.85 -43.36 3.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 109.648 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.05 106.35 3.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.124 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.654 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 0.7 OUTLIER -89.98 118.03 29.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.333 -0.855 . . . . 0.0 109.539 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.589 ' CG ' HD13 ' B' ' 186' ' ' LEU . 1.8 m-70 -81.83 -100.31 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.314 -0.866 . . . . 0.0 109.382 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' ' 43' ' ' GLU . . . -133.34 -14.31 1.4 Allowed Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.664 -1.255 . . . . 0.0 110.065 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 42' ' ' GLY . 6.0 mm-40 -157.52 -16.0 0.08 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.972 -1.31 . . . . 0.0 110.623 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.917 ' CD1' ' HA ' ' B' ' 182' ' ' ARG . 56.3 m95 -137.6 101.65 4.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.673 -1.267 . . . . 0.0 109.485 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.654 ' CD1' ' CG ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -93.32 144.4 25.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.206 -0.934 . . . . 0.0 110.211 -179.313 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.57 ' HG3' ' CD1' ' A' ' 57' ' ' PHE . 11.4 ttpt -90.08 108.08 19.51 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -102.8 -175.3 2.77 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.354 -0.841 . . . . 0.0 109.931 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 17.7 ttpt -125.88 130.43 51.31 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.605 -0.684 . . . . 0.0 109.31 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.599 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 6.9 t -75.84 126.78 31.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.072 -1.017 . . . . 0.0 109.963 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.4 mt -70.81 -7.99 49.3 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.3 tp -53.94 -55.6 25.51 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.53 -0.731 . . . . 0.0 109.445 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.629 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.7 t -161.04 28.14 0.14 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 110.119 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.629 ' CB ' ' O ' ' A' ' 52' ' ' THR . 14.1 mtmm 87.38 44.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.414 -0.804 . . . . 0.0 110.687 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.599 ' HB2' ' CB ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -86.77 131.58 34.09 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.042 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.456 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 2.5 pt-20 -122.01 118.46 28.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.879 -1.138 . . . . 0.0 109.625 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.628 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -157.66 168.36 34.32 Favored Glycine 0 N--CA 1.487 2.068 0 C-N-CA 119.427 -1.368 . . . . 0.0 109.904 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.76 ' CD2' ' HA3' ' B' ' 187' ' ' GLY . 27.1 m-85 -70.98 132.39 45.1 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.57 -0.959 . . . . 0.0 109.883 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.468 ' O ' HG13 ' A' ' 58' ' ' ILE . 6.6 pt -121.08 141.64 33.26 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.619 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 46.6 Cg_endo -69.18 154.86 69.38 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 121.721 1.614 . . . . 0.0 111.836 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.621 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 73.7 p -83.96 7.12 19.35 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.364 -0.835 . . . . 0.0 110.252 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.13 -53.28 2.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.936 -1.102 . . . . 0.0 110.515 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.572 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 2.6 m-85 -48.44 -62.72 1.35 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.075 -1.016 . . . . 0.0 111.173 -178.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.576 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 3.0 m -78.11 155.5 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 122.079 0.942 . . . . 0.0 111.18 -177.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.582 ' CB ' ' CD1' ' A' ' 16' ' ' LEU . . . -136.02 163.29 30.64 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.515 ' HD3' ' CG1' ' A' ' 13' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.046 -1.034 . . . . 0.0 109.228 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . 0.596 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 121.823 0.82 . . . . 0.0 109.875 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.704 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 42.9 Cg_endo -72.44 -170.66 0.61 Allowed 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.976 2.451 . . . . 0.0 110.211 178.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . 0.788 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 51.6 Cg_endo -87.06 -67.54 0.01 OUTLIER 'Trans proline' 0 C--O 1.212 -0.79 0 C-N-CA 121.991 1.794 . . . . 0.0 112.198 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . 0.917 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.8 OUTLIER 141.05 112.78 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.078 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . 0.573 ' HG2' ' CB ' ' B' ' 186' ' ' LEU . 44.1 Cg_endo -67.45 127.14 15.97 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 123.04 2.493 . . . . 0.0 112.087 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.491 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 37.99 52.88 1.57 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.378 -0.826 . . . . 0.0 109.375 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . 0.492 ' N ' ' ND2' ' B' ' 185' ' ' ASN . 0.2 OUTLIER 46.28 44.33 12.32 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.369 -0.832 . . . . 0.0 109.104 -179.526 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . 0.735 ' CD2' ' N ' ' B' ' 187' ' ' GLY . 7.8 tt -72.8 -82.83 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.479 -0.763 . . . . 0.0 108.97 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . 0.76 ' HA3' ' CD2' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.48 1.616 0 N-CA-C 108.161 -1.976 . . . . 0.0 108.161 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.63 108.36 1.57 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.41 172.78 11.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -1.136 . . . . 0.0 109.332 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.38 136.93 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.189 -0.945 . . . . 0.0 109.54 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.448 HG21 HG21 ' A' ' 37' ' ' VAL . 1.8 m -131.51 160.42 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.372 -0.83 . . . . 0.0 108.929 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.43 HG21 ' O ' ' A' ' 33' ' ' GLU . 10.8 p -121.12 137.64 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.965 -1.085 . . . . 0.0 109.295 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -71.04 134.51 47.15 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.445 -0.785 . . . . 0.0 110.108 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.567 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 42.1 mt -98.37 -14.97 19.9 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.642 ' CD2' ' CD ' ' B' ' 177' ' ' PRO . 4.7 m-85 -157.45 155.48 27.47 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.0 Cg_endo -62.42 146.05 95.67 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.58 1.52 . . . . 0.0 110.381 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.759 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 8.8 t80 -76.34 -68.76 0.56 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.222 -0.924 . . . . 0.0 112.04 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.758 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 40.9 t0 122.79 70.94 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -177.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -54.28 94.36 0.02 OUTLIER Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 20' ' ' ASP . 0.6 OUTLIER -105.0 -44.2 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.143 -1.21 . . . . 0.0 107.822 178.552 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.578 ' CE1' ' HA ' ' B' ' 188' ' ' GLU . 13.2 m-70 -75.48 156.35 85.24 Favored Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.6 -11.52 26.24 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.026 1.817 . . . . 0.0 111.994 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.69 -16.14 12.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.216 -0.927 . . . . 0.0 110.813 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 18.4 m-20 -57.24 138.89 54.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.839 -1.163 . . . . 0.0 110.422 -178.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.632 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -88.96 119.04 29.13 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.599 ' N ' HD23 ' A' ' 27' ' ' LEU . 4.8 p -77.79 138.03 38.76 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.224 -0.923 . . . . 0.0 110.179 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.759 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 8.1 p90 -143.78 155.24 44.09 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.536 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 7.2 mmtp -111.74 176.76 4.89 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.027 -1.046 . . . . 0.0 109.613 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.587 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -67.52 151.01 48.1 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.08 -1.013 . . . . 0.0 109.142 179.524 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.52 -7.76 3.55 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.749 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 1.1 mt-10 -74.75 144.15 43.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.868 -1.372 . . . . 0.0 109.938 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.482 ' CG ' HD11 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -95.78 138.08 33.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.0 109.406 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.555 ' CE ' HG13 ' A' ' 63' ' ' VAL . 0.9 OUTLIER -136.19 151.95 50.26 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.596 -0.69 . . . . 0.0 109.912 -179.423 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 4.5 ttpm? -105.87 124.27 49.31 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.442 -0.786 . . . . 0.0 109.498 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.448 HG21 HG21 ' A' ' 13' ' ' VAL . 2.0 t -80.98 137.23 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.359 -0.838 . . . . 0.0 108.92 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.1 mt -113.85 -39.48 3.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.113 -0.992 . . . . 0.0 109.688 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -150.82 91.43 1.72 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.939 . . . . 0.0 108.924 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.573 ' HG2' ' CD1' ' A' ' 45' ' ' TRP . 1.6 tm-20 -79.35 115.39 18.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.361 -0.837 . . . . 0.0 109.795 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.598 ' CG ' HD12 ' B' ' 186' ' ' LEU . 68.4 m-70 -79.08 -98.32 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.361 -0.837 . . . . 0.0 109.223 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.474 ' C ' ' HG2' ' A' ' 43' ' ' GLU . . . -143.33 -12.33 0.36 Allowed Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.664 -1.255 . . . . 0.0 110.197 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.533 ' O ' ' HG3' ' B' ' 180' ' ' PRO . 7.1 mm-40 -148.5 -25.57 0.33 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.002 -1.293 . . . . 0.0 110.171 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.767 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 64.9 m95 -135.5 102.85 5.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.947 -1.095 . . . . 0.0 109.568 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.611 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -90.8 141.66 28.57 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.075 -1.015 . . . . 0.0 109.985 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.516 ' HG2' ' C ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -90.5 106.53 18.56 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.13 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.52 -176.73 3.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.171 -0.956 . . . . 0.0 110.173 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 6.9 tttt -124.59 128.87 49.56 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.651 -0.656 . . . . 0.0 109.521 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.591 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -73.37 125.24 27.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.156 -0.965 . . . . 0.0 109.938 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.482 HD11 ' CG ' ' A' ' 34' ' ' LYS . 2.9 mp -71.22 -8.29 52.56 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 tp -53.72 -54.68 34.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.614 -0.679 . . . . 0.0 109.381 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.596 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 2.0 t -161.3 29.47 0.14 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 110.215 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.596 ' CB ' ' O ' ' A' ' 52' ' ' THR . 5.7 mtmt 86.31 44.0 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.403 -0.811 . . . . 0.0 110.585 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.591 ' HB2' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER -87.09 133.13 33.64 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.124 -0.985 . . . . 0.0 108.449 178.421 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -122.58 119.29 30.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.876 -1.14 . . . . 0.0 109.256 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.632 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -158.08 167.76 34.42 Favored Glycine 0 N--CA 1.487 2.092 0 C-N-CA 119.316 -1.421 . . . . 0.0 110.022 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.676 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 10.4 m-85 -73.61 133.03 43.4 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.57 -0.959 . . . . 0.0 110.009 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.516 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 4.0 pt -122.07 139.44 30.43 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.737 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 46.0 Cg_endo -68.6 145.77 65.12 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 121.878 1.719 . . . . 0.0 112.086 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.596 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 38.5 p -75.97 5.02 7.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.409 -0.807 . . . . 0.0 110.635 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.455 ' OD1' ' CG ' ' B' ' 177' ' ' PRO . 0.1 OUTLIER -105.72 -53.1 2.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.912 -1.117 . . . . 0.0 110.613 -179.186 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.608 ' CD2' ' HA ' ' A' ' 19' ' ' TYR . 4.0 m-85 -51.27 -60.73 2.8 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.116 -0.99 . . . . 0.0 110.788 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.555 HG13 ' CE ' ' A' ' 35' ' ' MET . 3.1 m -78.82 158.55 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 122.094 0.95 . . . . 0.0 111.302 -177.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.4 ' HB1' ' CD1' ' A' ' 16' ' ' LEU . . . -134.61 160.63 37.49 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.422 ' HA ' HG13 ' A' ' 13' ' ' VAL . 0.7 OUTLIER -74.35 150.16 40.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.916 -1.115 . . . . 0.0 109.422 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.4 tp -51.42 -27.91 11.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.43 -0.794 . . . . 0.0 110.012 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -77.29 -94.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.062 -1.024 . . . . 0.0 109.375 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.059 -1.026 . . . . 0.0 109.436 179.988 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 24.4 p90 . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . 0.571 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 1.4 t0 -167.25 -57.3 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.235 -0.916 . . . . 0.0 108.848 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 46.9 Cg_endo -67.51 -89.71 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.694 2.263 . . . . 0.0 111.867 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' GLY . . . . . . . . . . . . . . . 92.38 31.76 8.72 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.92 77.35 5.1 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.247 -1.149 . . . . 0.0 109.484 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . 0.504 ' O ' HG22 ' B' ' 176' ' ' THR . 50.5 Cg_endo -92.22 172.26 2.46 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.172 2.581 . . . . 0.0 111.836 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' THR . . . . . 0.546 ' CG2' ' HB3' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 173.47 101.09 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.346 -0.846 . . . . 0.0 109.437 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 177' ' ' PRO . . . . . 0.642 ' CD ' ' CD2' ' A' ' 17' ' ' TYR . 51.3 Cg_endo -71.89 159.2 51.11 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.668 2.246 . . . . 0.0 111.522 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . 0.407 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 48.0 Cg_endo -68.94 142.96 53.16 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.526 2.15 . . . . 0.0 111.242 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . 0.55 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -81.46 172.93 8.52 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.009 -1.057 . . . . 0.0 109.558 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.767 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.9 Cg_endo -70.69 -174.57 1.12 Allowed 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.902 2.401 . . . . 0.0 111.485 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . 0.734 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.1 Cg_endo -92.19 -23.04 0.41 Allowed 'Trans proline' 0 C--O 1.213 -0.726 0 C-N-CA 122.956 2.437 . . . . 0.0 114.347 -177.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . 0.734 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 41.5 mtt180 78.41 95.62 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.001 -1.062 . . . . 0.0 109.197 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 42.4 Cg_endo -66.02 114.44 2.99 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.634 2.223 . . . . 0.0 111.735 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' B' ' 185' ' ' ASN . . . 56.15 50.81 12.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.423 -0.798 . . . . 0.0 109.584 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' B' ' 184' ' ' ALA . 9.5 m-80 60.26 45.82 10.94 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.155 -0.966 . . . . 0.0 109.426 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . 0.598 HD12 ' CG ' ' A' ' 41' ' ' HIS . 49.2 tp -65.36 -78.09 0.05 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.344 -0.848 . . . . 0.0 109.058 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . 0.676 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . -73.08 2.01 37.49 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.578 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 16.6 mt-10 -81.2 -87.43 0.08 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.195 -1.18 . . . . 0.0 109.414 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 189' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.01 171.47 7.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.889 . . . . 0.0 109.49 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . 0.465 ' O ' ' CB ' ' B' ' 191' ' ' ALA . 36.9 mt-30 -66.88 99.67 0.65 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 109.505 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 191' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' B' ' 190' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.515 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.38 0.609 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.17 88.86 0.05 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.91 172.53 8.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.328 -1.101 . . . . 0.0 109.243 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -112.07 137.24 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -0.962 . . . . 0.0 109.536 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.419 HG23 ' CG2' ' A' ' 37' ' ' VAL . 1.1 m -131.1 160.44 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.371 -0.831 . . . . 0.0 108.97 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.92 139.91 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.007 -1.058 . . . . 0.0 109.341 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.515 ' HB3' ' CD1' ' A' ' 29' ' ' PHE . . . -73.36 133.31 43.77 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.448 -0.783 . . . . 0.0 109.989 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.589 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 79.6 mt -99.55 -15.2 18.71 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.589 ' CE1' ' HB2' ' A' ' 16' ' ' LEU . 1.0 OUTLIER -155.96 154.07 26.96 Favored Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.448 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.696 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.6 Cg_endo -63.3 150.13 89.41 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 121.823 1.682 . . . . 0.0 110.276 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.769 ' O ' ' CB ' ' A' ' 20' ' ' ASP . 39.6 t80 -93.32 -33.01 14.07 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.068 -1.453 . . . . 0.0 110.541 -178.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.769 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 29.9 t0 107.57 -53.67 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.431 -0.793 . . . . 0.0 110.446 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.33 79.5 0.76 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.3 mt -97.66 -46.03 12.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.61 ' CD2' ' O ' ' B' ' 188' ' ' GLU . 3.7 t60 -73.31 146.01 86.15 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.606 ' HD2' ' CD2' ' A' ' 23' ' ' HIS . 43.7 Cg_endo -66.28 -11.47 31.52 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 121.898 1.732 . . . . 0.0 111.342 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -114.1 -18.91 11.56 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.514 -0.741 . . . . 0.0 110.117 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.468 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.6 OUTLIER -57.81 144.23 39.31 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.004 -1.06 . . . . 0.0 109.919 -178.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.663 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.6 OUTLIER -91.23 118.47 30.5 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.178 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.568 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -83.28 145.04 29.32 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.597 -0.69 . . . . 0.0 109.153 179.266 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.746 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 18.7 p90 -148.15 160.75 42.58 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 11.6 mmtt -111.34 172.22 7.01 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.069 -1.02 . . . . 0.0 109.504 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.583 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -66.55 152.2 45.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.201 -0.937 . . . . 0.0 109.392 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 71.84 -8.01 6.6 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 31' ' ' LYS . 1.8 tt0 -76.58 142.05 40.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.018 -1.284 . . . . 0.0 109.785 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.3 138.89 33.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.892 . . . . 0.0 109.204 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.603 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 3.2 mpp? -136.11 152.32 50.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.644 -0.66 . . . . 0.0 109.662 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 3.7 ttpm? -109.62 126.19 53.37 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.48 -0.763 . . . . 0.0 109.503 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.419 ' CG2' HG23 ' A' ' 13' ' ' VAL . 2.2 t -82.13 129.39 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.389 -0.819 . . . . 0.0 109.003 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 mp -102.05 -44.18 5.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.113 -0.992 . . . . 0.0 109.785 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.1 103.51 3.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.164 -0.96 . . . . 0.0 109.085 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.59 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 1.8 tm-20 -81.08 127.31 32.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.357 -0.839 . . . . 0.0 109.656 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.574 ' CG ' HD12 ' B' ' 186' ' ' LEU . 63.9 m-70 -87.57 -105.56 0.07 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.348 -0.845 . . . . 0.0 109.182 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.469 ' O ' ' HG2' ' A' ' 43' ' ' GLU . . . -127.05 -19.83 1.91 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.581 ' HG3' ' CG ' ' B' ' 181' ' ' PRO . 1.1 mm-40 -157.24 -12.8 0.09 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.993 -1.298 . . . . 0.0 110.563 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 1.044 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 50.2 m95 -135.81 101.45 4.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.002 -1.061 . . . . 0.0 108.415 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.62 ' CZ2' ' CB ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -92.05 149.02 21.74 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.146 -0.971 . . . . 0.0 110.566 -178.849 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 4.9 tttt -92.9 107.28 19.1 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.91 -173.68 2.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.248 -0.908 . . . . 0.0 110.003 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 1.1 tttt -126.96 131.16 51.14 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.55 -0.719 . . . . 0.0 109.587 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.603 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 4.9 t -77.25 127.9 33.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.078 -1.014 . . . . 0.0 109.895 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.24 -6.66 44.57 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.239 -0.913 . . . . 0.0 108.55 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.0 tp -54.99 -55.61 28.9 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.345 -0.847 . . . . 0.0 109.228 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.613 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 2.7 t -160.13 28.57 0.17 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.244 -0.91 . . . . 0.0 110.157 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.613 ' HB2' ' O ' ' A' ' 52' ' ' THR . 0.1 OUTLIER 86.32 44.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.52 -0.738 . . . . 0.0 111.065 178.18 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.603 ' HB2' ' CB ' ' A' ' 49' ' ' SER . 1.6 mmpt? -86.61 131.99 34.01 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.15 119.27 30.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.934 -1.104 . . . . 0.0 109.577 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.663 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -159.81 170.5 36.0 Favored Glycine 0 N--CA 1.488 2.13 0 C-N-CA 119.54 -1.314 . . . . 0.0 109.914 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.612 ' CB ' ' HA3' ' B' ' 187' ' ' GLY . 5.2 m-85 -71.77 132.33 44.34 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.56 -0.965 . . . . 0.0 109.804 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.502 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 9.0 pt -121.12 142.55 35.15 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.629 ' HG3' ' CD2' ' B' ' 179' ' ' LEU . 48.6 Cg_endo -70.69 154.45 64.07 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 121.775 1.65 . . . . 0.0 112.226 -178.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.62 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 79.6 p -82.88 6.44 18.44 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -0.903 . . . . 0.0 109.692 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.639 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 9.2 p-10 -106.23 -52.56 2.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.034 -1.041 . . . . 0.0 110.96 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.64 ' CE2' ' CD2' ' B' ' 179' ' ' LEU . 2.9 m-85 -52.1 -61.97 1.93 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.175 -0.953 . . . . 0.0 111.071 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.603 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.7 m -80.48 156.28 4.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 122.034 0.921 . . . . 0.0 111.122 -177.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.411 ' HB1' ' CD1' ' A' ' 16' ' ' LEU . . . -132.83 159.07 40.88 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.51 151.5 39.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.063 -1.023 . . . . 0.0 109.479 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 16.7 tp -123.37 146.26 48.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.512 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -97.35 -84.5 0.37 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.179 -0.951 . . . . 0.0 109.494 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.453 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 16.7 m0 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . 0.598 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 10.5 t0 -172.63 -54.86 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.154 -0.966 . . . . 0.0 109.052 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 46.7 Cg_endo -66.87 -89.1 0.0 OUTLIER 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.593 2.195 . . . . 0.0 111.943 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' GLY . . . . . . . . . . . . . . . 98.66 36.11 4.67 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -162.14 99.75 1.15 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.4 -1.059 . . . . 0.0 109.432 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . 0.552 ' O ' ' CG2' ' B' ' 176' ' ' THR . 52.5 Cg_endo -77.0 -161.16 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.71 2.274 . . . . 0.0 111.738 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 176' ' ' THR . . . . . 0.552 ' CG2' ' O ' ' B' ' 175' ' ' PRO . 0.1 OUTLIER 164.58 113.73 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.458 -0.777 . . . . 0.0 109.227 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 177' ' ' PRO . . . . . 0.531 ' HD3' ' CE1' ' A' ' 17' ' ' TYR . 50.9 Cg_endo -77.83 171.47 17.28 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.659 2.239 . . . . 0.0 111.869 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.29 105.02 1.34 Allowed 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.686 2.257 . . . . 0.0 111.85 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . 0.64 ' CD2' ' CE2' ' A' ' 62' ' ' TYR . 41.8 mt -47.2 160.78 0.33 Allowed Pre-proline 0 N--CA 1.487 1.383 0 O-C-N 121.292 -0.88 . . . . 0.0 109.957 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 1.044 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 41.4 Cg_endo -67.23 179.6 2.32 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 123.108 2.539 . . . . 0.0 111.269 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . 0.613 ' HD2' ' HB2' ' B' ' 180' ' ' PRO . 55.4 Cg_endo -75.74 -48.79 0.14 Allowed 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.697 2.264 . . . . 0.0 113.527 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . 0.652 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.0 OUTLIER 80.59 81.66 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.07 -1.019 . . . . 0.0 108.879 -178.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . 0.495 ' O ' ' C ' ' B' ' 184' ' ' ALA . 54.6 Cg_endo -74.06 141.64 29.93 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.784 2.323 . . . . 0.0 112.114 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 37.74 62.7 0.87 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.835 . . . . 0.0 109.688 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . 0.445 ' HB3' ' HB3' ' B' ' 188' ' ' GLU . 0.4 OUTLIER 43.05 48.14 5.22 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -0.888 . . . . 0.0 109.197 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . 0.611 ' CD2' ' HB2' ' A' ' 44' ' ' TRP . 63.6 tp -64.54 -79.71 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.379 -0.826 . . . . 0.0 109.472 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . 0.612 ' HA3' ' CB ' ' A' ' 57' ' ' PHE . . . -63.76 -12.53 48.05 Favored Glycine 0 N--CA 1.481 1.695 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.61 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 0.2 OUTLIER -75.57 -80.06 0.09 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.539 -0.977 . . . . 0.0 109.299 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 189' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -79.93 -176.53 5.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -0.871 . . . . 0.0 109.422 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . 0.508 ' HG3' ' N ' ' B' ' 191' ' ' ALA . 0.0 OUTLIER -123.01 -24.99 4.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.522 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 191' ' ' ALA . . . . . 0.508 ' N ' ' HG3' ' B' ' 190' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.406 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.358 0.599 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 11' ' ' ASP . . . 115.66 -86.99 0.43 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.537 ' N ' ' HB ' ' A' ' 37' ' ' VAL . 9.5 m-20 64.09 -167.29 0.22 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -1.085 . . . . 0.0 109.929 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 18.8 mm -71.86 133.26 32.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.427 -0.796 . . . . 0.0 109.843 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.485 HG21 HG21 ' A' ' 37' ' ' VAL . 1.7 m -131.65 161.47 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.469 HG22 ' HG3' ' A' ' 34' ' ' LYS . 9.9 p -120.28 138.1 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.854 -1.154 . . . . 0.0 109.475 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.496 ' HA ' HG13 ' A' ' 63' ' ' VAL . . . -71.87 133.9 45.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.44 -0.788 . . . . 0.0 110.225 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.49 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 20.7 mt -98.89 -12.38 20.8 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.608 ' CD2' ' HD2' ' B' ' 177' ' ' PRO . 39.9 m-85 -158.57 154.84 24.06 Favored Pre-proline 0 N--CA 1.487 1.386 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.67 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 41.2 Cg_endo -64.68 148.75 90.37 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 121.723 1.615 . . . . 0.0 109.721 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.778 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 51.7 t80 -97.68 177.12 5.59 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 118.188 -1.405 . . . . 0.0 110.388 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.683 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 4.3 t0 -109.8 79.07 1.18 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.673 -0.642 . . . . 0.0 109.655 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.69 86.37 0.01 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.601 ' N ' ' O ' ' A' ' 20' ' ' ASP . 40.7 mt -105.99 -0.5 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.057 -1.261 . . . . 0.0 109.63 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.637 ' CE1' ' CB ' ' B' ' 188' ' ' GLU . 59.4 m-70 -120.45 158.37 51.44 Favored Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.01 -18.54 46.21 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.178 1.919 . . . . 0.0 111.844 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.413 ' OD2' ' HD2' ' B' ' 189' ' ' ARG . 2.5 m-20 -111.77 -13.56 13.69 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.501 -0.749 . . . . 0.0 110.45 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -57.68 139.11 54.56 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.838 -1.164 . . . . 0.0 109.52 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.666 ' CB ' ' HA2' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -96.59 121.53 38.52 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.312 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.65 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -80.25 140.91 36.02 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.369 -0.832 . . . . 0.0 109.796 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.778 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 30.7 p90 -145.62 157.55 43.96 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 108.576 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 2.8 mttm -110.49 173.44 6.33 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.033 -1.042 . . . . 0.0 109.596 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.552 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -66.99 151.75 47.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.198 -0.939 . . . . 0.0 109.32 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.54 -8.09 4.46 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 4.4 tt0 -75.13 143.29 43.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.973 -1.31 . . . . 0.0 109.559 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HG3' HG22 ' A' ' 14' ' ' VAL . 7.2 mtpp -97.21 138.93 33.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 109.799 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.581 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 2.5 mpp? -137.5 153.51 50.02 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 0.5 OUTLIER -106.64 129.19 54.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.454 -0.779 . . . . 0.0 109.287 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.537 ' HB ' ' N ' ' A' ' 11' ' ' ASP . 6.3 t -80.91 124.8 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.046 -1.034 . . . . 0.0 109.041 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 mt -101.62 -43.06 5.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.184 -0.948 . . . . 0.0 109.934 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.538 ' O ' ' CG ' ' A' ' 39' ' ' GLU . 1.2 pt-20 -145.58 97.57 3.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.133 -0.98 . . . . 0.0 109.306 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.592 ' HG3' ' CD1' ' A' ' 45' ' ' TRP . 3.5 tt0 -81.35 116.6 21.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.196 -0.94 . . . . 0.0 109.282 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.595 ' CG ' HD12 ' B' ' 186' ' ' LEU . 23.4 m-70 -85.0 -105.78 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.287 -0.883 . . . . 0.0 109.509 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.24 -16.59 1.71 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.492 ' HB2' ' HD3' ' B' ' 183' ' ' PRO . 16.6 mm-40 -153.92 -17.8 0.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.038 -1.272 . . . . 0.0 110.389 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.837 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 63.5 m95 -135.76 102.57 5.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.964 -1.085 . . . . 0.0 109.342 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.592 ' CD1' ' HG3' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -90.7 142.67 27.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.103 -0.998 . . . . 0.0 110.045 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.9 OUTLIER -91.84 105.77 17.96 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.063 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.81 -175.86 2.92 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.191 -0.943 . . . . 0.0 110.184 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -124.89 129.71 50.93 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.689 -0.632 . . . . 0.0 109.376 -179.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.607 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -74.77 125.83 29.61 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.097 -1.002 . . . . 0.0 109.943 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.27 -7.53 47.61 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.3 tp -53.78 -54.93 31.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.604 -0.685 . . . . 0.0 109.214 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.601 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 0.7 OUTLIER -161.38 29.54 0.13 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.264 -0.898 . . . . 0.0 109.994 179.672 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.601 ' CB ' ' O ' ' A' ' 52' ' ' THR . 5.7 mttp 86.45 44.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.454 -0.779 . . . . 0.0 110.423 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.607 ' HB2' ' HB3' ' A' ' 49' ' ' SER . 0.0 OUTLIER -85.94 132.46 34.07 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.335 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 20.0 pt-20 -122.84 120.32 33.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.933 -1.104 . . . . 0.0 109.103 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.666 ' HA2' ' CB ' ' A' ' 27' ' ' LEU . . . -162.58 165.72 36.33 Favored Glycine 0 N--CA 1.488 2.128 0 C-N-CA 119.105 -1.521 . . . . 0.0 110.253 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.634 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 8.5 m-85 -71.38 132.95 45.57 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.759 -0.847 . . . . 0.0 109.652 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.47 HD13 HG22 ' A' ' 63' ' ' VAL . 7.4 pt -121.91 143.14 37.87 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.734 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 44.2 Cg_endo -67.66 153.77 75.18 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.701 1.601 . . . . 0.0 111.614 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.528 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 65.5 p -82.71 6.77 16.91 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 110.783 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -110.31 -52.86 2.74 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.741 -1.224 . . . . 0.0 110.637 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.59 ' CE1' ' O ' ' B' ' 177' ' ' PRO . 5.1 m-85 -49.08 -63.15 1.19 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.094 -1.004 . . . . 0.0 110.938 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.581 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 3.3 m -78.85 155.01 4.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 122.027 0.918 . . . . 0.0 110.935 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.44 ' HB1' HD22 ' A' ' 16' ' ' LEU . . . -133.14 161.53 34.17 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -75.95 150.59 37.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.093 -1.004 . . . . 0.0 109.479 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.521 ' O ' ' CB ' ' A' ' 67' ' ' ASN . 4.9 mt -75.86 -158.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.0 109.306 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 66' ' ' LEU . 7.1 t30 76.7 121.78 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.117 -0.989 . . . . 0.0 109.541 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.2 m . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.475 179.899 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.302 0.572 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . 0.585 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 0.8 OUTLIER -170.48 -56.27 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.213 -0.93 . . . . 0.0 108.804 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 47.9 Cg_endo -67.97 -89.79 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.717 2.278 . . . . 0.0 111.896 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' GLY . . . . . . . . . . . . . . . 83.38 15.51 71.3 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' MET . . . . . . . . . . . . . 1.4 mmt 51.13 91.35 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.389 -1.065 . . . . 0.0 109.325 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . 0.579 ' O ' HG21 ' B' ' 176' ' ' THR . 53.8 Cg_endo -77.52 -161.35 0.14 Allowed 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 122.616 2.211 . . . . 0.0 111.561 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 176' ' ' THR . . . . . 0.588 HG21 ' HB3' ' A' ' 17' ' ' TYR . 0.6 OUTLIER -177.24 102.54 0.22 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.623 -0.673 . . . . 0.0 109.356 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 177' ' ' PRO . . . . . 0.608 ' HD2' ' CD2' ' A' ' 17' ' ' TYR . 47.9 Cg_endo -69.66 156.97 62.18 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.703 2.269 . . . . 0.0 111.689 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.17 148.45 68.9 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.546 2.164 . . . . 0.0 111.263 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . 0.578 ' CD2' ' CE1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -86.03 173.93 6.24 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.122 -0.986 . . . . 0.0 109.622 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.837 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.4 Cg_endo -69.92 -175.0 1.05 Allowed 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.963 2.442 . . . . 0.0 111.457 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . 0.715 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.6 Cg_endo -91.31 -25.31 0.34 Allowed 'Trans proline' 0 C--O 1.213 -0.76 0 C-N-CA 122.856 2.371 . . . . 0.0 114.531 -177.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . 0.715 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 39.4 mtt180 78.71 94.33 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 120.942 -1.098 . . . . 0.0 109.2 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . 0.572 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 46.3 Cg_endo -67.58 118.5 5.64 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.664 2.243 . . . . 0.0 111.75 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . 53.83 57.59 5.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.255 -0.903 . . . . 0.0 109.3 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . 0.434 ' N ' ' ND2' ' B' ' 185' ' ' ASN . 1.1 m120 51.09 50.75 18.43 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.319 -0.863 . . . . 0.0 109.414 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . 0.595 HD12 ' CG ' ' A' ' 41' ' ' HIS . 62.0 tp -71.72 -80.54 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.306 -0.871 . . . . 0.0 109.508 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . 0.634 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . -70.86 -3.13 49.63 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.637 ' CB ' ' CE1' ' A' ' 23' ' ' HIS . 10.5 mt-10 -75.69 -82.86 0.07 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.391 -1.064 . . . . 0.0 109.315 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 189' ' ' ARG . . . . . 0.456 ' CB ' ' O ' ' B' ' 188' ' ' GLU . 0.0 OUTLIER 72.5 85.64 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.385 -0.822 . . . . 0.0 109.556 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -86.65 145.82 26.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 0.0 109.402 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.53 179.947 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.296 0.569 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.85 38.51 0.02 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.439 ' O ' HG22 ' A' ' 37' ' ' VAL . 0.4 OUTLIER -108.94 137.84 46.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.325 -1.103 . . . . 0.0 109.415 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.445 HG22 HD11 ' A' ' 12' ' ' ILE . 25.5 mm -100.89 137.0 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.163 -0.96 . . . . 0.0 109.553 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.17 161.76 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.463 -0.773 . . . . 0.0 108.951 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.413 HG11 ' O ' ' A' ' 14' ' ' VAL . 6.7 p -121.23 139.06 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.006 -1.059 . . . . 0.0 109.317 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -71.08 133.68 46.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.364 -0.835 . . . . 0.0 109.697 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.574 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 55.7 mt -99.12 -12.86 20.11 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.621 ' CD2' ' HD2' ' B' ' 177' ' ' PRO . 34.3 m-85 -158.35 154.19 23.15 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.677 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 42.0 Cg_endo -64.36 149.07 90.79 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 121.662 1.575 . . . . 0.0 110.055 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.814 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 54.2 t80 -97.86 177.93 5.29 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.324 -1.35 . . . . 0.0 110.405 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.686 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 0.7 OUTLIER -109.01 80.58 1.33 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.498 -0.751 . . . . 0.0 109.303 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.45 94.68 0.05 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 20' ' ' ASP . 18.1 mm -108.19 -42.02 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.303 -1.116 . . . . 0.0 108.807 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.608 ' CG ' ' O ' ' B' ' 188' ' ' GLU . 67.5 m-70 -77.45 158.15 79.36 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.89 -13.77 34.78 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.232 1.955 . . . . 0.0 111.811 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.74 -14.35 13.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.258 -0.902 . . . . 0.0 110.525 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.61 138.69 55.02 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.873 -1.142 . . . . 0.0 109.864 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.683 HD23 ' N ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -93.87 120.76 34.56 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.041 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.683 ' N ' HD23 ' A' ' 27' ' ' LEU . 10.1 p -79.92 140.74 36.57 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.365 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.814 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 21.9 p90 -145.94 157.66 43.88 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.14 -0.975 . . . . 0.0 108.535 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -110.81 173.16 6.46 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.153 -0.967 . . . . 0.0 109.51 -179.44 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.564 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 7.8 pttm -67.09 152.02 46.54 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.183 -0.948 . . . . 0.0 109.38 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.42 -8.18 4.26 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -75.5 143.4 42.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.936 -1.332 . . . . 0.0 109.709 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.419 ' HB2' HD11 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -96.61 137.84 35.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 0.0 109.418 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.604 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 2.4 mpp? -135.01 151.79 51.13 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.492 0.663 . . . . 0.0 109.669 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 4.0 mttm -108.95 127.01 53.69 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.426 -0.797 . . . . 0.0 109.407 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 11' ' ' ASP . 0.4 OUTLIER -81.57 143.58 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.397 -0.814 . . . . 0.0 108.958 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.528 HD11 ' N ' ' A' ' 38' ' ' LEU . 7.8 mp -119.69 -40.89 2.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.064 -1.022 . . . . 0.0 109.833 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -140.38 92.13 2.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.16 -0.962 . . . . 0.0 108.96 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.576 ' HG2' ' CG ' ' A' ' 45' ' ' TRP . 1.9 mt-10 -74.09 120.37 19.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.479 -0.763 . . . . 0.0 109.536 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.578 ' CG ' HD12 ' B' ' 186' ' ' LEU . 47.7 m-70 -92.28 -106.49 0.11 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.235 -0.915 . . . . 0.0 109.555 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.36 -16.66 1.17 Allowed Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.179 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.486 ' HG2' ' HD2' ' B' ' 181' ' ' PRO . 0.5 OUTLIER -154.21 -17.04 0.13 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.968 -1.313 . . . . 0.0 110.351 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.812 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 59.8 m95 -136.97 101.73 4.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.038 -1.039 . . . . 0.0 109.155 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.6 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -91.07 139.57 30.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.904 -1.122 . . . . 0.0 109.992 -179.679 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.7 OUTLIER -86.13 107.41 17.84 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -102.26 -177.86 3.53 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.289 -0.882 . . . . 0.0 110.233 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 9.8 tttm -123.45 107.97 12.17 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.605 ' N ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -54.1 127.02 24.95 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.11 -0.994 . . . . 0.0 109.925 -179.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 52' ' ' THR . 3.7 mt -75.84 -11.2 59.93 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.464 ' O ' ' CB ' ' A' ' 52' ' ' THR . 22.4 tp -46.05 -20.89 0.11 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.719 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 0.6 OUTLIER 168.15 -21.47 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.392 -0.817 . . . . 0.0 109.851 179.151 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.719 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 140.55 42.61 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.536 -0.727 . . . . 0.0 109.972 179.629 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.605 ' O ' ' N ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -85.37 134.64 34.08 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.085 -1.01 . . . . 0.0 108.505 178.419 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.5 114.33 20.53 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.047 -1.033 . . . . 0.0 109.359 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.617 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -155.52 168.85 33.29 Favored Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.416 -1.373 . . . . 0.0 109.959 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.643 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 8.9 m-85 -71.41 131.93 44.08 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.574 -0.957 . . . . 0.0 109.656 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.532 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 5.2 pt -120.86 139.63 29.42 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.701 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 46.8 Cg_endo -69.14 158.74 56.59 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 121.671 1.581 . . . . 0.0 111.948 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.515 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 79.5 p -86.44 7.08 27.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.334 -0.853 . . . . 0.0 110.387 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' B' ' 178' ' ' PRO . 0.1 OUTLIER -109.28 -53.77 2.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.903 -1.123 . . . . 0.0 110.441 -179.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.575 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 2.8 m-85 -47.93 -63.38 1.08 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.133 -0.979 . . . . 0.0 111.115 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.604 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 3.0 m -78.53 155.0 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.929 . . . . 0.0 110.968 -177.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.474 ' CB ' ' CD1' ' A' ' 16' ' ' LEU . . . -134.8 162.67 31.71 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.4 pttm -75.58 148.53 38.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.044 -1.035 . . . . 0.0 109.251 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.64 169.67 8.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 109.574 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' A' ' 68' ' ' THR . 20.3 t-20 -123.47 -94.06 0.5 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.284 -0.885 . . . . 0.0 109.347 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.508 ' N ' ' OD1' ' A' ' 67' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.456 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . 0.425 ' O ' ' CB ' ' B' ' 171' ' ' ASP . 10.7 m0 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . 0.554 ' N ' ' HD3' ' B' ' 172' ' ' PRO . 0.8 OUTLIER 170.03 59.75 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.297 -0.877 . . . . 0.0 108.975 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' B' ' 171' ' ' ASP . 51.6 Cg_endo -92.77 -82.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.106 2.537 . . . . 0.0 111.942 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' GLY . . . . . . . . . . . . . . . 125.67 68.31 0.18 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' MET . . . . . 0.559 ' N ' ' CD ' ' B' ' 175' ' ' PRO . 0.1 OUTLIER -66.25 -47.11 61.42 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.2 -1.176 . . . . 0.0 109.49 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' B' ' 174' ' ' MET . 55.3 Cg_endo -79.44 -162.49 0.18 Allowed 'Trans proline' 0 C--O 1.213 -0.75 0 C-N-CA 122.606 2.204 . . . . 0.0 111.606 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 176' ' ' THR . . . . . 0.611 HG21 ' HB3' ' A' ' 17' ' ' TYR . 1.1 p -170.15 99.46 0.45 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.573 -0.704 . . . . 0.0 109.315 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 177' ' ' PRO . . . . . 0.621 ' HD2' ' CD2' ' A' ' 17' ' ' TYR . 50.5 Cg_endo -69.34 160.83 48.3 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.814 2.342 . . . . 0.0 111.853 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . 0.525 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 49.4 Cg_endo -70.29 160.07 50.84 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.613 2.209 . . . . 0.0 111.222 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . 0.605 ' CD2' ' CE1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -94.0 174.83 3.42 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.1 -1.0 . . . . 0.0 109.761 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.812 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.7 Cg_endo -69.34 -173.43 0.66 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 123.049 2.499 . . . . 0.0 111.484 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . 0.752 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 53.1 Cg_endo -92.95 -26.5 0.18 Allowed 'Trans proline' 0 C--O 1.213 -0.732 0 C-N-CA 122.95 2.433 . . . . 0.0 114.441 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . 0.752 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 43.3 mtt180 80.99 95.02 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.076 -1.015 . . . . 0.0 109.059 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 49.2 Cg_endo -69.98 135.98 31.29 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.745 2.297 . . . . 0.0 111.865 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 41.61 57.79 2.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 0.0 109.367 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 49.13 48.96 20.31 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.228 -0.92 . . . . 0.0 109.288 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . 0.585 ' CD2' ' HB2' ' A' ' 44' ' ' TRP . 48.4 tp -67.43 -87.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.408 -0.808 . . . . 0.0 109.319 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . 0.643 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . -69.21 -5.63 49.5 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.608 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 2.9 tt0 -72.48 -68.77 0.45 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.426 -1.043 . . . . 0.0 109.434 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 189' ' ' ARG . . . . . 0.538 ' CB ' ' O ' ' B' ' 188' ' ' GLU . 0.0 OUTLIER 78.25 105.05 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.382 -0.824 . . . . 0.0 109.432 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . 0.431 ' O ' ' CB ' ' B' ' 191' ' ' ALA . 0.0 OUTLIER 175.06 -174.13 0.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.411 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 191' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' B' ' 190' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.519 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.48 145.26 30.21 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -130.93 154.34 48.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.305 -1.115 . . . . 0.0 109.396 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.5 tp -99.23 138.84 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.164 -0.96 . . . . 0.0 109.451 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.486 ' CG2' HG21 ' A' ' 37' ' ' VAL . 0.8 OUTLIER -131.2 160.36 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.333 -0.855 . . . . 0.0 109.007 -179.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.455 HG21 ' O ' ' A' ' 33' ' ' GLU . 14.0 p -120.5 138.98 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.017 -1.052 . . . . 0.0 109.353 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -72.53 134.81 45.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.411 -0.806 . . . . 0.0 109.842 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.602 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 69.4 mt -99.85 -22.4 15.33 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.635 ' CD1' ' O ' ' B' ' 175' ' ' PRO . 32.3 m-85 -147.48 153.1 43.41 Favored Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.653 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.7 Cg_endo -63.21 149.67 90.73 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 121.845 1.697 . . . . 0.0 110.089 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.806 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 57.0 t80 -98.81 178.73 4.88 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.268 -1.373 . . . . 0.0 110.524 -177.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.686 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -109.96 80.38 1.31 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.01 95.89 0.06 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 20' ' ' ASP . 75.9 mt -108.8 -42.21 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.117 -1.226 . . . . 0.0 108.86 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.631 ' CE1' ' HG3' ' B' ' 188' ' ' GLU . 88.5 m-70 -76.81 157.87 81.29 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.59 -12.74 33.88 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.129 1.886 . . . . 0.0 111.657 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -112.92 -14.51 13.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.894 . . . . 0.0 110.64 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.471 ' CG ' ' HB2' ' A' ' 23' ' ' HIS . 79.9 m-20 -57.53 139.81 52.42 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.762 -1.212 . . . . 0.0 109.783 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.66 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.4 OUTLIER -95.1 121.53 36.83 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.159 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.539 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -80.07 140.49 36.46 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.448 -0.783 . . . . 0.0 109.491 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.806 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 25.7 p90 -145.39 156.95 44.09 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.163 -0.961 . . . . 0.0 108.676 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -110.64 173.32 6.39 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.151 -0.968 . . . . 0.0 109.596 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.542 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -67.26 151.49 47.41 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.186 -0.946 . . . . 0.0 109.322 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 71.51 -8.19 5.8 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.455 ' O ' HG21 ' A' ' 14' ' ' VAL . 0.9 OUTLIER -75.69 142.93 42.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.934 -1.333 . . . . 0.0 109.839 -179.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.434 ' HB3' HD11 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -97.0 138.94 33.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 109.456 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.597 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 2.5 mpp? -135.49 151.62 50.54 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.577 -0.702 . . . . 0.0 109.82 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 82.4 tttt -105.29 123.24 47.52 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.424 -0.798 . . . . 0.0 109.428 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.486 HG21 ' CG2' ' A' ' 13' ' ' VAL . 2.0 t -81.82 115.96 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.362 -0.836 . . . . 0.0 109.052 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.402 HD13 ' N ' ' A' ' 38' ' ' LEU . 9.3 mp -92.01 -39.65 11.54 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.085 -1.01 . . . . 0.0 109.887 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -142.29 102.65 4.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.102 -0.999 . . . . 0.0 109.06 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.563 ' HG3' ' CG ' ' A' ' 45' ' ' TRP . 1.0 OUTLIER -85.41 118.53 25.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.391 -0.818 . . . . 0.0 109.498 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.605 ' CG ' HD12 ' B' ' 186' ' ' LEU . 68.3 m-70 -89.26 -103.13 0.09 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.287 -0.883 . . . . 0.0 109.367 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.44 ' O ' ' CD ' ' A' ' 43' ' ' GLU . . . -138.71 -13.71 0.71 Allowed Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.426 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.534 ' HG2' ' HD2' ' B' ' 181' ' ' PRO . 0.6 OUTLIER -155.57 -20.95 0.11 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.832 -1.393 . . . . 0.0 110.584 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.798 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 58.9 m95 -136.47 95.27 3.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.874 -1.142 . . . . 0.0 109.047 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.568 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -87.03 141.46 28.65 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.992 -1.067 . . . . 0.0 110.492 -179.184 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.8 OUTLIER -87.1 106.74 18.07 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -104.32 -173.23 2.26 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.287 -0.883 . . . . 0.0 110.179 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 4.3 tttp -127.28 131.37 50.53 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.5 -0.75 . . . . 0.0 109.452 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.65 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 1.3 t -77.17 128.09 33.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.002 -1.061 . . . . 0.0 109.885 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.434 HD11 ' HB3' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -71.87 -7.68 49.87 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 51' ' ' LEU . 9.4 tp -53.7 -55.8 22.95 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.35 -0.844 . . . . 0.0 109.348 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.623 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.4 t -160.69 28.42 0.15 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.229 -0.92 . . . . 0.0 110.149 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.623 ' CB ' ' O ' ' A' ' 52' ' ' THR . 31.0 mtmt 86.8 44.5 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.444 -0.785 . . . . 0.0 111.122 178.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.65 ' HB2' ' CB ' ' A' ' 49' ' ' SER . 0.1 OUTLIER -87.67 131.95 34.27 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 8.9 pt-20 -121.83 120.66 35.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.932 -1.105 . . . . 0.0 109.641 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.66 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -158.37 168.94 34.82 Favored Glycine 0 N--CA 1.487 2.1 0 C-N-CA 119.539 -1.315 . . . . 0.0 109.887 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.755 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 11.5 m-85 -71.27 133.71 46.27 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.546 -0.973 . . . . 0.0 109.884 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.562 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 2.9 pt -122.31 142.37 36.8 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.659 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 47.8 Cg_endo -70.85 159.41 52.69 Favored 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 121.562 1.508 . . . . 0.0 111.818 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.513 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 90.3 p -87.31 7.2 29.78 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 110.073 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' B' ' 178' ' ' PRO . 0.3 OUTLIER -107.97 -54.86 2.44 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.006 -1.059 . . . . 0.0 110.351 -179.369 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.539 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 3.5 m-85 -48.6 -63.28 1.13 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.167 -0.958 . . . . 0.0 111.151 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.597 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.9 m -79.8 155.9 4.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.995 0.902 . . . . 0.0 111.133 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.46 ' CB ' HD13 ' A' ' 16' ' ' LEU . . . -132.3 160.47 36.15 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.83 152.31 37.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.999 -1.063 . . . . 0.0 109.463 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.89 72.02 4.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.888 . . . . 0.0 109.569 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -163.99 123.16 1.97 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.413 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . 0.406 ' O ' ' OD2' ' B' ' 171' ' ' ASP . 14.9 m0 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . 0.593 ' N ' ' HD3' ' B' ' 172' ' ' PRO . 0.6 OUTLIER 174.18 58.02 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.269 -0.894 . . . . 0.0 109.061 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.593 ' HD3' ' N ' ' B' ' 171' ' ' ASP . 51.7 Cg_endo -93.65 -78.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.234 2.623 . . . . 0.0 111.843 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' GLY . . . . . 0.536 ' O ' ' CG ' ' B' ' 174' ' ' MET . . . 153.49 -20.88 0.72 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' MET . . . . . 0.536 ' CG ' ' O ' ' B' ' 173' ' ' GLY . 5.9 ptm 39.69 51.37 3.77 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.482 -1.011 . . . . 0.0 109.661 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . 0.635 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 54.7 Cg_endo -78.95 -161.88 0.16 Allowed 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 122.524 2.149 . . . . 0.0 111.639 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 176' ' ' THR . . . . . 0.552 HG21 ' O ' ' B' ' 175' ' ' PRO . 5.6 p -152.41 91.94 3.52 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.402 -0.811 . . . . 0.0 109.202 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 177' ' ' PRO . . . . . 0.583 ' HD2' ' CD2' ' A' ' 17' ' ' TYR . 50.3 Cg_endo -69.19 173.99 9.66 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.759 2.306 . . . . 0.0 111.789 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . 0.523 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 49.4 Cg_endo -70.13 158.82 55.24 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.6 2.2 . . . . 0.0 111.313 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . 0.645 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -97.56 176.81 1.87 Allowed Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 121.077 -1.015 . . . . 0.0 109.589 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.798 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 39.3 Cg_endo -67.96 -174.48 0.62 Allowed 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 123.042 2.494 . . . . 0.0 112.075 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . 0.617 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.6 Cg_endo -92.78 -29.0 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 123.252 2.635 . . . . 0.0 114.213 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . 0.742 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.1 OUTLIER 84.23 104.95 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.162 -0.961 . . . . 0.0 109.877 -179.323 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . 0.645 ' HG2' ' HB2' ' B' ' 186' ' ' LEU . 44.7 Cg_endo -69.29 124.94 11.79 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 123.022 2.481 . . . . 0.0 111.998 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 40.44 69.27 0.33 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.36 -0.838 . . . . 0.0 109.567 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . 0.501 ' HA ' ' HB3' ' B' ' 188' ' ' GLU . 0.0 OUTLIER 42.06 47.22 3.83 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.289 -0.882 . . . . 0.0 109.413 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . 0.645 ' HB2' ' HG2' ' B' ' 183' ' ' PRO . 31.6 tp -56.19 -94.81 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . 0.755 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . -78.49 0.48 75.61 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.631 ' HG3' ' CE1' ' A' ' 23' ' ' HIS . 0.7 OUTLIER -69.77 -72.47 0.19 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.571 -0.958 . . . . 0.0 109.44 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 189' ' ' ARG . . . . . 0.426 ' O ' ' HB2' ' B' ' 185' ' ' ASN . 0.0 OUTLIER -169.04 134.24 1.57 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.415 -0.803 . . . . 0.0 109.315 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -130.65 175.0 9.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.284 -0.885 . . . . 0.0 109.502 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.526 -179.965 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.9 139.05 5.26 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -166.04 -178.96 4.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.343 -1.092 . . . . 0.0 109.416 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.526 HG22 HD11 ' A' ' 12' ' ' ILE . 21.6 mm -119.03 138.32 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.18 -0.95 . . . . 0.0 109.587 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.461 HG21 ' CG2' ' A' ' 37' ' ' VAL . 0.8 OUTLIER -132.21 161.91 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 p -120.83 140.45 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.936 -1.102 . . . . 0.0 109.463 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.508 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -72.79 133.87 44.69 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.336 -0.853 . . . . 0.0 109.566 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.584 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 84.3 mt -99.88 -15.51 18.35 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.612 ' CD2' ' HD3' ' B' ' 177' ' ' PRO . 3.5 m-85 -156.32 154.71 27.78 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.684 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.2 Cg_endo -63.45 149.05 92.13 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 121.903 1.735 . . . . 0.0 110.448 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.812 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 50.9 t80 -98.46 178.7 4.94 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.438 -1.305 . . . . 0.0 110.367 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.694 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 0.5 OUTLIER -109.66 80.65 1.34 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.631 -0.668 . . . . 0.0 109.291 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.95 94.58 0.05 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 20' ' ' ASP . 17.1 mm -108.28 -41.92 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.089 -1.242 . . . . 0.0 108.902 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.602 ' CG ' ' O ' ' B' ' 188' ' ' GLU . 20.5 m-70 -77.54 157.75 79.62 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.54 -13.32 35.03 Favored 'Trans proline' 0 C--O 1.213 -0.75 0 C-N-CA 122.271 1.981 . . . . 0.0 111.921 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 1.0 OUTLIER -112.11 -13.9 13.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.253 -0.904 . . . . 0.0 110.673 -179.069 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.439 ' CG ' ' HB2' ' A' ' 23' ' ' HIS . 84.4 m-20 -57.97 139.74 53.77 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.819 -1.176 . . . . 0.0 109.94 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.656 HD23 ' N ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -94.74 120.9 35.71 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.656 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -79.19 140.25 37.77 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.263 -0.898 . . . . 0.0 109.277 179.723 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.812 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 23.5 p90 -145.2 156.8 44.07 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.098 -1.001 . . . . 0.0 108.701 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 5.6 ptmt -110.81 173.24 6.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 109.319 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.565 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -66.59 151.96 46.27 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.983 -1.073 . . . . 0.0 109.482 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 71.76 -7.39 7.2 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.574 ' HB2' ' HG2' ' A' ' 30' ' ' LYS . 5.0 tp10 -76.15 142.62 41.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.892 -1.357 . . . . 0.0 109.944 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.456 ' HD2' HG23 ' A' ' 12' ' ' ILE . 1.4 ttpt -97.28 139.52 33.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.886 . . . . 0.0 109.382 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.563 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 2.0 mpp? -135.1 151.48 50.77 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.441 0.639 . . . . 0.0 109.735 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.615 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -104.39 123.47 47.49 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.546 -0.722 . . . . 0.0 109.163 179.797 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.461 ' CG2' HG21 ' A' ' 13' ' ' VAL . 2.2 t -81.43 114.1 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.29 -0.881 . . . . 0.0 109.088 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 36' ' ' LYS . 6.3 mp -90.23 -44.17 9.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 109.656 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -143.08 97.46 3.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.932 . . . . 0.0 108.921 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.576 ' HG3' ' CD1' ' A' ' 45' ' ' TRP . 3.3 tt0 -83.72 116.67 22.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.34 -0.85 . . . . 0.0 109.588 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.563 ' CG ' HD12 ' B' ' 186' ' ' LEU . 4.0 m-70 -78.27 -95.83 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.319 -0.863 . . . . 0.0 109.228 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.46 ' O ' ' CD ' ' A' ' 43' ' ' GLU . . . -148.38 -13.05 0.13 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.383 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.582 ' HB3' ' HD2' ' B' ' 181' ' ' PRO . 6.5 mm-40 -148.69 -26.38 0.31 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.969 -1.312 . . . . 0.0 110.008 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.921 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 47.8 m95 -134.02 102.26 5.35 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.17 -0.956 . . . . 0.0 108.768 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.636 ' CZ2' ' CB ' ' A' ' 60' ' ' SER . 0.1 OUTLIER -90.02 147.17 23.83 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.092 -1.005 . . . . 0.0 110.398 -179.129 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.577 ' HG3' ' CD1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -96.06 108.2 20.6 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -105.65 -172.89 2.18 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 110.346 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -125.56 127.11 45.86 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.609 -0.682 . . . . 0.0 109.266 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.597 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -70.82 126.06 28.54 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.183 -0.948 . . . . 0.0 109.835 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.449 HD12 ' HG2' ' A' ' 34' ' ' LYS . 1.6 mp -72.18 -7.97 52.14 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.4 tp -54.25 -54.83 34.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.528 -0.733 . . . . 0.0 109.17 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.6 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 1.3 t -161.06 30.08 0.14 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.173 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.6 ' HB2' ' O ' ' A' ' 52' ' ' THR . 38.3 mmtt 85.78 45.49 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.499 -0.751 . . . . 0.0 110.661 178.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 49' ' ' SER . 0.8 OUTLIER -87.05 132.29 33.85 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.137 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.477 ' CG ' ' HE3' ' A' ' 46' ' ' LYS . 15.4 tt0 -121.72 117.35 26.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.876 -1.14 . . . . 0.0 109.57 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.623 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -158.42 168.62 34.78 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.44 -1.362 . . . . 0.0 110.015 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.835 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 12.5 m-85 -73.66 135.15 43.72 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.679 -0.895 . . . . 0.0 110.16 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.448 HD12 ' HB2' ' A' ' 47' ' ' ALA . 7.4 pt -122.39 139.34 30.61 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.581 ' HB2' ' CD ' ' B' ' 180' ' ' PRO . 52.3 Cg_endo -72.6 131.96 18.14 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 121.519 1.479 . . . . 0.0 112.014 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.636 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 53.7 p -62.88 3.68 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.39 -0.819 . . . . 0.0 110.542 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.637 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 6.5 p-10 -98.36 -52.42 3.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.797 -1.189 . . . . 0.0 110.62 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.656 ' CE2' ' CD2' ' B' ' 179' ' ' LEU . 4.0 m-85 -57.28 -59.25 5.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.113 -0.992 . . . . 0.0 111.176 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.563 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 3.2 m -79.78 159.9 4.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 122.024 0.916 . . . . 0.0 111.235 -177.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.499 ' CB ' HD12 ' A' ' 16' ' ' LEU . . . -133.93 157.83 45.01 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.34 152.2 39.63 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.053 -1.029 . . . . 0.0 109.562 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.421 ' O ' HG22 ' A' ' 68' ' ' THR . 6.9 tp -103.74 -80.31 0.53 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.518 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.409 ' C ' ' O ' ' A' ' 66' ' ' LEU . 2.0 p-10 -44.61 152.94 0.18 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.313 -0.867 . . . . 0.0 109.575 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 66' ' ' LEU . 11.2 p . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.56 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 1.5 m-90 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.246 0.546 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . 0.585 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 0.2 OUTLIER -170.83 -55.55 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.4 0 O-C-N 121.196 -0.94 . . . . 0.0 109.001 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 46.3 Cg_endo -67.42 -89.93 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.682 2.255 . . . . 0.0 111.996 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' GLY . . . . . . . . . . . . . . . 163.27 73.13 0.02 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' MET . . . . . 0.626 ' N ' ' CD ' ' B' ' 175' ' ' PRO . 0.1 OUTLIER -74.78 -40.79 4.12 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.399 -1.059 . . . . 0.0 109.94 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' B' ' 174' ' ' MET . 49.3 Cg_endo -92.76 166.77 2.66 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.073 2.515 . . . . 0.0 112.075 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 176' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' B' ' 175' ' ' PRO . 0.1 OUTLIER 161.8 116.6 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.508 -0.745 . . . . 0.0 109.152 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 177' ' ' PRO . . . . . 0.612 ' HD3' ' CD2' ' A' ' 17' ' ' TYR . 49.9 Cg_endo -87.14 172.94 5.97 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.91 2.407 . . . . 0.0 111.986 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' B' ' 177' ' ' PRO . 47.6 Cg_endo -69.08 120.96 7.79 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.745 2.297 . . . . 0.0 111.975 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . 0.656 ' CD2' ' CE2' ' A' ' 62' ' ' TYR . 74.5 mt -60.25 153.33 58.64 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.468 -0.77 . . . . 0.0 109.88 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.921 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.8 Cg_endo -67.67 176.91 4.54 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.566 2.178 . . . . 0.0 111.5 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . 0.619 ' O ' ' CB ' ' B' ' 182' ' ' ARG . 56.1 Cg_endo -81.36 -37.57 0.28 Allowed 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.822 2.348 . . . . 0.0 114.029 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . 0.703 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.4 OUTLIER 82.22 98.02 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 120.997 -1.065 . . . . 0.0 109.295 -179.006 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . 0.64 ' HD2' HD21 ' B' ' 186' ' ' LEU . 45.4 Cg_endo -69.61 130.76 20.09 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 123.206 2.604 . . . . 0.0 112.329 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.509 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 35.63 72.89 0.09 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.436 -0.79 . . . . 0.0 109.821 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . 0.508 ' OD1' ' NE2' ' B' ' 190' ' ' GLN . 0.7 OUTLIER 40.59 45.34 1.96 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.37 -0.831 . . . . 0.0 109.438 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . 0.64 HD21 ' HD2' ' B' ' 183' ' ' PRO . 34.4 tp -54.6 -94.54 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . 0.835 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . -76.95 -4.06 82.13 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.602 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 0.1 OUTLIER -77.52 -74.05 0.27 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.475 -1.015 . . . . 0.0 109.268 179.649 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 189' ' ' ARG . . . . . 0.558 ' O ' ' CE1' ' A' ' 23' ' ' HIS . 6.9 ttt180 71.77 101.31 0.07 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.347 -0.846 . . . . 0.0 109.385 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . 0.508 ' NE2' ' OD1' ' B' ' 185' ' ' ASN . 0.0 OUTLIER -89.36 156.18 18.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.92 . . . . 0.0 109.529 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.917 -1.04 . . . . 0.0 109.579 179.935 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.321 0.582 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.15 142.08 3.29 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.455 ' O ' HG22 ' A' ' 37' ' ' VAL . 2.6 m-20 -127.7 142.5 51.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -1.126 . . . . 0.0 109.283 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.531 ' CD1' ' HG2' ' A' ' 36' ' ' LYS . 2.5 tp -91.02 138.64 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 0.0 109.663 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.462 HG21 HG21 ' A' ' 37' ' ' VAL . 1.9 m -131.01 160.75 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.407 -0.808 . . . . 0.0 108.908 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 33' ' ' GLU . 9.8 p -120.39 138.62 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.079 -1.013 . . . . 0.0 109.283 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.524 ' HB3' ' CD1' ' A' ' 29' ' ' PHE . . . -71.4 133.35 45.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.41 -0.806 . . . . 0.0 110.101 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.457 ' CD1' ' HB3' ' A' ' 64' ' ' ALA . 14.7 mt -98.59 -15.2 19.57 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.648 ' CD2' ' CD ' ' B' ' 177' ' ' PRO . 53.3 m-85 -155.0 153.87 27.99 Favored Pre-proline 0 N--CA 1.486 1.374 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 41.4 Cg_endo -64.48 149.59 89.72 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 121.75 1.633 . . . . 0.0 109.805 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.788 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 59.1 t80 -98.89 179.25 4.7 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.102 -1.439 . . . . 0.0 110.346 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.682 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 73.5 m-20 -110.37 80.78 1.34 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.525 -0.735 . . . . 0.0 109.303 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.82 94.95 0.05 OUTLIER Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 20' ' ' ASP . 69.0 mt -108.74 -41.54 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -1.173 . . . . 0.0 108.895 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.593 ' CD2' ' O ' ' B' ' 188' ' ' GLU . 0.2 OUTLIER -78.14 158.81 76.7 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.103 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.562 ' HD2' ' CD2' ' A' ' 23' ' ' HIS . 48.5 Cg_endo -69.67 -13.85 35.51 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.24 1.96 . . . . 0.0 111.91 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 4.4 t70 -112.28 -13.86 13.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 110.799 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.465 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.5 OUTLIER -57.84 139.6 53.75 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.74 -1.225 . . . . 0.0 109.817 -179.282 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.64 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.3 OUTLIER -95.33 121.37 36.91 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.148 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.628 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -79.44 139.98 37.5 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.338 -0.851 . . . . 0.0 109.439 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.788 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 32.6 p90 -145.2 157.09 44.17 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.19 -0.944 . . . . 0.0 108.711 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 1.4 tttt -110.56 172.95 6.56 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.492 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -66.77 151.88 46.59 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.216 -0.927 . . . . 0.0 109.343 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.7 -7.95 4.77 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.447 ' O ' HG21 ' A' ' 14' ' ' VAL . 5.7 tt0 -75.88 143.6 41.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.957 -1.32 . . . . 0.0 109.765 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.446 ' HD2' HD23 ' A' ' 50' ' ' LEU . 1.1 ptpt -96.97 139.63 32.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.307 -0.871 . . . . 0.0 109.398 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.59 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 3.4 mpp? -134.52 150.89 50.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.627 -0.671 . . . . 0.0 109.841 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 30.5 mtpt -102.55 123.08 45.64 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.455 -0.778 . . . . 0.0 109.42 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.462 HG21 HG21 ' A' ' 13' ' ' VAL . 3.1 t -81.14 134.71 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.166 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.4 mt -110.99 -43.3 3.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.144 -0.973 . . . . 0.0 109.703 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -149.2 93.13 2.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.178 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.646 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.1 tt0 -78.24 116.24 18.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.331 -0.855 . . . . 0.0 109.326 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.513 ' HB2' HD22 ' B' ' 186' ' ' LEU . 5.7 m-70 -79.81 -100.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.301 -0.874 . . . . 0.0 109.481 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.06 -11.63 1.04 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.693 -1.242 . . . . 0.0 110.114 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.531 ' O ' ' HG3' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -156.48 -19.15 0.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.061 -1.258 . . . . 0.0 110.594 -179.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.784 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 66.2 m95 -136.49 99.02 3.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.882 -1.136 . . . . 0.0 109.427 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.646 ' CD1' ' CG ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -89.17 142.14 27.91 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.005 -1.059 . . . . 0.0 110.037 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -92.03 107.0 18.89 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.121 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.29 -174.78 2.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.858 . . . . 0.0 110.238 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 27.1 ttmt -124.98 111.4 15.36 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.675 -0.641 . . . . 0.0 109.277 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.627 ' N ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -56.01 126.35 25.52 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.23 -0.919 . . . . 0.0 109.776 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -75.66 -11.25 59.97 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.129 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.474 ' O ' ' CB ' ' A' ' 52' ' ' THR . 1.5 tp -46.19 -20.9 0.12 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.724 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 0.5 OUTLIER 168.02 -21.87 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.009 179.148 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.724 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 140.93 41.89 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.431 -0.793 . . . . 0.0 110.18 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.627 ' O ' ' N ' ' A' ' 49' ' ' SER . 3.6 mtmt -87.22 134.4 33.54 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.046 -1.034 . . . . 0.0 108.375 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.401 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -122.45 119.1 29.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.95 -1.093 . . . . 0.0 109.48 -179.609 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.64 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -159.87 168.92 35.73 Favored Glycine 0 N--CA 1.486 2.027 0 C-N-CA 119.365 -1.398 . . . . 0.0 110.124 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.725 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 10.4 m-85 -72.92 133.66 44.45 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.636 -0.92 . . . . 0.0 109.929 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.483 ' O ' HG13 ' A' ' 58' ' ' ILE . 7.8 pt -121.89 140.8 32.7 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.699 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 48.4 Cg_endo -69.56 140.53 43.67 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 121.676 1.584 . . . . 0.0 111.976 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.612 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 32.6 p -71.43 5.42 2.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.344 -0.847 . . . . 0.0 110.68 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' B' ' 178' ' ' PRO . 0.1 OUTLIER -106.34 -53.28 2.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.794 -1.192 . . . . 0.0 110.58 -179.134 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.546 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 3.4 m-85 -50.99 -61.76 2.03 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.09 -1.006 . . . . 0.0 111.012 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.59 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 3.4 m -78.04 156.22 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.948 0.88 . . . . 0.0 111.235 -177.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.457 ' HB3' ' CD1' ' A' ' 16' ' ' LEU . . . -131.22 160.05 36.0 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.456 ' HA ' HG11 ' A' ' 13' ' ' VAL . 9.1 mttt -76.31 95.96 3.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.994 -1.066 . . . . 0.0 109.792 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.461 ' O ' HD21 ' A' ' 66' ' ' LEU . 6.0 tt -45.89 97.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 0.0 109.441 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 65' ' ' LYS . 38.6 t-20 -141.9 119.19 11.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.313 -0.867 . . . . 0.0 109.512 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 58.4 m . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.43 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . 0.573 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 2.2 t0 -170.75 -55.63 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.289 -0.882 . . . . 0.0 108.921 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 47.9 Cg_endo -68.1 -90.54 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.632 2.221 . . . . 0.0 111.956 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' B' ' 174' ' ' MET . . . 60.83 27.4 66.67 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' MET . . . . . 0.547 ' CB ' ' O ' ' B' ' 173' ' ' GLY . 1.1 ptp 160.5 117.03 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.331 -1.1 . . . . 0.0 109.307 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . 0.499 ' O ' HG21 ' B' ' 176' ' ' THR . 50.6 Cg_endo -90.76 171.37 3.38 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.144 2.563 . . . . 0.0 111.724 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 176' ' ' THR . . . . . 0.567 ' CG2' ' HB3' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 172.45 104.47 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.477 -0.764 . . . . 0.0 109.268 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 177' ' ' PRO . . . . . 0.648 ' CD ' ' CD2' ' A' ' 17' ' ' TYR . 46.4 Cg_endo -69.89 163.3 38.88 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.594 2.196 . . . . 0.0 111.478 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . 0.41 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 45.5 Cg_endo -67.77 141.49 54.53 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.668 2.245 . . . . 0.0 111.388 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . 0.602 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -83.89 174.49 5.85 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.172 -0.955 . . . . 0.0 109.628 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.784 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 39.1 Cg_endo -69.58 -176.04 1.31 Allowed 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.111 2.54 . . . . 0.0 111.917 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . 0.623 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 53.7 Cg_endo -90.33 -22.54 0.74 Allowed 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 123.075 2.517 . . . . 0.0 114.697 -177.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . 0.726 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.8 OUTLIER 77.5 91.26 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 120.772 -1.205 . . . . 0.0 109.237 -179.331 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . 0.525 ' HD2' HD21 ' B' ' 186' ' ' LEU . 50.7 Cg_endo -70.79 134.99 26.98 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.907 2.404 . . . . 0.0 112.029 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 39.27 64.81 0.76 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.328 -0.858 . . . . 0.0 109.625 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . 0.498 ' HA ' ' HB2' ' B' ' 188' ' ' GLU . 3.1 m-80 43.86 49.73 7.01 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.34 -0.85 . . . . 0.0 109.476 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . 0.573 ' CG ' ' HB2' ' A' ' 44' ' ' TRP . 35.3 tp -66.32 -87.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.321 -0.862 . . . . 0.0 109.34 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . 0.725 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . -65.16 -7.86 33.54 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.816 -1.713 . . . . 0.0 108.816 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.593 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 3.8 mt-10 -72.1 -90.35 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.335 -1.097 . . . . 0.0 109.377 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 189' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' B' ' 188' ' ' GLU . 0.0 OUTLIER 78.44 102.82 0.07 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.367 -0.833 . . . . 0.0 109.576 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . 0.459 ' HG2' ' NE2' ' A' ' 23' ' ' HIS . 6.1 mt-30 -137.36 72.13 1.41 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -0.929 . . . . 0.0 109.415 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.049 -0.976 . . . . 0.0 109.501 -179.997 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.363 0.601 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.3 171.81 50.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -158.66 -174.62 4.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.375 -1.074 . . . . 0.0 109.286 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.444 HD13 ' HA ' ' A' ' 36' ' ' LYS . 2.6 tp -111.99 137.08 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 109.529 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.4 m -132.83 161.79 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.385 -0.822 . . . . 0.0 109.161 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.426 HG13 HD11 ' A' ' 66' ' ' LEU . 11.7 p -120.26 138.84 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.97 -1.081 . . . . 0.0 109.219 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -71.64 133.65 45.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.327 -0.858 . . . . 0.0 109.896 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.571 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 25.4 mt -99.09 -12.1 20.83 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.633 ' CD2' ' CD ' ' B' ' 177' ' ' PRO . 39.5 m-85 -158.63 155.07 24.4 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.658 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 42.2 Cg_endo -64.71 149.04 90.35 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 121.761 1.641 . . . . 0.0 109.887 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.807 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 59.9 t80 -98.82 178.86 4.84 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 118.373 -1.331 . . . . 0.0 110.415 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.671 ' OD1' ' CZ ' ' A' ' 19' ' ' TYR . 6.2 p30 -110.21 80.29 1.3 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.584 -0.698 . . . . 0.0 109.522 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.61 95.86 0.05 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 20' ' ' ASP . 0.5 OUTLIER -108.96 -41.78 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.243 -1.151 . . . . 0.0 108.859 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.631 ' CD2' ' HA ' ' B' ' 188' ' ' GLU . 34.6 m-70 -77.72 159.41 76.69 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.33 -13.79 33.62 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.195 1.93 . . . . 0.0 111.804 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -112.37 -14.29 13.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.143 -0.973 . . . . 0.0 110.758 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.434 ' OD2' ' NH2' ' B' ' 182' ' ' ARG . 2.1 m-20 -57.32 139.06 53.99 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.825 -1.172 . . . . 0.0 109.646 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.651 HD23 ' N ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -94.66 121.26 36.05 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.113 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.651 ' N ' HD23 ' A' ' 27' ' ' LEU . 55.9 p -80.26 140.59 36.15 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.265 -0.897 . . . . 0.0 109.427 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.807 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 23.4 p90 -146.06 157.87 43.86 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.145 -0.972 . . . . 0.0 108.875 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -111.07 168.06 9.78 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.122 -0.987 . . . . 0.0 109.453 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.549 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -62.23 153.63 29.92 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.135 -0.978 . . . . 0.0 109.628 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.69 -8.11 3.5 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 5.2 tt0 -75.65 142.61 42.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.979 -1.307 . . . . 0.0 109.912 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -96.2 139.28 32.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.227 -0.921 . . . . 0.0 109.312 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.6 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 2.6 mpp? -135.28 151.44 50.57 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.606 -0.684 . . . . 0.0 109.919 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 5.8 tppp? -105.07 124.13 49.0 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.533 -0.729 . . . . 0.0 109.186 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.7 t -81.03 132.73 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.855 . . . . 0.0 109.291 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.7 mt -107.7 -47.43 3.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.152 -0.968 . . . . 0.0 109.63 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -142.42 97.47 3.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.943 . . . . 0.0 108.936 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.594 ' HG2' ' CD1' ' A' ' 45' ' ' TRP . 2.3 tm-20 -84.17 116.66 23.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.359 -0.838 . . . . 0.0 109.653 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.575 ' CG ' HD12 ' B' ' 186' ' ' LEU . 7.1 m-70 -80.58 -98.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.433 -0.792 . . . . 0.0 109.458 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.26 -11.36 0.67 Allowed Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.32 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.547 ' O ' ' HG3' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -156.85 -18.78 0.09 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.879 -1.365 . . . . 0.0 110.413 -179.692 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.844 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 67.2 m95 -135.78 96.17 3.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.902 -1.124 . . . . 0.0 109.124 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.622 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -88.21 145.27 25.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.022 -1.049 . . . . 0.0 110.119 -179.253 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.6 OUTLIER -93.7 107.43 19.31 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.219 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -104.55 -173.96 2.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.296 -0.878 . . . . 0.0 110.094 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 2.7 ttpm? -125.46 126.84 45.56 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.59 -0.694 . . . . 0.0 109.459 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.602 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -70.92 126.5 29.74 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.111 -0.993 . . . . 0.0 110.03 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.24 -7.47 49.52 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.8 tp -54.49 -55.05 33.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.503 -0.748 . . . . 0.0 109.253 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.5 t -161.16 29.69 0.14 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.122 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.587 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 86.36 45.85 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.482 -0.761 . . . . 0.0 110.671 178.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.602 ' HB2' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER -86.94 132.3 33.84 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.068 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.465 ' HG2' ' CE ' ' A' ' 46' ' ' LYS . 20.2 tt0 -121.59 116.38 24.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.942 -1.099 . . . . 0.0 109.353 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.607 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -157.13 169.26 34.19 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 119.385 -1.388 . . . . 0.0 110.032 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.7 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 11.0 m-85 -73.55 133.91 43.67 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.625 -0.926 . . . . 0.0 109.958 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 45' ' ' TRP . 2.6 pt -121.68 142.51 36.04 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.646 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 49.6 Cg_endo -69.93 152.0 68.3 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 121.792 1.661 . . . . 0.0 111.816 -178.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.543 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 66.1 p -80.81 5.67 15.27 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 110.006 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 4.4 p-10 -106.01 -52.48 2.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.997 -1.065 . . . . 0.0 110.941 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.584 ' CE1' HG21 ' B' ' 176' ' ' THR . 4.5 m-85 -52.63 -61.28 2.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.099 -1.001 . . . . 0.0 111.263 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.6 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.6 m -79.83 155.49 4.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 122.069 0.938 . . . . 0.0 111.092 -177.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.42 ' HB1' ' CD1' ' A' ' 16' ' ' LEU . . . -133.61 161.05 35.68 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.61 150.53 37.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.0 -1.063 . . . . 0.0 109.537 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.498 ' O ' ' CB ' ' A' ' 67' ' ' ASN . 0.6 OUTLIER -126.2 -24.4 3.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.103 -0.998 . . . . 0.0 109.638 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER 75.59 -81.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.912 . . . . 0.0 109.516 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.437 -179.961 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . 0.512 ' O ' ' HB2' ' B' ' 171' ' ' ASP . 1.6 m-90 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . 0.547 ' N ' ' HD3' ' B' ' 172' ' ' PRO . 4.3 t0 172.68 59.62 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.295 -0.878 . . . . 0.0 108.637 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' B' ' 171' ' ' ASP . 54.8 Cg_endo -88.68 -88.42 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.855 2.37 . . . . 0.0 112.009 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' GLY . . . . . . . . . . . . . . . 133.0 -36.3 2.17 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 178.43 109.0 0.15 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.284 -1.127 . . . . 0.0 109.398 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . 0.533 ' HG2' ' CE1' ' A' ' 17' ' ' TYR . 50.8 Cg_endo -91.0 174.25 2.69 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.135 2.557 . . . . 0.0 111.819 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 176' ' ' THR . . . . . 0.584 HG21 ' CE1' ' A' ' 62' ' ' TYR . 0.0 OUTLIER 178.37 105.31 0.14 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 109.496 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 177' ' ' PRO . . . . . 0.633 ' CD ' ' CD2' ' A' ' 17' ' ' TYR . 50.8 Cg_endo -75.64 174.58 12.56 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.446 2.097 . . . . 0.0 111.656 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . 0.507 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 46.6 Cg_endo -68.24 137.69 40.98 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.613 2.208 . . . . 0.0 111.667 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . 0.662 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -87.96 177.33 2.73 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.281 -0.887 . . . . 0.0 109.797 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.844 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 39.5 Cg_endo -68.92 -176.02 1.13 Allowed 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 123.03 2.487 . . . . 0.0 111.991 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . 0.721 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 52.0 Cg_endo -92.74 -20.57 0.49 Allowed 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 123.28 2.653 . . . . 0.0 114.661 -177.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . 0.741 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.0 OUTLIER 78.75 89.9 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 120.873 -1.142 . . . . 0.0 109.175 -179.106 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' B' ' 186' ' ' LEU . 49.1 Cg_endo -70.41 137.43 33.55 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.804 2.336 . . . . 0.0 112.039 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 37.26 60.87 1.0 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.424 -0.797 . . . . 0.0 109.562 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 46.91 47.71 15.44 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.154 -0.966 . . . . 0.0 109.125 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . 0.606 ' CG ' ' HB2' ' A' ' 44' ' ' TRP . 20.5 tp -61.18 -84.93 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.517 -0.739 . . . . 0.0 109.427 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . 0.7 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . -76.55 32.79 1.39 Allowed Glycine 0 N--CA 1.486 1.988 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.631 ' HA ' ' CD2' ' A' ' 23' ' ' HIS . 31.0 mt-10 -103.98 -73.18 0.68 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.282 -1.128 . . . . 0.0 109.466 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 189' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.38 165.83 5.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.391 -0.818 . . . . 0.0 109.413 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -101.57 31.2 3.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.472 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.461 -179.984 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.465 ' HA ' ' OE1' ' A' ' 9' ' ' GLN . 44.4 mm-40 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.89 -99.29 0.43 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.24 -176.12 5.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -1.181 . . . . 0.0 109.444 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.16 137.55 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.296 -0.877 . . . . 0.0 109.523 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.56 HG23 ' CG2' ' A' ' 37' ' ' VAL . 3.0 m -131.79 161.3 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 0.0 109.279 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 33' ' ' GLU . 9.5 p -120.13 139.99 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.126 -0.984 . . . . 0.0 109.186 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.566 ' HB3' ' CD1' ' A' ' 29' ' ' PHE . . . -73.1 133.06 44.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.475 -0.765 . . . . 0.0 110.122 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.516 ' CD1' ' HB3' ' A' ' 64' ' ' ALA . 8.7 mt -100.1 -14.01 18.75 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.653 ' HA ' ' CG ' ' A' ' 31' ' ' LYS . 34.1 m-85 -155.84 150.47 20.31 Favored Pre-proline 0 N--CA 1.489 1.476 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.68 ' HD3' ' HG3' ' A' ' 31' ' ' LYS . 39.6 Cg_endo -61.09 149.03 91.11 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 121.718 1.612 . . . . 0.0 109.742 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.775 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 60.9 t80 -97.95 178.23 5.18 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.041 -1.464 . . . . 0.0 110.525 -177.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.679 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 30.6 t0 -109.75 80.46 1.32 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.673 -0.642 . . . . 0.0 109.408 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.63 93.22 0.03 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.503 HG12 ' O ' ' A' ' 20' ' ' ASP . 0.6 OUTLIER -107.26 -42.81 6.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.142 -1.21 . . . . 0.0 108.675 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.643 ' CD2' ' HA ' ' B' ' 188' ' ' GLU . 59.0 m-70 -76.86 156.43 82.54 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.97 -13.94 37.61 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.287 1.991 . . . . 0.0 111.998 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -111.71 -13.72 13.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.341 -0.85 . . . . 0.0 110.493 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.487 ' OD2' ' OH ' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -57.97 140.52 52.09 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.827 -1.171 . . . . 0.0 109.989 -179.316 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.696 HD23 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -95.62 122.11 38.03 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.077 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.696 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -80.54 140.48 35.81 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.203 -0.935 . . . . 0.0 109.282 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.775 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 29.9 p90 -146.99 158.27 43.87 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.124 -0.985 . . . . 0.0 109.042 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 16.4 mttp -111.69 174.61 5.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.165 -0.959 . . . . 0.0 109.41 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.68 ' HG3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -66.54 155.88 36.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.875 -1.141 . . . . 0.0 109.428 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 67.71 -6.75 2.51 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' A' ' 31' ' ' LYS . 4.6 tp10 -75.24 140.51 43.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.86 -1.377 . . . . 0.0 109.573 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.9 138.99 32.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.532 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.573 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 3.5 mpp? -135.83 152.14 50.77 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.473 0.654 . . . . 0.0 109.753 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.9 OUTLIER -108.6 126.14 52.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.459 -0.776 . . . . 0.0 109.313 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.56 ' CG2' HG23 ' A' ' 13' ' ' VAL . 3.9 t -82.14 126.31 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.357 -0.839 . . . . 0.0 109.37 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.8 mt -99.33 -46.57 5.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.924 . . . . 0.0 109.429 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.5 90.62 2.58 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.588 ' CG ' ' CG ' ' A' ' 45' ' ' TRP . 1.4 tt0 -76.55 117.67 18.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.4 -0.812 . . . . 0.0 109.965 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.533 ' CD2' HD12 ' B' ' 186' ' ' LEU . 14.2 m-70 -87.34 -98.8 0.08 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.336 -0.853 . . . . 0.0 109.074 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.07 -7.52 0.11 Allowed Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.328 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.533 ' HB2' ' HD3' ' B' ' 183' ' ' PRO . 3.0 mp0 -149.43 -29.52 0.25 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.957 -1.32 . . . . 0.0 110.098 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.8 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 67.7 m95 -137.7 97.32 3.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 109.328 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.588 ' CG ' ' CG ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -88.42 146.64 25.12 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.976 -1.078 . . . . 0.0 110.147 -179.718 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.567 ' HG3' ' CD1' ' A' ' 57' ' ' PHE . 0.7 OUTLIER -93.15 107.07 18.94 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -104.75 -173.39 2.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.211 -0.931 . . . . 0.0 110.045 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -125.73 129.27 49.16 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.57 -0.706 . . . . 0.0 109.664 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.566 ' HB2' ' HB3' ' A' ' 54' ' ' LYS . 1.2 t -74.07 128.08 34.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.0 109.882 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.63 -8.88 57.49 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.3 tp -53.08 -55.11 26.39 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.41 -0.806 . . . . 0.0 109.329 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.596 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.8 t -161.24 29.61 0.14 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.094 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.596 ' CB ' ' O ' ' A' ' 52' ' ' THR . 3.9 mttm 86.59 45.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.356 -0.84 . . . . 0.0 110.607 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.592 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 8.1 tttt -85.79 132.67 34.07 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.52 116.7 24.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.939 -1.101 . . . . 0.0 109.412 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.607 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -157.62 169.09 34.44 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 119.459 -1.353 . . . . 0.0 109.972 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.824 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 6.3 m-85 -72.65 133.76 44.79 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.72 -0.871 . . . . 0.0 109.874 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.45 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 6.5 pt -121.97 143.6 39.13 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.714 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 50.1 Cg_endo -71.41 152.0 60.13 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 121.778 1.652 . . . . 0.0 112.176 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.477 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 28.1 t -80.32 6.26 12.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.314 -0.866 . . . . 0.0 110.81 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.554 ' ND2' ' O ' ' B' ' 178' ' ' PRO . 0.1 OUTLIER -108.99 -52.51 2.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.795 -1.19 . . . . 0.0 110.709 -179.147 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.582 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 3.9 m-85 -50.04 -62.59 1.49 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.043 -1.036 . . . . 0.0 110.9 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.573 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 3.1 m -79.14 155.31 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 121.925 0.869 . . . . 0.0 111.086 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.516 ' HB3' ' CD1' ' A' ' 16' ' ' LEU . . . -130.76 159.56 36.94 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.453 ' O ' HD11 ' A' ' 66' ' ' LEU . 11.1 mtpt -75.96 94.33 3.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.037 -1.04 . . . . 0.0 109.57 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.453 HD11 ' O ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -138.78 151.3 46.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.636 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -172.61 157.65 3.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.322 -0.861 . . . . 0.0 109.43 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.104 -0.997 . . . . 0.0 109.443 -179.931 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 63.8 m95 . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . 0.573 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 4.9 m-20 -169.61 -56.43 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.251 -0.905 . . . . 0.0 108.845 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 48.0 Cg_endo -67.88 -90.28 0.0 OUTLIER 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.724 2.282 . . . . 0.0 111.841 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' GLY . . . . . . . . . . . . . . . 175.76 42.43 0.05 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' MET . . . . . 0.553 ' N ' ' CD ' ' B' ' 175' ' ' PRO . 0.5 OUTLIER -50.27 -47.45 82.58 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.193 -1.181 . . . . 0.0 109.459 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' B' ' 174' ' ' MET . 55.2 Cg_endo -81.59 -164.75 0.29 Allowed 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.733 2.289 . . . . 0.0 111.859 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 176' ' ' THR . . . . . 0.546 HG21 ' HB3' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -173.18 100.83 0.33 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.429 -0.795 . . . . 0.0 109.198 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 177' ' ' PRO . . . . . 0.596 ' HD2' ' CD2' ' A' ' 17' ' ' TYR . 50.9 Cg_endo -69.71 161.57 45.42 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.801 2.334 . . . . 0.0 111.965 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . 0.554 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 51.4 Cg_endo -70.07 159.83 51.76 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.717 2.278 . . . . 0.0 111.066 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . 0.628 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -91.77 175.42 3.45 Favored Pre-proline 0 C--N 1.303 -1.421 0 O-C-N 121.007 -1.058 . . . . 0.0 109.778 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.8 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 40.2 Cg_endo -69.13 -172.15 0.48 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.268 2.645 . . . . 0.0 111.652 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . 0.686 ' O ' ' CB ' ' B' ' 182' ' ' ARG . 53.3 Cg_endo -88.54 -40.96 0.05 OUTLIER 'Trans proline' 0 C--O 1.214 -0.721 0 C-N-CA 122.679 2.253 . . . . 0.0 114.025 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . 0.739 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 2.7 ttm180 91.49 92.92 0.03 OUTLIER Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.299 -0.875 . . . . 0.0 109.39 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . 0.533 ' HD3' ' HB2' ' A' ' 43' ' ' GLU . 48.8 Cg_endo -71.99 133.99 22.59 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.996 2.464 . . . . 0.0 112.144 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 36.66 69.81 0.19 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.49 -0.757 . . . . 0.0 109.725 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . 0.453 ' C ' ' O ' ' B' ' 184' ' ' ALA . 2.9 p-10 39.46 45.42 1.27 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.417 -0.802 . . . . 0.0 109.44 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . 0.577 ' CG ' ' HB2' ' A' ' 44' ' ' TRP . 18.1 tp -53.82 -89.0 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.458 -0.776 . . . . 0.0 109.046 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . 0.824 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . -82.02 26.05 3.94 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.643 ' HA ' ' CD2' ' A' ' 23' ' ' HIS . 1.5 tt0 -99.51 -30.85 11.92 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.251 -1.147 . . . . 0.0 109.423 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 189' ' ' ARG . . . . . 0.455 ' C ' ' HG2' ' B' ' 190' ' ' GLN . 0.0 OUTLIER 47.31 40.2 10.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 109.536 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' B' ' 188' ' ' GLU . 13.9 mm100 -145.42 84.95 1.7 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.94 . . . . 0.0 109.55 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.501 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.317 0.579 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.41 112.92 3.62 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.74 162.92 13.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.347 -1.09 . . . . 0.0 109.405 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.7 tp -107.9 137.87 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.142 -0.974 . . . . 0.0 109.59 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.431 HG21 HG21 ' A' ' 37' ' ' VAL . 1.5 m -132.0 161.76 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.49 HG21 ' O ' ' A' ' 33' ' ' GLU . 8.0 p -120.94 139.18 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.024 -1.047 . . . . 0.0 109.279 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -71.53 134.55 46.57 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.395 -0.816 . . . . 0.0 109.731 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.651 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 19.2 mt -99.41 -21.72 15.86 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.651 ' CE1' ' HB2' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -148.68 152.55 37.93 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.439 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.656 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 39.8 Cg_endo -62.92 149.63 90.93 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 121.931 1.754 . . . . 0.0 110.185 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.791 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 55.9 t80 -98.84 179.13 4.75 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.153 -1.419 . . . . 0.0 110.432 -177.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.69 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 57.7 m-20 -110.84 79.86 1.25 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.682 -0.636 . . . . 0.0 109.356 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.8 95.15 0.04 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 20' ' ' ASP . 15.2 mm -108.42 -41.97 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -1.13 . . . . 0.0 108.893 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.516 ' CD2' ' O ' ' B' ' 188' ' ' GLU . 36.2 m80 -77.56 158.88 78.15 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.53 -14.17 36.39 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.284 1.989 . . . . 0.0 111.869 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.0 -13.51 13.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.0 110.416 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.66 138.08 55.76 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.821 -1.174 . . . . 0.0 109.809 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.632 HD23 ' N ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -95.53 121.22 36.99 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.632 ' N ' HD23 ' A' ' 27' ' ' LEU . 3.1 m -79.99 141.3 36.08 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.355 -0.84 . . . . 0.0 109.475 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.791 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 28.3 p90 -145.84 157.54 43.91 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.201 -0.937 . . . . 0.0 108.588 178.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 40.6 mttm -110.65 173.82 6.15 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.087 -1.008 . . . . 0.0 109.585 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.491 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -67.52 151.54 47.19 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.111 -0.993 . . . . 0.0 109.314 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.87 -8.09 4.83 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -75.43 140.46 42.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.928 -1.336 . . . . 0.0 109.788 -179.676 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -93.54 138.66 31.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.862 . . . . 0.0 109.263 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.599 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 1.9 mpp? -135.24 151.66 50.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.622 -0.674 . . . . 0.0 109.796 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -106.16 124.61 49.85 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.469 -0.769 . . . . 0.0 109.62 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.431 HG21 HG21 ' A' ' 13' ' ' VAL . 1.4 t -82.21 132.32 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.34 -0.85 . . . . 0.0 108.846 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.49 ' CD2' ' HD3' ' A' ' 36' ' ' LYS . 3.7 mt -110.37 -42.51 4.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.006 -1.059 . . . . 0.0 109.849 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -138.8 84.47 2.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.178 -0.951 . . . . 0.0 109.215 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.591 ' HG2' ' CD1' ' A' ' 45' ' ' TRP . 1.4 tt0 -67.96 116.14 8.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.861 . . . . 0.0 109.274 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.598 ' CG ' HD12 ' B' ' 186' ' ' LEU . 46.1 m-70 -86.04 -103.32 0.06 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.235 -0.916 . . . . 0.0 109.398 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.435 ' O ' ' HG3' ' A' ' 43' ' ' GLU . . . -136.4 -15.39 0.88 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.304 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.569 ' CG ' ' HD2' ' B' ' 181' ' ' PRO . 1.3 mt-10 -158.0 -20.24 0.08 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.944 -1.327 . . . . 0.0 110.525 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.925 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 57.1 m95 -133.51 93.81 3.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.919 -1.113 . . . . 0.0 108.676 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.63 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -85.85 146.57 26.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.074 -1.016 . . . . 0.0 110.796 -178.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 1.1 ttpt -94.21 105.85 17.83 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.41 -174.05 2.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.32 -0.862 . . . . 0.0 110.125 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.9 mttp -125.72 126.85 45.29 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.542 -0.724 . . . . 0.0 109.496 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.548 ' HB2' ' HB3' ' A' ' 54' ' ' LYS . 1.8 t -70.94 125.62 27.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.136 -0.978 . . . . 0.0 109.875 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.75 -8.69 54.09 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.499 ' C ' ' CD1' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -53.4 -55.27 26.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.508 -0.745 . . . . 0.0 109.352 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.611 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 1.5 t -161.16 30.11 0.14 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.267 -0.896 . . . . 0.0 110.186 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.611 ' HB2' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 85.58 45.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.499 -0.751 . . . . 0.0 110.651 178.547 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.593 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -86.8 132.18 33.91 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.122 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 1.4 pt-20 -121.82 117.56 26.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.89 -1.131 . . . . 0.0 109.455 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.614 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -157.67 168.67 34.38 Favored Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.346 -1.407 . . . . 0.0 110.158 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.72 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 15.5 m-85 -73.54 134.33 43.78 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.686 -0.89 . . . . 0.0 109.954 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.463 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 4.1 pt -122.37 141.16 34.09 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.587 ' HG3' ' CD2' ' B' ' 179' ' ' LEU . 53.4 Cg_endo -72.48 134.43 22.48 Favored 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 121.673 1.582 . . . . 0.0 111.997 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.623 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 24.3 p -65.2 4.69 0.45 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 110.422 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.67 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 5.9 p-10 -102.01 -51.64 3.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.871 -1.143 . . . . 0.0 110.86 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.67 ' N ' ' OD1' ' A' ' 61' ' ' ASN . 3.1 m-85 -55.27 -59.99 4.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.142 -0.974 . . . . 0.0 111.304 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.599 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 4.2 m -78.74 157.61 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 122.054 0.931 . . . . 0.0 111.41 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.506 ' HB3' ' CD1' ' A' ' 16' ' ' LEU . . . -135.63 161.88 34.29 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.509 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -75.55 93.28 2.99 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.046 -1.033 . . . . 0.0 109.265 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.477 ' O ' ' HB2' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -146.62 147.4 31.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.448 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.516 ' ND2' ' N ' ' A' ' 68' ' ' THR . 1.0 OUTLIER 171.06 157.95 0.08 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -0.873 . . . . 0.0 109.496 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.516 ' N ' ' ND2' ' A' ' 67' ' ' ASN . 1.6 t . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.487 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 12.5 m95 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.326 0.584 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . 0.586 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 1.9 m-20 -170.18 -56.15 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.209 -0.932 . . . . 0.0 108.809 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 47.8 Cg_endo -67.9 -90.36 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.678 2.252 . . . . 0.0 111.868 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' B' ' 174' ' ' MET . . . 80.09 32.16 36.6 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' MET . . . . . 0.489 ' HB2' ' O ' ' B' ' 173' ' ' GLY . 32.0 mtm 65.31 87.39 0.12 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.398 -1.06 . . . . 0.0 109.552 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . 0.56 ' O ' ' CG2' ' B' ' 176' ' ' THR . 53.8 Cg_endo -83.07 -167.13 0.43 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.677 2.252 . . . . 0.0 111.842 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 176' ' ' THR . . . . . 0.56 ' CG2' ' O ' ' B' ' 175' ' ' PRO . 0.2 OUTLIER 160.59 117.56 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 177' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -86.69 168.21 8.37 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.847 2.365 . . . . 0.0 111.959 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.81 114.82 3.67 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.754 2.302 . . . . 0.0 111.789 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . 0.653 ' CD2' ' CE2' ' A' ' 62' ' ' TYR . 46.2 mt -51.2 158.41 1.3 Allowed Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.328 -0.857 . . . . 0.0 109.955 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.925 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 39.6 Cg_endo -68.79 176.32 6.16 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.755 2.303 . . . . 0.0 111.648 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . 0.594 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 55.5 Cg_endo -86.82 -26.85 0.82 Allowed 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.885 2.39 . . . . 0.0 114.51 -177.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . 0.715 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.0 OUTLIER 79.41 95.67 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 120.818 -1.176 . . . . 0.0 109.458 -179.213 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . 0.652 ' HG2' ' HB2' ' B' ' 186' ' ' LEU . 48.0 Cg_endo -69.68 131.19 20.83 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 123.064 2.509 . . . . 0.0 112.269 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.506 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 35.64 69.13 0.19 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.448 -0.782 . . . . 0.0 109.874 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . 0.437 ' ND2' ' N ' ' B' ' 185' ' ' ASN . 0.2 OUTLIER 43.34 45.33 5.13 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.377 -0.827 . . . . 0.0 109.537 -179.824 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . 0.652 ' HB2' ' HG2' ' B' ' 183' ' ' PRO . 28.4 tp -55.7 -94.96 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . 0.72 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . -71.58 -8.25 66.69 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 107.859 -2.097 . . . . 0.0 107.859 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.539 ' CA ' ' HD3' ' B' ' 182' ' ' ARG . 6.3 tt0 -74.62 -6.31 47.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.617 -0.931 . . . . 0.0 109.412 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 189' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -177.63 -78.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.177 -0.952 . . . . 0.0 109.52 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . 0.454 ' O ' ' O ' ' B' ' 191' ' ' ALA . 0.0 OUTLIER -157.75 113.43 2.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.521 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 191' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' B' ' 184' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.43 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.246 0.546 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.22 118.15 5.46 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.88 170.4 7.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -1.141 . . . . 0.0 109.424 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.441 HD11 HG21 ' A' ' 12' ' ' ILE . 36.0 mm -102.86 133.93 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.195 -0.941 . . . . 0.0 109.366 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.552 ' CG2' ' CG2' ' A' ' 37' ' ' VAL . 1.0 OUTLIER -132.36 159.57 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.508 -0.745 . . . . 0.0 109.171 -179.424 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 p -119.45 135.51 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.878 -1.139 . . . . 0.0 108.95 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.612 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -70.21 131.62 44.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.409 -0.807 . . . . 0.0 110.594 -178.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.606 ' CD1' ' CB ' ' A' ' 64' ' ' ALA . 95.2 mt -98.79 -39.31 8.69 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' B' ' 175' ' ' PRO . 16.4 m-85 -122.33 139.28 30.44 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -63.0 150.61 88.15 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.625 2.217 . . . . 0.0 113.015 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.754 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 25.1 t80 -130.25 115.97 17.72 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.431 ' O ' HD12 ' A' ' 22' ' ' ILE . 0.5 OUTLIER -94.72 119.11 32.8 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 116.294 -2.162 . . . . 0.0 108.922 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -41.92 99.19 0.01 OUTLIER Glycine 0 N--CA 1.487 2.077 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.431 HD12 ' O ' ' A' ' 20' ' ' ASP . 12.9 mm -88.64 -54.03 8.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.597 ' CB ' ' CD ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -66.39 -171.02 0.07 OUTLIER Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 23' ' ' HIS . 52.2 Cg_endo -92.26 -13.48 1.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.54 2.16 . . . . 0.0 112.333 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -117.8 -11.14 10.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 0.0 110.779 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.471 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 99.5 m-20 -57.64 140.4 51.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.001 -1.062 . . . . 0.0 110.413 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.62 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.3 OUTLIER -97.64 126.43 42.94 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.557 ' N ' HD23 ' A' ' 27' ' ' LEU . 9.4 m -81.62 138.02 35.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.149 -0.969 . . . . 0.0 110.693 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.754 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 18.5 p90 -145.84 156.66 43.71 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.508 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -112.09 163.19 14.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.015 -1.053 . . . . 0.0 109.618 -179.368 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.436 ' C ' ' H ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -56.41 151.6 12.87 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.218 -0.926 . . . . 0.0 108.99 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.49 -8.42 3.07 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.519 ' OE2' ' O ' ' A' ' 34' ' ' LYS . 3.2 tm-20 -73.66 144.41 45.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.93 -1.336 . . . . 0.0 109.997 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.519 ' O ' ' OE2' ' A' ' 33' ' ' GLU . 4.0 mtmp? -96.03 135.98 37.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.91 . . . . 0.0 109.336 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.583 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 1.4 mpp? -134.52 150.67 50.8 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.518 -0.739 . . . . 0.0 110.02 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 13.0 tttt -105.74 117.52 34.24 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.529 -0.732 . . . . 0.0 109.182 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.552 ' CG2' ' CG2' ' A' ' 13' ' ' VAL . 2.5 t -76.92 132.42 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.386 -0.821 . . . . 0.0 109.185 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 98.2 mt -103.47 -50.53 3.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.722 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -140.89 103.94 4.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 108.913 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.653 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.2 tm-20 -87.54 119.22 27.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.459 -0.776 . . . . 0.0 109.784 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.583 ' CG ' HD12 ' B' ' 186' ' ' LEU . 3.0 m-70 -83.85 -98.39 0.05 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.379 -0.826 . . . . 0.0 109.206 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 43' ' ' GLU . . . -138.98 -13.1 0.71 Allowed Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.654 -1.26 . . . . 0.0 110.318 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' B' ' 180' ' ' PRO . 12.0 mt-10 -153.24 -16.43 0.15 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.918 -1.343 . . . . 0.0 110.412 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.775 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 65.3 m95 -140.21 100.1 3.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.939 -1.101 . . . . 0.0 109.53 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.662 ' CZ2' ' CB ' ' A' ' 60' ' ' SER . 0.1 OUTLIER -92.51 144.41 25.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.135 -0.978 . . . . 0.0 109.809 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -85.66 108.92 18.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.267 -0.895 . . . . 0.0 108.642 179.234 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.51 -177.87 3.5 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.264 -0.897 . . . . 0.0 110.01 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 8.5 mtpt -125.0 132.02 53.32 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.586 -0.697 . . . . 0.0 109.608 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.628 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 4.4 t -79.87 129.1 34.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.927 . . . . 0.0 109.717 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.457 HD13 ' CB ' ' A' ' 34' ' ' LYS . 19.6 mt -74.14 -5.24 40.56 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.7 tp -55.91 -54.76 40.77 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.334 -0.854 . . . . 0.0 109.132 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.633 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -160.4 27.56 0.16 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.33 -0.857 . . . . 0.0 110.04 179.323 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.633 ' HB2' ' O ' ' A' ' 52' ' ' THR . 5.0 mtpm? 87.2 43.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.586 -0.696 . . . . 0.0 110.805 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.628 ' HB2' ' CB ' ' A' ' 49' ' ' SER . 3.0 mmtp -85.27 132.57 34.24 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -122.63 116.54 23.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.955 -1.091 . . . . 0.0 109.424 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.62 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -152.67 170.62 31.8 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.659 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 5.1 m-85 -73.0 132.05 42.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.449 -1.03 . . . . 0.0 109.52 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.536 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 7.2 pt -121.14 140.17 30.64 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 108.965 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.642 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 49.3 Cg_endo -68.87 153.38 72.87 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.42 2.08 . . . . 0.0 112.022 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.662 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 77.4 p -85.61 6.55 26.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 109.948 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.574 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 3.4 p-10 -105.95 -47.58 3.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.145 -0.972 . . . . 0.0 110.158 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.637 ' CE2' ' CD2' ' B' ' 179' ' ' LEU . 10.4 m-30 -56.76 -59.97 4.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.495 -0.753 . . . . 0.0 110.956 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.583 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 3.1 m -80.11 163.28 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 111.296 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.606 ' CB ' ' CD1' ' A' ' 16' ' ' LEU . . . -137.24 130.59 31.16 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.507 ' O ' ' O ' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -48.37 179.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.154 -0.966 . . . . 0.0 109.849 -179.441 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.9 24.37 6.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.292 -0.88 . . . . 0.0 109.602 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -78.29 -154.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.895 . . . . 0.0 109.44 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.3 p . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.507 -179.987 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 5.0 p90 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . 0.566 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 0.9 OUTLIER -167.53 -57.14 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.28 -0.888 . . . . 0.0 108.865 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 45.5 Cg_endo -67.42 -89.35 0.0 OUTLIER 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.719 2.279 . . . . 0.0 111.821 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 173' ' ' GLY . . . . . 0.462 ' O ' ' HG2' ' B' ' 174' ' ' MET . . . -168.53 38.01 0.21 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 174' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' B' ' 173' ' ' GLY . 0.6 OUTLIER -144.22 91.54 6.4 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.317 -1.108 . . . . 0.0 109.399 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . 0.602 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 55.1 Cg_endo -77.81 -160.5 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.654 2.236 . . . . 0.0 111.705 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 176' ' ' THR . . . . . 0.479 HG23 ' HB3' ' A' ' 17' ' ' TYR . 21.1 p -150.27 93.22 3.89 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.429 -0.795 . . . . 0.0 109.316 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 177' ' ' PRO . . . . . 0.56 ' HD2' ' CD2' ' A' ' 17' ' ' TYR . 52.9 Cg_endo -74.08 174.17 12.87 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.683 2.255 . . . . 0.0 111.702 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' B' ' 177' ' ' PRO . 49.8 Cg_endo -71.03 110.38 2.8 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.547 2.164 . . . . 0.0 111.831 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . 0.637 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -49.94 177.05 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.342 -0.849 . . . . 0.0 109.258 179.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.775 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.4 Cg_endo -67.36 -175.84 0.75 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.872 2.382 . . . . 0.0 111.797 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . 0.747 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 53.5 Cg_endo -91.88 -22.58 0.48 Allowed 'Trans proline' 0 C--O 1.213 -0.775 0 C-N-CA 123.062 2.508 . . . . 0.0 114.709 -177.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . 0.747 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 20.7 mtt180 77.0 93.07 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.892 -1.13 . . . . 0.0 109.063 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' B' ' 186' ' ' LEU . 47.0 Cg_endo -68.38 130.89 22.0 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.666 2.244 . . . . 0.0 111.848 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 43.53 61.82 2.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.367 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 47.18 50.27 14.4 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.267 -0.895 . . . . 0.0 109.274 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . 0.583 HD12 ' CG ' ' A' ' 41' ' ' HIS . 49.9 tp -68.51 -83.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.412 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . 0.659 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . -68.18 -8.51 54.81 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.518 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -81.78 -86.73 0.09 Allowed 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.472 -1.017 . . . . 0.0 109.31 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 189' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.89 119.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.556 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -157.13 27.87 0.3 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.518 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.51 179.951 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.46 -118.66 0.67 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -159.64 155.83 26.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -1.126 . . . . 0.0 109.43 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 tp -106.3 142.13 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.233 -0.917 . . . . 0.0 109.648 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.492 HG23 ' CG2' ' A' ' 37' ' ' VAL . 3.5 m -132.33 162.46 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.443 -0.786 . . . . 0.0 109.175 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.7 p -121.78 138.64 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.123 -0.985 . . . . 0.0 109.209 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -71.2 136.85 48.26 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.469 -0.769 . . . . 0.0 109.829 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.614 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 55.6 mt -98.97 -25.46 14.57 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.639 ' CD1' ' O ' ' B' ' 175' ' ' PRO . 23.1 m-85 -144.66 154.85 56.46 Favored Pre-proline 0 N--CA 1.486 1.373 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.662 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 41.5 Cg_endo -63.99 149.36 90.7 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 121.941 1.761 . . . . 0.0 110.192 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.824 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 58.8 t80 -99.65 178.38 4.87 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 118.01 -1.476 . . . . 0.0 110.552 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.679 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -110.63 80.0 1.26 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.655 -0.653 . . . . 0.0 109.377 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.27 95.26 0.03 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.701 -1.759 . . . . 0.0 108.701 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.417 ' N ' ' O ' ' A' ' 20' ' ' ASP . 28.9 mt -109.89 -40.2 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.14 -1.212 . . . . 0.0 109.167 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.506 ' NE2' ' HG2' ' B' ' 188' ' ' GLU . 35.9 m-70 -80.18 158.91 71.53 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.88 -14.95 39.84 Favored 'Trans proline' 0 C--O 1.216 -0.586 0 C-N-CA 122.314 2.009 . . . . 0.0 112.159 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.447 ' OD1' ' HD2' ' B' ' 189' ' ' ARG . 5.1 m-20 -110.61 -11.46 14.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.022 -1.049 . . . . 0.0 110.488 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -59.95 143.2 52.25 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.857 -1.152 . . . . 0.0 109.655 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.697 ' CB ' ' HA2' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -102.42 122.92 45.25 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.647 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -77.35 138.94 39.62 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 109.568 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.824 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 19.8 p90 -143.66 155.4 44.23 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 108.542 178.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.591 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 1.8 ptpt -110.15 173.16 6.45 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.204 -0.935 . . . . 0.0 109.486 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.497 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -66.34 152.48 44.92 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.198 -0.939 . . . . 0.0 109.304 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.47 -7.76 3.49 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.422 ' H ' ' C ' ' A' ' 31' ' ' LYS . 0.5 OUTLIER -74.95 143.67 43.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.843 -1.386 . . . . 0.0 109.564 -179.677 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.42 138.83 33.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.901 . . . . 0.0 109.556 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.544 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 2.1 mpp? -134.86 151.58 51.03 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.594 -0.691 . . . . 0.0 109.657 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 2.6 tttt -104.99 128.82 53.45 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.406 -0.809 . . . . 0.0 109.179 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.492 ' CG2' HG23 ' A' ' 13' ' ' VAL . 1.7 t -81.58 135.11 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.416 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.8 mp -113.43 -41.13 3.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.313 -0.867 . . . . 0.0 109.513 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -149.91 88.38 1.53 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 109.233 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.628 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -74.76 114.49 13.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.378 -0.826 . . . . 0.0 109.438 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.548 ' HB2' ' CD2' ' B' ' 186' ' ' LEU . 3.2 m-70 -80.6 -101.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.518 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.411 ' C ' ' CD ' ' A' ' 43' ' ' GLU . . . -127.28 -14.91 2.59 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.048 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.559 ' CG ' ' HD3' ' B' ' 183' ' ' PRO . 0.0 OUTLIER -165.8 -10.87 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.022 -1.281 . . . . 0.0 110.3 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.822 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 71.2 m95 -131.1 89.2 2.7 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.859 -1.151 . . . . 0.0 108.701 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.628 ' CD1' ' CG ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -83.7 140.97 31.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.798 -1.189 . . . . 0.0 110.312 -179.064 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 4.3 tttt -91.42 103.54 16.16 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -101.92 -177.21 3.35 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.351 -0.843 . . . . 0.0 110.336 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -123.72 109.5 13.77 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.855 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.614 ' OG ' ' CB ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -57.45 129.53 42.25 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.807 -179.606 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.436 ' O ' ' N ' ' A' ' 52' ' ' THR . 0.3 OUTLIER -76.88 -8.61 57.67 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.318 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.472 ' O ' ' HB ' ' A' ' 52' ' ' THR . 55.5 tp -46.55 -22.68 0.3 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.738 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER 169.42 -21.94 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.38 -0.825 . . . . 0.0 110.115 178.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.738 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.1 OUTLIER 140.33 39.23 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.47 -0.769 . . . . 0.0 110.105 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.614 ' CB ' ' OG ' ' A' ' 49' ' ' SER . 0.3 OUTLIER -87.86 135.24 33.48 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -122.43 127.82 50.14 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.914 -1.117 . . . . 0.0 109.274 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.697 ' HA2' ' CB ' ' A' ' 27' ' ' LEU . . . -166.93 168.81 40.51 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.235 -1.46 . . . . 0.0 110.41 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.704 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 14.2 m-85 -71.62 132.89 45.26 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.754 -0.851 . . . . 0.0 109.898 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.513 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 8.1 pt -123.18 129.48 24.92 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.632 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 56.2 Cg_endo -75.1 126.49 9.94 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 121.634 1.556 . . . . 0.0 112.591 -178.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.623 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 32.2 t -55.28 -10.85 0.64 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.522 -0.736 . . . . 0.0 109.997 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.572 ' ND2' ' O ' ' B' ' 178' ' ' PRO . 5.3 t30 -88.35 0.81 55.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.034 -1.041 . . . . 0.0 110.383 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.604 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -117.08 -41.34 3.02 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.864 -1.148 . . . . 0.0 110.045 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.544 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.5 m -96.62 159.09 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.104 -0.997 . . . . 0.0 110.567 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.403 ' CB ' HD13 ' A' ' 16' ' ' LEU . . . -136.87 161.89 34.77 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -75.94 146.84 39.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.087 -1.008 . . . . 0.0 109.4 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.478 ' O ' ' ND2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -47.84 164.0 0.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.9 . . . . 0.0 109.596 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -153.72 102.14 2.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.352 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.508 -179.896 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . 0.409 ' CD1' ' C ' ' B' ' 170' ' ' TRP . 1.4 p90 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . 0.557 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 0.4 OUTLIER -166.5 -57.48 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.253 -0.904 . . . . 0.0 108.719 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 48.2 Cg_endo -67.91 -90.23 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.689 2.259 . . . . 0.0 111.803 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 173' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' B' ' 174' ' ' MET . . . 165.5 -35.69 0.26 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 174' ' ' MET . . . . . 0.41 ' C ' ' O ' ' B' ' 173' ' ' GLY . 0.0 OUTLIER 43.8 82.91 0.22 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.251 -1.147 . . . . 0.0 109.686 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . 0.639 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 55.5 Cg_endo -79.15 -161.69 0.16 Allowed 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 122.632 2.222 . . . . 0.0 111.72 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 176' ' ' THR . . . . . 0.512 HG21 ' O ' ' B' ' 175' ' ' PRO . 11.8 p -149.03 91.06 4.62 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.359 -0.838 . . . . 0.0 109.301 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 177' ' ' PRO . . . . . 0.585 ' HD2' ' CD2' ' A' ' 17' ' ' TYR . 47.5 Cg_endo -68.91 172.81 11.17 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.784 2.323 . . . . 0.0 112.004 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . 0.572 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 50.7 Cg_endo -69.21 137.23 36.52 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.854 2.369 . . . . 0.0 111.676 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . 0.631 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -78.77 176.42 3.7 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.172 -0.955 . . . . 0.0 109.598 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.822 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.5 Cg_endo -68.79 -176.57 1.26 Allowed 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 123.031 2.487 . . . . 0.0 111.647 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . 0.73 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.6 Cg_endo -89.82 -26.75 0.38 Allowed 'Trans proline' 0 C--O 1.213 -0.739 0 C-N-CA 122.886 2.391 . . . . 0.0 114.937 -177.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . 0.73 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 39.4 mtt180 78.14 91.56 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 120.879 -1.138 . . . . 0.0 109.13 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 50.2 Cg_endo -70.0 135.59 30.27 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.689 2.26 . . . . 0.0 111.787 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 42.38 55.38 4.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.884 . . . . 0.0 109.5 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . 0.52 ' N ' ' ND2' ' B' ' 185' ' ' ASN . 0.7 OUTLIER 51.68 50.54 18.52 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.26 -0.9 . . . . 0.0 109.281 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . 0.675 ' CD2' ' HB2' ' A' ' 44' ' ' TRP . 60.9 tp -70.48 -81.88 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.362 -0.836 . . . . 0.0 109.418 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . 0.704 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . -69.86 -5.72 53.16 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 108.924 -1.671 . . . . 0.0 108.924 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.541 ' N ' ' HD3' ' B' ' 182' ' ' ARG . 4.6 mt-10 -73.6 -81.4 0.06 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.393 -1.063 . . . . 0.0 109.242 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 189' ' ' ARG . . . . . 0.462 ' CB ' ' O ' ' B' ' 188' ' ' GLU . 0.0 OUTLIER 72.11 85.02 0.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.407 -0.808 . . . . 0.0 109.573 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -100.62 156.25 17.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.882 . . . . 0.0 109.468 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.44 179.989 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.407 ' O ' ' OD1' ' A' ' 11' ' ' ASP . . . -150.92 116.5 0.77 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -150.8 162.17 41.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -1.121 . . . . 0.0 109.266 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.48 HD13 HG22 ' A' ' 12' ' ' ILE . 30.7 mm -107.98 136.8 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.099 -1.0 . . . . 0.0 109.594 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.34 160.68 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.505 -0.747 . . . . 0.0 109.036 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 p -120.66 139.23 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.054 -1.029 . . . . 0.0 109.372 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -71.86 133.3 45.37 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.379 -0.826 . . . . 0.0 109.744 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.584 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 23.4 mt -99.13 -17.25 18.28 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.672 ' HA ' ' CG ' ' A' ' 31' ' ' LYS . 7.2 m-85 -152.62 151.61 27.21 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.685 ' HD3' ' HG3' ' A' ' 31' ' ' LYS . 40.7 Cg_endo -61.53 148.93 91.8 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 121.53 1.487 . . . . 0.0 109.655 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.811 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 36.6 t80 -89.29 -34.3 16.63 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 117.947 -1.501 . . . . 0.0 110.224 -177.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.756 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 30.3 t70 106.84 -53.52 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.26 93.31 0.2 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -109.42 -42.96 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.385 -1.067 . . . . 0.0 108.433 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.636 ' CE1' ' CG ' ' B' ' 188' ' ' GLU . 1.9 m80 -74.74 153.35 87.22 Favored Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.79 -9.69 26.71 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.075 1.85 . . . . 0.0 111.417 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.8 -17.4 11.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.368 -0.833 . . . . 0.0 110.545 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.5 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.5 OUTLIER -57.18 141.28 46.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.856 -1.152 . . . . 0.0 109.956 -178.838 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.613 HD23 ' N ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -90.03 119.14 30.12 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.867 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.613 ' N ' HD23 ' A' ' 27' ' ' LEU . 93.9 p -77.08 138.51 39.59 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.333 -0.855 . . . . 0.0 109.734 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.811 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 17.6 p90 -143.68 155.56 44.26 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.238 -0.914 . . . . 0.0 108.772 178.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -112.36 175.47 5.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.242 -0.911 . . . . 0.0 109.434 -179.356 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.685 ' HG3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -66.13 155.8 35.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.95 -1.093 . . . . 0.0 109.423 179.576 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 66.01 -6.94 1.32 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.461 ' H ' ' C ' ' A' ' 31' ' ' LYS . 0.5 OUTLIER -74.79 141.31 44.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.839 -1.389 . . . . 0.0 109.687 -179.602 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -94.87 136.97 34.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.324 -0.86 . . . . 0.0 109.415 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.579 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 1.1 mpp? -137.23 153.1 50.45 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.421 0.629 . . . . 0.0 109.758 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.654 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 13.7 tttm -110.31 123.67 50.24 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.472 -0.768 . . . . 0.0 109.26 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.456 HG22 ' HG3' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -88.71 115.66 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -82.88 -41.09 19.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.196 -0.94 . . . . 0.0 110.038 -179.365 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.54 126.02 11.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.147 -0.971 . . . . 0.0 109.505 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.613 ' HG2' ' CD2' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -95.19 131.44 41.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.451 -0.78 . . . . 0.0 109.406 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.577 ' CD2' HD13 ' B' ' 186' ' ' LEU . 78.5 m-70 -98.72 -122.84 0.14 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.266 -0.896 . . . . 0.0 108.997 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.23 -28.96 21.28 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.569 ' CB ' ' HD2' ' B' ' 181' ' ' PRO . 2.1 tp10 -172.44 5.28 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.039 -1.271 . . . . 0.0 110.672 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 1.01 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 64.4 m95 -136.26 97.29 3.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.834 -1.166 . . . . 0.0 108.372 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.638 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -93.23 145.89 24.1 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.921 -1.112 . . . . 0.0 110.337 -178.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -84.97 107.98 17.36 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.654 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -99.9 -179.62 4.22 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.363 -0.835 . . . . 0.0 109.909 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -122.76 129.97 52.36 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.62 -0.675 . . . . 0.0 109.493 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.526 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -76.75 126.79 31.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.75 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.64 -9.49 58.32 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.8 tp -52.11 -54.8 26.05 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.511 -0.743 . . . . 0.0 109.368 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.621 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.2 t -161.54 28.72 0.13 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.229 -0.92 . . . . 0.0 110.146 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.621 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.5 OUTLIER 87.09 44.33 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.47 -0.769 . . . . 0.0 110.715 178.726 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -85.46 132.64 34.18 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.077 -1.015 . . . . 0.0 108.337 178.517 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -122.4 114.75 21.17 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.859 -1.151 . . . . 0.0 109.483 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.599 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -152.22 171.84 31.49 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.657 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 8.1 m-85 -75.27 132.41 41.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.351 -1.088 . . . . 0.0 109.689 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.545 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 9.2 pt -121.93 137.42 27.3 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 108.605 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.58 ' HB2' ' CD ' ' B' ' 180' ' ' PRO . 50.9 Cg_endo -74.1 137.62 24.18 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.975 1.783 . . . . 0.0 112.763 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.593 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 28.3 t -67.93 4.3 1.23 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.583 -0.698 . . . . 0.0 110.317 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.547 HD21 ' HA ' ' B' ' 179' ' ' LEU . 0.8 OUTLIER -100.91 -55.34 2.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.022 -1.049 . . . . 0.0 110.063 -179.391 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.654 ' CE2' ' CD2' ' B' ' 179' ' ' LEU . 2.4 m-85 -51.81 -60.87 2.67 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.261 -0.899 . . . . 0.0 110.872 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.579 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 4.0 m -78.61 154.8 4.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 122.004 0.906 . . . . 0.0 111.182 -177.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.463 ' CB ' ' CD1' ' A' ' 16' ' ' LEU . . . -130.07 159.55 36.4 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -74.72 149.81 39.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.974 -1.078 . . . . 0.0 109.552 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.488 ' O ' ' CB ' ' A' ' 67' ' ' ASN . 15.7 tp -135.6 -18.99 1.64 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.337 -0.852 . . . . 0.0 109.749 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' A' ' 66' ' ' LEU . 5.2 m120 74.69 -152.58 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -0.953 . . . . 0.0 109.38 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.483 -179.947 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . 0.435 ' O ' ' CB ' ' B' ' 171' ' ' ASP . 27.9 m95 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . 0.555 ' N ' ' HD3' ' B' ' 172' ' ' PRO . 0.6 OUTLIER 167.3 60.49 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.219 -0.926 . . . . 0.0 108.948 179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.555 ' HD3' ' N ' ' B' ' 171' ' ' ASP . 52.0 Cg_endo -92.84 -82.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.171 2.581 . . . . 0.0 111.933 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 173' ' ' GLY . . . . . . . . . . . . . . . -113.37 32.41 6.1 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.99 105.65 0.36 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.186 -1.185 . . . . 0.0 109.48 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . 0.525 ' O ' ' CG2' ' B' ' 176' ' ' THR . 52.0 Cg_endo -89.52 -178.96 1.83 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.083 2.522 . . . . 0.0 111.776 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 176' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' B' ' 175' ' ' PRO . 0.1 OUTLIER 168.24 107.16 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.491 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 177' ' ' PRO . . . . . 0.655 ' CD ' ' CD2' ' A' ' 17' ' ' TYR . 49.2 Cg_endo -69.98 176.55 6.78 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.832 2.355 . . . . 0.0 111.83 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . 0.527 ' HD2' ' HB2' ' B' ' 177' ' ' PRO . 48.6 Cg_endo -68.29 118.51 5.68 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.767 2.311 . . . . 0.0 111.991 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . 0.654 ' CD2' ' CE2' ' A' ' 62' ' ' TYR . 33.4 mt -68.97 163.52 55.79 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.37 -0.831 . . . . 0.0 109.65 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 1.01 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 39.1 Cg_endo -70.56 176.12 7.81 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.483 2.122 . . . . 0.0 111.638 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . 0.578 ' O ' ' CB ' ' B' ' 182' ' ' ARG . 55.7 Cg_endo -76.47 -42.63 0.34 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.823 2.349 . . . . 0.0 113.916 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . 0.649 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.0 OUTLIER 78.94 81.44 0.1 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.039 -1.038 . . . . 0.0 108.49 -178.583 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . 0.507 ' HD2' HD21 ' B' ' 186' ' ' LEU . 51.5 Cg_endo -72.95 146.21 41.48 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.939 2.426 . . . . 0.0 112.33 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 36.35 61.93 0.76 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.607 -0.683 . . . . 0.0 109.616 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . 0.486 ' N ' ' ND2' ' B' ' 185' ' ' ASN . 0.7 OUTLIER 42.95 46.2 4.6 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.308 -0.87 . . . . 0.0 109.05 -179.65 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . 0.672 ' CD2' ' HB2' ' A' ' 44' ' ' TRP . 68.0 tp -61.85 -86.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.435 -0.79 . . . . 0.0 109.447 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . 0.657 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . -66.16 -11.4 55.34 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.636 ' CG ' ' CE1' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -69.66 -83.83 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.522 -0.987 . . . . 0.0 109.498 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 189' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.29 148.38 51.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.496 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -58.83 -70.4 0.15 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.237 -0.914 . . . . 0.0 109.456 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.483 -179.998 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.23 172.83 30.91 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.44 ' O ' HG12 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -144.74 127.47 16.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -1.137 . . . . 0.0 109.45 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.525 HD13 ' CG ' ' A' ' 36' ' ' LYS . 1.0 OUTLIER -101.43 137.79 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.884 . . . . 0.0 109.407 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.413 HG21 HG11 ' A' ' 37' ' ' VAL . 0.8 OUTLIER -130.99 159.93 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.6 p -120.55 138.46 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.981 -1.074 . . . . 0.0 109.482 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -72.29 134.58 45.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.465 -0.772 . . . . 0.0 110.111 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 62' ' ' TYR . 16.5 mt -99.26 -17.81 17.91 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.583 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 43.1 m-85 -152.55 153.87 31.02 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.65 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.6 Cg_endo -63.66 149.64 90.4 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 121.812 1.675 . . . . 0.0 110.042 179.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.804 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 65.7 t80 -97.58 179.14 4.95 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 118.219 -1.392 . . . . 0.0 110.224 -177.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.67 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 9.8 p-10 -110.15 80.93 1.36 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.569 -0.707 . . . . 0.0 109.313 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.5 91.92 0.03 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.466 ' N ' ' O ' ' A' ' 20' ' ' ASP . 67.1 mt -106.67 -43.17 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.265 -1.138 . . . . 0.0 108.765 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.606 ' CE1' ' HA ' ' B' ' 188' ' ' GLU . 41.1 m80 -75.86 156.14 84.59 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.01 -13.27 36.23 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.225 1.95 . . . . 0.0 111.799 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -111.86 -13.99 13.59 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.24 -0.913 . . . . 0.0 110.363 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.74 141.83 47.4 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.825 -1.172 . . . . 0.0 109.798 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.629 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.3 OUTLIER -98.64 124.06 43.2 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.595 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -81.08 140.26 35.2 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.322 -0.861 . . . . 0.0 109.81 -179.704 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.804 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 28.2 p90 -145.79 157.97 43.89 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 10.5 mtmm -111.27 174.03 6.06 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.047 -1.033 . . . . 0.0 109.557 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.539 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -67.38 151.9 46.64 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.186 -0.946 . . . . 0.0 109.314 179.803 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.39 -7.94 4.42 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 3.8 tt0 -75.55 143.43 42.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.917 -1.343 . . . . 0.0 109.838 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -96.3 138.18 34.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 0.0 109.273 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.596 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 1.7 mpp? -135.97 151.82 50.32 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.628 -0.67 . . . . 0.0 109.932 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 7.7 ttpt -109.02 122.37 47.11 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.507 HG22 ' HG3' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -89.93 119.0 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.296 -0.877 . . . . 0.0 108.758 178.832 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.468 HD23 ' HE2' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -89.01 -40.79 12.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.159 -0.963 . . . . 0.0 110.191 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.28 119.42 15.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.049 -1.032 . . . . 0.0 109.268 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.616 ' CG ' ' CG ' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -99.35 122.17 42.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.823 . . . . 0.0 109.453 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.567 ' CG ' HD12 ' B' ' 186' ' ' LEU . 5.2 m-70 -90.25 -103.86 0.1 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.957 . . . . 0.0 109.116 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.69 -14.06 1.55 Allowed Glycine 0 N--CA 1.489 2.174 0 C-N-CA 119.548 -1.31 . . . . 0.0 110.177 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.571 ' CG ' ' HD2' ' B' ' 181' ' ' PRO . 0.3 OUTLIER -158.77 -15.1 0.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.963 -1.316 . . . . 0.0 110.972 -179.506 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.825 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 62.7 m95 -138.92 99.52 3.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.725 -1.234 . . . . 0.0 109.608 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.671 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -93.18 142.98 26.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.881 -1.137 . . . . 0.0 109.511 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.9 OUTLIER -85.91 109.11 18.51 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.29 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.601 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -101.3 -174.62 2.65 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.333 -0.855 . . . . 0.0 109.818 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -126.97 129.39 48.05 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.478 -0.764 . . . . 0.0 109.298 -179.729 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.583 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 7.6 t -74.9 126.75 31.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.064 -1.023 . . . . 0.0 109.795 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.3 -7.43 46.96 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.151 -0.968 . . . . 0.0 108.521 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.67 -55.6 27.96 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.374 -0.829 . . . . 0.0 109.227 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.634 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.1 t -160.62 27.51 0.15 Allowed 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.136 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.634 ' CB ' ' O ' ' A' ' 52' ' ' THR . 5.1 mmtt 87.83 45.17 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.495 -0.753 . . . . 0.0 110.898 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.584 ' HB2' HD22 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -87.0 130.67 34.36 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 177.752 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.503 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 10.1 pt-20 -120.31 117.87 28.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.79 -1.194 . . . . 0.0 109.508 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.629 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -154.77 179.12 31.09 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.725 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 9.3 m-85 -80.07 132.56 35.99 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.454 -1.027 . . . . 0.0 109.954 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.535 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 8.8 pt -120.27 136.61 25.26 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.66 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 55.3 Cg_endo -73.95 135.16 20.8 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 121.827 1.685 . . . . 0.0 112.536 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.608 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 23.1 t -65.97 5.24 0.52 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.512 -0.743 . . . . 0.0 110.565 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.552 ' CG ' ' N ' ' A' ' 62' ' ' TYR . 1.2 p-10 -101.21 -51.81 3.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.765 -1.209 . . . . 0.0 110.458 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.583 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 4.8 m-85 -57.06 -59.01 5.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.117 -0.989 . . . . 0.0 110.947 -178.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.596 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 3.1 m -79.79 156.8 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.988 0.899 . . . . 0.0 111.272 -177.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.54 159.47 38.08 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.43 97.08 4.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.933 -1.105 . . . . 0.0 109.568 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 mt -147.14 123.94 11.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.173 -0.954 . . . . 0.0 109.598 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -154.55 165.3 36.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.926 . . . . 0.0 109.307 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.459 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . 0.479 ' O ' ' CB ' ' B' ' 171' ' ' ASP . 41.8 m0 . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . 0.531 ' N ' ' HD3' ' B' ' 172' ' ' PRO . 0.2 OUTLIER 165.89 61.31 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.228 -0.92 . . . . 0.0 108.953 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' B' ' 171' ' ' ASP . 51.9 Cg_endo -92.48 -91.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.222 2.615 . . . . 0.0 111.998 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 173' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' B' ' 174' ' ' MET . . . -131.48 19.23 4.83 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 174' ' ' MET . . . . . 0.445 ' HB3' ' O ' ' B' ' 173' ' ' GLY . 0.0 OUTLIER 176.41 69.65 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.36 -1.082 . . . . 0.0 109.179 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . 0.483 ' O ' HG22 ' B' ' 176' ' ' THR . 55.2 Cg_endo -79.19 -162.34 0.18 Allowed 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.733 2.289 . . . . 0.0 112.16 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 176' ' ' THR . . . . . 0.555 ' CG2' ' HB3' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -174.33 102.79 0.28 Allowed Pre-proline 0 N--CA 1.49 1.54 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 177' ' ' PRO . . . . . 0.553 ' HD2' ' CD2' ' A' ' 17' ' ' TYR . 48.5 Cg_endo -71.51 164.84 34.37 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.589 2.193 . . . . 0.0 111.75 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -67.9 136.09 37.29 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.522 2.148 . . . . 0.0 111.446 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . 0.631 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -80.16 176.23 3.99 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.203 -0.935 . . . . 0.0 109.568 -179.769 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.825 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.1 Cg_endo -68.68 178.51 3.84 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.903 2.402 . . . . 0.0 111.531 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . 0.729 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.3 Cg_endo -88.21 -21.59 1.54 Allowed 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 122.982 2.455 . . . . 0.0 114.411 -177.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . 0.729 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 24.6 mtt180 76.34 91.25 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.956 -1.09 . . . . 0.0 108.974 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . 0.547 ' HD2' HD21 ' B' ' 186' ' ' LEU . 50.9 Cg_endo -70.68 136.42 30.54 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.84 2.36 . . . . 0.0 112.017 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 41.0 63.73 1.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.834 . . . . 0.0 109.492 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . 0.417 ' CA ' ' HB2' ' B' ' 188' ' ' GLU . 0.0 OUTLIER 44.73 48.86 8.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.205 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . 0.588 ' CG ' ' HB2' ' A' ' 44' ' ' TRP . 42.6 tp -67.77 -87.15 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.441 -0.787 . . . . 0.0 109.413 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . 0.725 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . -64.67 -8.38 33.02 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.606 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 6.9 mt-10 -51.13 -90.67 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.361 -1.082 . . . . 0.0 109.5 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 189' ' ' ARG . . . . . . . . . . . . . 10.1 ptt85 -164.79 -169.02 1.6 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.161 -0.962 . . . . 0.0 109.584 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -100.49 161.17 13.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.26 -0.9 . . . . 0.0 109.497 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.092 -0.956 . . . . 0.0 109.404 179.96 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.46 168.94 18.62 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.1 161.72 37.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -1.147 . . . . 0.0 109.347 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.487 HG22 HD11 ' A' ' 12' ' ' ILE . 34.4 mm -111.8 136.79 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.119 -0.988 . . . . 0.0 109.729 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.523 HG23 ' CG2' ' A' ' 37' ' ' VAL . 1.3 m -133.09 162.92 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -118.65 139.17 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.84 -1.162 . . . . 0.0 109.069 179.176 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.659 ' O ' ' HA ' ' A' ' 31' ' ' LYS . . . -72.09 95.42 1.63 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.44 -0.788 . . . . 0.0 110.695 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.614 ' CD1' ' CB ' ' A' ' 64' ' ' ALA . 37.3 mt -60.99 -34.08 74.24 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.611 ' CD1' ' O ' ' B' ' 175' ' ' PRO . 29.1 m-85 -134.1 152.95 79.3 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.503 ' HB3' ' HA ' ' A' ' 30' ' ' LYS . 50.8 Cg_endo -70.27 150.9 65.79 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 122.409 2.073 . . . . 0.0 111.677 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.883 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 60.6 t80 -114.44 105.62 13.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.979 -1.075 . . . . 0.0 109.756 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 19' ' ' TYR . 40.3 m-20 -27.49 -37.75 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 19' ' ' TYR . . . 66.74 96.3 0.03 OUTLIER Glycine 0 N--CA 1.496 2.664 0 N-CA-C 106.206 -2.758 . . . . 0.0 106.206 -175.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.6 mt -115.04 -38.18 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.447 -1.031 . . . . 0.0 109.809 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.607 ' CG ' ' O ' ' B' ' 188' ' ' GLU . 0.9 OUTLIER -77.41 151.76 80.87 Favored Pre-proline 0 C--N 1.298 -1.64 0 O-C-N 121.346 -0.846 . . . . 0.0 108.753 179.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.34 -10.17 26.55 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.211 1.941 . . . . 0.0 110.774 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -114.9 -17.22 11.59 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.459 -0.776 . . . . 0.0 110.279 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.467 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -57.51 139.24 53.89 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.888 -1.133 . . . . 0.0 109.91 -178.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.632 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.4 OUTLIER -88.19 115.06 25.41 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.841 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.609 ' N ' HD23 ' A' ' 27' ' ' LEU . 84.6 p -76.3 141.22 41.69 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.369 -0.832 . . . . 0.0 109.404 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.883 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 24.6 p90 -145.81 156.74 43.77 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.31 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.503 ' HA ' ' HB3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -110.21 174.52 5.82 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.198 -0.939 . . . . 0.0 109.321 -179.704 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.659 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -67.4 151.09 48.03 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.093 -1.004 . . . . 0.0 109.315 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 71.38 -7.4 6.4 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -74.77 143.42 44.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.965 -1.314 . . . . 0.0 109.68 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -97.52 139.48 33.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.749 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.529 ' CE ' HG13 ' A' ' 63' ' ' VAL . 3.9 mtm -135.89 152.44 51.02 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.588 0.709 . . . . 0.0 109.744 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 17.2 ttmt -104.81 125.75 51.18 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.523 ' CG2' HG23 ' A' ' 13' ' ' VAL . 2.7 t -75.72 132.18 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.192 -0.943 . . . . 0.0 109.431 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 46' ' ' LYS . 12.3 mt -110.94 -48.54 3.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.199 -0.938 . . . . 0.0 109.649 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 1.8 pt-20 -143.27 91.94 2.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.161 -0.962 . . . . 0.0 109.051 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.59 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 0.8 OUTLIER -78.68 114.89 18.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.697 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.548 ' CG ' HD12 ' B' ' 186' ' ' LEU . 4.2 m-70 -82.47 -101.71 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.372 -0.83 . . . . 0.0 109.113 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -136.33 -12.87 1.05 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.519 ' HB2' ' HD3' ' B' ' 183' ' ' PRO . 0.8 OUTLIER -153.15 -19.76 0.15 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.026 -1.279 . . . . 0.0 110.544 -179.668 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.858 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 66.8 m95 -137.43 99.93 4.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.868 -1.145 . . . . 0.0 109.395 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.623 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -88.22 146.97 25.08 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.133 -0.979 . . . . 0.0 109.851 -179.879 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.527 ' HG3' ' CD1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -93.81 105.67 17.69 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.171 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.79 -177.96 3.52 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.298 -0.876 . . . . 0.0 110.281 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.619 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -123.73 128.07 49.07 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.644 -0.66 . . . . 0.0 109.684 -179.49 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.548 ' HB2' ' HB3' ' A' ' 54' ' ' LYS . 1.1 t -74.45 126.95 31.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.124 -0.985 . . . . 0.0 109.884 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.425 HD21 ' HA ' ' A' ' 50' ' ' LEU . 32.9 mt -72.23 -7.43 49.26 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.5 tp -53.58 -54.92 30.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.529 -0.732 . . . . 0.0 109.287 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.608 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 2.6 t -161.08 29.08 0.14 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.278 -0.889 . . . . 0.0 109.955 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 52' ' ' THR . 12.6 mttm 86.93 45.46 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.552 -0.718 . . . . 0.0 110.585 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.619 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 3.6 tttm -85.17 132.29 34.31 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -123.22 117.01 24.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.929 -1.107 . . . . 0.0 109.17 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.632 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -159.27 166.03 34.55 Favored Glycine 0 N--CA 1.486 1.988 0 C-N-CA 118.966 -1.588 . . . . 0.0 110.55 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.76 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 8.1 m-85 -71.97 134.1 45.74 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.752 -0.852 . . . . 0.0 109.714 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.501 ' CD1' HG23 ' A' ' 63' ' ' VAL . 13.7 pt -123.29 144.53 43.96 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.304 -0.873 . . . . 0.0 108.841 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.604 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 43.2 Cg_endo -67.54 142.92 60.8 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.915 1.743 . . . . 0.0 111.597 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.525 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 32.4 p -74.67 6.05 4.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.189 -0.944 . . . . 0.0 110.737 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' B' ' 178' ' ' PRO . 0.1 OUTLIER -108.41 -51.72 2.86 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.808 -1.183 . . . . 0.0 110.484 -179.208 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.584 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 5.8 m-30 -49.68 -61.26 2.22 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.19 -0.944 . . . . 0.0 111.271 -178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.529 HG13 ' CE ' ' A' ' 35' ' ' MET . 13.3 m -78.32 156.32 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.096 -1.002 . . . . 0.0 111.321 -177.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.614 ' CB ' ' CD1' ' A' ' 16' ' ' LEU . . . -135.74 163.5 30.03 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 3.7 ptpt -76.59 148.98 36.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.977 -1.077 . . . . 0.0 109.373 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER 171.93 113.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 109.699 179.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.422 ' OD1' ' HB ' ' A' ' 12' ' ' ILE . 0.1 OUTLIER -129.31 154.06 47.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.901 . . . . 0.0 109.144 179.697 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.5 m . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.451 -179.891 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . 0.492 ' O ' ' HB2' ' B' ' 171' ' ' ASP . 17.7 m95 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . 0.606 ' N ' ' HD3' ' B' ' 172' ' ' PRO . 24.6 t70 176.84 57.75 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.285 -0.884 . . . . 0.0 108.955 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.606 ' HD3' ' N ' ' B' ' 171' ' ' ASP . 52.6 Cg_endo -92.29 -82.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.112 2.542 . . . . 0.0 111.857 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 173' ' ' GLY . . . . . . . . . . . . . . . -143.45 27.07 2.11 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.15 73.05 11.13 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.305 -1.115 . . . . 0.0 109.492 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . 0.611 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 55.1 Cg_endo -77.05 -159.73 0.1 Allowed 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.638 2.226 . . . . 0.0 111.626 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 176' ' ' THR . . . . . 0.487 HG21 ' HB3' ' A' ' 17' ' ' TYR . 14.7 p -157.46 93.73 2.19 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.464 -0.773 . . . . 0.0 109.497 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 177' ' ' PRO . . . . . 0.513 ' HD2' ' CD2' ' A' ' 17' ' ' TYR . 51.3 Cg_endo -69.94 175.1 8.71 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.768 2.312 . . . . 0.0 111.825 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . 0.534 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 50.4 Cg_endo -70.67 163.34 39.35 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.589 2.192 . . . . 0.0 111.425 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . 0.58 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -98.31 175.24 2.61 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.244 -0.91 . . . . 0.0 109.519 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.858 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.3 Cg_endo -69.14 -175.29 0.96 Allowed 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.944 2.429 . . . . 0.0 111.568 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . 0.768 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.1 Cg_endo -90.36 -29.75 0.17 Allowed 'Trans proline' 0 C--O 1.213 -0.742 0 C-N-CA 122.928 2.419 . . . . 0.0 114.471 -177.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . 0.768 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 51.1 mtt180 81.97 95.34 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.227 -0.921 . . . . 0.0 109.212 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . 0.593 ' HG2' ' HB2' ' B' ' 186' ' ' LEU . 43.6 Cg_endo -67.41 128.41 18.24 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.852 2.368 . . . . 0.0 111.806 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 42.47 66.87 0.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.182 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . 0.459 ' HB3' ' HB2' ' B' ' 189' ' ' ARG . 0.6 OUTLIER 43.08 43.91 3.96 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.368 -0.833 . . . . 0.0 109.137 -179.465 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . 0.61 ' CD2' ' HB2' ' A' ' 44' ' ' TRP . 59.9 tp -55.67 -93.81 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . 0.76 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . -68.69 -8.62 57.24 Favored Glycine 0 N--CA 1.483 1.767 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.607 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 0.1 OUTLIER -71.98 -86.63 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.543 -0.975 . . . . 0.0 109.278 179.87 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 189' ' ' ARG . . . . . 0.459 ' HB2' ' HB3' ' B' ' 185' ' ' ASN . 0.3 OUTLIER -81.99 -169.0 2.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.072 -1.017 . . . . 0.0 109.433 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' B' ' 189' ' ' ARG . 1.0 OUTLIER -44.12 -72.92 0.05 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.923 . . . . 0.0 109.426 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.44 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 11' ' ' ASP . . . -106.92 100.97 1.65 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.452 ' O ' HG22 ' A' ' 37' ' ' VAL . 3.3 m-20 -150.59 149.49 29.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -1.107 . . . . 0.0 109.376 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 35.0 mm -105.27 136.09 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.927 . . . . 0.0 109.655 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 65' ' ' LYS . 1.5 m -132.64 161.79 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 p -120.09 137.75 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.982 -1.074 . . . . 0.0 109.071 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.605 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -69.22 131.77 45.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.395 -0.816 . . . . 0.0 109.976 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.601 ' CD1' ' CB ' ' A' ' 64' ' ' ALA . 62.5 mt -97.77 -30.21 12.92 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.653 ' CD2' ' CD ' ' B' ' 177' ' ' PRO . 47.7 m-85 -131.74 143.32 48.63 Favored Pre-proline 0 N--CA 1.486 1.373 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 40.8 Cg_endo -62.34 149.39 90.94 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.692 2.261 . . . . 0.0 112.699 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.797 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 21.6 t80 -129.29 113.3 14.83 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -98.2 118.0 33.85 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 116.75 -1.98 . . . . 0.0 108.546 179.434 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -40.44 90.25 0.01 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.538 ' N ' ' O ' ' A' ' 20' ' ' ASP . 2.4 mp -82.49 0.11 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 121.142 -1.211 . . . . 0.0 107.815 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.563 ' HB3' ' CD ' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -121.66 -172.55 0.24 Allowed Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.372 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.563 ' CD ' ' HB3' ' A' ' 23' ' ' HIS . 52.0 Cg_endo -90.86 -17.89 1.22 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.218 1.945 . . . . 0.0 112.602 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.462 ' CG ' ' CG ' ' B' ' 190' ' ' GLN . 30.6 m-20 -117.53 -12.09 10.4 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.389 -0.819 . . . . 0.0 111.09 -178.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.465 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 9.5 m-20 -58.52 142.56 48.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.927 -1.108 . . . . 0.0 110.708 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.672 ' CB ' ' HA2' ' A' ' 56' ' ' GLY . 0.1 OUTLIER -98.93 122.68 42.5 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.659 ' N ' HD23 ' A' ' 27' ' ' LEU . 15.9 m -76.92 137.53 39.15 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -0.925 . . . . 0.0 110.655 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.797 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 30.5 p90 -143.75 154.74 43.77 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -111.54 166.04 11.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.979 -1.076 . . . . 0.0 109.656 -179.35 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.436 ' C ' ' H ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -57.23 151.37 15.88 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.248 -0.907 . . . . 0.0 108.792 179.71 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.17 -7.69 3.18 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 9.0 tt0 -73.47 144.41 46.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.931 -1.335 . . . . 0.0 109.798 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.534 ' HB2' ' CD1' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -98.13 139.07 34.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 0.0 109.894 -179.708 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.482 ' HE3' ' HB2' ' A' ' 15' ' ' ALA . 4.6 mtm -134.89 151.08 50.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.578 -0.701 . . . . 0.0 109.662 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.623 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -103.05 121.05 41.77 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.504 -0.748 . . . . 0.0 109.252 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 11' ' ' ASP . 1.8 t -82.7 124.1 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.369 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.2 mt -99.4 -44.88 6.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.137 -0.977 . . . . 0.0 109.608 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -148.25 97.22 2.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.891 . . . . 0.0 109.157 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.637 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -78.72 122.76 26.41 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.38 -0.825 . . . . 0.0 109.618 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.604 ' CG ' HD13 ' B' ' 186' ' ' LEU . 43.4 m-70 -83.01 -101.77 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.342 -0.849 . . . . 0.0 109.223 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.34 -16.28 1.37 Allowed Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.366 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.568 ' CG ' ' HD2' ' B' ' 181' ' ' PRO . 0.0 OUTLIER -158.43 -16.99 0.07 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.913 -1.345 . . . . 0.0 110.755 -179.531 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 1.004 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 64.3 m95 -132.74 94.86 3.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.942 -1.099 . . . . 0.0 108.601 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.637 ' CD1' ' CG ' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -88.47 147.55 24.61 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.028 -1.045 . . . . 0.0 110.096 -179.114 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.7 OUTLIER -94.46 107.39 19.36 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.623 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -105.41 -175.41 2.79 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.273 -0.892 . . . . 0.0 110.23 -179.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -126.18 130.98 52.06 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.667 -0.645 . . . . 0.0 109.905 -179.207 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.596 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -77.06 128.34 34.29 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.157 -0.964 . . . . 0.0 109.698 179.476 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.534 ' CD1' ' HB2' ' A' ' 34' ' ' LYS . 1.2 mp -73.95 -7.21 51.52 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 49.2 tp -53.89 -54.46 38.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.399 -0.813 . . . . 0.0 109.32 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 2.8 t -160.88 29.16 0.15 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.267 -0.896 . . . . 0.0 110.036 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.587 ' CB ' ' O ' ' A' ' 52' ' ' THR . 17.4 mttp 85.91 42.98 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.528 -0.733 . . . . 0.0 110.879 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 49' ' ' SER . 7.4 mmtt -85.41 133.0 34.13 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -123.36 120.8 34.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.976 -1.078 . . . . 0.0 109.332 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.672 ' HA2' ' CB ' ' A' ' 27' ' ' LEU . . . -159.72 166.11 34.81 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.27 -1.443 . . . . 0.0 110.133 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.72 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 9.2 m-85 -70.19 133.3 46.94 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.64 -0.918 . . . . 0.0 109.437 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.48 ' O ' HG13 ' A' ' 58' ' ' ILE . 6.1 pt -121.97 136.68 26.46 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.311 -0.868 . . . . 0.0 108.717 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.597 ' HG3' ' CD2' ' B' ' 179' ' ' LEU . 50.0 Cg_endo -69.39 138.62 39.44 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.269 1.98 . . . . 0.0 112.325 -178.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.55 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 23.6 t -71.46 0.97 7.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 110.202 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.681 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 6.5 p-10 -95.45 -49.66 5.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.964 -1.085 . . . . 0.0 110.233 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.681 ' N ' ' OD1' ' A' ' 61' ' ' ASN . 11.6 m-30 -61.11 -56.94 15.0 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.337 -0.852 . . . . 0.0 111.211 -178.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.558 ' HA ' ' HA ' ' A' ' 15' ' ' ALA . 3.7 m -79.19 157.29 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 122.175 0.988 . . . . 0.0 111.443 -177.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.601 ' CB ' ' CD1' ' A' ' 16' ' ' LEU . . . -138.05 163.0 32.69 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.512 ' HA ' HG11 ' A' ' 13' ' ' VAL . 19.0 ttmm -74.85 147.31 41.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.036 -1.04 . . . . 0.0 109.17 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.21 -75.37 0.1 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.221 -0.924 . . . . 0.0 109.623 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -142.17 -140.9 0.13 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 109.461 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.479 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 1.3 p90 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . 0.573 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 0.3 OUTLIER -168.53 -56.58 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.249 -0.907 . . . . 0.0 108.886 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 47.7 Cg_endo -67.78 -90.25 0.0 OUTLIER 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.691 2.261 . . . . 0.0 111.861 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 173' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' B' ' 174' ' ' MET . . . -140.13 -38.75 0.09 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 174' ' ' MET . . . . . 0.5 ' N ' ' HD3' ' B' ' 175' ' ' PRO . 0.4 OUTLIER 42.24 62.24 7.99 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.385 -1.068 . . . . 0.0 109.468 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . 0.505 ' O ' HG22 ' B' ' 176' ' ' THR . 50.5 Cg_endo -92.24 171.91 2.49 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.195 2.596 . . . . 0.0 111.81 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 176' ' ' THR . . . . . 0.505 HG22 ' O ' ' B' ' 175' ' ' PRO . 0.0 OUTLIER 172.15 107.47 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.412 -0.805 . . . . 0.0 109.319 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 177' ' ' PRO . . . . . 0.653 ' CD ' ' CD2' ' A' ' 17' ' ' TYR . 48.0 Cg_endo -71.17 176.65 7.53 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.701 2.267 . . . . 0.0 111.675 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . 0.536 ' HD2' ' HB2' ' B' ' 177' ' ' PRO . 45.5 Cg_endo -67.33 97.24 0.42 Allowed 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.569 2.18 . . . . 0.0 111.752 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . 0.645 ' CD2' ' CE2' ' A' ' 62' ' ' TYR . 25.0 mt -39.24 162.42 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.487 -0.758 . . . . 0.0 109.689 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 1.004 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.1 Cg_endo -66.29 170.94 11.14 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.508 2.139 . . . . 0.0 111.254 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . 0.576 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 56.1 Cg_endo -79.05 -34.29 1.22 Allowed 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 122.903 2.402 . . . . 0.0 114.154 -177.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . 0.699 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.1 OUTLIER 78.27 84.26 0.09 OUTLIER Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 120.982 -1.074 . . . . 0.0 108.711 -178.865 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . 0.501 ' HD2' HD21 ' B' ' 186' ' ' LEU . 51.1 Cg_endo -71.65 139.27 33.68 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.791 2.328 . . . . 0.0 112.125 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.483 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 38.6 62.23 1.06 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.504 -0.747 . . . . 0.0 109.582 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . 0.484 ' N ' ' ND2' ' B' ' 185' ' ' ASN . 0.6 OUTLIER 44.68 48.58 8.78 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.273 -0.892 . . . . 0.0 109.157 -179.699 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . 0.617 ' CD2' ' HB2' ' A' ' 44' ' ' TRP . 56.2 tp -64.92 -83.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.413 -0.804 . . . . 0.0 109.352 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . 0.72 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . -64.83 -9.97 42.69 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.526 ' HG3' ' NE2' ' A' ' 23' ' ' HIS . 4.6 tt0 -70.93 -87.26 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.547 -0.972 . . . . 0.0 109.386 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 189' ' ' ARG . . . . . 0.478 ' HG3' ' HG2' ' B' ' 188' ' ' GLU . 9.6 mtt-85 -72.79 -164.17 0.15 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 109.301 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . 0.462 ' CG ' ' CG ' ' A' ' 25' ' ' ASP . 50.5 mt-30 -105.88 44.64 1.03 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -0.928 . . . . 0.0 109.498 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.437 179.958 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.97 -152.81 23.53 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.45 ' O ' HG12 ' A' ' 37' ' ' VAL . 73.4 m-20 -89.48 121.27 31.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -1.159 . . . . 0.0 109.276 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 19.9 mm -92.4 137.23 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.565 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.1 m -131.44 160.2 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.459 -0.776 . . . . 0.0 109.097 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.2 p -121.64 138.43 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 109.346 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.562 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -70.04 132.03 45.25 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.26 -0.9 . . . . 0.0 109.747 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.587 ' CD1' ' CB ' ' A' ' 64' ' ' ALA . 28.3 mt -98.03 -13.61 20.97 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.659 ' CD2' ' HD2' ' B' ' 177' ' ' PRO . 56.2 m-85 -155.46 152.7 25.16 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 42.6 Cg_endo -66.04 149.42 85.98 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 121.554 1.502 . . . . 0.0 109.589 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.832 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 20.6 t80 -102.34 -175.85 2.94 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.176 -1.41 . . . . 0.0 110.535 -178.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.735 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 31.2 m-20 -112.99 85.92 2.27 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.572 -0.705 . . . . 0.0 110.065 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.19 92.03 0.05 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.519 -1.832 . . . . 0.0 108.519 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.519 HG12 ' O ' ' A' ' 20' ' ' ASP . 0.4 OUTLIER -107.75 -42.94 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.262 -1.14 . . . . 0.0 108.767 179.604 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.641 ' CE1' ' HA ' ' B' ' 188' ' ' GLU . 56.3 m80 -76.09 156.93 83.81 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.4 -13.23 35.23 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.156 1.904 . . . . 0.0 111.859 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.514 ' OD2' ' NE ' ' B' ' 189' ' ' ARG . 4.9 m-20 -112.65 -13.78 13.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 110.462 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.47 ' OD2' ' OH ' ' A' ' 19' ' ' TYR . 43.2 m-20 -57.39 138.9 54.41 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.764 -1.21 . . . . 0.0 109.793 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.641 HD23 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -94.95 121.99 37.14 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.641 ' N ' HD23 ' A' ' 27' ' ' LEU . 1.1 m -78.77 139.25 38.44 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.153 -0.967 . . . . 0.0 109.598 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.832 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 17.5 p90 -146.87 158.1 43.83 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.242 -0.911 . . . . 0.0 108.918 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 mtmm -111.79 174.33 5.93 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.138 -0.976 . . . . 0.0 109.41 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.493 ' HD3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -66.73 153.02 44.32 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.12 -0.988 . . . . 0.0 109.305 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.27 -7.96 4.27 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.419 ' H ' ' C ' ' A' ' 31' ' ' LYS . 3.4 tt0 -74.53 144.03 44.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.918 -1.342 . . . . 0.0 109.615 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.415 ' HD3' HD11 ' A' ' 50' ' ' LEU . 2.6 ptpt -96.67 136.12 37.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.517 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.561 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 1.7 mpp? -137.85 153.69 49.57 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.415 0.626 . . . . 0.0 109.528 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.696 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 2.2 ttpt -110.87 125.42 53.61 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.377 -0.827 . . . . 0.0 109.004 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -87.65 128.43 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.9 . . . . 0.0 108.753 178.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 26.1 mt -88.58 -29.7 19.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 109.945 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -176.99 130.99 0.18 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.147 -0.971 . . . . 0.0 109.834 -179.444 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.642 ' HA ' ' CD1' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -78.53 132.44 37.2 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.441 -0.787 . . . . 0.0 109.162 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.604 ' CB ' HD13 ' B' ' 186' ' ' LEU . 18.7 m-70 -111.57 30.78 6.66 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.223 -0.923 . . . . 0.0 110.543 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.455 ' N ' ' OE2' ' A' ' 40' ' ' GLU . . . 108.73 -47.25 1.06 Allowed Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.516 -1.325 . . . . 0.0 110.744 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.411 ' HB2' ' HD3' ' B' ' 183' ' ' PRO . 0.0 OUTLIER -159.2 -5.9 0.07 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.023 -1.281 . . . . 0.0 110.388 -179.571 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.768 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 65.4 m95 -141.68 99.87 3.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.038 -1.039 . . . . 0.0 109.276 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.679 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -94.68 148.66 22.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.031 -1.043 . . . . 0.0 109.454 -179.621 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 17.7 tttt -88.56 109.11 19.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.256 -0.903 . . . . 0.0 108.973 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.696 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -100.97 178.6 4.62 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.449 -0.782 . . . . 0.0 109.863 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 2.7 mttt -121.1 129.78 53.45 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.647 -0.658 . . . . 0.0 109.588 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.557 ' HB2' ' HB3' ' A' ' 54' ' ' LYS . 1.1 t -77.6 128.41 34.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 110.056 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.415 HD11 ' HD3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -72.92 -9.25 58.5 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 tp -52.32 -54.92 25.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.407 -0.808 . . . . 0.0 109.383 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.611 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 2.6 t -161.5 29.35 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 110.041 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.611 ' CB ' ' O ' ' A' ' 52' ' ' THR . 8.7 mmtm 86.68 44.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.502 -0.749 . . . . 0.0 110.488 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -85.0 133.25 34.26 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.183 -0.948 . . . . 0.0 108.488 178.61 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.93 114.34 20.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.923 -1.111 . . . . 0.0 109.215 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.59 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -152.57 169.21 31.69 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.366 -1.397 . . . . 0.0 109.89 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.699 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 7.7 m-85 -73.4 132.0 42.49 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.546 -0.973 . . . . 0.0 109.57 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.529 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 11.0 pt -121.96 140.98 33.13 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.875 . . . . 0.0 109.069 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.577 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 49.2 Cg_endo -69.54 149.42 68.25 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.176 1.918 . . . . 0.0 112.094 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.523 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 21.2 t -77.57 7.78 5.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.328 -0.857 . . . . 0.0 110.656 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.536 ' ND2' ' O ' ' B' ' 178' ' ' PRO . 0.1 OUTLIER -111.74 -51.8 2.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.824 -1.173 . . . . 0.0 110.672 -179.143 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.67 ' CE2' ' HA ' ' A' ' 19' ' ' TYR . 2.6 m-30 -48.96 -52.16 26.32 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.105 -0.997 . . . . 0.0 110.83 -178.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.561 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.7 m -88.91 155.52 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -0.972 . . . . 0.0 111.19 -178.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.587 ' CB ' ' CD1' ' A' ' 16' ' ' LEU . . . -134.09 162.38 32.25 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.497 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 3.2 ptmt -77.12 94.57 4.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.954 -1.091 . . . . 0.0 109.344 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.458 ' C ' ' O ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER 39.88 55.39 2.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.235 -0.915 . . . . 0.0 109.63 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.489 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 1.2 t30 -74.55 108.45 7.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 109.556 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.465 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . 0.468 ' CD1' ' N ' ' B' ' 170' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.3 0.571 . . . . 0.0 109.464 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . 0.581 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 0.4 OUTLIER -170.5 -56.25 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.225 -0.922 . . . . 0.0 108.781 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 46.5 Cg_endo -67.92 -89.88 0.0 OUTLIER 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.7 2.266 . . . . 0.0 111.837 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 173' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' B' ' 174' ' ' MET . . . 72.63 38.78 57.09 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 174' ' ' MET . . . . . 0.435 ' O ' ' O ' ' B' ' 173' ' ' GLY . 5.1 mtt 59.23 112.07 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.204 -1.174 . . . . 0.0 109.409 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . 0.539 ' O ' HG21 ' B' ' 176' ' ' THR . 53.8 Cg_endo -78.94 -161.88 0.16 Allowed 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.601 2.201 . . . . 0.0 111.632 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 176' ' ' THR . . . . . 0.573 HG21 ' HB3' ' A' ' 17' ' ' TYR . 2.0 p -164.77 97.58 0.87 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.444 -0.785 . . . . 0.0 109.323 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 177' ' ' PRO . . . . . 0.659 ' HD2' ' CD2' ' A' ' 17' ' ' TYR . 50.2 Cg_endo -69.21 164.88 32.29 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.939 2.426 . . . . 0.0 112.046 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . 0.536 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 50.0 Cg_endo -70.31 157.3 59.74 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.721 2.281 . . . . 0.0 111.466 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . 0.614 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -92.81 175.72 3.04 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.148 -0.97 . . . . 0.0 109.802 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.768 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.4 Cg_endo -68.96 -172.3 0.48 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.068 2.512 . . . . 0.0 111.326 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . 0.814 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 52.7 Cg_endo -91.48 -35.17 0.06 OUTLIER 'Trans proline' 0 C--O 1.212 -0.783 0 C-N-CA 122.788 2.325 . . . . 0.0 114.694 -177.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . 0.814 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 32.4 mtt180 87.83 96.27 0.03 OUTLIER Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.314 -0.866 . . . . 0.0 109.013 -178.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . 0.501 ' HD2' ' CB ' ' B' ' 186' ' ' LEU . 47.4 Cg_endo -68.78 124.56 11.62 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.76 2.306 . . . . 0.0 111.904 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' B' ' 185' ' ' ASN . . . 45.69 67.4 0.74 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.862 . . . . 0.0 109.495 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . 0.448 ' CA ' ' HB3' ' B' ' 188' ' ' GLU . 14.9 m-20 43.08 50.5 5.5 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.354 -0.841 . . . . 0.0 109.535 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . 0.604 HD13 ' CB ' ' A' ' 41' ' ' HIS . 47.7 tp -67.6 -83.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.296 -0.877 . . . . 0.0 109.507 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . 0.699 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . -66.01 -8.18 41.02 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.641 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 33.5 tt0 -69.91 -86.04 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.469 -1.019 . . . . 0.0 109.421 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 189' ' ' ARG . . . . . 0.514 ' NE ' ' OD2' ' A' ' 25' ' ' ASP . 0.0 OUTLIER 73.05 140.52 0.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.308 -0.87 . . . . 0.0 109.533 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -139.14 -40.93 0.47 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.26 -0.9 . . . . 0.0 109.405 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.448 179.994 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.3 0.571 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.45 -117.31 0.76 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -134.98 157.72 46.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.164 -1.198 . . . . 0.0 109.505 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.473 ' CD1' ' CG ' ' A' ' 36' ' ' LYS . 5.2 tp -109.61 136.64 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.183 -0.948 . . . . 0.0 109.46 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.0 m -131.77 160.2 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.35 -0.844 . . . . 0.0 109.186 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.526 ' CG1' ' HG3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -119.64 138.7 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.068 -1.02 . . . . 0.0 109.302 179.121 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -72.14 133.67 45.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.451 -0.781 . . . . 0.0 109.946 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.587 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 7.6 mt -99.79 -8.31 24.35 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.61 ' CG ' ' HD2' ' B' ' 177' ' ' PRO . 27.6 m-85 -162.29 151.94 13.49 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.721 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 39.2 Cg_endo -62.19 149.16 91.58 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 121.733 1.622 . . . . 0.0 110.05 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.829 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 57.0 t80 -98.63 178.23 5.06 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 118.364 -1.335 . . . . 0.0 110.764 -177.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.68 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 6.4 m-20 -109.22 79.95 1.27 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.47 94.44 0.04 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.409 ' N ' ' O ' ' A' ' 20' ' ' ASP . 21.2 mt -107.17 -42.93 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.108 -1.231 . . . . 0.0 108.803 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.574 ' ND1' ' O ' ' B' ' 188' ' ' GLU . 0.2 OUTLIER -76.04 152.69 84.47 Favored Pre-proline 0 C--N 1.3 -1.563 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.516 ' HD2' ' ND1' ' A' ' 23' ' ' HIS . 43.9 Cg_endo -66.68 -11.42 31.8 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.299 1.999 . . . . 0.0 111.567 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.87 -14.68 13.49 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.89 . . . . 0.0 110.215 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' B' ' 187' ' ' GLY . 26.4 m-20 -58.07 142.17 47.73 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.883 -1.135 . . . . 0.0 109.784 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.673 HD23 ' N ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -98.55 122.21 41.46 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.673 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -78.03 139.77 39.12 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.327 -0.858 . . . . 0.0 109.449 179.669 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.829 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 24.3 p90 -145.29 156.74 44.0 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.232 -0.917 . . . . 0.0 108.74 178.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.647 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 3.2 tttp -111.18 174.28 5.94 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.172 -0.955 . . . . 0.0 109.539 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.568 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -67.37 151.85 46.72 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.108 -0.995 . . . . 0.0 109.346 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.96 -7.65 4.15 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.429 ' H ' ' C ' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -74.79 141.89 44.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.04 -1.271 . . . . 0.0 109.611 -179.735 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.526 ' HG3' ' CG1' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -95.86 138.61 33.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.89 . . . . 0.0 109.298 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.608 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 3.7 mpp? -133.2 149.63 52.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.53 -0.731 . . . . 0.0 109.88 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 12.2 mtpt -104.78 119.77 39.8 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.463 -0.773 . . . . 0.0 109.256 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -78.05 109.43 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.342 -0.849 . . . . 0.0 108.887 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.427 HD12 ' HE3' ' A' ' 48' ' ' LYS . 7.3 mt -88.15 -40.22 13.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.905 . . . . 0.0 109.991 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -134.99 97.47 3.75 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.032 -1.043 . . . . 0.0 109.158 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.697 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 0.7 OUTLIER -79.89 113.62 18.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.245 -0.91 . . . . 0.0 109.298 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.564 ' CB ' HD12 ' B' ' 186' ' ' LEU . 55.4 m-70 -106.33 -121.1 0.23 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.48 ' HA2' ' HG3' ' B' ' 183' ' ' PRO . . . -85.5 -124.58 1.43 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.509 ' HB3' ' HB2' ' B' ' 180' ' ' PRO . 7.0 mt-10 -78.46 10.33 3.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -1.104 . . . . 0.0 111.102 -178.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.849 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 64.6 m95 -141.1 98.1 3.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.528 -1.357 . . . . 0.0 109.824 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.697 ' HB3' ' HA ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -92.97 145.24 24.52 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.826 -1.171 . . . . 0.0 110.197 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -85.77 108.06 17.91 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.754 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -100.54 -177.16 3.41 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.264 -0.898 . . . . 0.0 109.97 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -123.94 109.03 13.06 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.648 -0.658 . . . . 0.0 109.394 -179.663 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.617 ' N ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -54.77 127.84 30.18 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.167 -0.958 . . . . 0.0 109.861 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 52' ' ' THR . 0.1 OUTLIER -76.76 -11.46 59.84 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.222 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.461 ' O ' ' HB ' ' A' ' 52' ' ' THR . 4.5 tp -46.06 -20.9 0.11 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.722 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 0.5 OUTLIER 168.1 -21.72 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.371 -0.831 . . . . 0.0 109.935 179.123 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.722 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 140.84 42.48 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.528 -0.733 . . . . 0.0 110.046 179.595 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.617 ' O ' ' N ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -85.67 134.36 33.98 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.131 -0.98 . . . . 0.0 108.424 178.4 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -121.67 114.16 20.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.909 -1.12 . . . . 0.0 109.439 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.599 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -152.49 172.46 31.65 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.67 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 6.8 m-85 -74.49 132.17 41.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.431 -1.04 . . . . 0.0 109.859 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.551 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 7.3 pt -121.42 138.24 27.97 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.629 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 48.6 Cg_endo -69.93 163.06 39.81 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 121.64 1.56 . . . . 0.0 112.01 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.564 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 82.8 p -90.89 8.25 35.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.389 -0.819 . . . . 0.0 110.095 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' B' ' 178' ' ' PRO . 0.4 OUTLIER -108.91 -54.9 2.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.028 -1.045 . . . . 0.0 110.109 -179.553 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.577 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 2.3 m-85 -47.24 -63.56 1.01 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.201 -0.937 . . . . 0.0 110.648 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.608 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.5 m -78.73 155.77 4.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.945 0.878 . . . . 0.0 110.96 -177.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.419 ' HB3' ' CD1' ' A' ' 16' ' ' LEU . . . -128.46 157.66 40.5 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp -75.64 154.88 36.33 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.948 -1.095 . . . . 0.0 109.583 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 67' ' ' ASN . 19.7 tp -126.91 90.95 3.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.923 . . . . 0.0 109.374 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 66' ' ' LEU . 0.7 OUTLIER -43.41 -81.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.558 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.488 179.974 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . 0.446 ' O ' ' HB3' ' B' ' 171' ' ' ASP . 6.0 m-90 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . 0.586 ' N ' ' HD3' ' B' ' 172' ' ' PRO . 1.5 p30 172.71 58.8 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.859 . . . . 0.0 109.005 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.586 ' HD3' ' N ' ' B' ' 171' ' ' ASP . 52.5 Cg_endo -93.76 -77.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.271 2.647 . . . . 0.0 112.053 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 173' ' ' GLY . . . . . . . . . . . . . . . 87.5 35.29 9.52 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 174' ' ' MET . . . . . 0.586 ' N ' ' CD ' ' B' ' 175' ' ' PRO . 0.0 OUTLIER -83.75 -44.39 0.8 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.301 -1.117 . . . . 0.0 109.703 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . 0.609 ' O ' ' CG2' ' B' ' 176' ' ' THR . 54.2 Cg_endo -81.0 -165.13 0.32 Allowed 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 122.525 2.15 . . . . 0.0 111.812 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 176' ' ' THR . . . . . 0.609 ' CG2' ' O ' ' B' ' 175' ' ' PRO . 2.9 p -171.12 100.14 0.41 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.588 -0.695 . . . . 0.0 109.176 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 177' ' ' PRO . . . . . 0.61 ' HD2' ' CG ' ' A' ' 17' ' ' TYR . 50.7 Cg_endo -68.94 165.0 31.49 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.777 2.318 . . . . 0.0 111.703 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . 0.585 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 48.6 Cg_endo -69.13 -165.52 0.14 Allowed 'Trans proline' 0 C--O 1.213 -0.761 0 C-N-CA 122.607 2.205 . . . . 0.0 110.893 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . 0.605 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -126.53 175.16 3.45 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.094 -1.004 . . . . 0.0 109.481 179.693 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.849 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 37.9 Cg_endo -67.24 -174.65 0.54 Allowed 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.922 2.415 . . . . 0.0 111.648 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . 0.76 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.8 Cg_endo -92.62 -23.69 0.33 Allowed 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 123.022 2.482 . . . . 0.0 114.617 -177.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . 0.76 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 27.6 mtt180 76.47 96.73 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.876 -1.14 . . . . 0.0 109.048 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 45.3 Cg_endo -67.0 107.24 1.29 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.6 2.2 . . . . 0.0 111.408 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' B' ' 185' ' ' ASN . . . 60.65 68.56 0.74 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.306 -0.871 . . . . 0.0 108.864 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . 0.459 ' HA ' ' HB2' ' B' ' 188' ' ' GLU . 2.9 p30 41.15 49.18 3.14 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.46 -0.775 . . . . 0.0 109.468 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . 0.599 ' CD2' ' HB2' ' A' ' 44' ' ' TRP . 64.5 tp -68.67 -75.33 0.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.357 -0.84 . . . . 0.0 109.278 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . 0.67 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . -65.64 -10.79 51.3 Favored Glycine 0 N--CA 1.484 1.838 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.574 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 1.6 mt-10 -81.98 -58.14 3.1 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.529 -0.983 . . . . 0.0 109.126 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 189' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.48 -156.84 0.76 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.428 -0.795 . . . . 0.0 109.427 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . 0.48 ' O ' ' CB ' ' B' ' 191' ' ' ALA . 0.0 OUTLIER -153.49 30.06 0.48 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 109.421 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 191' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' B' ' 190' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.463 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.62 89.6 2.01 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.407 ' O ' HG22 ' A' ' 37' ' ' VAL . 79.9 m-20 -126.84 140.7 52.16 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.333 -1.098 . . . . 0.0 109.309 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.528 ' CD1' ' HG3' ' A' ' 36' ' ' LYS . 24.2 mm -101.82 136.39 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.134 -0.979 . . . . 0.0 109.553 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.467 HG23 HG21 ' A' ' 37' ' ' VAL . 0.8 OUTLIER -132.07 160.69 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.71 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.459 HG11 ' O ' ' A' ' 14' ' ' VAL . 14.8 p -121.24 137.15 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.001 -1.062 . . . . 0.0 109.341 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.584 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -70.44 135.21 48.5 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.414 -0.804 . . . . 0.0 109.886 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.588 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 18.1 mt -97.73 -28.36 13.92 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.659 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 4.3 m-85 -141.27 155.79 67.78 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 39.7 Cg_endo -62.13 145.39 96.41 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 121.692 1.594 . . . . 0.0 110.73 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.72 ' O ' ' CB ' ' A' ' 20' ' ' ASP . 23.7 t80 -70.36 -76.45 0.1 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.448 -0.782 . . . . 0.0 112.102 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.72 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 6.0 m-20 127.03 72.46 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -178.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.57 82.77 0.01 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.189 -1.165 . . . . 0.0 110.189 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.55 ' N ' ' O ' ' A' ' 20' ' ' ASP . 9.4 mm -99.56 0.96 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.979 -1.306 . . . . 0.0 108.226 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.624 ' CD2' ' O ' ' B' ' 188' ' ' GLU . 0.7 OUTLIER -122.64 152.6 62.14 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.753 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.25 -14.49 34.6 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.838 1.692 . . . . 0.0 111.986 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.73 -19.11 11.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.401 -0.812 . . . . 0.0 110.875 -178.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.485 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.8 OUTLIER -55.72 139.34 45.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.872 -1.142 . . . . 0.0 110.103 -178.773 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.649 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.3 OUTLIER -87.79 117.32 26.55 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.315 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.566 ' N ' HD23 ' A' ' 27' ' ' LEU . 3.8 m -76.87 138.7 39.93 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.331 -0.856 . . . . 0.0 110.216 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.691 ' CE2' ' HB2' ' A' ' 19' ' ' TYR . 10.6 p90 -143.38 154.77 44.07 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 0.8 OUTLIER -111.18 171.28 7.57 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.006 -1.058 . . . . 0.0 109.652 -179.291 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.509 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -63.15 152.19 38.04 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.201 -0.937 . . . . 0.0 109.081 179.792 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 68.02 -7.59 2.32 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.438 ' H ' ' C ' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -74.15 143.4 45.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.827 -1.396 . . . . 0.0 110.009 -179.461 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.406 ' HE2' ' HB2' ' A' ' 34' ' ' LYS . 3.9 mppt? -95.22 137.14 34.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.34 -0.85 . . . . 0.0 109.457 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.571 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -136.13 151.88 50.24 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.611 -0.68 . . . . 0.0 109.813 -179.448 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.528 ' HG3' ' CD1' ' A' ' 12' ' ' ILE . 4.5 ttmt -109.87 126.79 54.21 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.455 -0.778 . . . . 0.0 109.776 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.467 HG21 HG23 ' A' ' 13' ' ' VAL . 1.4 t -82.68 138.28 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.386 -0.821 . . . . 0.0 108.942 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 36' ' ' LYS . 6.3 mp -112.54 -31.0 6.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.07 -1.019 . . . . 0.0 109.927 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.03 96.08 1.2 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.184 -0.948 . . . . 0.0 109.303 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.577 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 1.0 OUTLIER -49.93 130.52 21.9 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.477 -0.764 . . . . 0.0 108.993 179.646 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.594 ' O ' HD22 ' B' ' 186' ' ' LEU . 1.8 m-70 -128.51 102.12 6.48 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.486 ' C ' ' O ' ' A' ' 41' ' ' HIS . . . 41.18 -142.37 0.93 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.612 ' CB ' ' HD2' ' B' ' 181' ' ' PRO . 4.7 mt-10 -77.1 11.04 1.99 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -1.137 . . . . 0.0 110.707 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 1.028 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 64.5 m95 -137.4 100.36 4.21 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.668 -1.27 . . . . 0.0 109.67 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.58 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -94.44 149.27 21.41 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.817 -1.177 . . . . 0.0 110.215 -179.616 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -95.52 110.96 22.96 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.112 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -107.33 -175.3 2.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.177 -0.952 . . . . 0.0 110.297 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 9.9 ttpt -125.14 130.75 52.83 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.646 -0.659 . . . . 0.0 109.595 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.591 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -76.35 128.21 34.4 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 109.735 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.48 -6.11 46.46 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.435 HD22 HG23 ' A' ' 52' ' ' THR . 6.8 tp -55.9 -54.73 41.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.455 -0.778 . . . . 0.0 109.259 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.598 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.3 t -160.45 29.68 0.16 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.143 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.598 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 85.25 43.03 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.466 -0.771 . . . . 0.0 111.09 178.199 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.591 ' HB2' ' CB ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -86.42 132.5 33.93 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.474 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 12.9 pt-20 -122.62 118.91 29.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.937 -1.102 . . . . 0.0 109.387 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.649 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -155.6 166.57 32.85 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.013 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.718 ' CG ' ' HA3' ' B' ' 187' ' ' GLY . 7.0 m-85 -71.87 134.97 46.4 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.7 -0.883 . . . . 0.0 109.695 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.517 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 3.0 pt -124.55 144.89 47.53 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.406 -0.809 . . . . 0.0 109.148 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.612 ' HG3' ' CD2' ' B' ' 179' ' ' LEU . 47.1 Cg_endo -69.31 162.67 40.91 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 121.977 1.785 . . . . 0.0 111.393 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.512 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 98.2 p -92.13 8.98 35.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.016 -1.052 . . . . 0.0 110.894 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.575 ' C ' ' OD1' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -112.08 -51.7 2.83 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.765 -1.209 . . . . 0.0 110.153 -179.581 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.659 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 1.3 m-85 -44.66 -62.22 1.28 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.163 -0.961 . . . . 0.0 110.787 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.571 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.9 m -79.64 156.7 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 122.104 0.954 . . . . 0.0 111.486 -177.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.49 ' HB1' ' CD1' ' A' ' 16' ' ' LEU . . . -133.35 161.22 35.1 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.9 tttp -75.96 151.0 37.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.995 -1.066 . . . . 0.0 109.395 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.38 -81.28 0.33 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.152 -0.967 . . . . 0.0 109.498 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -49.25 147.06 3.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.345 -0.847 . . . . 0.0 109.522 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.2 p . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.043 -0.98 . . . . 0.0 109.514 -179.918 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . 0.524 ' CD1' ' C ' ' B' ' 170' ' ' TRP . 1.8 p90 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.258 0.551 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . 0.532 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 0.1 OUTLIER -161.77 -58.73 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.828 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 48.1 Cg_endo -68.25 -90.62 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.756 2.304 . . . . 0.0 111.778 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 173' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' B' ' 174' ' ' MET . . . 120.86 7.84 8.44 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 174' ' ' MET . . . . . 0.457 ' HA ' ' HE3' ' B' ' 174' ' ' MET . 37.1 mmt 43.19 89.58 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.223 -1.163 . . . . 0.0 109.432 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . 0.563 ' HD2' ' CE1' ' A' ' 17' ' ' TYR . 55.3 Cg_endo -77.77 -160.67 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.615 2.21 . . . . 0.0 111.882 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 176' ' ' THR . . . . . 0.491 HG21 ' HB3' ' A' ' 17' ' ' TYR . 3.1 p -156.38 96.16 2.26 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 177' ' ' PRO . . . . . 0.53 ' HG2' ' OD1' ' A' ' 61' ' ' ASN . 48.5 Cg_endo -70.24 174.77 9.43 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.779 2.319 . . . . 0.0 111.783 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' B' ' 179' ' ' LEU . 46.5 Cg_endo -68.18 108.6 1.79 Allowed 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.599 2.2 . . . . 0.0 111.743 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . 0.64 ' CD2' ' CE2' ' A' ' 62' ' ' TYR . 30.1 mt -40.38 163.54 0.08 OUTLIER Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.44 -0.787 . . . . 0.0 109.657 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 1.028 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.3 Cg_endo -65.92 177.08 3.18 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.781 2.321 . . . . 0.0 111.83 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . 0.617 ' O ' ' CB ' ' B' ' 182' ' ' ARG . 53.9 Cg_endo -73.65 -48.01 0.26 Allowed 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.933 2.422 . . . . 0.0 113.873 -177.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . 0.694 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.0 OUTLIER 84.81 91.78 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.151 -0.968 . . . . 0.0 108.946 -178.724 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . 0.731 ' HD2' HD21 ' B' ' 186' ' ' LEU . 43.9 Cg_endo -69.07 129.66 18.74 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 123.085 2.523 . . . . 0.0 112.326 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 38.21 67.03 0.43 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.477 -0.764 . . . . 0.0 109.464 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . 0.489 ' HA ' ' CB ' ' B' ' 188' ' ' GLU . 0.5 OUTLIER 42.93 43.47 3.56 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.357 -0.84 . . . . 0.0 109.026 -179.55 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . 0.731 HD21 ' HD2' ' B' ' 183' ' ' PRO . 42.4 tp -54.27 -94.54 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . 0.718 ' HA3' ' CG ' ' A' ' 57' ' ' PHE . . . -64.2 -12.43 50.11 Favored Glycine 0 N--CA 1.482 1.729 0 N-CA-C 107.474 -2.25 . . . . 0.0 107.474 178.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.624 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 0.1 OUTLIER -67.64 -73.17 0.15 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.688 -0.89 . . . . 0.0 109.094 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 189' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' B' ' 188' ' ' GLU . 0.0 OUTLIER 74.25 158.35 0.2 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.442 -0.786 . . . . 0.0 109.576 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . 0.45 ' O ' ' HB3' ' B' ' 191' ' ' ALA . 0.0 OUTLIER -143.44 23.45 1.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 109.529 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 191' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' B' ' 190' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.432 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.93 100.93 0.17 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.435 ' O ' HG22 ' A' ' 37' ' ' VAL . 0.3 OUTLIER -114.65 139.02 49.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -1.13 . . . . 0.0 109.326 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.451 HD12 ' HG3' ' A' ' 36' ' ' LYS . 17.6 mm -92.93 136.67 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 109.618 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.515 ' CG1' ' HD3' ' A' ' 65' ' ' LYS . 1.1 m -132.14 161.8 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.6 p -120.97 139.2 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.137 -0.977 . . . . 0.0 109.075 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.525 ' HB3' ' CD1' ' A' ' 29' ' ' PHE . . . -71.05 132.92 45.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.346 -0.846 . . . . 0.0 109.807 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.582 ' CD1' ' CB ' ' A' ' 64' ' ' ALA . 24.4 mt -98.66 -11.97 21.51 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.611 ' CD2' ' HD2' ' B' ' 177' ' ' PRO . 54.8 m-85 -159.55 153.69 19.96 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.661 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 42.0 Cg_endo -64.55 149.09 90.49 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 121.672 1.582 . . . . 0.0 109.983 179.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.796 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 56.4 t80 -97.79 178.6 5.09 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 118.303 -1.359 . . . . 0.0 110.265 -177.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.682 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 12.2 m-20 -109.47 80.66 1.34 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.56 -0.713 . . . . 0.0 109.322 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.51 95.38 0.06 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.6 mt -108.5 -42.24 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.157 -1.202 . . . . 0.0 108.896 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.657 ' CG ' ' O ' ' B' ' 188' ' ' GLU . 3.4 m-70 -76.98 159.6 78.19 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -71.11 -12.12 29.89 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.141 1.894 . . . . 0.0 111.778 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -113.86 -14.94 12.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 110.869 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.462 ' CG ' ' HB2' ' A' ' 23' ' ' HIS . 90.7 m-20 -57.19 139.47 52.54 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.719 -1.238 . . . . 0.0 109.955 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.628 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.4 OUTLIER -93.77 120.86 34.58 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.005 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.551 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -80.68 141.41 34.93 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.351 -0.843 . . . . 0.0 109.595 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.796 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 30.5 p90 -146.05 157.79 43.86 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.181 -0.949 . . . . 0.0 108.599 178.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 6.4 mttt -110.7 173.7 6.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.147 -0.97 . . . . 0.0 109.594 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.537 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -67.43 151.43 47.42 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.141 -0.975 . . . . 0.0 109.314 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.96 -8.25 4.79 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 31' ' ' LYS . 3.1 tt0 -75.84 143.63 41.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.953 -1.322 . . . . 0.0 109.755 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.31 138.95 33.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 109.509 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.576 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 2.5 mpp? -134.91 151.47 50.91 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.564 -0.71 . . . . 0.0 109.761 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 8.3 ttpp -105.15 124.13 49.0 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.507 -0.745 . . . . 0.0 109.53 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 11' ' ' ASP . 2.2 t -81.13 136.97 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.297 -0.877 . . . . 0.0 109.216 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.584 ' CD1' ' N ' ' A' ' 38' ' ' LEU . 7.1 mp -111.85 -43.36 3.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 109.648 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.05 106.35 3.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.124 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.654 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 0.7 OUTLIER -89.98 118.03 29.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.333 -0.855 . . . . 0.0 109.539 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.589 ' CG ' HD13 ' B' ' 186' ' ' LEU . 1.8 m-70 -81.83 -100.31 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.314 -0.866 . . . . 0.0 109.382 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' ' 43' ' ' GLU . . . -133.34 -14.31 1.4 Allowed Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.664 -1.255 . . . . 0.0 110.065 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 42' ' ' GLY . 6.0 mm-40 -157.52 -16.0 0.08 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.972 -1.31 . . . . 0.0 110.623 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.917 ' CD1' ' HA ' ' B' ' 182' ' ' ARG . 56.3 m95 -137.6 101.65 4.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.673 -1.267 . . . . 0.0 109.485 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.654 ' CD1' ' CG ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -93.32 144.4 25.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.206 -0.934 . . . . 0.0 110.211 -179.313 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.57 ' HG3' ' CD1' ' A' ' 57' ' ' PHE . 11.4 ttpt -90.08 108.08 19.51 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -102.8 -175.3 2.77 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.354 -0.841 . . . . 0.0 109.931 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 17.7 ttpt -125.88 130.43 51.31 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.605 -0.684 . . . . 0.0 109.31 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.599 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 6.9 t -75.84 126.78 31.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.072 -1.017 . . . . 0.0 109.963 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.4 mt -70.81 -7.99 49.3 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.3 tp -53.94 -55.6 25.51 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.53 -0.731 . . . . 0.0 109.445 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.629 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.7 t -161.04 28.14 0.14 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 110.119 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.629 ' CB ' ' O ' ' A' ' 52' ' ' THR . 14.1 mtmm 87.38 44.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.414 -0.804 . . . . 0.0 110.687 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.599 ' HB2' ' CB ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -86.77 131.58 34.09 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.042 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.456 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 2.5 pt-20 -122.01 118.46 28.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.879 -1.138 . . . . 0.0 109.625 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.628 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -157.66 168.36 34.32 Favored Glycine 0 N--CA 1.487 2.068 0 C-N-CA 119.427 -1.368 . . . . 0.0 109.904 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.76 ' CD2' ' HA3' ' B' ' 187' ' ' GLY . 27.1 m-85 -70.98 132.39 45.1 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.57 -0.959 . . . . 0.0 109.883 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.468 ' O ' HG13 ' A' ' 58' ' ' ILE . 6.6 pt -121.08 141.64 33.26 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.619 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 46.6 Cg_endo -69.18 154.86 69.38 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 121.721 1.614 . . . . 0.0 111.836 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.621 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 73.7 p -83.96 7.12 19.35 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.364 -0.835 . . . . 0.0 110.252 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.13 -53.28 2.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.936 -1.102 . . . . 0.0 110.515 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.572 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 2.6 m-85 -48.44 -62.72 1.35 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.075 -1.016 . . . . 0.0 111.173 -178.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.576 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 3.0 m -78.11 155.5 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 122.079 0.942 . . . . 0.0 111.18 -177.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.582 ' CB ' ' CD1' ' A' ' 16' ' ' LEU . . . -136.02 163.29 30.64 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.515 ' HD3' ' CG1' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -75.73 148.66 38.4 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.046 -1.034 . . . . 0.0 109.228 179.615 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.0 mp -80.18 78.06 6.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.17 -0.956 . . . . 0.0 109.772 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -149.04 12.77 0.86 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 109.675 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.413 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . 0.582 ' CZ3' ' HA3' ' B' ' 173' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . 0.552 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 0.4 OUTLIER -164.0 -58.49 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.238 -0.914 . . . . 0.0 108.714 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 46.8 Cg_endo -67.67 -89.33 0.0 OUTLIER 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.817 2.344 . . . . 0.0 111.773 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 173' ' ' GLY . . . . . 0.582 ' HA3' ' CZ3' ' B' ' 170' ' ' TRP . . . 110.56 75.6 0.82 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 174' ' ' MET . . . . . 0.476 ' O ' ' O ' ' B' ' 173' ' ' GLY . 43.5 mtm 59.07 118.82 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.306 -1.114 . . . . 0.0 109.476 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . 0.574 ' O ' HG21 ' B' ' 176' ' ' THR . 54.4 Cg_endo -79.61 -163.66 0.24 Allowed 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 122.556 2.171 . . . . 0.0 111.493 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 176' ' ' THR . . . . . 0.603 HG21 ' HB3' ' A' ' 17' ' ' TYR . 0.7 OUTLIER -176.16 102.62 0.24 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.474 -0.766 . . . . 0.0 109.142 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 177' ' ' PRO . . . . . 0.611 ' HD2' ' CD2' ' A' ' 17' ' ' TYR . 48.0 Cg_endo -69.66 157.32 61.0 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.716 2.277 . . . . 0.0 111.709 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.63 144.21 59.44 Favored 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 122.598 2.199 . . . . 0.0 111.478 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . 0.596 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -83.77 174.52 5.81 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.135 -0.978 . . . . 0.0 109.875 -179.705 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.704 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 42.9 Cg_endo -72.44 -170.66 0.61 Allowed 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.976 2.451 . . . . 0.0 110.211 178.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . 0.788 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 51.6 Cg_endo -87.06 -67.54 0.01 OUTLIER 'Trans proline' 0 C--O 1.212 -0.79 0 C-N-CA 121.991 1.794 . . . . 0.0 112.198 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . 0.917 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.8 OUTLIER 141.05 112.78 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.078 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . 0.573 ' HG2' ' CB ' ' B' ' 186' ' ' LEU . 44.1 Cg_endo -67.45 127.14 15.97 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 123.04 2.493 . . . . 0.0 112.087 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.491 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 37.99 52.88 1.57 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.378 -0.826 . . . . 0.0 109.375 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . 0.492 ' N ' ' ND2' ' B' ' 185' ' ' ASN . 0.2 OUTLIER 46.28 44.33 12.32 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.369 -0.832 . . . . 0.0 109.104 -179.526 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . 0.735 ' CD2' ' N ' ' B' ' 187' ' ' GLY . 7.8 tt -72.8 -82.83 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.479 -0.763 . . . . 0.0 108.97 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . 0.76 ' HA3' ' CD2' ' A' ' 57' ' ' PHE . . . -62.17 -11.99 35.37 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 108.161 -1.976 . . . . 0.0 108.161 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.657 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 64.0 tt0 -72.89 -102.45 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.506 -0.996 . . . . 0.0 109.156 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 189' ' ' ARG . . . . . 0.496 ' N ' ' HG2' ' B' ' 188' ' ' GLU . 0.0 OUTLIER -96.94 157.63 15.81 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.057 -1.027 . . . . 0.0 109.433 179.656 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -83.09 164.5 20.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.919 . . . . 0.0 109.504 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.427 -179.957 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.38 136.93 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.189 -0.945 . . . . 0.0 109.54 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.59 HG12 ' HA ' ' A' ' 65' ' ' LYS . 1.8 m -131.51 160.42 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.372 -0.83 . . . . 0.0 108.929 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.8 p -121.12 137.64 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.965 -1.085 . . . . 0.0 109.295 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.751 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.04 134.51 47.15 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.445 -0.785 . . . . 0.0 110.108 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.64 ' CD1' ' HB2' ' A' ' 64' ' ' ALA . 42.1 mt -98.37 -14.97 19.9 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.597 ' HA ' ' HB3' ' A' ' 31' ' ' LYS . 4.7 m-85 -157.45 155.48 27.47 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.0 Cg_endo -62.42 146.05 95.67 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.58 1.52 . . . . 0.0 110.381 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.769 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 8.8 t80 -76.34 -68.76 0.56 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.222 -0.924 . . . . 0.0 112.04 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.758 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 40.9 t0 122.79 70.94 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -177.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -54.28 94.36 0.02 OUTLIER Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 20' ' ' ASP . 0.6 OUTLIER -105.0 -44.2 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.143 -1.21 . . . . 0.0 107.822 178.552 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.473 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 26.1 m80 -75.48 156.35 85.24 Favored Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.6 -11.52 26.24 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.026 1.817 . . . . 0.0 111.994 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.69 -16.14 12.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.216 -0.927 . . . . 0.0 110.813 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.473 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 18.4 m-20 -57.24 138.89 54.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.839 -1.163 . . . . 0.0 110.422 -178.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.975 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -88.96 119.04 29.13 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.901 ' N ' HD22 ' A' ' 27' ' ' LEU . 4.8 p -77.79 138.03 38.76 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.224 -0.923 . . . . 0.0 110.179 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.769 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 8.1 p90 -143.78 155.24 44.09 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.751 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 7.2 mmtp -111.74 176.76 4.89 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.027 -1.046 . . . . 0.0 109.613 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.597 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -67.52 151.01 48.1 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.08 -1.013 . . . . 0.0 109.142 179.524 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.52 -7.76 3.55 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.749 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 1.1 mt-10 -74.75 144.15 43.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.868 -1.372 . . . . 0.0 109.938 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.519 ' CG ' HD13 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -95.78 138.08 33.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.0 109.406 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.53 ' CE ' HG11 ' A' ' 63' ' ' VAL . 0.9 OUTLIER -136.19 151.95 50.26 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.596 -0.69 . . . . 0.0 109.912 -179.423 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 4.5 ttpm? -105.87 124.27 49.31 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.442 -0.786 . . . . 0.0 109.498 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.523 ' CG2' HG22 ' A' ' 13' ' ' VAL . 2.0 t -80.98 137.23 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.359 -0.838 . . . . 0.0 108.92 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.1 mt -113.85 -39.48 3.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.113 -0.992 . . . . 0.0 109.688 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -150.82 91.43 1.72 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.939 . . . . 0.0 108.924 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.596 ' HG2' ' CD1' ' A' ' 45' ' ' TRP . 1.6 tm-20 -79.35 115.39 18.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.361 -0.837 . . . . 0.0 109.795 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.718 ' HB2' HD21 ' B' ' 186' ' ' LEU . 72.3 m80 -79.08 -98.32 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.361 -0.837 . . . . 0.0 109.223 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.461 ' C ' ' HG2' ' A' ' 43' ' ' GLU . . . -143.33 -12.33 0.36 Allowed Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.664 -1.255 . . . . 0.0 110.197 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.554 ' O ' ' HG3' ' B' ' 180' ' ' PRO . 7.1 mm-40 -148.5 -25.57 0.33 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.002 -1.293 . . . . 0.0 110.171 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.779 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 64.9 m95 -135.5 102.85 5.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.947 -1.095 . . . . 0.0 109.568 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.611 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -90.8 141.66 28.57 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.075 -1.015 . . . . 0.0 109.985 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.528 ' HG2' ' C ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -90.5 106.53 18.56 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.13 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.52 -176.73 3.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.171 -0.956 . . . . 0.0 110.173 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 6.9 tttt -124.59 128.87 49.56 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.651 -0.656 . . . . 0.0 109.521 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.645 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -73.37 125.24 27.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.156 -0.965 . . . . 0.0 109.938 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.519 HD13 ' CG ' ' A' ' 34' ' ' LYS . 2.9 mp -71.22 -8.29 52.56 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 tp -53.72 -54.68 34.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.614 -0.679 . . . . 0.0 109.381 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.596 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 2.0 t -161.3 29.47 0.14 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 110.215 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.596 ' CB ' ' O ' ' A' ' 52' ' ' THR . 5.7 mtmt 86.31 44.0 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.403 -0.811 . . . . 0.0 110.585 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.645 ' HB2' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER -87.09 133.13 33.64 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.124 -0.985 . . . . 0.0 108.449 178.421 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 1.6 pt-20 -122.58 119.29 30.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.876 -1.14 . . . . 0.0 109.256 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.659 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -158.08 167.76 34.42 Favored Glycine 0 N--CA 1.487 2.092 0 C-N-CA 119.316 -1.421 . . . . 0.0 110.022 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.688 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 10.4 m-85 -73.61 133.03 43.4 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.57 -0.959 . . . . 0.0 110.009 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.516 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 4.0 pt -122.07 139.44 30.43 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.772 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 46.0 Cg_endo -68.6 145.77 65.12 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 121.878 1.719 . . . . 0.0 112.086 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.596 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 38.5 p -75.97 5.02 7.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.409 -0.807 . . . . 0.0 110.635 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -105.72 -53.1 2.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.912 -1.117 . . . . 0.0 110.613 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.622 ' CD2' ' HA ' ' A' ' 19' ' ' TYR . 4.0 m-85 -51.27 -60.73 2.8 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.116 -0.99 . . . . 0.0 110.788 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 15' ' ' ALA . 3.1 m -78.82 158.55 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 122.094 0.95 . . . . 0.0 111.302 -177.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.64 ' HB2' ' CD1' ' A' ' 16' ' ' LEU . . . -134.61 160.63 37.49 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.59 ' HA ' HG12 ' A' ' 13' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 O-C-N 120.916 -1.115 . . . . 0.0 109.422 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 0.563 HD22 ' HE1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 121.752 0.787 . . . . 0.0 109.558 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.779 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.9 Cg_endo -70.69 -174.57 1.12 Allowed 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.902 2.401 . . . . 0.0 111.485 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 181' ' ' PRO . . . . . 0.721 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.1 Cg_endo -92.19 -23.04 0.41 Allowed 'Trans proline' 0 C--O 1.213 -0.726 0 C-N-CA 122.956 2.437 . . . . 0.0 114.347 -177.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.721 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 41.5 mtt180 78.41 95.62 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.001 -1.062 . . . . 0.0 109.197 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 42.4 Cg_endo -66.02 114.44 2.99 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.634 2.223 . . . . 0.0 111.735 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 184' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' B' ' 185' ' ' ASN . . . 56.15 50.81 12.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.423 -0.798 . . . . 0.0 109.584 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 185' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' B' ' 184' ' ' ALA . 9.5 m-80 60.26 45.82 10.94 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.155 -0.966 . . . . 0.0 109.426 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 186' ' ' LEU . . . . . 0.718 HD21 ' HB2' ' A' ' 41' ' ' HIS . 49.2 tp -65.36 -78.09 0.05 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.344 -0.848 . . . . 0.0 109.058 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 187' ' ' GLY . . . . . 0.688 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.485 1.939 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.483 HD12 ' HG3' ' A' ' 36' ' ' LYS . 0.7 OUTLIER -112.07 137.24 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -0.962 . . . . 0.0 109.536 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.1 m -131.1 160.44 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.371 -0.831 . . . . 0.0 108.97 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.92 139.91 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.007 -1.058 . . . . 0.0 109.341 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.672 ' HB2' ' HE3' ' A' ' 35' ' ' MET . . . -73.36 133.31 43.77 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.448 -0.783 . . . . 0.0 109.989 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.761 HD11 ' HB2' ' A' ' 64' ' ' ALA . 79.6 mt -99.55 -15.2 18.71 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.615 ' CE1' ' HB2' ' A' ' 16' ' ' LEU . 1.0 OUTLIER -155.96 154.07 26.96 Favored Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.448 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.733 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.6 Cg_endo -63.3 150.13 89.41 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 121.823 1.682 . . . . 0.0 110.276 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.769 ' O ' ' CB ' ' A' ' 20' ' ' ASP . 39.6 t80 -93.32 -33.01 14.07 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.068 -1.453 . . . . 0.0 110.541 -178.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.769 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 29.9 t0 107.57 -53.67 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.431 -0.793 . . . . 0.0 110.446 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.4 ' HA3' ' OG ' ' A' ' 28' ' ' SER . . . 78.33 79.5 0.76 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 -177.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.3 mt -97.66 -46.03 12.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.56 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 1.9 t-80 -73.31 146.01 86.15 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.56 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 43.7 Cg_endo -66.28 -11.47 31.52 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 121.898 1.732 . . . . 0.0 111.342 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -114.1 -18.91 11.56 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.514 -0.741 . . . . 0.0 110.117 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.494 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.6 OUTLIER -57.81 144.23 39.31 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.004 -1.06 . . . . 0.0 109.919 -178.824 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.928 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -91.23 118.47 30.5 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.178 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.804 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -83.28 145.04 29.32 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.597 -0.69 . . . . 0.0 109.153 179.266 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.765 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 18.7 p90 -148.15 160.75 42.58 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.621 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 11.6 mmtt -111.34 172.22 7.01 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.069 -1.02 . . . . 0.0 109.504 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.597 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -66.55 152.2 45.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.201 -0.937 . . . . 0.0 109.392 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 71.84 -8.01 6.6 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -76.58 142.05 40.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.018 -1.284 . . . . 0.0 109.785 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.3 138.89 33.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.892 . . . . 0.0 109.204 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.672 ' HE3' ' HB2' ' A' ' 15' ' ' ALA . 3.2 mpp? -136.11 152.32 50.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.644 -0.66 . . . . 0.0 109.662 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 3.7 ttpm? -109.62 126.19 53.37 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.48 -0.763 . . . . 0.0 109.503 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -82.13 129.39 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.389 -0.819 . . . . 0.0 109.003 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.877 HD12 ' O ' ' A' ' 46' ' ' LYS . 1.1 mp -102.05 -44.18 5.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.113 -0.992 . . . . 0.0 109.785 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.1 103.51 3.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.164 -0.96 . . . . 0.0 109.085 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.604 ' HG2' ' CD1' ' A' ' 45' ' ' TRP . 1.8 tm-20 -81.08 127.31 32.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.357 -0.839 . . . . 0.0 109.656 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.755 ' CG ' HD11 ' B' ' 186' ' ' LEU . 63.9 m-70 -87.57 -105.56 0.07 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.348 -0.845 . . . . 0.0 109.182 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 43' ' ' GLU . . . -127.05 -19.83 1.91 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.574 ' HG3' ' CG ' ' B' ' 181' ' ' PRO . 1.1 mm-40 -157.24 -12.8 0.09 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.993 -1.298 . . . . 0.0 110.563 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 1.063 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 50.2 m95 -135.81 101.45 4.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.002 -1.061 . . . . 0.0 108.415 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.62 ' CZ2' ' CB ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -92.05 149.02 21.74 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.146 -0.971 . . . . 0.0 110.566 -178.849 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.877 ' O ' HD12 ' A' ' 38' ' ' LEU . 4.9 tttt -92.9 107.28 19.1 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.91 -173.68 2.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.248 -0.908 . . . . 0.0 110.003 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 1.1 tttt -126.96 131.16 51.14 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.55 -0.719 . . . . 0.0 109.587 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.607 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 4.9 t -77.25 127.9 33.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.078 -1.014 . . . . 0.0 109.895 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.24 -6.66 44.57 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.239 -0.913 . . . . 0.0 108.55 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 51' ' ' LEU . 11.0 tp -54.99 -55.61 28.9 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.345 -0.847 . . . . 0.0 109.228 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.627 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 2.7 t -160.13 28.57 0.17 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.244 -0.91 . . . . 0.0 110.157 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.627 ' HB2' ' O ' ' A' ' 52' ' ' THR . 0.1 OUTLIER 86.32 44.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.52 -0.738 . . . . 0.0 111.065 178.18 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.607 ' HB2' ' CB ' ' A' ' 49' ' ' SER . 1.6 mmpt? -86.61 131.99 34.01 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.15 119.27 30.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.934 -1.104 . . . . 0.0 109.577 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.696 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -159.81 170.5 36.0 Favored Glycine 0 N--CA 1.488 2.13 0 C-N-CA 119.54 -1.314 . . . . 0.0 109.914 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.632 ' CB ' ' HA2' ' B' ' 187' ' ' GLY . 5.2 m-85 -71.77 132.33 44.34 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.56 -0.965 . . . . 0.0 109.804 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.415 ' O ' HG13 ' A' ' 58' ' ' ILE . 9.0 pt -121.12 142.55 35.15 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.634 ' HG3' ' CD2' ' B' ' 179' ' ' LEU . 48.6 Cg_endo -70.69 154.45 64.07 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 121.775 1.65 . . . . 0.0 112.226 -178.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.62 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 79.6 p -82.88 6.44 18.44 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -0.903 . . . . 0.0 109.692 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.639 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 9.2 p-10 -106.23 -52.56 2.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.034 -1.041 . . . . 0.0 110.96 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 1.153 ' CE2' HD21 ' B' ' 179' ' ' LEU . 2.9 m-85 -52.1 -61.97 1.93 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.175 -0.953 . . . . 0.0 111.071 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.603 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.7 m -80.48 156.28 4.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 122.034 0.921 . . . . 0.0 111.122 -177.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.761 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -132.83 159.07 40.88 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.063 -1.023 . . . . 0.0 109.479 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 1.153 HD21 ' CE2' ' A' ' 62' ' ' TYR . 41.8 mt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 121.687 0.756 . . . . 0.0 109.957 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 1.063 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 41.4 Cg_endo -67.23 179.6 2.32 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 123.108 2.539 . . . . 0.0 111.269 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 181' ' ' PRO . . . . . 0.631 ' HD2' ' HB2' ' B' ' 180' ' ' PRO . 55.4 Cg_endo -75.74 -48.79 0.14 Allowed 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.697 2.264 . . . . 0.0 113.527 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.661 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.0 OUTLIER 80.59 81.66 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.07 -1.019 . . . . 0.0 108.879 -178.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 54.6 Cg_endo -74.06 141.64 29.93 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.784 2.323 . . . . 0.0 112.114 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 184' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 37.74 62.7 0.87 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.835 . . . . 0.0 109.688 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 185' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' B' ' 184' ' ' ALA . 0.6 OUTLIER 43.05 48.14 5.22 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -0.888 . . . . 0.0 109.197 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 186' ' ' LEU . . . . . 0.755 HD11 ' CG ' ' A' ' 41' ' ' HIS . 63.6 tp -64.54 -79.71 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.379 -0.826 . . . . 0.0 109.472 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 187' ' ' GLY . . . . . 0.632 ' HA2' ' CB ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.481 1.695 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.876 ' O ' HG23 ' A' ' 37' ' ' VAL . 9.5 m-20 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.425 0.631 . . . . 0.0 109.929 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.811 HD12 ' HG2' ' A' ' 36' ' ' LYS . 18.8 mm -71.86 133.26 32.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.427 -0.796 . . . . 0.0 109.843 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.448 HG22 HG23 ' A' ' 37' ' ' VAL . 1.7 m -131.65 161.47 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.9 p -120.28 138.1 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.854 -1.154 . . . . 0.0 109.475 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.87 133.9 45.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.44 -0.788 . . . . 0.0 110.225 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.064 HD11 ' HB2' ' A' ' 64' ' ' ALA . 20.7 mt -98.89 -12.38 20.8 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.599 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 39.9 m-85 -158.57 154.84 24.06 Favored Pre-proline 0 N--CA 1.487 1.386 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.713 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 41.2 Cg_endo -64.68 148.75 90.37 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 121.723 1.615 . . . . 0.0 109.721 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.799 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 51.7 t80 -97.68 177.12 5.59 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 118.188 -1.405 . . . . 0.0 110.388 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.683 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 4.3 t0 -109.8 79.07 1.18 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.673 -0.642 . . . . 0.0 109.655 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.69 86.37 0.01 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.601 ' N ' ' O ' ' A' ' 20' ' ' ASP . 40.7 mt -105.99 -0.5 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.057 -1.261 . . . . 0.0 109.63 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -120.45 158.37 51.44 Favored Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.01 -18.54 46.21 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.178 1.919 . . . . 0.0 111.844 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -111.77 -13.56 13.69 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.501 -0.749 . . . . 0.0 110.45 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -57.68 139.11 54.56 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.838 -1.164 . . . . 0.0 109.52 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.013 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -96.59 121.53 38.52 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.312 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.875 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -80.25 140.91 36.02 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.369 -0.832 . . . . 0.0 109.796 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.799 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 30.7 p90 -145.62 157.55 43.96 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 108.576 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.661 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.8 mttm -110.49 173.44 6.33 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.033 -1.042 . . . . 0.0 109.596 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.57 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -66.99 151.75 47.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.198 -0.939 . . . . 0.0 109.32 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.54 -8.09 4.46 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 4.4 tt0 -75.13 143.29 43.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.973 -1.31 . . . . 0.0 109.559 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -97.21 138.93 33.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 109.799 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.581 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 2.5 mpp? -137.5 153.51 50.02 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.811 ' HG2' HD12 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -106.64 129.19 54.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.454 -0.779 . . . . 0.0 109.287 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 11' ' ' ASP . 6.3 t -80.91 124.8 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.046 -1.034 . . . . 0.0 109.041 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.44 HD11 ' HG3' ' A' ' 48' ' ' LYS . 7.2 mt -101.62 -43.06 5.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.184 -0.948 . . . . 0.0 109.934 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 39' ' ' GLU . 1.2 pt-20 -145.58 97.57 3.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.133 -0.98 . . . . 0.0 109.306 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.615 ' HG3' ' CD1' ' A' ' 45' ' ' TRP . 3.5 tt0 -81.35 116.6 21.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.196 -0.94 . . . . 0.0 109.282 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.785 ' HB2' HD21 ' B' ' 186' ' ' LEU . 23.4 m-70 -85.0 -105.78 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.287 -0.883 . . . . 0.0 109.509 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.24 -16.59 1.71 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.525 ' HB2' ' HD3' ' B' ' 183' ' ' PRO . 16.6 mm-40 -153.92 -17.8 0.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.038 -1.272 . . . . 0.0 110.389 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.851 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 63.5 m95 -135.76 102.57 5.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.964 -1.085 . . . . 0.0 109.342 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.615 ' CD1' ' HG3' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -90.7 142.67 27.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.103 -0.998 . . . . 0.0 110.045 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.9 OUTLIER -91.84 105.77 17.96 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.063 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.81 -175.86 2.92 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.191 -0.943 . . . . 0.0 110.184 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.612 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -124.89 129.71 50.93 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.689 -0.632 . . . . 0.0 109.376 -179.566 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.663 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -74.77 125.83 29.61 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.097 -1.002 . . . . 0.0 109.943 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.27 -7.53 47.61 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.471 ' HA ' HD12 ' A' ' 51' ' ' LEU . 15.3 tp -53.78 -54.93 31.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.604 -0.685 . . . . 0.0 109.214 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.601 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 0.7 OUTLIER -161.38 29.54 0.13 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.264 -0.898 . . . . 0.0 109.994 179.672 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.601 ' CB ' ' O ' ' A' ' 52' ' ' THR . 5.7 mttp 86.45 44.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.454 -0.779 . . . . 0.0 110.423 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.663 ' HB2' ' HB3' ' A' ' 49' ' ' SER . 0.0 OUTLIER -85.94 132.46 34.07 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.335 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 20.0 pt-20 -122.84 120.32 33.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.933 -1.104 . . . . 0.0 109.103 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.661 ' HA3' ' CB ' ' A' ' 27' ' ' LEU . . . -162.58 165.72 36.33 Favored Glycine 0 N--CA 1.488 2.128 0 C-N-CA 119.105 -1.521 . . . . 0.0 110.253 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.641 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 8.5 m-85 -71.38 132.95 45.57 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.759 -0.847 . . . . 0.0 109.652 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.588 HD12 HG21 ' A' ' 63' ' ' VAL . 7.4 pt -121.91 143.14 37.87 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.77 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 44.2 Cg_endo -67.66 153.77 75.18 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.701 1.601 . . . . 0.0 111.614 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.528 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 65.5 p -82.71 6.77 16.91 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 110.783 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -110.31 -52.86 2.74 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.741 -1.224 . . . . 0.0 110.637 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.599 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 5.1 m-85 -49.08 -63.15 1.19 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.094 -1.004 . . . . 0.0 110.938 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.588 HG21 HD12 ' A' ' 58' ' ' ILE . 3.3 m -78.85 155.01 4.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 122.027 0.918 . . . . 0.0 110.935 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 1.064 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -133.14 161.53 34.17 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.3 mttt . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.093 -1.004 . . . . 0.0 109.479 179.895 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 0.586 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.712 0.768 . . . . 0.0 109.622 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.851 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.4 Cg_endo -69.92 -175.0 1.05 Allowed 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.963 2.442 . . . . 0.0 111.457 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 181' ' ' PRO . . . . . 0.704 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.6 Cg_endo -91.31 -25.31 0.34 Allowed 'Trans proline' 0 C--O 1.213 -0.76 0 C-N-CA 122.856 2.371 . . . . 0.0 114.531 -177.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.711 ' CG ' ' CE2' ' A' ' 44' ' ' TRP . 39.4 mtt180 78.71 94.33 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 120.942 -1.098 . . . . 0.0 109.2 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.594 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 46.3 Cg_endo -67.58 118.5 5.64 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.664 2.243 . . . . 0.0 111.75 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . 53.83 57.59 5.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.255 -0.903 . . . . 0.0 109.3 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 51.09 50.75 18.43 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.319 -0.863 . . . . 0.0 109.414 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 186' ' ' LEU . . . . . 0.785 HD21 ' HB2' ' A' ' 41' ' ' HIS . 62.0 tp -71.72 -80.54 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.306 -0.871 . . . . 0.0 109.508 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 187' ' ' GLY . . . . . 0.641 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.486 1.98 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.549 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.547 HD12 ' HG2' ' A' ' 36' ' ' LYS . 25.5 mm -100.89 137.0 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.163 -0.96 . . . . 0.0 109.553 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.17 161.76 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.463 -0.773 . . . . 0.0 108.951 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 p -121.23 139.06 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.006 -1.059 . . . . 0.0 109.317 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.08 133.68 46.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.364 -0.835 . . . . 0.0 109.697 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.089 HD11 ' HB2' ' A' ' 64' ' ' ALA . 55.7 mt -99.12 -12.86 20.11 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.585 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 34.3 m-85 -158.35 154.19 23.15 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.719 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 42.0 Cg_endo -64.36 149.07 90.79 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 121.662 1.575 . . . . 0.0 110.055 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.834 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 54.2 t80 -97.86 177.93 5.29 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.324 -1.35 . . . . 0.0 110.405 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.686 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 0.7 OUTLIER -109.01 80.58 1.33 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.498 -0.751 . . . . 0.0 109.303 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.45 94.68 0.05 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 20' ' ' ASP . 18.1 mm -108.19 -42.02 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.303 -1.116 . . . . 0.0 108.807 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -77.45 158.15 79.36 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.89 -13.77 34.78 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.232 1.955 . . . . 0.0 111.811 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.74 -14.35 13.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.258 -0.902 . . . . 0.0 110.525 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.61 138.69 55.02 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.873 -1.142 . . . . 0.0 109.864 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.937 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -93.87 120.76 34.56 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.041 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.874 ' N ' HD22 ' A' ' 27' ' ' LEU . 10.1 p -79.92 140.74 36.57 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.365 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.834 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 21.9 p90 -145.94 157.66 43.88 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.14 -0.975 . . . . 0.0 108.535 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.653 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.5 OUTLIER -110.81 173.16 6.46 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.153 -0.967 . . . . 0.0 109.51 -179.44 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 7.8 pttm -67.09 152.02 46.54 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.183 -0.948 . . . . 0.0 109.38 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.42 -8.18 4.26 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.5 143.4 42.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.936 -1.332 . . . . 0.0 109.709 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.61 137.84 35.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 0.0 109.418 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.604 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 2.4 mpp? -135.01 151.79 51.13 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.492 0.663 . . . . 0.0 109.669 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.547 ' HG2' HD12 ' A' ' 12' ' ' ILE . 4.0 mttm -108.95 127.01 53.69 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.426 -0.797 . . . . 0.0 109.407 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.578 HG11 ' HG3' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -81.57 143.58 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.397 -0.814 . . . . 0.0 108.958 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.521 HD12 ' C ' ' A' ' 37' ' ' VAL . 7.8 mp -119.69 -40.89 2.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.064 -1.022 . . . . 0.0 109.833 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -140.38 92.13 2.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.16 -0.962 . . . . 0.0 108.96 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.6 ' HG2' ' CG ' ' A' ' 45' ' ' TRP . 1.9 mt-10 -74.09 120.37 19.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.479 -0.763 . . . . 0.0 109.536 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.74 ' HB2' HD21 ' B' ' 186' ' ' LEU . 44.2 m80 -92.28 -106.49 0.11 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.235 -0.915 . . . . 0.0 109.555 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.36 -16.66 1.17 Allowed Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.179 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.513 ' HG2' ' HD2' ' B' ' 181' ' ' PRO . 0.5 OUTLIER -154.21 -17.04 0.13 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.968 -1.313 . . . . 0.0 110.351 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.822 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 59.8 m95 -136.97 101.73 4.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.038 -1.039 . . . . 0.0 109.155 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.6 ' CG ' ' HG2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -91.07 139.57 30.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.904 -1.122 . . . . 0.0 109.992 -179.679 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.7 OUTLIER -86.13 107.41 17.84 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.973 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -102.26 -177.86 3.53 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.289 -0.882 . . . . 0.0 110.233 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 9.8 tttm -123.45 107.97 12.17 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.605 ' N ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -54.1 127.02 24.95 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.11 -0.994 . . . . 0.0 109.925 -179.764 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 52' ' ' THR . 3.7 mt -75.84 -11.2 59.93 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.482 ' C ' HG22 ' A' ' 52' ' ' THR . 22.4 tp -46.05 -20.89 0.11 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.719 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 0.6 OUTLIER 168.15 -21.47 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.392 -0.817 . . . . 0.0 109.851 179.151 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.719 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 140.55 42.61 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.536 -0.727 . . . . 0.0 109.972 179.629 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.655 ' HB3' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -85.37 134.64 34.08 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.085 -1.01 . . . . 0.0 108.505 178.419 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.474 ' OE1' HD22 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -122.5 114.33 20.53 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.047 -1.033 . . . . 0.0 109.359 -179.825 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.644 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -155.52 168.85 33.29 Favored Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.416 -1.373 . . . . 0.0 109.959 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.658 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 8.9 m-85 -71.41 131.93 44.08 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.574 -0.957 . . . . 0.0 109.656 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.532 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 5.2 pt -120.86 139.63 29.42 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.743 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 46.8 Cg_endo -69.14 158.74 56.59 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 121.671 1.581 . . . . 0.0 111.948 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.515 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 79.5 p -86.44 7.08 27.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.334 -0.853 . . . . 0.0 110.387 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.28 -53.77 2.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.903 -1.123 . . . . 0.0 110.441 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.585 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 2.8 m-85 -47.93 -63.38 1.08 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.133 -0.979 . . . . 0.0 111.115 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.604 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 3.0 m -78.53 155.0 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.929 . . . . 0.0 110.968 -177.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 1.089 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -134.8 162.67 31.71 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.4 pttm . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.044 -1.035 . . . . 0.0 109.251 179.747 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 0.614 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 121.697 0.76 . . . . 0.0 109.761 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.822 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.7 Cg_endo -69.34 -173.43 0.66 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 123.049 2.499 . . . . 0.0 111.484 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 181' ' ' PRO . . . . . 0.737 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 53.1 Cg_endo -92.95 -26.5 0.18 Allowed 'Trans proline' 0 C--O 1.213 -0.732 0 C-N-CA 122.95 2.433 . . . . 0.0 114.441 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.737 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 43.3 mtt180 80.99 95.02 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.076 -1.015 . . . . 0.0 109.059 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.549 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 49.2 Cg_endo -69.98 135.98 31.29 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.745 2.297 . . . . 0.0 111.865 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 184' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 41.61 57.79 2.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 0.0 109.367 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 49.13 48.96 20.31 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.228 -0.92 . . . . 0.0 109.288 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 186' ' ' LEU . . . . . 0.74 HD21 ' HB2' ' A' ' 41' ' ' HIS . 48.4 tp -67.43 -87.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.408 -0.808 . . . . 0.0 109.319 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 187' ' ' GLY . . . . . 0.658 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.486 2.014 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 36' ' ' LYS . 4.5 tp -99.23 138.84 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.164 -0.96 . . . . 0.0 109.451 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.603 HG22 ' CG2' ' A' ' 37' ' ' VAL . 0.8 OUTLIER -131.2 160.36 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.333 -0.855 . . . . 0.0 109.007 -179.842 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.0 p -120.5 138.98 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.017 -1.052 . . . . 0.0 109.353 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -72.53 134.81 45.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.411 -0.806 . . . . 0.0 109.842 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.801 HD11 ' HB2' ' A' ' 64' ' ' ALA . 69.4 mt -99.85 -22.4 15.33 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 16' ' ' LEU . 32.3 m-85 -147.48 153.1 43.41 Favored Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.696 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.7 Cg_endo -63.21 149.67 90.73 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 121.845 1.697 . . . . 0.0 110.089 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.824 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 57.0 t80 -98.81 178.73 4.88 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.268 -1.373 . . . . 0.0 110.524 -177.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.686 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -109.96 80.38 1.31 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.01 95.89 0.06 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 20' ' ' ASP . 75.9 mt -108.8 -42.21 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.117 -1.226 . . . . 0.0 108.86 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.472 ' HB2' ' CG ' ' A' ' 26' ' ' ASP . 38.3 m80 -76.81 157.87 81.29 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.59 -12.74 33.88 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.129 1.886 . . . . 0.0 111.657 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -112.92 -14.51 13.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.894 . . . . 0.0 110.64 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.472 ' CG ' ' HB2' ' A' ' 23' ' ' HIS . 79.9 m-20 -57.53 139.81 52.42 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.762 -1.212 . . . . 0.0 109.783 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.886 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -95.1 121.53 36.83 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.159 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.869 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -80.07 140.49 36.46 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.448 -0.783 . . . . 0.0 109.491 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.824 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 25.7 p90 -145.39 156.95 44.09 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.163 -0.961 . . . . 0.0 108.676 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.637 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -110.64 173.32 6.39 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.151 -0.968 . . . . 0.0 109.596 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.555 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -67.26 151.49 47.41 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.186 -0.946 . . . . 0.0 109.322 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 71.51 -8.19 5.8 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.69 142.93 42.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.934 -1.333 . . . . 0.0 109.839 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.0 138.94 33.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 109.456 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.609 ' CE ' HG11 ' A' ' 63' ' ' VAL . 2.5 mpp? -135.49 151.62 50.54 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.577 -0.702 . . . . 0.0 109.82 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 82.4 tttt -105.29 123.24 47.52 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.424 -0.798 . . . . 0.0 109.428 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.846 HG11 ' OE2' ' A' ' 40' ' ' GLU . 2.0 t -81.82 115.96 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.362 -0.836 . . . . 0.0 109.052 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 38' ' ' LEU . 9.3 mp -92.01 -39.65 11.54 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.085 -1.01 . . . . 0.0 109.887 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -142.29 102.65 4.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.102 -0.999 . . . . 0.0 109.06 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.846 ' OE2' HG11 ' A' ' 37' ' ' VAL . 1.0 OUTLIER -85.41 118.53 25.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.391 -0.818 . . . . 0.0 109.498 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.651 ' HB2' HD21 ' B' ' 186' ' ' LEU . 68.3 m-70 -89.26 -103.13 0.09 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.287 -0.883 . . . . 0.0 109.367 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.44 ' O ' ' CD ' ' A' ' 43' ' ' GLU . . . -138.71 -13.71 0.71 Allowed Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.426 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.561 ' HG2' ' HD2' ' B' ' 181' ' ' PRO . 0.6 OUTLIER -155.57 -20.95 0.11 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.832 -1.393 . . . . 0.0 110.584 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.818 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 58.9 m95 -136.47 95.27 3.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.874 -1.142 . . . . 0.0 109.047 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.589 ' CG ' ' HG3' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -87.03 141.46 28.65 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.992 -1.067 . . . . 0.0 110.492 -179.184 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.8 OUTLIER -87.1 106.74 18.07 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -104.32 -173.23 2.26 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.287 -0.883 . . . . 0.0 110.179 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 4.3 tttp -127.28 131.37 50.53 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.5 -0.75 . . . . 0.0 109.452 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.668 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 1.3 t -77.17 128.09 33.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.002 -1.061 . . . . 0.0 109.885 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.87 -7.68 49.87 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 51' ' ' LEU . 9.4 tp -53.7 -55.8 22.95 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.35 -0.844 . . . . 0.0 109.348 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.623 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.4 t -160.69 28.42 0.15 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.229 -0.92 . . . . 0.0 110.149 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.623 ' CB ' ' O ' ' A' ' 52' ' ' THR . 31.0 mtmt 86.8 44.5 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.444 -0.785 . . . . 0.0 111.122 178.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.758 ' HB3' HD23 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -87.67 131.95 34.27 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.795 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 8.9 pt-20 -121.83 120.66 35.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.932 -1.105 . . . . 0.0 109.641 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.688 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -158.37 168.94 34.82 Favored Glycine 0 N--CA 1.487 2.1 0 C-N-CA 119.539 -1.315 . . . . 0.0 109.887 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.79 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 11.5 m-85 -71.27 133.71 46.27 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.546 -0.973 . . . . 0.0 109.884 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.562 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 2.9 pt -122.31 142.37 36.8 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.696 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 47.8 Cg_endo -70.85 159.41 52.69 Favored 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 121.562 1.508 . . . . 0.0 111.818 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.513 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 90.3 p -87.31 7.2 29.78 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 110.073 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.97 -54.86 2.44 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.006 -1.059 . . . . 0.0 110.351 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.703 ' HE2' HD23 ' B' ' 179' ' ' LEU . 3.5 m-85 -48.6 -63.28 1.13 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.167 -0.958 . . . . 0.0 111.151 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.609 HG11 ' CE ' ' A' ' 35' ' ' MET . 2.9 m -79.8 155.9 4.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.995 0.902 . . . . 0.0 111.133 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.801 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -132.3 160.47 36.15 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.439 ' HA ' HG12 ' A' ' 13' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 O-C-N 120.999 -1.063 . . . . 0.0 109.463 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 0.703 HD23 ' HE2' ' A' ' 62' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 121.668 0.747 . . . . 0.0 109.589 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.818 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 39.3 Cg_endo -67.96 -174.48 0.62 Allowed 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 123.042 2.494 . . . . 0.0 112.075 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 181' ' ' PRO . . . . . 0.638 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.6 Cg_endo -92.78 -29.0 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 123.252 2.635 . . . . 0.0 114.213 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.757 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.1 OUTLIER 84.23 104.95 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.162 -0.961 . . . . 0.0 109.877 -179.323 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.715 ' CG ' HD22 ' B' ' 186' ' ' LEU . 44.7 Cg_endo -69.29 124.94 11.79 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 123.022 2.481 . . . . 0.0 111.998 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 184' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 40.44 69.27 0.33 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.36 -0.838 . . . . 0.0 109.567 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 185' ' ' ASN . . . . . 0.454 ' C ' ' O ' ' B' ' 184' ' ' ALA . 0.0 OUTLIER 42.06 47.22 3.83 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.289 -0.882 . . . . 0.0 109.413 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 186' ' ' LEU . . . . . 0.737 HD23 ' HB2' ' A' ' 44' ' ' TRP . 31.6 tp -56.19 -94.81 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 187' ' ' GLY . . . . . 0.79 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.697 HD13 ' HA ' ' A' ' 36' ' ' LYS . 21.6 mm -119.03 138.32 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.18 -0.95 . . . . 0.0 109.587 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.8 HG12 ' HA ' ' A' ' 65' ' ' LYS . 0.8 OUTLIER -132.21 161.91 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 p -120.83 140.45 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.936 -1.102 . . . . 0.0 109.463 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -72.79 133.87 44.69 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.336 -0.853 . . . . 0.0 109.566 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.995 HD11 ' HB2' ' A' ' 64' ' ' ALA . 84.3 mt -99.88 -15.51 18.35 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 16' ' ' LEU . 3.5 m-85 -156.32 154.71 27.78 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.729 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.2 Cg_endo -63.45 149.05 92.13 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 121.903 1.735 . . . . 0.0 110.448 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.831 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 50.9 t80 -98.46 178.7 4.94 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.438 -1.305 . . . . 0.0 110.367 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.694 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 0.5 OUTLIER -109.66 80.65 1.34 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.631 -0.668 . . . . 0.0 109.291 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.95 94.58 0.05 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 20' ' ' ASP . 17.1 mm -108.28 -41.92 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.089 -1.242 . . . . 0.0 108.902 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.449 ' HB2' ' CG ' ' A' ' 26' ' ' ASP . 20.5 m-70 -77.54 157.75 79.62 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.54 -13.32 35.03 Favored 'Trans proline' 0 C--O 1.213 -0.75 0 C-N-CA 122.271 1.981 . . . . 0.0 111.921 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 1.0 OUTLIER -112.11 -13.9 13.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.253 -0.904 . . . . 0.0 110.673 -179.069 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.449 ' CG ' ' HB2' ' A' ' 23' ' ' HIS . 84.4 m-20 -57.97 139.74 53.77 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.819 -1.176 . . . . 0.0 109.94 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.948 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -94.74 120.9 35.71 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.874 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.872 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -79.19 140.25 37.77 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.263 -0.898 . . . . 0.0 109.277 179.723 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.831 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 23.5 p90 -145.2 156.8 44.07 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.098 -1.001 . . . . 0.0 108.701 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.621 ' HG2' ' HB2' ' A' ' 33' ' ' GLU . 5.6 ptmt -110.81 173.24 6.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 109.319 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -66.59 151.96 46.27 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.983 -1.073 . . . . 0.0 109.482 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 71.76 -7.39 7.2 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.621 ' HB2' ' HG2' ' A' ' 30' ' ' LYS . 5.0 tp10 -76.15 142.62 41.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.892 -1.357 . . . . 0.0 109.944 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.481 ' HD2' HG21 ' A' ' 12' ' ' ILE . 1.4 ttpt -97.28 139.52 33.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.886 . . . . 0.0 109.382 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.673 ' CE ' HG11 ' A' ' 63' ' ' VAL . 2.0 mpp? -135.1 151.48 50.77 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.441 0.639 . . . . 0.0 109.735 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.697 ' HA ' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -104.39 123.47 47.49 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.546 -0.722 . . . . 0.0 109.163 179.797 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.607 ' CG2' HG22 ' A' ' 13' ' ' VAL . 2.2 t -81.43 114.1 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.29 -0.881 . . . . 0.0 109.088 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 38' ' ' LEU . 6.3 mp -90.23 -44.17 9.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 109.656 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -143.08 97.46 3.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.932 . . . . 0.0 108.921 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.565 ' HG3' ' CD1' ' A' ' 45' ' ' TRP . 3.3 tt0 -83.72 116.67 22.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.34 -0.85 . . . . 0.0 109.588 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.696 ' HB2' HD21 ' B' ' 186' ' ' LEU . 4.0 m-70 -78.27 -95.83 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.319 -0.863 . . . . 0.0 109.228 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.46 ' O ' ' CD ' ' A' ' 43' ' ' GLU . . . -148.38 -13.05 0.13 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.383 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.602 ' HB3' ' HD2' ' B' ' 181' ' ' PRO . 6.5 mm-40 -148.69 -26.38 0.31 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.969 -1.312 . . . . 0.0 110.008 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.933 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 47.8 m95 -134.02 102.26 5.35 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.17 -0.956 . . . . 0.0 108.768 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.636 ' CZ2' ' CB ' ' A' ' 60' ' ' SER . 0.1 OUTLIER -90.02 147.17 23.83 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.092 -1.005 . . . . 0.0 110.398 -179.129 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -96.06 108.2 20.6 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -105.65 -172.89 2.18 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 110.346 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -125.56 127.11 45.86 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.609 -0.682 . . . . 0.0 109.266 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.65 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -70.82 126.06 28.54 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.183 -0.948 . . . . 0.0 109.835 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.6 mp -72.18 -7.97 52.14 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.4 tp -54.25 -54.83 34.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.528 -0.733 . . . . 0.0 109.17 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.587 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 1.3 t -161.06 30.08 0.14 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.173 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 52' ' ' THR . 38.3 mmtt 85.78 45.49 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.499 -0.751 . . . . 0.0 110.661 178.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.65 ' HB2' ' HB3' ' A' ' 49' ' ' SER . 0.8 OUTLIER -87.05 132.29 33.85 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.137 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.501 ' CG ' ' HE3' ' A' ' 46' ' ' LYS . 15.4 tt0 -121.72 117.35 26.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.876 -1.14 . . . . 0.0 109.57 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.651 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -158.42 168.62 34.78 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.44 -1.362 . . . . 0.0 110.015 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.871 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 12.5 m-85 -73.66 135.15 43.72 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.679 -0.895 . . . . 0.0 110.16 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.588 HD12 HG21 ' A' ' 63' ' ' VAL . 7.4 pt -122.39 139.34 30.61 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.596 ' HB2' ' CD ' ' B' ' 180' ' ' PRO . 52.3 Cg_endo -72.6 131.96 18.14 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 121.519 1.479 . . . . 0.0 112.014 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.636 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 53.7 p -62.88 3.68 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.39 -0.819 . . . . 0.0 110.542 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.637 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 6.5 p-10 -98.36 -52.42 3.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.797 -1.189 . . . . 0.0 110.62 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 1.18 ' CE2' HD21 ' B' ' 179' ' ' LEU . 4.0 m-85 -57.28 -59.25 5.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.113 -0.992 . . . . 0.0 111.176 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.673 HG11 ' CE ' ' A' ' 35' ' ' MET . 3.2 m -79.78 159.9 4.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 122.024 0.916 . . . . 0.0 111.235 -177.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.995 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -133.93 157.83 45.01 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.8 ' HA ' HG12 ' A' ' 13' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.053 -1.029 . . . . 0.0 109.562 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 1.18 HD21 ' CE2' ' A' ' 62' ' ' TYR . 74.5 mt . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 121.483 0.659 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.933 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.8 Cg_endo -67.67 176.91 4.54 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.566 2.178 . . . . 0.0 111.5 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 181' ' ' PRO . . . . . 0.619 ' O ' ' CB ' ' B' ' 182' ' ' ARG . 56.1 Cg_endo -81.36 -37.57 0.28 Allowed 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.822 2.348 . . . . 0.0 114.029 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.718 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.4 OUTLIER 82.22 98.02 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 120.997 -1.065 . . . . 0.0 109.295 -179.006 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.71 ' CG ' HD22 ' B' ' 186' ' ' LEU . 45.4 Cg_endo -69.61 130.76 20.09 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 123.206 2.604 . . . . 0.0 112.329 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 184' ' ' ALA . . . . . 0.509 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 35.63 72.89 0.09 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.436 -0.79 . . . . 0.0 109.821 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 185' ' ' ASN . . . . . 0.464 ' C ' ' O ' ' B' ' 184' ' ' ALA . 0.7 OUTLIER 40.59 45.34 1.96 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.37 -0.831 . . . . 0.0 109.438 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 186' ' ' LEU . . . . . 0.715 HD23 ' HB2' ' A' ' 44' ' ' TRP . 34.4 tp -54.6 -94.54 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 187' ' ' GLY . . . . . 0.871 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.486 1.988 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.566 ' O ' HG23 ' A' ' 37' ' ' VAL . 2.6 m-20 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.557 ' CD1' ' HG2' ' A' ' 36' ' ' LYS . 2.5 tp -91.02 138.64 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 0.0 109.663 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 65' ' ' LYS . 1.9 m -131.01 160.75 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.407 -0.808 . . . . 0.0 108.908 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.8 p -120.39 138.62 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.079 -1.013 . . . . 0.0 109.283 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.4 133.35 45.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.41 -0.806 . . . . 0.0 110.101 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.956 HD11 ' HB2' ' A' ' 64' ' ' ALA . 14.7 mt -98.59 -15.2 19.57 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.559 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 53.3 m-85 -155.0 153.87 27.99 Favored Pre-proline 0 N--CA 1.486 1.374 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.698 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 41.4 Cg_endo -64.48 149.59 89.72 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 121.75 1.633 . . . . 0.0 109.805 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.81 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 59.1 t80 -98.89 179.25 4.7 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.102 -1.439 . . . . 0.0 110.346 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.682 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 73.5 m-20 -110.37 80.78 1.34 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.525 -0.735 . . . . 0.0 109.303 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.82 94.95 0.05 OUTLIER Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 20' ' ' ASP . 69.0 mt -108.74 -41.54 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -1.173 . . . . 0.0 108.895 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.579 ' CD2' ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -78.14 158.81 76.7 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.103 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.579 ' HD2' ' CD2' ' A' ' 23' ' ' HIS . 48.5 Cg_endo -69.67 -13.85 35.51 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.24 1.96 . . . . 0.0 111.91 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 4.4 t70 -112.28 -13.86 13.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 110.799 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.486 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.5 OUTLIER -57.84 139.6 53.75 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.74 -1.225 . . . . 0.0 109.817 -179.282 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.929 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -95.33 121.37 36.91 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.148 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.876 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -79.44 139.98 37.5 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.338 -0.851 . . . . 0.0 109.439 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.81 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 32.6 p90 -145.2 157.09 44.17 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.19 -0.944 . . . . 0.0 108.711 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.665 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 1.4 tttt -110.56 172.95 6.56 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.492 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.539 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -66.77 151.88 46.59 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.216 -0.927 . . . . 0.0 109.343 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.7 -7.95 4.77 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -75.88 143.6 41.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.957 -1.32 . . . . 0.0 109.765 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.76 ' HD2' HD13 ' A' ' 50' ' ' LEU . 1.1 ptpt -96.97 139.63 32.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.307 -0.871 . . . . 0.0 109.398 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.59 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 3.4 mpp? -134.52 150.89 50.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.627 -0.671 . . . . 0.0 109.841 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.557 ' HG2' ' CD1' ' A' ' 12' ' ' ILE . 30.5 mtpt -102.55 123.08 45.64 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.455 -0.778 . . . . 0.0 109.42 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 11' ' ' ASP . 3.1 t -81.14 134.71 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.166 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.4 mt -110.99 -43.3 3.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.144 -0.973 . . . . 0.0 109.703 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -149.2 93.13 2.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.178 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.646 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.1 tt0 -78.24 116.24 18.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.331 -0.855 . . . . 0.0 109.326 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.739 ' HB2' HD21 ' B' ' 186' ' ' LEU . 5.7 m-70 -79.81 -100.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.301 -0.874 . . . . 0.0 109.481 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.06 -11.63 1.04 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.693 -1.242 . . . . 0.0 110.114 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.546 ' O ' ' HG3' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -156.48 -19.15 0.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.061 -1.258 . . . . 0.0 110.594 -179.711 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.797 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 66.2 m95 -136.49 99.02 3.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.882 -1.136 . . . . 0.0 109.427 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.646 ' CD1' ' CG ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -89.17 142.14 27.91 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.005 -1.059 . . . . 0.0 110.037 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -92.03 107.0 18.89 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.121 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.29 -174.78 2.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.858 . . . . 0.0 110.238 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 27.1 ttmt -124.98 111.4 15.36 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.675 -0.641 . . . . 0.0 109.277 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.627 ' N ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -56.01 126.35 25.52 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.23 -0.919 . . . . 0.0 109.776 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.76 HD13 ' HD2' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -75.66 -11.25 59.97 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.129 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.515 ' C ' HG22 ' A' ' 52' ' ' THR . 1.5 tp -46.19 -20.9 0.12 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.724 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 0.5 OUTLIER 168.02 -21.87 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.009 179.148 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.724 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 140.93 41.89 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.431 -0.793 . . . . 0.0 110.18 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.735 ' HB3' HD23 ' A' ' 27' ' ' LEU . 3.6 mtmt -87.22 134.4 33.54 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.046 -1.034 . . . . 0.0 108.375 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -122.45 119.1 29.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.95 -1.093 . . . . 0.0 109.48 -179.609 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.669 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -159.87 168.92 35.73 Favored Glycine 0 N--CA 1.486 2.027 0 C-N-CA 119.365 -1.398 . . . . 0.0 110.124 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.744 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 10.4 m-85 -72.92 133.66 44.45 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.636 -0.92 . . . . 0.0 109.929 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.551 HD12 HG21 ' A' ' 63' ' ' VAL . 7.8 pt -121.89 140.8 32.7 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.738 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 48.4 Cg_endo -69.56 140.53 43.67 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 121.676 1.584 . . . . 0.0 111.976 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.612 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 32.6 p -71.43 5.42 2.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.344 -0.847 . . . . 0.0 110.68 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.34 -53.28 2.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.794 -1.192 . . . . 0.0 110.58 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.576 ' CE2' HD23 ' B' ' 179' ' ' LEU . 3.4 m-85 -50.99 -61.76 2.03 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.09 -1.006 . . . . 0.0 111.012 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.59 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 3.4 m -78.04 156.22 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.948 0.88 . . . . 0.0 111.235 -177.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.956 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -131.22 160.05 36.0 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.556 ' HA ' HG12 ' A' ' 13' ' ' VAL . 9.1 mttt . . . . . 0 N--CA 1.49 1.557 0 O-C-N 120.994 -1.066 . . . . 0.0 109.792 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 0.614 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.705 0.764 . . . . 0.0 109.628 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.797 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 39.1 Cg_endo -69.58 -176.04 1.31 Allowed 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.111 2.54 . . . . 0.0 111.917 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 181' ' ' PRO . . . . . 0.638 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 53.7 Cg_endo -90.33 -22.54 0.74 Allowed 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 123.075 2.517 . . . . 0.0 114.697 -177.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.738 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.8 OUTLIER 77.5 91.26 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 120.772 -1.205 . . . . 0.0 109.237 -179.331 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.513 ' HD3' ' HB2' ' A' ' 43' ' ' GLU . 50.7 Cg_endo -70.79 134.99 26.98 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.907 2.404 . . . . 0.0 112.029 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 184' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 39.27 64.81 0.76 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.328 -0.858 . . . . 0.0 109.625 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 185' ' ' ASN . . . . . 0.428 ' C ' ' O ' ' B' ' 184' ' ' ALA . 3.1 m-80 43.86 49.73 7.01 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.34 -0.85 . . . . 0.0 109.476 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 186' ' ' LEU . . . . . 0.739 HD21 ' HB2' ' A' ' 41' ' ' HIS . 35.3 tp -66.32 -87.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.321 -0.862 . . . . 0.0 109.34 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 187' ' ' GLY . . . . . 0.744 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.486 1.979 0 N-CA-C 108.816 -1.713 . . . . 0.0 108.816 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.736 HD12 ' HD3' ' A' ' 36' ' ' LYS . 2.6 tp -111.99 137.08 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 109.529 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.576 HG22 HG23 ' A' ' 37' ' ' VAL . 1.4 m -132.83 161.79 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.385 -0.822 . . . . 0.0 109.161 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.7 p -120.26 138.84 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.97 -1.081 . . . . 0.0 109.219 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.64 133.65 45.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.327 -0.858 . . . . 0.0 109.896 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.979 HD11 ' HB2' ' A' ' 64' ' ' ALA . 25.4 mt -99.09 -12.1 20.83 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.586 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 39.5 m-85 -158.63 155.07 24.4 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.7 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 42.2 Cg_endo -64.71 149.04 90.35 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 121.761 1.641 . . . . 0.0 109.887 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.826 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 59.9 t80 -98.82 178.86 4.84 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 118.373 -1.331 . . . . 0.0 110.415 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.758 ' OD2' HD21 ' B' ' 179' ' ' LEU . 6.2 p30 -110.21 80.29 1.3 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.584 -0.698 . . . . 0.0 109.522 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.61 95.86 0.05 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 20' ' ' ASP . 0.5 OUTLIER -108.96 -41.78 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.243 -1.151 . . . . 0.0 108.859 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -77.72 159.41 76.69 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.33 -13.79 33.62 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.195 1.93 . . . . 0.0 111.804 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -112.37 -14.29 13.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.143 -0.973 . . . . 0.0 110.758 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.434 ' OD2' ' NH2' ' B' ' 182' ' ' ARG . 2.1 m-20 -57.32 139.06 53.99 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.825 -1.172 . . . . 0.0 109.646 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.951 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -94.66 121.26 36.05 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.113 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.892 ' N ' HD22 ' A' ' 27' ' ' LEU . 55.9 p -80.26 140.59 36.15 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.265 -0.897 . . . . 0.0 109.427 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.826 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 23.4 p90 -146.06 157.87 43.86 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.145 -0.972 . . . . 0.0 108.875 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.61 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -111.07 168.06 9.78 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.122 -0.987 . . . . 0.0 109.453 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.567 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -62.23 153.63 29.92 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.135 -0.978 . . . . 0.0 109.628 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.69 -8.11 3.5 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 5.2 tt0 -75.65 142.61 42.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.979 -1.307 . . . . 0.0 109.912 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.483 ' HB3' HD13 ' A' ' 50' ' ' LEU . 0.7 OUTLIER -96.2 139.28 32.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.227 -0.921 . . . . 0.0 109.312 179.701 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.603 ' CE ' HG11 ' A' ' 63' ' ' VAL . 2.6 mpp? -135.28 151.44 50.57 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.606 -0.684 . . . . 0.0 109.919 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.736 ' HD3' HD12 ' A' ' 12' ' ' ILE . 5.8 tppp? -105.07 124.13 49.0 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.533 -0.729 . . . . 0.0 109.186 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.576 HG23 HG22 ' A' ' 13' ' ' VAL . 6.7 t -81.03 132.73 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.855 . . . . 0.0 109.291 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.7 mt -107.7 -47.43 3.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.152 -0.968 . . . . 0.0 109.63 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -142.42 97.47 3.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.943 . . . . 0.0 108.936 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.616 ' HG2' ' CD1' ' A' ' 45' ' ' TRP . 2.3 tm-20 -84.17 116.66 23.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.359 -0.838 . . . . 0.0 109.653 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.809 ' HB2' HD21 ' B' ' 186' ' ' LEU . 18.3 m80 -80.58 -98.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.433 -0.792 . . . . 0.0 109.458 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.26 -11.36 0.67 Allowed Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.32 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.566 ' O ' ' HG3' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -156.85 -18.78 0.09 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.879 -1.365 . . . . 0.0 110.413 -179.692 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.86 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 67.2 m95 -135.78 96.17 3.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.902 -1.124 . . . . 0.0 109.124 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.622 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -88.21 145.27 25.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.022 -1.049 . . . . 0.0 110.119 -179.253 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.6 OUTLIER -93.7 107.43 19.31 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.219 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -104.55 -173.96 2.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.296 -0.878 . . . . 0.0 110.094 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 2.7 ttpm? -125.46 126.84 45.56 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.59 -0.694 . . . . 0.0 109.459 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.657 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -70.92 126.5 29.74 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.111 -0.993 . . . . 0.0 110.03 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.483 HD13 ' HB3' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -72.24 -7.47 49.52 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.784 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 51' ' ' LEU . 27.8 tp -54.49 -55.05 33.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.503 -0.748 . . . . 0.0 109.253 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.5 t -161.16 29.69 0.14 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.122 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.587 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 86.36 45.85 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.482 -0.761 . . . . 0.0 110.671 178.622 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.657 ' HB2' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER -86.94 132.3 33.84 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.068 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.454 ' HG2' ' CE ' ' A' ' 46' ' ' LYS . 20.2 tt0 -121.59 116.38 24.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.942 -1.099 . . . . 0.0 109.353 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.635 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -157.13 169.26 34.19 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 119.385 -1.388 . . . . 0.0 110.032 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.724 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 11.0 m-85 -73.55 133.91 43.67 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.625 -0.926 . . . . 0.0 109.958 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 45' ' ' TRP . 2.6 pt -121.68 142.51 36.04 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.677 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 49.6 Cg_endo -69.93 152.0 68.3 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 121.792 1.661 . . . . 0.0 111.816 -178.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.543 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 66.1 p -80.81 5.67 15.27 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 110.006 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 4.4 p-10 -106.01 -52.48 2.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.997 -1.065 . . . . 0.0 110.941 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.695 ' CE2' HD23 ' B' ' 179' ' ' LEU . 4.5 m-85 -52.63 -61.28 2.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.099 -1.001 . . . . 0.0 111.263 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.603 HG11 ' CE ' ' A' ' 35' ' ' MET . 2.6 m -79.83 155.49 4.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 122.069 0.938 . . . . 0.0 111.092 -177.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.979 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -133.61 161.05 35.68 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.0 -1.063 . . . . 0.0 109.537 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 0.758 HD21 ' OD2' ' A' ' 20' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 121.755 0.788 . . . . 0.0 109.797 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.86 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 39.5 Cg_endo -68.92 -176.02 1.13 Allowed 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 123.03 2.487 . . . . 0.0 111.991 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 181' ' ' PRO . . . . . 0.739 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 52.0 Cg_endo -92.74 -20.57 0.49 Allowed 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 123.28 2.653 . . . . 0.0 114.661 -177.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.756 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.0 OUTLIER 78.75 89.9 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 120.873 -1.142 . . . . 0.0 109.175 -179.106 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.576 ' HG2' HD22 ' B' ' 186' ' ' LEU . 49.1 Cg_endo -70.41 137.43 33.55 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.804 2.336 . . . . 0.0 112.039 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 184' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 37.26 60.87 1.0 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.424 -0.797 . . . . 0.0 109.562 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 46.91 47.71 15.44 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.154 -0.966 . . . . 0.0 109.125 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 186' ' ' LEU . . . . . 0.809 HD21 ' HB2' ' A' ' 41' ' ' HIS . 20.5 tp -61.18 -84.93 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.517 -0.739 . . . . 0.0 109.427 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 187' ' ' GLY . . . . . 0.724 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.486 1.988 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.16 137.55 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.296 -0.877 . . . . 0.0 109.523 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 m -131.79 161.3 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 0.0 109.279 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.5 p -120.13 139.99 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.126 -0.984 . . . . 0.0 109.186 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -73.1 133.06 44.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.475 -0.765 . . . . 0.0 110.122 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.044 HD11 ' HB2' ' A' ' 64' ' ' ALA . 8.7 mt -100.1 -14.01 18.75 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.658 ' HA ' ' CG ' ' A' ' 31' ' ' LYS . 34.1 m-85 -155.84 150.47 20.31 Favored Pre-proline 0 N--CA 1.489 1.476 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.722 ' HD3' ' HG3' ' A' ' 31' ' ' LYS . 39.6 Cg_endo -61.09 149.03 91.11 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 121.718 1.612 . . . . 0.0 109.742 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.793 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 60.9 t80 -97.95 178.23 5.18 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.041 -1.464 . . . . 0.0 110.525 -177.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.679 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 30.6 t0 -109.75 80.46 1.32 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.673 -0.642 . . . . 0.0 109.408 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.63 93.22 0.03 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.524 HG12 ' O ' ' A' ' 20' ' ' ASP . 0.6 OUTLIER -107.26 -42.81 6.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.142 -1.21 . . . . 0.0 108.675 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.79 ' CE1' ' NH1' ' B' ' 182' ' ' ARG . 28.1 m80 -76.86 156.43 82.54 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.97 -13.94 37.61 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.287 1.991 . . . . 0.0 111.998 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -111.71 -13.72 13.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.341 -0.85 . . . . 0.0 110.493 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.481 ' OD2' ' OH ' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -57.97 140.52 52.09 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.827 -1.171 . . . . 0.0 109.989 -179.316 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.96 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -95.62 122.11 38.03 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.077 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.879 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -80.54 140.48 35.81 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.203 -0.935 . . . . 0.0 109.282 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.793 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 29.9 p90 -146.99 158.27 43.87 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.124 -0.985 . . . . 0.0 109.042 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.667 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 16.4 mttp -111.69 174.61 5.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.165 -0.959 . . . . 0.0 109.41 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.722 ' HG3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -66.54 155.88 36.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.875 -1.141 . . . . 0.0 109.428 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 67.71 -6.75 2.51 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -75.24 140.51 43.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.86 -1.377 . . . . 0.0 109.573 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.9 138.99 32.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.532 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.581 ' CE ' HG11 ' A' ' 63' ' ' VAL . 3.5 mpp? -135.83 152.14 50.77 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.473 0.654 . . . . 0.0 109.753 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.9 OUTLIER -108.6 126.14 52.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.459 -0.776 . . . . 0.0 109.313 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.554 HG11 ' HG3' ' A' ' 40' ' ' GLU . 3.9 t -82.14 126.31 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.357 -0.839 . . . . 0.0 109.37 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.496 HD11 ' OE2' ' A' ' 55' ' ' GLU . 36.8 mt -99.33 -46.57 5.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.924 . . . . 0.0 109.429 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.5 90.62 2.58 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.596 ' HG2' ' CD1' ' A' ' 45' ' ' TRP . 1.4 tt0 -76.55 117.67 18.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.4 -0.812 . . . . 0.0 109.965 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.407 ' HB2' HD21 ' B' ' 186' ' ' LEU . 5.1 m80 -87.34 -98.8 0.08 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.336 -0.853 . . . . 0.0 109.074 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.07 -7.52 0.11 Allowed Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.328 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.565 ' HB2' ' HD3' ' B' ' 183' ' ' PRO . 3.0 mp0 -149.43 -29.52 0.25 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.957 -1.32 . . . . 0.0 110.098 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.819 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 67.7 m95 -137.7 97.32 3.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 109.328 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.596 ' CD1' ' HG2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -88.42 146.64 25.12 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.976 -1.078 . . . . 0.0 110.147 -179.718 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.572 ' HG3' ' CD1' ' A' ' 57' ' ' PHE . 0.7 OUTLIER -93.15 107.07 18.94 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -104.75 -173.39 2.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.211 -0.931 . . . . 0.0 110.045 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.606 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -125.73 129.27 49.16 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.57 -0.706 . . . . 0.0 109.664 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.62 ' HB2' ' HB3' ' A' ' 54' ' ' LYS . 1.2 t -74.07 128.08 34.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.0 109.882 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.63 -8.88 57.49 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 51' ' ' LEU . 15.3 tp -53.08 -55.11 26.39 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.41 -0.806 . . . . 0.0 109.329 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.596 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.8 t -161.24 29.61 0.14 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.094 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.596 ' CB ' ' O ' ' A' ' 52' ' ' THR . 3.9 mttm 86.59 45.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.356 -0.84 . . . . 0.0 110.607 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.62 ' HB3' ' HB2' ' A' ' 49' ' ' SER . 8.1 tttt -85.79 132.67 34.07 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.496 ' OE2' HD11 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -122.52 116.7 24.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.939 -1.101 . . . . 0.0 109.412 -179.696 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.636 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -157.62 169.09 34.44 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 119.459 -1.353 . . . . 0.0 109.972 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.855 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 6.3 m-85 -72.65 133.76 44.79 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.72 -0.871 . . . . 0.0 109.874 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.45 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 6.5 pt -121.97 143.6 39.13 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.754 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 50.1 Cg_endo -71.41 152.0 60.13 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 121.778 1.652 . . . . 0.0 112.176 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.477 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 28.1 t -80.32 6.26 12.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.314 -0.866 . . . . 0.0 110.81 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.99 -52.51 2.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.795 -1.19 . . . . 0.0 110.709 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.62 ' HE2' HD23 ' B' ' 179' ' ' LEU . 3.9 m-85 -50.04 -62.59 1.49 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.043 -1.036 . . . . 0.0 110.9 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.581 HG11 ' CE ' ' A' ' 35' ' ' MET . 3.1 m -79.14 155.31 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 121.925 0.869 . . . . 0.0 111.086 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 1.044 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -130.76 159.56 36.94 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.037 -1.04 . . . . 0.0 109.57 -179.916 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 0.642 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 121.757 0.789 . . . . 0.0 109.778 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.819 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 40.2 Cg_endo -69.13 -172.15 0.48 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.268 2.645 . . . . 0.0 111.652 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 181' ' ' PRO . . . . . 0.686 ' O ' ' CB ' ' B' ' 182' ' ' ARG . 53.3 Cg_endo -88.54 -40.96 0.05 OUTLIER 'Trans proline' 0 C--O 1.214 -0.721 0 C-N-CA 122.679 2.253 . . . . 0.0 114.025 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.79 ' NH1' ' CE1' ' A' ' 23' ' ' HIS . 2.7 ttm180 91.49 92.92 0.03 OUTLIER Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.299 -0.875 . . . . 0.0 109.39 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.565 ' HD3' ' HB2' ' A' ' 43' ' ' GLU . 48.8 Cg_endo -71.99 133.99 22.59 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.996 2.464 . . . . 0.0 112.144 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 184' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 36.66 69.81 0.19 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.49 -0.757 . . . . 0.0 109.725 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 185' ' ' ASN . . . . . 0.453 ' C ' ' O ' ' B' ' 184' ' ' ALA . 2.9 p-10 39.46 45.42 1.27 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.417 -0.802 . . . . 0.0 109.44 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 186' ' ' LEU . . . . . 0.597 ' CG ' ' HB2' ' A' ' 44' ' ' TRP . 18.1 tp -53.82 -89.0 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.458 -0.776 . . . . 0.0 109.046 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 187' ' ' GLY . . . . . 0.855 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.488 2.128 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.7 tp -107.9 137.87 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.142 -0.974 . . . . 0.0 109.59 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 65' ' ' LYS . 1.5 m -132.0 161.76 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.0 p -120.94 139.18 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.024 -1.047 . . . . 0.0 109.279 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.53 134.55 46.57 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.395 -0.816 . . . . 0.0 109.731 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.712 ' CD1' ' HB2' ' A' ' 64' ' ' ALA . 19.2 mt -99.41 -21.72 15.86 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.68 ' CE1' ' HB2' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -148.68 152.55 37.93 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.439 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.697 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 39.8 Cg_endo -62.92 149.63 90.93 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 121.931 1.754 . . . . 0.0 110.185 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.811 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 55.9 t80 -98.84 179.13 4.75 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.153 -1.419 . . . . 0.0 110.432 -177.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.69 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 57.7 m-20 -110.84 79.86 1.25 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.682 -0.636 . . . . 0.0 109.356 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.8 95.15 0.04 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 20' ' ' ASP . 15.2 mm -108.42 -41.97 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -1.13 . . . . 0.0 108.893 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.415 ' CE1' ' NH1' ' B' ' 182' ' ' ARG . 36.2 m80 -77.56 158.88 78.15 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.53 -14.17 36.39 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.284 1.989 . . . . 0.0 111.869 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.0 -13.51 13.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.0 110.416 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.66 138.08 55.76 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.821 -1.174 . . . . 0.0 109.809 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.929 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -95.53 121.22 36.99 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.875 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.874 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.1 m -79.99 141.3 36.08 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.355 -0.84 . . . . 0.0 109.475 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.811 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 28.3 p90 -145.84 157.54 43.91 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.201 -0.937 . . . . 0.0 108.588 178.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.665 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 40.6 mttm -110.65 173.82 6.15 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.087 -1.008 . . . . 0.0 109.585 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.506 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -67.52 151.54 47.19 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.111 -0.993 . . . . 0.0 109.314 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.87 -8.09 4.83 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -75.43 140.46 42.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.928 -1.336 . . . . 0.0 109.788 -179.676 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -93.54 138.66 31.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.862 . . . . 0.0 109.263 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.629 ' CE ' HG11 ' A' ' 63' ' ' VAL . 1.9 mpp? -135.24 151.66 50.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.622 -0.674 . . . . 0.0 109.796 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.739 ' HD3' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -106.16 124.61 49.85 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.469 -0.769 . . . . 0.0 109.62 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.628 HG11 ' HG3' ' A' ' 40' ' ' GLU . 1.4 t -82.21 132.32 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.34 -0.85 . . . . 0.0 108.846 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.739 HD23 ' HD3' ' A' ' 36' ' ' LYS . 3.7 mt -110.37 -42.51 4.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.006 -1.059 . . . . 0.0 109.849 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -138.8 84.47 2.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.178 -0.951 . . . . 0.0 109.215 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.628 ' HG3' HG11 ' A' ' 37' ' ' VAL . 1.4 tt0 -67.96 116.14 8.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.861 . . . . 0.0 109.274 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.746 ' HB2' HD21 ' B' ' 186' ' ' LEU . 60.0 m80 -86.04 -103.32 0.06 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.235 -0.916 . . . . 0.0 109.398 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.425 ' O ' ' HG3' ' A' ' 43' ' ' GLU . . . -136.4 -15.39 0.88 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.304 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.582 ' CG ' ' HD2' ' B' ' 181' ' ' PRO . 1.3 mt-10 -158.0 -20.24 0.08 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.944 -1.327 . . . . 0.0 110.525 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.939 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 57.1 m95 -133.51 93.81 3.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.919 -1.113 . . . . 0.0 108.676 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.63 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -85.85 146.57 26.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.074 -1.016 . . . . 0.0 110.796 -178.52 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 1.1 ttpt -94.21 105.85 17.83 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.41 -174.05 2.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.32 -0.862 . . . . 0.0 110.125 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.9 mttp -125.72 126.85 45.29 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.542 -0.724 . . . . 0.0 109.496 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.601 ' HB2' ' HB3' ' A' ' 54' ' ' LYS . 1.8 t -70.94 125.62 27.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.136 -0.978 . . . . 0.0 109.875 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.75 -8.69 54.09 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.656 HD13 ' O ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -53.4 -55.27 26.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.508 -0.745 . . . . 0.0 109.352 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.633 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 1.5 t -161.16 30.11 0.14 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.267 -0.896 . . . . 0.0 110.186 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.633 ' HB2' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 85.58 45.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.499 -0.751 . . . . 0.0 110.651 178.547 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -86.8 132.18 33.91 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.122 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 1.4 pt-20 -121.82 117.56 26.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.89 -1.131 . . . . 0.0 109.455 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.642 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -157.67 168.67 34.38 Favored Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.346 -1.407 . . . . 0.0 110.158 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.75 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 15.5 m-85 -73.54 134.33 43.78 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.686 -0.89 . . . . 0.0 109.954 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.463 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 4.1 pt -122.37 141.16 34.09 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.59 ' HG3' ' CD2' ' B' ' 179' ' ' LEU . 53.4 Cg_endo -72.48 134.43 22.48 Favored 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 121.673 1.582 . . . . 0.0 111.997 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.623 ' HB3' ' CE2' ' A' ' 45' ' ' TRP . 24.3 p -65.2 4.69 0.45 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 110.422 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.67 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 5.9 p-10 -102.01 -51.64 3.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.871 -1.143 . . . . 0.0 110.86 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 1.182 ' CE2' HD21 ' B' ' 179' ' ' LEU . 3.1 m-85 -55.27 -59.99 4.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.142 -0.974 . . . . 0.0 111.304 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.629 HG11 ' CE ' ' A' ' 35' ' ' MET . 4.2 m -78.74 157.61 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 122.054 0.931 . . . . 0.0 111.41 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.712 ' HB2' ' CD1' ' A' ' 16' ' ' LEU . . . -135.63 161.88 34.29 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.509 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.454 0 O-C-N 121.046 -1.033 . . . . 0.0 109.265 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 1.182 HD21 ' CE2' ' A' ' 62' ' ' TYR . 46.2 mt . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 121.527 0.68 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.939 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 39.6 Cg_endo -68.79 176.32 6.16 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.755 2.303 . . . . 0.0 111.648 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 181' ' ' PRO . . . . . 0.61 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 55.5 Cg_endo -86.82 -26.85 0.82 Allowed 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.885 2.39 . . . . 0.0 114.51 -177.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.727 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.0 OUTLIER 79.41 95.67 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 120.818 -1.176 . . . . 0.0 109.458 -179.213 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.752 ' CG ' HD22 ' B' ' 186' ' ' LEU . 48.0 Cg_endo -69.68 131.19 20.83 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 123.064 2.509 . . . . 0.0 112.269 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 184' ' ' ALA . . . . . 0.506 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 35.64 69.13 0.19 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.448 -0.782 . . . . 0.0 109.874 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 185' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' B' ' 184' ' ' ALA . 0.2 OUTLIER 43.34 45.33 5.13 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.377 -0.827 . . . . 0.0 109.537 -179.824 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 186' ' ' LEU . . . . . 0.753 HD23 ' HB2' ' A' ' 44' ' ' TRP . 28.4 tp -55.7 -94.96 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 187' ' ' GLY . . . . . 0.75 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.484 1.874 0 N-CA-C 107.859 -2.097 . . . . 0.0 107.859 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 36.0 mm -102.86 133.93 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.195 -0.941 . . . . 0.0 109.366 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 1.001 HG12 ' HA ' ' A' ' 65' ' ' LYS . 1.0 OUTLIER -132.36 159.57 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.508 -0.745 . . . . 0.0 109.171 -179.424 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 p -119.45 135.51 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.878 -1.139 . . . . 0.0 108.95 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.612 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -70.21 131.62 44.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.409 -0.807 . . . . 0.0 110.594 -178.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.024 HD11 ' HB2' ' A' ' 64' ' ' ALA . 95.2 mt -98.79 -39.31 8.69 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.461 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 16.4 m-85 -122.33 139.28 30.44 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -63.0 150.61 88.15 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.625 2.217 . . . . 0.0 113.015 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.786 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 25.1 t80 -130.25 115.97 17.72 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.417 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.5 OUTLIER -94.72 119.11 32.8 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 116.294 -2.162 . . . . 0.0 108.922 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -41.92 99.19 0.01 OUTLIER Glycine 0 N--CA 1.487 2.077 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 20' ' ' ASP . 12.9 mm -88.64 -54.03 8.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.608 ' CG ' ' HD3' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -66.39 -171.02 0.07 OUTLIER Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.608 ' HD3' ' CG ' ' A' ' 23' ' ' HIS . 52.2 Cg_endo -92.26 -13.48 1.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.54 2.16 . . . . 0.0 112.333 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -117.8 -11.14 10.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 0.0 110.779 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.488 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 99.5 m-20 -57.64 140.4 51.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.001 -1.062 . . . . 0.0 110.413 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.01 HD22 ' N ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -97.64 126.43 42.94 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.928 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . 1.01 ' N ' HD22 ' A' ' 27' ' ' LEU . 9.4 m -81.62 138.02 35.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.149 -0.969 . . . . 0.0 110.693 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.786 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 18.5 p90 -145.84 156.66 43.71 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -112.09 163.19 14.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.015 -1.053 . . . . 0.0 109.618 -179.368 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.41 151.6 12.87 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.218 -0.926 . . . . 0.0 108.99 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.49 -8.42 3.07 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 3.2 tm-20 -73.66 144.41 45.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.93 -1.336 . . . . 0.0 109.997 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.712 ' HB2' HD12 ' A' ' 50' ' ' LEU . 4.0 mtmp? -96.03 135.98 37.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.91 . . . . 0.0 109.336 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.583 ' CE ' HG11 ' A' ' 63' ' ' VAL . 1.4 mpp? -134.52 150.67 50.8 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.518 -0.739 . . . . 0.0 110.02 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 13.0 tttt -105.74 117.52 34.24 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.529 -0.732 . . . . 0.0 109.182 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.677 HG23 HG22 ' A' ' 13' ' ' VAL . 2.5 t -76.92 132.42 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.386 -0.821 . . . . 0.0 109.185 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 98.2 mt -103.47 -50.53 3.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.722 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -140.89 103.94 4.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 108.913 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.653 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.2 tm-20 -87.54 119.22 27.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.459 -0.776 . . . . 0.0 109.784 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.704 ' HB2' HD21 ' B' ' 186' ' ' LEU . 4.0 m80 -83.85 -98.39 0.05 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.379 -0.826 . . . . 0.0 109.206 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.483 ' O ' ' HG2' ' A' ' 43' ' ' GLU . . . -138.98 -13.1 0.71 Allowed Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.654 -1.26 . . . . 0.0 110.318 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' B' ' 180' ' ' PRO . 12.0 mt-10 -153.24 -16.43 0.15 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.918 -1.343 . . . . 0.0 110.412 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.784 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 65.3 m95 -140.21 100.1 3.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.939 -1.101 . . . . 0.0 109.53 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.662 ' CZ2' ' CB ' ' A' ' 60' ' ' SER . 0.1 OUTLIER -92.51 144.41 25.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.135 -0.978 . . . . 0.0 109.809 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -85.66 108.92 18.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.267 -0.895 . . . . 0.0 108.642 179.234 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.51 -177.87 3.5 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.264 -0.897 . . . . 0.0 110.01 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 8.5 mtpt -125.0 132.02 53.32 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.586 -0.697 . . . . 0.0 109.608 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.629 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 4.4 t -79.87 129.1 34.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.927 . . . . 0.0 109.717 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.712 HD12 ' HB2' ' A' ' 34' ' ' LYS . 19.6 mt -74.14 -5.24 40.56 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.7 tp -55.91 -54.76 40.77 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.334 -0.854 . . . . 0.0 109.132 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.624 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -160.4 27.56 0.16 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.33 -0.857 . . . . 0.0 110.04 179.323 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.624 ' HB2' ' O ' ' A' ' 52' ' ' THR . 5.0 mtpm? 87.2 43.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.586 -0.696 . . . . 0.0 110.805 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.629 ' HB2' ' CB ' ' A' ' 49' ' ' SER . 3.0 mmtp -85.27 132.57 34.24 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -122.63 116.54 23.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.955 -1.091 . . . . 0.0 109.424 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.649 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -152.67 170.62 31.8 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.67 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 5.1 m-85 -73.0 132.05 42.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.449 -1.03 . . . . 0.0 109.52 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.536 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 7.2 pt -121.14 140.17 30.64 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 108.965 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.675 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 49.3 Cg_endo -68.87 153.38 72.87 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.42 2.08 . . . . 0.0 112.022 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.662 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 77.4 p -85.61 6.55 26.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 109.948 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.574 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 3.4 p-10 -105.95 -47.58 3.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.145 -0.972 . . . . 0.0 110.158 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.783 ' CE2' HD23 ' B' ' 179' ' ' LEU . 10.4 m-30 -56.76 -59.97 4.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.495 -0.753 . . . . 0.0 110.956 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 15' ' ' ALA . 3.1 m -80.11 163.28 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 111.296 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 1.024 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -137.24 130.59 31.16 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 1.001 ' HA ' HG12 ' A' ' 13' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.154 -0.966 . . . . 0.0 109.849 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 0.783 HD23 ' CE2' ' A' ' 62' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 121.456 0.646 . . . . 0.0 109.258 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.784 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.4 Cg_endo -67.36 -175.84 0.75 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.872 2.382 . . . . 0.0 111.797 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 181' ' ' PRO . . . . . 0.738 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 53.5 Cg_endo -91.88 -22.58 0.48 Allowed 'Trans proline' 0 C--O 1.213 -0.775 0 C-N-CA 123.062 2.508 . . . . 0.0 114.709 -177.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.738 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 20.7 mtt180 77.0 93.07 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.892 -1.13 . . . . 0.0 109.063 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 47.0 Cg_endo -68.38 130.89 22.0 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.666 2.244 . . . . 0.0 111.848 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 184' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 43.53 61.82 2.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.367 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 47.18 50.27 14.4 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.267 -0.895 . . . . 0.0 109.274 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 186' ' ' LEU . . . . . 0.704 HD21 ' HB2' ' A' ' 41' ' ' HIS . 49.9 tp -68.51 -83.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.412 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 187' ' ' GLY . . . . . 0.67 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.486 1.977 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.439 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.403 HD12 ' HG3' ' A' ' 36' ' ' LYS . 2.6 tp -106.3 142.13 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.233 -0.917 . . . . 0.0 109.648 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.5 m -132.33 162.46 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.443 -0.786 . . . . 0.0 109.175 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 9.7 p -121.78 138.64 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.123 -0.985 . . . . 0.0 109.209 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.2 136.85 48.26 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.469 -0.769 . . . . 0.0 109.829 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.649 HD11 ' HB2' ' A' ' 64' ' ' ALA . 55.6 mt -98.97 -25.46 14.57 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.619 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 23.1 m-85 -144.66 154.85 56.46 Favored Pre-proline 0 N--CA 1.486 1.373 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.704 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 41.5 Cg_endo -63.99 149.36 90.7 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 121.941 1.761 . . . . 0.0 110.192 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.844 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 58.8 t80 -99.65 178.38 4.87 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 118.01 -1.476 . . . . 0.0 110.552 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.679 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -110.63 80.0 1.26 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.655 -0.653 . . . . 0.0 109.377 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.27 95.26 0.03 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.701 -1.759 . . . . 0.0 108.701 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.417 ' N ' ' O ' ' A' ' 20' ' ' ASP . 28.9 mt -109.89 -40.2 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.14 -1.212 . . . . 0.0 109.167 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -80.18 158.91 71.53 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.88 -14.95 39.84 Favored 'Trans proline' 0 C--O 1.216 -0.586 0 C-N-CA 122.314 2.009 . . . . 0.0 112.159 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -110.61 -11.46 14.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.022 -1.049 . . . . 0.0 110.488 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -59.95 143.2 52.25 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.857 -1.152 . . . . 0.0 109.655 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.948 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -102.42 122.92 45.25 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.78 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.913 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -77.35 138.94 39.62 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 109.568 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.844 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 19.8 p90 -143.66 155.4 44.23 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 108.542 178.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.654 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 1.8 ptpt -110.15 173.16 6.45 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.204 -0.935 . . . . 0.0 109.486 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.512 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -66.34 152.48 44.92 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.198 -0.939 . . . . 0.0 109.304 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.47 -7.76 3.49 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.5 OUTLIER -74.95 143.67 43.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.843 -1.386 . . . . 0.0 109.564 -179.677 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -96.42 138.83 33.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.901 . . . . 0.0 109.556 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.544 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 2.1 mpp? -134.86 151.58 51.03 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.594 -0.691 . . . . 0.0 109.657 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.592 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 2.6 tttt -104.99 128.82 53.45 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.406 -0.809 . . . . 0.0 109.179 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.492 ' O ' HD12 ' A' ' 38' ' ' LEU . 1.7 t -81.58 135.11 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.416 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 37' ' ' VAL . 6.8 mp -113.43 -41.13 3.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.313 -0.867 . . . . 0.0 109.513 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -149.91 88.38 1.53 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 109.233 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.628 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -74.76 114.49 13.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.378 -0.826 . . . . 0.0 109.438 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.812 ' HB2' HD21 ' B' ' 186' ' ' LEU . 3.2 m-70 -80.6 -101.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.518 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.411 ' C ' ' CD ' ' A' ' 43' ' ' GLU . . . -127.28 -14.91 2.59 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.048 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.571 ' CG ' ' HD3' ' B' ' 183' ' ' PRO . 0.0 OUTLIER -165.8 -10.87 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.022 -1.281 . . . . 0.0 110.3 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.84 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 71.2 m95 -131.1 89.2 2.7 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.859 -1.151 . . . . 0.0 108.701 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.628 ' CD1' ' CG ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -83.7 140.97 31.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.798 -1.189 . . . . 0.0 110.312 -179.064 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 4.3 tttt -91.42 103.54 16.16 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.592 ' HB1' ' O ' ' A' ' 36' ' ' LYS . . . -101.92 -177.21 3.35 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.351 -0.843 . . . . 0.0 110.336 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.489 ' HE2' HD21 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -123.72 109.5 13.77 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.855 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.614 ' OG ' ' CB ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -57.45 129.53 42.25 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.807 -179.606 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.436 ' O ' ' N ' ' A' ' 52' ' ' THR . 0.3 OUTLIER -76.88 -8.61 57.67 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.318 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.474 ' O ' ' HB ' ' A' ' 52' ' ' THR . 55.5 tp -46.55 -22.68 0.3 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.738 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER 169.42 -21.94 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.38 -0.825 . . . . 0.0 110.115 178.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.738 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.1 OUTLIER 140.33 39.23 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.47 -0.769 . . . . 0.0 110.105 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.646 ' HB3' HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -87.86 135.24 33.48 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.871 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -122.43 127.82 50.14 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.914 -1.117 . . . . 0.0 109.274 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.691 ' HA3' ' CB ' ' A' ' 27' ' ' LEU . . . -166.93 168.81 40.51 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.235 -1.46 . . . . 0.0 110.41 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.717 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 14.2 m-85 -71.62 132.89 45.26 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.754 -0.851 . . . . 0.0 109.898 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.513 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 8.1 pt -123.18 129.48 24.92 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.668 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 56.2 Cg_endo -75.1 126.49 9.94 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 121.634 1.556 . . . . 0.0 112.591 -178.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.612 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 32.2 t -55.28 -10.85 0.64 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.522 -0.736 . . . . 0.0 109.997 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.487 ' HB3' ' HD3' ' B' ' 180' ' ' PRO . 8.0 t-20 -88.35 0.81 55.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.034 -1.041 . . . . 0.0 110.383 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.619 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -117.08 -41.34 3.02 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.864 -1.148 . . . . 0.0 110.045 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.544 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.5 m -96.62 159.09 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.104 -0.997 . . . . 0.0 110.567 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.649 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -136.87 161.89 34.77 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.087 -1.008 . . . . 0.0 109.4 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 0.643 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.711 0.767 . . . . 0.0 109.598 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.84 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.5 Cg_endo -68.79 -176.57 1.26 Allowed 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 123.031 2.487 . . . . 0.0 111.647 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 181' ' ' PRO . . . . . 0.719 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.6 Cg_endo -89.82 -26.75 0.38 Allowed 'Trans proline' 0 C--O 1.213 -0.739 0 C-N-CA 122.886 2.391 . . . . 0.0 114.937 -177.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.719 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 39.4 mtt180 78.14 91.56 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 120.879 -1.138 . . . . 0.0 109.13 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.59 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 50.2 Cg_endo -70.0 135.59 30.27 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.689 2.26 . . . . 0.0 111.787 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 184' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 42.38 55.38 4.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.884 . . . . 0.0 109.5 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 51.68 50.54 18.52 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.26 -0.9 . . . . 0.0 109.281 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 186' ' ' LEU . . . . . 0.812 HD21 ' HB2' ' A' ' 41' ' ' HIS . 60.9 tp -70.48 -81.88 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.362 -0.836 . . . . 0.0 109.418 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 187' ' ' GLY . . . . . 0.717 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.485 1.948 0 N-CA-C 108.924 -1.671 . . . . 0.0 108.924 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.7 mm -107.98 136.8 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.099 -1.0 . . . . 0.0 109.594 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.496 HG22 HG12 ' A' ' 37' ' ' VAL . 1.0 OUTLIER -131.34 160.68 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.505 -0.747 . . . . 0.0 109.036 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 p -120.66 139.23 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.054 -1.029 . . . . 0.0 109.372 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.86 133.3 45.37 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.379 -0.826 . . . . 0.0 109.744 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.983 HD11 ' CB ' ' A' ' 64' ' ' ALA . 23.4 mt -99.13 -17.25 18.28 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.672 ' HA ' ' CG ' ' A' ' 31' ' ' LYS . 7.2 m-85 -152.62 151.61 27.21 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.731 ' HD3' ' HG3' ' A' ' 31' ' ' LYS . 40.7 Cg_endo -61.53 148.93 91.8 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 121.53 1.487 . . . . 0.0 109.655 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.828 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 36.6 t80 -89.29 -34.3 16.63 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 117.947 -1.501 . . . . 0.0 110.224 -177.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.756 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 30.3 t70 106.84 -53.52 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.26 93.31 0.2 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.423 ' H ' HD12 ' A' ' 22' ' ' ILE . 0.5 OUTLIER -109.42 -42.96 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.385 -1.067 . . . . 0.0 108.433 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.513 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 1.9 m80 -74.74 153.35 87.22 Favored Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.79 -9.69 26.71 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.075 1.85 . . . . 0.0 111.417 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.8 -17.4 11.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.368 -0.833 . . . . 0.0 110.545 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.513 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.5 OUTLIER -57.18 141.28 46.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.856 -1.152 . . . . 0.0 109.956 -178.838 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.951 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -90.03 119.14 30.12 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.867 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.879 ' N ' HD22 ' A' ' 27' ' ' LEU . 93.9 p -77.08 138.51 39.59 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.333 -0.855 . . . . 0.0 109.734 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.828 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 17.6 p90 -143.68 155.56 44.26 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.238 -0.914 . . . . 0.0 108.772 178.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.692 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -112.36 175.47 5.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.242 -0.911 . . . . 0.0 109.434 -179.356 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.731 ' HG3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -66.13 155.8 35.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.95 -1.093 . . . . 0.0 109.423 179.576 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 66.01 -6.94 1.32 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.418 ' H ' ' C ' ' A' ' 31' ' ' LYS . 0.5 OUTLIER -74.79 141.31 44.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.839 -1.389 . . . . 0.0 109.687 -179.602 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -94.87 136.97 34.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.324 -0.86 . . . . 0.0 109.415 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.587 ' CE ' HG11 ' A' ' 63' ' ' VAL . 1.1 mpp? -137.23 153.1 50.45 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.421 0.629 . . . . 0.0 109.758 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.635 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 13.7 tttm -110.31 123.67 50.24 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.472 -0.768 . . . . 0.0 109.26 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.57 HG21 ' CD ' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -88.71 115.66 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.696 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -82.88 -41.09 19.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.196 -0.94 . . . . 0.0 110.038 -179.365 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.54 126.02 11.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.147 -0.971 . . . . 0.0 109.505 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.64 ' HG2' ' CD2' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -95.19 131.44 41.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.451 -0.78 . . . . 0.0 109.406 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.791 ' HB2' HD21 ' B' ' 186' ' ' LEU . 49.7 m80 -98.72 -122.84 0.14 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.266 -0.896 . . . . 0.0 108.997 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.23 -28.96 21.28 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.574 ' CB ' ' HD2' ' B' ' 181' ' ' PRO . 2.1 tp10 -172.44 5.28 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.039 -1.271 . . . . 0.0 110.672 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 1.025 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 64.4 m95 -136.26 97.29 3.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.834 -1.166 . . . . 0.0 108.372 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.64 ' CD2' ' HG2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -93.23 145.89 24.1 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.921 -1.112 . . . . 0.0 110.337 -178.868 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -84.97 107.98 17.36 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.914 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.635 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -99.9 -179.62 4.22 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.363 -0.835 . . . . 0.0 109.909 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -122.76 129.97 52.36 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.62 -0.675 . . . . 0.0 109.493 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.574 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -76.75 126.79 31.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.75 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.64 -9.49 58.32 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.8 tp -52.11 -54.8 26.05 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.511 -0.743 . . . . 0.0 109.368 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.621 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.2 t -161.54 28.72 0.13 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.229 -0.92 . . . . 0.0 110.146 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.621 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.5 OUTLIER 87.09 44.33 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.47 -0.769 . . . . 0.0 110.715 178.726 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -85.46 132.64 34.18 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.077 -1.015 . . . . 0.0 108.337 178.517 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -122.4 114.75 21.17 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.859 -1.151 . . . . 0.0 109.483 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.627 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -152.22 171.84 31.49 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.666 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 8.1 m-85 -75.27 132.41 41.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.351 -1.088 . . . . 0.0 109.689 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.509 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 9.2 pt -121.93 137.42 27.3 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 108.605 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.603 ' HB2' ' CD ' ' B' ' 180' ' ' PRO . 50.9 Cg_endo -74.1 137.62 24.18 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.975 1.783 . . . . 0.0 112.763 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.578 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 28.3 t -67.93 4.3 1.23 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.583 -0.698 . . . . 0.0 110.317 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.569 ' HB3' ' HD3' ' B' ' 180' ' ' PRO . 0.5 OUTLIER -100.91 -55.34 2.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.022 -1.049 . . . . 0.0 110.063 -179.391 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 1.183 ' CE2' HD21 ' B' ' 179' ' ' LEU . 2.4 m-85 -51.81 -60.87 2.67 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.261 -0.899 . . . . 0.0 110.872 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.587 HG11 ' CE ' ' A' ' 35' ' ' MET . 4.0 m -78.61 154.8 4.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 122.004 0.906 . . . . 0.0 111.182 -177.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.983 ' CB ' HD11 ' A' ' 16' ' ' LEU . . . -130.07 159.55 36.4 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.481 ' HA ' HG12 ' A' ' 13' ' ' VAL . 2.1 ttpm? . . . . . 0 N--CA 1.49 1.527 0 O-C-N 120.974 -1.078 . . . . 0.0 109.552 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 1.183 HD21 ' CE2' ' A' ' 62' ' ' TYR . 33.4 mt . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.45 0.643 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 1.025 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 39.1 Cg_endo -70.56 176.12 7.81 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.483 2.122 . . . . 0.0 111.638 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 181' ' ' PRO . . . . . 0.578 ' O ' ' CB ' ' B' ' 182' ' ' ARG . 55.7 Cg_endo -76.47 -42.63 0.34 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.823 2.349 . . . . 0.0 113.916 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.659 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.0 OUTLIER 78.94 81.44 0.1 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.039 -1.038 . . . . 0.0 108.49 -178.583 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.485 ' O ' ' C ' ' B' ' 184' ' ' ALA . 51.5 Cg_endo -72.95 146.21 41.48 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.939 2.426 . . . . 0.0 112.33 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 184' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 36.35 61.93 0.76 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.607 -0.683 . . . . 0.0 109.616 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 185' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' B' ' 184' ' ' ALA . 1.1 m-20 42.95 46.2 4.6 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.308 -0.87 . . . . 0.0 109.05 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 186' ' ' LEU . . . . . 0.791 HD21 ' HB2' ' A' ' 41' ' ' HIS . 68.0 tp -61.85 -86.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.435 -0.79 . . . . 0.0 109.447 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 187' ' ' GLY . . . . . 0.666 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.486 1.999 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.475 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.498 ' CD1' ' HG3' ' A' ' 36' ' ' LYS . 1.0 OUTLIER -101.43 137.79 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.884 . . . . 0.0 109.407 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.493 HG11 ' HZ3' ' A' ' 45' ' ' TRP . 0.8 OUTLIER -130.99 159.93 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.6 p -120.55 138.46 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.981 -1.074 . . . . 0.0 109.482 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -72.29 134.58 45.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.465 -0.772 . . . . 0.0 110.111 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.038 HD11 ' HB2' ' A' ' 64' ' ' ALA . 16.5 mt -99.26 -17.81 17.91 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.593 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 43.1 m-85 -152.55 153.87 31.02 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.689 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.6 Cg_endo -63.66 149.64 90.4 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 121.812 1.675 . . . . 0.0 110.042 179.14 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.823 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 65.7 t80 -97.58 179.14 4.95 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 118.219 -1.392 . . . . 0.0 110.224 -177.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.67 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 9.8 p-10 -110.15 80.93 1.36 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.569 -0.707 . . . . 0.0 109.313 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.5 91.92 0.03 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.577 HD12 ' OD2' ' A' ' 20' ' ' ASP . 67.1 mt -106.67 -43.17 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.265 -1.138 . . . . 0.0 108.765 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.59 ' CE1' ' NH2' ' B' ' 182' ' ' ARG . 41.1 m80 -75.86 156.14 84.59 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.01 -13.27 36.23 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.225 1.95 . . . . 0.0 111.799 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -111.86 -13.99 13.59 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.24 -0.913 . . . . 0.0 110.363 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.74 141.83 47.4 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.825 -1.172 . . . . 0.0 109.798 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.93 HD22 ' N ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -98.64 124.06 43.2 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.93 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -81.08 140.26 35.2 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.322 -0.861 . . . . 0.0 109.81 -179.704 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.823 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 28.2 p90 -145.79 157.97 43.89 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.654 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 10.5 mtmm -111.27 174.03 6.06 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.047 -1.033 . . . . 0.0 109.557 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.553 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -67.38 151.9 46.64 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.186 -0.946 . . . . 0.0 109.314 179.803 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.39 -7.94 4.42 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 3.8 tt0 -75.55 143.43 42.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.917 -1.343 . . . . 0.0 109.838 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -96.3 138.18 34.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 0.0 109.273 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.623 ' CE ' HG11 ' A' ' 63' ' ' VAL . 1.7 mpp? -135.97 151.82 50.32 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.628 -0.67 . . . . 0.0 109.932 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 7.7 ttpt -109.02 122.37 47.11 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -89.93 119.0 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.296 -0.877 . . . . 0.0 108.758 178.832 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.732 HD12 ' O ' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -89.01 -40.79 12.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.159 -0.963 . . . . 0.0 110.191 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.28 119.42 15.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.049 -1.032 . . . . 0.0 109.268 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.636 ' HG3' ' CG ' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -99.35 122.17 42.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.823 . . . . 0.0 109.453 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.633 ' HB2' HD21 ' B' ' 186' ' ' LEU . 5.2 m-70 -90.25 -103.86 0.1 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.957 . . . . 0.0 109.116 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.69 -14.06 1.55 Allowed Glycine 0 N--CA 1.489 2.174 0 C-N-CA 119.548 -1.31 . . . . 0.0 110.177 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.593 ' CG ' ' HD2' ' B' ' 181' ' ' PRO . 0.3 OUTLIER -158.77 -15.1 0.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.963 -1.316 . . . . 0.0 110.972 -179.506 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.843 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 62.7 m95 -138.92 99.52 3.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.725 -1.234 . . . . 0.0 109.608 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.671 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -93.18 142.98 26.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.881 -1.137 . . . . 0.0 109.511 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.732 ' O ' HD12 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -85.91 109.11 18.51 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.29 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -101.3 -174.62 2.65 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.333 -0.855 . . . . 0.0 109.818 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -126.97 129.39 48.05 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.478 -0.764 . . . . 0.0 109.298 -179.729 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.589 ' HB2' ' HB2' ' A' ' 54' ' ' LYS . 7.6 t -74.9 126.75 31.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.064 -1.023 . . . . 0.0 109.795 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.3 -7.43 46.96 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.151 -0.968 . . . . 0.0 108.521 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.67 -55.6 27.96 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.374 -0.829 . . . . 0.0 109.227 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.634 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.1 t -160.62 27.51 0.15 Allowed 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.136 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.634 ' CB ' ' O ' ' A' ' 52' ' ' THR . 5.1 mmtt 87.83 45.17 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.495 -0.753 . . . . 0.0 110.898 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.589 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 0.1 OUTLIER -87.0 130.67 34.36 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 177.752 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 10.1 pt-20 -120.31 117.87 28.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.79 -1.194 . . . . 0.0 109.508 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.656 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -154.77 179.12 31.09 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.742 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 9.3 m-85 -80.07 132.56 35.99 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.454 -1.027 . . . . 0.0 109.954 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.484 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 8.8 pt -120.27 136.61 25.26 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.693 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 55.3 Cg_endo -73.95 135.16 20.8 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 121.827 1.685 . . . . 0.0 112.536 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.598 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 23.1 t -65.97 5.24 0.52 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.512 -0.743 . . . . 0.0 110.565 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.552 ' CG ' ' N ' ' A' ' 62' ' ' TYR . 1.2 p-10 -101.21 -51.81 3.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.765 -1.209 . . . . 0.0 110.458 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.686 ' CE2' HD23 ' B' ' 179' ' ' LEU . 4.8 m-85 -57.06 -59.01 5.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.117 -0.989 . . . . 0.0 110.947 -178.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.623 HG11 ' CE ' ' A' ' 35' ' ' MET . 3.1 m -79.79 156.8 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.988 0.899 . . . . 0.0 111.272 -177.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 1.038 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -131.54 159.47 38.08 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.437 ' HA ' HG12 ' A' ' 13' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 O-C-N 120.933 -1.105 . . . . 0.0 109.568 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 0.686 HD23 ' CE2' ' A' ' 62' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 121.687 0.756 . . . . 0.0 109.568 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.843 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.1 Cg_endo -68.68 178.51 3.84 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.903 2.402 . . . . 0.0 111.531 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 181' ' ' PRO . . . . . 0.727 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.3 Cg_endo -88.21 -21.59 1.54 Allowed 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 122.982 2.455 . . . . 0.0 114.411 -177.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.727 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 24.6 mtt180 76.34 91.25 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.956 -1.09 . . . . 0.0 108.974 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' B' ' 186' ' ' LEU . 50.9 Cg_endo -70.68 136.42 30.54 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.84 2.36 . . . . 0.0 112.017 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 184' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 41.0 63.73 1.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.834 . . . . 0.0 109.492 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 185' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' B' ' 184' ' ' ALA . 0.0 OUTLIER 44.73 48.86 8.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.205 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 186' ' ' LEU . . . . . 0.633 HD21 ' HB2' ' A' ' 41' ' ' HIS . 42.6 tp -67.77 -87.15 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.441 -0.787 . . . . 0.0 109.413 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 187' ' ' GLY . . . . . 0.742 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.487 2.034 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 34.4 mm -111.8 136.79 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.119 -0.988 . . . . 0.0 109.729 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.497 HG12 ' HA ' ' A' ' 65' ' ' LYS . 1.3 m -133.09 162.92 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -118.65 139.17 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.84 -1.162 . . . . 0.0 109.069 179.176 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.707 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -72.09 95.42 1.63 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.44 -0.788 . . . . 0.0 110.695 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.024 HD11 ' CB ' ' A' ' 64' ' ' ALA . 37.3 mt -60.99 -34.08 74.24 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.602 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 29.1 m-85 -134.1 152.95 79.3 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.501 ' HB3' ' HA ' ' A' ' 30' ' ' LYS . 50.8 Cg_endo -70.27 150.9 65.79 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 122.409 2.073 . . . . 0.0 111.677 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.92 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 60.6 t80 -114.44 105.62 13.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.979 -1.075 . . . . 0.0 109.756 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 19' ' ' TYR . 40.3 m-20 -27.49 -37.75 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 19' ' ' TYR . . . 66.74 96.3 0.03 OUTLIER Glycine 0 N--CA 1.496 2.664 0 N-CA-C 106.206 -2.758 . . . . 0.0 106.206 -175.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.6 mt -115.04 -38.18 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.447 -1.031 . . . . 0.0 109.809 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.477 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 0.9 OUTLIER -77.41 151.76 80.87 Favored Pre-proline 0 C--N 1.298 -1.64 0 O-C-N 121.346 -0.846 . . . . 0.0 108.753 179.663 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.34 -10.17 26.55 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.211 1.941 . . . . 0.0 110.774 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -114.9 -17.22 11.59 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.459 -0.776 . . . . 0.0 110.279 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.477 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -57.51 139.24 53.89 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.888 -1.133 . . . . 0.0 109.91 -178.756 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.948 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -88.19 115.06 25.41 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.841 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.758 ' N ' HD22 ' A' ' 27' ' ' LEU . 84.6 p -76.3 141.22 41.69 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.369 -0.832 . . . . 0.0 109.404 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.92 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 24.6 p90 -145.81 156.74 43.77 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.31 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.581 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -110.21 174.52 5.82 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.198 -0.939 . . . . 0.0 109.321 -179.704 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -67.4 151.09 48.03 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.093 -1.004 . . . . 0.0 109.315 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 71.38 -7.4 6.4 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -74.77 143.42 44.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.965 -1.314 . . . . 0.0 109.68 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -97.52 139.48 33.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.749 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.658 ' HE3' HG11 ' A' ' 63' ' ' VAL . 3.9 mtm -135.89 152.44 51.02 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.588 0.709 . . . . 0.0 109.744 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.608 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 17.2 ttmt -104.81 125.75 51.18 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 11' ' ' ASP . 2.7 t -75.72 132.18 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.192 -0.943 . . . . 0.0 109.431 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 46' ' ' LYS . 12.3 mt -110.94 -48.54 3.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.199 -0.938 . . . . 0.0 109.649 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 1.8 pt-20 -143.27 91.94 2.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.161 -0.962 . . . . 0.0 109.051 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.588 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 0.8 OUTLIER -78.68 114.89 18.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.697 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.626 ' HB2' HD21 ' B' ' 186' ' ' LEU . 4.2 m-70 -82.47 -101.71 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.372 -0.83 . . . . 0.0 109.113 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -136.33 -12.87 1.05 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.555 ' HB2' ' HD3' ' B' ' 183' ' ' PRO . 0.8 OUTLIER -153.15 -19.76 0.15 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.026 -1.279 . . . . 0.0 110.544 -179.668 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.873 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 66.8 m95 -137.43 99.93 4.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.868 -1.145 . . . . 0.0 109.395 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.623 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -88.22 146.97 25.08 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.133 -0.979 . . . . 0.0 109.851 -179.879 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -93.81 105.67 17.69 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.171 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.79 -177.96 3.52 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.298 -0.876 . . . . 0.0 110.281 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.631 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -123.73 128.07 49.07 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.644 -0.66 . . . . 0.0 109.684 -179.49 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.597 ' HB2' ' HB3' ' A' ' 54' ' ' LYS . 1.1 t -74.45 126.95 31.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.124 -0.985 . . . . 0.0 109.884 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 50' ' ' LEU . 32.9 mt -72.23 -7.43 49.26 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.5 tp -53.58 -54.92 30.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.529 -0.732 . . . . 0.0 109.287 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.596 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 2.6 t -161.08 29.08 0.14 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.278 -0.889 . . . . 0.0 109.955 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 52' ' ' THR . 12.6 mttm 86.93 45.46 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.552 -0.718 . . . . 0.0 110.585 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.631 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 3.6 tttm -85.17 132.29 34.31 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -123.22 117.01 24.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.929 -1.107 . . . . 0.0 109.17 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.661 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -159.27 166.03 34.55 Favored Glycine 0 N--CA 1.486 1.988 0 C-N-CA 118.966 -1.588 . . . . 0.0 110.55 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.782 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 8.1 m-85 -71.97 134.1 45.74 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.752 -0.852 . . . . 0.0 109.714 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.593 HD12 HG21 ' A' ' 63' ' ' VAL . 13.7 pt -123.29 144.53 43.96 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.304 -0.873 . . . . 0.0 108.841 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.632 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 43.2 Cg_endo -67.54 142.92 60.8 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.915 1.743 . . . . 0.0 111.597 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.525 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 32.4 p -74.67 6.05 4.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.189 -0.944 . . . . 0.0 110.737 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.42 ' OD1' ' C ' ' A' ' 61' ' ' ASN . 0.1 OUTLIER -108.41 -51.72 2.86 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.808 -1.183 . . . . 0.0 110.484 -179.208 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.602 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 5.8 m-30 -49.68 -61.26 2.22 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.19 -0.944 . . . . 0.0 111.271 -178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.707 HG12 ' HA ' ' A' ' 15' ' ' ALA . 13.3 m -78.32 156.32 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.096 -1.002 . . . . 0.0 111.321 -177.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 1.024 ' CB ' HD11 ' A' ' 16' ' ' LEU . . . -135.74 163.5 30.03 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.497 ' HA ' HG12 ' A' ' 13' ' ' VAL . 3.7 ptpt . . . . . 0 N--CA 1.488 1.469 0 O-C-N 120.977 -1.077 . . . . 0.0 109.373 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 0.604 HD22 ' HE1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.682 0.753 . . . . 0.0 109.519 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.873 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.3 Cg_endo -69.14 -175.29 0.96 Allowed 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.944 2.429 . . . . 0.0 111.568 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 181' ' ' PRO . . . . . 0.756 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.1 Cg_endo -90.36 -29.75 0.17 Allowed 'Trans proline' 0 C--O 1.213 -0.742 0 C-N-CA 122.928 2.419 . . . . 0.0 114.471 -177.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.756 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 51.1 mtt180 81.97 95.34 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.227 -0.921 . . . . 0.0 109.212 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.62 ' CG ' HD22 ' B' ' 186' ' ' LEU . 43.6 Cg_endo -67.41 128.41 18.24 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.852 2.368 . . . . 0.0 111.806 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 184' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 42.47 66.87 0.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.182 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 185' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' B' ' 184' ' ' ALA . 0.6 OUTLIER 43.08 43.91 3.96 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.368 -0.833 . . . . 0.0 109.137 -179.465 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 186' ' ' LEU . . . . . 0.626 HD21 ' HB2' ' A' ' 41' ' ' HIS . 59.9 tp -55.67 -93.81 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 187' ' ' GLY . . . . . 0.782 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.483 1.767 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.501 ' O ' HG23 ' A' ' 37' ' ' VAL . 3.3 m-20 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.564 HD12 ' HG3' ' A' ' 36' ' ' LYS . 35.0 mm -105.27 136.09 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.927 . . . . 0.0 109.655 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.529 HG22 ' CG2' ' A' ' 37' ' ' VAL . 1.5 m -132.64 161.79 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 p -120.09 137.75 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.982 -1.074 . . . . 0.0 109.071 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.605 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -69.22 131.77 45.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.395 -0.816 . . . . 0.0 109.976 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.062 HD11 ' CB ' ' A' ' 64' ' ' ALA . 62.5 mt -97.77 -30.21 12.92 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.619 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 47.7 m-85 -131.74 143.32 48.63 Favored Pre-proline 0 N--CA 1.486 1.373 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.8 Cg_endo -62.34 149.39 90.94 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.692 2.261 . . . . 0.0 112.699 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.824 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 21.6 t80 -129.29 113.3 14.83 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -98.2 118.0 33.85 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 116.75 -1.98 . . . . 0.0 108.546 179.434 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -40.44 90.25 0.01 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.593 HG22 ' O ' ' A' ' 22' ' ' ILE . 2.4 mp -82.49 0.11 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 121.142 -1.211 . . . . 0.0 107.815 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.549 ' HB3' ' CD ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -121.66 -172.55 0.24 Allowed Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.372 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.549 ' CD ' ' HB3' ' A' ' 23' ' ' HIS . 52.0 Cg_endo -90.86 -17.89 1.22 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.218 1.945 . . . . 0.0 112.602 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -117.53 -12.09 10.4 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.389 -0.819 . . . . 0.0 111.09 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.48 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 9.5 m-20 -58.52 142.56 48.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.927 -1.108 . . . . 0.0 110.708 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.018 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -98.93 122.68 42.5 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.887 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.959 ' N ' HD22 ' A' ' 27' ' ' LEU . 15.9 m -76.92 137.53 39.15 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -0.925 . . . . 0.0 110.655 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.824 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 30.5 p90 -143.75 154.74 43.77 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.555 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -111.54 166.04 11.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.979 -1.076 . . . . 0.0 109.656 -179.35 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.23 151.37 15.88 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.248 -0.907 . . . . 0.0 108.792 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.17 -7.69 3.18 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 9.0 tt0 -73.47 144.41 46.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.931 -1.335 . . . . 0.0 109.798 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.891 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -98.13 139.07 34.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 0.0 109.894 -179.708 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.608 ' SD ' HG21 ' A' ' 58' ' ' ILE . 4.6 mtm -134.89 151.08 50.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.578 -0.701 . . . . 0.0 109.662 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -103.05 121.05 41.77 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.504 -0.748 . . . . 0.0 109.252 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.529 ' CG2' HG22 ' A' ' 13' ' ' VAL . 1.8 t -82.7 124.1 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.369 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.2 mt -99.4 -44.88 6.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.137 -0.977 . . . . 0.0 109.608 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -148.25 97.22 2.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.891 . . . . 0.0 109.157 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.637 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -78.72 122.76 26.41 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.38 -0.825 . . . . 0.0 109.618 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.696 ' HB2' HD21 ' B' ' 186' ' ' LEU . 61.9 m80 -83.01 -101.77 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.342 -0.849 . . . . 0.0 109.223 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.34 -16.28 1.37 Allowed Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.366 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.581 ' CG ' ' HD2' ' B' ' 181' ' ' PRO . 0.0 OUTLIER -158.43 -16.99 0.07 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.913 -1.345 . . . . 0.0 110.755 -179.531 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 1.019 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 64.3 m95 -132.74 94.86 3.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.942 -1.099 . . . . 0.0 108.601 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.637 ' CD1' ' CG ' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -88.47 147.55 24.61 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.028 -1.045 . . . . 0.0 110.096 -179.114 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.7 OUTLIER -94.46 107.39 19.36 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.601 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -105.41 -175.41 2.79 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.273 -0.892 . . . . 0.0 110.23 -179.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -126.18 130.98 52.06 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.667 -0.645 . . . . 0.0 109.905 -179.207 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.64 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -77.06 128.34 34.29 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.157 -0.964 . . . . 0.0 109.698 179.476 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.891 HD12 ' O ' ' A' ' 34' ' ' LYS . 1.2 mp -73.95 -7.21 51.52 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 49.2 tp -53.89 -54.46 38.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.399 -0.813 . . . . 0.0 109.32 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 2.8 t -160.88 29.16 0.15 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.267 -0.896 . . . . 0.0 110.036 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.587 ' CB ' ' O ' ' A' ' 52' ' ' THR . 17.4 mttp 85.91 42.98 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.528 -0.733 . . . . 0.0 110.879 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.681 ' HB3' HD23 ' A' ' 27' ' ' LEU . 7.4 mmtt -85.41 133.0 34.13 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -123.36 120.8 34.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.976 -1.078 . . . . 0.0 109.332 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.666 ' HA3' ' CB ' ' A' ' 27' ' ' LEU . . . -159.72 166.11 34.81 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.27 -1.443 . . . . 0.0 110.133 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.732 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 9.2 m-85 -70.19 133.3 46.94 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.64 -0.918 . . . . 0.0 109.437 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.608 HG21 ' SD ' ' A' ' 35' ' ' MET . 6.1 pt -121.97 136.68 26.46 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.311 -0.868 . . . . 0.0 108.717 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.6 ' HG3' ' CD2' ' B' ' 179' ' ' LEU . 50.0 Cg_endo -69.39 138.62 39.44 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.269 1.98 . . . . 0.0 112.325 -178.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.55 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 23.6 t -71.46 0.97 7.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 110.202 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.681 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 6.5 p-10 -95.45 -49.66 5.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.964 -1.085 . . . . 0.0 110.233 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 1.174 ' CE2' HD21 ' B' ' 179' ' ' LEU . 11.6 m-30 -61.11 -56.94 15.0 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.337 -0.852 . . . . 0.0 111.211 -178.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 15' ' ' ALA . 3.7 m -79.19 157.29 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 122.175 0.988 . . . . 0.0 111.443 -177.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 1.062 ' CB ' HD11 ' A' ' 16' ' ' LEU . . . -138.05 163.0 32.69 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.519 ' HA ' HG12 ' A' ' 13' ' ' VAL . 19.0 ttmm . . . . . 0 N--CA 1.489 1.488 0 O-C-N 121.036 -1.04 . . . . 0.0 109.17 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 1.174 HD21 ' CE2' ' A' ' 62' ' ' TYR . 25.0 mt . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 121.494 0.664 . . . . 0.0 109.689 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 1.019 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.1 Cg_endo -66.29 170.94 11.14 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.508 2.139 . . . . 0.0 111.254 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 181' ' ' PRO . . . . . 0.592 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 56.1 Cg_endo -79.05 -34.29 1.22 Allowed 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 122.903 2.402 . . . . 0.0 114.154 -177.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.711 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.1 OUTLIER 78.27 84.26 0.09 OUTLIER Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 120.982 -1.074 . . . . 0.0 108.711 -178.865 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 51.1 Cg_endo -71.65 139.27 33.68 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.791 2.328 . . . . 0.0 112.125 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 184' ' ' ALA . . . . . 0.483 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 38.6 62.23 1.06 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.504 -0.747 . . . . 0.0 109.582 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 185' ' ' ASN . . . . . 0.409 ' C ' ' O ' ' B' ' 184' ' ' ALA . 0.8 OUTLIER 44.68 48.58 8.78 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.273 -0.892 . . . . 0.0 109.157 -179.699 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 186' ' ' LEU . . . . . 0.696 HD21 ' HB2' ' A' ' 41' ' ' HIS . 56.2 tp -64.92 -83.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.413 -0.804 . . . . 0.0 109.352 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 187' ' ' GLY . . . . . 0.732 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.485 1.948 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.544 ' O ' HG13 ' A' ' 37' ' ' VAL . 73.4 m-20 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 19.9 mm -92.4 137.23 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.565 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.605 HG22 HG12 ' A' ' 37' ' ' VAL . 2.1 m -131.44 160.2 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.459 -0.776 . . . . 0.0 109.097 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.2 p -121.64 138.43 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 109.346 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.708 ' HB2' ' HE3' ' A' ' 35' ' ' MET . . . -70.04 132.03 45.25 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.26 -0.9 . . . . 0.0 109.747 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.075 HD11 ' CB ' ' A' ' 64' ' ' ALA . 28.3 mt -98.03 -13.61 20.97 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.57 ' CD1' ' O ' ' A' ' 16' ' ' LEU . 56.2 m-85 -155.46 152.7 25.16 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.579 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 42.6 Cg_endo -66.04 149.42 85.98 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 121.554 1.502 . . . . 0.0 109.589 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.866 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 20.6 t80 -102.34 -175.85 2.94 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.176 -1.41 . . . . 0.0 110.535 -178.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.735 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 31.2 m-20 -112.99 85.92 2.27 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.572 -0.705 . . . . 0.0 110.065 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.19 92.03 0.05 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.519 -1.832 . . . . 0.0 108.519 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.751 HD11 ' NH2' ' B' ' 182' ' ' ARG . 0.4 OUTLIER -107.75 -42.94 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.262 -1.14 . . . . 0.0 108.767 179.604 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.572 ' CE1' ' NH2' ' B' ' 182' ' ' ARG . 56.3 m80 -76.09 156.93 83.81 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.4 -13.23 35.23 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.156 1.904 . . . . 0.0 111.859 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -112.65 -13.78 13.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 110.462 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.468 ' OD2' ' OH ' ' A' ' 19' ' ' TYR . 43.2 m-20 -57.39 138.9 54.41 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.764 -1.21 . . . . 0.0 109.793 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.943 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -94.95 121.99 37.14 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.868 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.9 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.1 m -78.77 139.25 38.44 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.153 -0.967 . . . . 0.0 109.598 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.866 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 17.5 p90 -146.87 158.1 43.83 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.242 -0.911 . . . . 0.0 108.918 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.659 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 21.4 mtmm -111.79 174.33 5.93 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.138 -0.976 . . . . 0.0 109.41 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.512 ' HD3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -66.73 153.02 44.32 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.12 -0.988 . . . . 0.0 109.305 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.27 -7.96 4.27 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 15' ' ' ALA . 3.4 tt0 -74.53 144.03 44.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.918 -1.342 . . . . 0.0 109.615 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.484 ' HD3' HD13 ' A' ' 50' ' ' LEU . 2.6 ptpt -96.67 136.12 37.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.517 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.708 ' HE3' ' HB2' ' A' ' 15' ' ' ALA . 1.7 mpp? -137.85 153.69 49.57 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.415 0.626 . . . . 0.0 109.528 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.68 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 2.2 ttpt -110.87 125.42 53.61 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.377 -0.827 . . . . 0.0 109.004 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.605 HG12 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -87.65 128.43 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.9 . . . . 0.0 108.753 178.953 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 26.1 mt -88.58 -29.7 19.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 109.945 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -176.99 130.99 0.18 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.147 -0.971 . . . . 0.0 109.834 -179.444 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.654 ' HA ' ' CD1' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -78.53 132.44 37.2 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.441 -0.787 . . . . 0.0 109.162 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.656 ' CB ' HD11 ' B' ' 186' ' ' LEU . 18.7 m-70 -111.57 30.78 6.66 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.223 -0.923 . . . . 0.0 110.543 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.416 ' N ' ' OE2' ' A' ' 40' ' ' GLU . . . 108.73 -47.25 1.06 Allowed Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.516 -1.325 . . . . 0.0 110.744 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.444 ' HB2' ' HD3' ' B' ' 183' ' ' PRO . 0.0 OUTLIER -159.2 -5.9 0.07 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.023 -1.281 . . . . 0.0 110.388 -179.571 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.783 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 65.4 m95 -141.68 99.87 3.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.038 -1.039 . . . . 0.0 109.276 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.679 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -94.68 148.66 22.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.031 -1.043 . . . . 0.0 109.454 -179.621 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 17.7 tttt -88.56 109.11 19.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.256 -0.903 . . . . 0.0 108.973 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.68 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -100.97 178.6 4.62 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.449 -0.782 . . . . 0.0 109.863 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 2.7 mttt -121.1 129.78 53.45 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.647 -0.658 . . . . 0.0 109.588 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.609 ' HB2' ' HB3' ' A' ' 54' ' ' LYS . 1.1 t -77.6 128.41 34.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 110.056 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.484 HD13 ' HD3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -72.92 -9.25 58.5 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.911 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 tp -52.32 -54.92 25.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.407 -0.808 . . . . 0.0 109.383 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.611 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 2.6 t -161.5 29.35 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 110.041 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.611 ' CB ' ' O ' ' A' ' 52' ' ' THR . 8.7 mmtm 86.68 44.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.502 -0.749 . . . . 0.0 110.488 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.609 ' HB3' ' HB2' ' A' ' 49' ' ' SER . 0.5 OUTLIER -85.0 133.25 34.26 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.183 -0.948 . . . . 0.0 108.488 178.61 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.93 114.34 20.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.923 -1.111 . . . . 0.0 109.215 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.618 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -152.57 169.21 31.69 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.366 -1.397 . . . . 0.0 109.89 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.711 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 7.7 m-85 -73.4 132.0 42.49 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.546 -0.973 . . . . 0.0 109.57 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 58' ' ' ILE . 11.0 pt -121.96 140.98 33.13 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.875 . . . . 0.0 109.069 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.597 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 49.2 Cg_endo -69.54 149.42 68.25 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.176 1.918 . . . . 0.0 112.094 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.523 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 21.2 t -77.57 7.78 5.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.328 -0.857 . . . . 0.0 110.656 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.74 -51.8 2.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.824 -1.173 . . . . 0.0 110.672 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.7 ' CE2' ' HA ' ' A' ' 19' ' ' TYR . 2.6 m-30 -48.96 -52.16 26.32 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.105 -0.997 . . . . 0.0 110.83 -178.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.561 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.7 m -88.91 155.52 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -0.972 . . . . 0.0 111.19 -178.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 1.075 ' CB ' HD11 ' A' ' 16' ' ' LEU . . . -134.09 162.38 32.25 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.505 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 3.2 ptmt . . . . . 0 N--CA 1.49 1.545 0 O-C-N 120.954 -1.091 . . . . 0.0 109.344 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 0.628 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 121.685 0.755 . . . . 0.0 109.802 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.783 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.4 Cg_endo -68.96 -172.3 0.48 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.068 2.512 . . . . 0.0 111.326 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 181' ' ' PRO . . . . . 0.804 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 52.7 Cg_endo -91.48 -35.17 0.06 OUTLIER 'Trans proline' 0 C--O 1.212 -0.783 0 C-N-CA 122.788 2.325 . . . . 0.0 114.694 -177.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.804 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 32.4 mtt180 87.83 96.27 0.03 OUTLIER Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.314 -0.866 . . . . 0.0 109.013 -178.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 47.4 Cg_endo -68.78 124.56 11.62 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.76 2.306 . . . . 0.0 111.904 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 184' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' B' ' 185' ' ' ASN . . . 45.69 67.4 0.74 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.862 . . . . 0.0 109.495 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 185' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' B' ' 184' ' ' ALA . 14.9 m-20 43.08 50.5 5.5 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.354 -0.841 . . . . 0.0 109.535 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 186' ' ' LEU . . . . . 0.656 HD11 ' CB ' ' A' ' 41' ' ' HIS . 47.7 tp -67.6 -83.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.296 -0.877 . . . . 0.0 109.507 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 187' ' ' GLY . . . . . 0.711 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.485 1.953 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.709 HD12 ' HA ' ' A' ' 36' ' ' LYS . 5.2 tp -109.61 136.64 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.183 -0.948 . . . . 0.0 109.46 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.0 m -131.77 160.2 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.35 -0.844 . . . . 0.0 109.186 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' HG3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -119.64 138.7 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.068 -1.02 . . . . 0.0 109.302 179.121 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.768 ' HB2' ' HE3' ' A' ' 35' ' ' MET . . . -72.14 133.67 45.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.451 -0.781 . . . . 0.0 109.946 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.053 HD11 ' HB2' ' A' ' 64' ' ' ALA . 7.6 mt -99.79 -8.31 24.35 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.59 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 27.6 m-85 -162.29 151.94 13.49 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.771 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 39.2 Cg_endo -62.19 149.16 91.58 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 121.733 1.622 . . . . 0.0 110.05 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.848 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 57.0 t80 -98.63 178.23 5.06 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 118.364 -1.335 . . . . 0.0 110.764 -177.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.68 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 6.4 m-20 -109.22 79.95 1.27 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.47 94.44 0.04 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.409 ' N ' ' O ' ' A' ' 20' ' ' ASP . 21.2 mt -107.17 -42.93 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.108 -1.231 . . . . 0.0 108.803 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.53 ' ND1' ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -76.04 152.69 84.47 Favored Pre-proline 0 C--N 1.3 -1.563 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.53 ' HD2' ' ND1' ' A' ' 23' ' ' HIS . 43.9 Cg_endo -66.68 -11.42 31.8 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.299 1.999 . . . . 0.0 111.567 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.87 -14.68 13.49 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.89 . . . . 0.0 110.215 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' B' ' 187' ' ' GLY . 26.4 m-20 -58.07 142.17 47.73 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.883 -1.135 . . . . 0.0 109.784 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.908 HD22 ' N ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -98.55 122.21 41.46 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.945 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.908 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -78.03 139.77 39.12 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.327 -0.858 . . . . 0.0 109.449 179.669 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.848 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 24.3 p90 -145.29 156.74 44.0 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.232 -0.917 . . . . 0.0 108.74 178.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.691 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 3.2 tttp -111.18 174.28 5.94 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.172 -0.955 . . . . 0.0 109.539 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.584 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -67.37 151.85 46.72 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.108 -0.995 . . . . 0.0 109.346 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.96 -7.65 4.15 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -74.79 141.89 44.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.04 -1.271 . . . . 0.0 109.611 -179.735 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.634 ' HG3' HG13 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -95.86 138.61 33.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.89 . . . . 0.0 109.298 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.768 ' HE3' ' HB2' ' A' ' 15' ' ' ALA . 3.7 mpp? -133.2 149.63 52.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.53 -0.731 . . . . 0.0 109.88 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.709 ' HA ' HD12 ' A' ' 12' ' ' ILE . 12.2 mtpt -104.78 119.77 39.8 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.463 -0.773 . . . . 0.0 109.256 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -78.05 109.43 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.342 -0.849 . . . . 0.0 108.887 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 mt -88.15 -40.22 13.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.905 . . . . 0.0 109.991 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -134.99 97.47 3.75 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.032 -1.043 . . . . 0.0 109.158 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.7 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 0.7 OUTLIER -79.89 113.62 18.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.245 -0.91 . . . . 0.0 109.298 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -106.33 -121.1 0.23 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.499 ' HA3' ' HG3' ' B' ' 183' ' ' PRO . . . -85.5 -124.58 1.43 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' B' ' 180' ' ' PRO . 7.0 mt-10 -78.46 10.33 3.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -1.104 . . . . 0.0 111.102 -178.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.866 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 64.6 m95 -141.1 98.1 3.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.528 -1.357 . . . . 0.0 109.824 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.7 ' HB3' ' HA ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -92.97 145.24 24.52 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.826 -1.171 . . . . 0.0 110.197 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -85.77 108.06 17.91 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.754 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -100.54 -177.16 3.41 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.264 -0.898 . . . . 0.0 109.97 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -123.94 109.03 13.06 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.648 -0.658 . . . . 0.0 109.394 -179.663 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.617 ' N ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -54.77 127.84 30.18 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.167 -0.958 . . . . 0.0 109.861 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 52' ' ' THR . 0.1 OUTLIER -76.76 -11.46 59.84 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.222 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.512 ' C ' HG22 ' A' ' 52' ' ' THR . 4.5 tp -46.06 -20.9 0.11 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.722 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 0.5 OUTLIER 168.1 -21.72 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.371 -0.831 . . . . 0.0 109.935 179.123 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.722 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 140.84 42.48 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.528 -0.733 . . . . 0.0 110.046 179.595 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.683 ' HB3' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -85.67 134.36 33.98 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.131 -0.98 . . . . 0.0 108.424 178.4 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -121.67 114.16 20.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.909 -1.12 . . . . 0.0 109.439 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.625 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -152.49 172.46 31.65 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.677 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 6.8 m-85 -74.49 132.17 41.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.431 -1.04 . . . . 0.0 109.859 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.551 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 7.3 pt -121.42 138.24 27.97 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.667 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 48.6 Cg_endo -69.93 163.06 39.81 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 121.64 1.56 . . . . 0.0 112.01 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.564 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 82.8 p -90.89 8.25 35.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.389 -0.819 . . . . 0.0 110.095 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.91 -54.9 2.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.028 -1.045 . . . . 0.0 110.109 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.747 ' HE2' HD23 ' B' ' 179' ' ' LEU . 2.3 m-85 -47.24 -63.56 1.01 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.201 -0.937 . . . . 0.0 110.648 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.608 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.5 m -78.73 155.77 4.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.945 0.878 . . . . 0.0 110.96 -177.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 1.053 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -128.46 157.66 40.5 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp . . . . . 0 C--N 1.301 -1.525 0 O-C-N 120.948 -1.095 . . . . 0.0 109.583 -179.674 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 0.747 HD23 ' HE2' ' A' ' 62' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 121.597 0.713 . . . . 0.0 109.481 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.866 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 37.9 Cg_endo -67.24 -174.65 0.54 Allowed 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.922 2.415 . . . . 0.0 111.648 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 181' ' ' PRO . . . . . 0.751 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.8 Cg_endo -92.62 -23.69 0.33 Allowed 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 123.022 2.482 . . . . 0.0 114.617 -177.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.751 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 27.6 mtt180 76.47 96.73 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.876 -1.14 . . . . 0.0 109.048 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 45.3 Cg_endo -67.0 107.24 1.29 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.6 2.2 . . . . 0.0 111.408 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 184' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' B' ' 185' ' ' ASN . . . 60.65 68.56 0.74 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.306 -0.871 . . . . 0.0 108.864 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 185' ' ' ASN . . . . . 0.458 ' C ' ' O ' ' B' ' 184' ' ' ALA . 2.9 p30 41.15 49.18 3.14 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.46 -0.775 . . . . 0.0 109.468 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 186' ' ' LEU . . . . . 0.619 HD23 ' HB2' ' A' ' 44' ' ' TRP . 64.5 tp -68.67 -75.33 0.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.357 -0.84 . . . . 0.0 109.278 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 187' ' ' GLY . . . . . 0.677 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.484 1.838 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.558 ' O ' HG23 ' A' ' 37' ' ' VAL . 79.9 m-20 . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.679 HD11 ' HG3' ' A' ' 36' ' ' LYS . 24.2 mm -101.82 136.39 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.134 -0.979 . . . . 0.0 109.553 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.07 160.69 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.8 p -121.24 137.15 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.001 -1.062 . . . . 0.0 109.341 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -70.44 135.21 48.5 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.414 -0.804 . . . . 0.0 109.886 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.03 HD11 ' HB2' ' A' ' 64' ' ' ALA . 18.1 mt -97.73 -28.36 13.92 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.666 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 4.3 m-85 -141.27 155.79 67.78 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 39.7 Cg_endo -62.13 145.39 96.41 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 121.692 1.594 . . . . 0.0 110.73 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.72 ' O ' ' CB ' ' A' ' 20' ' ' ASP . 23.7 t80 -70.36 -76.45 0.1 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.448 -0.782 . . . . 0.0 112.102 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.72 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 6.0 m-20 127.03 72.46 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -178.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.57 82.77 0.01 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.189 -1.165 . . . . 0.0 110.189 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.55 ' N ' ' O ' ' A' ' 20' ' ' ASP . 9.4 mm -99.56 0.96 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.979 -1.306 . . . . 0.0 108.226 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.498 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -122.64 152.6 62.14 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.753 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.25 -14.49 34.6 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.838 1.692 . . . . 0.0 111.986 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.73 -19.11 11.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.401 -0.812 . . . . 0.0 110.875 -178.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.498 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.8 OUTLIER -55.72 139.34 45.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.872 -1.142 . . . . 0.0 110.103 -178.773 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.967 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -87.79 117.32 26.55 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.315 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.887 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.8 m -76.87 138.7 39.93 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.331 -0.856 . . . . 0.0 110.216 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.705 ' CE2' ' HB2' ' A' ' 19' ' ' TYR . 10.6 p90 -143.38 154.77 44.07 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.683 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.8 OUTLIER -111.18 171.28 7.57 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.006 -1.058 . . . . 0.0 109.652 -179.291 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -63.15 152.19 38.04 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.201 -0.937 . . . . 0.0 109.081 179.792 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 68.02 -7.59 2.32 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.4 ' H ' ' C ' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -74.15 143.4 45.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.827 -1.396 . . . . 0.0 110.009 -179.461 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HE2' ' HB2' ' A' ' 34' ' ' LYS . 3.9 mppt? -95.22 137.14 34.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.34 -0.85 . . . . 0.0 109.457 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.571 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -136.13 151.88 50.24 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.611 -0.68 . . . . 0.0 109.813 -179.448 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.679 ' HG3' HD11 ' A' ' 12' ' ' ILE . 4.5 ttmt -109.87 126.79 54.21 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.455 -0.778 . . . . 0.0 109.776 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 11' ' ' ASP . 1.4 t -82.68 138.28 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.386 -0.821 . . . . 0.0 108.942 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.604 HD12 ' N ' ' A' ' 38' ' ' LEU . 6.3 mp -112.54 -31.0 6.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.07 -1.019 . . . . 0.0 109.927 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.03 96.08 1.2 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.184 -0.948 . . . . 0.0 109.303 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.579 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 1.0 OUTLIER -49.93 130.52 21.9 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.477 -0.764 . . . . 0.0 108.993 179.646 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.921 ' HB3' HD21 ' B' ' 186' ' ' LEU . 1.8 m-70 -128.51 102.12 6.48 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.486 ' C ' ' O ' ' A' ' 41' ' ' HIS . . . 41.18 -142.37 0.93 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.616 ' CB ' ' HD2' ' B' ' 181' ' ' PRO . 4.7 mt-10 -77.1 11.04 1.99 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -1.137 . . . . 0.0 110.707 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 1.053 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 64.5 m95 -137.4 100.36 4.21 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.668 -1.27 . . . . 0.0 109.67 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.58 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -94.44 149.27 21.41 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.817 -1.177 . . . . 0.0 110.215 -179.616 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -95.52 110.96 22.96 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.112 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -107.33 -175.3 2.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.177 -0.952 . . . . 0.0 110.297 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 9.9 ttpt -125.14 130.75 52.83 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.646 -0.659 . . . . 0.0 109.595 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.626 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -76.35 128.21 34.4 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 109.735 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.48 -6.11 46.46 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.8 tp -55.9 -54.73 41.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.455 -0.778 . . . . 0.0 109.259 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.606 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 1.3 t -160.45 29.68 0.16 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.143 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.606 ' HB2' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 85.25 43.03 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.466 -0.771 . . . . 0.0 111.09 178.199 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.76 ' HB3' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -86.42 132.5 33.93 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.922 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.474 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 12.9 pt-20 -122.62 118.91 29.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.937 -1.102 . . . . 0.0 109.387 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.678 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -155.6 166.57 32.85 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.013 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.745 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 7.0 m-85 -71.87 134.97 46.4 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.7 -0.883 . . . . 0.0 109.695 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.517 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 3.0 pt -124.55 144.89 47.53 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.406 -0.809 . . . . 0.0 109.148 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.613 ' HG3' ' CD2' ' B' ' 179' ' ' LEU . 47.1 Cg_endo -69.31 162.67 40.91 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 121.977 1.785 . . . . 0.0 111.393 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.531 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 98.2 p -92.13 8.98 35.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.016 -1.052 . . . . 0.0 110.894 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.575 ' OD1' ' C ' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -112.08 -51.7 2.83 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.765 -1.209 . . . . 0.0 110.153 -179.581 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 1.141 ' CE2' HD21 ' B' ' 179' ' ' LEU . 1.3 m-85 -44.66 -62.22 1.28 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.163 -0.961 . . . . 0.0 110.787 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.571 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.9 m -79.64 156.7 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 122.104 0.954 . . . . 0.0 111.486 -177.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 1.03 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -133.35 161.22 35.1 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.9 tttp . . . . . 0 N--CA 1.489 1.519 0 O-C-N 120.995 -1.066 . . . . 0.0 109.395 179.956 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 1.141 HD21 ' CE2' ' A' ' 62' ' ' TYR . 30.1 mt . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 121.443 0.639 . . . . 0.0 109.657 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 1.053 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.3 Cg_endo -65.92 177.08 3.18 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.781 2.321 . . . . 0.0 111.83 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 181' ' ' PRO . . . . . 0.617 ' O ' ' CB ' ' B' ' 182' ' ' ARG . 53.9 Cg_endo -73.65 -48.01 0.26 Allowed 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.933 2.422 . . . . 0.0 113.873 -177.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.709 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.0 OUTLIER 84.81 91.78 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.151 -0.968 . . . . 0.0 108.946 -178.724 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.692 ' HG2' ' HB2' ' B' ' 186' ' ' LEU . 43.9 Cg_endo -69.07 129.66 18.74 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 123.085 2.523 . . . . 0.0 112.326 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 184' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 38.21 67.03 0.43 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.477 -0.764 . . . . 0.0 109.464 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 185' ' ' ASN . . . . . 0.463 ' C ' ' O ' ' B' ' 184' ' ' ALA . 0.6 OUTLIER 42.93 43.47 3.56 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.357 -0.84 . . . . 0.0 109.026 -179.55 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 186' ' ' LEU . . . . . 0.98 HD23 ' HB2' ' A' ' 44' ' ' TRP . 42.4 tp -54.27 -94.54 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 187' ' ' GLY . . . . . 0.745 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 107.474 -2.25 . . . . 0.0 107.474 178.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.571 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 36' ' ' LYS . 17.6 mm -92.93 136.67 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 109.618 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.87 HG12 ' HD3' ' A' ' 65' ' ' LYS . 1.1 m -132.14 161.8 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.6 p -120.97 139.2 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.137 -0.977 . . . . 0.0 109.075 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.671 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.05 132.92 45.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.346 -0.846 . . . . 0.0 109.807 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.081 HD11 ' CB ' ' A' ' 64' ' ' ALA . 24.4 mt -98.66 -11.97 21.51 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.584 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 54.8 m-85 -159.55 153.69 19.96 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.701 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 42.0 Cg_endo -64.55 149.09 90.49 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 121.672 1.582 . . . . 0.0 109.983 179.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.816 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 56.4 t80 -97.79 178.6 5.09 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 118.303 -1.359 . . . . 0.0 110.265 -177.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.682 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 12.2 m-20 -109.47 80.66 1.34 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.56 -0.713 . . . . 0.0 109.322 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.51 95.38 0.06 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.6 mt -108.5 -42.24 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.157 -1.202 . . . . 0.0 108.896 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.48 ' HB2' ' CG ' ' A' ' 26' ' ' ASP . 3.4 m-70 -76.98 159.6 78.19 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -71.11 -12.12 29.89 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.141 1.894 . . . . 0.0 111.778 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -113.86 -14.94 12.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 110.869 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.48 ' CG ' ' HB2' ' A' ' 23' ' ' HIS . 90.7 m-20 -57.19 139.47 52.54 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.719 -1.238 . . . . 0.0 109.955 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.896 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -93.77 120.86 34.58 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.005 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.855 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -80.68 141.41 34.93 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.351 -0.843 . . . . 0.0 109.595 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.816 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 30.5 p90 -146.05 157.79 43.86 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.181 -0.949 . . . . 0.0 108.599 178.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.671 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 6.4 mttt -110.7 173.7 6.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.147 -0.97 . . . . 0.0 109.594 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.552 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -67.43 151.43 47.42 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.141 -0.975 . . . . 0.0 109.314 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.96 -8.25 4.79 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -75.84 143.63 41.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.953 -1.322 . . . . 0.0 109.755 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.31 138.95 33.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 109.509 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.576 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 2.5 mpp? -134.91 151.47 50.91 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.564 -0.71 . . . . 0.0 109.761 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 8.3 ttpp -105.15 124.13 49.0 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.507 -0.745 . . . . 0.0 109.53 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.808 ' C ' HD12 ' A' ' 38' ' ' LEU . 2.2 t -81.13 136.97 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.297 -0.877 . . . . 0.0 109.216 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.808 HD12 ' C ' ' A' ' 37' ' ' VAL . 7.1 mp -111.85 -43.36 3.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 109.648 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.05 106.35 3.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.124 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.654 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 0.7 OUTLIER -89.98 118.03 29.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.333 -0.855 . . . . 0.0 109.539 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.615 ' CG ' HD12 ' B' ' 186' ' ' LEU . 1.8 m-70 -81.83 -100.31 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.314 -0.866 . . . . 0.0 109.382 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.465 ' O ' ' HG2' ' A' ' 43' ' ' GLU . . . -133.34 -14.31 1.4 Allowed Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.664 -1.255 . . . . 0.0 110.065 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 42' ' ' GLY . 6.0 mm-40 -157.52 -16.0 0.08 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.972 -1.31 . . . . 0.0 110.623 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.94 ' CD1' ' HA ' ' B' ' 182' ' ' ARG . 56.3 m95 -137.6 101.65 4.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.673 -1.267 . . . . 0.0 109.485 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.654 ' CD1' ' CG ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -93.32 144.4 25.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.206 -0.934 . . . . 0.0 110.211 -179.313 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 11.4 ttpt -90.08 108.08 19.51 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -102.8 -175.3 2.77 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.354 -0.841 . . . . 0.0 109.931 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 17.7 ttpt -125.88 130.43 51.31 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.605 -0.684 . . . . 0.0 109.31 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.595 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 6.9 t -75.84 126.78 31.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.072 -1.017 . . . . 0.0 109.963 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 50' ' ' LEU . 14.4 mt -70.81 -7.99 49.3 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.3 tp -53.94 -55.6 25.51 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.53 -0.731 . . . . 0.0 109.445 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.629 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.7 t -161.04 28.14 0.14 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 110.119 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.629 ' CB ' ' O ' ' A' ' 52' ' ' THR . 14.1 mtmm 87.38 44.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.414 -0.804 . . . . 0.0 110.687 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.595 ' HB2' ' CB ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -86.77 131.58 34.09 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.042 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.456 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 2.5 pt-20 -122.01 118.46 28.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.879 -1.138 . . . . 0.0 109.625 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.658 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -157.66 168.36 34.32 Favored Glycine 0 N--CA 1.487 2.068 0 C-N-CA 119.427 -1.368 . . . . 0.0 109.904 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.963 ' CD1' HD21 ' B' ' 186' ' ' LEU . 27.1 m-85 -70.98 132.39 45.1 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.57 -0.959 . . . . 0.0 109.883 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 58' ' ' ILE . 6.6 pt -121.08 141.64 33.26 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.654 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 46.6 Cg_endo -69.18 154.86 69.38 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 121.721 1.614 . . . . 0.0 111.836 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.621 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 73.7 p -83.96 7.12 19.35 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.364 -0.835 . . . . 0.0 110.252 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.13 -53.28 2.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.936 -1.102 . . . . 0.0 110.515 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.584 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 2.6 m-85 -48.44 -62.72 1.35 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.075 -1.016 . . . . 0.0 111.173 -178.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.576 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 3.0 m -78.11 155.5 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 122.079 0.942 . . . . 0.0 111.18 -177.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 1.081 ' CB ' HD11 ' A' ' 16' ' ' LEU . . . -136.02 163.29 30.64 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.87 ' HD3' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.046 -1.034 . . . . 0.0 109.228 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 0.608 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 121.823 0.82 . . . . 0.0 109.875 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.717 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 42.9 Cg_endo -72.44 -170.66 0.61 Allowed 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.976 2.451 . . . . 0.0 110.211 178.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 181' ' ' PRO . . . . . 0.766 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 51.6 Cg_endo -87.06 -67.54 0.01 OUTLIER 'Trans proline' 0 C--O 1.212 -0.79 0 C-N-CA 121.991 1.794 . . . . 0.0 112.198 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.94 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.8 OUTLIER 141.05 112.78 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.078 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.581 ' HG2' ' CB ' ' B' ' 186' ' ' LEU . 44.1 Cg_endo -67.45 127.14 15.97 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 123.04 2.493 . . . . 0.0 112.087 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 184' ' ' ALA . . . . . 0.491 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 37.99 52.88 1.57 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.378 -0.826 . . . . 0.0 109.375 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 185' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' B' ' 184' ' ' ALA . 0.1 OUTLIER 46.28 44.33 12.32 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.369 -0.832 . . . . 0.0 109.104 -179.526 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 186' ' ' LEU . . . . . 1.053 HD23 ' N ' ' B' ' 187' ' ' GLY . 7.8 tt -72.8 -82.83 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.479 -0.763 . . . . 0.0 108.97 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 187' ' ' GLY . . . . . 1.053 ' N ' HD23 ' B' ' 186' ' ' LEU . . . . . . . . 0 N--CA 1.48 1.616 0 N-CA-C 108.161 -1.976 . . . . 0.0 108.161 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.63 108.36 1.57 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.41 172.78 11.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -1.136 . . . . 0.0 109.332 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.38 136.93 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.189 -0.945 . . . . 0.0 109.54 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.59 HG12 ' HA ' ' A' ' 65' ' ' LYS . 1.8 m -131.51 160.42 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.372 -0.83 . . . . 0.0 108.929 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.8 p -121.12 137.64 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.965 -1.085 . . . . 0.0 109.295 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.751 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.04 134.51 47.15 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.445 -0.785 . . . . 0.0 110.108 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.64 ' CD1' ' HB2' ' A' ' 64' ' ' ALA . 42.1 mt -98.37 -14.97 19.9 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.642 ' CD2' ' CD ' ' B' ' 177' ' ' PRO . 4.7 m-85 -157.45 155.48 27.47 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.0 Cg_endo -62.42 146.05 95.67 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.58 1.52 . . . . 0.0 110.381 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.769 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 8.8 t80 -76.34 -68.76 0.56 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.222 -0.924 . . . . 0.0 112.04 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.758 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 40.9 t0 122.79 70.94 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -177.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -54.28 94.36 0.02 OUTLIER Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 20' ' ' ASP . 0.6 OUTLIER -105.0 -44.2 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.143 -1.21 . . . . 0.0 107.822 178.552 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.493 ' CD2' ' O ' ' B' ' 188' ' ' GLU . 26.1 m80 -75.48 156.35 85.24 Favored Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.6 -11.52 26.24 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.026 1.817 . . . . 0.0 111.994 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.69 -16.14 12.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.216 -0.927 . . . . 0.0 110.813 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.473 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 18.4 m-20 -57.24 138.89 54.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.839 -1.163 . . . . 0.0 110.422 -178.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.975 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -88.96 119.04 29.13 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.901 ' N ' HD22 ' A' ' 27' ' ' LEU . 4.8 p -77.79 138.03 38.76 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.224 -0.923 . . . . 0.0 110.179 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.769 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 8.1 p90 -143.78 155.24 44.09 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.751 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 7.2 mmtp -111.74 176.76 4.89 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.027 -1.046 . . . . 0.0 109.613 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.597 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -67.52 151.01 48.1 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.08 -1.013 . . . . 0.0 109.142 179.524 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.52 -7.76 3.55 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.749 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 1.1 mt-10 -74.75 144.15 43.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.868 -1.372 . . . . 0.0 109.938 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.519 ' CG ' HD13 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -95.78 138.08 33.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.0 109.406 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.53 ' CE ' HG11 ' A' ' 63' ' ' VAL . 0.9 OUTLIER -136.19 151.95 50.26 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.596 -0.69 . . . . 0.0 109.912 -179.423 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 4.5 ttpm? -105.87 124.27 49.31 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.442 -0.786 . . . . 0.0 109.498 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.523 ' CG2' HG22 ' A' ' 13' ' ' VAL . 2.0 t -80.98 137.23 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.359 -0.838 . . . . 0.0 108.92 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.1 mt -113.85 -39.48 3.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.113 -0.992 . . . . 0.0 109.688 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -150.82 91.43 1.72 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.939 . . . . 0.0 108.924 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.596 ' HG2' ' CD1' ' A' ' 45' ' ' TRP . 1.6 tm-20 -79.35 115.39 18.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.361 -0.837 . . . . 0.0 109.795 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.718 ' HB2' HD21 ' B' ' 186' ' ' LEU . 72.3 m80 -79.08 -98.32 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.361 -0.837 . . . . 0.0 109.223 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.461 ' C ' ' HG2' ' A' ' 43' ' ' GLU . . . -143.33 -12.33 0.36 Allowed Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.664 -1.255 . . . . 0.0 110.197 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.554 ' O ' ' HG3' ' B' ' 180' ' ' PRO . 7.1 mm-40 -148.5 -25.57 0.33 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.002 -1.293 . . . . 0.0 110.171 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.779 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 64.9 m95 -135.5 102.85 5.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.947 -1.095 . . . . 0.0 109.568 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.611 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -90.8 141.66 28.57 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.075 -1.015 . . . . 0.0 109.985 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.528 ' HG2' ' C ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -90.5 106.53 18.56 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.13 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.52 -176.73 3.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.171 -0.956 . . . . 0.0 110.173 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 6.9 tttt -124.59 128.87 49.56 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.651 -0.656 . . . . 0.0 109.521 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.645 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -73.37 125.24 27.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.156 -0.965 . . . . 0.0 109.938 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.519 HD13 ' CG ' ' A' ' 34' ' ' LYS . 2.9 mp -71.22 -8.29 52.56 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 tp -53.72 -54.68 34.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.614 -0.679 . . . . 0.0 109.381 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.596 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 2.0 t -161.3 29.47 0.14 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 110.215 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.596 ' CB ' ' O ' ' A' ' 52' ' ' THR . 5.7 mtmt 86.31 44.0 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.403 -0.811 . . . . 0.0 110.585 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.645 ' HB2' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER -87.09 133.13 33.64 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.124 -0.985 . . . . 0.0 108.449 178.421 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 1.6 pt-20 -122.58 119.29 30.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.876 -1.14 . . . . 0.0 109.256 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.659 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -158.08 167.76 34.42 Favored Glycine 0 N--CA 1.487 2.092 0 C-N-CA 119.316 -1.421 . . . . 0.0 110.022 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.688 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 10.4 m-85 -73.61 133.03 43.4 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.57 -0.959 . . . . 0.0 110.009 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.516 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 4.0 pt -122.07 139.44 30.43 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.772 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 46.0 Cg_endo -68.6 145.77 65.12 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 121.878 1.719 . . . . 0.0 112.086 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.596 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 38.5 p -75.97 5.02 7.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.409 -0.807 . . . . 0.0 110.635 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.455 ' OD1' ' CG ' ' B' ' 177' ' ' PRO . 0.1 OUTLIER -105.72 -53.1 2.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.912 -1.117 . . . . 0.0 110.613 -179.186 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.622 ' CD2' ' HA ' ' A' ' 19' ' ' TYR . 4.0 m-85 -51.27 -60.73 2.8 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.116 -0.99 . . . . 0.0 110.788 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 15' ' ' ALA . 3.1 m -78.82 158.55 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 122.094 0.95 . . . . 0.0 111.302 -177.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.64 ' HB2' ' CD1' ' A' ' 16' ' ' LEU . . . -134.61 160.63 37.49 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.59 ' HA ' HG12 ' A' ' 13' ' ' VAL . 0.7 OUTLIER -74.35 150.16 40.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.916 -1.115 . . . . 0.0 109.422 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.4 tp -51.42 -27.91 11.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.43 -0.794 . . . . 0.0 110.012 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -77.29 -94.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.062 -1.024 . . . . 0.0 109.375 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.059 -1.026 . . . . 0.0 109.436 179.988 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 24.4 p90 . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 171' ' ' ASP . . . . . 0.588 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 1.4 t0 -167.25 -57.3 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.235 -0.916 . . . . 0.0 108.848 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 172' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 46.9 Cg_endo -67.51 -89.71 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.694 2.263 . . . . 0.0 111.867 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 173' ' ' GLY . . . . . . . . . . . . . . . 92.38 31.76 8.72 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.92 77.35 5.1 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.247 -1.149 . . . . 0.0 109.484 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 175' ' ' PRO . . . . . 0.5 ' O ' HG23 ' B' ' 176' ' ' THR . 50.5 Cg_endo -92.22 172.26 2.46 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.172 2.581 . . . . 0.0 111.836 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 176' ' ' THR . . . . . 0.568 ' CG2' ' HB3' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 173.47 101.09 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.346 -0.846 . . . . 0.0 109.437 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 177' ' ' PRO . . . . . 0.642 ' CD ' ' CD2' ' A' ' 17' ' ' TYR . 51.3 Cg_endo -71.89 159.2 51.11 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.668 2.246 . . . . 0.0 111.522 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 178' ' ' PRO . . . . . 0.407 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 48.0 Cg_endo -68.94 142.96 53.16 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.526 2.15 . . . . 0.0 111.242 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 0.563 HD22 ' HE1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -81.46 172.93 8.52 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.009 -1.057 . . . . 0.0 109.558 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.779 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.9 Cg_endo -70.69 -174.57 1.12 Allowed 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.902 2.401 . . . . 0.0 111.485 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 181' ' ' PRO . . . . . 0.721 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.1 Cg_endo -92.19 -23.04 0.41 Allowed 'Trans proline' 0 C--O 1.213 -0.726 0 C-N-CA 122.956 2.437 . . . . 0.0 114.347 -177.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.721 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 41.5 mtt180 78.41 95.62 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.001 -1.062 . . . . 0.0 109.197 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 42.4 Cg_endo -66.02 114.44 2.99 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.634 2.223 . . . . 0.0 111.735 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 184' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' B' ' 185' ' ' ASN . . . 56.15 50.81 12.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.423 -0.798 . . . . 0.0 109.584 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 185' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' B' ' 184' ' ' ALA . 9.5 m-80 60.26 45.82 10.94 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.155 -0.966 . . . . 0.0 109.426 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 186' ' ' LEU . . . . . 0.718 HD21 ' HB2' ' A' ' 41' ' ' HIS . 49.2 tp -65.36 -78.09 0.05 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.344 -0.848 . . . . 0.0 109.058 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 187' ' ' GLY . . . . . 0.688 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -73.08 2.01 37.49 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.564 ' CG ' ' HD2' ' B' ' 182' ' ' ARG . 16.6 mt-10 -81.2 -87.43 0.08 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.195 -1.18 . . . . 0.0 109.414 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 189' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.01 171.47 7.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.889 . . . . 0.0 109.49 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 190' ' ' GLN . . . . . 0.655 ' O ' ' HB3' ' B' ' 191' ' ' ALA . 36.9 mt-30 -66.88 99.67 0.65 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 109.505 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 191' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' B' ' 190' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.515 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.38 0.609 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.17 88.86 0.05 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.91 172.53 8.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.328 -1.101 . . . . 0.0 109.243 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.483 HD12 ' HG3' ' A' ' 36' ' ' LYS . 0.7 OUTLIER -112.07 137.24 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -0.962 . . . . 0.0 109.536 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.1 m -131.1 160.44 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.371 -0.831 . . . . 0.0 108.97 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.92 139.91 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.007 -1.058 . . . . 0.0 109.341 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.672 ' HB2' ' HE3' ' A' ' 35' ' ' MET . . . -73.36 133.31 43.77 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.448 -0.783 . . . . 0.0 109.989 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.761 HD11 ' HB2' ' A' ' 64' ' ' ALA . 79.6 mt -99.55 -15.2 18.71 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.615 ' CE1' ' HB2' ' A' ' 16' ' ' LEU . 1.0 OUTLIER -155.96 154.07 26.96 Favored Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.448 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.733 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.6 Cg_endo -63.3 150.13 89.41 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 121.823 1.682 . . . . 0.0 110.276 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.769 ' O ' ' CB ' ' A' ' 20' ' ' ASP . 39.6 t80 -93.32 -33.01 14.07 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.068 -1.453 . . . . 0.0 110.541 -178.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.769 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 29.9 t0 107.57 -53.67 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.431 -0.793 . . . . 0.0 110.446 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.4 ' HA3' ' OG ' ' A' ' 28' ' ' SER . . . 78.33 79.5 0.76 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 -177.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.3 mt -97.66 -46.03 12.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.696 ' CD2' ' HG2' ' B' ' 188' ' ' GLU . 1.9 t-80 -73.31 146.01 86.15 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.56 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 43.7 Cg_endo -66.28 -11.47 31.52 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 121.898 1.732 . . . . 0.0 111.342 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -114.1 -18.91 11.56 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.514 -0.741 . . . . 0.0 110.117 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.494 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.6 OUTLIER -57.81 144.23 39.31 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.004 -1.06 . . . . 0.0 109.919 -178.824 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.928 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -91.23 118.47 30.5 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.178 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.804 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -83.28 145.04 29.32 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.597 -0.69 . . . . 0.0 109.153 179.266 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.765 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 18.7 p90 -148.15 160.75 42.58 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.621 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 11.6 mmtt -111.34 172.22 7.01 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.069 -1.02 . . . . 0.0 109.504 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.597 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -66.55 152.2 45.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.201 -0.937 . . . . 0.0 109.392 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 71.84 -8.01 6.6 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -76.58 142.05 40.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.018 -1.284 . . . . 0.0 109.785 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.3 138.89 33.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.892 . . . . 0.0 109.204 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.672 ' HE3' ' HB2' ' A' ' 15' ' ' ALA . 3.2 mpp? -136.11 152.32 50.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.644 -0.66 . . . . 0.0 109.662 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 3.7 ttpm? -109.62 126.19 53.37 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.48 -0.763 . . . . 0.0 109.503 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -82.13 129.39 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.389 -0.819 . . . . 0.0 109.003 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.877 HD12 ' O ' ' A' ' 46' ' ' LYS . 1.1 mp -102.05 -44.18 5.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.113 -0.992 . . . . 0.0 109.785 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.1 103.51 3.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.164 -0.96 . . . . 0.0 109.085 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.604 ' HG2' ' CD1' ' A' ' 45' ' ' TRP . 1.8 tm-20 -81.08 127.31 32.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.357 -0.839 . . . . 0.0 109.656 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.755 ' CG ' HD11 ' B' ' 186' ' ' LEU . 63.9 m-70 -87.57 -105.56 0.07 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.348 -0.845 . . . . 0.0 109.182 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 43' ' ' GLU . . . -127.05 -19.83 1.91 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.574 ' HG3' ' CG ' ' B' ' 181' ' ' PRO . 1.1 mm-40 -157.24 -12.8 0.09 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.993 -1.298 . . . . 0.0 110.563 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 1.063 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 50.2 m95 -135.81 101.45 4.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.002 -1.061 . . . . 0.0 108.415 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.62 ' CZ2' ' CB ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -92.05 149.02 21.74 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.146 -0.971 . . . . 0.0 110.566 -178.849 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.877 ' O ' HD12 ' A' ' 38' ' ' LEU . 4.9 tttt -92.9 107.28 19.1 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.91 -173.68 2.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.248 -0.908 . . . . 0.0 110.003 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 1.1 tttt -126.96 131.16 51.14 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.55 -0.719 . . . . 0.0 109.587 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.607 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 4.9 t -77.25 127.9 33.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.078 -1.014 . . . . 0.0 109.895 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.24 -6.66 44.57 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.239 -0.913 . . . . 0.0 108.55 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 51' ' ' LEU . 11.0 tp -54.99 -55.61 28.9 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.345 -0.847 . . . . 0.0 109.228 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.627 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 2.7 t -160.13 28.57 0.17 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.244 -0.91 . . . . 0.0 110.157 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.627 ' HB2' ' O ' ' A' ' 52' ' ' THR . 0.1 OUTLIER 86.32 44.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.52 -0.738 . . . . 0.0 111.065 178.18 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.607 ' HB2' ' CB ' ' A' ' 49' ' ' SER . 1.6 mmpt? -86.61 131.99 34.01 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.15 119.27 30.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.934 -1.104 . . . . 0.0 109.577 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.696 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -159.81 170.5 36.0 Favored Glycine 0 N--CA 1.488 2.13 0 C-N-CA 119.54 -1.314 . . . . 0.0 109.914 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.632 ' CB ' ' HA2' ' B' ' 187' ' ' GLY . 5.2 m-85 -71.77 132.33 44.34 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.56 -0.965 . . . . 0.0 109.804 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.415 ' O ' HG13 ' A' ' 58' ' ' ILE . 9.0 pt -121.12 142.55 35.15 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.634 ' HG3' ' CD2' ' B' ' 179' ' ' LEU . 48.6 Cg_endo -70.69 154.45 64.07 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 121.775 1.65 . . . . 0.0 112.226 -178.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.62 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 79.6 p -82.88 6.44 18.44 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -0.903 . . . . 0.0 109.692 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.639 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 9.2 p-10 -106.23 -52.56 2.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.034 -1.041 . . . . 0.0 110.96 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 1.153 ' CE2' HD21 ' B' ' 179' ' ' LEU . 2.9 m-85 -52.1 -61.97 1.93 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.175 -0.953 . . . . 0.0 111.071 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.603 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.7 m -80.48 156.28 4.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 122.034 0.921 . . . . 0.0 111.122 -177.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.761 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -132.83 159.07 40.88 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.51 151.5 39.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.063 -1.023 . . . . 0.0 109.479 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 66' ' ' LEU . 16.7 tp -123.37 146.26 48.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.512 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -97.35 -84.5 0.37 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.179 -0.951 . . . . 0.0 109.494 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.453 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 16.7 m0 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 171' ' ' ASP . . . . . 0.616 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 10.5 t0 -172.63 -54.86 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.154 -0.966 . . . . 0.0 109.052 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 172' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 46.7 Cg_endo -66.87 -89.1 0.0 OUTLIER 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.593 2.195 . . . . 0.0 111.943 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 173' ' ' GLY . . . . . . . . . . . . . . . 98.66 36.11 4.67 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 174' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -162.14 99.75 1.15 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.4 -1.059 . . . . 0.0 109.432 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 175' ' ' PRO . . . . . 0.79 ' O ' HG23 ' B' ' 176' ' ' THR . 52.5 Cg_endo -77.0 -161.16 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.71 2.274 . . . . 0.0 111.738 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 176' ' ' THR . . . . . 0.79 HG23 ' O ' ' B' ' 175' ' ' PRO . 0.1 OUTLIER 164.58 113.73 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.458 -0.777 . . . . 0.0 109.227 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 177' ' ' PRO . . . . . 0.535 ' HD3' ' CE1' ' A' ' 17' ' ' TYR . 50.9 Cg_endo -77.83 171.47 17.28 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.659 2.239 . . . . 0.0 111.869 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.29 105.02 1.34 Allowed 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.686 2.257 . . . . 0.0 111.85 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 1.153 HD21 ' CE2' ' A' ' 62' ' ' TYR . 41.8 mt -47.2 160.78 0.33 Allowed Pre-proline 0 N--CA 1.487 1.383 0 O-C-N 121.292 -0.88 . . . . 0.0 109.957 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 1.063 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 41.4 Cg_endo -67.23 179.6 2.32 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 123.108 2.539 . . . . 0.0 111.269 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 181' ' ' PRO . . . . . 0.631 ' HD2' ' HB2' ' B' ' 180' ' ' PRO . 55.4 Cg_endo -75.74 -48.79 0.14 Allowed 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.697 2.264 . . . . 0.0 113.527 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.661 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.0 OUTLIER 80.59 81.66 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.07 -1.019 . . . . 0.0 108.879 -178.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 54.6 Cg_endo -74.06 141.64 29.93 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.784 2.323 . . . . 0.0 112.114 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 184' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 37.74 62.7 0.87 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.835 . . . . 0.0 109.688 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 185' ' ' ASN . . . . . 0.476 ' HB3' ' HB3' ' B' ' 188' ' ' GLU . 0.6 OUTLIER 43.05 48.14 5.22 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -0.888 . . . . 0.0 109.197 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 186' ' ' LEU . . . . . 0.755 HD11 ' CG ' ' A' ' 41' ' ' HIS . 63.6 tp -64.54 -79.71 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.379 -0.826 . . . . 0.0 109.472 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 187' ' ' GLY . . . . . 0.632 ' HA2' ' CB ' ' A' ' 57' ' ' PHE . . . -63.76 -12.53 48.05 Favored Glycine 0 N--CA 1.481 1.695 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.696 ' HG2' ' CD2' ' A' ' 23' ' ' HIS . 0.2 OUTLIER -75.57 -80.06 0.09 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.539 -0.977 . . . . 0.0 109.299 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 189' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -79.93 -176.53 5.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -0.871 . . . . 0.0 109.422 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 190' ' ' GLN . . . . . 0.497 ' HG3' ' N ' ' B' ' 191' ' ' ALA . 0.0 OUTLIER -123.01 -24.99 4.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.522 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 191' ' ' ALA . . . . . 0.497 ' N ' ' HG3' ' B' ' 190' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.406 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.358 0.599 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.539 ' HA3' ' CG1' ' A' ' 37' ' ' VAL . . . 115.66 -86.99 0.43 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.876 ' O ' HG23 ' A' ' 37' ' ' VAL . 9.5 m-20 64.09 -167.29 0.22 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -1.085 . . . . 0.0 109.929 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.811 HD12 ' HG2' ' A' ' 36' ' ' LYS . 18.8 mm -71.86 133.26 32.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.427 -0.796 . . . . 0.0 109.843 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.448 HG22 HG23 ' A' ' 37' ' ' VAL . 1.7 m -131.65 161.47 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.9 p -120.28 138.1 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.854 -1.154 . . . . 0.0 109.475 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.87 133.9 45.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.44 -0.788 . . . . 0.0 110.225 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.064 HD11 ' HB2' ' A' ' 64' ' ' ALA . 20.7 mt -98.89 -12.38 20.8 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.909 ' HB3' HG22 ' B' ' 176' ' ' THR . 39.9 m-85 -158.57 154.84 24.06 Favored Pre-proline 0 N--CA 1.487 1.386 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.713 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 41.2 Cg_endo -64.68 148.75 90.37 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 121.723 1.615 . . . . 0.0 109.721 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.799 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 51.7 t80 -97.68 177.12 5.59 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 118.188 -1.405 . . . . 0.0 110.388 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.683 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 4.3 t0 -109.8 79.07 1.18 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.673 -0.642 . . . . 0.0 109.655 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.69 86.37 0.01 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.601 ' N ' ' O ' ' A' ' 20' ' ' ASP . 40.7 mt -105.99 -0.5 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.057 -1.261 . . . . 0.0 109.63 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.584 ' CD2' ' C ' ' B' ' 188' ' ' GLU . 71.2 m80 -120.45 158.37 51.44 Favored Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.01 -18.54 46.21 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.178 1.919 . . . . 0.0 111.844 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.421 ' OD2' ' HD2' ' B' ' 189' ' ' ARG . 2.5 m-20 -111.77 -13.56 13.69 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.501 -0.749 . . . . 0.0 110.45 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -57.68 139.11 54.56 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.838 -1.164 . . . . 0.0 109.52 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.013 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -96.59 121.53 38.52 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.312 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.875 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -80.25 140.91 36.02 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.369 -0.832 . . . . 0.0 109.796 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.799 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 30.7 p90 -145.62 157.55 43.96 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 108.576 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.661 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.8 mttm -110.49 173.44 6.33 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.033 -1.042 . . . . 0.0 109.596 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.57 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -66.99 151.75 47.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.198 -0.939 . . . . 0.0 109.32 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.54 -8.09 4.46 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 4.4 tt0 -75.13 143.29 43.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.973 -1.31 . . . . 0.0 109.559 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -97.21 138.93 33.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 109.799 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.581 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 2.5 mpp? -137.5 153.51 50.02 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.811 ' HG2' HD12 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -106.64 129.19 54.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.454 -0.779 . . . . 0.0 109.287 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 11' ' ' ASP . 6.3 t -80.91 124.8 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.046 -1.034 . . . . 0.0 109.041 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.44 HD11 ' HG3' ' A' ' 48' ' ' LYS . 7.2 mt -101.62 -43.06 5.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.184 -0.948 . . . . 0.0 109.934 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 39' ' ' GLU . 1.2 pt-20 -145.58 97.57 3.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.133 -0.98 . . . . 0.0 109.306 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.615 ' HG3' ' CD1' ' A' ' 45' ' ' TRP . 3.5 tt0 -81.35 116.6 21.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.196 -0.94 . . . . 0.0 109.282 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.785 ' HB2' HD21 ' B' ' 186' ' ' LEU . 23.4 m-70 -85.0 -105.78 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.287 -0.883 . . . . 0.0 109.509 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.24 -16.59 1.71 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.525 ' HB2' ' HD3' ' B' ' 183' ' ' PRO . 16.6 mm-40 -153.92 -17.8 0.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.038 -1.272 . . . . 0.0 110.389 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.851 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 63.5 m95 -135.76 102.57 5.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.964 -1.085 . . . . 0.0 109.342 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.615 ' CD1' ' HG3' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -90.7 142.67 27.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.103 -0.998 . . . . 0.0 110.045 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.9 OUTLIER -91.84 105.77 17.96 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.063 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.81 -175.86 2.92 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.191 -0.943 . . . . 0.0 110.184 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.612 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -124.89 129.71 50.93 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.689 -0.632 . . . . 0.0 109.376 -179.566 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.663 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -74.77 125.83 29.61 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.097 -1.002 . . . . 0.0 109.943 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.27 -7.53 47.61 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.471 ' HA ' HD12 ' A' ' 51' ' ' LEU . 15.3 tp -53.78 -54.93 31.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.604 -0.685 . . . . 0.0 109.214 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.601 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 0.7 OUTLIER -161.38 29.54 0.13 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.264 -0.898 . . . . 0.0 109.994 179.672 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.601 ' CB ' ' O ' ' A' ' 52' ' ' THR . 5.7 mttp 86.45 44.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.454 -0.779 . . . . 0.0 110.423 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.663 ' HB2' ' HB3' ' A' ' 49' ' ' SER . 0.0 OUTLIER -85.94 132.46 34.07 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.335 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 20.0 pt-20 -122.84 120.32 33.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.933 -1.104 . . . . 0.0 109.103 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.661 ' HA3' ' CB ' ' A' ' 27' ' ' LEU . . . -162.58 165.72 36.33 Favored Glycine 0 N--CA 1.488 2.128 0 C-N-CA 119.105 -1.521 . . . . 0.0 110.253 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.641 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 8.5 m-85 -71.38 132.95 45.57 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.759 -0.847 . . . . 0.0 109.652 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.588 HD12 HG21 ' A' ' 63' ' ' VAL . 7.4 pt -121.91 143.14 37.87 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.77 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 44.2 Cg_endo -67.66 153.77 75.18 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.701 1.601 . . . . 0.0 111.614 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.528 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 65.5 p -82.71 6.77 16.91 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 110.783 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -110.31 -52.86 2.74 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.741 -1.224 . . . . 0.0 110.637 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.599 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 5.1 m-85 -49.08 -63.15 1.19 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.094 -1.004 . . . . 0.0 110.938 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.588 HG21 HD12 ' A' ' 58' ' ' ILE . 3.3 m -78.85 155.01 4.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 122.027 0.918 . . . . 0.0 110.935 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.064 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -133.14 161.53 34.17 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -75.95 150.59 37.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.093 -1.004 . . . . 0.0 109.479 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.521 ' O ' ' CB ' ' A' ' 67' ' ' ASN . 4.9 mt -75.86 -158.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.0 109.306 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 66' ' ' LEU . 7.1 t30 76.7 121.78 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.117 -0.989 . . . . 0.0 109.541 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.2 m . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.475 179.899 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.302 0.572 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 171' ' ' ASP . . . . . 0.605 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 0.8 OUTLIER -170.48 -56.27 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.213 -0.93 . . . . 0.0 108.804 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 172' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 47.9 Cg_endo -67.97 -89.79 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.717 2.278 . . . . 0.0 111.896 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 173' ' ' GLY . . . . . . . . . . . . . . . 83.38 15.51 71.3 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 174' ' ' MET . . . . . . . . . . . . . 1.4 mmt 51.13 91.35 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.389 -1.065 . . . . 0.0 109.325 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 175' ' ' PRO . . . . . 0.865 ' O ' HG23 ' B' ' 176' ' ' THR . 53.8 Cg_endo -77.52 -161.35 0.14 Allowed 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 122.616 2.211 . . . . 0.0 111.561 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 176' ' ' THR . . . . . 0.909 HG22 ' HB3' ' A' ' 17' ' ' TYR . 0.6 OUTLIER -177.24 102.54 0.22 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.623 -0.673 . . . . 0.0 109.356 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 177' ' ' PRO . . . . . 0.618 ' HD2' ' CD2' ' A' ' 17' ' ' TYR . 47.9 Cg_endo -69.66 156.97 62.18 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.703 2.269 . . . . 0.0 111.689 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.17 148.45 68.9 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.546 2.164 . . . . 0.0 111.263 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 0.586 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -86.03 173.93 6.24 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.122 -0.986 . . . . 0.0 109.622 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.851 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.4 Cg_endo -69.92 -175.0 1.05 Allowed 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.963 2.442 . . . . 0.0 111.457 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 181' ' ' PRO . . . . . 0.704 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.6 Cg_endo -91.31 -25.31 0.34 Allowed 'Trans proline' 0 C--O 1.213 -0.76 0 C-N-CA 122.856 2.371 . . . . 0.0 114.531 -177.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.711 ' CG ' ' CE2' ' A' ' 44' ' ' TRP . 39.4 mtt180 78.71 94.33 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 120.942 -1.098 . . . . 0.0 109.2 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.594 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 46.3 Cg_endo -67.58 118.5 5.64 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.664 2.243 . . . . 0.0 111.75 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . 53.83 57.59 5.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.255 -0.903 . . . . 0.0 109.3 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 51.09 50.75 18.43 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.319 -0.863 . . . . 0.0 109.414 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 186' ' ' LEU . . . . . 0.785 HD21 ' HB2' ' A' ' 41' ' ' HIS . 62.0 tp -71.72 -80.54 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.306 -0.871 . . . . 0.0 109.508 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 187' ' ' GLY . . . . . 0.641 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -70.86 -3.13 49.63 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.584 ' C ' ' CD2' ' A' ' 23' ' ' HIS . 10.5 mt-10 -75.69 -82.86 0.07 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.391 -1.064 . . . . 0.0 109.315 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 189' ' ' ARG . . . . . 0.456 ' CB ' ' O ' ' B' ' 188' ' ' GLU . 0.0 OUTLIER 72.5 85.64 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.385 -0.822 . . . . 0.0 109.556 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -86.65 145.82 26.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 0.0 109.402 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.53 179.947 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.296 0.569 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.85 38.51 0.02 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.549 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.4 OUTLIER -108.94 137.84 46.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.325 -1.103 . . . . 0.0 109.415 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.547 HD12 ' HG2' ' A' ' 36' ' ' LYS . 25.5 mm -100.89 137.0 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.163 -0.96 . . . . 0.0 109.553 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.17 161.76 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.463 -0.773 . . . . 0.0 108.951 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 p -121.23 139.06 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.006 -1.059 . . . . 0.0 109.317 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.08 133.68 46.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.364 -0.835 . . . . 0.0 109.697 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.089 HD11 ' HB2' ' A' ' 64' ' ' ALA . 55.7 mt -99.12 -12.86 20.11 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.984 ' HB3' HG22 ' B' ' 176' ' ' THR . 34.3 m-85 -158.35 154.19 23.15 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.719 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 42.0 Cg_endo -64.36 149.07 90.79 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 121.662 1.575 . . . . 0.0 110.055 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.834 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 54.2 t80 -97.86 177.93 5.29 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.324 -1.35 . . . . 0.0 110.405 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.686 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 0.7 OUTLIER -109.01 80.58 1.33 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.498 -0.751 . . . . 0.0 109.303 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.45 94.68 0.05 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 20' ' ' ASP . 18.1 mm -108.19 -42.02 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.303 -1.116 . . . . 0.0 108.807 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.608 ' CG ' ' O ' ' B' ' 188' ' ' GLU . 67.5 m-70 -77.45 158.15 79.36 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.89 -13.77 34.78 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.232 1.955 . . . . 0.0 111.811 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.74 -14.35 13.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.258 -0.902 . . . . 0.0 110.525 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.61 138.69 55.02 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.873 -1.142 . . . . 0.0 109.864 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.937 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -93.87 120.76 34.56 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.041 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.874 ' N ' HD22 ' A' ' 27' ' ' LEU . 10.1 p -79.92 140.74 36.57 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.365 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.834 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 21.9 p90 -145.94 157.66 43.88 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.14 -0.975 . . . . 0.0 108.535 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.653 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.5 OUTLIER -110.81 173.16 6.46 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.153 -0.967 . . . . 0.0 109.51 -179.44 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 7.8 pttm -67.09 152.02 46.54 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.183 -0.948 . . . . 0.0 109.38 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.42 -8.18 4.26 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.5 143.4 42.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.936 -1.332 . . . . 0.0 109.709 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.61 137.84 35.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 0.0 109.418 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.604 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 2.4 mpp? -135.01 151.79 51.13 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.492 0.663 . . . . 0.0 109.669 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.547 ' HG2' HD12 ' A' ' 12' ' ' ILE . 4.0 mttm -108.95 127.01 53.69 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.426 -0.797 . . . . 0.0 109.407 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.578 HG11 ' HG3' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -81.57 143.58 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.397 -0.814 . . . . 0.0 108.958 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.521 HD12 ' C ' ' A' ' 37' ' ' VAL . 7.8 mp -119.69 -40.89 2.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.064 -1.022 . . . . 0.0 109.833 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -140.38 92.13 2.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.16 -0.962 . . . . 0.0 108.96 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.6 ' HG2' ' CG ' ' A' ' 45' ' ' TRP . 1.9 mt-10 -74.09 120.37 19.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.479 -0.763 . . . . 0.0 109.536 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.74 ' HB2' HD21 ' B' ' 186' ' ' LEU . 44.2 m80 -92.28 -106.49 0.11 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.235 -0.915 . . . . 0.0 109.555 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.36 -16.66 1.17 Allowed Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.179 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.513 ' HG2' ' HD2' ' B' ' 181' ' ' PRO . 0.5 OUTLIER -154.21 -17.04 0.13 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.968 -1.313 . . . . 0.0 110.351 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.822 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 59.8 m95 -136.97 101.73 4.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.038 -1.039 . . . . 0.0 109.155 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.6 ' CG ' ' HG2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -91.07 139.57 30.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.904 -1.122 . . . . 0.0 109.992 -179.679 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.7 OUTLIER -86.13 107.41 17.84 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -102.26 -177.86 3.53 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.289 -0.882 . . . . 0.0 110.233 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 9.8 tttm -123.45 107.97 12.17 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.605 ' N ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -54.1 127.02 24.95 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.11 -0.994 . . . . 0.0 109.925 -179.764 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 52' ' ' THR . 3.7 mt -75.84 -11.2 59.93 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.482 ' C ' HG22 ' A' ' 52' ' ' THR . 22.4 tp -46.05 -20.89 0.11 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.719 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 0.6 OUTLIER 168.15 -21.47 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.392 -0.817 . . . . 0.0 109.851 179.151 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.719 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 140.55 42.61 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.536 -0.727 . . . . 0.0 109.972 179.629 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.655 ' HB3' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -85.37 134.64 34.08 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.085 -1.01 . . . . 0.0 108.505 178.419 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.474 ' OE1' HD22 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -122.5 114.33 20.53 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.047 -1.033 . . . . 0.0 109.359 -179.825 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.644 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -155.52 168.85 33.29 Favored Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.416 -1.373 . . . . 0.0 109.959 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.658 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 8.9 m-85 -71.41 131.93 44.08 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.574 -0.957 . . . . 0.0 109.656 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.532 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 5.2 pt -120.86 139.63 29.42 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.743 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 46.8 Cg_endo -69.14 158.74 56.59 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 121.671 1.581 . . . . 0.0 111.948 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.515 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 79.5 p -86.44 7.08 27.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.334 -0.853 . . . . 0.0 110.387 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' B' ' 178' ' ' PRO . 0.1 OUTLIER -109.28 -53.77 2.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.903 -1.123 . . . . 0.0 110.441 -179.356 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.585 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 2.8 m-85 -47.93 -63.38 1.08 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.133 -0.979 . . . . 0.0 111.115 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.604 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 3.0 m -78.53 155.0 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.929 . . . . 0.0 110.968 -177.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.089 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -134.8 162.67 31.71 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.4 pttm -75.58 148.53 38.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.044 -1.035 . . . . 0.0 109.251 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.64 169.67 8.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 109.574 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' A' ' 68' ' ' THR . 20.3 t-20 -123.47 -94.06 0.5 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.284 -0.885 . . . . 0.0 109.347 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.508 ' N ' ' OD1' ' A' ' 67' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.456 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 170' ' ' TRP . . . . . 0.425 ' O ' ' CB ' ' B' ' 171' ' ' ASP . 10.7 m0 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 171' ' ' ASP . . . . . 0.57 ' N ' ' HD3' ' B' ' 172' ' ' PRO . 0.8 OUTLIER 170.03 59.75 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.297 -0.877 . . . . 0.0 108.975 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 172' ' ' PRO . . . . . 0.57 ' HD3' ' N ' ' B' ' 171' ' ' ASP . 51.6 Cg_endo -92.77 -82.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.106 2.537 . . . . 0.0 111.942 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 173' ' ' GLY . . . . . . . . . . . . . . . 125.67 68.31 0.18 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 174' ' ' MET . . . . . 0.566 ' N ' ' HD2' ' B' ' 175' ' ' PRO . 0.1 OUTLIER -66.25 -47.11 61.42 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.2 -1.176 . . . . 0.0 109.49 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 175' ' ' PRO . . . . . 0.869 ' O ' HG23 ' B' ' 176' ' ' THR . 55.3 Cg_endo -79.44 -162.49 0.18 Allowed 'Trans proline' 0 C--O 1.213 -0.75 0 C-N-CA 122.606 2.204 . . . . 0.0 111.606 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 176' ' ' THR . . . . . 0.984 HG22 ' HB3' ' A' ' 17' ' ' TYR . 1.1 p -170.15 99.46 0.45 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.573 -0.704 . . . . 0.0 109.315 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 177' ' ' PRO . . . . . 0.631 ' HD2' ' CD2' ' A' ' 17' ' ' TYR . 50.5 Cg_endo -69.34 160.83 48.3 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.814 2.342 . . . . 0.0 111.853 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 178' ' ' PRO . . . . . 0.525 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 49.4 Cg_endo -70.29 160.07 50.84 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.613 2.209 . . . . 0.0 111.222 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 0.614 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -94.0 174.83 3.42 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.1 -1.0 . . . . 0.0 109.761 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.822 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.7 Cg_endo -69.34 -173.43 0.66 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 123.049 2.499 . . . . 0.0 111.484 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 181' ' ' PRO . . . . . 0.737 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 53.1 Cg_endo -92.95 -26.5 0.18 Allowed 'Trans proline' 0 C--O 1.213 -0.732 0 C-N-CA 122.95 2.433 . . . . 0.0 114.441 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.737 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 43.3 mtt180 80.99 95.02 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.076 -1.015 . . . . 0.0 109.059 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.549 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 49.2 Cg_endo -69.98 135.98 31.29 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.745 2.297 . . . . 0.0 111.865 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 184' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 41.61 57.79 2.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 0.0 109.367 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 49.13 48.96 20.31 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.228 -0.92 . . . . 0.0 109.288 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 186' ' ' LEU . . . . . 0.74 HD21 ' HB2' ' A' ' 41' ' ' HIS . 48.4 tp -67.43 -87.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.408 -0.808 . . . . 0.0 109.319 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 187' ' ' GLY . . . . . 0.658 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -69.21 -5.63 49.5 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.608 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 2.9 tt0 -72.48 -68.77 0.45 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.426 -1.043 . . . . 0.0 109.434 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 189' ' ' ARG . . . . . 0.538 ' CB ' ' O ' ' B' ' 188' ' ' GLU . 0.0 OUTLIER 78.25 105.05 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.382 -0.824 . . . . 0.0 109.432 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 190' ' ' GLN . . . . . 0.631 ' O ' ' HB3' ' B' ' 191' ' ' ALA . 0.0 OUTLIER 175.06 -174.13 0.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.411 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 191' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' B' ' 190' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.519 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.48 145.26 30.21 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -130.93 154.34 48.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.305 -1.115 . . . . 0.0 109.396 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 36' ' ' LYS . 4.5 tp -99.23 138.84 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.164 -0.96 . . . . 0.0 109.451 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.603 HG22 ' CG2' ' A' ' 37' ' ' VAL . 0.8 OUTLIER -131.2 160.36 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.333 -0.855 . . . . 0.0 109.007 -179.842 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.0 p -120.5 138.98 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.017 -1.052 . . . . 0.0 109.353 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -72.53 134.81 45.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.411 -0.806 . . . . 0.0 109.842 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.801 HD11 ' HB2' ' A' ' 64' ' ' ALA . 69.4 mt -99.85 -22.4 15.33 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.916 ' HB3' HG22 ' B' ' 176' ' ' THR . 32.3 m-85 -147.48 153.1 43.41 Favored Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.696 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.7 Cg_endo -63.21 149.67 90.73 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 121.845 1.697 . . . . 0.0 110.089 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.824 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 57.0 t80 -98.81 178.73 4.88 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.268 -1.373 . . . . 0.0 110.524 -177.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.686 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -109.96 80.38 1.31 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.01 95.89 0.06 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 20' ' ' ASP . 75.9 mt -108.8 -42.21 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.117 -1.226 . . . . 0.0 108.86 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.643 ' CE1' ' HG3' ' B' ' 188' ' ' GLU . 88.5 m-70 -76.81 157.87 81.29 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.59 -12.74 33.88 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.129 1.886 . . . . 0.0 111.657 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -112.92 -14.51 13.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.894 . . . . 0.0 110.64 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.472 ' CG ' ' HB2' ' A' ' 23' ' ' HIS . 79.9 m-20 -57.53 139.81 52.42 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.762 -1.212 . . . . 0.0 109.783 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.886 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -95.1 121.53 36.83 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.159 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.869 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -80.07 140.49 36.46 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.448 -0.783 . . . . 0.0 109.491 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.824 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 25.7 p90 -145.39 156.95 44.09 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.163 -0.961 . . . . 0.0 108.676 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.637 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -110.64 173.32 6.39 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.151 -0.968 . . . . 0.0 109.596 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.555 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -67.26 151.49 47.41 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.186 -0.946 . . . . 0.0 109.322 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 71.51 -8.19 5.8 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.69 142.93 42.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.934 -1.333 . . . . 0.0 109.839 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.0 138.94 33.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 109.456 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.609 ' CE ' HG11 ' A' ' 63' ' ' VAL . 2.5 mpp? -135.49 151.62 50.54 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.577 -0.702 . . . . 0.0 109.82 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 82.4 tttt -105.29 123.24 47.52 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.424 -0.798 . . . . 0.0 109.428 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.846 HG11 ' OE2' ' A' ' 40' ' ' GLU . 2.0 t -81.82 115.96 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.362 -0.836 . . . . 0.0 109.052 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 38' ' ' LEU . 9.3 mp -92.01 -39.65 11.54 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.085 -1.01 . . . . 0.0 109.887 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -142.29 102.65 4.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.102 -0.999 . . . . 0.0 109.06 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.846 ' OE2' HG11 ' A' ' 37' ' ' VAL . 1.0 OUTLIER -85.41 118.53 25.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.391 -0.818 . . . . 0.0 109.498 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.651 ' HB2' HD21 ' B' ' 186' ' ' LEU . 68.3 m-70 -89.26 -103.13 0.09 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.287 -0.883 . . . . 0.0 109.367 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.44 ' O ' ' CD ' ' A' ' 43' ' ' GLU . . . -138.71 -13.71 0.71 Allowed Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.426 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.561 ' HG2' ' HD2' ' B' ' 181' ' ' PRO . 0.6 OUTLIER -155.57 -20.95 0.11 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.832 -1.393 . . . . 0.0 110.584 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.818 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 58.9 m95 -136.47 95.27 3.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.874 -1.142 . . . . 0.0 109.047 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.589 ' CG ' ' HG3' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -87.03 141.46 28.65 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.992 -1.067 . . . . 0.0 110.492 -179.184 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.8 OUTLIER -87.1 106.74 18.07 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -104.32 -173.23 2.26 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.287 -0.883 . . . . 0.0 110.179 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 4.3 tttp -127.28 131.37 50.53 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.5 -0.75 . . . . 0.0 109.452 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.668 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 1.3 t -77.17 128.09 33.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.002 -1.061 . . . . 0.0 109.885 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.87 -7.68 49.87 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 51' ' ' LEU . 9.4 tp -53.7 -55.8 22.95 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.35 -0.844 . . . . 0.0 109.348 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.623 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.4 t -160.69 28.42 0.15 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.229 -0.92 . . . . 0.0 110.149 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.623 ' CB ' ' O ' ' A' ' 52' ' ' THR . 31.0 mtmt 86.8 44.5 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.444 -0.785 . . . . 0.0 111.122 178.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.758 ' HB3' HD23 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -87.67 131.95 34.27 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.795 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 8.9 pt-20 -121.83 120.66 35.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.932 -1.105 . . . . 0.0 109.641 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.688 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -158.37 168.94 34.82 Favored Glycine 0 N--CA 1.487 2.1 0 C-N-CA 119.539 -1.315 . . . . 0.0 109.887 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.79 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 11.5 m-85 -71.27 133.71 46.27 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.546 -0.973 . . . . 0.0 109.884 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.562 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 2.9 pt -122.31 142.37 36.8 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.696 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 47.8 Cg_endo -70.85 159.41 52.69 Favored 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 121.562 1.508 . . . . 0.0 111.818 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.513 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 90.3 p -87.31 7.2 29.78 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 110.073 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.556 ' C ' ' ND2' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -107.97 -54.86 2.44 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.006 -1.059 . . . . 0.0 110.351 -179.369 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.703 ' HE2' HD23 ' B' ' 179' ' ' LEU . 3.5 m-85 -48.6 -63.28 1.13 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.167 -0.958 . . . . 0.0 111.151 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.609 HG11 ' CE ' ' A' ' 35' ' ' MET . 2.9 m -79.8 155.9 4.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.995 0.902 . . . . 0.0 111.133 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.801 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -132.3 160.47 36.15 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.439 ' HA ' HG12 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -75.83 152.31 37.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.999 -1.063 . . . . 0.0 109.463 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.89 72.02 4.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.888 . . . . 0.0 109.569 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -163.99 123.16 1.97 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.413 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 170' ' ' TRP . . . . . 0.406 ' O ' ' OD2' ' B' ' 171' ' ' ASP . 14.9 m0 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 171' ' ' ASP . . . . . 0.604 ' N ' ' HD3' ' B' ' 172' ' ' PRO . 0.6 OUTLIER 174.18 58.02 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.269 -0.894 . . . . 0.0 109.061 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 172' ' ' PRO . . . . . 0.604 ' HD3' ' N ' ' B' ' 171' ' ' ASP . 51.7 Cg_endo -93.65 -78.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.234 2.623 . . . . 0.0 111.843 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 173' ' ' GLY . . . . . 0.536 ' O ' ' CG ' ' B' ' 174' ' ' MET . . . 153.49 -20.88 0.72 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 174' ' ' MET . . . . . 0.553 ' N ' ' HD3' ' B' ' 175' ' ' PRO . 5.9 ptm 39.69 51.37 3.77 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.482 -1.011 . . . . 0.0 109.661 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 175' ' ' PRO . . . . . 0.635 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 54.7 Cg_endo -78.95 -161.88 0.16 Allowed 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 122.524 2.149 . . . . 0.0 111.639 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 176' ' ' THR . . . . . 0.916 HG22 ' HB3' ' A' ' 17' ' ' TYR . 5.6 p -152.41 91.94 3.52 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.402 -0.811 . . . . 0.0 109.202 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 177' ' ' PRO . . . . . 0.595 ' HD2' ' CD2' ' A' ' 17' ' ' TYR . 50.3 Cg_endo -69.19 173.99 9.66 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.759 2.306 . . . . 0.0 111.789 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 178' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' B' ' 177' ' ' PRO . 49.4 Cg_endo -70.13 158.82 55.24 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.6 2.2 . . . . 0.0 111.313 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 0.703 HD23 ' HE2' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -97.56 176.81 1.87 Allowed Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 121.077 -1.015 . . . . 0.0 109.589 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.818 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 39.3 Cg_endo -67.96 -174.48 0.62 Allowed 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 123.042 2.494 . . . . 0.0 112.075 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 181' ' ' PRO . . . . . 0.638 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.6 Cg_endo -92.78 -29.0 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 123.252 2.635 . . . . 0.0 114.213 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.757 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.1 OUTLIER 84.23 104.95 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.162 -0.961 . . . . 0.0 109.877 -179.323 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.715 ' CG ' HD22 ' B' ' 186' ' ' LEU . 44.7 Cg_endo -69.29 124.94 11.79 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 123.022 2.481 . . . . 0.0 111.998 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 184' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 40.44 69.27 0.33 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.36 -0.838 . . . . 0.0 109.567 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 185' ' ' ASN . . . . . 0.534 ' HA ' ' HB3' ' B' ' 188' ' ' GLU . 0.0 OUTLIER 42.06 47.22 3.83 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.289 -0.882 . . . . 0.0 109.413 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 186' ' ' LEU . . . . . 0.737 HD23 ' HB2' ' A' ' 44' ' ' TRP . 31.6 tp -56.19 -94.81 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 187' ' ' GLY . . . . . 0.79 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -78.49 0.48 75.61 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.643 ' HG3' ' CE1' ' A' ' 23' ' ' HIS . 0.7 OUTLIER -69.77 -72.47 0.19 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.571 -0.958 . . . . 0.0 109.44 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 189' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' B' ' 185' ' ' ASN . 0.0 OUTLIER -169.04 134.24 1.57 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.415 -0.803 . . . . 0.0 109.315 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -130.65 175.0 9.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.284 -0.885 . . . . 0.0 109.502 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.526 -179.965 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.9 139.05 5.26 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -166.04 -178.96 4.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.343 -1.092 . . . . 0.0 109.416 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.697 HD13 ' HA ' ' A' ' 36' ' ' LYS . 21.6 mm -119.03 138.32 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.18 -0.95 . . . . 0.0 109.587 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.8 HG12 ' HA ' ' A' ' 65' ' ' LYS . 0.8 OUTLIER -132.21 161.91 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 p -120.83 140.45 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.936 -1.102 . . . . 0.0 109.463 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -72.79 133.87 44.69 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.336 -0.853 . . . . 0.0 109.566 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.995 HD11 ' HB2' ' A' ' 64' ' ' ALA . 84.3 mt -99.88 -15.51 18.35 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.628 ' CD2' ' HD3' ' B' ' 177' ' ' PRO . 3.5 m-85 -156.32 154.71 27.78 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.729 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.2 Cg_endo -63.45 149.05 92.13 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 121.903 1.735 . . . . 0.0 110.448 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.831 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 50.9 t80 -98.46 178.7 4.94 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.438 -1.305 . . . . 0.0 110.367 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.694 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 0.5 OUTLIER -109.66 80.65 1.34 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.631 -0.668 . . . . 0.0 109.291 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.95 94.58 0.05 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 20' ' ' ASP . 17.1 mm -108.28 -41.92 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.089 -1.242 . . . . 0.0 108.902 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.602 ' CG ' ' O ' ' B' ' 188' ' ' GLU . 20.5 m-70 -77.54 157.75 79.62 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.54 -13.32 35.03 Favored 'Trans proline' 0 C--O 1.213 -0.75 0 C-N-CA 122.271 1.981 . . . . 0.0 111.921 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 1.0 OUTLIER -112.11 -13.9 13.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.253 -0.904 . . . . 0.0 110.673 -179.069 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.449 ' CG ' ' HB2' ' A' ' 23' ' ' HIS . 84.4 m-20 -57.97 139.74 53.77 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.819 -1.176 . . . . 0.0 109.94 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.948 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -94.74 120.9 35.71 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.874 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.872 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -79.19 140.25 37.77 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.263 -0.898 . . . . 0.0 109.277 179.723 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.831 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 23.5 p90 -145.2 156.8 44.07 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.098 -1.001 . . . . 0.0 108.701 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.621 ' HG2' ' HB2' ' A' ' 33' ' ' GLU . 5.6 ptmt -110.81 173.24 6.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 109.319 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -66.59 151.96 46.27 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.983 -1.073 . . . . 0.0 109.482 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 71.76 -7.39 7.2 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.621 ' HB2' ' HG2' ' A' ' 30' ' ' LYS . 5.0 tp10 -76.15 142.62 41.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.892 -1.357 . . . . 0.0 109.944 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.481 ' HD2' HG21 ' A' ' 12' ' ' ILE . 1.4 ttpt -97.28 139.52 33.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.886 . . . . 0.0 109.382 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.673 ' CE ' HG11 ' A' ' 63' ' ' VAL . 2.0 mpp? -135.1 151.48 50.77 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.441 0.639 . . . . 0.0 109.735 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.697 ' HA ' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -104.39 123.47 47.49 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.546 -0.722 . . . . 0.0 109.163 179.797 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.607 ' CG2' HG22 ' A' ' 13' ' ' VAL . 2.2 t -81.43 114.1 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.29 -0.881 . . . . 0.0 109.088 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 38' ' ' LEU . 6.3 mp -90.23 -44.17 9.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 109.656 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -143.08 97.46 3.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.932 . . . . 0.0 108.921 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.565 ' HG3' ' CD1' ' A' ' 45' ' ' TRP . 3.3 tt0 -83.72 116.67 22.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.34 -0.85 . . . . 0.0 109.588 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.696 ' HB2' HD21 ' B' ' 186' ' ' LEU . 4.0 m-70 -78.27 -95.83 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.319 -0.863 . . . . 0.0 109.228 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.46 ' O ' ' CD ' ' A' ' 43' ' ' GLU . . . -148.38 -13.05 0.13 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.383 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.602 ' HB3' ' HD2' ' B' ' 181' ' ' PRO . 6.5 mm-40 -148.69 -26.38 0.31 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.969 -1.312 . . . . 0.0 110.008 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.933 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 47.8 m95 -134.02 102.26 5.35 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.17 -0.956 . . . . 0.0 108.768 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.636 ' CZ2' ' CB ' ' A' ' 60' ' ' SER . 0.1 OUTLIER -90.02 147.17 23.83 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.092 -1.005 . . . . 0.0 110.398 -179.129 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -96.06 108.2 20.6 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -105.65 -172.89 2.18 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 110.346 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -125.56 127.11 45.86 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.609 -0.682 . . . . 0.0 109.266 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.65 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -70.82 126.06 28.54 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.183 -0.948 . . . . 0.0 109.835 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.6 mp -72.18 -7.97 52.14 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.4 tp -54.25 -54.83 34.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.528 -0.733 . . . . 0.0 109.17 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.587 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 1.3 t -161.06 30.08 0.14 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.173 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 52' ' ' THR . 38.3 mmtt 85.78 45.49 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.499 -0.751 . . . . 0.0 110.661 178.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.65 ' HB2' ' HB3' ' A' ' 49' ' ' SER . 0.8 OUTLIER -87.05 132.29 33.85 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.137 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.501 ' CG ' ' HE3' ' A' ' 46' ' ' LYS . 15.4 tt0 -121.72 117.35 26.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.876 -1.14 . . . . 0.0 109.57 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.651 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -158.42 168.62 34.78 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.44 -1.362 . . . . 0.0 110.015 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.871 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 12.5 m-85 -73.66 135.15 43.72 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.679 -0.895 . . . . 0.0 110.16 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.588 HD12 HG21 ' A' ' 63' ' ' VAL . 7.4 pt -122.39 139.34 30.61 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.596 ' HB2' ' CD ' ' B' ' 180' ' ' PRO . 52.3 Cg_endo -72.6 131.96 18.14 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 121.519 1.479 . . . . 0.0 112.014 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.636 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 53.7 p -62.88 3.68 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.39 -0.819 . . . . 0.0 110.542 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.637 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 6.5 p-10 -98.36 -52.42 3.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.797 -1.189 . . . . 0.0 110.62 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 1.18 ' CE2' HD21 ' B' ' 179' ' ' LEU . 4.0 m-85 -57.28 -59.25 5.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.113 -0.992 . . . . 0.0 111.176 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.673 HG11 ' CE ' ' A' ' 35' ' ' MET . 3.2 m -79.78 159.9 4.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 122.024 0.916 . . . . 0.0 111.235 -177.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.995 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -133.93 157.83 45.01 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.8 ' HA ' HG12 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -74.34 152.2 39.63 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.053 -1.029 . . . . 0.0 109.562 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.429 ' O ' HG23 ' A' ' 68' ' ' THR . 6.9 tp -103.74 -80.31 0.53 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.518 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.409 ' C ' ' O ' ' A' ' 66' ' ' LEU . 10.7 p30 -44.61 152.94 0.18 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.313 -0.867 . . . . 0.0 109.575 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 66' ' ' LEU . 11.2 p . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.56 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 1.5 m-90 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.246 0.546 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 171' ' ' ASP . . . . . 0.603 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 0.2 OUTLIER -170.83 -55.55 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.4 0 O-C-N 121.196 -0.94 . . . . 0.0 109.001 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 172' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 46.3 Cg_endo -67.42 -89.93 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.682 2.255 . . . . 0.0 111.996 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 173' ' ' GLY . . . . . . . . . . . . . . . 163.27 73.13 0.02 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 174' ' ' MET . . . . . 0.626 ' N ' ' CD ' ' B' ' 175' ' ' PRO . 0.1 OUTLIER -74.78 -40.79 4.12 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.399 -1.059 . . . . 0.0 109.94 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 175' ' ' PRO . . . . . 0.756 ' O ' HG23 ' B' ' 176' ' ' THR . 49.3 Cg_endo -92.76 166.77 2.66 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.073 2.515 . . . . 0.0 112.075 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 176' ' ' THR . . . . . 0.756 HG23 ' O ' ' B' ' 175' ' ' PRO . 0.1 OUTLIER 161.8 116.6 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.508 -0.745 . . . . 0.0 109.152 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 177' ' ' PRO . . . . . 0.628 ' HD3' ' CD2' ' A' ' 17' ' ' TYR . 49.9 Cg_endo -87.14 172.94 5.97 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.91 2.407 . . . . 0.0 111.986 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.08 120.96 7.79 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.745 2.297 . . . . 0.0 111.975 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 1.18 HD21 ' CE2' ' A' ' 62' ' ' TYR . 74.5 mt -60.25 153.33 58.64 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.468 -0.77 . . . . 0.0 109.88 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.933 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.8 Cg_endo -67.67 176.91 4.54 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.566 2.178 . . . . 0.0 111.5 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 181' ' ' PRO . . . . . 0.619 ' O ' ' CB ' ' B' ' 182' ' ' ARG . 56.1 Cg_endo -81.36 -37.57 0.28 Allowed 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.822 2.348 . . . . 0.0 114.029 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.718 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.4 OUTLIER 82.22 98.02 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 120.997 -1.065 . . . . 0.0 109.295 -179.006 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.71 ' CG ' HD22 ' B' ' 186' ' ' LEU . 45.4 Cg_endo -69.61 130.76 20.09 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 123.206 2.604 . . . . 0.0 112.329 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 184' ' ' ALA . . . . . 0.509 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 35.63 72.89 0.09 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.436 -0.79 . . . . 0.0 109.821 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 185' ' ' ASN . . . . . 0.508 ' OD1' ' NE2' ' B' ' 190' ' ' GLN . 0.7 OUTLIER 40.59 45.34 1.96 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.37 -0.831 . . . . 0.0 109.438 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 186' ' ' LEU . . . . . 0.715 HD23 ' HB2' ' A' ' 44' ' ' TRP . 34.4 tp -54.6 -94.54 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 187' ' ' GLY . . . . . 0.871 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -76.95 -4.06 82.13 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.602 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 0.1 OUTLIER -77.52 -74.05 0.27 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.475 -1.015 . . . . 0.0 109.268 179.649 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 189' ' ' ARG . . . . . 0.558 ' O ' ' CE1' ' A' ' 23' ' ' HIS . 6.9 ttt180 71.77 101.31 0.07 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.347 -0.846 . . . . 0.0 109.385 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 190' ' ' GLN . . . . . 0.508 ' NE2' ' OD1' ' B' ' 185' ' ' ASN . 0.0 OUTLIER -89.36 156.18 18.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.92 . . . . 0.0 109.529 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.917 -1.04 . . . . 0.0 109.579 179.935 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.321 0.582 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.15 142.08 3.29 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.566 ' O ' HG23 ' A' ' 37' ' ' VAL . 2.6 m-20 -127.7 142.5 51.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -1.126 . . . . 0.0 109.283 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.557 ' CD1' ' HG2' ' A' ' 36' ' ' LYS . 2.5 tp -91.02 138.64 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 0.0 109.663 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 65' ' ' LYS . 1.9 m -131.01 160.75 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.407 -0.808 . . . . 0.0 108.908 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.8 p -120.39 138.62 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.079 -1.013 . . . . 0.0 109.283 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.4 133.35 45.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.41 -0.806 . . . . 0.0 110.101 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.956 HD11 ' HB2' ' A' ' 64' ' ' ALA . 14.7 mt -98.59 -15.2 19.57 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.648 ' CD2' ' CD ' ' B' ' 177' ' ' PRO . 53.3 m-85 -155.0 153.87 27.99 Favored Pre-proline 0 N--CA 1.486 1.374 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.698 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 41.4 Cg_endo -64.48 149.59 89.72 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 121.75 1.633 . . . . 0.0 109.805 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.81 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 59.1 t80 -98.89 179.25 4.7 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.102 -1.439 . . . . 0.0 110.346 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.682 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 73.5 m-20 -110.37 80.78 1.34 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.525 -0.735 . . . . 0.0 109.303 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.82 94.95 0.05 OUTLIER Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 20' ' ' ASP . 69.0 mt -108.74 -41.54 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -1.173 . . . . 0.0 108.895 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.593 ' CD2' ' O ' ' B' ' 188' ' ' GLU . 0.2 OUTLIER -78.14 158.81 76.7 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.103 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.579 ' HD2' ' CD2' ' A' ' 23' ' ' HIS . 48.5 Cg_endo -69.67 -13.85 35.51 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.24 1.96 . . . . 0.0 111.91 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 4.4 t70 -112.28 -13.86 13.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 110.799 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.486 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.5 OUTLIER -57.84 139.6 53.75 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.74 -1.225 . . . . 0.0 109.817 -179.282 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.929 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -95.33 121.37 36.91 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.148 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.876 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -79.44 139.98 37.5 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.338 -0.851 . . . . 0.0 109.439 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.81 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 32.6 p90 -145.2 157.09 44.17 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.19 -0.944 . . . . 0.0 108.711 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.665 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 1.4 tttt -110.56 172.95 6.56 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.492 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.539 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -66.77 151.88 46.59 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.216 -0.927 . . . . 0.0 109.343 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.7 -7.95 4.77 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -75.88 143.6 41.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.957 -1.32 . . . . 0.0 109.765 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.76 ' HD2' HD13 ' A' ' 50' ' ' LEU . 1.1 ptpt -96.97 139.63 32.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.307 -0.871 . . . . 0.0 109.398 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.59 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 3.4 mpp? -134.52 150.89 50.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.627 -0.671 . . . . 0.0 109.841 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.557 ' HG2' ' CD1' ' A' ' 12' ' ' ILE . 30.5 mtpt -102.55 123.08 45.64 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.455 -0.778 . . . . 0.0 109.42 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 11' ' ' ASP . 3.1 t -81.14 134.71 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.166 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.4 mt -110.99 -43.3 3.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.144 -0.973 . . . . 0.0 109.703 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -149.2 93.13 2.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.178 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.646 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.1 tt0 -78.24 116.24 18.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.331 -0.855 . . . . 0.0 109.326 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.739 ' HB2' HD21 ' B' ' 186' ' ' LEU . 5.7 m-70 -79.81 -100.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.301 -0.874 . . . . 0.0 109.481 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.06 -11.63 1.04 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.693 -1.242 . . . . 0.0 110.114 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.546 ' O ' ' HG3' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -156.48 -19.15 0.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.061 -1.258 . . . . 0.0 110.594 -179.711 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.797 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 66.2 m95 -136.49 99.02 3.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.882 -1.136 . . . . 0.0 109.427 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.646 ' CD1' ' CG ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -89.17 142.14 27.91 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.005 -1.059 . . . . 0.0 110.037 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -92.03 107.0 18.89 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.121 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.29 -174.78 2.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.858 . . . . 0.0 110.238 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 27.1 ttmt -124.98 111.4 15.36 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.675 -0.641 . . . . 0.0 109.277 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.627 ' N ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -56.01 126.35 25.52 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.23 -0.919 . . . . 0.0 109.776 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.76 HD13 ' HD2' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -75.66 -11.25 59.97 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.129 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.515 ' C ' HG22 ' A' ' 52' ' ' THR . 1.5 tp -46.19 -20.9 0.12 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.724 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 0.5 OUTLIER 168.02 -21.87 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.009 179.148 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.724 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 140.93 41.89 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.431 -0.793 . . . . 0.0 110.18 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.735 ' HB3' HD23 ' A' ' 27' ' ' LEU . 3.6 mtmt -87.22 134.4 33.54 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.046 -1.034 . . . . 0.0 108.375 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -122.45 119.1 29.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.95 -1.093 . . . . 0.0 109.48 -179.609 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.669 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -159.87 168.92 35.73 Favored Glycine 0 N--CA 1.486 2.027 0 C-N-CA 119.365 -1.398 . . . . 0.0 110.124 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.744 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 10.4 m-85 -72.92 133.66 44.45 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.636 -0.92 . . . . 0.0 109.929 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.551 HD12 HG21 ' A' ' 63' ' ' VAL . 7.8 pt -121.89 140.8 32.7 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.738 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 48.4 Cg_endo -69.56 140.53 43.67 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 121.676 1.584 . . . . 0.0 111.976 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.612 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 32.6 p -71.43 5.42 2.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.344 -0.847 . . . . 0.0 110.68 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' B' ' 178' ' ' PRO . 0.1 OUTLIER -106.34 -53.28 2.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.794 -1.192 . . . . 0.0 110.58 -179.134 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.576 ' CE2' HD23 ' B' ' 179' ' ' LEU . 3.4 m-85 -50.99 -61.76 2.03 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.09 -1.006 . . . . 0.0 111.012 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.59 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 3.4 m -78.04 156.22 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.948 0.88 . . . . 0.0 111.235 -177.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.956 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -131.22 160.05 36.0 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.556 ' HA ' HG12 ' A' ' 13' ' ' VAL . 9.1 mttt -76.31 95.96 3.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.994 -1.066 . . . . 0.0 109.792 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.55 ' O ' HD23 ' A' ' 66' ' ' LEU . 6.0 tt -45.89 97.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 0.0 109.441 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 65' ' ' LYS . 38.6 t-20 -141.9 119.19 11.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.313 -0.867 . . . . 0.0 109.512 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 58.4 m . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.43 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 171' ' ' ASP . . . . . 0.594 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 2.2 t0 -170.75 -55.63 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.289 -0.882 . . . . 0.0 108.921 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 172' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 47.9 Cg_endo -68.1 -90.54 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.632 2.221 . . . . 0.0 111.956 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 173' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' B' ' 174' ' ' MET . . . 60.83 27.4 66.67 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 174' ' ' MET . . . . . 0.547 ' CB ' ' O ' ' B' ' 173' ' ' GLY . 1.1 ptp 160.5 117.03 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.331 -1.1 . . . . 0.0 109.307 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 175' ' ' PRO . . . . . 0.506 ' O ' HG23 ' B' ' 176' ' ' THR . 50.6 Cg_endo -90.76 171.37 3.38 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.144 2.563 . . . . 0.0 111.724 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 176' ' ' THR . . . . . 0.588 ' CG2' ' HB3' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 172.45 104.47 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.477 -0.764 . . . . 0.0 109.268 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 177' ' ' PRO . . . . . 0.648 ' CD ' ' CD2' ' A' ' 17' ' ' TYR . 46.4 Cg_endo -69.89 163.3 38.88 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.594 2.196 . . . . 0.0 111.478 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 178' ' ' PRO . . . . . 0.41 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 45.5 Cg_endo -67.77 141.49 54.53 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.668 2.245 . . . . 0.0 111.388 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 0.614 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -83.89 174.49 5.85 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.172 -0.955 . . . . 0.0 109.628 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.797 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 39.1 Cg_endo -69.58 -176.04 1.31 Allowed 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.111 2.54 . . . . 0.0 111.917 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 181' ' ' PRO . . . . . 0.638 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 53.7 Cg_endo -90.33 -22.54 0.74 Allowed 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 123.075 2.517 . . . . 0.0 114.697 -177.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.738 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.8 OUTLIER 77.5 91.26 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 120.772 -1.205 . . . . 0.0 109.237 -179.331 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.513 ' HD3' ' HB2' ' A' ' 43' ' ' GLU . 50.7 Cg_endo -70.79 134.99 26.98 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.907 2.404 . . . . 0.0 112.029 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 184' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 39.27 64.81 0.76 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.328 -0.858 . . . . 0.0 109.625 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 185' ' ' ASN . . . . . 0.514 ' HA ' ' HB2' ' B' ' 188' ' ' GLU . 3.1 m-80 43.86 49.73 7.01 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.34 -0.85 . . . . 0.0 109.476 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 186' ' ' LEU . . . . . 0.739 HD21 ' HB2' ' A' ' 41' ' ' HIS . 35.3 tp -66.32 -87.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.321 -0.862 . . . . 0.0 109.34 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 187' ' ' GLY . . . . . 0.744 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -65.16 -7.86 33.54 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.816 -1.713 . . . . 0.0 108.816 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.593 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 3.8 mt-10 -72.1 -90.35 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.335 -1.097 . . . . 0.0 109.377 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 189' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' B' ' 188' ' ' GLU . 0.0 OUTLIER 78.44 102.82 0.07 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.367 -0.833 . . . . 0.0 109.576 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 190' ' ' GLN . . . . . 0.478 ' HG2' ' NE2' ' A' ' 23' ' ' HIS . 19.2 mt-30 -137.36 72.13 1.41 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -0.929 . . . . 0.0 109.415 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.049 -0.976 . . . . 0.0 109.501 -179.997 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.363 0.601 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.3 171.81 50.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -158.66 -174.62 4.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.375 -1.074 . . . . 0.0 109.286 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.736 HD12 ' HD3' ' A' ' 36' ' ' LYS . 2.6 tp -111.99 137.08 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 109.529 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.576 HG22 HG23 ' A' ' 37' ' ' VAL . 1.4 m -132.83 161.79 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.385 -0.822 . . . . 0.0 109.161 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.7 p -120.26 138.84 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.97 -1.081 . . . . 0.0 109.219 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.64 133.65 45.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.327 -0.858 . . . . 0.0 109.896 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.979 HD11 ' HB2' ' A' ' 64' ' ' ALA . 25.4 mt -99.09 -12.1 20.83 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.815 ' HB3' HG23 ' B' ' 176' ' ' THR . 39.5 m-85 -158.63 155.07 24.4 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.7 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 42.2 Cg_endo -64.71 149.04 90.35 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 121.761 1.641 . . . . 0.0 109.887 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.826 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 59.9 t80 -98.82 178.86 4.84 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 118.373 -1.331 . . . . 0.0 110.415 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.758 ' OD2' HD21 ' B' ' 179' ' ' LEU . 6.2 p30 -110.21 80.29 1.3 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.584 -0.698 . . . . 0.0 109.522 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.61 95.86 0.05 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 20' ' ' ASP . 0.5 OUTLIER -108.96 -41.78 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.243 -1.151 . . . . 0.0 108.859 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.645 ' CE1' ' HG2' ' B' ' 188' ' ' GLU . 13.3 m80 -77.72 159.41 76.69 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.33 -13.79 33.62 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.195 1.93 . . . . 0.0 111.804 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -112.37 -14.29 13.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.143 -0.973 . . . . 0.0 110.758 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.434 ' OD2' ' NH2' ' B' ' 182' ' ' ARG . 2.1 m-20 -57.32 139.06 53.99 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.825 -1.172 . . . . 0.0 109.646 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.951 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -94.66 121.26 36.05 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.113 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.892 ' N ' HD22 ' A' ' 27' ' ' LEU . 55.9 p -80.26 140.59 36.15 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.265 -0.897 . . . . 0.0 109.427 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.826 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 23.4 p90 -146.06 157.87 43.86 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.145 -0.972 . . . . 0.0 108.875 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.61 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -111.07 168.06 9.78 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.122 -0.987 . . . . 0.0 109.453 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.567 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -62.23 153.63 29.92 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.135 -0.978 . . . . 0.0 109.628 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.69 -8.11 3.5 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 5.2 tt0 -75.65 142.61 42.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.979 -1.307 . . . . 0.0 109.912 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.483 ' HB3' HD13 ' A' ' 50' ' ' LEU . 0.7 OUTLIER -96.2 139.28 32.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.227 -0.921 . . . . 0.0 109.312 179.701 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.603 ' CE ' HG11 ' A' ' 63' ' ' VAL . 2.6 mpp? -135.28 151.44 50.57 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.606 -0.684 . . . . 0.0 109.919 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.736 ' HD3' HD12 ' A' ' 12' ' ' ILE . 5.8 tppp? -105.07 124.13 49.0 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.533 -0.729 . . . . 0.0 109.186 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.576 HG23 HG22 ' A' ' 13' ' ' VAL . 6.7 t -81.03 132.73 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.855 . . . . 0.0 109.291 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.7 mt -107.7 -47.43 3.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.152 -0.968 . . . . 0.0 109.63 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -142.42 97.47 3.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.943 . . . . 0.0 108.936 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.616 ' HG2' ' CD1' ' A' ' 45' ' ' TRP . 2.3 tm-20 -84.17 116.66 23.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.359 -0.838 . . . . 0.0 109.653 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.809 ' HB2' HD21 ' B' ' 186' ' ' LEU . 18.3 m80 -80.58 -98.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.433 -0.792 . . . . 0.0 109.458 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.26 -11.36 0.67 Allowed Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.32 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.566 ' O ' ' HG3' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -156.85 -18.78 0.09 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.879 -1.365 . . . . 0.0 110.413 -179.692 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.86 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 67.2 m95 -135.78 96.17 3.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.902 -1.124 . . . . 0.0 109.124 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.622 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -88.21 145.27 25.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.022 -1.049 . . . . 0.0 110.119 -179.253 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.6 OUTLIER -93.7 107.43 19.31 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.219 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -104.55 -173.96 2.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.296 -0.878 . . . . 0.0 110.094 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 2.7 ttpm? -125.46 126.84 45.56 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.59 -0.694 . . . . 0.0 109.459 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.657 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -70.92 126.5 29.74 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.111 -0.993 . . . . 0.0 110.03 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.483 HD13 ' HB3' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -72.24 -7.47 49.52 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.784 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 51' ' ' LEU . 27.8 tp -54.49 -55.05 33.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.503 -0.748 . . . . 0.0 109.253 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.5 t -161.16 29.69 0.14 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.122 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.587 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 86.36 45.85 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.482 -0.761 . . . . 0.0 110.671 178.622 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.657 ' HB2' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER -86.94 132.3 33.84 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.068 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.454 ' HG2' ' CE ' ' A' ' 46' ' ' LYS . 20.2 tt0 -121.59 116.38 24.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.942 -1.099 . . . . 0.0 109.353 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.635 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -157.13 169.26 34.19 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 119.385 -1.388 . . . . 0.0 110.032 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.724 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 11.0 m-85 -73.55 133.91 43.67 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.625 -0.926 . . . . 0.0 109.958 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 45' ' ' TRP . 2.6 pt -121.68 142.51 36.04 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.677 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 49.6 Cg_endo -69.93 152.0 68.3 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 121.792 1.661 . . . . 0.0 111.816 -178.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.543 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 66.1 p -80.81 5.67 15.27 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 110.006 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 4.4 p-10 -106.01 -52.48 2.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.997 -1.065 . . . . 0.0 110.941 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.882 ' CE1' HG22 ' B' ' 176' ' ' THR . 4.5 m-85 -52.63 -61.28 2.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.099 -1.001 . . . . 0.0 111.263 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.603 HG11 ' CE ' ' A' ' 35' ' ' MET . 2.6 m -79.83 155.49 4.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 122.069 0.938 . . . . 0.0 111.092 -177.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.979 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -133.61 161.05 35.68 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.61 150.53 37.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.0 -1.063 . . . . 0.0 109.537 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.501 ' O ' ' HB2' ' A' ' 67' ' ' ASN . 0.6 OUTLIER -126.2 -24.4 3.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.103 -0.998 . . . . 0.0 109.638 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER 75.59 -81.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.912 . . . . 0.0 109.516 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.437 -179.961 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 170' ' ' TRP . . . . . 0.5 ' O ' ' HB2' ' B' ' 171' ' ' ASP . 1.6 m-90 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 171' ' ' ASP . . . . . 0.562 ' N ' ' HD3' ' B' ' 172' ' ' PRO . 4.3 t0 172.68 59.62 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.295 -0.878 . . . . 0.0 108.637 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 172' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' B' ' 171' ' ' ASP . 54.8 Cg_endo -88.68 -88.42 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.855 2.37 . . . . 0.0 112.009 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 173' ' ' GLY . . . . . . . . . . . . . . . 133.0 -36.3 2.17 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 178.43 109.0 0.15 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.284 -1.127 . . . . 0.0 109.398 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 175' ' ' PRO . . . . . 0.533 ' HG2' ' CE1' ' A' ' 17' ' ' TYR . 50.8 Cg_endo -91.0 174.25 2.69 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.135 2.557 . . . . 0.0 111.819 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 176' ' ' THR . . . . . 0.882 HG22 ' CE1' ' A' ' 62' ' ' TYR . 0.0 OUTLIER 178.37 105.31 0.14 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 109.496 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 177' ' ' PRO . . . . . 0.633 ' CD ' ' CD2' ' A' ' 17' ' ' TYR . 50.8 Cg_endo -75.64 174.58 12.56 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.446 2.097 . . . . 0.0 111.656 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 178' ' ' PRO . . . . . 0.507 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 46.6 Cg_endo -68.24 137.69 40.98 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.613 2.208 . . . . 0.0 111.667 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 0.758 HD21 ' OD2' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -87.96 177.33 2.73 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.281 -0.887 . . . . 0.0 109.797 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.86 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 39.5 Cg_endo -68.92 -176.02 1.13 Allowed 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 123.03 2.487 . . . . 0.0 111.991 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 181' ' ' PRO . . . . . 0.739 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 52.0 Cg_endo -92.74 -20.57 0.49 Allowed 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 123.28 2.653 . . . . 0.0 114.661 -177.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.756 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.0 OUTLIER 78.75 89.9 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 120.873 -1.142 . . . . 0.0 109.175 -179.106 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.576 ' HG2' HD22 ' B' ' 186' ' ' LEU . 49.1 Cg_endo -70.41 137.43 33.55 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.804 2.336 . . . . 0.0 112.039 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 184' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 37.26 60.87 1.0 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.424 -0.797 . . . . 0.0 109.562 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 46.91 47.71 15.44 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.154 -0.966 . . . . 0.0 109.125 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 186' ' ' LEU . . . . . 0.809 HD21 ' HB2' ' A' ' 41' ' ' HIS . 20.5 tp -61.18 -84.93 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.517 -0.739 . . . . 0.0 109.427 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 187' ' ' GLY . . . . . 0.724 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -76.55 32.79 1.39 Allowed Glycine 0 N--CA 1.486 1.988 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.645 ' HG2' ' CE1' ' A' ' 23' ' ' HIS . 31.0 mt-10 -103.98 -73.18 0.68 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.282 -1.128 . . . . 0.0 109.466 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 189' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.38 165.83 5.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.391 -0.818 . . . . 0.0 109.413 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -101.57 31.2 3.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.472 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.461 -179.984 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.471 ' HA ' ' OE1' ' A' ' 9' ' ' GLN . 44.4 mm-40 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.89 -99.29 0.43 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.24 -176.12 5.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -1.181 . . . . 0.0 109.444 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.16 137.55 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.296 -0.877 . . . . 0.0 109.523 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 m -131.79 161.3 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 0.0 109.279 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.5 p -120.13 139.99 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.126 -0.984 . . . . 0.0 109.186 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -73.1 133.06 44.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.475 -0.765 . . . . 0.0 110.122 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.044 HD11 ' HB2' ' A' ' 64' ' ' ALA . 8.7 mt -100.1 -14.01 18.75 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 1.027 ' HB3' HG22 ' B' ' 176' ' ' THR . 34.1 m-85 -155.84 150.47 20.31 Favored Pre-proline 0 N--CA 1.489 1.476 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.722 ' HD3' ' HG3' ' A' ' 31' ' ' LYS . 39.6 Cg_endo -61.09 149.03 91.11 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 121.718 1.612 . . . . 0.0 109.742 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.793 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 60.9 t80 -97.95 178.23 5.18 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.041 -1.464 . . . . 0.0 110.525 -177.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.679 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 30.6 t0 -109.75 80.46 1.32 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.673 -0.642 . . . . 0.0 109.408 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.63 93.22 0.03 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.524 HG12 ' O ' ' A' ' 20' ' ' ASP . 0.6 OUTLIER -107.26 -42.81 6.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.142 -1.21 . . . . 0.0 108.675 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.79 ' CE1' ' NH1' ' B' ' 182' ' ' ARG . 28.1 m80 -76.86 156.43 82.54 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.97 -13.94 37.61 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.287 1.991 . . . . 0.0 111.998 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -111.71 -13.72 13.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.341 -0.85 . . . . 0.0 110.493 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.481 ' OD2' ' OH ' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -57.97 140.52 52.09 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.827 -1.171 . . . . 0.0 109.989 -179.316 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.96 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -95.62 122.11 38.03 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.077 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.879 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -80.54 140.48 35.81 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.203 -0.935 . . . . 0.0 109.282 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.793 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 29.9 p90 -146.99 158.27 43.87 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.124 -0.985 . . . . 0.0 109.042 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.667 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 16.4 mttp -111.69 174.61 5.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.165 -0.959 . . . . 0.0 109.41 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.722 ' HG3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -66.54 155.88 36.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.875 -1.141 . . . . 0.0 109.428 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 67.71 -6.75 2.51 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -75.24 140.51 43.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.86 -1.377 . . . . 0.0 109.573 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.9 138.99 32.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.532 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.581 ' CE ' HG11 ' A' ' 63' ' ' VAL . 3.5 mpp? -135.83 152.14 50.77 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.473 0.654 . . . . 0.0 109.753 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.9 OUTLIER -108.6 126.14 52.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.459 -0.776 . . . . 0.0 109.313 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.554 HG11 ' HG3' ' A' ' 40' ' ' GLU . 3.9 t -82.14 126.31 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.357 -0.839 . . . . 0.0 109.37 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.496 HD11 ' OE2' ' A' ' 55' ' ' GLU . 36.8 mt -99.33 -46.57 5.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.924 . . . . 0.0 109.429 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.5 90.62 2.58 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.596 ' HG2' ' CD1' ' A' ' 45' ' ' TRP . 1.4 tt0 -76.55 117.67 18.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.4 -0.812 . . . . 0.0 109.965 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.407 ' HB2' HD21 ' B' ' 186' ' ' LEU . 5.1 m80 -87.34 -98.8 0.08 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.336 -0.853 . . . . 0.0 109.074 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.07 -7.52 0.11 Allowed Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.328 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.565 ' HB2' ' HD3' ' B' ' 183' ' ' PRO . 3.0 mp0 -149.43 -29.52 0.25 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.957 -1.32 . . . . 0.0 110.098 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.819 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 67.7 m95 -137.7 97.32 3.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 109.328 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.596 ' CD1' ' HG2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -88.42 146.64 25.12 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.976 -1.078 . . . . 0.0 110.147 -179.718 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.572 ' HG3' ' CD1' ' A' ' 57' ' ' PHE . 0.7 OUTLIER -93.15 107.07 18.94 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -104.75 -173.39 2.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.211 -0.931 . . . . 0.0 110.045 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.606 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -125.73 129.27 49.16 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.57 -0.706 . . . . 0.0 109.664 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.62 ' HB2' ' HB3' ' A' ' 54' ' ' LYS . 1.2 t -74.07 128.08 34.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.0 109.882 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.63 -8.88 57.49 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 51' ' ' LEU . 15.3 tp -53.08 -55.11 26.39 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.41 -0.806 . . . . 0.0 109.329 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.596 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.8 t -161.24 29.61 0.14 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.094 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.596 ' CB ' ' O ' ' A' ' 52' ' ' THR . 3.9 mttm 86.59 45.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.356 -0.84 . . . . 0.0 110.607 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.62 ' HB3' ' HB2' ' A' ' 49' ' ' SER . 8.1 tttt -85.79 132.67 34.07 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.496 ' OE2' HD11 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -122.52 116.7 24.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.939 -1.101 . . . . 0.0 109.412 -179.696 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.636 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -157.62 169.09 34.44 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 119.459 -1.353 . . . . 0.0 109.972 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.855 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 6.3 m-85 -72.65 133.76 44.79 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.72 -0.871 . . . . 0.0 109.874 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.45 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 6.5 pt -121.97 143.6 39.13 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.754 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 50.1 Cg_endo -71.41 152.0 60.13 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 121.778 1.652 . . . . 0.0 112.176 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.477 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 28.1 t -80.32 6.26 12.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.314 -0.866 . . . . 0.0 110.81 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.554 ' ND2' ' O ' ' B' ' 178' ' ' PRO . 0.1 OUTLIER -108.99 -52.51 2.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.795 -1.19 . . . . 0.0 110.709 -179.147 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.62 ' HE2' HD23 ' B' ' 179' ' ' LEU . 3.9 m-85 -50.04 -62.59 1.49 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.043 -1.036 . . . . 0.0 110.9 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.581 HG11 ' CE ' ' A' ' 35' ' ' MET . 3.1 m -79.14 155.31 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 121.925 0.869 . . . . 0.0 111.086 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.044 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -130.76 159.56 36.94 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.429 ' O ' HD12 ' A' ' 66' ' ' LEU . 11.1 mtpt -75.96 94.33 3.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.037 -1.04 . . . . 0.0 109.57 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -138.78 151.3 46.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.636 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -172.61 157.65 3.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.322 -0.861 . . . . 0.0 109.43 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.104 -0.997 . . . . 0.0 109.443 -179.931 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 63.8 m95 . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 171' ' ' ASP . . . . . 0.592 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 4.9 m-20 -169.61 -56.43 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.251 -0.905 . . . . 0.0 108.845 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 172' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 48.0 Cg_endo -67.88 -90.28 0.0 OUTLIER 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.724 2.282 . . . . 0.0 111.841 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 173' ' ' GLY . . . . . . . . . . . . . . . 175.76 42.43 0.05 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 174' ' ' MET . . . . . 0.553 ' N ' ' CD ' ' B' ' 175' ' ' PRO . 0.5 OUTLIER -50.27 -47.45 82.58 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.193 -1.181 . . . . 0.0 109.459 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 175' ' ' PRO . . . . . 0.908 ' O ' HG23 ' B' ' 176' ' ' THR . 55.2 Cg_endo -81.59 -164.75 0.29 Allowed 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.733 2.289 . . . . 0.0 111.859 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 176' ' ' THR . . . . . 1.027 HG22 ' HB3' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -173.18 100.83 0.33 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.429 -0.795 . . . . 0.0 109.198 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 177' ' ' PRO . . . . . 0.602 ' HD2' ' CD2' ' A' ' 17' ' ' TYR . 50.9 Cg_endo -69.71 161.57 45.42 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.801 2.334 . . . . 0.0 111.965 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 178' ' ' PRO . . . . . 0.554 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 51.4 Cg_endo -70.07 159.83 51.76 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.717 2.278 . . . . 0.0 111.066 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 0.642 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -91.77 175.42 3.45 Favored Pre-proline 0 C--N 1.303 -1.421 0 O-C-N 121.007 -1.058 . . . . 0.0 109.778 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.819 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 40.2 Cg_endo -69.13 -172.15 0.48 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.268 2.645 . . . . 0.0 111.652 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 181' ' ' PRO . . . . . 0.686 ' O ' ' CB ' ' B' ' 182' ' ' ARG . 53.3 Cg_endo -88.54 -40.96 0.05 OUTLIER 'Trans proline' 0 C--O 1.214 -0.721 0 C-N-CA 122.679 2.253 . . . . 0.0 114.025 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.79 ' NH1' ' CE1' ' A' ' 23' ' ' HIS . 2.7 ttm180 91.49 92.92 0.03 OUTLIER Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.299 -0.875 . . . . 0.0 109.39 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.565 ' HD3' ' HB2' ' A' ' 43' ' ' GLU . 48.8 Cg_endo -71.99 133.99 22.59 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.996 2.464 . . . . 0.0 112.144 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 184' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 36.66 69.81 0.19 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.49 -0.757 . . . . 0.0 109.725 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 185' ' ' ASN . . . . . 0.453 ' C ' ' O ' ' B' ' 184' ' ' ALA . 2.9 p-10 39.46 45.42 1.27 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.417 -0.802 . . . . 0.0 109.44 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 186' ' ' LEU . . . . . 0.597 ' CG ' ' HB2' ' A' ' 44' ' ' TRP . 18.1 tp -53.82 -89.0 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.458 -0.776 . . . . 0.0 109.046 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 187' ' ' GLY . . . . . 0.855 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -82.02 26.05 3.94 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.722 ' HG3' ' CE1' ' A' ' 23' ' ' HIS . 1.5 tt0 -99.51 -30.85 11.92 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.251 -1.147 . . . . 0.0 109.423 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 189' ' ' ARG . . . . . 0.451 ' C ' ' HG2' ' B' ' 190' ' ' GLN . 0.0 OUTLIER 47.31 40.2 10.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 109.536 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 190' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' B' ' 188' ' ' GLU . 13.9 mm100 -145.42 84.95 1.7 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.94 . . . . 0.0 109.55 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.501 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.317 0.579 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.41 112.92 3.62 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.74 162.92 13.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.347 -1.09 . . . . 0.0 109.405 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.7 tp -107.9 137.87 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.142 -0.974 . . . . 0.0 109.59 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 65' ' ' LYS . 1.5 m -132.0 161.76 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.44 HG12 ' HB2' ' A' ' 66' ' ' LEU . 8.0 p -120.94 139.18 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.024 -1.047 . . . . 0.0 109.279 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.53 134.55 46.57 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.395 -0.816 . . . . 0.0 109.731 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.712 ' CD1' ' HB2' ' A' ' 64' ' ' ALA . 19.2 mt -99.41 -21.72 15.86 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.68 ' CE1' ' HB2' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -148.68 152.55 37.93 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.439 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.697 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 39.8 Cg_endo -62.92 149.63 90.93 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 121.931 1.754 . . . . 0.0 110.185 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.811 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 55.9 t80 -98.84 179.13 4.75 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.153 -1.419 . . . . 0.0 110.432 -177.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.69 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 57.7 m-20 -110.84 79.86 1.25 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.682 -0.636 . . . . 0.0 109.356 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.8 95.15 0.04 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 20' ' ' ASP . 15.2 mm -108.42 -41.97 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -1.13 . . . . 0.0 108.893 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.516 ' CD2' ' O ' ' B' ' 188' ' ' GLU . 36.2 m80 -77.56 158.88 78.15 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.53 -14.17 36.39 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.284 1.989 . . . . 0.0 111.869 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.0 -13.51 13.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.0 110.416 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.66 138.08 55.76 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.821 -1.174 . . . . 0.0 109.809 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.929 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -95.53 121.22 36.99 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.875 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.874 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.1 m -79.99 141.3 36.08 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.355 -0.84 . . . . 0.0 109.475 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.811 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 28.3 p90 -145.84 157.54 43.91 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.201 -0.937 . . . . 0.0 108.588 178.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.665 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 40.6 mttm -110.65 173.82 6.15 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.087 -1.008 . . . . 0.0 109.585 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.506 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -67.52 151.54 47.19 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.111 -0.993 . . . . 0.0 109.314 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.87 -8.09 4.83 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -75.43 140.46 42.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.928 -1.336 . . . . 0.0 109.788 -179.676 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -93.54 138.66 31.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.862 . . . . 0.0 109.263 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.629 ' CE ' HG11 ' A' ' 63' ' ' VAL . 1.9 mpp? -135.24 151.66 50.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.622 -0.674 . . . . 0.0 109.796 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.739 ' HD3' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -106.16 124.61 49.85 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.469 -0.769 . . . . 0.0 109.62 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.628 HG11 ' HG3' ' A' ' 40' ' ' GLU . 1.4 t -82.21 132.32 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.34 -0.85 . . . . 0.0 108.846 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.739 HD23 ' HD3' ' A' ' 36' ' ' LYS . 3.7 mt -110.37 -42.51 4.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.006 -1.059 . . . . 0.0 109.849 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -138.8 84.47 2.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.178 -0.951 . . . . 0.0 109.215 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.628 ' HG3' HG11 ' A' ' 37' ' ' VAL . 1.4 tt0 -67.96 116.14 8.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.861 . . . . 0.0 109.274 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.746 ' HB2' HD21 ' B' ' 186' ' ' LEU . 60.0 m80 -86.04 -103.32 0.06 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.235 -0.916 . . . . 0.0 109.398 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.425 ' O ' ' HG3' ' A' ' 43' ' ' GLU . . . -136.4 -15.39 0.88 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.304 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.582 ' CG ' ' HD2' ' B' ' 181' ' ' PRO . 1.3 mt-10 -158.0 -20.24 0.08 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.944 -1.327 . . . . 0.0 110.525 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.939 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 57.1 m95 -133.51 93.81 3.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.919 -1.113 . . . . 0.0 108.676 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.63 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -85.85 146.57 26.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.074 -1.016 . . . . 0.0 110.796 -178.52 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 1.1 ttpt -94.21 105.85 17.83 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.41 -174.05 2.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.32 -0.862 . . . . 0.0 110.125 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.9 mttp -125.72 126.85 45.29 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.542 -0.724 . . . . 0.0 109.496 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.601 ' HB2' ' HB3' ' A' ' 54' ' ' LYS . 1.8 t -70.94 125.62 27.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.136 -0.978 . . . . 0.0 109.875 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.75 -8.69 54.09 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.656 HD13 ' O ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -53.4 -55.27 26.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.508 -0.745 . . . . 0.0 109.352 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.633 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 1.5 t -161.16 30.11 0.14 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.267 -0.896 . . . . 0.0 110.186 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.633 ' HB2' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 85.58 45.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.499 -0.751 . . . . 0.0 110.651 178.547 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -86.8 132.18 33.91 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.122 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 1.4 pt-20 -121.82 117.56 26.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.89 -1.131 . . . . 0.0 109.455 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.642 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -157.67 168.67 34.38 Favored Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.346 -1.407 . . . . 0.0 110.158 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.75 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 15.5 m-85 -73.54 134.33 43.78 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.686 -0.89 . . . . 0.0 109.954 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.463 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 4.1 pt -122.37 141.16 34.09 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.59 ' HG3' ' CD2' ' B' ' 179' ' ' LEU . 53.4 Cg_endo -72.48 134.43 22.48 Favored 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 121.673 1.582 . . . . 0.0 111.997 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.623 ' HB3' ' CE2' ' A' ' 45' ' ' TRP . 24.3 p -65.2 4.69 0.45 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 110.422 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.67 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 5.9 p-10 -102.01 -51.64 3.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.871 -1.143 . . . . 0.0 110.86 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 1.182 ' CE2' HD21 ' B' ' 179' ' ' LEU . 3.1 m-85 -55.27 -59.99 4.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.142 -0.974 . . . . 0.0 111.304 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.629 HG11 ' CE ' ' A' ' 35' ' ' MET . 4.2 m -78.74 157.61 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 122.054 0.931 . . . . 0.0 111.41 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.712 ' HB2' ' CD1' ' A' ' 16' ' ' LEU . . . -135.63 161.88 34.29 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.509 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -75.55 93.28 2.99 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.046 -1.033 . . . . 0.0 109.265 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -146.62 147.4 31.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.448 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.516 ' ND2' ' N ' ' A' ' 68' ' ' THR . 1.0 OUTLIER 171.06 157.95 0.08 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -0.873 . . . . 0.0 109.496 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.516 ' N ' ' ND2' ' A' ' 67' ' ' ASN . 1.6 t . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.487 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 12.5 m95 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.326 0.584 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 171' ' ' ASP . . . . . 0.606 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 1.9 m-20 -170.18 -56.15 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.209 -0.932 . . . . 0.0 108.809 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 172' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 47.8 Cg_endo -67.9 -90.36 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.678 2.252 . . . . 0.0 111.868 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 173' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' B' ' 174' ' ' MET . . . 80.09 32.16 36.6 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 174' ' ' MET . . . . . 0.475 ' HB2' ' O ' ' B' ' 173' ' ' GLY . 32.0 mtm 65.31 87.39 0.12 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.398 -1.06 . . . . 0.0 109.552 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 175' ' ' PRO . . . . . 0.765 ' O ' HG23 ' B' ' 176' ' ' THR . 53.8 Cg_endo -83.07 -167.13 0.43 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.677 2.252 . . . . 0.0 111.842 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 176' ' ' THR . . . . . 0.765 HG23 ' O ' ' B' ' 175' ' ' PRO . 0.2 OUTLIER 160.59 117.56 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 177' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -86.69 168.21 8.37 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.847 2.365 . . . . 0.0 111.959 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.81 114.82 3.67 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.754 2.302 . . . . 0.0 111.789 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 1.182 HD21 ' CE2' ' A' ' 62' ' ' TYR . 46.2 mt -51.2 158.41 1.3 Allowed Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.328 -0.857 . . . . 0.0 109.955 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.939 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 39.6 Cg_endo -68.79 176.32 6.16 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.755 2.303 . . . . 0.0 111.648 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 181' ' ' PRO . . . . . 0.61 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 55.5 Cg_endo -86.82 -26.85 0.82 Allowed 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.885 2.39 . . . . 0.0 114.51 -177.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.727 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.0 OUTLIER 79.41 95.67 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 120.818 -1.176 . . . . 0.0 109.458 -179.213 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.752 ' CG ' HD22 ' B' ' 186' ' ' LEU . 48.0 Cg_endo -69.68 131.19 20.83 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 123.064 2.509 . . . . 0.0 112.269 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 184' ' ' ALA . . . . . 0.506 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 35.64 69.13 0.19 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.448 -0.782 . . . . 0.0 109.874 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 185' ' ' ASN . . . . . 0.447 ' HA ' ' HB3' ' B' ' 188' ' ' GLU . 0.2 OUTLIER 43.34 45.33 5.13 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.377 -0.827 . . . . 0.0 109.537 -179.824 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 186' ' ' LEU . . . . . 0.753 HD23 ' HB2' ' A' ' 44' ' ' TRP . 28.4 tp -55.7 -94.96 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 187' ' ' GLY . . . . . 0.75 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -71.58 -8.25 66.69 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 107.859 -2.097 . . . . 0.0 107.859 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.544 ' CA ' ' HD3' ' B' ' 182' ' ' ARG . 6.3 tt0 -74.62 -6.31 47.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.617 -0.931 . . . . 0.0 109.412 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 189' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -177.63 -78.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.177 -0.952 . . . . 0.0 109.52 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 190' ' ' GLN . . . . . 0.454 ' O ' ' O ' ' B' ' 191' ' ' ALA . 1.7 mt-30 -157.75 113.43 2.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.521 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 191' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' B' ' 184' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.43 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.246 0.546 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.22 118.15 5.46 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.88 170.4 7.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -1.141 . . . . 0.0 109.424 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 36.0 mm -102.86 133.93 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.195 -0.941 . . . . 0.0 109.366 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 1.001 HG12 ' HA ' ' A' ' 65' ' ' LYS . 1.0 OUTLIER -132.36 159.57 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.508 -0.745 . . . . 0.0 109.171 -179.424 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 p -119.45 135.51 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.878 -1.139 . . . . 0.0 108.95 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.612 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -70.21 131.62 44.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.409 -0.807 . . . . 0.0 110.594 -178.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.024 HD11 ' HB2' ' A' ' 64' ' ' ALA . 95.2 mt -98.79 -39.31 8.69 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' B' ' 175' ' ' PRO . 16.4 m-85 -122.33 139.28 30.44 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -63.0 150.61 88.15 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.625 2.217 . . . . 0.0 113.015 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.786 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 25.1 t80 -130.25 115.97 17.72 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.417 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.5 OUTLIER -94.72 119.11 32.8 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 116.294 -2.162 . . . . 0.0 108.922 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -41.92 99.19 0.01 OUTLIER Glycine 0 N--CA 1.487 2.077 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 20' ' ' ASP . 12.9 mm -88.64 -54.03 8.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.608 ' CG ' ' HD3' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -66.39 -171.02 0.07 OUTLIER Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.608 ' HD3' ' CG ' ' A' ' 23' ' ' HIS . 52.2 Cg_endo -92.26 -13.48 1.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.54 2.16 . . . . 0.0 112.333 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -117.8 -11.14 10.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 0.0 110.779 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.488 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 99.5 m-20 -57.64 140.4 51.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.001 -1.062 . . . . 0.0 110.413 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.01 HD22 ' N ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -97.64 126.43 42.94 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.928 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . 1.01 ' N ' HD22 ' A' ' 27' ' ' LEU . 9.4 m -81.62 138.02 35.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.149 -0.969 . . . . 0.0 110.693 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.786 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 18.5 p90 -145.84 156.66 43.71 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -112.09 163.19 14.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.015 -1.053 . . . . 0.0 109.618 -179.368 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.41 151.6 12.87 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.218 -0.926 . . . . 0.0 108.99 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.49 -8.42 3.07 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 3.2 tm-20 -73.66 144.41 45.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.93 -1.336 . . . . 0.0 109.997 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.712 ' HB2' HD12 ' A' ' 50' ' ' LEU . 4.0 mtmp? -96.03 135.98 37.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.91 . . . . 0.0 109.336 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.583 ' CE ' HG11 ' A' ' 63' ' ' VAL . 1.4 mpp? -134.52 150.67 50.8 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.518 -0.739 . . . . 0.0 110.02 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 13.0 tttt -105.74 117.52 34.24 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.529 -0.732 . . . . 0.0 109.182 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.677 HG23 HG22 ' A' ' 13' ' ' VAL . 2.5 t -76.92 132.42 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.386 -0.821 . . . . 0.0 109.185 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 98.2 mt -103.47 -50.53 3.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.722 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -140.89 103.94 4.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 108.913 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.653 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.2 tm-20 -87.54 119.22 27.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.459 -0.776 . . . . 0.0 109.784 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.704 ' HB2' HD21 ' B' ' 186' ' ' LEU . 4.0 m80 -83.85 -98.39 0.05 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.379 -0.826 . . . . 0.0 109.206 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.483 ' O ' ' HG2' ' A' ' 43' ' ' GLU . . . -138.98 -13.1 0.71 Allowed Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.654 -1.26 . . . . 0.0 110.318 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' B' ' 180' ' ' PRO . 12.0 mt-10 -153.24 -16.43 0.15 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.918 -1.343 . . . . 0.0 110.412 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.784 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 65.3 m95 -140.21 100.1 3.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.939 -1.101 . . . . 0.0 109.53 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.662 ' CZ2' ' CB ' ' A' ' 60' ' ' SER . 0.1 OUTLIER -92.51 144.41 25.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.135 -0.978 . . . . 0.0 109.809 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -85.66 108.92 18.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.267 -0.895 . . . . 0.0 108.642 179.234 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.51 -177.87 3.5 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.264 -0.897 . . . . 0.0 110.01 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 8.5 mtpt -125.0 132.02 53.32 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.586 -0.697 . . . . 0.0 109.608 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.629 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 4.4 t -79.87 129.1 34.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.927 . . . . 0.0 109.717 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.712 HD12 ' HB2' ' A' ' 34' ' ' LYS . 19.6 mt -74.14 -5.24 40.56 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.7 tp -55.91 -54.76 40.77 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.334 -0.854 . . . . 0.0 109.132 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.624 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -160.4 27.56 0.16 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.33 -0.857 . . . . 0.0 110.04 179.323 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.624 ' HB2' ' O ' ' A' ' 52' ' ' THR . 5.0 mtpm? 87.2 43.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.586 -0.696 . . . . 0.0 110.805 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.629 ' HB2' ' CB ' ' A' ' 49' ' ' SER . 3.0 mmtp -85.27 132.57 34.24 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -122.63 116.54 23.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.955 -1.091 . . . . 0.0 109.424 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.649 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -152.67 170.62 31.8 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.67 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 5.1 m-85 -73.0 132.05 42.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.449 -1.03 . . . . 0.0 109.52 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.536 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 7.2 pt -121.14 140.17 30.64 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 108.965 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.675 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 49.3 Cg_endo -68.87 153.38 72.87 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.42 2.08 . . . . 0.0 112.022 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.662 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 77.4 p -85.61 6.55 26.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 109.948 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.574 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 3.4 p-10 -105.95 -47.58 3.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.145 -0.972 . . . . 0.0 110.158 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.783 ' CE2' HD23 ' B' ' 179' ' ' LEU . 10.4 m-30 -56.76 -59.97 4.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.495 -0.753 . . . . 0.0 110.956 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 15' ' ' ALA . 3.1 m -80.11 163.28 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 111.296 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.024 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -137.24 130.59 31.16 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 1.001 ' HA ' HG12 ' A' ' 13' ' ' VAL . 0.7 OUTLIER -48.37 179.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.154 -0.966 . . . . 0.0 109.849 -179.441 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.502 ' HA ' HD23 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -126.9 24.37 6.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.292 -0.88 . . . . 0.0 109.602 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -78.29 -154.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.895 . . . . 0.0 109.44 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.3 p . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.507 -179.987 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 5.0 p90 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 171' ' ' ASP . . . . . 0.583 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 0.9 OUTLIER -167.53 -57.14 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.28 -0.888 . . . . 0.0 108.865 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 172' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 45.5 Cg_endo -67.42 -89.35 0.0 OUTLIER 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.719 2.279 . . . . 0.0 111.821 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 173' ' ' GLY . . . . . 0.469 ' O ' ' HG2' ' B' ' 174' ' ' MET . . . -168.53 38.01 0.21 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 174' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' B' ' 173' ' ' GLY . 0.6 OUTLIER -144.22 91.54 6.4 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.317 -1.108 . . . . 0.0 109.399 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 175' ' ' PRO . . . . . 0.602 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 55.1 Cg_endo -77.81 -160.5 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.654 2.236 . . . . 0.0 111.705 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 176' ' ' THR . . . . . 0.585 HG22 ' HB3' ' A' ' 17' ' ' TYR . 21.1 p -150.27 93.22 3.89 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.429 -0.795 . . . . 0.0 109.316 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 177' ' ' PRO . . . . . 0.573 ' HD2' ' CD2' ' A' ' 17' ' ' TYR . 52.9 Cg_endo -74.08 174.17 12.87 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.683 2.255 . . . . 0.0 111.702 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 178' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' B' ' 177' ' ' PRO . 49.8 Cg_endo -71.03 110.38 2.8 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.547 2.164 . . . . 0.0 111.831 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 0.783 HD23 ' CE2' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -49.94 177.05 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.342 -0.849 . . . . 0.0 109.258 179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.784 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.4 Cg_endo -67.36 -175.84 0.75 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.872 2.382 . . . . 0.0 111.797 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 181' ' ' PRO . . . . . 0.738 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 53.5 Cg_endo -91.88 -22.58 0.48 Allowed 'Trans proline' 0 C--O 1.213 -0.775 0 C-N-CA 123.062 2.508 . . . . 0.0 114.709 -177.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.738 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 20.7 mtt180 77.0 93.07 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.892 -1.13 . . . . 0.0 109.063 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 47.0 Cg_endo -68.38 130.89 22.0 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.666 2.244 . . . . 0.0 111.848 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 184' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 43.53 61.82 2.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.367 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 47.18 50.27 14.4 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.267 -0.895 . . . . 0.0 109.274 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 186' ' ' LEU . . . . . 0.704 HD21 ' HB2' ' A' ' 41' ' ' HIS . 49.9 tp -68.51 -83.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.412 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 187' ' ' GLY . . . . . 0.67 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -68.18 -8.51 54.81 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.518 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -81.78 -86.73 0.09 Allowed 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.472 -1.017 . . . . 0.0 109.31 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 189' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.89 119.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.556 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -157.13 27.87 0.3 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.518 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.51 179.951 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.46 -118.66 0.67 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.439 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -159.64 155.83 26.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -1.126 . . . . 0.0 109.43 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.403 HD12 ' HG3' ' A' ' 36' ' ' LYS . 2.6 tp -106.3 142.13 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.233 -0.917 . . . . 0.0 109.648 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.5 m -132.33 162.46 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.443 -0.786 . . . . 0.0 109.175 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 9.7 p -121.78 138.64 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.123 -0.985 . . . . 0.0 109.209 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.2 136.85 48.26 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.469 -0.769 . . . . 0.0 109.829 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.649 HD11 ' HB2' ' A' ' 64' ' ' ALA . 55.6 mt -98.97 -25.46 14.57 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.807 ' HB3' HG22 ' B' ' 176' ' ' THR . 23.1 m-85 -144.66 154.85 56.46 Favored Pre-proline 0 N--CA 1.486 1.373 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.704 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 41.5 Cg_endo -63.99 149.36 90.7 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 121.941 1.761 . . . . 0.0 110.192 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.844 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 58.8 t80 -99.65 178.38 4.87 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 118.01 -1.476 . . . . 0.0 110.552 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.679 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -110.63 80.0 1.26 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.655 -0.653 . . . . 0.0 109.377 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.27 95.26 0.03 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.701 -1.759 . . . . 0.0 108.701 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.417 ' N ' ' O ' ' A' ' 20' ' ' ASP . 28.9 mt -109.89 -40.2 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.14 -1.212 . . . . 0.0 109.167 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.495 ' NE2' ' HG2' ' B' ' 188' ' ' GLU . 35.9 m-70 -80.18 158.91 71.53 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.88 -14.95 39.84 Favored 'Trans proline' 0 C--O 1.216 -0.586 0 C-N-CA 122.314 2.009 . . . . 0.0 112.159 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.454 ' OD1' ' HD2' ' B' ' 189' ' ' ARG . 5.1 m-20 -110.61 -11.46 14.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.022 -1.049 . . . . 0.0 110.488 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -59.95 143.2 52.25 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.857 -1.152 . . . . 0.0 109.655 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.948 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -102.42 122.92 45.25 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.78 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.913 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -77.35 138.94 39.62 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 109.568 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.844 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 19.8 p90 -143.66 155.4 44.23 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 108.542 178.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.654 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 1.8 ptpt -110.15 173.16 6.45 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.204 -0.935 . . . . 0.0 109.486 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.512 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -66.34 152.48 44.92 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.198 -0.939 . . . . 0.0 109.304 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.47 -7.76 3.49 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.5 OUTLIER -74.95 143.67 43.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.843 -1.386 . . . . 0.0 109.564 -179.677 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -96.42 138.83 33.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.901 . . . . 0.0 109.556 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.544 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 2.1 mpp? -134.86 151.58 51.03 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.594 -0.691 . . . . 0.0 109.657 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.592 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 2.6 tttt -104.99 128.82 53.45 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.406 -0.809 . . . . 0.0 109.179 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.492 ' O ' HD12 ' A' ' 38' ' ' LEU . 1.7 t -81.58 135.11 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.416 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 37' ' ' VAL . 6.8 mp -113.43 -41.13 3.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.313 -0.867 . . . . 0.0 109.513 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -149.91 88.38 1.53 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 109.233 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.628 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -74.76 114.49 13.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.378 -0.826 . . . . 0.0 109.438 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.812 ' HB2' HD21 ' B' ' 186' ' ' LEU . 3.2 m-70 -80.6 -101.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.518 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.411 ' C ' ' CD ' ' A' ' 43' ' ' GLU . . . -127.28 -14.91 2.59 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.048 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.571 ' CG ' ' HD3' ' B' ' 183' ' ' PRO . 0.0 OUTLIER -165.8 -10.87 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.022 -1.281 . . . . 0.0 110.3 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.84 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 71.2 m95 -131.1 89.2 2.7 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.859 -1.151 . . . . 0.0 108.701 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.628 ' CD1' ' CG ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -83.7 140.97 31.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.798 -1.189 . . . . 0.0 110.312 -179.064 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 4.3 tttt -91.42 103.54 16.16 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.592 ' HB1' ' O ' ' A' ' 36' ' ' LYS . . . -101.92 -177.21 3.35 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.351 -0.843 . . . . 0.0 110.336 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.489 ' HE2' HD21 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -123.72 109.5 13.77 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.855 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.614 ' OG ' ' CB ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -57.45 129.53 42.25 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.807 -179.606 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.436 ' O ' ' N ' ' A' ' 52' ' ' THR . 0.3 OUTLIER -76.88 -8.61 57.67 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.318 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.474 ' O ' ' HB ' ' A' ' 52' ' ' THR . 55.5 tp -46.55 -22.68 0.3 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.738 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER 169.42 -21.94 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.38 -0.825 . . . . 0.0 110.115 178.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.738 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.1 OUTLIER 140.33 39.23 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.47 -0.769 . . . . 0.0 110.105 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.646 ' HB3' HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -87.86 135.24 33.48 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.871 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -122.43 127.82 50.14 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.914 -1.117 . . . . 0.0 109.274 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.691 ' HA3' ' CB ' ' A' ' 27' ' ' LEU . . . -166.93 168.81 40.51 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.235 -1.46 . . . . 0.0 110.41 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.717 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 14.2 m-85 -71.62 132.89 45.26 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.754 -0.851 . . . . 0.0 109.898 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.513 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 8.1 pt -123.18 129.48 24.92 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.668 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 56.2 Cg_endo -75.1 126.49 9.94 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 121.634 1.556 . . . . 0.0 112.591 -178.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.612 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 32.2 t -55.28 -10.85 0.64 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.522 -0.736 . . . . 0.0 109.997 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.487 ' HB3' ' HD3' ' B' ' 180' ' ' PRO . 8.0 t-20 -88.35 0.81 55.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.034 -1.041 . . . . 0.0 110.383 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.619 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -117.08 -41.34 3.02 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.864 -1.148 . . . . 0.0 110.045 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.544 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.5 m -96.62 159.09 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.104 -0.997 . . . . 0.0 110.567 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.649 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -136.87 161.89 34.77 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -75.94 146.84 39.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.087 -1.008 . . . . 0.0 109.4 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.478 ' O ' ' ND2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -47.84 164.0 0.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.9 . . . . 0.0 109.596 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -153.72 102.14 2.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.352 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.508 -179.896 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 170' ' ' TRP . . . . . 0.409 ' CD1' ' C ' ' B' ' 170' ' ' TRP . 1.4 p90 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 171' ' ' ASP . . . . . 0.579 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 0.4 OUTLIER -166.5 -57.48 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.253 -0.904 . . . . 0.0 108.719 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 172' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 48.2 Cg_endo -67.91 -90.23 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.689 2.259 . . . . 0.0 111.803 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 173' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' B' ' 174' ' ' MET . . . 165.5 -35.69 0.26 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 174' ' ' MET . . . . . 0.41 ' C ' ' O ' ' B' ' 173' ' ' GLY . 0.0 OUTLIER 43.8 82.91 0.22 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.251 -1.147 . . . . 0.0 109.686 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 175' ' ' PRO . . . . . 0.639 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 55.5 Cg_endo -79.15 -161.69 0.16 Allowed 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 122.632 2.222 . . . . 0.0 111.72 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 176' ' ' THR . . . . . 0.807 HG22 ' HB3' ' A' ' 17' ' ' TYR . 11.8 p -149.03 91.06 4.62 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.359 -0.838 . . . . 0.0 109.301 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 177' ' ' PRO . . . . . 0.599 ' HD2' ' CD2' ' A' ' 17' ' ' TYR . 47.5 Cg_endo -68.91 172.81 11.17 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.784 2.323 . . . . 0.0 112.004 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 178' ' ' PRO . . . . . 0.412 ' O ' ' OD1' ' A' ' 61' ' ' ASN . 50.7 Cg_endo -69.21 137.23 36.52 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.854 2.369 . . . . 0.0 111.676 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 0.643 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -78.77 176.42 3.7 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.172 -0.955 . . . . 0.0 109.598 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.84 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.5 Cg_endo -68.79 -176.57 1.26 Allowed 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 123.031 2.487 . . . . 0.0 111.647 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 181' ' ' PRO . . . . . 0.719 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.6 Cg_endo -89.82 -26.75 0.38 Allowed 'Trans proline' 0 C--O 1.213 -0.739 0 C-N-CA 122.886 2.391 . . . . 0.0 114.937 -177.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.719 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 39.4 mtt180 78.14 91.56 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 120.879 -1.138 . . . . 0.0 109.13 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.59 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 50.2 Cg_endo -70.0 135.59 30.27 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.689 2.26 . . . . 0.0 111.787 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 184' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 42.38 55.38 4.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.884 . . . . 0.0 109.5 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 185' ' ' ASN . . . . . 0.486 ' HA ' ' HB2' ' B' ' 188' ' ' GLU . 1.2 m-20 51.68 50.54 18.52 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.26 -0.9 . . . . 0.0 109.281 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 186' ' ' LEU . . . . . 0.812 HD21 ' HB2' ' A' ' 41' ' ' HIS . 60.9 tp -70.48 -81.88 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.362 -0.836 . . . . 0.0 109.418 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 187' ' ' GLY . . . . . 0.717 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -69.86 -5.72 53.16 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 108.924 -1.671 . . . . 0.0 108.924 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.556 ' N ' ' HD3' ' B' ' 182' ' ' ARG . 4.6 mt-10 -73.6 -81.4 0.06 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.393 -1.063 . . . . 0.0 109.242 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 189' ' ' ARG . . . . . 0.462 ' CB ' ' O ' ' B' ' 188' ' ' GLU . 0.0 OUTLIER 72.11 85.02 0.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.407 -0.808 . . . . 0.0 109.573 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -100.62 156.25 17.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.882 . . . . 0.0 109.468 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.44 179.989 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.407 ' O ' ' OD1' ' A' ' 11' ' ' ASP . . . -150.92 116.5 0.77 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -150.8 162.17 41.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -1.121 . . . . 0.0 109.266 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.7 mm -107.98 136.8 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.099 -1.0 . . . . 0.0 109.594 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.496 HG22 HG12 ' A' ' 37' ' ' VAL . 1.0 OUTLIER -131.34 160.68 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.505 -0.747 . . . . 0.0 109.036 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 p -120.66 139.23 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.054 -1.029 . . . . 0.0 109.372 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.86 133.3 45.37 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.379 -0.826 . . . . 0.0 109.744 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.983 HD11 ' CB ' ' A' ' 64' ' ' ALA . 23.4 mt -99.13 -17.25 18.28 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.672 ' HA ' ' CG ' ' A' ' 31' ' ' LYS . 7.2 m-85 -152.62 151.61 27.21 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.731 ' HD3' ' HG3' ' A' ' 31' ' ' LYS . 40.7 Cg_endo -61.53 148.93 91.8 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 121.53 1.487 . . . . 0.0 109.655 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.828 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 36.6 t80 -89.29 -34.3 16.63 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 117.947 -1.501 . . . . 0.0 110.224 -177.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.756 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 30.3 t70 106.84 -53.52 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.26 93.31 0.2 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.423 ' H ' HD12 ' A' ' 22' ' ' ILE . 0.5 OUTLIER -109.42 -42.96 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.385 -1.067 . . . . 0.0 108.433 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.513 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 1.5 m-70 -74.74 153.35 87.22 Favored Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.79 -9.69 26.71 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.075 1.85 . . . . 0.0 111.417 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.8 -17.4 11.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.368 -0.833 . . . . 0.0 110.545 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.513 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.5 OUTLIER -57.18 141.28 46.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.856 -1.152 . . . . 0.0 109.956 -178.838 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.951 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -90.03 119.14 30.12 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.867 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.879 ' N ' HD22 ' A' ' 27' ' ' LEU . 93.9 p -77.08 138.51 39.59 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.333 -0.855 . . . . 0.0 109.734 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.828 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 17.6 p90 -143.68 155.56 44.26 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.238 -0.914 . . . . 0.0 108.772 178.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.692 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -112.36 175.47 5.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.242 -0.911 . . . . 0.0 109.434 -179.356 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.731 ' HG3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -66.13 155.8 35.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.95 -1.093 . . . . 0.0 109.423 179.576 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 66.01 -6.94 1.32 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.418 ' H ' ' C ' ' A' ' 31' ' ' LYS . 0.5 OUTLIER -74.79 141.31 44.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.839 -1.389 . . . . 0.0 109.687 -179.602 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -94.87 136.97 34.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.324 -0.86 . . . . 0.0 109.415 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.587 ' CE ' HG11 ' A' ' 63' ' ' VAL . 1.1 mpp? -137.23 153.1 50.45 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.421 0.629 . . . . 0.0 109.758 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.635 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 13.7 tttm -110.31 123.67 50.24 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.472 -0.768 . . . . 0.0 109.26 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.57 HG21 ' CD ' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -88.71 115.66 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.696 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -82.88 -41.09 19.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.196 -0.94 . . . . 0.0 110.038 -179.365 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.54 126.02 11.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.147 -0.971 . . . . 0.0 109.505 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.64 ' HG2' ' CD2' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -95.19 131.44 41.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.451 -0.78 . . . . 0.0 109.406 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.791 ' HB2' HD21 ' B' ' 186' ' ' LEU . 49.7 m80 -98.72 -122.84 0.14 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.266 -0.896 . . . . 0.0 108.997 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.23 -28.96 21.28 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.574 ' CB ' ' HD2' ' B' ' 181' ' ' PRO . 2.1 tp10 -172.44 5.28 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.039 -1.271 . . . . 0.0 110.672 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 1.025 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 64.4 m95 -136.26 97.29 3.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.834 -1.166 . . . . 0.0 108.372 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.64 ' CD2' ' HG2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -93.23 145.89 24.1 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.921 -1.112 . . . . 0.0 110.337 -178.868 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -84.97 107.98 17.36 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.635 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -99.9 -179.62 4.22 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.363 -0.835 . . . . 0.0 109.909 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -122.76 129.97 52.36 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.62 -0.675 . . . . 0.0 109.493 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.574 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -76.75 126.79 31.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.75 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.64 -9.49 58.32 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.8 tp -52.11 -54.8 26.05 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.511 -0.743 . . . . 0.0 109.368 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.621 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.2 t -161.54 28.72 0.13 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.229 -0.92 . . . . 0.0 110.146 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.621 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.5 OUTLIER 87.09 44.33 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.47 -0.769 . . . . 0.0 110.715 178.726 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -85.46 132.64 34.18 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.077 -1.015 . . . . 0.0 108.337 178.517 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -122.4 114.75 21.17 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.859 -1.151 . . . . 0.0 109.483 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.627 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -152.22 171.84 31.49 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.666 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 8.1 m-85 -75.27 132.41 41.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.351 -1.088 . . . . 0.0 109.689 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.509 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 9.2 pt -121.93 137.42 27.3 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 108.605 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.603 ' HB2' ' CD ' ' B' ' 180' ' ' PRO . 50.9 Cg_endo -74.1 137.62 24.18 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.975 1.783 . . . . 0.0 112.763 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.578 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 28.3 t -67.93 4.3 1.23 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.583 -0.698 . . . . 0.0 110.317 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.598 HD22 ' HA ' ' B' ' 179' ' ' LEU . 0.8 OUTLIER -100.91 -55.34 2.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.022 -1.049 . . . . 0.0 110.063 -179.391 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 1.183 ' CE2' HD21 ' B' ' 179' ' ' LEU . 2.4 m-85 -51.81 -60.87 2.67 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.261 -0.899 . . . . 0.0 110.872 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.587 HG11 ' CE ' ' A' ' 35' ' ' MET . 4.0 m -78.61 154.8 4.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 122.004 0.906 . . . . 0.0 111.182 -177.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.983 ' CB ' HD11 ' A' ' 16' ' ' LEU . . . -130.07 159.55 36.4 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.481 ' HA ' HG12 ' A' ' 13' ' ' VAL . 2.1 ttpm? -74.72 149.81 39.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.974 -1.078 . . . . 0.0 109.552 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.488 ' O ' ' CB ' ' A' ' 67' ' ' ASN . 15.7 tp -135.6 -18.99 1.64 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.337 -0.852 . . . . 0.0 109.749 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' A' ' 66' ' ' LEU . 5.2 m120 74.69 -152.58 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -0.953 . . . . 0.0 109.38 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.483 -179.947 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 170' ' ' TRP . . . . . 0.435 ' O ' ' CB ' ' B' ' 171' ' ' ASP . 27.9 m95 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 171' ' ' ASP . . . . . 0.566 ' N ' ' HD3' ' B' ' 172' ' ' PRO . 0.6 OUTLIER 167.3 60.49 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.219 -0.926 . . . . 0.0 108.948 179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 172' ' ' PRO . . . . . 0.566 ' HD3' ' N ' ' B' ' 171' ' ' ASP . 52.0 Cg_endo -92.84 -82.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.171 2.581 . . . . 0.0 111.933 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 173' ' ' GLY . . . . . . . . . . . . . . . -113.37 32.41 6.1 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.99 105.65 0.36 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.186 -1.185 . . . . 0.0 109.48 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 175' ' ' PRO . . . . . 0.785 ' O ' HG23 ' B' ' 176' ' ' THR . 52.0 Cg_endo -89.52 -178.96 1.83 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.083 2.522 . . . . 0.0 111.776 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 176' ' ' THR . . . . . 0.8 HG22 ' CE1' ' A' ' 62' ' ' TYR . 0.1 OUTLIER 168.24 107.16 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.491 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 177' ' ' PRO . . . . . 0.655 ' CD ' ' CD2' ' A' ' 17' ' ' TYR . 49.2 Cg_endo -69.98 176.55 6.78 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.832 2.355 . . . . 0.0 111.83 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 178' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' B' ' 177' ' ' PRO . 48.6 Cg_endo -68.29 118.51 5.68 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.767 2.311 . . . . 0.0 111.991 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 1.183 HD21 ' CE2' ' A' ' 62' ' ' TYR . 33.4 mt -68.97 163.52 55.79 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.37 -0.831 . . . . 0.0 109.65 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 1.025 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 39.1 Cg_endo -70.56 176.12 7.81 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.483 2.122 . . . . 0.0 111.638 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 181' ' ' PRO . . . . . 0.578 ' O ' ' CB ' ' B' ' 182' ' ' ARG . 55.7 Cg_endo -76.47 -42.63 0.34 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.823 2.349 . . . . 0.0 113.916 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.659 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.0 OUTLIER 78.94 81.44 0.1 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.039 -1.038 . . . . 0.0 108.49 -178.583 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.485 ' O ' ' C ' ' B' ' 184' ' ' ALA . 51.5 Cg_endo -72.95 146.21 41.48 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.939 2.426 . . . . 0.0 112.33 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 184' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 36.35 61.93 0.76 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.607 -0.683 . . . . 0.0 109.616 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 185' ' ' ASN . . . . . 0.5 ' HA ' ' HB2' ' B' ' 188' ' ' GLU . 1.1 m-20 42.95 46.2 4.6 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.308 -0.87 . . . . 0.0 109.05 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 186' ' ' LEU . . . . . 0.791 HD21 ' HB2' ' A' ' 41' ' ' HIS . 68.0 tp -61.85 -86.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.435 -0.79 . . . . 0.0 109.447 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 187' ' ' GLY . . . . . 0.666 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -66.16 -11.4 55.34 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.502 ' N ' ' NE ' ' B' ' 182' ' ' ARG . 0.3 OUTLIER -69.66 -83.83 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.522 -0.987 . . . . 0.0 109.498 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 189' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.29 148.38 51.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.496 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 190' ' ' GLN . . . . . 0.411 ' O ' ' HB3' ' B' ' 191' ' ' ALA . 2.6 mp0 -58.83 -70.4 0.15 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.237 -0.914 . . . . 0.0 109.456 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 191' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' B' ' 190' ' ' GLN . . . . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.483 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.23 172.83 30.91 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.475 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -144.74 127.47 16.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -1.137 . . . . 0.0 109.45 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.498 ' CD1' ' HG3' ' A' ' 36' ' ' LYS . 1.0 OUTLIER -101.43 137.79 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.884 . . . . 0.0 109.407 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.493 HG11 ' HZ3' ' A' ' 45' ' ' TRP . 0.8 OUTLIER -130.99 159.93 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.474 HG12 ' HB2' ' A' ' 66' ' ' LEU . 14.6 p -120.55 138.46 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.981 -1.074 . . . . 0.0 109.482 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -72.29 134.58 45.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.465 -0.772 . . . . 0.0 110.111 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.038 HD11 ' HB2' ' A' ' 64' ' ' ALA . 16.5 mt -99.26 -17.81 17.91 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.593 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 43.1 m-85 -152.55 153.87 31.02 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.689 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.6 Cg_endo -63.66 149.64 90.4 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 121.812 1.675 . . . . 0.0 110.042 179.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.823 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 65.7 t80 -97.58 179.14 4.95 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 118.219 -1.392 . . . . 0.0 110.224 -177.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.67 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 9.8 p-10 -110.15 80.93 1.36 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.569 -0.707 . . . . 0.0 109.313 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.5 91.92 0.03 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.577 HD12 ' OD2' ' A' ' 20' ' ' ASP . 67.1 mt -106.67 -43.17 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.265 -1.138 . . . . 0.0 108.765 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.619 ' CE1' ' HA ' ' B' ' 188' ' ' GLU . 41.1 m80 -75.86 156.14 84.59 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.01 -13.27 36.23 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.225 1.95 . . . . 0.0 111.799 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -111.86 -13.99 13.59 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.24 -0.913 . . . . 0.0 110.363 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.74 141.83 47.4 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.825 -1.172 . . . . 0.0 109.798 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.93 HD22 ' N ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -98.64 124.06 43.2 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.93 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -81.08 140.26 35.2 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.322 -0.861 . . . . 0.0 109.81 -179.704 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.823 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 28.2 p90 -145.79 157.97 43.89 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.654 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 10.5 mtmm -111.27 174.03 6.06 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.047 -1.033 . . . . 0.0 109.557 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.553 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -67.38 151.9 46.64 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.186 -0.946 . . . . 0.0 109.314 179.803 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.39 -7.94 4.42 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 3.8 tt0 -75.55 143.43 42.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.917 -1.343 . . . . 0.0 109.838 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -96.3 138.18 34.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 0.0 109.273 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.623 ' CE ' HG11 ' A' ' 63' ' ' VAL . 1.7 mpp? -135.97 151.82 50.32 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.628 -0.67 . . . . 0.0 109.932 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 7.7 ttpt -109.02 122.37 47.11 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -89.93 119.0 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.296 -0.877 . . . . 0.0 108.758 178.832 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.732 HD12 ' O ' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -89.01 -40.79 12.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.159 -0.963 . . . . 0.0 110.191 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.28 119.42 15.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.049 -1.032 . . . . 0.0 109.268 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.636 ' HG3' ' CG ' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -99.35 122.17 42.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.823 . . . . 0.0 109.453 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.633 ' HB2' HD21 ' B' ' 186' ' ' LEU . 5.2 m-70 -90.25 -103.86 0.1 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.957 . . . . 0.0 109.116 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.69 -14.06 1.55 Allowed Glycine 0 N--CA 1.489 2.174 0 C-N-CA 119.548 -1.31 . . . . 0.0 110.177 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.593 ' CG ' ' HD2' ' B' ' 181' ' ' PRO . 0.3 OUTLIER -158.77 -15.1 0.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.963 -1.316 . . . . 0.0 110.972 -179.506 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.843 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 62.7 m95 -138.92 99.52 3.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.725 -1.234 . . . . 0.0 109.608 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.671 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -93.18 142.98 26.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.881 -1.137 . . . . 0.0 109.511 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.732 ' O ' HD12 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -85.91 109.11 18.51 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.29 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -101.3 -174.62 2.65 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.333 -0.855 . . . . 0.0 109.818 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -126.97 129.39 48.05 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.478 -0.764 . . . . 0.0 109.298 -179.729 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.589 ' HB2' ' HB2' ' A' ' 54' ' ' LYS . 7.6 t -74.9 126.75 31.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.064 -1.023 . . . . 0.0 109.795 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.3 -7.43 46.96 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.151 -0.968 . . . . 0.0 108.521 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.67 -55.6 27.96 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.374 -0.829 . . . . 0.0 109.227 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.634 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.1 t -160.62 27.51 0.15 Allowed 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.136 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.634 ' CB ' ' O ' ' A' ' 52' ' ' THR . 5.1 mmtt 87.83 45.17 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.495 -0.753 . . . . 0.0 110.898 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.589 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 0.1 OUTLIER -87.0 130.67 34.36 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 177.752 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 10.1 pt-20 -120.31 117.87 28.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.79 -1.194 . . . . 0.0 109.508 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.656 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -154.77 179.12 31.09 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.742 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 9.3 m-85 -80.07 132.56 35.99 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.454 -1.027 . . . . 0.0 109.954 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.484 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 8.8 pt -120.27 136.61 25.26 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.693 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 55.3 Cg_endo -73.95 135.16 20.8 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 121.827 1.685 . . . . 0.0 112.536 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.598 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 23.1 t -65.97 5.24 0.52 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.512 -0.743 . . . . 0.0 110.565 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.552 ' CG ' ' N ' ' A' ' 62' ' ' TYR . 1.2 p-10 -101.21 -51.81 3.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.765 -1.209 . . . . 0.0 110.458 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.686 ' CE2' HD23 ' B' ' 179' ' ' LEU . 4.8 m-85 -57.06 -59.01 5.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.117 -0.989 . . . . 0.0 110.947 -178.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.623 HG11 ' CE ' ' A' ' 35' ' ' MET . 3.1 m -79.79 156.8 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.988 0.899 . . . . 0.0 111.272 -177.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.038 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -131.54 159.47 38.08 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.437 ' HA ' HG12 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -76.43 97.08 4.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.933 -1.105 . . . . 0.0 109.568 -179.789 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.474 ' HB2' HG12 ' A' ' 14' ' ' VAL . 1.4 mt -147.14 123.94 11.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.173 -0.954 . . . . 0.0 109.598 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -154.55 165.3 36.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.926 . . . . 0.0 109.307 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.459 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 170' ' ' TRP . . . . . 0.479 ' O ' ' CB ' ' B' ' 171' ' ' ASP . 41.8 m0 . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 171' ' ' ASP . . . . . 0.546 ' N ' ' HD3' ' B' ' 172' ' ' PRO . 0.2 OUTLIER 165.89 61.31 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.228 -0.92 . . . . 0.0 108.953 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 172' ' ' PRO . . . . . 0.546 ' HD3' ' N ' ' B' ' 171' ' ' ASP . 51.9 Cg_endo -92.48 -91.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.222 2.615 . . . . 0.0 111.998 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 173' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' B' ' 174' ' ' MET . . . -131.48 19.23 4.83 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 174' ' ' MET . . . . . 0.436 ' HB3' ' O ' ' B' ' 173' ' ' GLY . 0.0 OUTLIER 176.41 69.65 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.36 -1.082 . . . . 0.0 109.179 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 175' ' ' PRO . . . . . 0.528 ' O ' HG23 ' B' ' 176' ' ' THR . 55.2 Cg_endo -79.19 -162.34 0.18 Allowed 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.733 2.289 . . . . 0.0 112.16 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 176' ' ' THR . . . . . 0.573 ' CG2' ' HB3' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -174.33 102.79 0.28 Allowed Pre-proline 0 N--CA 1.49 1.54 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 177' ' ' PRO . . . . . 0.568 ' HD2' ' CD2' ' A' ' 17' ' ' TYR . 48.5 Cg_endo -71.51 164.84 34.37 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.589 2.193 . . . . 0.0 111.75 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -67.9 136.09 37.29 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.522 2.148 . . . . 0.0 111.446 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 0.686 HD23 ' CE2' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -80.16 176.23 3.99 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.203 -0.935 . . . . 0.0 109.568 -179.769 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.843 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.1 Cg_endo -68.68 178.51 3.84 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.903 2.402 . . . . 0.0 111.531 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 181' ' ' PRO . . . . . 0.727 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.3 Cg_endo -88.21 -21.59 1.54 Allowed 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 122.982 2.455 . . . . 0.0 114.411 -177.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.727 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 24.6 mtt180 76.34 91.25 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.956 -1.09 . . . . 0.0 108.974 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' B' ' 186' ' ' LEU . 50.9 Cg_endo -70.68 136.42 30.54 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.84 2.36 . . . . 0.0 112.017 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 184' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 41.0 63.73 1.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.834 . . . . 0.0 109.492 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 185' ' ' ASN . . . . . 0.425 ' CA ' ' HB2' ' B' ' 188' ' ' GLU . 0.0 OUTLIER 44.73 48.86 8.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.205 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 186' ' ' LEU . . . . . 0.633 HD21 ' HB2' ' A' ' 41' ' ' HIS . 42.6 tp -67.77 -87.15 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.441 -0.787 . . . . 0.0 109.413 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 187' ' ' GLY . . . . . 0.742 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -64.67 -8.38 33.02 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.619 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 6.9 mt-10 -51.13 -90.67 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.361 -1.082 . . . . 0.0 109.5 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 189' ' ' ARG . . . . . . . . . . . . . 10.1 ptt85 -164.79 -169.02 1.6 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.161 -0.962 . . . . 0.0 109.584 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -100.49 161.17 13.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.26 -0.9 . . . . 0.0 109.497 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.092 -0.956 . . . . 0.0 109.404 179.96 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.46 168.94 18.62 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -143.1 161.72 37.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -1.147 . . . . 0.0 109.347 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.431 ' HB ' ' OD1' ' A' ' 67' ' ' ASN . 34.4 mm -111.8 136.79 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.119 -0.988 . . . . 0.0 109.729 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.497 HG12 ' HA ' ' A' ' 65' ' ' LYS . 1.3 m -133.09 162.92 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -118.65 139.17 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.84 -1.162 . . . . 0.0 109.069 179.176 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.707 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -72.09 95.42 1.63 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.44 -0.788 . . . . 0.0 110.695 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.024 HD11 ' CB ' ' A' ' 64' ' ' ALA . 37.3 mt -60.99 -34.08 74.24 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.743 ' HB3' HG22 ' B' ' 176' ' ' THR . 29.1 m-85 -134.1 152.95 79.3 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.589 ' HD2' HG22 ' B' ' 176' ' ' THR . 50.8 Cg_endo -70.27 150.9 65.79 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 122.409 2.073 . . . . 0.0 111.677 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.92 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 60.6 t80 -114.44 105.62 13.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.979 -1.075 . . . . 0.0 109.756 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 19' ' ' TYR . 40.3 m-20 -27.49 -37.75 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 19' ' ' TYR . . . 66.74 96.3 0.03 OUTLIER Glycine 0 N--CA 1.496 2.664 0 N-CA-C 106.206 -2.758 . . . . 0.0 106.206 -175.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.6 mt -115.04 -38.18 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.447 -1.031 . . . . 0.0 109.809 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.607 ' CG ' ' O ' ' B' ' 188' ' ' GLU . 0.9 OUTLIER -77.41 151.76 80.87 Favored Pre-proline 0 C--N 1.298 -1.64 0 O-C-N 121.346 -0.846 . . . . 0.0 108.753 179.663 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.34 -10.17 26.55 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.211 1.941 . . . . 0.0 110.774 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -114.9 -17.22 11.59 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.459 -0.776 . . . . 0.0 110.279 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.477 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -57.51 139.24 53.89 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.888 -1.133 . . . . 0.0 109.91 -178.756 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.948 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -88.19 115.06 25.41 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.841 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.758 ' N ' HD22 ' A' ' 27' ' ' LEU . 84.6 p -76.3 141.22 41.69 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.369 -0.832 . . . . 0.0 109.404 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.92 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 24.6 p90 -145.81 156.74 43.77 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.31 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.581 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -110.21 174.52 5.82 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.198 -0.939 . . . . 0.0 109.321 -179.704 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -67.4 151.09 48.03 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.093 -1.004 . . . . 0.0 109.315 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 71.38 -7.4 6.4 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -74.77 143.42 44.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.965 -1.314 . . . . 0.0 109.68 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -97.52 139.48 33.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.749 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.658 ' HE3' HG11 ' A' ' 63' ' ' VAL . 3.9 mtm -135.89 152.44 51.02 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.588 0.709 . . . . 0.0 109.744 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.608 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 17.2 ttmt -104.81 125.75 51.18 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 11' ' ' ASP . 2.7 t -75.72 132.18 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.192 -0.943 . . . . 0.0 109.431 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 46' ' ' LYS . 12.3 mt -110.94 -48.54 3.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.199 -0.938 . . . . 0.0 109.649 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 1.8 pt-20 -143.27 91.94 2.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.161 -0.962 . . . . 0.0 109.051 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.588 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 0.8 OUTLIER -78.68 114.89 18.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.697 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.626 ' HB2' HD21 ' B' ' 186' ' ' LEU . 4.2 m-70 -82.47 -101.71 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.372 -0.83 . . . . 0.0 109.113 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -136.33 -12.87 1.05 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.555 ' HB2' ' HD3' ' B' ' 183' ' ' PRO . 0.8 OUTLIER -153.15 -19.76 0.15 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.026 -1.279 . . . . 0.0 110.544 -179.668 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.873 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 66.8 m95 -137.43 99.93 4.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.868 -1.145 . . . . 0.0 109.395 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.623 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -88.22 146.97 25.08 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.133 -0.979 . . . . 0.0 109.851 -179.879 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -93.81 105.67 17.69 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.171 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.79 -177.96 3.52 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.298 -0.876 . . . . 0.0 110.281 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.631 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -123.73 128.07 49.07 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.644 -0.66 . . . . 0.0 109.684 -179.49 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.597 ' HB2' ' HB3' ' A' ' 54' ' ' LYS . 1.1 t -74.45 126.95 31.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.124 -0.985 . . . . 0.0 109.884 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 50' ' ' LEU . 32.9 mt -72.23 -7.43 49.26 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.5 tp -53.58 -54.92 30.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.529 -0.732 . . . . 0.0 109.287 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.596 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 2.6 t -161.08 29.08 0.14 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.278 -0.889 . . . . 0.0 109.955 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 52' ' ' THR . 12.6 mttm 86.93 45.46 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.552 -0.718 . . . . 0.0 110.585 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.631 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 3.6 tttm -85.17 132.29 34.31 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -123.22 117.01 24.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.929 -1.107 . . . . 0.0 109.17 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.661 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -159.27 166.03 34.55 Favored Glycine 0 N--CA 1.486 1.988 0 C-N-CA 118.966 -1.588 . . . . 0.0 110.55 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.782 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 8.1 m-85 -71.97 134.1 45.74 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.752 -0.852 . . . . 0.0 109.714 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.593 HD12 HG21 ' A' ' 63' ' ' VAL . 13.7 pt -123.29 144.53 43.96 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.304 -0.873 . . . . 0.0 108.841 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.632 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 43.2 Cg_endo -67.54 142.92 60.8 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.915 1.743 . . . . 0.0 111.597 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.525 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 32.4 p -74.67 6.05 4.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.189 -0.944 . . . . 0.0 110.737 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' B' ' 178' ' ' PRO . 0.1 OUTLIER -108.41 -51.72 2.86 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.808 -1.183 . . . . 0.0 110.484 -179.208 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.602 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 5.8 m-30 -49.68 -61.26 2.22 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.19 -0.944 . . . . 0.0 111.271 -178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.707 HG12 ' HA ' ' A' ' 15' ' ' ALA . 13.3 m -78.32 156.32 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.096 -1.002 . . . . 0.0 111.321 -177.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.024 ' CB ' HD11 ' A' ' 16' ' ' LEU . . . -135.74 163.5 30.03 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.497 ' HA ' HG12 ' A' ' 13' ' ' VAL . 3.7 ptpt -76.59 148.98 36.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.977 -1.077 . . . . 0.0 109.373 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER 171.93 113.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 109.699 179.941 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.431 ' OD1' ' HB ' ' A' ' 12' ' ' ILE . 0.1 OUTLIER -129.31 154.06 47.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.901 . . . . 0.0 109.144 179.697 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.5 m . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.451 -179.891 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 170' ' ' TRP . . . . . 0.486 ' O ' ' HB2' ' B' ' 171' ' ' ASP . 17.7 m95 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 171' ' ' ASP . . . . . 0.62 ' N ' ' HD3' ' B' ' 172' ' ' PRO . 24.6 t70 176.84 57.75 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.285 -0.884 . . . . 0.0 108.955 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 172' ' ' PRO . . . . . 0.62 ' HD3' ' N ' ' B' ' 171' ' ' ASP . 52.6 Cg_endo -92.29 -82.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.112 2.542 . . . . 0.0 111.857 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 173' ' ' GLY . . . . . . . . . . . . . . . -143.45 27.07 2.11 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.15 73.05 11.13 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.305 -1.115 . . . . 0.0 109.492 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 175' ' ' PRO . . . . . 0.611 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 55.1 Cg_endo -77.05 -159.73 0.1 Allowed 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.638 2.226 . . . . 0.0 111.626 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 176' ' ' THR . . . . . 0.743 HG22 ' HB3' ' A' ' 17' ' ' TYR . 14.7 p -157.46 93.73 2.19 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.464 -0.773 . . . . 0.0 109.497 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 177' ' ' PRO . . . . . 0.525 ' HD2' ' CD2' ' A' ' 17' ' ' TYR . 51.3 Cg_endo -69.94 175.1 8.71 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.768 2.312 . . . . 0.0 111.825 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 178' ' ' PRO . . . . . 0.534 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 50.4 Cg_endo -70.67 163.34 39.35 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.589 2.192 . . . . 0.0 111.425 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 0.604 HD22 ' HE1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -98.31 175.24 2.61 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.244 -0.91 . . . . 0.0 109.519 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.873 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.3 Cg_endo -69.14 -175.29 0.96 Allowed 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.944 2.429 . . . . 0.0 111.568 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 181' ' ' PRO . . . . . 0.756 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.1 Cg_endo -90.36 -29.75 0.17 Allowed 'Trans proline' 0 C--O 1.213 -0.742 0 C-N-CA 122.928 2.419 . . . . 0.0 114.471 -177.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.756 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 51.1 mtt180 81.97 95.34 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.227 -0.921 . . . . 0.0 109.212 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.62 ' CG ' HD22 ' B' ' 186' ' ' LEU . 43.6 Cg_endo -67.41 128.41 18.24 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.852 2.368 . . . . 0.0 111.806 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 184' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 42.47 66.87 0.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.182 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 185' ' ' ASN . . . . . 0.483 ' HB3' ' HB2' ' B' ' 189' ' ' ARG . 0.6 OUTLIER 43.08 43.91 3.96 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.368 -0.833 . . . . 0.0 109.137 -179.465 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 186' ' ' LEU . . . . . 0.626 HD21 ' HB2' ' A' ' 41' ' ' HIS . 59.9 tp -55.67 -93.81 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 187' ' ' GLY . . . . . 0.782 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -68.69 -8.62 57.24 Favored Glycine 0 N--CA 1.483 1.767 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.607 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 0.1 OUTLIER -71.98 -86.63 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.543 -0.975 . . . . 0.0 109.278 179.87 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 189' ' ' ARG . . . . . 0.483 ' HB2' ' HB3' ' B' ' 185' ' ' ASN . 0.3 OUTLIER -81.99 -169.0 2.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.072 -1.017 . . . . 0.0 109.433 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 190' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' B' ' 189' ' ' ARG . 1.0 OUTLIER -44.12 -72.92 0.05 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.923 . . . . 0.0 109.426 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.44 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 11' ' ' ASP . . . -106.92 100.97 1.65 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.501 ' O ' HG23 ' A' ' 37' ' ' VAL . 3.3 m-20 -150.59 149.49 29.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -1.107 . . . . 0.0 109.376 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.564 HD12 ' HG3' ' A' ' 36' ' ' LYS . 35.0 mm -105.27 136.09 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.927 . . . . 0.0 109.655 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.529 HG22 ' CG2' ' A' ' 37' ' ' VAL . 1.5 m -132.64 161.79 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 p -120.09 137.75 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.982 -1.074 . . . . 0.0 109.071 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.605 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -69.22 131.77 45.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.395 -0.816 . . . . 0.0 109.976 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.062 HD11 ' CB ' ' A' ' 64' ' ' ALA . 62.5 mt -97.77 -30.21 12.92 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.653 ' CD2' ' CD ' ' B' ' 177' ' ' PRO . 47.7 m-85 -131.74 143.32 48.63 Favored Pre-proline 0 N--CA 1.486 1.373 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.8 Cg_endo -62.34 149.39 90.94 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.692 2.261 . . . . 0.0 112.699 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.824 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 21.6 t80 -129.29 113.3 14.83 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -98.2 118.0 33.85 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 116.75 -1.98 . . . . 0.0 108.546 179.434 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -40.44 90.25 0.01 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.593 HG22 ' O ' ' A' ' 22' ' ' ILE . 2.4 mp -82.49 0.11 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 121.142 -1.211 . . . . 0.0 107.815 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.549 ' HB3' ' CD ' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -121.66 -172.55 0.24 Allowed Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.372 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.549 ' CD ' ' HB3' ' A' ' 23' ' ' HIS . 52.0 Cg_endo -90.86 -17.89 1.22 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.218 1.945 . . . . 0.0 112.602 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.462 ' CG ' ' CG ' ' B' ' 190' ' ' GLN . 30.6 m-20 -117.53 -12.09 10.4 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.389 -0.819 . . . . 0.0 111.09 -178.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.48 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 9.5 m-20 -58.52 142.56 48.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.927 -1.108 . . . . 0.0 110.708 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.018 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -98.93 122.68 42.5 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.887 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.959 ' N ' HD22 ' A' ' 27' ' ' LEU . 15.9 m -76.92 137.53 39.15 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -0.925 . . . . 0.0 110.655 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.824 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 30.5 p90 -143.75 154.74 43.77 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.555 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -111.54 166.04 11.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.979 -1.076 . . . . 0.0 109.656 -179.35 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.23 151.37 15.88 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.248 -0.907 . . . . 0.0 108.792 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.17 -7.69 3.18 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 9.0 tt0 -73.47 144.41 46.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.931 -1.335 . . . . 0.0 109.798 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.891 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -98.13 139.07 34.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 0.0 109.894 -179.708 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.608 ' SD ' HG21 ' A' ' 58' ' ' ILE . 4.6 mtm -134.89 151.08 50.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.578 -0.701 . . . . 0.0 109.662 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -103.05 121.05 41.77 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.504 -0.748 . . . . 0.0 109.252 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.529 ' CG2' HG22 ' A' ' 13' ' ' VAL . 1.8 t -82.7 124.1 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.369 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.2 mt -99.4 -44.88 6.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.137 -0.977 . . . . 0.0 109.608 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -148.25 97.22 2.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.891 . . . . 0.0 109.157 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.637 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -78.72 122.76 26.41 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.38 -0.825 . . . . 0.0 109.618 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.696 ' HB2' HD21 ' B' ' 186' ' ' LEU . 61.9 m80 -83.01 -101.77 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.342 -0.849 . . . . 0.0 109.223 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.34 -16.28 1.37 Allowed Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.366 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.581 ' CG ' ' HD2' ' B' ' 181' ' ' PRO . 0.0 OUTLIER -158.43 -16.99 0.07 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.913 -1.345 . . . . 0.0 110.755 -179.531 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 1.019 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 64.3 m95 -132.74 94.86 3.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.942 -1.099 . . . . 0.0 108.601 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.637 ' CD1' ' CG ' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -88.47 147.55 24.61 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.028 -1.045 . . . . 0.0 110.096 -179.114 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.7 OUTLIER -94.46 107.39 19.36 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.601 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -105.41 -175.41 2.79 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.273 -0.892 . . . . 0.0 110.23 -179.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -126.18 130.98 52.06 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.667 -0.645 . . . . 0.0 109.905 -179.207 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.64 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -77.06 128.34 34.29 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.157 -0.964 . . . . 0.0 109.698 179.476 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.891 HD12 ' O ' ' A' ' 34' ' ' LYS . 1.2 mp -73.95 -7.21 51.52 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 49.2 tp -53.89 -54.46 38.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.399 -0.813 . . . . 0.0 109.32 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 2.8 t -160.88 29.16 0.15 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.267 -0.896 . . . . 0.0 110.036 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.587 ' CB ' ' O ' ' A' ' 52' ' ' THR . 17.4 mttp 85.91 42.98 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.528 -0.733 . . . . 0.0 110.879 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.681 ' HB3' HD23 ' A' ' 27' ' ' LEU . 7.4 mmtt -85.41 133.0 34.13 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -123.36 120.8 34.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.976 -1.078 . . . . 0.0 109.332 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.666 ' HA3' ' CB ' ' A' ' 27' ' ' LEU . . . -159.72 166.11 34.81 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.27 -1.443 . . . . 0.0 110.133 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.732 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 9.2 m-85 -70.19 133.3 46.94 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.64 -0.918 . . . . 0.0 109.437 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.608 HG21 ' SD ' ' A' ' 35' ' ' MET . 6.1 pt -121.97 136.68 26.46 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.311 -0.868 . . . . 0.0 108.717 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.6 ' HG3' ' CD2' ' B' ' 179' ' ' LEU . 50.0 Cg_endo -69.39 138.62 39.44 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.269 1.98 . . . . 0.0 112.325 -178.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.55 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 23.6 t -71.46 0.97 7.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 110.202 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.681 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 6.5 p-10 -95.45 -49.66 5.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.964 -1.085 . . . . 0.0 110.233 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 1.174 ' CE2' HD21 ' B' ' 179' ' ' LEU . 11.6 m-30 -61.11 -56.94 15.0 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.337 -0.852 . . . . 0.0 111.211 -178.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 15' ' ' ALA . 3.7 m -79.19 157.29 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 122.175 0.988 . . . . 0.0 111.443 -177.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.062 ' CB ' HD11 ' A' ' 16' ' ' LEU . . . -138.05 163.0 32.69 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.519 ' HA ' HG12 ' A' ' 13' ' ' VAL . 19.0 ttmm -74.85 147.31 41.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.036 -1.04 . . . . 0.0 109.17 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.21 -75.37 0.1 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.221 -0.924 . . . . 0.0 109.623 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -142.17 -140.9 0.13 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 109.461 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.479 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 1.3 p90 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 171' ' ' ASP . . . . . 0.594 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 0.3 OUTLIER -168.53 -56.58 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.249 -0.907 . . . . 0.0 108.886 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 172' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 47.7 Cg_endo -67.78 -90.25 0.0 OUTLIER 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.691 2.261 . . . . 0.0 111.861 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 173' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' B' ' 174' ' ' MET . . . -140.13 -38.75 0.09 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 174' ' ' MET . . . . . 0.508 ' N ' ' HD3' ' B' ' 175' ' ' PRO . 0.4 OUTLIER 42.24 62.24 7.99 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.385 -1.068 . . . . 0.0 109.468 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 175' ' ' PRO . . . . . 0.597 ' O ' HG23 ' B' ' 176' ' ' THR . 50.5 Cg_endo -92.24 171.91 2.49 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.195 2.596 . . . . 0.0 111.81 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 176' ' ' THR . . . . . 0.647 HG22 ' CE1' ' A' ' 62' ' ' TYR . 0.0 OUTLIER 172.15 107.47 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.412 -0.805 . . . . 0.0 109.319 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 177' ' ' PRO . . . . . 0.653 ' CD ' ' CD2' ' A' ' 17' ' ' TYR . 48.0 Cg_endo -71.17 176.65 7.53 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.701 2.267 . . . . 0.0 111.675 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 178' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' B' ' 177' ' ' PRO . 45.5 Cg_endo -67.33 97.24 0.42 Allowed 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.569 2.18 . . . . 0.0 111.752 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 1.174 HD21 ' CE2' ' A' ' 62' ' ' TYR . 25.0 mt -39.24 162.42 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.487 -0.758 . . . . 0.0 109.689 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 1.019 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.1 Cg_endo -66.29 170.94 11.14 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.508 2.139 . . . . 0.0 111.254 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 181' ' ' PRO . . . . . 0.592 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 56.1 Cg_endo -79.05 -34.29 1.22 Allowed 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 122.903 2.402 . . . . 0.0 114.154 -177.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.711 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.1 OUTLIER 78.27 84.26 0.09 OUTLIER Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 120.982 -1.074 . . . . 0.0 108.711 -178.865 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 51.1 Cg_endo -71.65 139.27 33.68 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.791 2.328 . . . . 0.0 112.125 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 184' ' ' ALA . . . . . 0.483 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 38.6 62.23 1.06 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.504 -0.747 . . . . 0.0 109.582 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 185' ' ' ASN . . . . . 0.496 ' CA ' ' HB3' ' B' ' 188' ' ' GLU . 0.8 OUTLIER 44.68 48.58 8.78 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.273 -0.892 . . . . 0.0 109.157 -179.699 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 186' ' ' LEU . . . . . 0.696 HD21 ' HB2' ' A' ' 41' ' ' HIS . 56.2 tp -64.92 -83.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.413 -0.804 . . . . 0.0 109.352 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 187' ' ' GLY . . . . . 0.732 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -64.83 -9.97 42.69 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.518 ' HG3' ' NE2' ' A' ' 23' ' ' HIS . 4.6 tt0 -70.93 -87.26 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.547 -0.972 . . . . 0.0 109.386 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 189' ' ' ARG . . . . . 0.491 ' HG3' ' HG2' ' B' ' 188' ' ' GLU . 9.6 mtt-85 -72.79 -164.17 0.15 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 109.301 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 190' ' ' GLN . . . . . 0.462 ' CG ' ' CG ' ' A' ' 25' ' ' ASP . 50.5 mt-30 -105.88 44.64 1.03 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -0.928 . . . . 0.0 109.498 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.437 179.958 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.97 -152.81 23.53 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.544 ' O ' HG13 ' A' ' 37' ' ' VAL . 73.4 m-20 -89.48 121.27 31.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -1.159 . . . . 0.0 109.276 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 19.9 mm -92.4 137.23 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.565 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.605 HG22 HG12 ' A' ' 37' ' ' VAL . 2.1 m -131.44 160.2 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.459 -0.776 . . . . 0.0 109.097 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.2 p -121.64 138.43 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 109.346 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.708 ' HB2' ' HE3' ' A' ' 35' ' ' MET . . . -70.04 132.03 45.25 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.26 -0.9 . . . . 0.0 109.747 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.075 HD11 ' CB ' ' A' ' 64' ' ' ALA . 28.3 mt -98.03 -13.61 20.97 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.992 ' HB3' HG22 ' B' ' 176' ' ' THR . 56.2 m-85 -155.46 152.7 25.16 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.579 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 42.6 Cg_endo -66.04 149.42 85.98 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 121.554 1.502 . . . . 0.0 109.589 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.866 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 20.6 t80 -102.34 -175.85 2.94 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.176 -1.41 . . . . 0.0 110.535 -178.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.735 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 31.2 m-20 -112.99 85.92 2.27 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.572 -0.705 . . . . 0.0 110.065 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.19 92.03 0.05 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.519 -1.832 . . . . 0.0 108.519 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.751 HD11 ' NH2' ' B' ' 182' ' ' ARG . 0.4 OUTLIER -107.75 -42.94 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.262 -1.14 . . . . 0.0 108.767 179.604 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.654 ' CE1' ' HA ' ' B' ' 188' ' ' GLU . 56.3 m80 -76.09 156.93 83.81 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.4 -13.23 35.23 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.156 1.904 . . . . 0.0 111.859 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.514 ' OD2' ' NE ' ' B' ' 189' ' ' ARG . 4.9 m-20 -112.65 -13.78 13.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 110.462 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.468 ' OD2' ' OH ' ' A' ' 19' ' ' TYR . 43.2 m-20 -57.39 138.9 54.41 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.764 -1.21 . . . . 0.0 109.793 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.943 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -94.95 121.99 37.14 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.868 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.9 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.1 m -78.77 139.25 38.44 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.153 -0.967 . . . . 0.0 109.598 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.866 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 17.5 p90 -146.87 158.1 43.83 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.242 -0.911 . . . . 0.0 108.918 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.659 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 21.4 mtmm -111.79 174.33 5.93 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.138 -0.976 . . . . 0.0 109.41 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.512 ' HD3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -66.73 153.02 44.32 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.12 -0.988 . . . . 0.0 109.305 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.27 -7.96 4.27 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 15' ' ' ALA . 3.4 tt0 -74.53 144.03 44.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.918 -1.342 . . . . 0.0 109.615 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.484 ' HD3' HD13 ' A' ' 50' ' ' LEU . 2.6 ptpt -96.67 136.12 37.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.517 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.708 ' HE3' ' HB2' ' A' ' 15' ' ' ALA . 1.7 mpp? -137.85 153.69 49.57 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.415 0.626 . . . . 0.0 109.528 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.68 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 2.2 ttpt -110.87 125.42 53.61 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.377 -0.827 . . . . 0.0 109.004 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.605 HG12 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -87.65 128.43 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.9 . . . . 0.0 108.753 178.953 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 26.1 mt -88.58 -29.7 19.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 109.945 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -176.99 130.99 0.18 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.147 -0.971 . . . . 0.0 109.834 -179.444 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.654 ' HA ' ' CD1' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -78.53 132.44 37.2 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.441 -0.787 . . . . 0.0 109.162 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.656 ' CB ' HD11 ' B' ' 186' ' ' LEU . 18.7 m-70 -111.57 30.78 6.66 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.223 -0.923 . . . . 0.0 110.543 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.416 ' N ' ' OE2' ' A' ' 40' ' ' GLU . . . 108.73 -47.25 1.06 Allowed Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.516 -1.325 . . . . 0.0 110.744 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.444 ' HB2' ' HD3' ' B' ' 183' ' ' PRO . 0.0 OUTLIER -159.2 -5.9 0.07 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.023 -1.281 . . . . 0.0 110.388 -179.571 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.783 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 65.4 m95 -141.68 99.87 3.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.038 -1.039 . . . . 0.0 109.276 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.679 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -94.68 148.66 22.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.031 -1.043 . . . . 0.0 109.454 -179.621 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 17.7 tttt -88.56 109.11 19.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.256 -0.903 . . . . 0.0 108.973 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.68 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -100.97 178.6 4.62 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.449 -0.782 . . . . 0.0 109.863 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 2.7 mttt -121.1 129.78 53.45 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.647 -0.658 . . . . 0.0 109.588 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.609 ' HB2' ' HB3' ' A' ' 54' ' ' LYS . 1.1 t -77.6 128.41 34.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 110.056 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.484 HD13 ' HD3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -72.92 -9.25 58.5 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.911 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 tp -52.32 -54.92 25.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.407 -0.808 . . . . 0.0 109.383 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.611 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 2.6 t -161.5 29.35 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 110.041 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.611 ' CB ' ' O ' ' A' ' 52' ' ' THR . 8.7 mmtm 86.68 44.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.502 -0.749 . . . . 0.0 110.488 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.609 ' HB3' ' HB2' ' A' ' 49' ' ' SER . 0.5 OUTLIER -85.0 133.25 34.26 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.183 -0.948 . . . . 0.0 108.488 178.61 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.93 114.34 20.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.923 -1.111 . . . . 0.0 109.215 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.618 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -152.57 169.21 31.69 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.366 -1.397 . . . . 0.0 109.89 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.711 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 7.7 m-85 -73.4 132.0 42.49 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.546 -0.973 . . . . 0.0 109.57 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 58' ' ' ILE . 11.0 pt -121.96 140.98 33.13 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.875 . . . . 0.0 109.069 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.597 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 49.2 Cg_endo -69.54 149.42 68.25 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.176 1.918 . . . . 0.0 112.094 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.523 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 21.2 t -77.57 7.78 5.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.328 -0.857 . . . . 0.0 110.656 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.536 ' ND2' ' O ' ' B' ' 178' ' ' PRO . 0.1 OUTLIER -111.74 -51.8 2.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.824 -1.173 . . . . 0.0 110.672 -179.143 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.7 ' CE2' ' HA ' ' A' ' 19' ' ' TYR . 2.6 m-30 -48.96 -52.16 26.32 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.105 -0.997 . . . . 0.0 110.83 -178.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.561 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.7 m -88.91 155.52 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -0.972 . . . . 0.0 111.19 -178.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.075 ' CB ' HD11 ' A' ' 16' ' ' LEU . . . -134.09 162.38 32.25 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.505 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 3.2 ptmt -77.12 94.57 4.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.954 -1.091 . . . . 0.0 109.344 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.458 ' C ' ' O ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER 39.88 55.39 2.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.235 -0.915 . . . . 0.0 109.63 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 64' ' ' ALA . 1.2 t30 -74.55 108.45 7.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 109.556 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.465 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 170' ' ' TRP . . . . . 0.468 ' CD1' ' N ' ' B' ' 170' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.3 0.571 . . . . 0.0 109.464 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 171' ' ' ASP . . . . . 0.601 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 0.4 OUTLIER -170.5 -56.25 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.225 -0.922 . . . . 0.0 108.781 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 172' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 46.5 Cg_endo -67.92 -89.88 0.0 OUTLIER 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.7 2.266 . . . . 0.0 111.837 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 173' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' B' ' 174' ' ' MET . . . 72.63 38.78 57.09 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 174' ' ' MET . . . . . 0.435 ' O ' ' O ' ' B' ' 173' ' ' GLY . 5.1 mtt 59.23 112.07 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.204 -1.174 . . . . 0.0 109.409 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 175' ' ' PRO . . . . . 0.771 ' O ' HG23 ' B' ' 176' ' ' THR . 53.8 Cg_endo -78.94 -161.88 0.16 Allowed 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.601 2.201 . . . . 0.0 111.632 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 176' ' ' THR . . . . . 0.992 HG22 ' HB3' ' A' ' 17' ' ' TYR . 2.0 p -164.77 97.58 0.87 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.444 -0.785 . . . . 0.0 109.323 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 177' ' ' PRO . . . . . 0.671 ' HD2' ' CD2' ' A' ' 17' ' ' TYR . 50.2 Cg_endo -69.21 164.88 32.29 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.939 2.426 . . . . 0.0 112.046 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 178' ' ' PRO . . . . . 0.536 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 50.0 Cg_endo -70.31 157.3 59.74 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.721 2.281 . . . . 0.0 111.466 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 0.628 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -92.81 175.72 3.04 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.148 -0.97 . . . . 0.0 109.802 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.783 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.4 Cg_endo -68.96 -172.3 0.48 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.068 2.512 . . . . 0.0 111.326 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 181' ' ' PRO . . . . . 0.804 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 52.7 Cg_endo -91.48 -35.17 0.06 OUTLIER 'Trans proline' 0 C--O 1.212 -0.783 0 C-N-CA 122.788 2.325 . . . . 0.0 114.694 -177.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.804 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 32.4 mtt180 87.83 96.27 0.03 OUTLIER Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.314 -0.866 . . . . 0.0 109.013 -178.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 47.4 Cg_endo -68.78 124.56 11.62 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.76 2.306 . . . . 0.0 111.904 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 184' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' B' ' 185' ' ' ASN . . . 45.69 67.4 0.74 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.862 . . . . 0.0 109.495 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 185' ' ' ASN . . . . . 0.466 ' CA ' ' HB3' ' B' ' 188' ' ' GLU . 14.9 m-20 43.08 50.5 5.5 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.354 -0.841 . . . . 0.0 109.535 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 186' ' ' LEU . . . . . 0.656 HD11 ' CB ' ' A' ' 41' ' ' HIS . 47.7 tp -67.6 -83.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.296 -0.877 . . . . 0.0 109.507 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 187' ' ' GLY . . . . . 0.711 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -66.01 -8.18 41.02 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.654 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 33.5 tt0 -69.91 -86.04 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.469 -1.019 . . . . 0.0 109.421 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 189' ' ' ARG . . . . . 0.514 ' NE ' ' OD2' ' A' ' 25' ' ' ASP . 0.0 OUTLIER 73.05 140.52 0.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.308 -0.87 . . . . 0.0 109.533 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -139.14 -40.93 0.47 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.26 -0.9 . . . . 0.0 109.405 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.448 179.994 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.3 0.571 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.45 -117.31 0.76 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -134.98 157.72 46.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.164 -1.198 . . . . 0.0 109.505 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.709 HD12 ' HA ' ' A' ' 36' ' ' LYS . 5.2 tp -109.61 136.64 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.183 -0.948 . . . . 0.0 109.46 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.0 m -131.77 160.2 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.35 -0.844 . . . . 0.0 109.186 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' HG3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -119.64 138.7 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.068 -1.02 . . . . 0.0 109.302 179.121 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.768 ' HB2' ' HE3' ' A' ' 35' ' ' MET . . . -72.14 133.67 45.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.451 -0.781 . . . . 0.0 109.946 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.053 HD11 ' HB2' ' A' ' 64' ' ' ALA . 7.6 mt -99.79 -8.31 24.35 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.92 ' HB3' HG22 ' B' ' 176' ' ' THR . 27.6 m-85 -162.29 151.94 13.49 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.771 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 39.2 Cg_endo -62.19 149.16 91.58 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 121.733 1.622 . . . . 0.0 110.05 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.848 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 57.0 t80 -98.63 178.23 5.06 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 118.364 -1.335 . . . . 0.0 110.764 -177.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.68 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 6.4 m-20 -109.22 79.95 1.27 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.47 94.44 0.04 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.409 ' N ' ' O ' ' A' ' 20' ' ' ASP . 21.2 mt -107.17 -42.93 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.108 -1.231 . . . . 0.0 108.803 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.574 ' ND1' ' O ' ' B' ' 188' ' ' GLU . 0.2 OUTLIER -76.04 152.69 84.47 Favored Pre-proline 0 C--N 1.3 -1.563 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.53 ' HD2' ' ND1' ' A' ' 23' ' ' HIS . 43.9 Cg_endo -66.68 -11.42 31.8 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.299 1.999 . . . . 0.0 111.567 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.87 -14.68 13.49 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.89 . . . . 0.0 110.215 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' B' ' 187' ' ' GLY . 26.4 m-20 -58.07 142.17 47.73 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.883 -1.135 . . . . 0.0 109.784 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.908 HD22 ' N ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -98.55 122.21 41.46 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.908 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -78.03 139.77 39.12 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.327 -0.858 . . . . 0.0 109.449 179.669 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.848 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 24.3 p90 -145.29 156.74 44.0 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.232 -0.917 . . . . 0.0 108.74 178.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.691 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 3.2 tttp -111.18 174.28 5.94 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.172 -0.955 . . . . 0.0 109.539 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.584 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -67.37 151.85 46.72 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.108 -0.995 . . . . 0.0 109.346 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.96 -7.65 4.15 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -74.79 141.89 44.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.04 -1.271 . . . . 0.0 109.611 -179.735 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.634 ' HG3' HG13 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -95.86 138.61 33.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.89 . . . . 0.0 109.298 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.768 ' HE3' ' HB2' ' A' ' 15' ' ' ALA . 3.7 mpp? -133.2 149.63 52.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.53 -0.731 . . . . 0.0 109.88 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.709 ' HA ' HD12 ' A' ' 12' ' ' ILE . 12.2 mtpt -104.78 119.77 39.8 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.463 -0.773 . . . . 0.0 109.256 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -78.05 109.43 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.342 -0.849 . . . . 0.0 108.887 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 mt -88.15 -40.22 13.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.905 . . . . 0.0 109.991 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -134.99 97.47 3.75 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.032 -1.043 . . . . 0.0 109.158 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.7 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 0.7 OUTLIER -79.89 113.62 18.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.245 -0.91 . . . . 0.0 109.298 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -106.33 -121.1 0.23 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.499 ' HA3' ' HG3' ' B' ' 183' ' ' PRO . . . -85.5 -124.58 1.43 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' B' ' 180' ' ' PRO . 7.0 mt-10 -78.46 10.33 3.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -1.104 . . . . 0.0 111.102 -178.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.866 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 64.6 m95 -141.1 98.1 3.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.528 -1.357 . . . . 0.0 109.824 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.7 ' HB3' ' HA ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -92.97 145.24 24.52 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.826 -1.171 . . . . 0.0 110.197 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -85.77 108.06 17.91 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.754 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -100.54 -177.16 3.41 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.264 -0.898 . . . . 0.0 109.97 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -123.94 109.03 13.06 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.648 -0.658 . . . . 0.0 109.394 -179.663 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.617 ' N ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -54.77 127.84 30.18 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.167 -0.958 . . . . 0.0 109.861 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 52' ' ' THR . 0.1 OUTLIER -76.76 -11.46 59.84 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.222 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.512 ' C ' HG22 ' A' ' 52' ' ' THR . 4.5 tp -46.06 -20.9 0.11 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.722 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 0.5 OUTLIER 168.1 -21.72 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.371 -0.831 . . . . 0.0 109.935 179.123 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.722 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 140.84 42.48 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.528 -0.733 . . . . 0.0 110.046 179.595 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.683 ' HB3' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -85.67 134.36 33.98 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.131 -0.98 . . . . 0.0 108.424 178.4 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -121.67 114.16 20.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.909 -1.12 . . . . 0.0 109.439 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.625 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -152.49 172.46 31.65 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.677 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 6.8 m-85 -74.49 132.17 41.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.431 -1.04 . . . . 0.0 109.859 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.551 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 7.3 pt -121.42 138.24 27.97 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.667 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 48.6 Cg_endo -69.93 163.06 39.81 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 121.64 1.56 . . . . 0.0 112.01 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.564 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 82.8 p -90.89 8.25 35.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.389 -0.819 . . . . 0.0 110.095 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' B' ' 178' ' ' PRO . 0.2 OUTLIER -108.91 -54.9 2.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.028 -1.045 . . . . 0.0 110.109 -179.553 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.747 ' HE2' HD23 ' B' ' 179' ' ' LEU . 2.3 m-85 -47.24 -63.56 1.01 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.201 -0.937 . . . . 0.0 110.648 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.608 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.5 m -78.73 155.77 4.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.945 0.878 . . . . 0.0 110.96 -177.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.053 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -128.46 157.66 40.5 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp -75.64 154.88 36.33 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.948 -1.095 . . . . 0.0 109.583 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 67' ' ' ASN . 19.7 tp -126.91 90.95 3.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.923 . . . . 0.0 109.374 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 66' ' ' LEU . 0.7 OUTLIER -43.41 -81.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.558 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.488 179.974 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 170' ' ' TRP . . . . . 0.431 ' O ' ' HB3' ' B' ' 171' ' ' ASP . 6.0 m-90 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 171' ' ' ASP . . . . . 0.595 ' N ' ' HD3' ' B' ' 172' ' ' PRO . 1.5 p30 172.71 58.8 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.859 . . . . 0.0 109.005 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 172' ' ' PRO . . . . . 0.595 ' HD3' ' N ' ' B' ' 171' ' ' ASP . 52.5 Cg_endo -93.76 -77.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.271 2.647 . . . . 0.0 112.053 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 173' ' ' GLY . . . . . . . . . . . . . . . 87.5 35.29 9.52 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 174' ' ' MET . . . . . 0.586 ' N ' ' CD ' ' B' ' 175' ' ' PRO . 0.0 OUTLIER -83.75 -44.39 0.8 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.301 -1.117 . . . . 0.0 109.703 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 175' ' ' PRO . . . . . 0.931 ' O ' HG23 ' B' ' 176' ' ' THR . 54.2 Cg_endo -81.0 -165.13 0.32 Allowed 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 122.525 2.15 . . . . 0.0 111.812 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 176' ' ' THR . . . . . 0.931 HG23 ' O ' ' B' ' 175' ' ' PRO . 2.9 p -171.12 100.14 0.41 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.588 -0.695 . . . . 0.0 109.176 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 177' ' ' PRO . . . . . 0.63 ' HD2' ' CG ' ' A' ' 17' ' ' TYR . 50.7 Cg_endo -68.94 165.0 31.49 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.777 2.318 . . . . 0.0 111.703 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 178' ' ' PRO . . . . . 0.435 ' O ' ' OD1' ' A' ' 61' ' ' ASN . 48.6 Cg_endo -69.13 -165.52 0.14 Allowed 'Trans proline' 0 C--O 1.213 -0.761 0 C-N-CA 122.607 2.205 . . . . 0.0 110.893 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 0.747 HD23 ' HE2' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -126.53 175.16 3.45 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.094 -1.004 . . . . 0.0 109.481 179.693 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.866 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 37.9 Cg_endo -67.24 -174.65 0.54 Allowed 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.922 2.415 . . . . 0.0 111.648 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 181' ' ' PRO . . . . . 0.751 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.8 Cg_endo -92.62 -23.69 0.33 Allowed 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 123.022 2.482 . . . . 0.0 114.617 -177.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.751 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 27.6 mtt180 76.47 96.73 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.876 -1.14 . . . . 0.0 109.048 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 45.3 Cg_endo -67.0 107.24 1.29 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.6 2.2 . . . . 0.0 111.408 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 184' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' B' ' 185' ' ' ASN . . . 60.65 68.56 0.74 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.306 -0.871 . . . . 0.0 108.864 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 185' ' ' ASN . . . . . 0.48 ' HA ' ' HB2' ' B' ' 188' ' ' GLU . 2.9 p30 41.15 49.18 3.14 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.46 -0.775 . . . . 0.0 109.468 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 186' ' ' LEU . . . . . 0.619 HD23 ' HB2' ' A' ' 44' ' ' TRP . 64.5 tp -68.67 -75.33 0.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.357 -0.84 . . . . 0.0 109.278 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 187' ' ' GLY . . . . . 0.677 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -65.64 -10.79 51.3 Favored Glycine 0 N--CA 1.484 1.838 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.574 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 1.6 mt-10 -81.98 -58.14 3.1 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.529 -0.983 . . . . 0.0 109.126 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 189' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.48 -156.84 0.76 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.428 -0.795 . . . . 0.0 109.427 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 190' ' ' GLN . . . . . 0.658 ' O ' ' HB2' ' B' ' 191' ' ' ALA . 0.0 OUTLIER -153.49 30.06 0.48 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 109.421 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 191' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' B' ' 190' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.463 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.62 89.6 2.01 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.558 ' O ' HG23 ' A' ' 37' ' ' VAL . 79.9 m-20 -126.84 140.7 52.16 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.333 -1.098 . . . . 0.0 109.309 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.679 HD11 ' HG3' ' A' ' 36' ' ' LYS . 24.2 mm -101.82 136.39 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.134 -0.979 . . . . 0.0 109.553 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.07 160.69 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.8 p -121.24 137.15 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.001 -1.062 . . . . 0.0 109.341 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -70.44 135.21 48.5 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.414 -0.804 . . . . 0.0 109.886 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.03 HD11 ' HB2' ' A' ' 64' ' ' ALA . 18.1 mt -97.73 -28.36 13.92 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.666 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 4.3 m-85 -141.27 155.79 67.78 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 39.7 Cg_endo -62.13 145.39 96.41 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 121.692 1.594 . . . . 0.0 110.73 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.72 ' O ' ' CB ' ' A' ' 20' ' ' ASP . 23.7 t80 -70.36 -76.45 0.1 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.448 -0.782 . . . . 0.0 112.102 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.72 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 6.0 m-20 127.03 72.46 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -178.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.57 82.77 0.01 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.189 -1.165 . . . . 0.0 110.189 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.55 ' N ' ' O ' ' A' ' 20' ' ' ASP . 9.4 mm -99.56 0.96 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.979 -1.306 . . . . 0.0 108.226 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.498 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 1.7 m-70 -122.64 152.6 62.14 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.25 -14.49 34.6 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.838 1.692 . . . . 0.0 111.986 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.73 -19.11 11.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.401 -0.812 . . . . 0.0 110.875 -178.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.498 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.8 OUTLIER -55.72 139.34 45.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.872 -1.142 . . . . 0.0 110.103 -178.773 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.967 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -87.79 117.32 26.55 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.315 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.887 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.8 m -76.87 138.7 39.93 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.331 -0.856 . . . . 0.0 110.216 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.705 ' CE2' ' HB2' ' A' ' 19' ' ' TYR . 10.6 p90 -143.38 154.77 44.07 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.683 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.8 OUTLIER -111.18 171.28 7.57 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.006 -1.058 . . . . 0.0 109.652 -179.291 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -63.15 152.19 38.04 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.201 -0.937 . . . . 0.0 109.081 179.792 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 68.02 -7.59 2.32 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.4 ' H ' ' C ' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -74.15 143.4 45.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.827 -1.396 . . . . 0.0 110.009 -179.461 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HE2' ' HB2' ' A' ' 34' ' ' LYS . 3.9 mppt? -95.22 137.14 34.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.34 -0.85 . . . . 0.0 109.457 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.571 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -136.13 151.88 50.24 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.611 -0.68 . . . . 0.0 109.813 -179.448 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.679 ' HG3' HD11 ' A' ' 12' ' ' ILE . 4.5 ttmt -109.87 126.79 54.21 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.455 -0.778 . . . . 0.0 109.776 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 11' ' ' ASP . 1.4 t -82.68 138.28 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.386 -0.821 . . . . 0.0 108.942 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.604 HD12 ' N ' ' A' ' 38' ' ' LEU . 6.3 mp -112.54 -31.0 6.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.07 -1.019 . . . . 0.0 109.927 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.03 96.08 1.2 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.184 -0.948 . . . . 0.0 109.303 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.579 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 1.0 OUTLIER -49.93 130.52 21.9 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.477 -0.764 . . . . 0.0 108.993 179.646 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.921 ' HB3' HD21 ' B' ' 186' ' ' LEU . 1.8 m-70 -128.51 102.12 6.48 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.486 ' C ' ' O ' ' A' ' 41' ' ' HIS . . . 41.18 -142.37 0.93 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.616 ' CB ' ' HD2' ' B' ' 181' ' ' PRO . 4.7 mt-10 -77.1 11.04 1.99 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -1.137 . . . . 0.0 110.707 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 1.053 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 64.5 m95 -137.4 100.36 4.21 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.668 -1.27 . . . . 0.0 109.67 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.58 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -94.44 149.27 21.41 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.817 -1.177 . . . . 0.0 110.215 -179.616 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -95.52 110.96 22.96 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.112 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -107.33 -175.3 2.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.177 -0.952 . . . . 0.0 110.297 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 9.9 ttpt -125.14 130.75 52.83 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.646 -0.659 . . . . 0.0 109.595 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.626 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -76.35 128.21 34.4 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 109.735 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.48 -6.11 46.46 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.8 tp -55.9 -54.73 41.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.455 -0.778 . . . . 0.0 109.259 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.606 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 1.3 t -160.45 29.68 0.16 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.143 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.606 ' HB2' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 85.25 43.03 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.466 -0.771 . . . . 0.0 111.09 178.199 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.76 ' HB3' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -86.42 132.5 33.93 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.922 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.474 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 12.9 pt-20 -122.62 118.91 29.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.937 -1.102 . . . . 0.0 109.387 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.678 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -155.6 166.57 32.85 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.013 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.745 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 7.0 m-85 -71.87 134.97 46.4 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.7 -0.883 . . . . 0.0 109.695 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.517 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 3.0 pt -124.55 144.89 47.53 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.406 -0.809 . . . . 0.0 109.148 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.613 ' HG3' ' CD2' ' B' ' 179' ' ' LEU . 47.1 Cg_endo -69.31 162.67 40.91 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 121.977 1.785 . . . . 0.0 111.393 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.531 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 98.2 p -92.13 8.98 35.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.016 -1.052 . . . . 0.0 110.894 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.575 ' OD1' ' C ' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -112.08 -51.7 2.83 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.765 -1.209 . . . . 0.0 110.153 -179.581 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 1.141 ' CE2' HD21 ' B' ' 179' ' ' LEU . 1.3 m-85 -44.66 -62.22 1.28 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.163 -0.961 . . . . 0.0 110.787 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.571 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.9 m -79.64 156.7 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 122.104 0.954 . . . . 0.0 111.486 -177.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.03 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -133.35 161.22 35.1 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.9 tttp -75.96 151.0 37.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.995 -1.066 . . . . 0.0 109.395 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.38 -81.28 0.33 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.152 -0.967 . . . . 0.0 109.498 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -49.25 147.06 3.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.345 -0.847 . . . . 0.0 109.522 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.2 p . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.043 -0.98 . . . . 0.0 109.514 -179.918 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 170' ' ' TRP . . . . . 0.524 ' CD1' ' C ' ' B' ' 170' ' ' TRP . 1.8 p90 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.258 0.551 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 171' ' ' ASP . . . . . 0.589 ' H ' ' HD2' ' B' ' 172' ' ' PRO . 0.1 OUTLIER -161.77 -58.73 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.828 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 172' ' ' PRO . . . . . 0.589 ' HD2' ' H ' ' B' ' 171' ' ' ASP . 48.1 Cg_endo -68.25 -90.62 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.756 2.304 . . . . 0.0 111.778 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 173' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' B' ' 174' ' ' MET . . . 120.86 7.84 8.44 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 174' ' ' MET . . . . . 0.432 ' O ' ' O ' ' B' ' 173' ' ' GLY . 37.1 mmt 43.19 89.58 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.223 -1.163 . . . . 0.0 109.432 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 175' ' ' PRO . . . . . 0.56 ' HD2' ' CE1' ' A' ' 17' ' ' TYR . 55.3 Cg_endo -77.77 -160.67 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.615 2.21 . . . . 0.0 111.882 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 176' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 17' ' ' TYR . 3.1 p -156.38 96.16 2.26 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 177' ' ' PRO . . . . . 0.558 ' HG2' ' OD1' ' A' ' 61' ' ' ASN . 48.5 Cg_endo -70.24 174.77 9.43 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.779 2.319 . . . . 0.0 111.783 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 178' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' B' ' 179' ' ' LEU . 46.5 Cg_endo -68.18 108.6 1.79 Allowed 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.599 2.2 . . . . 0.0 111.743 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 1.141 HD21 ' CE2' ' A' ' 62' ' ' TYR . 30.1 mt -40.38 163.54 0.08 OUTLIER Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.44 -0.787 . . . . 0.0 109.657 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 1.053 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.3 Cg_endo -65.92 177.08 3.18 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.781 2.321 . . . . 0.0 111.83 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 181' ' ' PRO . . . . . 0.617 ' O ' ' CB ' ' B' ' 182' ' ' ARG . 53.9 Cg_endo -73.65 -48.01 0.26 Allowed 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.933 2.422 . . . . 0.0 113.873 -177.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.709 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.0 OUTLIER 84.81 91.78 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.151 -0.968 . . . . 0.0 108.946 -178.724 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.692 ' HG2' ' HB2' ' B' ' 186' ' ' LEU . 43.9 Cg_endo -69.07 129.66 18.74 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 123.085 2.523 . . . . 0.0 112.326 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 184' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 38.21 67.03 0.43 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.477 -0.764 . . . . 0.0 109.464 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 185' ' ' ASN . . . . . 0.499 ' HA ' ' CB ' ' B' ' 188' ' ' GLU . 0.6 OUTLIER 42.93 43.47 3.56 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.357 -0.84 . . . . 0.0 109.026 -179.55 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 186' ' ' LEU . . . . . 0.98 HD23 ' HB2' ' A' ' 44' ' ' TRP . 42.4 tp -54.27 -94.54 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 187' ' ' GLY . . . . . 0.745 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -64.2 -12.43 50.11 Favored Glycine 0 N--CA 1.482 1.729 0 N-CA-C 107.474 -2.25 . . . . 0.0 107.474 178.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.533 ' HA ' ' CZ ' ' B' ' 182' ' ' ARG . 0.1 OUTLIER -67.64 -73.17 0.15 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.688 -0.89 . . . . 0.0 109.094 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 189' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' B' ' 188' ' ' GLU . 0.0 OUTLIER 74.25 158.35 0.2 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.442 -0.786 . . . . 0.0 109.576 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 190' ' ' GLN . . . . . 0.459 ' O ' ' HB3' ' B' ' 191' ' ' ALA . 0.2 OUTLIER -143.44 23.45 1.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 109.529 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 191' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' B' ' 190' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.432 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.93 100.93 0.17 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.571 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.3 OUTLIER -114.65 139.02 49.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -1.13 . . . . 0.0 109.326 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 36' ' ' LYS . 17.6 mm -92.93 136.67 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 109.618 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.87 HG12 ' HD3' ' A' ' 65' ' ' LYS . 1.1 m -132.14 161.8 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.6 p -120.97 139.2 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.137 -0.977 . . . . 0.0 109.075 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.671 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.05 132.92 45.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.346 -0.846 . . . . 0.0 109.807 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.081 HD11 ' CB ' ' A' ' 64' ' ' ALA . 24.4 mt -98.66 -11.97 21.51 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.938 ' HB3' HG22 ' B' ' 176' ' ' THR . 54.8 m-85 -159.55 153.69 19.96 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.701 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 42.0 Cg_endo -64.55 149.09 90.49 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 121.672 1.582 . . . . 0.0 109.983 179.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.816 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 56.4 t80 -97.79 178.6 5.09 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 118.303 -1.359 . . . . 0.0 110.265 -177.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.682 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 12.2 m-20 -109.47 80.66 1.34 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.56 -0.713 . . . . 0.0 109.322 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.51 95.38 0.06 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.6 mt -108.5 -42.24 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.157 -1.202 . . . . 0.0 108.896 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.657 ' CG ' ' O ' ' B' ' 188' ' ' GLU . 3.4 m-70 -76.98 159.6 78.19 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -71.11 -12.12 29.89 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.141 1.894 . . . . 0.0 111.778 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -113.86 -14.94 12.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 110.869 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.48 ' CG ' ' HB2' ' A' ' 23' ' ' HIS . 90.7 m-20 -57.19 139.47 52.54 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.719 -1.238 . . . . 0.0 109.955 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.896 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -93.77 120.86 34.58 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.005 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.855 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -80.68 141.41 34.93 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.351 -0.843 . . . . 0.0 109.595 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.816 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 30.5 p90 -146.05 157.79 43.86 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.181 -0.949 . . . . 0.0 108.599 178.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.671 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 6.4 mttt -110.7 173.7 6.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.147 -0.97 . . . . 0.0 109.594 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.552 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -67.43 151.43 47.42 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.141 -0.975 . . . . 0.0 109.314 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.96 -8.25 4.79 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -75.84 143.63 41.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.953 -1.322 . . . . 0.0 109.755 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.31 138.95 33.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 109.509 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.576 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 2.5 mpp? -134.91 151.47 50.91 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.564 -0.71 . . . . 0.0 109.761 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 8.3 ttpp -105.15 124.13 49.0 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.507 -0.745 . . . . 0.0 109.53 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.808 ' C ' HD12 ' A' ' 38' ' ' LEU . 2.2 t -81.13 136.97 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.297 -0.877 . . . . 0.0 109.216 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.808 HD12 ' C ' ' A' ' 37' ' ' VAL . 7.1 mp -111.85 -43.36 3.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 109.648 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.05 106.35 3.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.124 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.654 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 0.7 OUTLIER -89.98 118.03 29.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.333 -0.855 . . . . 0.0 109.539 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.615 ' CG ' HD12 ' B' ' 186' ' ' LEU . 1.8 m-70 -81.83 -100.31 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.314 -0.866 . . . . 0.0 109.382 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.465 ' O ' ' HG2' ' A' ' 43' ' ' GLU . . . -133.34 -14.31 1.4 Allowed Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.664 -1.255 . . . . 0.0 110.065 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 42' ' ' GLY . 6.0 mm-40 -157.52 -16.0 0.08 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.972 -1.31 . . . . 0.0 110.623 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.94 ' CD1' ' HA ' ' B' ' 182' ' ' ARG . 56.3 m95 -137.6 101.65 4.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.673 -1.267 . . . . 0.0 109.485 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.654 ' CD1' ' CG ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -93.32 144.4 25.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.206 -0.934 . . . . 0.0 110.211 -179.313 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 11.4 ttpt -90.08 108.08 19.51 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -102.8 -175.3 2.77 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.354 -0.841 . . . . 0.0 109.931 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 17.7 ttpt -125.88 130.43 51.31 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.605 -0.684 . . . . 0.0 109.31 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.595 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 6.9 t -75.84 126.78 31.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.072 -1.017 . . . . 0.0 109.963 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 50' ' ' LEU . 14.4 mt -70.81 -7.99 49.3 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.3 tp -53.94 -55.6 25.51 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.53 -0.731 . . . . 0.0 109.445 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.629 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.7 t -161.04 28.14 0.14 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 110.119 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.629 ' CB ' ' O ' ' A' ' 52' ' ' THR . 14.1 mtmm 87.38 44.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.414 -0.804 . . . . 0.0 110.687 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.595 ' HB2' ' CB ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -86.77 131.58 34.09 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.042 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.456 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 2.5 pt-20 -122.01 118.46 28.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.879 -1.138 . . . . 0.0 109.625 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.658 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -157.66 168.36 34.32 Favored Glycine 0 N--CA 1.487 2.068 0 C-N-CA 119.427 -1.368 . . . . 0.0 109.904 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.963 ' CD1' HD21 ' B' ' 186' ' ' LEU . 27.1 m-85 -70.98 132.39 45.1 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.57 -0.959 . . . . 0.0 109.883 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 58' ' ' ILE . 6.6 pt -121.08 141.64 33.26 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.654 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 46.6 Cg_endo -69.18 154.86 69.38 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 121.721 1.614 . . . . 0.0 111.836 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.621 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 73.7 p -83.96 7.12 19.35 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.364 -0.835 . . . . 0.0 110.252 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.13 -53.28 2.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.936 -1.102 . . . . 0.0 110.515 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.584 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 2.6 m-85 -48.44 -62.72 1.35 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.075 -1.016 . . . . 0.0 111.173 -178.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.576 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 3.0 m -78.11 155.5 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 122.079 0.942 . . . . 0.0 111.18 -177.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.081 ' CB ' HD11 ' A' ' 16' ' ' LEU . . . -136.02 163.29 30.64 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.87 ' HD3' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -75.73 148.66 38.4 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.046 -1.034 . . . . 0.0 109.228 179.615 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.0 mp -80.18 78.06 6.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.17 -0.956 . . . . 0.0 109.772 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -149.04 12.77 0.86 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 109.675 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.413 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 170' ' ' TRP . . . . . 0.597 ' CZ3' ' HA2' ' B' ' 173' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 171' ' ' ASP . . . . . 0.572 ' H ' ' HD2' ' B' ' 172' ' ' PRO . 0.4 OUTLIER -164.0 -58.49 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.238 -0.914 . . . . 0.0 108.714 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 172' ' ' PRO . . . . . 0.572 ' HD2' ' H ' ' B' ' 171' ' ' ASP . 46.8 Cg_endo -67.67 -89.33 0.0 OUTLIER 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.817 2.344 . . . . 0.0 111.773 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 173' ' ' GLY . . . . . 0.597 ' HA2' ' CZ3' ' B' ' 170' ' ' TRP . . . 110.56 75.6 0.82 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 174' ' ' MET . . . . . 0.476 ' O ' ' O ' ' B' ' 173' ' ' GLY . 43.5 mtm 59.07 118.82 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.306 -1.114 . . . . 0.0 109.476 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 175' ' ' PRO . . . . . 0.926 ' O ' HG23 ' B' ' 176' ' ' THR . 54.4 Cg_endo -79.61 -163.66 0.24 Allowed 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 122.556 2.171 . . . . 0.0 111.493 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 176' ' ' THR . . . . . 0.938 HG22 ' HB3' ' A' ' 17' ' ' TYR . 0.7 OUTLIER -176.16 102.62 0.24 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.474 -0.766 . . . . 0.0 109.142 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 177' ' ' PRO . . . . . 0.625 ' HD2' ' CD2' ' A' ' 17' ' ' TYR . 48.0 Cg_endo -69.66 157.32 61.0 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.716 2.277 . . . . 0.0 111.709 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.63 144.21 59.44 Favored 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 122.598 2.199 . . . . 0.0 111.478 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 0.608 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -83.77 174.52 5.81 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.135 -0.978 . . . . 0.0 109.875 -179.705 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.717 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 42.9 Cg_endo -72.44 -170.66 0.61 Allowed 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.976 2.451 . . . . 0.0 110.211 178.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 181' ' ' PRO . . . . . 0.766 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 51.6 Cg_endo -87.06 -67.54 0.01 OUTLIER 'Trans proline' 0 C--O 1.212 -0.79 0 C-N-CA 121.991 1.794 . . . . 0.0 112.198 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.94 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.8 OUTLIER 141.05 112.78 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.078 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.581 ' HG2' ' CB ' ' B' ' 186' ' ' LEU . 44.1 Cg_endo -67.45 127.14 15.97 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 123.04 2.493 . . . . 0.0 112.087 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 184' ' ' ALA . . . . . 0.491 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 37.99 52.88 1.57 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.378 -0.826 . . . . 0.0 109.375 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 185' ' ' ASN . . . . . 0.432 ' HA ' ' HB3' ' B' ' 188' ' ' GLU . 0.1 OUTLIER 46.28 44.33 12.32 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.369 -0.832 . . . . 0.0 109.104 -179.526 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 186' ' ' LEU . . . . . 1.053 HD23 ' N ' ' B' ' 187' ' ' GLY . 7.8 tt -72.8 -82.83 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.479 -0.763 . . . . 0.0 108.97 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 187' ' ' GLY . . . . . 1.053 ' N ' HD23 ' B' ' 186' ' ' LEU . . . -62.17 -11.99 35.37 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 108.161 -1.976 . . . . 0.0 108.161 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.657 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 64.0 tt0 -72.89 -102.45 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.506 -0.996 . . . . 0.0 109.156 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 189' ' ' ARG . . . . . 0.498 ' N ' ' HG2' ' B' ' 188' ' ' GLU . 0.0 OUTLIER -96.94 157.63 15.81 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.057 -1.027 . . . . 0.0 109.433 179.656 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -83.09 164.5 20.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.919 . . . . 0.0 109.504 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.427 -179.957 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.38 136.93 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.189 -0.945 . . . . 0.0 109.54 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.59 HG12 ' HA ' ' A' ' 65' ' ' LYS . 1.8 m -131.51 160.42 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.372 -0.83 . . . . 0.0 108.929 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.8 p -121.12 137.64 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.965 -1.085 . . . . 0.0 109.295 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.751 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.04 134.51 47.15 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.445 -0.785 . . . . 0.0 110.108 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.64 ' CD1' ' HB2' ' A' ' 64' ' ' ALA . 42.1 mt -98.37 -14.97 19.9 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.597 ' HA ' ' HB3' ' A' ' 31' ' ' LYS . 4.7 m-85 -157.45 155.48 27.47 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.0 Cg_endo -62.42 146.05 95.67 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.58 1.52 . . . . 0.0 110.381 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.769 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 8.8 t80 -76.34 -68.76 0.56 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.222 -0.924 . . . . 0.0 112.04 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.758 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 40.9 t0 122.79 70.94 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -177.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -54.28 94.36 0.02 OUTLIER Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 20' ' ' ASP . 0.6 OUTLIER -105.0 -44.2 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.143 -1.21 . . . . 0.0 107.822 178.552 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.473 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 13.2 m-70 -75.48 156.35 85.24 Favored Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.6 -11.52 26.24 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.026 1.817 . . . . 0.0 111.994 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.69 -16.14 12.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.216 -0.927 . . . . 0.0 110.813 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.473 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 18.4 m-20 -57.24 138.89 54.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.839 -1.163 . . . . 0.0 110.422 -178.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.975 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -88.96 119.04 29.13 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.901 ' N ' HD22 ' A' ' 27' ' ' LEU . 4.8 p -77.79 138.03 38.76 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.224 -0.923 . . . . 0.0 110.179 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.769 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 8.1 p90 -143.78 155.24 44.09 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.751 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 7.2 mmtp -111.74 176.76 4.89 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.027 -1.046 . . . . 0.0 109.613 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.597 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -67.52 151.01 48.1 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.08 -1.013 . . . . 0.0 109.142 179.524 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.52 -7.76 3.55 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.749 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 1.1 mt-10 -74.75 144.15 43.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.868 -1.372 . . . . 0.0 109.938 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.519 ' CG ' HD13 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -95.78 138.08 33.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.0 109.406 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.53 ' CE ' HG11 ' A' ' 63' ' ' VAL . 0.9 OUTLIER -136.19 151.95 50.26 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.596 -0.69 . . . . 0.0 109.912 -179.423 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 4.5 ttpm? -105.87 124.27 49.31 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.442 -0.786 . . . . 0.0 109.498 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.523 ' CG2' HG22 ' A' ' 13' ' ' VAL . 2.0 t -80.98 137.23 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.359 -0.838 . . . . 0.0 108.92 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.1 mt -113.85 -39.48 3.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.113 -0.992 . . . . 0.0 109.688 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -150.82 91.43 1.72 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.939 . . . . 0.0 108.924 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.596 ' HG2' ' CD1' ' A' ' 45' ' ' TRP . 1.6 tm-20 -79.35 115.39 18.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.361 -0.837 . . . . 0.0 109.795 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.718 ' HB2' HD21 ' B' ' 186' ' ' LEU . 68.4 m-70 -79.08 -98.32 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.361 -0.837 . . . . 0.0 109.223 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.461 ' C ' ' HG2' ' A' ' 43' ' ' GLU . . . -143.33 -12.33 0.36 Allowed Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.664 -1.255 . . . . 0.0 110.197 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.554 ' O ' ' HG3' ' B' ' 180' ' ' PRO . 7.1 mm-40 -148.5 -25.57 0.33 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.002 -1.293 . . . . 0.0 110.171 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.779 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 64.9 m95 -135.5 102.85 5.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.947 -1.095 . . . . 0.0 109.568 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.611 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -90.8 141.66 28.57 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.075 -1.015 . . . . 0.0 109.985 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.528 ' HG2' ' C ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -90.5 106.53 18.56 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.13 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.52 -176.73 3.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.171 -0.956 . . . . 0.0 110.173 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 6.9 tttt -124.59 128.87 49.56 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.651 -0.656 . . . . 0.0 109.521 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.645 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -73.37 125.24 27.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.156 -0.965 . . . . 0.0 109.938 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.519 HD13 ' CG ' ' A' ' 34' ' ' LYS . 2.9 mp -71.22 -8.29 52.56 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 tp -53.72 -54.68 34.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.614 -0.679 . . . . 0.0 109.381 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.596 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 2.0 t -161.3 29.47 0.14 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 110.215 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.596 ' CB ' ' O ' ' A' ' 52' ' ' THR . 5.7 mtmt 86.31 44.0 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.403 -0.811 . . . . 0.0 110.585 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.645 ' HB2' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER -87.09 133.13 33.64 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.124 -0.985 . . . . 0.0 108.449 178.421 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 1.6 pt-20 -122.58 119.29 30.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.876 -1.14 . . . . 0.0 109.256 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.659 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -158.08 167.76 34.42 Favored Glycine 0 N--CA 1.487 2.092 0 C-N-CA 119.316 -1.421 . . . . 0.0 110.022 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.688 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 10.4 m-85 -73.61 133.03 43.4 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.57 -0.959 . . . . 0.0 110.009 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.516 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 4.0 pt -122.07 139.44 30.43 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.772 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 46.0 Cg_endo -68.6 145.77 65.12 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 121.878 1.719 . . . . 0.0 112.086 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.596 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 38.5 p -75.97 5.02 7.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.409 -0.807 . . . . 0.0 110.635 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.72 -53.1 2.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.912 -1.117 . . . . 0.0 110.613 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.622 ' CD2' ' HA ' ' A' ' 19' ' ' TYR . 4.0 m-85 -51.27 -60.73 2.8 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.116 -0.99 . . . . 0.0 110.788 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 15' ' ' ALA . 3.1 m -78.82 158.55 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 122.094 0.95 . . . . 0.0 111.302 -177.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.64 ' HB2' ' CD1' ' A' ' 16' ' ' LEU . . . -134.61 160.63 37.49 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.59 ' HA ' HG12 ' A' ' 13' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 O-C-N 120.916 -1.115 . . . . 0.0 109.422 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 0.563 HD22 ' HE1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 121.752 0.787 . . . . 0.0 109.558 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.779 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.9 Cg_endo -70.69 -174.57 1.12 Allowed 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.902 2.401 . . . . 0.0 111.485 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . 0.721 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.1 Cg_endo -92.19 -23.04 0.41 Allowed 'Trans proline' 0 C--O 1.213 -0.726 0 C-N-CA 122.956 2.437 . . . . 0.0 114.347 -177.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.721 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 41.5 mtt180 78.41 95.62 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.001 -1.062 . . . . 0.0 109.197 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 42.4 Cg_endo -66.02 114.44 2.99 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.634 2.223 . . . . 0.0 111.735 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' B' ' 185' ' ' ASN . . . 56.15 50.81 12.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.423 -0.798 . . . . 0.0 109.584 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' B' ' 184' ' ' ALA . 9.5 m-80 60.26 45.82 10.94 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.155 -0.966 . . . . 0.0 109.426 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . 0.718 HD21 ' HB2' ' A' ' 41' ' ' HIS . 49.2 tp -65.36 -78.09 0.05 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.344 -0.848 . . . . 0.0 109.058 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . 0.688 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.485 1.939 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.483 HD12 ' HG3' ' A' ' 36' ' ' LYS . 0.7 OUTLIER -112.07 137.24 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -0.962 . . . . 0.0 109.536 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.1 m -131.1 160.44 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.371 -0.831 . . . . 0.0 108.97 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.92 139.91 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.007 -1.058 . . . . 0.0 109.341 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.672 ' HB2' ' HE3' ' A' ' 35' ' ' MET . . . -73.36 133.31 43.77 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.448 -0.783 . . . . 0.0 109.989 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.761 HD11 ' HB2' ' A' ' 64' ' ' ALA . 79.6 mt -99.55 -15.2 18.71 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.615 ' CE1' ' HB2' ' A' ' 16' ' ' LEU . 1.0 OUTLIER -155.96 154.07 26.96 Favored Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.448 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.733 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.6 Cg_endo -63.3 150.13 89.41 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 121.823 1.682 . . . . 0.0 110.276 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.769 ' O ' ' CB ' ' A' ' 20' ' ' ASP . 39.6 t80 -93.32 -33.01 14.07 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.068 -1.453 . . . . 0.0 110.541 -178.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.769 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 29.9 t0 107.57 -53.67 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.431 -0.793 . . . . 0.0 110.446 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.4 ' HA3' ' OG ' ' A' ' 28' ' ' SER . . . 78.33 79.5 0.76 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 -177.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.3 mt -97.66 -46.03 12.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.609 ' CD2' ' HD2' ' A' ' 24' ' ' PRO . 3.7 t60 -73.31 146.01 86.15 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.609 ' HD2' ' CD2' ' A' ' 23' ' ' HIS . 43.7 Cg_endo -66.28 -11.47 31.52 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 121.898 1.732 . . . . 0.0 111.342 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -114.1 -18.91 11.56 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.514 -0.741 . . . . 0.0 110.117 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.494 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.6 OUTLIER -57.81 144.23 39.31 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.004 -1.06 . . . . 0.0 109.919 -178.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.928 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -91.23 118.47 30.5 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.178 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.804 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -83.28 145.04 29.32 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.597 -0.69 . . . . 0.0 109.153 179.266 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.765 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 18.7 p90 -148.15 160.75 42.58 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.621 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 11.6 mmtt -111.34 172.22 7.01 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.069 -1.02 . . . . 0.0 109.504 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.597 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -66.55 152.2 45.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.201 -0.937 . . . . 0.0 109.392 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 71.84 -8.01 6.6 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -76.58 142.05 40.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.018 -1.284 . . . . 0.0 109.785 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.3 138.89 33.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.892 . . . . 0.0 109.204 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.672 ' HE3' ' HB2' ' A' ' 15' ' ' ALA . 3.2 mpp? -136.11 152.32 50.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.644 -0.66 . . . . 0.0 109.662 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 3.7 ttpm? -109.62 126.19 53.37 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.48 -0.763 . . . . 0.0 109.503 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -82.13 129.39 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.389 -0.819 . . . . 0.0 109.003 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.877 HD12 ' O ' ' A' ' 46' ' ' LYS . 1.1 mp -102.05 -44.18 5.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.113 -0.992 . . . . 0.0 109.785 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.1 103.51 3.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.164 -0.96 . . . . 0.0 109.085 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.604 ' HG2' ' CD1' ' A' ' 45' ' ' TRP . 1.8 tm-20 -81.08 127.31 32.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.357 -0.839 . . . . 0.0 109.656 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.755 ' CG ' HD11 ' B' ' 186' ' ' LEU . 63.9 m-70 -87.57 -105.56 0.07 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.348 -0.845 . . . . 0.0 109.182 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 43' ' ' GLU . . . -127.05 -19.83 1.91 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.574 ' HG3' ' CG ' ' B' ' 181' ' ' PRO . 1.1 mm-40 -157.24 -12.8 0.09 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.993 -1.298 . . . . 0.0 110.563 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 1.063 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 50.2 m95 -135.81 101.45 4.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.002 -1.061 . . . . 0.0 108.415 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.62 ' CZ2' ' CB ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -92.05 149.02 21.74 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.146 -0.971 . . . . 0.0 110.566 -178.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.877 ' O ' HD12 ' A' ' 38' ' ' LEU . 4.9 tttt -92.9 107.28 19.1 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.91 -173.68 2.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.248 -0.908 . . . . 0.0 110.003 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 1.1 tttt -126.96 131.16 51.14 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.55 -0.719 . . . . 0.0 109.587 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.607 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 4.9 t -77.25 127.9 33.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.078 -1.014 . . . . 0.0 109.895 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.24 -6.66 44.57 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.239 -0.913 . . . . 0.0 108.55 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 51' ' ' LEU . 11.0 tp -54.99 -55.61 28.9 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.345 -0.847 . . . . 0.0 109.228 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.627 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 2.7 t -160.13 28.57 0.17 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.244 -0.91 . . . . 0.0 110.157 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.627 ' HB2' ' O ' ' A' ' 52' ' ' THR . 0.1 OUTLIER 86.32 44.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.52 -0.738 . . . . 0.0 111.065 178.18 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.607 ' HB2' ' CB ' ' A' ' 49' ' ' SER . 1.6 mmpt? -86.61 131.99 34.01 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.15 119.27 30.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.934 -1.104 . . . . 0.0 109.577 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.696 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -159.81 170.5 36.0 Favored Glycine 0 N--CA 1.488 2.13 0 C-N-CA 119.54 -1.314 . . . . 0.0 109.914 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.632 ' CB ' ' HA2' ' B' ' 187' ' ' GLY . 5.2 m-85 -71.77 132.33 44.34 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.56 -0.965 . . . . 0.0 109.804 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.415 ' O ' HG13 ' A' ' 58' ' ' ILE . 9.0 pt -121.12 142.55 35.15 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.634 ' HG3' ' CD2' ' B' ' 179' ' ' LEU . 48.6 Cg_endo -70.69 154.45 64.07 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 121.775 1.65 . . . . 0.0 112.226 -178.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.62 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 79.6 p -82.88 6.44 18.44 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -0.903 . . . . 0.0 109.692 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.639 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 9.2 p-10 -106.23 -52.56 2.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.034 -1.041 . . . . 0.0 110.96 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 1.153 ' CE2' HD21 ' B' ' 179' ' ' LEU . 2.9 m-85 -52.1 -61.97 1.93 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.175 -0.953 . . . . 0.0 111.071 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.603 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.7 m -80.48 156.28 4.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 122.034 0.921 . . . . 0.0 111.122 -177.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.761 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -132.83 159.07 40.88 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.063 -1.023 . . . . 0.0 109.479 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 1.153 HD21 ' CE2' ' A' ' 62' ' ' TYR . 41.8 mt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 121.687 0.756 . . . . 0.0 109.957 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 1.063 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 41.4 Cg_endo -67.23 179.6 2.32 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 123.108 2.539 . . . . 0.0 111.269 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . 0.631 ' HD2' ' HB2' ' B' ' 180' ' ' PRO . 55.4 Cg_endo -75.74 -48.79 0.14 Allowed 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.697 2.264 . . . . 0.0 113.527 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.661 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.0 OUTLIER 80.59 81.66 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.07 -1.019 . . . . 0.0 108.879 -178.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 54.6 Cg_endo -74.06 141.64 29.93 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.784 2.323 . . . . 0.0 112.114 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 37.74 62.7 0.87 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.835 . . . . 0.0 109.688 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' B' ' 184' ' ' ALA . 0.4 OUTLIER 43.05 48.14 5.22 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -0.888 . . . . 0.0 109.197 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . 0.755 HD11 ' CG ' ' A' ' 41' ' ' HIS . 63.6 tp -64.54 -79.71 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.379 -0.826 . . . . 0.0 109.472 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . 0.632 ' HA2' ' CB ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.481 1.695 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.876 ' O ' HG23 ' A' ' 37' ' ' VAL . 9.5 m-20 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.425 0.631 . . . . 0.0 109.929 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.811 HD12 ' HG2' ' A' ' 36' ' ' LYS . 18.8 mm -71.86 133.26 32.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.427 -0.796 . . . . 0.0 109.843 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.448 HG22 HG23 ' A' ' 37' ' ' VAL . 1.7 m -131.65 161.47 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.9 p -120.28 138.1 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.854 -1.154 . . . . 0.0 109.475 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.87 133.9 45.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.44 -0.788 . . . . 0.0 110.225 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.064 HD11 ' HB2' ' A' ' 64' ' ' ALA . 20.7 mt -98.89 -12.38 20.8 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.599 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 39.9 m-85 -158.57 154.84 24.06 Favored Pre-proline 0 N--CA 1.487 1.386 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.713 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 41.2 Cg_endo -64.68 148.75 90.37 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 121.723 1.615 . . . . 0.0 109.721 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.799 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 51.7 t80 -97.68 177.12 5.59 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 118.188 -1.405 . . . . 0.0 110.388 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.683 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 4.3 t0 -109.8 79.07 1.18 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.673 -0.642 . . . . 0.0 109.655 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.69 86.37 0.01 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.601 ' N ' ' O ' ' A' ' 20' ' ' ASP . 40.7 mt -105.99 -0.5 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.057 -1.261 . . . . 0.0 109.63 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 -120.45 158.37 51.44 Favored Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.01 -18.54 46.21 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.178 1.919 . . . . 0.0 111.844 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -111.77 -13.56 13.69 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.501 -0.749 . . . . 0.0 110.45 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -57.68 139.11 54.56 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.838 -1.164 . . . . 0.0 109.52 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.013 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -96.59 121.53 38.52 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.312 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.875 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -80.25 140.91 36.02 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.369 -0.832 . . . . 0.0 109.796 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.799 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 30.7 p90 -145.62 157.55 43.96 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 108.576 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.661 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.8 mttm -110.49 173.44 6.33 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.033 -1.042 . . . . 0.0 109.596 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.57 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -66.99 151.75 47.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.198 -0.939 . . . . 0.0 109.32 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.54 -8.09 4.46 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 4.4 tt0 -75.13 143.29 43.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.973 -1.31 . . . . 0.0 109.559 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -97.21 138.93 33.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 109.799 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.581 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 2.5 mpp? -137.5 153.51 50.02 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.811 ' HG2' HD12 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -106.64 129.19 54.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.454 -0.779 . . . . 0.0 109.287 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 11' ' ' ASP . 6.3 t -80.91 124.8 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.046 -1.034 . . . . 0.0 109.041 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.44 HD11 ' HG3' ' A' ' 48' ' ' LYS . 7.2 mt -101.62 -43.06 5.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.184 -0.948 . . . . 0.0 109.934 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 39' ' ' GLU . 1.2 pt-20 -145.58 97.57 3.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.133 -0.98 . . . . 0.0 109.306 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.615 ' HG3' ' CD1' ' A' ' 45' ' ' TRP . 3.5 tt0 -81.35 116.6 21.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.196 -0.94 . . . . 0.0 109.282 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.785 ' HB2' HD21 ' B' ' 186' ' ' LEU . 23.4 m-70 -85.0 -105.78 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.287 -0.883 . . . . 0.0 109.509 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.24 -16.59 1.71 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.525 ' HB2' ' HD3' ' B' ' 183' ' ' PRO . 16.6 mm-40 -153.92 -17.8 0.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.038 -1.272 . . . . 0.0 110.389 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.851 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 63.5 m95 -135.76 102.57 5.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.964 -1.085 . . . . 0.0 109.342 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.615 ' CD1' ' HG3' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -90.7 142.67 27.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.103 -0.998 . . . . 0.0 110.045 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.9 OUTLIER -91.84 105.77 17.96 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.063 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.81 -175.86 2.92 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.191 -0.943 . . . . 0.0 110.184 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.612 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -124.89 129.71 50.93 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.689 -0.632 . . . . 0.0 109.376 -179.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.663 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -74.77 125.83 29.61 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.097 -1.002 . . . . 0.0 109.943 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.27 -7.53 47.61 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.471 ' HA ' HD12 ' A' ' 51' ' ' LEU . 15.3 tp -53.78 -54.93 31.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.604 -0.685 . . . . 0.0 109.214 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.601 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 0.7 OUTLIER -161.38 29.54 0.13 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.264 -0.898 . . . . 0.0 109.994 179.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.601 ' CB ' ' O ' ' A' ' 52' ' ' THR . 5.7 mttp 86.45 44.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.454 -0.779 . . . . 0.0 110.423 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.663 ' HB2' ' HB3' ' A' ' 49' ' ' SER . 0.0 OUTLIER -85.94 132.46 34.07 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.335 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 20.0 pt-20 -122.84 120.32 33.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.933 -1.104 . . . . 0.0 109.103 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.661 ' HA3' ' CB ' ' A' ' 27' ' ' LEU . . . -162.58 165.72 36.33 Favored Glycine 0 N--CA 1.488 2.128 0 C-N-CA 119.105 -1.521 . . . . 0.0 110.253 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.641 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 8.5 m-85 -71.38 132.95 45.57 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.759 -0.847 . . . . 0.0 109.652 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.588 HD12 HG21 ' A' ' 63' ' ' VAL . 7.4 pt -121.91 143.14 37.87 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.77 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 44.2 Cg_endo -67.66 153.77 75.18 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.701 1.601 . . . . 0.0 111.614 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.528 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 65.5 p -82.71 6.77 16.91 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 110.783 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -110.31 -52.86 2.74 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.741 -1.224 . . . . 0.0 110.637 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.599 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 5.1 m-85 -49.08 -63.15 1.19 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.094 -1.004 . . . . 0.0 110.938 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.588 HG21 HD12 ' A' ' 58' ' ' ILE . 3.3 m -78.85 155.01 4.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 122.027 0.918 . . . . 0.0 110.935 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 1.064 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -133.14 161.53 34.17 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.3 mttt . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.093 -1.004 . . . . 0.0 109.479 179.895 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 0.586 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.712 0.768 . . . . 0.0 109.622 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.851 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.4 Cg_endo -69.92 -175.0 1.05 Allowed 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.963 2.442 . . . . 0.0 111.457 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . 0.704 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.6 Cg_endo -91.31 -25.31 0.34 Allowed 'Trans proline' 0 C--O 1.213 -0.76 0 C-N-CA 122.856 2.371 . . . . 0.0 114.531 -177.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.711 ' CG ' ' CE2' ' A' ' 44' ' ' TRP . 39.4 mtt180 78.71 94.33 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 120.942 -1.098 . . . . 0.0 109.2 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.594 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 46.3 Cg_endo -67.58 118.5 5.64 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.664 2.243 . . . . 0.0 111.75 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . 53.83 57.59 5.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.255 -0.903 . . . . 0.0 109.3 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . 0.434 ' N ' ' ND2' ' B' ' 185' ' ' ASN . 1.1 m120 51.09 50.75 18.43 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.319 -0.863 . . . . 0.0 109.414 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . 0.785 HD21 ' HB2' ' A' ' 41' ' ' HIS . 62.0 tp -71.72 -80.54 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.306 -0.871 . . . . 0.0 109.508 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . 0.641 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.486 1.98 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.549 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.547 HD12 ' HG2' ' A' ' 36' ' ' LYS . 25.5 mm -100.89 137.0 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.163 -0.96 . . . . 0.0 109.553 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.17 161.76 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.463 -0.773 . . . . 0.0 108.951 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 p -121.23 139.06 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.006 -1.059 . . . . 0.0 109.317 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.08 133.68 46.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.364 -0.835 . . . . 0.0 109.697 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.089 HD11 ' HB2' ' A' ' 64' ' ' ALA . 55.7 mt -99.12 -12.86 20.11 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.585 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 34.3 m-85 -158.35 154.19 23.15 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.719 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 42.0 Cg_endo -64.36 149.07 90.79 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 121.662 1.575 . . . . 0.0 110.055 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.834 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 54.2 t80 -97.86 177.93 5.29 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.324 -1.35 . . . . 0.0 110.405 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.686 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 0.7 OUTLIER -109.01 80.58 1.33 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.498 -0.751 . . . . 0.0 109.303 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.45 94.68 0.05 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 20' ' ' ASP . 18.1 mm -108.19 -42.02 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.303 -1.116 . . . . 0.0 108.807 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -77.45 158.15 79.36 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.89 -13.77 34.78 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.232 1.955 . . . . 0.0 111.811 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.74 -14.35 13.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.258 -0.902 . . . . 0.0 110.525 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.61 138.69 55.02 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.873 -1.142 . . . . 0.0 109.864 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.937 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -93.87 120.76 34.56 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.041 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.874 ' N ' HD22 ' A' ' 27' ' ' LEU . 10.1 p -79.92 140.74 36.57 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.365 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.834 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 21.9 p90 -145.94 157.66 43.88 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.14 -0.975 . . . . 0.0 108.535 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.653 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.5 OUTLIER -110.81 173.16 6.46 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.153 -0.967 . . . . 0.0 109.51 -179.44 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 7.8 pttm -67.09 152.02 46.54 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.183 -0.948 . . . . 0.0 109.38 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.42 -8.18 4.26 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.5 143.4 42.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.936 -1.332 . . . . 0.0 109.709 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.61 137.84 35.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 0.0 109.418 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.604 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 2.4 mpp? -135.01 151.79 51.13 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.492 0.663 . . . . 0.0 109.669 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.547 ' HG2' HD12 ' A' ' 12' ' ' ILE . 4.0 mttm -108.95 127.01 53.69 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.426 -0.797 . . . . 0.0 109.407 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.578 HG11 ' HG3' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -81.57 143.58 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.397 -0.814 . . . . 0.0 108.958 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.521 HD12 ' C ' ' A' ' 37' ' ' VAL . 7.8 mp -119.69 -40.89 2.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.064 -1.022 . . . . 0.0 109.833 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -140.38 92.13 2.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.16 -0.962 . . . . 0.0 108.96 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.6 ' HG2' ' CG ' ' A' ' 45' ' ' TRP . 1.9 mt-10 -74.09 120.37 19.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.479 -0.763 . . . . 0.0 109.536 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.74 ' HB2' HD21 ' B' ' 186' ' ' LEU . 47.7 m-70 -92.28 -106.49 0.11 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.235 -0.915 . . . . 0.0 109.555 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.36 -16.66 1.17 Allowed Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.179 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.513 ' HG2' ' HD2' ' B' ' 181' ' ' PRO . 0.5 OUTLIER -154.21 -17.04 0.13 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.968 -1.313 . . . . 0.0 110.351 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.822 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 59.8 m95 -136.97 101.73 4.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.038 -1.039 . . . . 0.0 109.155 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.6 ' CG ' ' HG2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -91.07 139.57 30.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.904 -1.122 . . . . 0.0 109.992 -179.679 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.7 OUTLIER -86.13 107.41 17.84 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -102.26 -177.86 3.53 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.289 -0.882 . . . . 0.0 110.233 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 9.8 tttm -123.45 107.97 12.17 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.605 ' N ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -54.1 127.02 24.95 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.11 -0.994 . . . . 0.0 109.925 -179.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 52' ' ' THR . 3.7 mt -75.84 -11.2 59.93 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.482 ' C ' HG22 ' A' ' 52' ' ' THR . 22.4 tp -46.05 -20.89 0.11 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.719 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 0.6 OUTLIER 168.15 -21.47 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.392 -0.817 . . . . 0.0 109.851 179.151 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.719 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 140.55 42.61 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.536 -0.727 . . . . 0.0 109.972 179.629 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.655 ' HB3' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -85.37 134.64 34.08 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.085 -1.01 . . . . 0.0 108.505 178.419 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.474 ' OE1' HD22 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -122.5 114.33 20.53 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.047 -1.033 . . . . 0.0 109.359 -179.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.644 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -155.52 168.85 33.29 Favored Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.416 -1.373 . . . . 0.0 109.959 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.658 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 8.9 m-85 -71.41 131.93 44.08 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.574 -0.957 . . . . 0.0 109.656 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.532 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 5.2 pt -120.86 139.63 29.42 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.743 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 46.8 Cg_endo -69.14 158.74 56.59 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 121.671 1.581 . . . . 0.0 111.948 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.515 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 79.5 p -86.44 7.08 27.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.334 -0.853 . . . . 0.0 110.387 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.28 -53.77 2.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.903 -1.123 . . . . 0.0 110.441 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.585 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 2.8 m-85 -47.93 -63.38 1.08 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.133 -0.979 . . . . 0.0 111.115 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.604 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 3.0 m -78.53 155.0 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.929 . . . . 0.0 110.968 -177.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 1.089 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -134.8 162.67 31.71 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.4 pttm . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.044 -1.035 . . . . 0.0 109.251 179.747 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 0.614 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 121.697 0.76 . . . . 0.0 109.761 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.822 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.7 Cg_endo -69.34 -173.43 0.66 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 123.049 2.499 . . . . 0.0 111.484 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . 0.737 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 53.1 Cg_endo -92.95 -26.5 0.18 Allowed 'Trans proline' 0 C--O 1.213 -0.732 0 C-N-CA 122.95 2.433 . . . . 0.0 114.441 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.737 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 43.3 mtt180 80.99 95.02 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.076 -1.015 . . . . 0.0 109.059 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.549 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 49.2 Cg_endo -69.98 135.98 31.29 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.745 2.297 . . . . 0.0 111.865 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 41.61 57.79 2.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 0.0 109.367 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 49.13 48.96 20.31 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.228 -0.92 . . . . 0.0 109.288 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . 0.74 HD21 ' HB2' ' A' ' 41' ' ' HIS . 48.4 tp -67.43 -87.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.408 -0.808 . . . . 0.0 109.319 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . 0.658 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.486 2.014 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 36' ' ' LYS . 4.5 tp -99.23 138.84 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.164 -0.96 . . . . 0.0 109.451 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.603 HG22 ' CG2' ' A' ' 37' ' ' VAL . 0.8 OUTLIER -131.2 160.36 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.333 -0.855 . . . . 0.0 109.007 -179.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.0 p -120.5 138.98 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.017 -1.052 . . . . 0.0 109.353 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -72.53 134.81 45.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.411 -0.806 . . . . 0.0 109.842 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.801 HD11 ' HB2' ' A' ' 64' ' ' ALA . 69.4 mt -99.85 -22.4 15.33 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 16' ' ' LEU . 32.3 m-85 -147.48 153.1 43.41 Favored Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.696 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.7 Cg_endo -63.21 149.67 90.73 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 121.845 1.697 . . . . 0.0 110.089 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.824 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 57.0 t80 -98.81 178.73 4.88 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.268 -1.373 . . . . 0.0 110.524 -177.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.686 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -109.96 80.38 1.31 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.01 95.89 0.06 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 20' ' ' ASP . 75.9 mt -108.8 -42.21 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.117 -1.226 . . . . 0.0 108.86 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.472 ' HB2' ' CG ' ' A' ' 26' ' ' ASP . 88.5 m-70 -76.81 157.87 81.29 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.59 -12.74 33.88 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.129 1.886 . . . . 0.0 111.657 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -112.92 -14.51 13.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.894 . . . . 0.0 110.64 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.472 ' CG ' ' HB2' ' A' ' 23' ' ' HIS . 79.9 m-20 -57.53 139.81 52.42 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.762 -1.212 . . . . 0.0 109.783 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.886 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -95.1 121.53 36.83 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.159 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.869 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -80.07 140.49 36.46 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.448 -0.783 . . . . 0.0 109.491 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.824 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 25.7 p90 -145.39 156.95 44.09 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.163 -0.961 . . . . 0.0 108.676 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.637 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -110.64 173.32 6.39 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.151 -0.968 . . . . 0.0 109.596 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.555 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -67.26 151.49 47.41 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.186 -0.946 . . . . 0.0 109.322 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 71.51 -8.19 5.8 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.69 142.93 42.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.934 -1.333 . . . . 0.0 109.839 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.0 138.94 33.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 109.456 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.609 ' CE ' HG11 ' A' ' 63' ' ' VAL . 2.5 mpp? -135.49 151.62 50.54 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.577 -0.702 . . . . 0.0 109.82 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 82.4 tttt -105.29 123.24 47.52 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.424 -0.798 . . . . 0.0 109.428 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.846 HG11 ' OE2' ' A' ' 40' ' ' GLU . 2.0 t -81.82 115.96 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.362 -0.836 . . . . 0.0 109.052 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 38' ' ' LEU . 9.3 mp -92.01 -39.65 11.54 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.085 -1.01 . . . . 0.0 109.887 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -142.29 102.65 4.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.102 -0.999 . . . . 0.0 109.06 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.846 ' OE2' HG11 ' A' ' 37' ' ' VAL . 1.0 OUTLIER -85.41 118.53 25.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.391 -0.818 . . . . 0.0 109.498 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.651 ' HB2' HD21 ' B' ' 186' ' ' LEU . 68.3 m-70 -89.26 -103.13 0.09 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.287 -0.883 . . . . 0.0 109.367 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.44 ' O ' ' CD ' ' A' ' 43' ' ' GLU . . . -138.71 -13.71 0.71 Allowed Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.426 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.561 ' HG2' ' HD2' ' B' ' 181' ' ' PRO . 0.6 OUTLIER -155.57 -20.95 0.11 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.832 -1.393 . . . . 0.0 110.584 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.818 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 58.9 m95 -136.47 95.27 3.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.874 -1.142 . . . . 0.0 109.047 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.589 ' CG ' ' HG3' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -87.03 141.46 28.65 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.992 -1.067 . . . . 0.0 110.492 -179.184 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.8 OUTLIER -87.1 106.74 18.07 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -104.32 -173.23 2.26 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.287 -0.883 . . . . 0.0 110.179 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 4.3 tttp -127.28 131.37 50.53 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.5 -0.75 . . . . 0.0 109.452 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.668 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 1.3 t -77.17 128.09 33.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.002 -1.061 . . . . 0.0 109.885 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.87 -7.68 49.87 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 51' ' ' LEU . 9.4 tp -53.7 -55.8 22.95 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.35 -0.844 . . . . 0.0 109.348 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.623 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.4 t -160.69 28.42 0.15 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.229 -0.92 . . . . 0.0 110.149 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.623 ' CB ' ' O ' ' A' ' 52' ' ' THR . 31.0 mtmt 86.8 44.5 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.444 -0.785 . . . . 0.0 111.122 178.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.758 ' HB3' HD23 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -87.67 131.95 34.27 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 8.9 pt-20 -121.83 120.66 35.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.932 -1.105 . . . . 0.0 109.641 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.688 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -158.37 168.94 34.82 Favored Glycine 0 N--CA 1.487 2.1 0 C-N-CA 119.539 -1.315 . . . . 0.0 109.887 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.79 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 11.5 m-85 -71.27 133.71 46.27 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.546 -0.973 . . . . 0.0 109.884 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.562 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 2.9 pt -122.31 142.37 36.8 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.696 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 47.8 Cg_endo -70.85 159.41 52.69 Favored 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 121.562 1.508 . . . . 0.0 111.818 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.513 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 90.3 p -87.31 7.2 29.78 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 110.073 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.97 -54.86 2.44 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.006 -1.059 . . . . 0.0 110.351 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.703 ' HE2' HD23 ' B' ' 179' ' ' LEU . 3.5 m-85 -48.6 -63.28 1.13 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.167 -0.958 . . . . 0.0 111.151 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.609 HG11 ' CE ' ' A' ' 35' ' ' MET . 2.9 m -79.8 155.9 4.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.995 0.902 . . . . 0.0 111.133 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.801 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -132.3 160.47 36.15 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.439 ' HA ' HG12 ' A' ' 13' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 O-C-N 120.999 -1.063 . . . . 0.0 109.463 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 0.703 HD23 ' HE2' ' A' ' 62' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 121.668 0.747 . . . . 0.0 109.589 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.818 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 39.3 Cg_endo -67.96 -174.48 0.62 Allowed 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 123.042 2.494 . . . . 0.0 112.075 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . 0.638 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.6 Cg_endo -92.78 -29.0 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 123.252 2.635 . . . . 0.0 114.213 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.757 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.1 OUTLIER 84.23 104.95 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.162 -0.961 . . . . 0.0 109.877 -179.323 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.715 ' CG ' HD22 ' B' ' 186' ' ' LEU . 44.7 Cg_endo -69.29 124.94 11.79 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 123.022 2.481 . . . . 0.0 111.998 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 40.44 69.27 0.33 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.36 -0.838 . . . . 0.0 109.567 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . 0.454 ' C ' ' O ' ' B' ' 184' ' ' ALA . 0.0 OUTLIER 42.06 47.22 3.83 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.289 -0.882 . . . . 0.0 109.413 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . 0.737 HD23 ' HB2' ' A' ' 44' ' ' TRP . 31.6 tp -56.19 -94.81 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . 0.79 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.697 HD13 ' HA ' ' A' ' 36' ' ' LYS . 21.6 mm -119.03 138.32 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.18 -0.95 . . . . 0.0 109.587 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.8 HG12 ' HA ' ' A' ' 65' ' ' LYS . 0.8 OUTLIER -132.21 161.91 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 p -120.83 140.45 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.936 -1.102 . . . . 0.0 109.463 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -72.79 133.87 44.69 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.336 -0.853 . . . . 0.0 109.566 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.995 HD11 ' HB2' ' A' ' 64' ' ' ALA . 84.3 mt -99.88 -15.51 18.35 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 16' ' ' LEU . 3.5 m-85 -156.32 154.71 27.78 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.729 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.2 Cg_endo -63.45 149.05 92.13 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 121.903 1.735 . . . . 0.0 110.448 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.831 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 50.9 t80 -98.46 178.7 4.94 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.438 -1.305 . . . . 0.0 110.367 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.694 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 0.5 OUTLIER -109.66 80.65 1.34 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.631 -0.668 . . . . 0.0 109.291 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.95 94.58 0.05 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 20' ' ' ASP . 17.1 mm -108.28 -41.92 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.089 -1.242 . . . . 0.0 108.902 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.449 ' HB2' ' CG ' ' A' ' 26' ' ' ASP . 20.5 m-70 -77.54 157.75 79.62 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.54 -13.32 35.03 Favored 'Trans proline' 0 C--O 1.213 -0.75 0 C-N-CA 122.271 1.981 . . . . 0.0 111.921 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 1.0 OUTLIER -112.11 -13.9 13.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.253 -0.904 . . . . 0.0 110.673 -179.069 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.449 ' CG ' ' HB2' ' A' ' 23' ' ' HIS . 84.4 m-20 -57.97 139.74 53.77 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.819 -1.176 . . . . 0.0 109.94 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.948 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -94.74 120.9 35.71 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.872 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -79.19 140.25 37.77 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.263 -0.898 . . . . 0.0 109.277 179.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.831 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 23.5 p90 -145.2 156.8 44.07 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.098 -1.001 . . . . 0.0 108.701 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.621 ' HG2' ' HB2' ' A' ' 33' ' ' GLU . 5.6 ptmt -110.81 173.24 6.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 109.319 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -66.59 151.96 46.27 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.983 -1.073 . . . . 0.0 109.482 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 71.76 -7.39 7.2 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.621 ' HB2' ' HG2' ' A' ' 30' ' ' LYS . 5.0 tp10 -76.15 142.62 41.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.892 -1.357 . . . . 0.0 109.944 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.481 ' HD2' HG21 ' A' ' 12' ' ' ILE . 1.4 ttpt -97.28 139.52 33.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.886 . . . . 0.0 109.382 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.673 ' CE ' HG11 ' A' ' 63' ' ' VAL . 2.0 mpp? -135.1 151.48 50.77 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.441 0.639 . . . . 0.0 109.735 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.697 ' HA ' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -104.39 123.47 47.49 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.546 -0.722 . . . . 0.0 109.163 179.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.607 ' CG2' HG22 ' A' ' 13' ' ' VAL . 2.2 t -81.43 114.1 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.29 -0.881 . . . . 0.0 109.088 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 38' ' ' LEU . 6.3 mp -90.23 -44.17 9.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 109.656 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -143.08 97.46 3.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.932 . . . . 0.0 108.921 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.565 ' HG3' ' CD1' ' A' ' 45' ' ' TRP . 3.3 tt0 -83.72 116.67 22.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.34 -0.85 . . . . 0.0 109.588 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.696 ' HB2' HD21 ' B' ' 186' ' ' LEU . 4.0 m-70 -78.27 -95.83 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.319 -0.863 . . . . 0.0 109.228 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.46 ' O ' ' CD ' ' A' ' 43' ' ' GLU . . . -148.38 -13.05 0.13 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.383 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.602 ' HB3' ' HD2' ' B' ' 181' ' ' PRO . 6.5 mm-40 -148.69 -26.38 0.31 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.969 -1.312 . . . . 0.0 110.008 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.933 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 47.8 m95 -134.02 102.26 5.35 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.17 -0.956 . . . . 0.0 108.768 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.636 ' CZ2' ' CB ' ' A' ' 60' ' ' SER . 0.1 OUTLIER -90.02 147.17 23.83 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.092 -1.005 . . . . 0.0 110.398 -179.129 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -96.06 108.2 20.6 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -105.65 -172.89 2.18 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 110.346 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -125.56 127.11 45.86 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.609 -0.682 . . . . 0.0 109.266 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.65 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -70.82 126.06 28.54 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.183 -0.948 . . . . 0.0 109.835 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.6 mp -72.18 -7.97 52.14 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.4 tp -54.25 -54.83 34.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.528 -0.733 . . . . 0.0 109.17 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.587 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 1.3 t -161.06 30.08 0.14 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.173 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 52' ' ' THR . 38.3 mmtt 85.78 45.49 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.499 -0.751 . . . . 0.0 110.661 178.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.65 ' HB2' ' HB3' ' A' ' 49' ' ' SER . 0.8 OUTLIER -87.05 132.29 33.85 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.137 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.501 ' CG ' ' HE3' ' A' ' 46' ' ' LYS . 15.4 tt0 -121.72 117.35 26.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.876 -1.14 . . . . 0.0 109.57 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.651 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -158.42 168.62 34.78 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.44 -1.362 . . . . 0.0 110.015 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.871 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 12.5 m-85 -73.66 135.15 43.72 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.679 -0.895 . . . . 0.0 110.16 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.588 HD12 HG21 ' A' ' 63' ' ' VAL . 7.4 pt -122.39 139.34 30.61 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.596 ' HB2' ' CD ' ' B' ' 180' ' ' PRO . 52.3 Cg_endo -72.6 131.96 18.14 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 121.519 1.479 . . . . 0.0 112.014 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.636 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 53.7 p -62.88 3.68 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.39 -0.819 . . . . 0.0 110.542 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.637 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 6.5 p-10 -98.36 -52.42 3.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.797 -1.189 . . . . 0.0 110.62 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 1.18 ' CE2' HD21 ' B' ' 179' ' ' LEU . 4.0 m-85 -57.28 -59.25 5.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.113 -0.992 . . . . 0.0 111.176 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.673 HG11 ' CE ' ' A' ' 35' ' ' MET . 3.2 m -79.78 159.9 4.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 122.024 0.916 . . . . 0.0 111.235 -177.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.995 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -133.93 157.83 45.01 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.8 ' HA ' HG12 ' A' ' 13' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.053 -1.029 . . . . 0.0 109.562 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 1.18 HD21 ' CE2' ' A' ' 62' ' ' TYR . 74.5 mt . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 121.483 0.659 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.933 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.8 Cg_endo -67.67 176.91 4.54 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.566 2.178 . . . . 0.0 111.5 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . 0.619 ' O ' ' CB ' ' B' ' 182' ' ' ARG . 56.1 Cg_endo -81.36 -37.57 0.28 Allowed 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.822 2.348 . . . . 0.0 114.029 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.718 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.4 OUTLIER 82.22 98.02 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 120.997 -1.065 . . . . 0.0 109.295 -179.006 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.71 ' CG ' HD22 ' B' ' 186' ' ' LEU . 45.4 Cg_endo -69.61 130.76 20.09 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 123.206 2.604 . . . . 0.0 112.329 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . 0.509 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 35.63 72.89 0.09 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.436 -0.79 . . . . 0.0 109.821 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . 0.464 ' C ' ' O ' ' B' ' 184' ' ' ALA . 0.7 OUTLIER 40.59 45.34 1.96 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.37 -0.831 . . . . 0.0 109.438 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . 0.715 HD23 ' HB2' ' A' ' 44' ' ' TRP . 34.4 tp -54.6 -94.54 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . 0.871 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.486 1.988 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.566 ' O ' HG23 ' A' ' 37' ' ' VAL . 2.6 m-20 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.557 ' CD1' ' HG2' ' A' ' 36' ' ' LYS . 2.5 tp -91.02 138.64 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 0.0 109.663 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 65' ' ' LYS . 1.9 m -131.01 160.75 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.407 -0.808 . . . . 0.0 108.908 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.8 p -120.39 138.62 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.079 -1.013 . . . . 0.0 109.283 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.4 133.35 45.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.41 -0.806 . . . . 0.0 110.101 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.956 HD11 ' HB2' ' A' ' 64' ' ' ALA . 14.7 mt -98.59 -15.2 19.57 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.559 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 53.3 m-85 -155.0 153.87 27.99 Favored Pre-proline 0 N--CA 1.486 1.374 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.698 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 41.4 Cg_endo -64.48 149.59 89.72 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 121.75 1.633 . . . . 0.0 109.805 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.81 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 59.1 t80 -98.89 179.25 4.7 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.102 -1.439 . . . . 0.0 110.346 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.682 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 73.5 m-20 -110.37 80.78 1.34 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.525 -0.735 . . . . 0.0 109.303 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.82 94.95 0.05 OUTLIER Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 20' ' ' ASP . 69.0 mt -108.74 -41.54 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -1.173 . . . . 0.0 108.895 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.579 ' CD2' ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -78.14 158.81 76.7 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.103 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.579 ' HD2' ' CD2' ' A' ' 23' ' ' HIS . 48.5 Cg_endo -69.67 -13.85 35.51 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.24 1.96 . . . . 0.0 111.91 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 4.4 t70 -112.28 -13.86 13.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 110.799 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.486 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.5 OUTLIER -57.84 139.6 53.75 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.74 -1.225 . . . . 0.0 109.817 -179.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.929 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -95.33 121.37 36.91 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.148 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.876 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -79.44 139.98 37.5 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.338 -0.851 . . . . 0.0 109.439 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.81 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 32.6 p90 -145.2 157.09 44.17 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.19 -0.944 . . . . 0.0 108.711 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.665 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 1.4 tttt -110.56 172.95 6.56 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.492 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.539 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -66.77 151.88 46.59 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.216 -0.927 . . . . 0.0 109.343 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.7 -7.95 4.77 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -75.88 143.6 41.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.957 -1.32 . . . . 0.0 109.765 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.76 ' HD2' HD13 ' A' ' 50' ' ' LEU . 1.1 ptpt -96.97 139.63 32.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.307 -0.871 . . . . 0.0 109.398 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.59 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 3.4 mpp? -134.52 150.89 50.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.627 -0.671 . . . . 0.0 109.841 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.557 ' HG2' ' CD1' ' A' ' 12' ' ' ILE . 30.5 mtpt -102.55 123.08 45.64 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.455 -0.778 . . . . 0.0 109.42 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 11' ' ' ASP . 3.1 t -81.14 134.71 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.166 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.4 mt -110.99 -43.3 3.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.144 -0.973 . . . . 0.0 109.703 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -149.2 93.13 2.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.178 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.646 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.1 tt0 -78.24 116.24 18.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.331 -0.855 . . . . 0.0 109.326 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.739 ' HB2' HD21 ' B' ' 186' ' ' LEU . 5.7 m-70 -79.81 -100.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.301 -0.874 . . . . 0.0 109.481 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.06 -11.63 1.04 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.693 -1.242 . . . . 0.0 110.114 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.546 ' O ' ' HG3' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -156.48 -19.15 0.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.061 -1.258 . . . . 0.0 110.594 -179.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.797 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 66.2 m95 -136.49 99.02 3.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.882 -1.136 . . . . 0.0 109.427 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.646 ' CD1' ' CG ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -89.17 142.14 27.91 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.005 -1.059 . . . . 0.0 110.037 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -92.03 107.0 18.89 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.121 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.29 -174.78 2.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.858 . . . . 0.0 110.238 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 27.1 ttmt -124.98 111.4 15.36 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.675 -0.641 . . . . 0.0 109.277 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.627 ' N ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -56.01 126.35 25.52 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.23 -0.919 . . . . 0.0 109.776 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.76 HD13 ' HD2' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -75.66 -11.25 59.97 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.129 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.515 ' C ' HG22 ' A' ' 52' ' ' THR . 1.5 tp -46.19 -20.9 0.12 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.724 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 0.5 OUTLIER 168.02 -21.87 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.009 179.148 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.724 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 140.93 41.89 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.431 -0.793 . . . . 0.0 110.18 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.735 ' HB3' HD23 ' A' ' 27' ' ' LEU . 3.6 mtmt -87.22 134.4 33.54 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.046 -1.034 . . . . 0.0 108.375 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -122.45 119.1 29.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.95 -1.093 . . . . 0.0 109.48 -179.609 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.669 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -159.87 168.92 35.73 Favored Glycine 0 N--CA 1.486 2.027 0 C-N-CA 119.365 -1.398 . . . . 0.0 110.124 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.744 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 10.4 m-85 -72.92 133.66 44.45 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.636 -0.92 . . . . 0.0 109.929 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.551 HD12 HG21 ' A' ' 63' ' ' VAL . 7.8 pt -121.89 140.8 32.7 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.738 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 48.4 Cg_endo -69.56 140.53 43.67 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 121.676 1.584 . . . . 0.0 111.976 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.612 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 32.6 p -71.43 5.42 2.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.344 -0.847 . . . . 0.0 110.68 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.34 -53.28 2.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.794 -1.192 . . . . 0.0 110.58 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.576 ' CE2' HD23 ' B' ' 179' ' ' LEU . 3.4 m-85 -50.99 -61.76 2.03 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.09 -1.006 . . . . 0.0 111.012 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.59 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 3.4 m -78.04 156.22 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.948 0.88 . . . . 0.0 111.235 -177.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.956 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -131.22 160.05 36.0 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.556 ' HA ' HG12 ' A' ' 13' ' ' VAL . 9.1 mttt . . . . . 0 N--CA 1.49 1.557 0 O-C-N 120.994 -1.066 . . . . 0.0 109.792 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 0.614 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.705 0.764 . . . . 0.0 109.628 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.797 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 39.1 Cg_endo -69.58 -176.04 1.31 Allowed 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.111 2.54 . . . . 0.0 111.917 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . 0.638 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 53.7 Cg_endo -90.33 -22.54 0.74 Allowed 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 123.075 2.517 . . . . 0.0 114.697 -177.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.738 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.8 OUTLIER 77.5 91.26 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 120.772 -1.205 . . . . 0.0 109.237 -179.331 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.513 ' HD3' ' HB2' ' A' ' 43' ' ' GLU . 50.7 Cg_endo -70.79 134.99 26.98 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.907 2.404 . . . . 0.0 112.029 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 39.27 64.81 0.76 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.328 -0.858 . . . . 0.0 109.625 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . 0.428 ' C ' ' O ' ' B' ' 184' ' ' ALA . 3.1 m-80 43.86 49.73 7.01 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.34 -0.85 . . . . 0.0 109.476 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . 0.739 HD21 ' HB2' ' A' ' 41' ' ' HIS . 35.3 tp -66.32 -87.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.321 -0.862 . . . . 0.0 109.34 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . 0.744 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.486 1.979 0 N-CA-C 108.816 -1.713 . . . . 0.0 108.816 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.736 HD12 ' HD3' ' A' ' 36' ' ' LYS . 2.6 tp -111.99 137.08 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 109.529 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.576 HG22 HG23 ' A' ' 37' ' ' VAL . 1.4 m -132.83 161.79 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.385 -0.822 . . . . 0.0 109.161 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.7 p -120.26 138.84 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.97 -1.081 . . . . 0.0 109.219 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.64 133.65 45.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.327 -0.858 . . . . 0.0 109.896 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.979 HD11 ' HB2' ' A' ' 64' ' ' ALA . 25.4 mt -99.09 -12.1 20.83 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.586 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 39.5 m-85 -158.63 155.07 24.4 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.7 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 42.2 Cg_endo -64.71 149.04 90.35 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 121.761 1.641 . . . . 0.0 109.887 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.826 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 59.9 t80 -98.82 178.86 4.84 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 118.373 -1.331 . . . . 0.0 110.415 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.758 ' OD2' HD21 ' B' ' 179' ' ' LEU . 6.2 p30 -110.21 80.29 1.3 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.584 -0.698 . . . . 0.0 109.522 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.61 95.86 0.05 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 20' ' ' ASP . 0.5 OUTLIER -108.96 -41.78 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.243 -1.151 . . . . 0.0 108.859 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -77.72 159.41 76.69 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.33 -13.79 33.62 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.195 1.93 . . . . 0.0 111.804 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -112.37 -14.29 13.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.143 -0.973 . . . . 0.0 110.758 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.434 ' OD2' ' NH2' ' B' ' 182' ' ' ARG . 2.1 m-20 -57.32 139.06 53.99 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.825 -1.172 . . . . 0.0 109.646 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.951 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -94.66 121.26 36.05 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.113 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.892 ' N ' HD22 ' A' ' 27' ' ' LEU . 55.9 p -80.26 140.59 36.15 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.265 -0.897 . . . . 0.0 109.427 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.826 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 23.4 p90 -146.06 157.87 43.86 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.145 -0.972 . . . . 0.0 108.875 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.61 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -111.07 168.06 9.78 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.122 -0.987 . . . . 0.0 109.453 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.567 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -62.23 153.63 29.92 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.135 -0.978 . . . . 0.0 109.628 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.69 -8.11 3.5 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 5.2 tt0 -75.65 142.61 42.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.979 -1.307 . . . . 0.0 109.912 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.483 ' HB3' HD13 ' A' ' 50' ' ' LEU . 0.7 OUTLIER -96.2 139.28 32.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.227 -0.921 . . . . 0.0 109.312 179.701 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.603 ' CE ' HG11 ' A' ' 63' ' ' VAL . 2.6 mpp? -135.28 151.44 50.57 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.606 -0.684 . . . . 0.0 109.919 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.736 ' HD3' HD12 ' A' ' 12' ' ' ILE . 5.8 tppp? -105.07 124.13 49.0 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.533 -0.729 . . . . 0.0 109.186 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.576 HG23 HG22 ' A' ' 13' ' ' VAL . 6.7 t -81.03 132.73 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.855 . . . . 0.0 109.291 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.7 mt -107.7 -47.43 3.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.152 -0.968 . . . . 0.0 109.63 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -142.42 97.47 3.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.943 . . . . 0.0 108.936 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.616 ' HG2' ' CD1' ' A' ' 45' ' ' TRP . 2.3 tm-20 -84.17 116.66 23.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.359 -0.838 . . . . 0.0 109.653 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.809 ' HB2' HD21 ' B' ' 186' ' ' LEU . 7.1 m-70 -80.58 -98.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.433 -0.792 . . . . 0.0 109.458 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.26 -11.36 0.67 Allowed Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.32 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.566 ' O ' ' HG3' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -156.85 -18.78 0.09 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.879 -1.365 . . . . 0.0 110.413 -179.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.86 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 67.2 m95 -135.78 96.17 3.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.902 -1.124 . . . . 0.0 109.124 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.622 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -88.21 145.27 25.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.022 -1.049 . . . . 0.0 110.119 -179.253 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.6 OUTLIER -93.7 107.43 19.31 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.219 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -104.55 -173.96 2.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.296 -0.878 . . . . 0.0 110.094 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 2.7 ttpm? -125.46 126.84 45.56 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.59 -0.694 . . . . 0.0 109.459 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.657 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -70.92 126.5 29.74 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.111 -0.993 . . . . 0.0 110.03 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.483 HD13 ' HB3' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -72.24 -7.47 49.52 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 51' ' ' LEU . 27.8 tp -54.49 -55.05 33.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.503 -0.748 . . . . 0.0 109.253 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.5 t -161.16 29.69 0.14 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.122 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.587 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 86.36 45.85 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.482 -0.761 . . . . 0.0 110.671 178.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.657 ' HB2' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER -86.94 132.3 33.84 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.068 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.454 ' HG2' ' CE ' ' A' ' 46' ' ' LYS . 20.2 tt0 -121.59 116.38 24.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.942 -1.099 . . . . 0.0 109.353 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.635 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -157.13 169.26 34.19 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 119.385 -1.388 . . . . 0.0 110.032 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.724 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 11.0 m-85 -73.55 133.91 43.67 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.625 -0.926 . . . . 0.0 109.958 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 45' ' ' TRP . 2.6 pt -121.68 142.51 36.04 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.677 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 49.6 Cg_endo -69.93 152.0 68.3 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 121.792 1.661 . . . . 0.0 111.816 -178.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.543 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 66.1 p -80.81 5.67 15.27 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 110.006 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 4.4 p-10 -106.01 -52.48 2.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.997 -1.065 . . . . 0.0 110.941 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.695 ' CE2' HD23 ' B' ' 179' ' ' LEU . 4.5 m-85 -52.63 -61.28 2.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.099 -1.001 . . . . 0.0 111.263 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.603 HG11 ' CE ' ' A' ' 35' ' ' MET . 2.6 m -79.83 155.49 4.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 122.069 0.938 . . . . 0.0 111.092 -177.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.979 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -133.61 161.05 35.68 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.0 -1.063 . . . . 0.0 109.537 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 0.758 HD21 ' OD2' ' A' ' 20' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 121.755 0.788 . . . . 0.0 109.797 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.86 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 39.5 Cg_endo -68.92 -176.02 1.13 Allowed 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 123.03 2.487 . . . . 0.0 111.991 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . 0.739 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 52.0 Cg_endo -92.74 -20.57 0.49 Allowed 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 123.28 2.653 . . . . 0.0 114.661 -177.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.756 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.0 OUTLIER 78.75 89.9 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 120.873 -1.142 . . . . 0.0 109.175 -179.106 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.576 ' HG2' HD22 ' B' ' 186' ' ' LEU . 49.1 Cg_endo -70.41 137.43 33.55 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.804 2.336 . . . . 0.0 112.039 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 37.26 60.87 1.0 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.424 -0.797 . . . . 0.0 109.562 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 46.91 47.71 15.44 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.154 -0.966 . . . . 0.0 109.125 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . 0.809 HD21 ' HB2' ' A' ' 41' ' ' HIS . 20.5 tp -61.18 -84.93 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.517 -0.739 . . . . 0.0 109.427 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . 0.724 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.486 1.988 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.16 137.55 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.296 -0.877 . . . . 0.0 109.523 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 m -131.79 161.3 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 0.0 109.279 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.5 p -120.13 139.99 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.126 -0.984 . . . . 0.0 109.186 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -73.1 133.06 44.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.475 -0.765 . . . . 0.0 110.122 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.044 HD11 ' HB2' ' A' ' 64' ' ' ALA . 8.7 mt -100.1 -14.01 18.75 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.658 ' HA ' ' CG ' ' A' ' 31' ' ' LYS . 34.1 m-85 -155.84 150.47 20.31 Favored Pre-proline 0 N--CA 1.489 1.476 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.722 ' HD3' ' HG3' ' A' ' 31' ' ' LYS . 39.6 Cg_endo -61.09 149.03 91.11 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 121.718 1.612 . . . . 0.0 109.742 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.793 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 60.9 t80 -97.95 178.23 5.18 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.041 -1.464 . . . . 0.0 110.525 -177.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.679 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 30.6 t0 -109.75 80.46 1.32 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.673 -0.642 . . . . 0.0 109.408 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.63 93.22 0.03 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.524 HG12 ' O ' ' A' ' 20' ' ' ASP . 0.6 OUTLIER -107.26 -42.81 6.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.142 -1.21 . . . . 0.0 108.675 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.592 ' CD2' ' NH1' ' B' ' 182' ' ' ARG . 59.0 m-70 -76.86 156.43 82.54 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.97 -13.94 37.61 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.287 1.991 . . . . 0.0 111.998 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -111.71 -13.72 13.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.341 -0.85 . . . . 0.0 110.493 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.481 ' OD2' ' OH ' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -57.97 140.52 52.09 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.827 -1.171 . . . . 0.0 109.989 -179.316 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.96 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -95.62 122.11 38.03 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.077 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.879 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -80.54 140.48 35.81 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.203 -0.935 . . . . 0.0 109.282 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.793 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 29.9 p90 -146.99 158.27 43.87 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.124 -0.985 . . . . 0.0 109.042 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.667 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 16.4 mttp -111.69 174.61 5.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.165 -0.959 . . . . 0.0 109.41 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.722 ' HG3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -66.54 155.88 36.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.875 -1.141 . . . . 0.0 109.428 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 67.71 -6.75 2.51 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -75.24 140.51 43.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.86 -1.377 . . . . 0.0 109.573 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.9 138.99 32.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.532 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.581 ' CE ' HG11 ' A' ' 63' ' ' VAL . 3.5 mpp? -135.83 152.14 50.77 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.473 0.654 . . . . 0.0 109.753 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.9 OUTLIER -108.6 126.14 52.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.459 -0.776 . . . . 0.0 109.313 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.554 HG11 ' HG3' ' A' ' 40' ' ' GLU . 3.9 t -82.14 126.31 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.357 -0.839 . . . . 0.0 109.37 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.496 HD11 ' OE2' ' A' ' 55' ' ' GLU . 36.8 mt -99.33 -46.57 5.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.924 . . . . 0.0 109.429 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.5 90.62 2.58 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.596 ' HG2' ' CD1' ' A' ' 45' ' ' TRP . 1.4 tt0 -76.55 117.67 18.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.4 -0.812 . . . . 0.0 109.965 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.464 ' CD2' HD11 ' B' ' 186' ' ' LEU . 14.2 m-70 -87.34 -98.8 0.08 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.336 -0.853 . . . . 0.0 109.074 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.07 -7.52 0.11 Allowed Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.328 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.565 ' HB2' ' HD3' ' B' ' 183' ' ' PRO . 3.0 mp0 -149.43 -29.52 0.25 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.957 -1.32 . . . . 0.0 110.098 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.819 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 67.7 m95 -137.7 97.32 3.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 109.328 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.596 ' CD1' ' HG2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -88.42 146.64 25.12 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.976 -1.078 . . . . 0.0 110.147 -179.718 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.572 ' HG3' ' CD1' ' A' ' 57' ' ' PHE . 0.7 OUTLIER -93.15 107.07 18.94 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -104.75 -173.39 2.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.211 -0.931 . . . . 0.0 110.045 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.606 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -125.73 129.27 49.16 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.57 -0.706 . . . . 0.0 109.664 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.62 ' HB2' ' HB3' ' A' ' 54' ' ' LYS . 1.2 t -74.07 128.08 34.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.0 109.882 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.63 -8.88 57.49 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 51' ' ' LEU . 15.3 tp -53.08 -55.11 26.39 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.41 -0.806 . . . . 0.0 109.329 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.596 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.8 t -161.24 29.61 0.14 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.094 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.596 ' CB ' ' O ' ' A' ' 52' ' ' THR . 3.9 mttm 86.59 45.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.356 -0.84 . . . . 0.0 110.607 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.62 ' HB3' ' HB2' ' A' ' 49' ' ' SER . 8.1 tttt -85.79 132.67 34.07 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.496 ' OE2' HD11 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -122.52 116.7 24.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.939 -1.101 . . . . 0.0 109.412 -179.696 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.636 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -157.62 169.09 34.44 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 119.459 -1.353 . . . . 0.0 109.972 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.855 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 6.3 m-85 -72.65 133.76 44.79 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.72 -0.871 . . . . 0.0 109.874 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.45 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 6.5 pt -121.97 143.6 39.13 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.754 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 50.1 Cg_endo -71.41 152.0 60.13 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 121.778 1.652 . . . . 0.0 112.176 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.477 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 28.1 t -80.32 6.26 12.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.314 -0.866 . . . . 0.0 110.81 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.99 -52.51 2.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.795 -1.19 . . . . 0.0 110.709 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.62 ' HE2' HD23 ' B' ' 179' ' ' LEU . 3.9 m-85 -50.04 -62.59 1.49 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.043 -1.036 . . . . 0.0 110.9 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.581 HG11 ' CE ' ' A' ' 35' ' ' MET . 3.1 m -79.14 155.31 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 121.925 0.869 . . . . 0.0 111.086 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 1.044 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -130.76 159.56 36.94 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.037 -1.04 . . . . 0.0 109.57 -179.916 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 0.642 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 121.757 0.789 . . . . 0.0 109.778 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.819 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 40.2 Cg_endo -69.13 -172.15 0.48 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.268 2.645 . . . . 0.0 111.652 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . 0.686 ' O ' ' CB ' ' B' ' 182' ' ' ARG . 53.3 Cg_endo -88.54 -40.96 0.05 OUTLIER 'Trans proline' 0 C--O 1.214 -0.721 0 C-N-CA 122.679 2.253 . . . . 0.0 114.025 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.755 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 2.7 ttm180 91.49 92.92 0.03 OUTLIER Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.299 -0.875 . . . . 0.0 109.39 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.565 ' HD3' ' HB2' ' A' ' 43' ' ' GLU . 48.8 Cg_endo -71.99 133.99 22.59 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.996 2.464 . . . . 0.0 112.144 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 36.66 69.81 0.19 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.49 -0.757 . . . . 0.0 109.725 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . 0.453 ' C ' ' O ' ' B' ' 184' ' ' ALA . 2.9 p-10 39.46 45.42 1.27 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.417 -0.802 . . . . 0.0 109.44 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . 0.597 ' CG ' ' HB2' ' A' ' 44' ' ' TRP . 18.1 tp -53.82 -89.0 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.458 -0.776 . . . . 0.0 109.046 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . 0.855 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.488 2.128 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.7 tp -107.9 137.87 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.142 -0.974 . . . . 0.0 109.59 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 65' ' ' LYS . 1.5 m -132.0 161.76 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.0 p -120.94 139.18 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.024 -1.047 . . . . 0.0 109.279 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.53 134.55 46.57 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.395 -0.816 . . . . 0.0 109.731 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.712 ' CD1' ' HB2' ' A' ' 64' ' ' ALA . 19.2 mt -99.41 -21.72 15.86 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.68 ' CE1' ' HB2' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -148.68 152.55 37.93 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.439 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.697 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 39.8 Cg_endo -62.92 149.63 90.93 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 121.931 1.754 . . . . 0.0 110.185 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.811 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 55.9 t80 -98.84 179.13 4.75 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.153 -1.419 . . . . 0.0 110.432 -177.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.69 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 57.7 m-20 -110.84 79.86 1.25 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.682 -0.636 . . . . 0.0 109.356 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.8 95.15 0.04 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 20' ' ' ASP . 15.2 mm -108.42 -41.97 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -1.13 . . . . 0.0 108.893 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.415 ' CE1' ' NH1' ' B' ' 182' ' ' ARG . 36.2 m80 -77.56 158.88 78.15 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.53 -14.17 36.39 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.284 1.989 . . . . 0.0 111.869 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.0 -13.51 13.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.0 110.416 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.66 138.08 55.76 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.821 -1.174 . . . . 0.0 109.809 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.929 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -95.53 121.22 36.99 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.874 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.1 m -79.99 141.3 36.08 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.355 -0.84 . . . . 0.0 109.475 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.811 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 28.3 p90 -145.84 157.54 43.91 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.201 -0.937 . . . . 0.0 108.588 178.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.665 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 40.6 mttm -110.65 173.82 6.15 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.087 -1.008 . . . . 0.0 109.585 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.506 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -67.52 151.54 47.19 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.111 -0.993 . . . . 0.0 109.314 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.87 -8.09 4.83 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -75.43 140.46 42.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.928 -1.336 . . . . 0.0 109.788 -179.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -93.54 138.66 31.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.862 . . . . 0.0 109.263 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.629 ' CE ' HG11 ' A' ' 63' ' ' VAL . 1.9 mpp? -135.24 151.66 50.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.622 -0.674 . . . . 0.0 109.796 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.739 ' HD3' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -106.16 124.61 49.85 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.469 -0.769 . . . . 0.0 109.62 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.628 HG11 ' HG3' ' A' ' 40' ' ' GLU . 1.4 t -82.21 132.32 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.34 -0.85 . . . . 0.0 108.846 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.739 HD23 ' HD3' ' A' ' 36' ' ' LYS . 3.7 mt -110.37 -42.51 4.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.006 -1.059 . . . . 0.0 109.849 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -138.8 84.47 2.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.178 -0.951 . . . . 0.0 109.215 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.628 ' HG3' HG11 ' A' ' 37' ' ' VAL . 1.4 tt0 -67.96 116.14 8.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.861 . . . . 0.0 109.274 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.746 ' HB2' HD21 ' B' ' 186' ' ' LEU . 46.1 m-70 -86.04 -103.32 0.06 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.235 -0.916 . . . . 0.0 109.398 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.425 ' O ' ' HG3' ' A' ' 43' ' ' GLU . . . -136.4 -15.39 0.88 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.304 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.582 ' CG ' ' HD2' ' B' ' 181' ' ' PRO . 1.3 mt-10 -158.0 -20.24 0.08 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.944 -1.327 . . . . 0.0 110.525 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.939 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 57.1 m95 -133.51 93.81 3.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.919 -1.113 . . . . 0.0 108.676 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.63 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -85.85 146.57 26.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.074 -1.016 . . . . 0.0 110.796 -178.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 1.1 ttpt -94.21 105.85 17.83 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.41 -174.05 2.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.32 -0.862 . . . . 0.0 110.125 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.9 mttp -125.72 126.85 45.29 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.542 -0.724 . . . . 0.0 109.496 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.601 ' HB2' ' HB3' ' A' ' 54' ' ' LYS . 1.8 t -70.94 125.62 27.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.136 -0.978 . . . . 0.0 109.875 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.75 -8.69 54.09 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.656 HD13 ' O ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -53.4 -55.27 26.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.508 -0.745 . . . . 0.0 109.352 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.633 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 1.5 t -161.16 30.11 0.14 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.267 -0.896 . . . . 0.0 110.186 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.633 ' HB2' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 85.58 45.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.499 -0.751 . . . . 0.0 110.651 178.547 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -86.8 132.18 33.91 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.122 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 1.4 pt-20 -121.82 117.56 26.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.89 -1.131 . . . . 0.0 109.455 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.642 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -157.67 168.67 34.38 Favored Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.346 -1.407 . . . . 0.0 110.158 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.75 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 15.5 m-85 -73.54 134.33 43.78 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.686 -0.89 . . . . 0.0 109.954 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.463 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 4.1 pt -122.37 141.16 34.09 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.59 ' HG3' ' CD2' ' B' ' 179' ' ' LEU . 53.4 Cg_endo -72.48 134.43 22.48 Favored 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 121.673 1.582 . . . . 0.0 111.997 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.623 ' HB3' ' CE2' ' A' ' 45' ' ' TRP . 24.3 p -65.2 4.69 0.45 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 110.422 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.67 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 5.9 p-10 -102.01 -51.64 3.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.871 -1.143 . . . . 0.0 110.86 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 1.182 ' CE2' HD21 ' B' ' 179' ' ' LEU . 3.1 m-85 -55.27 -59.99 4.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.142 -0.974 . . . . 0.0 111.304 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.629 HG11 ' CE ' ' A' ' 35' ' ' MET . 4.2 m -78.74 157.61 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 122.054 0.931 . . . . 0.0 111.41 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.712 ' HB2' ' CD1' ' A' ' 16' ' ' LEU . . . -135.63 161.88 34.29 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.509 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.454 0 O-C-N 121.046 -1.033 . . . . 0.0 109.265 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 1.182 HD21 ' CE2' ' A' ' 62' ' ' TYR . 46.2 mt . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 121.527 0.68 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.939 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 39.6 Cg_endo -68.79 176.32 6.16 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.755 2.303 . . . . 0.0 111.648 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . 0.61 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 55.5 Cg_endo -86.82 -26.85 0.82 Allowed 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.885 2.39 . . . . 0.0 114.51 -177.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.727 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.0 OUTLIER 79.41 95.67 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 120.818 -1.176 . . . . 0.0 109.458 -179.213 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.752 ' CG ' HD22 ' B' ' 186' ' ' LEU . 48.0 Cg_endo -69.68 131.19 20.83 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 123.064 2.509 . . . . 0.0 112.269 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . 0.506 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 35.64 69.13 0.19 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.448 -0.782 . . . . 0.0 109.874 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . 0.437 ' ND2' ' N ' ' B' ' 185' ' ' ASN . 0.2 OUTLIER 43.34 45.33 5.13 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.377 -0.827 . . . . 0.0 109.537 -179.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . 0.753 HD23 ' HB2' ' A' ' 44' ' ' TRP . 28.4 tp -55.7 -94.96 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . 0.75 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.484 1.874 0 N-CA-C 107.859 -2.097 . . . . 0.0 107.859 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 36.0 mm -102.86 133.93 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.195 -0.941 . . . . 0.0 109.366 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 1.001 HG12 ' HA ' ' A' ' 65' ' ' LYS . 1.0 OUTLIER -132.36 159.57 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.508 -0.745 . . . . 0.0 109.171 -179.424 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 p -119.45 135.51 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.878 -1.139 . . . . 0.0 108.95 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.612 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -70.21 131.62 44.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.409 -0.807 . . . . 0.0 110.594 -178.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.024 HD11 ' HB2' ' A' ' 64' ' ' ALA . 95.2 mt -98.79 -39.31 8.69 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.461 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 16.4 m-85 -122.33 139.28 30.44 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -63.0 150.61 88.15 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.625 2.217 . . . . 0.0 113.015 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.786 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 25.1 t80 -130.25 115.97 17.72 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.417 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.5 OUTLIER -94.72 119.11 32.8 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 116.294 -2.162 . . . . 0.0 108.922 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -41.92 99.19 0.01 OUTLIER Glycine 0 N--CA 1.487 2.077 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 20' ' ' ASP . 12.9 mm -88.64 -54.03 8.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.608 ' CG ' ' HD3' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -66.39 -171.02 0.07 OUTLIER Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.608 ' HD3' ' CG ' ' A' ' 23' ' ' HIS . 52.2 Cg_endo -92.26 -13.48 1.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.54 2.16 . . . . 0.0 112.333 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -117.8 -11.14 10.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 0.0 110.779 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.488 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 99.5 m-20 -57.64 140.4 51.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.001 -1.062 . . . . 0.0 110.413 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.01 HD22 ' N ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -97.64 126.43 42.94 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 1.01 ' N ' HD22 ' A' ' 27' ' ' LEU . 9.4 m -81.62 138.02 35.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.149 -0.969 . . . . 0.0 110.693 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.786 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 18.5 p90 -145.84 156.66 43.71 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -112.09 163.19 14.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.015 -1.053 . . . . 0.0 109.618 -179.368 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.41 151.6 12.87 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.218 -0.926 . . . . 0.0 108.99 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.49 -8.42 3.07 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 3.2 tm-20 -73.66 144.41 45.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.93 -1.336 . . . . 0.0 109.997 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.712 ' HB2' HD12 ' A' ' 50' ' ' LEU . 4.0 mtmp? -96.03 135.98 37.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.91 . . . . 0.0 109.336 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.583 ' CE ' HG11 ' A' ' 63' ' ' VAL . 1.4 mpp? -134.52 150.67 50.8 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.518 -0.739 . . . . 0.0 110.02 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 13.0 tttt -105.74 117.52 34.24 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.529 -0.732 . . . . 0.0 109.182 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.677 HG23 HG22 ' A' ' 13' ' ' VAL . 2.5 t -76.92 132.42 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.386 -0.821 . . . . 0.0 109.185 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 98.2 mt -103.47 -50.53 3.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.722 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -140.89 103.94 4.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 108.913 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.653 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.2 tm-20 -87.54 119.22 27.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.459 -0.776 . . . . 0.0 109.784 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.704 ' HB2' HD21 ' B' ' 186' ' ' LEU . 3.0 m-70 -83.85 -98.39 0.05 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.379 -0.826 . . . . 0.0 109.206 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.483 ' O ' ' HG2' ' A' ' 43' ' ' GLU . . . -138.98 -13.1 0.71 Allowed Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.654 -1.26 . . . . 0.0 110.318 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' B' ' 180' ' ' PRO . 12.0 mt-10 -153.24 -16.43 0.15 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.918 -1.343 . . . . 0.0 110.412 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.784 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 65.3 m95 -140.21 100.1 3.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.939 -1.101 . . . . 0.0 109.53 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.662 ' CZ2' ' CB ' ' A' ' 60' ' ' SER . 0.1 OUTLIER -92.51 144.41 25.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.135 -0.978 . . . . 0.0 109.809 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -85.66 108.92 18.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.267 -0.895 . . . . 0.0 108.642 179.234 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.51 -177.87 3.5 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.264 -0.897 . . . . 0.0 110.01 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 8.5 mtpt -125.0 132.02 53.32 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.586 -0.697 . . . . 0.0 109.608 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.629 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 4.4 t -79.87 129.1 34.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.927 . . . . 0.0 109.717 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.712 HD12 ' HB2' ' A' ' 34' ' ' LYS . 19.6 mt -74.14 -5.24 40.56 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.7 tp -55.91 -54.76 40.77 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.334 -0.854 . . . . 0.0 109.132 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.624 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -160.4 27.56 0.16 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.33 -0.857 . . . . 0.0 110.04 179.323 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.624 ' HB2' ' O ' ' A' ' 52' ' ' THR . 5.0 mtpm? 87.2 43.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.586 -0.696 . . . . 0.0 110.805 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.629 ' HB2' ' CB ' ' A' ' 49' ' ' SER . 3.0 mmtp -85.27 132.57 34.24 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -122.63 116.54 23.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.955 -1.091 . . . . 0.0 109.424 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.649 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -152.67 170.62 31.8 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.67 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 5.1 m-85 -73.0 132.05 42.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.449 -1.03 . . . . 0.0 109.52 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.536 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 7.2 pt -121.14 140.17 30.64 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 108.965 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.675 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 49.3 Cg_endo -68.87 153.38 72.87 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.42 2.08 . . . . 0.0 112.022 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.662 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 77.4 p -85.61 6.55 26.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 109.948 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.574 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 3.4 p-10 -105.95 -47.58 3.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.145 -0.972 . . . . 0.0 110.158 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.783 ' CE2' HD23 ' B' ' 179' ' ' LEU . 10.4 m-30 -56.76 -59.97 4.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.495 -0.753 . . . . 0.0 110.956 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 15' ' ' ALA . 3.1 m -80.11 163.28 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 111.296 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 1.024 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -137.24 130.59 31.16 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 1.001 ' HA ' HG12 ' A' ' 13' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.154 -0.966 . . . . 0.0 109.849 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 0.783 HD23 ' CE2' ' A' ' 62' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 121.456 0.646 . . . . 0.0 109.258 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.784 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.4 Cg_endo -67.36 -175.84 0.75 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.872 2.382 . . . . 0.0 111.797 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . 0.738 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 53.5 Cg_endo -91.88 -22.58 0.48 Allowed 'Trans proline' 0 C--O 1.213 -0.775 0 C-N-CA 123.062 2.508 . . . . 0.0 114.709 -177.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.738 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 20.7 mtt180 77.0 93.07 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.892 -1.13 . . . . 0.0 109.063 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 47.0 Cg_endo -68.38 130.89 22.0 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.666 2.244 . . . . 0.0 111.848 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 43.53 61.82 2.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.367 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 47.18 50.27 14.4 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.267 -0.895 . . . . 0.0 109.274 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . 0.704 HD21 ' HB2' ' A' ' 41' ' ' HIS . 49.9 tp -68.51 -83.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.412 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . 0.67 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.486 1.977 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.439 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.403 HD12 ' HG3' ' A' ' 36' ' ' LYS . 2.6 tp -106.3 142.13 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.233 -0.917 . . . . 0.0 109.648 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.5 m -132.33 162.46 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.443 -0.786 . . . . 0.0 109.175 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 9.7 p -121.78 138.64 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.123 -0.985 . . . . 0.0 109.209 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.2 136.85 48.26 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.469 -0.769 . . . . 0.0 109.829 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.649 HD11 ' HB2' ' A' ' 64' ' ' ALA . 55.6 mt -98.97 -25.46 14.57 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.619 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 23.1 m-85 -144.66 154.85 56.46 Favored Pre-proline 0 N--CA 1.486 1.373 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.704 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 41.5 Cg_endo -63.99 149.36 90.7 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 121.941 1.761 . . . . 0.0 110.192 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.844 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 58.8 t80 -99.65 178.38 4.87 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 118.01 -1.476 . . . . 0.0 110.552 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.679 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -110.63 80.0 1.26 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.655 -0.653 . . . . 0.0 109.377 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.27 95.26 0.03 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.701 -1.759 . . . . 0.0 108.701 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.417 ' N ' ' O ' ' A' ' 20' ' ' ASP . 28.9 mt -109.89 -40.2 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.14 -1.212 . . . . 0.0 109.167 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -80.18 158.91 71.53 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.88 -14.95 39.84 Favored 'Trans proline' 0 C--O 1.216 -0.586 0 C-N-CA 122.314 2.009 . . . . 0.0 112.159 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -110.61 -11.46 14.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.022 -1.049 . . . . 0.0 110.488 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -59.95 143.2 52.25 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.857 -1.152 . . . . 0.0 109.655 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.948 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -102.42 122.92 45.25 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.913 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -77.35 138.94 39.62 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 109.568 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.844 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 19.8 p90 -143.66 155.4 44.23 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 108.542 178.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.654 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 1.8 ptpt -110.15 173.16 6.45 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.204 -0.935 . . . . 0.0 109.486 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.512 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -66.34 152.48 44.92 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.198 -0.939 . . . . 0.0 109.304 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.47 -7.76 3.49 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.5 OUTLIER -74.95 143.67 43.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.843 -1.386 . . . . 0.0 109.564 -179.677 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -96.42 138.83 33.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.901 . . . . 0.0 109.556 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.544 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 2.1 mpp? -134.86 151.58 51.03 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.594 -0.691 . . . . 0.0 109.657 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.592 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 2.6 tttt -104.99 128.82 53.45 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.406 -0.809 . . . . 0.0 109.179 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.492 ' O ' HD12 ' A' ' 38' ' ' LEU . 1.7 t -81.58 135.11 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.416 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 37' ' ' VAL . 6.8 mp -113.43 -41.13 3.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.313 -0.867 . . . . 0.0 109.513 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -149.91 88.38 1.53 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 109.233 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.628 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -74.76 114.49 13.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.378 -0.826 . . . . 0.0 109.438 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.812 ' HB2' HD21 ' B' ' 186' ' ' LEU . 3.2 m-70 -80.6 -101.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.518 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.411 ' C ' ' CD ' ' A' ' 43' ' ' GLU . . . -127.28 -14.91 2.59 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.048 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.571 ' CG ' ' HD3' ' B' ' 183' ' ' PRO . 0.0 OUTLIER -165.8 -10.87 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.022 -1.281 . . . . 0.0 110.3 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.84 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 71.2 m95 -131.1 89.2 2.7 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.859 -1.151 . . . . 0.0 108.701 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.628 ' CD1' ' CG ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -83.7 140.97 31.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.798 -1.189 . . . . 0.0 110.312 -179.064 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 4.3 tttt -91.42 103.54 16.16 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.592 ' HB1' ' O ' ' A' ' 36' ' ' LYS . . . -101.92 -177.21 3.35 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.351 -0.843 . . . . 0.0 110.336 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.489 ' HE2' HD21 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -123.72 109.5 13.77 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.855 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.614 ' OG ' ' CB ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -57.45 129.53 42.25 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.807 -179.606 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.436 ' O ' ' N ' ' A' ' 52' ' ' THR . 0.3 OUTLIER -76.88 -8.61 57.67 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.318 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.474 ' O ' ' HB ' ' A' ' 52' ' ' THR . 55.5 tp -46.55 -22.68 0.3 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.738 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER 169.42 -21.94 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.38 -0.825 . . . . 0.0 110.115 178.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.738 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.1 OUTLIER 140.33 39.23 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.47 -0.769 . . . . 0.0 110.105 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.646 ' HB3' HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -87.86 135.24 33.48 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -122.43 127.82 50.14 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.914 -1.117 . . . . 0.0 109.274 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.691 ' HA3' ' CB ' ' A' ' 27' ' ' LEU . . . -166.93 168.81 40.51 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.235 -1.46 . . . . 0.0 110.41 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.717 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 14.2 m-85 -71.62 132.89 45.26 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.754 -0.851 . . . . 0.0 109.898 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.513 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 8.1 pt -123.18 129.48 24.92 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.668 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 56.2 Cg_endo -75.1 126.49 9.94 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 121.634 1.556 . . . . 0.0 112.591 -178.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.612 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 32.2 t -55.28 -10.85 0.64 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.522 -0.736 . . . . 0.0 109.997 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.487 ' HB3' ' HD3' ' B' ' 180' ' ' PRO . 5.3 t30 -88.35 0.81 55.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.034 -1.041 . . . . 0.0 110.383 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.619 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -117.08 -41.34 3.02 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.864 -1.148 . . . . 0.0 110.045 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.544 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.5 m -96.62 159.09 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.104 -0.997 . . . . 0.0 110.567 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.649 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -136.87 161.89 34.77 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.087 -1.008 . . . . 0.0 109.4 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 0.643 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.711 0.767 . . . . 0.0 109.598 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.84 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.5 Cg_endo -68.79 -176.57 1.26 Allowed 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 123.031 2.487 . . . . 0.0 111.647 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . 0.719 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.6 Cg_endo -89.82 -26.75 0.38 Allowed 'Trans proline' 0 C--O 1.213 -0.739 0 C-N-CA 122.886 2.391 . . . . 0.0 114.937 -177.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.719 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 39.4 mtt180 78.14 91.56 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 120.879 -1.138 . . . . 0.0 109.13 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.59 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 50.2 Cg_endo -70.0 135.59 30.27 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.689 2.26 . . . . 0.0 111.787 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 42.38 55.38 4.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.884 . . . . 0.0 109.5 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . 0.52 ' N ' ' ND2' ' B' ' 185' ' ' ASN . 0.7 OUTLIER 51.68 50.54 18.52 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.26 -0.9 . . . . 0.0 109.281 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . 0.812 HD21 ' HB2' ' A' ' 41' ' ' HIS . 60.9 tp -70.48 -81.88 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.362 -0.836 . . . . 0.0 109.418 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . 0.717 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.485 1.948 0 N-CA-C 108.924 -1.671 . . . . 0.0 108.924 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.7 mm -107.98 136.8 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.099 -1.0 . . . . 0.0 109.594 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.496 HG22 HG12 ' A' ' 37' ' ' VAL . 1.0 OUTLIER -131.34 160.68 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.505 -0.747 . . . . 0.0 109.036 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 p -120.66 139.23 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.054 -1.029 . . . . 0.0 109.372 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.86 133.3 45.37 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.379 -0.826 . . . . 0.0 109.744 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.983 HD11 ' CB ' ' A' ' 64' ' ' ALA . 23.4 mt -99.13 -17.25 18.28 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.672 ' HA ' ' CG ' ' A' ' 31' ' ' LYS . 7.2 m-85 -152.62 151.61 27.21 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.731 ' HD3' ' HG3' ' A' ' 31' ' ' LYS . 40.7 Cg_endo -61.53 148.93 91.8 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 121.53 1.487 . . . . 0.0 109.655 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.828 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 36.6 t80 -89.29 -34.3 16.63 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 117.947 -1.501 . . . . 0.0 110.224 -177.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.756 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 30.3 t70 106.84 -53.52 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.26 93.31 0.2 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.423 ' H ' HD12 ' A' ' 22' ' ' ILE . 0.5 OUTLIER -109.42 -42.96 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.385 -1.067 . . . . 0.0 108.433 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.513 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 1.9 m80 -74.74 153.35 87.22 Favored Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.79 -9.69 26.71 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.075 1.85 . . . . 0.0 111.417 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.8 -17.4 11.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.368 -0.833 . . . . 0.0 110.545 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.513 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.5 OUTLIER -57.18 141.28 46.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.856 -1.152 . . . . 0.0 109.956 -178.838 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.951 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -90.03 119.14 30.12 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.867 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.879 ' N ' HD22 ' A' ' 27' ' ' LEU . 93.9 p -77.08 138.51 39.59 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.333 -0.855 . . . . 0.0 109.734 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.828 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 17.6 p90 -143.68 155.56 44.26 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.238 -0.914 . . . . 0.0 108.772 178.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.692 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -112.36 175.47 5.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.242 -0.911 . . . . 0.0 109.434 -179.356 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.731 ' HG3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -66.13 155.8 35.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.95 -1.093 . . . . 0.0 109.423 179.576 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 66.01 -6.94 1.32 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.418 ' H ' ' C ' ' A' ' 31' ' ' LYS . 0.5 OUTLIER -74.79 141.31 44.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.839 -1.389 . . . . 0.0 109.687 -179.602 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -94.87 136.97 34.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.324 -0.86 . . . . 0.0 109.415 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.587 ' CE ' HG11 ' A' ' 63' ' ' VAL . 1.1 mpp? -137.23 153.1 50.45 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.421 0.629 . . . . 0.0 109.758 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.635 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 13.7 tttm -110.31 123.67 50.24 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.472 -0.768 . . . . 0.0 109.26 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.57 HG21 ' CD ' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -88.71 115.66 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -82.88 -41.09 19.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.196 -0.94 . . . . 0.0 110.038 -179.365 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.54 126.02 11.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.147 -0.971 . . . . 0.0 109.505 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.64 ' HG2' ' CD2' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -95.19 131.44 41.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.451 -0.78 . . . . 0.0 109.406 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.791 ' HB2' HD21 ' B' ' 186' ' ' LEU . 78.5 m-70 -98.72 -122.84 0.14 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.266 -0.896 . . . . 0.0 108.997 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.23 -28.96 21.28 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.574 ' CB ' ' HD2' ' B' ' 181' ' ' PRO . 2.1 tp10 -172.44 5.28 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.039 -1.271 . . . . 0.0 110.672 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 1.025 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 64.4 m95 -136.26 97.29 3.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.834 -1.166 . . . . 0.0 108.372 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.64 ' CD2' ' HG2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -93.23 145.89 24.1 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.921 -1.112 . . . . 0.0 110.337 -178.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -84.97 107.98 17.36 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.635 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -99.9 -179.62 4.22 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.363 -0.835 . . . . 0.0 109.909 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -122.76 129.97 52.36 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.62 -0.675 . . . . 0.0 109.493 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.574 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -76.75 126.79 31.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.75 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.64 -9.49 58.32 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.8 tp -52.11 -54.8 26.05 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.511 -0.743 . . . . 0.0 109.368 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.621 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.2 t -161.54 28.72 0.13 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.229 -0.92 . . . . 0.0 110.146 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.621 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.5 OUTLIER 87.09 44.33 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.47 -0.769 . . . . 0.0 110.715 178.726 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -85.46 132.64 34.18 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.077 -1.015 . . . . 0.0 108.337 178.517 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -122.4 114.75 21.17 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.859 -1.151 . . . . 0.0 109.483 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.627 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -152.22 171.84 31.49 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.666 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 8.1 m-85 -75.27 132.41 41.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.351 -1.088 . . . . 0.0 109.689 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.509 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 9.2 pt -121.93 137.42 27.3 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 108.605 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.603 ' HB2' ' CD ' ' B' ' 180' ' ' PRO . 50.9 Cg_endo -74.1 137.62 24.18 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.975 1.783 . . . . 0.0 112.763 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.578 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 28.3 t -67.93 4.3 1.23 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.583 -0.698 . . . . 0.0 110.317 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.598 HD22 ' HA ' ' B' ' 179' ' ' LEU . 0.8 OUTLIER -100.91 -55.34 2.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.022 -1.049 . . . . 0.0 110.063 -179.391 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 1.183 ' CE2' HD21 ' B' ' 179' ' ' LEU . 2.4 m-85 -51.81 -60.87 2.67 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.261 -0.899 . . . . 0.0 110.872 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.587 HG11 ' CE ' ' A' ' 35' ' ' MET . 4.0 m -78.61 154.8 4.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 122.004 0.906 . . . . 0.0 111.182 -177.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.983 ' CB ' HD11 ' A' ' 16' ' ' LEU . . . -130.07 159.55 36.4 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.481 ' HA ' HG12 ' A' ' 13' ' ' VAL . 2.1 ttpm? . . . . . 0 N--CA 1.49 1.527 0 O-C-N 120.974 -1.078 . . . . 0.0 109.552 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 1.183 HD21 ' CE2' ' A' ' 62' ' ' TYR . 33.4 mt . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.45 0.643 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 1.025 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 39.1 Cg_endo -70.56 176.12 7.81 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.483 2.122 . . . . 0.0 111.638 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . 0.578 ' O ' ' CB ' ' B' ' 182' ' ' ARG . 55.7 Cg_endo -76.47 -42.63 0.34 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.823 2.349 . . . . 0.0 113.916 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.659 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.0 OUTLIER 78.94 81.44 0.1 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.039 -1.038 . . . . 0.0 108.49 -178.583 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.485 ' O ' ' C ' ' B' ' 184' ' ' ALA . 51.5 Cg_endo -72.95 146.21 41.48 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.939 2.426 . . . . 0.0 112.33 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 36.35 61.93 0.76 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.607 -0.683 . . . . 0.0 109.616 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . 0.486 ' N ' ' ND2' ' B' ' 185' ' ' ASN . 0.7 OUTLIER 42.95 46.2 4.6 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.308 -0.87 . . . . 0.0 109.05 -179.65 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . 0.791 HD21 ' HB2' ' A' ' 41' ' ' HIS . 68.0 tp -61.85 -86.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.435 -0.79 . . . . 0.0 109.447 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . 0.666 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.486 1.999 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.475 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.498 ' CD1' ' HG3' ' A' ' 36' ' ' LYS . 1.0 OUTLIER -101.43 137.79 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.884 . . . . 0.0 109.407 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.493 HG11 ' HZ3' ' A' ' 45' ' ' TRP . 0.8 OUTLIER -130.99 159.93 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.6 p -120.55 138.46 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.981 -1.074 . . . . 0.0 109.482 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -72.29 134.58 45.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.465 -0.772 . . . . 0.0 110.111 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.038 HD11 ' HB2' ' A' ' 64' ' ' ALA . 16.5 mt -99.26 -17.81 17.91 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.593 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 43.1 m-85 -152.55 153.87 31.02 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.689 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.6 Cg_endo -63.66 149.64 90.4 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 121.812 1.675 . . . . 0.0 110.042 179.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.823 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 65.7 t80 -97.58 179.14 4.95 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 118.219 -1.392 . . . . 0.0 110.224 -177.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.67 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 9.8 p-10 -110.15 80.93 1.36 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.569 -0.707 . . . . 0.0 109.313 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.5 91.92 0.03 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.577 HD12 ' OD2' ' A' ' 20' ' ' ASP . 67.1 mt -106.67 -43.17 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.265 -1.138 . . . . 0.0 108.765 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.59 ' CE1' ' NH2' ' B' ' 182' ' ' ARG . 41.1 m80 -75.86 156.14 84.59 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.01 -13.27 36.23 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.225 1.95 . . . . 0.0 111.799 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -111.86 -13.99 13.59 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.24 -0.913 . . . . 0.0 110.363 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.74 141.83 47.4 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.825 -1.172 . . . . 0.0 109.798 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.93 HD22 ' N ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -98.64 124.06 43.2 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.93 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -81.08 140.26 35.2 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.322 -0.861 . . . . 0.0 109.81 -179.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.823 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 28.2 p90 -145.79 157.97 43.89 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.654 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 10.5 mtmm -111.27 174.03 6.06 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.047 -1.033 . . . . 0.0 109.557 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.553 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -67.38 151.9 46.64 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.186 -0.946 . . . . 0.0 109.314 179.803 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.39 -7.94 4.42 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 3.8 tt0 -75.55 143.43 42.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.917 -1.343 . . . . 0.0 109.838 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -96.3 138.18 34.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 0.0 109.273 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.623 ' CE ' HG11 ' A' ' 63' ' ' VAL . 1.7 mpp? -135.97 151.82 50.32 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.628 -0.67 . . . . 0.0 109.932 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 7.7 ttpt -109.02 122.37 47.11 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -89.93 119.0 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.296 -0.877 . . . . 0.0 108.758 178.832 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.732 HD12 ' O ' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -89.01 -40.79 12.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.159 -0.963 . . . . 0.0 110.191 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.28 119.42 15.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.049 -1.032 . . . . 0.0 109.268 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.636 ' HG3' ' CG ' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -99.35 122.17 42.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.823 . . . . 0.0 109.453 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.633 ' HB2' HD21 ' B' ' 186' ' ' LEU . 5.2 m-70 -90.25 -103.86 0.1 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.957 . . . . 0.0 109.116 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.69 -14.06 1.55 Allowed Glycine 0 N--CA 1.489 2.174 0 C-N-CA 119.548 -1.31 . . . . 0.0 110.177 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.593 ' CG ' ' HD2' ' B' ' 181' ' ' PRO . 0.3 OUTLIER -158.77 -15.1 0.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.963 -1.316 . . . . 0.0 110.972 -179.506 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.843 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 62.7 m95 -138.92 99.52 3.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.725 -1.234 . . . . 0.0 109.608 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.671 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -93.18 142.98 26.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.881 -1.137 . . . . 0.0 109.511 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.732 ' O ' HD12 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -85.91 109.11 18.51 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.29 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -101.3 -174.62 2.65 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.333 -0.855 . . . . 0.0 109.818 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -126.97 129.39 48.05 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.478 -0.764 . . . . 0.0 109.298 -179.729 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.589 ' HB2' ' HB2' ' A' ' 54' ' ' LYS . 7.6 t -74.9 126.75 31.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.064 -1.023 . . . . 0.0 109.795 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.3 -7.43 46.96 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.151 -0.968 . . . . 0.0 108.521 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.67 -55.6 27.96 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.374 -0.829 . . . . 0.0 109.227 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.634 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.1 t -160.62 27.51 0.15 Allowed 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.136 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.634 ' CB ' ' O ' ' A' ' 52' ' ' THR . 5.1 mmtt 87.83 45.17 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.495 -0.753 . . . . 0.0 110.898 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.589 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 0.1 OUTLIER -87.0 130.67 34.36 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 177.752 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 10.1 pt-20 -120.31 117.87 28.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.79 -1.194 . . . . 0.0 109.508 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.656 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -154.77 179.12 31.09 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.742 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 9.3 m-85 -80.07 132.56 35.99 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.454 -1.027 . . . . 0.0 109.954 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.484 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 8.8 pt -120.27 136.61 25.26 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.693 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 55.3 Cg_endo -73.95 135.16 20.8 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 121.827 1.685 . . . . 0.0 112.536 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.598 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 23.1 t -65.97 5.24 0.52 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.512 -0.743 . . . . 0.0 110.565 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.552 ' CG ' ' N ' ' A' ' 62' ' ' TYR . 1.2 p-10 -101.21 -51.81 3.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.765 -1.209 . . . . 0.0 110.458 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.686 ' CE2' HD23 ' B' ' 179' ' ' LEU . 4.8 m-85 -57.06 -59.01 5.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.117 -0.989 . . . . 0.0 110.947 -178.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.623 HG11 ' CE ' ' A' ' 35' ' ' MET . 3.1 m -79.79 156.8 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.988 0.899 . . . . 0.0 111.272 -177.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 1.038 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -131.54 159.47 38.08 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.437 ' HA ' HG12 ' A' ' 13' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 O-C-N 120.933 -1.105 . . . . 0.0 109.568 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 0.686 HD23 ' CE2' ' A' ' 62' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 121.687 0.756 . . . . 0.0 109.568 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.843 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.1 Cg_endo -68.68 178.51 3.84 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.903 2.402 . . . . 0.0 111.531 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . 0.727 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.3 Cg_endo -88.21 -21.59 1.54 Allowed 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 122.982 2.455 . . . . 0.0 114.411 -177.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.727 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 24.6 mtt180 76.34 91.25 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.956 -1.09 . . . . 0.0 108.974 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' B' ' 186' ' ' LEU . 50.9 Cg_endo -70.68 136.42 30.54 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.84 2.36 . . . . 0.0 112.017 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 41.0 63.73 1.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.834 . . . . 0.0 109.492 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' B' ' 184' ' ' ALA . 0.0 OUTLIER 44.73 48.86 8.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.205 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . 0.633 HD21 ' HB2' ' A' ' 41' ' ' HIS . 42.6 tp -67.77 -87.15 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.441 -0.787 . . . . 0.0 109.413 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . 0.742 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.487 2.034 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 34.4 mm -111.8 136.79 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.119 -0.988 . . . . 0.0 109.729 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.497 HG12 ' HA ' ' A' ' 65' ' ' LYS . 1.3 m -133.09 162.92 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -118.65 139.17 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.84 -1.162 . . . . 0.0 109.069 179.176 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.707 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -72.09 95.42 1.63 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.44 -0.788 . . . . 0.0 110.695 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.024 HD11 ' CB ' ' A' ' 64' ' ' ALA . 37.3 mt -60.99 -34.08 74.24 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.602 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 29.1 m-85 -134.1 152.95 79.3 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.501 ' HB3' ' HA ' ' A' ' 30' ' ' LYS . 50.8 Cg_endo -70.27 150.9 65.79 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 122.409 2.073 . . . . 0.0 111.677 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.92 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 60.6 t80 -114.44 105.62 13.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.979 -1.075 . . . . 0.0 109.756 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 19' ' ' TYR . 40.3 m-20 -27.49 -37.75 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 19' ' ' TYR . . . 66.74 96.3 0.03 OUTLIER Glycine 0 N--CA 1.496 2.664 0 N-CA-C 106.206 -2.758 . . . . 0.0 106.206 -175.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.6 mt -115.04 -38.18 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.447 -1.031 . . . . 0.0 109.809 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.477 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 0.9 OUTLIER -77.41 151.76 80.87 Favored Pre-proline 0 C--N 1.298 -1.64 0 O-C-N 121.346 -0.846 . . . . 0.0 108.753 179.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.34 -10.17 26.55 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.211 1.941 . . . . 0.0 110.774 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -114.9 -17.22 11.59 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.459 -0.776 . . . . 0.0 110.279 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.477 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -57.51 139.24 53.89 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.888 -1.133 . . . . 0.0 109.91 -178.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.948 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -88.19 115.06 25.41 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.841 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.758 ' N ' HD22 ' A' ' 27' ' ' LEU . 84.6 p -76.3 141.22 41.69 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.369 -0.832 . . . . 0.0 109.404 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.92 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 24.6 p90 -145.81 156.74 43.77 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.31 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.581 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -110.21 174.52 5.82 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.198 -0.939 . . . . 0.0 109.321 -179.704 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -67.4 151.09 48.03 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.093 -1.004 . . . . 0.0 109.315 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 71.38 -7.4 6.4 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -74.77 143.42 44.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.965 -1.314 . . . . 0.0 109.68 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -97.52 139.48 33.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.749 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.658 ' HE3' HG11 ' A' ' 63' ' ' VAL . 3.9 mtm -135.89 152.44 51.02 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.588 0.709 . . . . 0.0 109.744 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.608 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 17.2 ttmt -104.81 125.75 51.18 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 11' ' ' ASP . 2.7 t -75.72 132.18 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.192 -0.943 . . . . 0.0 109.431 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 46' ' ' LYS . 12.3 mt -110.94 -48.54 3.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.199 -0.938 . . . . 0.0 109.649 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 1.8 pt-20 -143.27 91.94 2.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.161 -0.962 . . . . 0.0 109.051 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.588 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 0.8 OUTLIER -78.68 114.89 18.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.697 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.626 ' HB2' HD21 ' B' ' 186' ' ' LEU . 4.2 m-70 -82.47 -101.71 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.372 -0.83 . . . . 0.0 109.113 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -136.33 -12.87 1.05 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.555 ' HB2' ' HD3' ' B' ' 183' ' ' PRO . 0.8 OUTLIER -153.15 -19.76 0.15 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.026 -1.279 . . . . 0.0 110.544 -179.668 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.873 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 66.8 m95 -137.43 99.93 4.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.868 -1.145 . . . . 0.0 109.395 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.623 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -88.22 146.97 25.08 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.133 -0.979 . . . . 0.0 109.851 -179.879 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -93.81 105.67 17.69 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.171 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.79 -177.96 3.52 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.298 -0.876 . . . . 0.0 110.281 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.631 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -123.73 128.07 49.07 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.644 -0.66 . . . . 0.0 109.684 -179.49 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.597 ' HB2' ' HB3' ' A' ' 54' ' ' LYS . 1.1 t -74.45 126.95 31.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.124 -0.985 . . . . 0.0 109.884 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 50' ' ' LEU . 32.9 mt -72.23 -7.43 49.26 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.5 tp -53.58 -54.92 30.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.529 -0.732 . . . . 0.0 109.287 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.596 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 2.6 t -161.08 29.08 0.14 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.278 -0.889 . . . . 0.0 109.955 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 52' ' ' THR . 12.6 mttm 86.93 45.46 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.552 -0.718 . . . . 0.0 110.585 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.631 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 3.6 tttm -85.17 132.29 34.31 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -123.22 117.01 24.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.929 -1.107 . . . . 0.0 109.17 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.661 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -159.27 166.03 34.55 Favored Glycine 0 N--CA 1.486 1.988 0 C-N-CA 118.966 -1.588 . . . . 0.0 110.55 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.782 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 8.1 m-85 -71.97 134.1 45.74 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.752 -0.852 . . . . 0.0 109.714 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.593 HD12 HG21 ' A' ' 63' ' ' VAL . 13.7 pt -123.29 144.53 43.96 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.304 -0.873 . . . . 0.0 108.841 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.632 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 43.2 Cg_endo -67.54 142.92 60.8 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.915 1.743 . . . . 0.0 111.597 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.525 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 32.4 p -74.67 6.05 4.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.189 -0.944 . . . . 0.0 110.737 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.42 ' OD1' ' C ' ' A' ' 61' ' ' ASN . 0.1 OUTLIER -108.41 -51.72 2.86 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.808 -1.183 . . . . 0.0 110.484 -179.208 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.602 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 5.8 m-30 -49.68 -61.26 2.22 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.19 -0.944 . . . . 0.0 111.271 -178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.707 HG12 ' HA ' ' A' ' 15' ' ' ALA . 13.3 m -78.32 156.32 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.096 -1.002 . . . . 0.0 111.321 -177.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 1.024 ' CB ' HD11 ' A' ' 16' ' ' LEU . . . -135.74 163.5 30.03 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.497 ' HA ' HG12 ' A' ' 13' ' ' VAL . 3.7 ptpt . . . . . 0 N--CA 1.488 1.469 0 O-C-N 120.977 -1.077 . . . . 0.0 109.373 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 0.604 HD22 ' HE1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.682 0.753 . . . . 0.0 109.519 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.873 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.3 Cg_endo -69.14 -175.29 0.96 Allowed 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.944 2.429 . . . . 0.0 111.568 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . 0.756 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.1 Cg_endo -90.36 -29.75 0.17 Allowed 'Trans proline' 0 C--O 1.213 -0.742 0 C-N-CA 122.928 2.419 . . . . 0.0 114.471 -177.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.756 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 51.1 mtt180 81.97 95.34 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.227 -0.921 . . . . 0.0 109.212 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.62 ' CG ' HD22 ' B' ' 186' ' ' LEU . 43.6 Cg_endo -67.41 128.41 18.24 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.852 2.368 . . . . 0.0 111.806 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 42.47 66.87 0.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.182 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' B' ' 184' ' ' ALA . 0.6 OUTLIER 43.08 43.91 3.96 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.368 -0.833 . . . . 0.0 109.137 -179.465 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . 0.626 HD21 ' HB2' ' A' ' 41' ' ' HIS . 59.9 tp -55.67 -93.81 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . 0.782 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.483 1.767 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.501 ' O ' HG23 ' A' ' 37' ' ' VAL . 3.3 m-20 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.564 HD12 ' HG3' ' A' ' 36' ' ' LYS . 35.0 mm -105.27 136.09 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.927 . . . . 0.0 109.655 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.529 HG22 ' CG2' ' A' ' 37' ' ' VAL . 1.5 m -132.64 161.79 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 p -120.09 137.75 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.982 -1.074 . . . . 0.0 109.071 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.605 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -69.22 131.77 45.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.395 -0.816 . . . . 0.0 109.976 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.062 HD11 ' CB ' ' A' ' 64' ' ' ALA . 62.5 mt -97.77 -30.21 12.92 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.619 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 47.7 m-85 -131.74 143.32 48.63 Favored Pre-proline 0 N--CA 1.486 1.373 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.8 Cg_endo -62.34 149.39 90.94 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.692 2.261 . . . . 0.0 112.699 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.824 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 21.6 t80 -129.29 113.3 14.83 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -98.2 118.0 33.85 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 116.75 -1.98 . . . . 0.0 108.546 179.434 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -40.44 90.25 0.01 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.593 HG22 ' O ' ' A' ' 22' ' ' ILE . 2.4 mp -82.49 0.11 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 121.142 -1.211 . . . . 0.0 107.815 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.549 ' HB3' ' CD ' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -121.66 -172.55 0.24 Allowed Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.372 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.549 ' CD ' ' HB3' ' A' ' 23' ' ' HIS . 52.0 Cg_endo -90.86 -17.89 1.22 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.218 1.945 . . . . 0.0 112.602 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -117.53 -12.09 10.4 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.389 -0.819 . . . . 0.0 111.09 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.48 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 9.5 m-20 -58.52 142.56 48.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.927 -1.108 . . . . 0.0 110.708 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.018 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -98.93 122.68 42.5 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.959 ' N ' HD22 ' A' ' 27' ' ' LEU . 15.9 m -76.92 137.53 39.15 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -0.925 . . . . 0.0 110.655 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.824 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 30.5 p90 -143.75 154.74 43.77 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.555 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -111.54 166.04 11.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.979 -1.076 . . . . 0.0 109.656 -179.35 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.23 151.37 15.88 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.248 -0.907 . . . . 0.0 108.792 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.17 -7.69 3.18 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 9.0 tt0 -73.47 144.41 46.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.931 -1.335 . . . . 0.0 109.798 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.891 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -98.13 139.07 34.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 0.0 109.894 -179.708 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.608 ' SD ' HG21 ' A' ' 58' ' ' ILE . 4.6 mtm -134.89 151.08 50.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.578 -0.701 . . . . 0.0 109.662 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -103.05 121.05 41.77 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.504 -0.748 . . . . 0.0 109.252 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.529 ' CG2' HG22 ' A' ' 13' ' ' VAL . 1.8 t -82.7 124.1 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.369 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.2 mt -99.4 -44.88 6.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.137 -0.977 . . . . 0.0 109.608 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -148.25 97.22 2.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.891 . . . . 0.0 109.157 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.637 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -78.72 122.76 26.41 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.38 -0.825 . . . . 0.0 109.618 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.696 ' HB2' HD21 ' B' ' 186' ' ' LEU . 43.4 m-70 -83.01 -101.77 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.342 -0.849 . . . . 0.0 109.223 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.34 -16.28 1.37 Allowed Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.366 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.581 ' CG ' ' HD2' ' B' ' 181' ' ' PRO . 0.0 OUTLIER -158.43 -16.99 0.07 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.913 -1.345 . . . . 0.0 110.755 -179.531 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 1.019 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 64.3 m95 -132.74 94.86 3.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.942 -1.099 . . . . 0.0 108.601 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.637 ' CD1' ' CG ' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -88.47 147.55 24.61 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.028 -1.045 . . . . 0.0 110.096 -179.114 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.7 OUTLIER -94.46 107.39 19.36 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.601 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -105.41 -175.41 2.79 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.273 -0.892 . . . . 0.0 110.23 -179.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -126.18 130.98 52.06 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.667 -0.645 . . . . 0.0 109.905 -179.207 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.64 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -77.06 128.34 34.29 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.157 -0.964 . . . . 0.0 109.698 179.476 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.891 HD12 ' O ' ' A' ' 34' ' ' LYS . 1.2 mp -73.95 -7.21 51.52 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 49.2 tp -53.89 -54.46 38.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.399 -0.813 . . . . 0.0 109.32 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 2.8 t -160.88 29.16 0.15 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.267 -0.896 . . . . 0.0 110.036 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.587 ' CB ' ' O ' ' A' ' 52' ' ' THR . 17.4 mttp 85.91 42.98 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.528 -0.733 . . . . 0.0 110.879 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.681 ' HB3' HD23 ' A' ' 27' ' ' LEU . 7.4 mmtt -85.41 133.0 34.13 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -123.36 120.8 34.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.976 -1.078 . . . . 0.0 109.332 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.666 ' HA3' ' CB ' ' A' ' 27' ' ' LEU . . . -159.72 166.11 34.81 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.27 -1.443 . . . . 0.0 110.133 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.732 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 9.2 m-85 -70.19 133.3 46.94 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.64 -0.918 . . . . 0.0 109.437 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.608 HG21 ' SD ' ' A' ' 35' ' ' MET . 6.1 pt -121.97 136.68 26.46 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.311 -0.868 . . . . 0.0 108.717 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.6 ' HG3' ' CD2' ' B' ' 179' ' ' LEU . 50.0 Cg_endo -69.39 138.62 39.44 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.269 1.98 . . . . 0.0 112.325 -178.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.55 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 23.6 t -71.46 0.97 7.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 110.202 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.681 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 6.5 p-10 -95.45 -49.66 5.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.964 -1.085 . . . . 0.0 110.233 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 1.174 ' CE2' HD21 ' B' ' 179' ' ' LEU . 11.6 m-30 -61.11 -56.94 15.0 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.337 -0.852 . . . . 0.0 111.211 -178.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 15' ' ' ALA . 3.7 m -79.19 157.29 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 122.175 0.988 . . . . 0.0 111.443 -177.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 1.062 ' CB ' HD11 ' A' ' 16' ' ' LEU . . . -138.05 163.0 32.69 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.519 ' HA ' HG12 ' A' ' 13' ' ' VAL . 19.0 ttmm . . . . . 0 N--CA 1.489 1.488 0 O-C-N 121.036 -1.04 . . . . 0.0 109.17 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 1.174 HD21 ' CE2' ' A' ' 62' ' ' TYR . 25.0 mt . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 121.494 0.664 . . . . 0.0 109.689 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 1.019 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.1 Cg_endo -66.29 170.94 11.14 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.508 2.139 . . . . 0.0 111.254 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . 0.592 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 56.1 Cg_endo -79.05 -34.29 1.22 Allowed 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 122.903 2.402 . . . . 0.0 114.154 -177.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.711 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.1 OUTLIER 78.27 84.26 0.09 OUTLIER Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 120.982 -1.074 . . . . 0.0 108.711 -178.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 51.1 Cg_endo -71.65 139.27 33.68 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.791 2.328 . . . . 0.0 112.125 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . 0.483 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 38.6 62.23 1.06 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.504 -0.747 . . . . 0.0 109.582 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . 0.484 ' N ' ' ND2' ' B' ' 185' ' ' ASN . 0.6 OUTLIER 44.68 48.58 8.78 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.273 -0.892 . . . . 0.0 109.157 -179.699 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . 0.696 HD21 ' HB2' ' A' ' 41' ' ' HIS . 56.2 tp -64.92 -83.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.413 -0.804 . . . . 0.0 109.352 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . 0.732 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.485 1.948 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.544 ' O ' HG13 ' A' ' 37' ' ' VAL . 73.4 m-20 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 19.9 mm -92.4 137.23 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.565 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.605 HG22 HG12 ' A' ' 37' ' ' VAL . 2.1 m -131.44 160.2 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.459 -0.776 . . . . 0.0 109.097 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.2 p -121.64 138.43 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 109.346 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.708 ' HB2' ' HE3' ' A' ' 35' ' ' MET . . . -70.04 132.03 45.25 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.26 -0.9 . . . . 0.0 109.747 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.075 HD11 ' CB ' ' A' ' 64' ' ' ALA . 28.3 mt -98.03 -13.61 20.97 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.57 ' CD1' ' O ' ' A' ' 16' ' ' LEU . 56.2 m-85 -155.46 152.7 25.16 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.579 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 42.6 Cg_endo -66.04 149.42 85.98 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 121.554 1.502 . . . . 0.0 109.589 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.866 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 20.6 t80 -102.34 -175.85 2.94 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.176 -1.41 . . . . 0.0 110.535 -178.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.735 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 31.2 m-20 -112.99 85.92 2.27 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.572 -0.705 . . . . 0.0 110.065 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.19 92.03 0.05 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.519 -1.832 . . . . 0.0 108.519 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.751 HD11 ' NH2' ' B' ' 182' ' ' ARG . 0.4 OUTLIER -107.75 -42.94 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.262 -1.14 . . . . 0.0 108.767 179.604 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.572 ' CE1' ' NH2' ' B' ' 182' ' ' ARG . 56.3 m80 -76.09 156.93 83.81 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.4 -13.23 35.23 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.156 1.904 . . . . 0.0 111.859 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -112.65 -13.78 13.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 110.462 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.468 ' OD2' ' OH ' ' A' ' 19' ' ' TYR . 43.2 m-20 -57.39 138.9 54.41 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.764 -1.21 . . . . 0.0 109.793 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.943 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -94.95 121.99 37.14 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.9 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.1 m -78.77 139.25 38.44 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.153 -0.967 . . . . 0.0 109.598 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.866 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 17.5 p90 -146.87 158.1 43.83 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.242 -0.911 . . . . 0.0 108.918 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.659 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 21.4 mtmm -111.79 174.33 5.93 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.138 -0.976 . . . . 0.0 109.41 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.512 ' HD3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -66.73 153.02 44.32 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.12 -0.988 . . . . 0.0 109.305 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.27 -7.96 4.27 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 15' ' ' ALA . 3.4 tt0 -74.53 144.03 44.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.918 -1.342 . . . . 0.0 109.615 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.484 ' HD3' HD13 ' A' ' 50' ' ' LEU . 2.6 ptpt -96.67 136.12 37.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.517 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.708 ' HE3' ' HB2' ' A' ' 15' ' ' ALA . 1.7 mpp? -137.85 153.69 49.57 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.415 0.626 . . . . 0.0 109.528 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.68 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 2.2 ttpt -110.87 125.42 53.61 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.377 -0.827 . . . . 0.0 109.004 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.605 HG12 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -87.65 128.43 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.9 . . . . 0.0 108.753 178.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 26.1 mt -88.58 -29.7 19.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 109.945 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -176.99 130.99 0.18 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.147 -0.971 . . . . 0.0 109.834 -179.444 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.654 ' HA ' ' CD1' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -78.53 132.44 37.2 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.441 -0.787 . . . . 0.0 109.162 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.656 ' CB ' HD11 ' B' ' 186' ' ' LEU . 18.7 m-70 -111.57 30.78 6.66 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.223 -0.923 . . . . 0.0 110.543 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.416 ' N ' ' OE2' ' A' ' 40' ' ' GLU . . . 108.73 -47.25 1.06 Allowed Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.516 -1.325 . . . . 0.0 110.744 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.444 ' HB2' ' HD3' ' B' ' 183' ' ' PRO . 0.0 OUTLIER -159.2 -5.9 0.07 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.023 -1.281 . . . . 0.0 110.388 -179.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.783 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 65.4 m95 -141.68 99.87 3.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.038 -1.039 . . . . 0.0 109.276 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.679 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -94.68 148.66 22.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.031 -1.043 . . . . 0.0 109.454 -179.621 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 17.7 tttt -88.56 109.11 19.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.256 -0.903 . . . . 0.0 108.973 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.68 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -100.97 178.6 4.62 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.449 -0.782 . . . . 0.0 109.863 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 2.7 mttt -121.1 129.78 53.45 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.647 -0.658 . . . . 0.0 109.588 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.609 ' HB2' ' HB3' ' A' ' 54' ' ' LYS . 1.1 t -77.6 128.41 34.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 110.056 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.484 HD13 ' HD3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -72.92 -9.25 58.5 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 tp -52.32 -54.92 25.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.407 -0.808 . . . . 0.0 109.383 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.611 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 2.6 t -161.5 29.35 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 110.041 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.611 ' CB ' ' O ' ' A' ' 52' ' ' THR . 8.7 mmtm 86.68 44.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.502 -0.749 . . . . 0.0 110.488 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.609 ' HB3' ' HB2' ' A' ' 49' ' ' SER . 0.5 OUTLIER -85.0 133.25 34.26 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.183 -0.948 . . . . 0.0 108.488 178.61 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.93 114.34 20.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.923 -1.111 . . . . 0.0 109.215 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.618 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -152.57 169.21 31.69 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.366 -1.397 . . . . 0.0 109.89 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.711 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 7.7 m-85 -73.4 132.0 42.49 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.546 -0.973 . . . . 0.0 109.57 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 58' ' ' ILE . 11.0 pt -121.96 140.98 33.13 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.875 . . . . 0.0 109.069 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.597 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 49.2 Cg_endo -69.54 149.42 68.25 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.176 1.918 . . . . 0.0 112.094 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.523 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 21.2 t -77.57 7.78 5.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.328 -0.857 . . . . 0.0 110.656 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.74 -51.8 2.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.824 -1.173 . . . . 0.0 110.672 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.7 ' CE2' ' HA ' ' A' ' 19' ' ' TYR . 2.6 m-30 -48.96 -52.16 26.32 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.105 -0.997 . . . . 0.0 110.83 -178.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.561 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.7 m -88.91 155.52 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -0.972 . . . . 0.0 111.19 -178.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 1.075 ' CB ' HD11 ' A' ' 16' ' ' LEU . . . -134.09 162.38 32.25 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.505 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 3.2 ptmt . . . . . 0 N--CA 1.49 1.545 0 O-C-N 120.954 -1.091 . . . . 0.0 109.344 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 0.628 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 121.685 0.755 . . . . 0.0 109.802 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.783 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.4 Cg_endo -68.96 -172.3 0.48 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.068 2.512 . . . . 0.0 111.326 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . 0.804 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 52.7 Cg_endo -91.48 -35.17 0.06 OUTLIER 'Trans proline' 0 C--O 1.212 -0.783 0 C-N-CA 122.788 2.325 . . . . 0.0 114.694 -177.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.804 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 32.4 mtt180 87.83 96.27 0.03 OUTLIER Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.314 -0.866 . . . . 0.0 109.013 -178.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 47.4 Cg_endo -68.78 124.56 11.62 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.76 2.306 . . . . 0.0 111.904 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' B' ' 185' ' ' ASN . . . 45.69 67.4 0.74 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.862 . . . . 0.0 109.495 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' B' ' 184' ' ' ALA . 14.9 m-20 43.08 50.5 5.5 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.354 -0.841 . . . . 0.0 109.535 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . 0.656 HD11 ' CB ' ' A' ' 41' ' ' HIS . 47.7 tp -67.6 -83.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.296 -0.877 . . . . 0.0 109.507 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . 0.711 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.485 1.953 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.709 HD12 ' HA ' ' A' ' 36' ' ' LYS . 5.2 tp -109.61 136.64 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.183 -0.948 . . . . 0.0 109.46 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.0 m -131.77 160.2 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.35 -0.844 . . . . 0.0 109.186 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' HG3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -119.64 138.7 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.068 -1.02 . . . . 0.0 109.302 179.121 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.768 ' HB2' ' HE3' ' A' ' 35' ' ' MET . . . -72.14 133.67 45.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.451 -0.781 . . . . 0.0 109.946 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.053 HD11 ' HB2' ' A' ' 64' ' ' ALA . 7.6 mt -99.79 -8.31 24.35 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.59 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 27.6 m-85 -162.29 151.94 13.49 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.771 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 39.2 Cg_endo -62.19 149.16 91.58 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 121.733 1.622 . . . . 0.0 110.05 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.848 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 57.0 t80 -98.63 178.23 5.06 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 118.364 -1.335 . . . . 0.0 110.764 -177.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.68 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 6.4 m-20 -109.22 79.95 1.27 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.47 94.44 0.04 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.409 ' N ' ' O ' ' A' ' 20' ' ' ASP . 21.2 mt -107.17 -42.93 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.108 -1.231 . . . . 0.0 108.803 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.53 ' ND1' ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -76.04 152.69 84.47 Favored Pre-proline 0 C--N 1.3 -1.563 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.53 ' HD2' ' ND1' ' A' ' 23' ' ' HIS . 43.9 Cg_endo -66.68 -11.42 31.8 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.299 1.999 . . . . 0.0 111.567 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.87 -14.68 13.49 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.89 . . . . 0.0 110.215 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' B' ' 187' ' ' GLY . 26.4 m-20 -58.07 142.17 47.73 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.883 -1.135 . . . . 0.0 109.784 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.908 HD22 ' N ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -98.55 122.21 41.46 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.908 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -78.03 139.77 39.12 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.327 -0.858 . . . . 0.0 109.449 179.669 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.848 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 24.3 p90 -145.29 156.74 44.0 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.232 -0.917 . . . . 0.0 108.74 178.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.691 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 3.2 tttp -111.18 174.28 5.94 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.172 -0.955 . . . . 0.0 109.539 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.584 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -67.37 151.85 46.72 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.108 -0.995 . . . . 0.0 109.346 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.96 -7.65 4.15 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -74.79 141.89 44.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.04 -1.271 . . . . 0.0 109.611 -179.735 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.634 ' HG3' HG13 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -95.86 138.61 33.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.89 . . . . 0.0 109.298 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.768 ' HE3' ' HB2' ' A' ' 15' ' ' ALA . 3.7 mpp? -133.2 149.63 52.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.53 -0.731 . . . . 0.0 109.88 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.709 ' HA ' HD12 ' A' ' 12' ' ' ILE . 12.2 mtpt -104.78 119.77 39.8 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.463 -0.773 . . . . 0.0 109.256 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -78.05 109.43 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.342 -0.849 . . . . 0.0 108.887 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 mt -88.15 -40.22 13.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.905 . . . . 0.0 109.991 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -134.99 97.47 3.75 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.032 -1.043 . . . . 0.0 109.158 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.7 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 0.7 OUTLIER -79.89 113.62 18.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.245 -0.91 . . . . 0.0 109.298 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -106.33 -121.1 0.23 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.499 ' HA3' ' HG3' ' B' ' 183' ' ' PRO . . . -85.5 -124.58 1.43 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' B' ' 180' ' ' PRO . 7.0 mt-10 -78.46 10.33 3.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -1.104 . . . . 0.0 111.102 -178.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.866 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 64.6 m95 -141.1 98.1 3.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.528 -1.357 . . . . 0.0 109.824 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.7 ' HB3' ' HA ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -92.97 145.24 24.52 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.826 -1.171 . . . . 0.0 110.197 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -85.77 108.06 17.91 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.754 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -100.54 -177.16 3.41 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.264 -0.898 . . . . 0.0 109.97 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -123.94 109.03 13.06 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.648 -0.658 . . . . 0.0 109.394 -179.663 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.617 ' N ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -54.77 127.84 30.18 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.167 -0.958 . . . . 0.0 109.861 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 52' ' ' THR . 0.1 OUTLIER -76.76 -11.46 59.84 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.222 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.512 ' C ' HG22 ' A' ' 52' ' ' THR . 4.5 tp -46.06 -20.9 0.11 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.722 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 0.5 OUTLIER 168.1 -21.72 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.371 -0.831 . . . . 0.0 109.935 179.123 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.722 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 140.84 42.48 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.528 -0.733 . . . . 0.0 110.046 179.595 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.683 ' HB3' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -85.67 134.36 33.98 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.131 -0.98 . . . . 0.0 108.424 178.4 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -121.67 114.16 20.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.909 -1.12 . . . . 0.0 109.439 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.625 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -152.49 172.46 31.65 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.677 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 6.8 m-85 -74.49 132.17 41.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.431 -1.04 . . . . 0.0 109.859 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.551 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 7.3 pt -121.42 138.24 27.97 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.667 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 48.6 Cg_endo -69.93 163.06 39.81 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 121.64 1.56 . . . . 0.0 112.01 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.564 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 82.8 p -90.89 8.25 35.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.389 -0.819 . . . . 0.0 110.095 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.91 -54.9 2.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.028 -1.045 . . . . 0.0 110.109 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.747 ' HE2' HD23 ' B' ' 179' ' ' LEU . 2.3 m-85 -47.24 -63.56 1.01 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.201 -0.937 . . . . 0.0 110.648 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.608 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.5 m -78.73 155.77 4.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.945 0.878 . . . . 0.0 110.96 -177.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 1.053 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -128.46 157.66 40.5 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp . . . . . 0 C--N 1.301 -1.525 0 O-C-N 120.948 -1.095 . . . . 0.0 109.583 -179.674 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 0.747 HD23 ' HE2' ' A' ' 62' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 121.597 0.713 . . . . 0.0 109.481 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.866 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 37.9 Cg_endo -67.24 -174.65 0.54 Allowed 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.922 2.415 . . . . 0.0 111.648 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . 0.751 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.8 Cg_endo -92.62 -23.69 0.33 Allowed 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 123.022 2.482 . . . . 0.0 114.617 -177.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.751 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 27.6 mtt180 76.47 96.73 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.876 -1.14 . . . . 0.0 109.048 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 45.3 Cg_endo -67.0 107.24 1.29 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.6 2.2 . . . . 0.0 111.408 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' B' ' 185' ' ' ASN . . . 60.65 68.56 0.74 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.306 -0.871 . . . . 0.0 108.864 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . 0.458 ' C ' ' O ' ' B' ' 184' ' ' ALA . 2.9 p30 41.15 49.18 3.14 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.46 -0.775 . . . . 0.0 109.468 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . 0.619 HD23 ' HB2' ' A' ' 44' ' ' TRP . 64.5 tp -68.67 -75.33 0.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.357 -0.84 . . . . 0.0 109.278 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . 0.677 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.484 1.838 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.558 ' O ' HG23 ' A' ' 37' ' ' VAL . 79.9 m-20 . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.679 HD11 ' HG3' ' A' ' 36' ' ' LYS . 24.2 mm -101.82 136.39 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.134 -0.979 . . . . 0.0 109.553 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.07 160.69 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.8 p -121.24 137.15 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.001 -1.062 . . . . 0.0 109.341 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -70.44 135.21 48.5 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.414 -0.804 . . . . 0.0 109.886 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.03 HD11 ' HB2' ' A' ' 64' ' ' ALA . 18.1 mt -97.73 -28.36 13.92 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.666 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 4.3 m-85 -141.27 155.79 67.78 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 39.7 Cg_endo -62.13 145.39 96.41 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 121.692 1.594 . . . . 0.0 110.73 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.72 ' O ' ' CB ' ' A' ' 20' ' ' ASP . 23.7 t80 -70.36 -76.45 0.1 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.448 -0.782 . . . . 0.0 112.102 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.72 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 6.0 m-20 127.03 72.46 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -178.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.57 82.77 0.01 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.189 -1.165 . . . . 0.0 110.189 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.55 ' N ' ' O ' ' A' ' 20' ' ' ASP . 9.4 mm -99.56 0.96 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.979 -1.306 . . . . 0.0 108.226 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.498 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -122.64 152.6 62.14 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.753 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.25 -14.49 34.6 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.838 1.692 . . . . 0.0 111.986 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.73 -19.11 11.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.401 -0.812 . . . . 0.0 110.875 -178.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.498 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.8 OUTLIER -55.72 139.34 45.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.872 -1.142 . . . . 0.0 110.103 -178.773 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.967 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -87.79 117.32 26.55 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.315 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.887 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.8 m -76.87 138.7 39.93 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.331 -0.856 . . . . 0.0 110.216 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.705 ' CE2' ' HB2' ' A' ' 19' ' ' TYR . 10.6 p90 -143.38 154.77 44.07 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.683 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.8 OUTLIER -111.18 171.28 7.57 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.006 -1.058 . . . . 0.0 109.652 -179.291 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -63.15 152.19 38.04 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.201 -0.937 . . . . 0.0 109.081 179.792 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 68.02 -7.59 2.32 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.4 ' H ' ' C ' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -74.15 143.4 45.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.827 -1.396 . . . . 0.0 110.009 -179.461 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HE2' ' HB2' ' A' ' 34' ' ' LYS . 3.9 mppt? -95.22 137.14 34.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.34 -0.85 . . . . 0.0 109.457 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.571 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -136.13 151.88 50.24 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.611 -0.68 . . . . 0.0 109.813 -179.448 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.679 ' HG3' HD11 ' A' ' 12' ' ' ILE . 4.5 ttmt -109.87 126.79 54.21 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.455 -0.778 . . . . 0.0 109.776 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 11' ' ' ASP . 1.4 t -82.68 138.28 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.386 -0.821 . . . . 0.0 108.942 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.604 HD12 ' N ' ' A' ' 38' ' ' LEU . 6.3 mp -112.54 -31.0 6.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.07 -1.019 . . . . 0.0 109.927 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.03 96.08 1.2 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.184 -0.948 . . . . 0.0 109.303 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.579 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 1.0 OUTLIER -49.93 130.52 21.9 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.477 -0.764 . . . . 0.0 108.993 179.646 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.921 ' HB3' HD21 ' B' ' 186' ' ' LEU . 1.8 m-70 -128.51 102.12 6.48 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.486 ' C ' ' O ' ' A' ' 41' ' ' HIS . . . 41.18 -142.37 0.93 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.616 ' CB ' ' HD2' ' B' ' 181' ' ' PRO . 4.7 mt-10 -77.1 11.04 1.99 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -1.137 . . . . 0.0 110.707 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 1.053 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 64.5 m95 -137.4 100.36 4.21 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.668 -1.27 . . . . 0.0 109.67 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.58 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -94.44 149.27 21.41 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.817 -1.177 . . . . 0.0 110.215 -179.616 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -95.52 110.96 22.96 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.112 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -107.33 -175.3 2.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.177 -0.952 . . . . 0.0 110.297 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 9.9 ttpt -125.14 130.75 52.83 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.646 -0.659 . . . . 0.0 109.595 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.626 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -76.35 128.21 34.4 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 109.735 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.48 -6.11 46.46 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.8 tp -55.9 -54.73 41.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.455 -0.778 . . . . 0.0 109.259 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.606 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 1.3 t -160.45 29.68 0.16 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.143 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.606 ' HB2' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 85.25 43.03 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.466 -0.771 . . . . 0.0 111.09 178.199 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.76 ' HB3' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -86.42 132.5 33.93 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.474 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 12.9 pt-20 -122.62 118.91 29.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.937 -1.102 . . . . 0.0 109.387 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.678 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -155.6 166.57 32.85 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.013 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.745 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 7.0 m-85 -71.87 134.97 46.4 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.7 -0.883 . . . . 0.0 109.695 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.517 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 3.0 pt -124.55 144.89 47.53 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.406 -0.809 . . . . 0.0 109.148 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.613 ' HG3' ' CD2' ' B' ' 179' ' ' LEU . 47.1 Cg_endo -69.31 162.67 40.91 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 121.977 1.785 . . . . 0.0 111.393 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.531 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 98.2 p -92.13 8.98 35.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.016 -1.052 . . . . 0.0 110.894 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.575 ' OD1' ' C ' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -112.08 -51.7 2.83 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.765 -1.209 . . . . 0.0 110.153 -179.581 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 1.141 ' CE2' HD21 ' B' ' 179' ' ' LEU . 1.3 m-85 -44.66 -62.22 1.28 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.163 -0.961 . . . . 0.0 110.787 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.571 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.9 m -79.64 156.7 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 122.104 0.954 . . . . 0.0 111.486 -177.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 1.03 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -133.35 161.22 35.1 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.9 tttp . . . . . 0 N--CA 1.489 1.519 0 O-C-N 120.995 -1.066 . . . . 0.0 109.395 179.956 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 1.141 HD21 ' CE2' ' A' ' 62' ' ' TYR . 30.1 mt . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 121.443 0.639 . . . . 0.0 109.657 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 1.053 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.3 Cg_endo -65.92 177.08 3.18 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.781 2.321 . . . . 0.0 111.83 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . 0.617 ' O ' ' CB ' ' B' ' 182' ' ' ARG . 53.9 Cg_endo -73.65 -48.01 0.26 Allowed 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.933 2.422 . . . . 0.0 113.873 -177.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.709 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.0 OUTLIER 84.81 91.78 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.151 -0.968 . . . . 0.0 108.946 -178.724 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.692 ' HG2' ' HB2' ' B' ' 186' ' ' LEU . 43.9 Cg_endo -69.07 129.66 18.74 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 123.085 2.523 . . . . 0.0 112.326 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 38.21 67.03 0.43 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.477 -0.764 . . . . 0.0 109.464 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . 0.484 ' N ' ' ND2' ' B' ' 185' ' ' ASN . 0.5 OUTLIER 42.93 43.47 3.56 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.357 -0.84 . . . . 0.0 109.026 -179.55 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . 0.98 HD23 ' HB2' ' A' ' 44' ' ' TRP . 42.4 tp -54.27 -94.54 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . 0.745 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 107.474 -2.25 . . . . 0.0 107.474 178.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.571 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 36' ' ' LYS . 17.6 mm -92.93 136.67 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 109.618 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.87 HG12 ' HD3' ' A' ' 65' ' ' LYS . 1.1 m -132.14 161.8 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.6 p -120.97 139.2 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.137 -0.977 . . . . 0.0 109.075 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.671 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.05 132.92 45.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.346 -0.846 . . . . 0.0 109.807 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.081 HD11 ' CB ' ' A' ' 64' ' ' ALA . 24.4 mt -98.66 -11.97 21.51 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.584 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 54.8 m-85 -159.55 153.69 19.96 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.701 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 42.0 Cg_endo -64.55 149.09 90.49 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 121.672 1.582 . . . . 0.0 109.983 179.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.816 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 56.4 t80 -97.79 178.6 5.09 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 118.303 -1.359 . . . . 0.0 110.265 -177.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.682 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 12.2 m-20 -109.47 80.66 1.34 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.56 -0.713 . . . . 0.0 109.322 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.51 95.38 0.06 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.6 mt -108.5 -42.24 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.157 -1.202 . . . . 0.0 108.896 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.48 ' HB2' ' CG ' ' A' ' 26' ' ' ASP . 3.4 m-70 -76.98 159.6 78.19 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -71.11 -12.12 29.89 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.141 1.894 . . . . 0.0 111.778 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -113.86 -14.94 12.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 110.869 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.48 ' CG ' ' HB2' ' A' ' 23' ' ' HIS . 90.7 m-20 -57.19 139.47 52.54 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.719 -1.238 . . . . 0.0 109.955 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.896 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -93.77 120.86 34.58 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.005 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.855 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -80.68 141.41 34.93 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.351 -0.843 . . . . 0.0 109.595 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.816 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 30.5 p90 -146.05 157.79 43.86 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.181 -0.949 . . . . 0.0 108.599 178.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.671 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 6.4 mttt -110.7 173.7 6.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.147 -0.97 . . . . 0.0 109.594 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.552 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -67.43 151.43 47.42 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.141 -0.975 . . . . 0.0 109.314 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.96 -8.25 4.79 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -75.84 143.63 41.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.953 -1.322 . . . . 0.0 109.755 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.31 138.95 33.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 109.509 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.576 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 2.5 mpp? -134.91 151.47 50.91 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.564 -0.71 . . . . 0.0 109.761 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 8.3 ttpp -105.15 124.13 49.0 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.507 -0.745 . . . . 0.0 109.53 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.808 ' C ' HD12 ' A' ' 38' ' ' LEU . 2.2 t -81.13 136.97 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.297 -0.877 . . . . 0.0 109.216 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.808 HD12 ' C ' ' A' ' 37' ' ' VAL . 7.1 mp -111.85 -43.36 3.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 109.648 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.05 106.35 3.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.124 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.654 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 0.7 OUTLIER -89.98 118.03 29.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.333 -0.855 . . . . 0.0 109.539 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.615 ' CG ' HD12 ' B' ' 186' ' ' LEU . 1.8 m-70 -81.83 -100.31 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.314 -0.866 . . . . 0.0 109.382 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.465 ' O ' ' HG2' ' A' ' 43' ' ' GLU . . . -133.34 -14.31 1.4 Allowed Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.664 -1.255 . . . . 0.0 110.065 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 42' ' ' GLY . 6.0 mm-40 -157.52 -16.0 0.08 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.972 -1.31 . . . . 0.0 110.623 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.94 ' CD1' ' HA ' ' B' ' 182' ' ' ARG . 56.3 m95 -137.6 101.65 4.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.673 -1.267 . . . . 0.0 109.485 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.654 ' CD1' ' CG ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -93.32 144.4 25.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.206 -0.934 . . . . 0.0 110.211 -179.313 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 11.4 ttpt -90.08 108.08 19.51 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -102.8 -175.3 2.77 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.354 -0.841 . . . . 0.0 109.931 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 17.7 ttpt -125.88 130.43 51.31 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.605 -0.684 . . . . 0.0 109.31 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.595 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 6.9 t -75.84 126.78 31.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.072 -1.017 . . . . 0.0 109.963 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 50' ' ' LEU . 14.4 mt -70.81 -7.99 49.3 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.3 tp -53.94 -55.6 25.51 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.53 -0.731 . . . . 0.0 109.445 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.629 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.7 t -161.04 28.14 0.14 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 110.119 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.629 ' CB ' ' O ' ' A' ' 52' ' ' THR . 14.1 mtmm 87.38 44.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.414 -0.804 . . . . 0.0 110.687 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.595 ' HB2' ' CB ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -86.77 131.58 34.09 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.042 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.456 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 2.5 pt-20 -122.01 118.46 28.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.879 -1.138 . . . . 0.0 109.625 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.658 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -157.66 168.36 34.32 Favored Glycine 0 N--CA 1.487 2.068 0 C-N-CA 119.427 -1.368 . . . . 0.0 109.904 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.963 ' CD1' HD21 ' B' ' 186' ' ' LEU . 27.1 m-85 -70.98 132.39 45.1 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.57 -0.959 . . . . 0.0 109.883 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 58' ' ' ILE . 6.6 pt -121.08 141.64 33.26 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.654 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 46.6 Cg_endo -69.18 154.86 69.38 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 121.721 1.614 . . . . 0.0 111.836 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.621 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 73.7 p -83.96 7.12 19.35 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.364 -0.835 . . . . 0.0 110.252 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.13 -53.28 2.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.936 -1.102 . . . . 0.0 110.515 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.584 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 2.6 m-85 -48.44 -62.72 1.35 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.075 -1.016 . . . . 0.0 111.173 -178.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.576 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 3.0 m -78.11 155.5 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 122.079 0.942 . . . . 0.0 111.18 -177.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 1.081 ' CB ' HD11 ' A' ' 16' ' ' LEU . . . -136.02 163.29 30.64 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.87 ' HD3' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.046 -1.034 . . . . 0.0 109.228 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 0.608 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 121.823 0.82 . . . . 0.0 109.875 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.717 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 42.9 Cg_endo -72.44 -170.66 0.61 Allowed 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.976 2.451 . . . . 0.0 110.211 178.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . 0.766 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 51.6 Cg_endo -87.06 -67.54 0.01 OUTLIER 'Trans proline' 0 C--O 1.212 -0.79 0 C-N-CA 121.991 1.794 . . . . 0.0 112.198 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.94 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.8 OUTLIER 141.05 112.78 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.078 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.581 ' HG2' ' CB ' ' B' ' 186' ' ' LEU . 44.1 Cg_endo -67.45 127.14 15.97 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 123.04 2.493 . . . . 0.0 112.087 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . 0.491 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 37.99 52.88 1.57 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.378 -0.826 . . . . 0.0 109.375 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . 0.492 ' N ' ' ND2' ' B' ' 185' ' ' ASN . 0.2 OUTLIER 46.28 44.33 12.32 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.369 -0.832 . . . . 0.0 109.104 -179.526 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . 1.053 HD23 ' N ' ' B' ' 187' ' ' GLY . 7.8 tt -72.8 -82.83 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.479 -0.763 . . . . 0.0 108.97 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . 1.053 ' N ' HD23 ' B' ' 186' ' ' LEU . . . . . . . . 0 N--CA 1.48 1.616 0 N-CA-C 108.161 -1.976 . . . . 0.0 108.161 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.63 108.36 1.57 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.41 172.78 11.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -1.136 . . . . 0.0 109.332 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.38 136.93 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.189 -0.945 . . . . 0.0 109.54 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.59 HG12 ' HA ' ' A' ' 65' ' ' LYS . 1.8 m -131.51 160.42 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.372 -0.83 . . . . 0.0 108.929 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.8 p -121.12 137.64 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.965 -1.085 . . . . 0.0 109.295 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.751 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.04 134.51 47.15 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.445 -0.785 . . . . 0.0 110.108 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.64 ' CD1' ' HB2' ' A' ' 64' ' ' ALA . 42.1 mt -98.37 -14.97 19.9 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.642 ' CD2' ' CD ' ' B' ' 177' ' ' PRO . 4.7 m-85 -157.45 155.48 27.47 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.0 Cg_endo -62.42 146.05 95.67 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.58 1.52 . . . . 0.0 110.381 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.769 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 8.8 t80 -76.34 -68.76 0.56 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.222 -0.924 . . . . 0.0 112.04 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.758 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 40.9 t0 122.79 70.94 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -177.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -54.28 94.36 0.02 OUTLIER Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 20' ' ' ASP . 0.6 OUTLIER -105.0 -44.2 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.143 -1.21 . . . . 0.0 107.822 178.552 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.587 ' CE1' ' HA ' ' B' ' 188' ' ' GLU . 13.2 m-70 -75.48 156.35 85.24 Favored Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.6 -11.52 26.24 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.026 1.817 . . . . 0.0 111.994 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.69 -16.14 12.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.216 -0.927 . . . . 0.0 110.813 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.473 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 18.4 m-20 -57.24 138.89 54.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.839 -1.163 . . . . 0.0 110.422 -178.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.975 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -88.96 119.04 29.13 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.901 ' N ' HD22 ' A' ' 27' ' ' LEU . 4.8 p -77.79 138.03 38.76 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.224 -0.923 . . . . 0.0 110.179 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.769 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 8.1 p90 -143.78 155.24 44.09 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.751 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 7.2 mmtp -111.74 176.76 4.89 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.027 -1.046 . . . . 0.0 109.613 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.597 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -67.52 151.01 48.1 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.08 -1.013 . . . . 0.0 109.142 179.524 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.52 -7.76 3.55 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.749 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 1.1 mt-10 -74.75 144.15 43.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.868 -1.372 . . . . 0.0 109.938 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.519 ' CG ' HD13 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -95.78 138.08 33.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.0 109.406 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.53 ' CE ' HG11 ' A' ' 63' ' ' VAL . 0.9 OUTLIER -136.19 151.95 50.26 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.596 -0.69 . . . . 0.0 109.912 -179.423 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 4.5 ttpm? -105.87 124.27 49.31 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.442 -0.786 . . . . 0.0 109.498 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.523 ' CG2' HG22 ' A' ' 13' ' ' VAL . 2.0 t -80.98 137.23 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.359 -0.838 . . . . 0.0 108.92 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.1 mt -113.85 -39.48 3.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.113 -0.992 . . . . 0.0 109.688 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -150.82 91.43 1.72 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.939 . . . . 0.0 108.924 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.596 ' HG2' ' CD1' ' A' ' 45' ' ' TRP . 1.6 tm-20 -79.35 115.39 18.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.361 -0.837 . . . . 0.0 109.795 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.718 ' HB2' HD21 ' B' ' 186' ' ' LEU . 68.4 m-70 -79.08 -98.32 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.361 -0.837 . . . . 0.0 109.223 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.461 ' C ' ' HG2' ' A' ' 43' ' ' GLU . . . -143.33 -12.33 0.36 Allowed Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.664 -1.255 . . . . 0.0 110.197 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.554 ' O ' ' HG3' ' B' ' 180' ' ' PRO . 7.1 mm-40 -148.5 -25.57 0.33 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.002 -1.293 . . . . 0.0 110.171 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.779 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 64.9 m95 -135.5 102.85 5.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.947 -1.095 . . . . 0.0 109.568 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.611 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -90.8 141.66 28.57 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.075 -1.015 . . . . 0.0 109.985 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.528 ' HG2' ' C ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -90.5 106.53 18.56 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.13 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.52 -176.73 3.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.171 -0.956 . . . . 0.0 110.173 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 6.9 tttt -124.59 128.87 49.56 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.651 -0.656 . . . . 0.0 109.521 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.645 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -73.37 125.24 27.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.156 -0.965 . . . . 0.0 109.938 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.519 HD13 ' CG ' ' A' ' 34' ' ' LYS . 2.9 mp -71.22 -8.29 52.56 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 tp -53.72 -54.68 34.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.614 -0.679 . . . . 0.0 109.381 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.596 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 2.0 t -161.3 29.47 0.14 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 110.215 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.596 ' CB ' ' O ' ' A' ' 52' ' ' THR . 5.7 mtmt 86.31 44.0 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.403 -0.811 . . . . 0.0 110.585 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.645 ' HB2' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER -87.09 133.13 33.64 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.124 -0.985 . . . . 0.0 108.449 178.421 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 1.6 pt-20 -122.58 119.29 30.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.876 -1.14 . . . . 0.0 109.256 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.659 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -158.08 167.76 34.42 Favored Glycine 0 N--CA 1.487 2.092 0 C-N-CA 119.316 -1.421 . . . . 0.0 110.022 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.688 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 10.4 m-85 -73.61 133.03 43.4 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.57 -0.959 . . . . 0.0 110.009 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.516 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 4.0 pt -122.07 139.44 30.43 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.772 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 46.0 Cg_endo -68.6 145.77 65.12 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 121.878 1.719 . . . . 0.0 112.086 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.596 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 38.5 p -75.97 5.02 7.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.409 -0.807 . . . . 0.0 110.635 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.455 ' OD1' ' CG ' ' B' ' 177' ' ' PRO . 0.1 OUTLIER -105.72 -53.1 2.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.912 -1.117 . . . . 0.0 110.613 -179.186 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.622 ' CD2' ' HA ' ' A' ' 19' ' ' TYR . 4.0 m-85 -51.27 -60.73 2.8 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.116 -0.99 . . . . 0.0 110.788 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 15' ' ' ALA . 3.1 m -78.82 158.55 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 122.094 0.95 . . . . 0.0 111.302 -177.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.64 ' HB2' ' CD1' ' A' ' 16' ' ' LEU . . . -134.61 160.63 37.49 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.59 ' HA ' HG12 ' A' ' 13' ' ' VAL . 0.7 OUTLIER -74.35 150.16 40.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.916 -1.115 . . . . 0.0 109.422 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.4 tp -51.42 -27.91 11.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.43 -0.794 . . . . 0.0 110.012 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -77.29 -94.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.062 -1.024 . . . . 0.0 109.375 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.059 -1.026 . . . . 0.0 109.436 179.988 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 24.4 p90 . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . 0.588 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 1.4 t0 -167.25 -57.3 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.235 -0.916 . . . . 0.0 108.848 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 46.9 Cg_endo -67.51 -89.71 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.694 2.263 . . . . 0.0 111.867 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' GLY . . . . . . . . . . . . . . . 92.38 31.76 8.72 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.92 77.35 5.1 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.247 -1.149 . . . . 0.0 109.484 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . 0.5 ' O ' HG23 ' B' ' 176' ' ' THR . 50.5 Cg_endo -92.22 172.26 2.46 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.172 2.581 . . . . 0.0 111.836 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' THR . . . . . 0.568 ' CG2' ' HB3' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 173.47 101.09 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.346 -0.846 . . . . 0.0 109.437 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 177' ' ' PRO . . . . . 0.642 ' CD ' ' CD2' ' A' ' 17' ' ' TYR . 51.3 Cg_endo -71.89 159.2 51.11 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.668 2.246 . . . . 0.0 111.522 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . 0.407 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 48.0 Cg_endo -68.94 142.96 53.16 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.526 2.15 . . . . 0.0 111.242 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 0.563 HD22 ' HE1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -81.46 172.93 8.52 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.009 -1.057 . . . . 0.0 109.558 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.779 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.9 Cg_endo -70.69 -174.57 1.12 Allowed 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.902 2.401 . . . . 0.0 111.485 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . 0.721 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.1 Cg_endo -92.19 -23.04 0.41 Allowed 'Trans proline' 0 C--O 1.213 -0.726 0 C-N-CA 122.956 2.437 . . . . 0.0 114.347 -177.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.721 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 41.5 mtt180 78.41 95.62 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.001 -1.062 . . . . 0.0 109.197 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 42.4 Cg_endo -66.02 114.44 2.99 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.634 2.223 . . . . 0.0 111.735 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' B' ' 185' ' ' ASN . . . 56.15 50.81 12.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.423 -0.798 . . . . 0.0 109.584 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' B' ' 184' ' ' ALA . 9.5 m-80 60.26 45.82 10.94 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.155 -0.966 . . . . 0.0 109.426 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . 0.718 HD21 ' HB2' ' A' ' 41' ' ' HIS . 49.2 tp -65.36 -78.09 0.05 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.344 -0.848 . . . . 0.0 109.058 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . 0.688 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -73.08 2.01 37.49 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.587 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 16.6 mt-10 -81.2 -87.43 0.08 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.195 -1.18 . . . . 0.0 109.414 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 189' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.01 171.47 7.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.889 . . . . 0.0 109.49 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . 0.655 ' O ' ' HB3' ' B' ' 191' ' ' ALA . 36.9 mt-30 -66.88 99.67 0.65 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 109.505 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 191' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' B' ' 190' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.515 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.38 0.609 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.17 88.86 0.05 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.91 172.53 8.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.328 -1.101 . . . . 0.0 109.243 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.483 HD12 ' HG3' ' A' ' 36' ' ' LYS . 0.7 OUTLIER -112.07 137.24 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -0.962 . . . . 0.0 109.536 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.1 m -131.1 160.44 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.371 -0.831 . . . . 0.0 108.97 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.92 139.91 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.007 -1.058 . . . . 0.0 109.341 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.672 ' HB2' ' HE3' ' A' ' 35' ' ' MET . . . -73.36 133.31 43.77 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.448 -0.783 . . . . 0.0 109.989 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.761 HD11 ' HB2' ' A' ' 64' ' ' ALA . 79.6 mt -99.55 -15.2 18.71 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.615 ' CE1' ' HB2' ' A' ' 16' ' ' LEU . 1.0 OUTLIER -155.96 154.07 26.96 Favored Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.448 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.733 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.6 Cg_endo -63.3 150.13 89.41 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 121.823 1.682 . . . . 0.0 110.276 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.769 ' O ' ' CB ' ' A' ' 20' ' ' ASP . 39.6 t80 -93.32 -33.01 14.07 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.068 -1.453 . . . . 0.0 110.541 -178.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.769 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 29.9 t0 107.57 -53.67 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.431 -0.793 . . . . 0.0 110.446 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.4 ' HA3' ' OG ' ' A' ' 28' ' ' SER . . . 78.33 79.5 0.76 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 -177.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.3 mt -97.66 -46.03 12.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.61 ' CD2' ' O ' ' B' ' 188' ' ' GLU . 3.7 t60 -73.31 146.01 86.15 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.609 ' HD2' ' CD2' ' A' ' 23' ' ' HIS . 43.7 Cg_endo -66.28 -11.47 31.52 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 121.898 1.732 . . . . 0.0 111.342 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -114.1 -18.91 11.56 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.514 -0.741 . . . . 0.0 110.117 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.494 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.6 OUTLIER -57.81 144.23 39.31 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.004 -1.06 . . . . 0.0 109.919 -178.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.928 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -91.23 118.47 30.5 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.178 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.804 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -83.28 145.04 29.32 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.597 -0.69 . . . . 0.0 109.153 179.266 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.765 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 18.7 p90 -148.15 160.75 42.58 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.621 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 11.6 mmtt -111.34 172.22 7.01 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.069 -1.02 . . . . 0.0 109.504 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.597 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -66.55 152.2 45.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.201 -0.937 . . . . 0.0 109.392 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 71.84 -8.01 6.6 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -76.58 142.05 40.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.018 -1.284 . . . . 0.0 109.785 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.3 138.89 33.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.892 . . . . 0.0 109.204 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.672 ' HE3' ' HB2' ' A' ' 15' ' ' ALA . 3.2 mpp? -136.11 152.32 50.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.644 -0.66 . . . . 0.0 109.662 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 3.7 ttpm? -109.62 126.19 53.37 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.48 -0.763 . . . . 0.0 109.503 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -82.13 129.39 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.389 -0.819 . . . . 0.0 109.003 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.877 HD12 ' O ' ' A' ' 46' ' ' LYS . 1.1 mp -102.05 -44.18 5.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.113 -0.992 . . . . 0.0 109.785 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.1 103.51 3.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.164 -0.96 . . . . 0.0 109.085 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.604 ' HG2' ' CD1' ' A' ' 45' ' ' TRP . 1.8 tm-20 -81.08 127.31 32.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.357 -0.839 . . . . 0.0 109.656 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.755 ' CG ' HD11 ' B' ' 186' ' ' LEU . 63.9 m-70 -87.57 -105.56 0.07 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.348 -0.845 . . . . 0.0 109.182 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 43' ' ' GLU . . . -127.05 -19.83 1.91 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.574 ' HG3' ' CG ' ' B' ' 181' ' ' PRO . 1.1 mm-40 -157.24 -12.8 0.09 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.993 -1.298 . . . . 0.0 110.563 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 1.063 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 50.2 m95 -135.81 101.45 4.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.002 -1.061 . . . . 0.0 108.415 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.62 ' CZ2' ' CB ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -92.05 149.02 21.74 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.146 -0.971 . . . . 0.0 110.566 -178.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.877 ' O ' HD12 ' A' ' 38' ' ' LEU . 4.9 tttt -92.9 107.28 19.1 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.91 -173.68 2.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.248 -0.908 . . . . 0.0 110.003 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 1.1 tttt -126.96 131.16 51.14 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.55 -0.719 . . . . 0.0 109.587 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.607 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 4.9 t -77.25 127.9 33.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.078 -1.014 . . . . 0.0 109.895 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.24 -6.66 44.57 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.239 -0.913 . . . . 0.0 108.55 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 51' ' ' LEU . 11.0 tp -54.99 -55.61 28.9 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.345 -0.847 . . . . 0.0 109.228 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.627 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 2.7 t -160.13 28.57 0.17 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.244 -0.91 . . . . 0.0 110.157 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.627 ' HB2' ' O ' ' A' ' 52' ' ' THR . 0.1 OUTLIER 86.32 44.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.52 -0.738 . . . . 0.0 111.065 178.18 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.607 ' HB2' ' CB ' ' A' ' 49' ' ' SER . 1.6 mmpt? -86.61 131.99 34.01 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.15 119.27 30.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.934 -1.104 . . . . 0.0 109.577 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.696 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -159.81 170.5 36.0 Favored Glycine 0 N--CA 1.488 2.13 0 C-N-CA 119.54 -1.314 . . . . 0.0 109.914 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.632 ' CB ' ' HA2' ' B' ' 187' ' ' GLY . 5.2 m-85 -71.77 132.33 44.34 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.56 -0.965 . . . . 0.0 109.804 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.415 ' O ' HG13 ' A' ' 58' ' ' ILE . 9.0 pt -121.12 142.55 35.15 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.634 ' HG3' ' CD2' ' B' ' 179' ' ' LEU . 48.6 Cg_endo -70.69 154.45 64.07 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 121.775 1.65 . . . . 0.0 112.226 -178.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.62 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 79.6 p -82.88 6.44 18.44 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -0.903 . . . . 0.0 109.692 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.639 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 9.2 p-10 -106.23 -52.56 2.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.034 -1.041 . . . . 0.0 110.96 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 1.153 ' CE2' HD21 ' B' ' 179' ' ' LEU . 2.9 m-85 -52.1 -61.97 1.93 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.175 -0.953 . . . . 0.0 111.071 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.603 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.7 m -80.48 156.28 4.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 122.034 0.921 . . . . 0.0 111.122 -177.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.761 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -132.83 159.07 40.88 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.51 151.5 39.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.063 -1.023 . . . . 0.0 109.479 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 66' ' ' LEU . 16.7 tp -123.37 146.26 48.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.512 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -97.35 -84.5 0.37 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.179 -0.951 . . . . 0.0 109.494 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.453 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 16.7 m0 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . 0.616 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 10.5 t0 -172.63 -54.86 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.154 -0.966 . . . . 0.0 109.052 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 46.7 Cg_endo -66.87 -89.1 0.0 OUTLIER 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.593 2.195 . . . . 0.0 111.943 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' GLY . . . . . . . . . . . . . . . 98.66 36.11 4.67 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -162.14 99.75 1.15 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.4 -1.059 . . . . 0.0 109.432 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . 0.79 ' O ' HG23 ' B' ' 176' ' ' THR . 52.5 Cg_endo -77.0 -161.16 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.71 2.274 . . . . 0.0 111.738 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 176' ' ' THR . . . . . 0.79 HG23 ' O ' ' B' ' 175' ' ' PRO . 0.1 OUTLIER 164.58 113.73 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.458 -0.777 . . . . 0.0 109.227 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 177' ' ' PRO . . . . . 0.535 ' HD3' ' CE1' ' A' ' 17' ' ' TYR . 50.9 Cg_endo -77.83 171.47 17.28 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.659 2.239 . . . . 0.0 111.869 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.29 105.02 1.34 Allowed 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.686 2.257 . . . . 0.0 111.85 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 1.153 HD21 ' CE2' ' A' ' 62' ' ' TYR . 41.8 mt -47.2 160.78 0.33 Allowed Pre-proline 0 N--CA 1.487 1.383 0 O-C-N 121.292 -0.88 . . . . 0.0 109.957 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 1.063 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 41.4 Cg_endo -67.23 179.6 2.32 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 123.108 2.539 . . . . 0.0 111.269 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . 0.631 ' HD2' ' HB2' ' B' ' 180' ' ' PRO . 55.4 Cg_endo -75.74 -48.79 0.14 Allowed 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.697 2.264 . . . . 0.0 113.527 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.661 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.0 OUTLIER 80.59 81.66 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.07 -1.019 . . . . 0.0 108.879 -178.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 54.6 Cg_endo -74.06 141.64 29.93 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.784 2.323 . . . . 0.0 112.114 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 37.74 62.7 0.87 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.835 . . . . 0.0 109.688 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . 0.476 ' HB3' ' HB3' ' B' ' 188' ' ' GLU . 0.4 OUTLIER 43.05 48.14 5.22 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -0.888 . . . . 0.0 109.197 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . 0.755 HD11 ' CG ' ' A' ' 41' ' ' HIS . 63.6 tp -64.54 -79.71 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.379 -0.826 . . . . 0.0 109.472 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . 0.632 ' HA2' ' CB ' ' A' ' 57' ' ' PHE . . . -63.76 -12.53 48.05 Favored Glycine 0 N--CA 1.481 1.695 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.61 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 0.2 OUTLIER -75.57 -80.06 0.09 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.539 -0.977 . . . . 0.0 109.299 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 189' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -79.93 -176.53 5.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -0.871 . . . . 0.0 109.422 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . 0.497 ' HG3' ' N ' ' B' ' 191' ' ' ALA . 0.0 OUTLIER -123.01 -24.99 4.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.522 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 191' ' ' ALA . . . . . 0.497 ' N ' ' HG3' ' B' ' 190' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.406 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.358 0.599 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.539 ' HA3' ' CG1' ' A' ' 37' ' ' VAL . . . 115.66 -86.99 0.43 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.876 ' O ' HG23 ' A' ' 37' ' ' VAL . 9.5 m-20 64.09 -167.29 0.22 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -1.085 . . . . 0.0 109.929 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.811 HD12 ' HG2' ' A' ' 36' ' ' LYS . 18.8 mm -71.86 133.26 32.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.427 -0.796 . . . . 0.0 109.843 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.448 HG22 HG23 ' A' ' 37' ' ' VAL . 1.7 m -131.65 161.47 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.9 p -120.28 138.1 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.854 -1.154 . . . . 0.0 109.475 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.87 133.9 45.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.44 -0.788 . . . . 0.0 110.225 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.064 HD11 ' HB2' ' A' ' 64' ' ' ALA . 20.7 mt -98.89 -12.38 20.8 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.909 ' HB3' HG22 ' B' ' 176' ' ' THR . 39.9 m-85 -158.57 154.84 24.06 Favored Pre-proline 0 N--CA 1.487 1.386 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.713 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 41.2 Cg_endo -64.68 148.75 90.37 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 121.723 1.615 . . . . 0.0 109.721 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.799 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 51.7 t80 -97.68 177.12 5.59 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 118.188 -1.405 . . . . 0.0 110.388 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.683 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 4.3 t0 -109.8 79.07 1.18 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.673 -0.642 . . . . 0.0 109.655 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.69 86.37 0.01 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.601 ' N ' ' O ' ' A' ' 20' ' ' ASP . 40.7 mt -105.99 -0.5 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.057 -1.261 . . . . 0.0 109.63 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.637 ' CE1' ' CB ' ' B' ' 188' ' ' GLU . 59.4 m-70 -120.45 158.37 51.44 Favored Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.01 -18.54 46.21 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.178 1.919 . . . . 0.0 111.844 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.421 ' OD2' ' HD2' ' B' ' 189' ' ' ARG . 2.5 m-20 -111.77 -13.56 13.69 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.501 -0.749 . . . . 0.0 110.45 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -57.68 139.11 54.56 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.838 -1.164 . . . . 0.0 109.52 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.013 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -96.59 121.53 38.52 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.312 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.875 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -80.25 140.91 36.02 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.369 -0.832 . . . . 0.0 109.796 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.799 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 30.7 p90 -145.62 157.55 43.96 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 108.576 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.661 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.8 mttm -110.49 173.44 6.33 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.033 -1.042 . . . . 0.0 109.596 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.57 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -66.99 151.75 47.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.198 -0.939 . . . . 0.0 109.32 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.54 -8.09 4.46 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 4.4 tt0 -75.13 143.29 43.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.973 -1.31 . . . . 0.0 109.559 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -97.21 138.93 33.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 109.799 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.581 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 2.5 mpp? -137.5 153.51 50.02 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.811 ' HG2' HD12 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -106.64 129.19 54.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.454 -0.779 . . . . 0.0 109.287 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 11' ' ' ASP . 6.3 t -80.91 124.8 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.046 -1.034 . . . . 0.0 109.041 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.44 HD11 ' HG3' ' A' ' 48' ' ' LYS . 7.2 mt -101.62 -43.06 5.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.184 -0.948 . . . . 0.0 109.934 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 39' ' ' GLU . 1.2 pt-20 -145.58 97.57 3.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.133 -0.98 . . . . 0.0 109.306 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.615 ' HG3' ' CD1' ' A' ' 45' ' ' TRP . 3.5 tt0 -81.35 116.6 21.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.196 -0.94 . . . . 0.0 109.282 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.785 ' HB2' HD21 ' B' ' 186' ' ' LEU . 23.4 m-70 -85.0 -105.78 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.287 -0.883 . . . . 0.0 109.509 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.24 -16.59 1.71 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.525 ' HB2' ' HD3' ' B' ' 183' ' ' PRO . 16.6 mm-40 -153.92 -17.8 0.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.038 -1.272 . . . . 0.0 110.389 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.851 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 63.5 m95 -135.76 102.57 5.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.964 -1.085 . . . . 0.0 109.342 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.615 ' CD1' ' HG3' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -90.7 142.67 27.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.103 -0.998 . . . . 0.0 110.045 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.9 OUTLIER -91.84 105.77 17.96 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.063 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.81 -175.86 2.92 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.191 -0.943 . . . . 0.0 110.184 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.612 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -124.89 129.71 50.93 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.689 -0.632 . . . . 0.0 109.376 -179.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.663 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -74.77 125.83 29.61 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.097 -1.002 . . . . 0.0 109.943 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.27 -7.53 47.61 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.471 ' HA ' HD12 ' A' ' 51' ' ' LEU . 15.3 tp -53.78 -54.93 31.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.604 -0.685 . . . . 0.0 109.214 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.601 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 0.7 OUTLIER -161.38 29.54 0.13 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.264 -0.898 . . . . 0.0 109.994 179.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.601 ' CB ' ' O ' ' A' ' 52' ' ' THR . 5.7 mttp 86.45 44.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.454 -0.779 . . . . 0.0 110.423 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.663 ' HB2' ' HB3' ' A' ' 49' ' ' SER . 0.0 OUTLIER -85.94 132.46 34.07 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.335 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 20.0 pt-20 -122.84 120.32 33.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.933 -1.104 . . . . 0.0 109.103 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.661 ' HA3' ' CB ' ' A' ' 27' ' ' LEU . . . -162.58 165.72 36.33 Favored Glycine 0 N--CA 1.488 2.128 0 C-N-CA 119.105 -1.521 . . . . 0.0 110.253 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.641 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 8.5 m-85 -71.38 132.95 45.57 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.759 -0.847 . . . . 0.0 109.652 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.588 HD12 HG21 ' A' ' 63' ' ' VAL . 7.4 pt -121.91 143.14 37.87 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.77 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 44.2 Cg_endo -67.66 153.77 75.18 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.701 1.601 . . . . 0.0 111.614 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.528 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 65.5 p -82.71 6.77 16.91 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 110.783 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -110.31 -52.86 2.74 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.741 -1.224 . . . . 0.0 110.637 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.599 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 5.1 m-85 -49.08 -63.15 1.19 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.094 -1.004 . . . . 0.0 110.938 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.588 HG21 HD12 ' A' ' 58' ' ' ILE . 3.3 m -78.85 155.01 4.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 122.027 0.918 . . . . 0.0 110.935 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.064 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -133.14 161.53 34.17 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -75.95 150.59 37.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.093 -1.004 . . . . 0.0 109.479 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.521 ' O ' ' CB ' ' A' ' 67' ' ' ASN . 4.9 mt -75.86 -158.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.0 109.306 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 66' ' ' LEU . 7.1 t30 76.7 121.78 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.117 -0.989 . . . . 0.0 109.541 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.2 m . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.475 179.899 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.302 0.572 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . 0.605 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 0.8 OUTLIER -170.48 -56.27 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.213 -0.93 . . . . 0.0 108.804 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 47.9 Cg_endo -67.97 -89.79 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.717 2.278 . . . . 0.0 111.896 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' GLY . . . . . . . . . . . . . . . 83.38 15.51 71.3 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' MET . . . . . . . . . . . . . 1.4 mmt 51.13 91.35 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.389 -1.065 . . . . 0.0 109.325 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . 0.865 ' O ' HG23 ' B' ' 176' ' ' THR . 53.8 Cg_endo -77.52 -161.35 0.14 Allowed 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 122.616 2.211 . . . . 0.0 111.561 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 176' ' ' THR . . . . . 0.909 HG22 ' HB3' ' A' ' 17' ' ' TYR . 0.6 OUTLIER -177.24 102.54 0.22 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.623 -0.673 . . . . 0.0 109.356 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 177' ' ' PRO . . . . . 0.618 ' HD2' ' CD2' ' A' ' 17' ' ' TYR . 47.9 Cg_endo -69.66 156.97 62.18 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.703 2.269 . . . . 0.0 111.689 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.17 148.45 68.9 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.546 2.164 . . . . 0.0 111.263 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 0.586 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -86.03 173.93 6.24 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.122 -0.986 . . . . 0.0 109.622 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.851 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.4 Cg_endo -69.92 -175.0 1.05 Allowed 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.963 2.442 . . . . 0.0 111.457 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . 0.704 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.6 Cg_endo -91.31 -25.31 0.34 Allowed 'Trans proline' 0 C--O 1.213 -0.76 0 C-N-CA 122.856 2.371 . . . . 0.0 114.531 -177.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.711 ' CG ' ' CE2' ' A' ' 44' ' ' TRP . 39.4 mtt180 78.71 94.33 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 120.942 -1.098 . . . . 0.0 109.2 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.594 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 46.3 Cg_endo -67.58 118.5 5.64 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.664 2.243 . . . . 0.0 111.75 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . 53.83 57.59 5.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.255 -0.903 . . . . 0.0 109.3 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . 0.434 ' N ' ' ND2' ' B' ' 185' ' ' ASN . 1.1 m120 51.09 50.75 18.43 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.319 -0.863 . . . . 0.0 109.414 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . 0.785 HD21 ' HB2' ' A' ' 41' ' ' HIS . 62.0 tp -71.72 -80.54 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.306 -0.871 . . . . 0.0 109.508 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . 0.641 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -70.86 -3.13 49.63 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.637 ' CB ' ' CE1' ' A' ' 23' ' ' HIS . 10.5 mt-10 -75.69 -82.86 0.07 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.391 -1.064 . . . . 0.0 109.315 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 189' ' ' ARG . . . . . 0.456 ' CB ' ' O ' ' B' ' 188' ' ' GLU . 0.0 OUTLIER 72.5 85.64 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.385 -0.822 . . . . 0.0 109.556 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -86.65 145.82 26.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 0.0 109.402 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.53 179.947 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.296 0.569 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.85 38.51 0.02 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.549 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.4 OUTLIER -108.94 137.84 46.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.325 -1.103 . . . . 0.0 109.415 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.547 HD12 ' HG2' ' A' ' 36' ' ' LYS . 25.5 mm -100.89 137.0 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.163 -0.96 . . . . 0.0 109.553 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.17 161.76 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.463 -0.773 . . . . 0.0 108.951 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 p -121.23 139.06 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.006 -1.059 . . . . 0.0 109.317 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.08 133.68 46.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.364 -0.835 . . . . 0.0 109.697 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.089 HD11 ' HB2' ' A' ' 64' ' ' ALA . 55.7 mt -99.12 -12.86 20.11 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.984 ' HB3' HG22 ' B' ' 176' ' ' THR . 34.3 m-85 -158.35 154.19 23.15 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.719 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 42.0 Cg_endo -64.36 149.07 90.79 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 121.662 1.575 . . . . 0.0 110.055 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.834 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 54.2 t80 -97.86 177.93 5.29 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.324 -1.35 . . . . 0.0 110.405 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.686 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 0.7 OUTLIER -109.01 80.58 1.33 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.498 -0.751 . . . . 0.0 109.303 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.45 94.68 0.05 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 20' ' ' ASP . 18.1 mm -108.19 -42.02 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.303 -1.116 . . . . 0.0 108.807 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.608 ' CG ' ' O ' ' B' ' 188' ' ' GLU . 67.5 m-70 -77.45 158.15 79.36 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.89 -13.77 34.78 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.232 1.955 . . . . 0.0 111.811 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.74 -14.35 13.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.258 -0.902 . . . . 0.0 110.525 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.61 138.69 55.02 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.873 -1.142 . . . . 0.0 109.864 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.937 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -93.87 120.76 34.56 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.041 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.874 ' N ' HD22 ' A' ' 27' ' ' LEU . 10.1 p -79.92 140.74 36.57 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.365 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.834 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 21.9 p90 -145.94 157.66 43.88 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.14 -0.975 . . . . 0.0 108.535 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.653 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.5 OUTLIER -110.81 173.16 6.46 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.153 -0.967 . . . . 0.0 109.51 -179.44 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 7.8 pttm -67.09 152.02 46.54 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.183 -0.948 . . . . 0.0 109.38 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.42 -8.18 4.26 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.5 143.4 42.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.936 -1.332 . . . . 0.0 109.709 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.61 137.84 35.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 0.0 109.418 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.604 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 2.4 mpp? -135.01 151.79 51.13 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.492 0.663 . . . . 0.0 109.669 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.547 ' HG2' HD12 ' A' ' 12' ' ' ILE . 4.0 mttm -108.95 127.01 53.69 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.426 -0.797 . . . . 0.0 109.407 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.578 HG11 ' HG3' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -81.57 143.58 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.397 -0.814 . . . . 0.0 108.958 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.521 HD12 ' C ' ' A' ' 37' ' ' VAL . 7.8 mp -119.69 -40.89 2.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.064 -1.022 . . . . 0.0 109.833 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -140.38 92.13 2.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.16 -0.962 . . . . 0.0 108.96 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.6 ' HG2' ' CG ' ' A' ' 45' ' ' TRP . 1.9 mt-10 -74.09 120.37 19.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.479 -0.763 . . . . 0.0 109.536 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.74 ' HB2' HD21 ' B' ' 186' ' ' LEU . 47.7 m-70 -92.28 -106.49 0.11 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.235 -0.915 . . . . 0.0 109.555 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.36 -16.66 1.17 Allowed Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.179 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.513 ' HG2' ' HD2' ' B' ' 181' ' ' PRO . 0.5 OUTLIER -154.21 -17.04 0.13 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.968 -1.313 . . . . 0.0 110.351 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.822 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 59.8 m95 -136.97 101.73 4.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.038 -1.039 . . . . 0.0 109.155 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.6 ' CG ' ' HG2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -91.07 139.57 30.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.904 -1.122 . . . . 0.0 109.992 -179.679 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.7 OUTLIER -86.13 107.41 17.84 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -102.26 -177.86 3.53 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.289 -0.882 . . . . 0.0 110.233 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 9.8 tttm -123.45 107.97 12.17 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.605 ' N ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -54.1 127.02 24.95 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.11 -0.994 . . . . 0.0 109.925 -179.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 52' ' ' THR . 3.7 mt -75.84 -11.2 59.93 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.482 ' C ' HG22 ' A' ' 52' ' ' THR . 22.4 tp -46.05 -20.89 0.11 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.719 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 0.6 OUTLIER 168.15 -21.47 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.392 -0.817 . . . . 0.0 109.851 179.151 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.719 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 140.55 42.61 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.536 -0.727 . . . . 0.0 109.972 179.629 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.655 ' HB3' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -85.37 134.64 34.08 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.085 -1.01 . . . . 0.0 108.505 178.419 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.474 ' OE1' HD22 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -122.5 114.33 20.53 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.047 -1.033 . . . . 0.0 109.359 -179.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.644 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -155.52 168.85 33.29 Favored Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.416 -1.373 . . . . 0.0 109.959 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.658 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 8.9 m-85 -71.41 131.93 44.08 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.574 -0.957 . . . . 0.0 109.656 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.532 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 5.2 pt -120.86 139.63 29.42 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.743 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 46.8 Cg_endo -69.14 158.74 56.59 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 121.671 1.581 . . . . 0.0 111.948 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.515 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 79.5 p -86.44 7.08 27.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.334 -0.853 . . . . 0.0 110.387 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' B' ' 178' ' ' PRO . 0.1 OUTLIER -109.28 -53.77 2.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.903 -1.123 . . . . 0.0 110.441 -179.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.585 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 2.8 m-85 -47.93 -63.38 1.08 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.133 -0.979 . . . . 0.0 111.115 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.604 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 3.0 m -78.53 155.0 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.929 . . . . 0.0 110.968 -177.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.089 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -134.8 162.67 31.71 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.4 pttm -75.58 148.53 38.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.044 -1.035 . . . . 0.0 109.251 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.64 169.67 8.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 109.574 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' A' ' 68' ' ' THR . 20.3 t-20 -123.47 -94.06 0.5 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.284 -0.885 . . . . 0.0 109.347 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.508 ' N ' ' OD1' ' A' ' 67' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.456 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . 0.425 ' O ' ' CB ' ' B' ' 171' ' ' ASP . 10.7 m0 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . 0.57 ' N ' ' HD3' ' B' ' 172' ' ' PRO . 0.8 OUTLIER 170.03 59.75 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.297 -0.877 . . . . 0.0 108.975 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . 0.57 ' HD3' ' N ' ' B' ' 171' ' ' ASP . 51.6 Cg_endo -92.77 -82.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.106 2.537 . . . . 0.0 111.942 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' GLY . . . . . . . . . . . . . . . 125.67 68.31 0.18 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' MET . . . . . 0.566 ' N ' ' HD2' ' B' ' 175' ' ' PRO . 0.1 OUTLIER -66.25 -47.11 61.42 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.2 -1.176 . . . . 0.0 109.49 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . 0.869 ' O ' HG23 ' B' ' 176' ' ' THR . 55.3 Cg_endo -79.44 -162.49 0.18 Allowed 'Trans proline' 0 C--O 1.213 -0.75 0 C-N-CA 122.606 2.204 . . . . 0.0 111.606 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 176' ' ' THR . . . . . 0.984 HG22 ' HB3' ' A' ' 17' ' ' TYR . 1.1 p -170.15 99.46 0.45 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.573 -0.704 . . . . 0.0 109.315 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 177' ' ' PRO . . . . . 0.631 ' HD2' ' CD2' ' A' ' 17' ' ' TYR . 50.5 Cg_endo -69.34 160.83 48.3 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.814 2.342 . . . . 0.0 111.853 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . 0.525 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 49.4 Cg_endo -70.29 160.07 50.84 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.613 2.209 . . . . 0.0 111.222 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 0.614 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -94.0 174.83 3.42 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.1 -1.0 . . . . 0.0 109.761 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.822 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.7 Cg_endo -69.34 -173.43 0.66 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 123.049 2.499 . . . . 0.0 111.484 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . 0.737 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 53.1 Cg_endo -92.95 -26.5 0.18 Allowed 'Trans proline' 0 C--O 1.213 -0.732 0 C-N-CA 122.95 2.433 . . . . 0.0 114.441 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.737 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 43.3 mtt180 80.99 95.02 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.076 -1.015 . . . . 0.0 109.059 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.549 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 49.2 Cg_endo -69.98 135.98 31.29 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.745 2.297 . . . . 0.0 111.865 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 41.61 57.79 2.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 0.0 109.367 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 49.13 48.96 20.31 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.228 -0.92 . . . . 0.0 109.288 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . 0.74 HD21 ' HB2' ' A' ' 41' ' ' HIS . 48.4 tp -67.43 -87.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.408 -0.808 . . . . 0.0 109.319 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . 0.658 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -69.21 -5.63 49.5 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.608 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 2.9 tt0 -72.48 -68.77 0.45 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.426 -1.043 . . . . 0.0 109.434 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 189' ' ' ARG . . . . . 0.538 ' CB ' ' O ' ' B' ' 188' ' ' GLU . 0.0 OUTLIER 78.25 105.05 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.382 -0.824 . . . . 0.0 109.432 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . 0.631 ' O ' ' HB3' ' B' ' 191' ' ' ALA . 0.0 OUTLIER 175.06 -174.13 0.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.411 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 191' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' B' ' 190' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.519 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.48 145.26 30.21 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -130.93 154.34 48.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.305 -1.115 . . . . 0.0 109.396 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 36' ' ' LYS . 4.5 tp -99.23 138.84 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.164 -0.96 . . . . 0.0 109.451 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.603 HG22 ' CG2' ' A' ' 37' ' ' VAL . 0.8 OUTLIER -131.2 160.36 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.333 -0.855 . . . . 0.0 109.007 -179.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.0 p -120.5 138.98 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.017 -1.052 . . . . 0.0 109.353 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -72.53 134.81 45.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.411 -0.806 . . . . 0.0 109.842 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.801 HD11 ' HB2' ' A' ' 64' ' ' ALA . 69.4 mt -99.85 -22.4 15.33 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.916 ' HB3' HG22 ' B' ' 176' ' ' THR . 32.3 m-85 -147.48 153.1 43.41 Favored Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.696 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.7 Cg_endo -63.21 149.67 90.73 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 121.845 1.697 . . . . 0.0 110.089 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.824 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 57.0 t80 -98.81 178.73 4.88 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.268 -1.373 . . . . 0.0 110.524 -177.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.686 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -109.96 80.38 1.31 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.01 95.89 0.06 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 20' ' ' ASP . 75.9 mt -108.8 -42.21 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.117 -1.226 . . . . 0.0 108.86 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.643 ' CE1' ' HG3' ' B' ' 188' ' ' GLU . 88.5 m-70 -76.81 157.87 81.29 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.59 -12.74 33.88 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.129 1.886 . . . . 0.0 111.657 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -112.92 -14.51 13.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.894 . . . . 0.0 110.64 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.472 ' CG ' ' HB2' ' A' ' 23' ' ' HIS . 79.9 m-20 -57.53 139.81 52.42 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.762 -1.212 . . . . 0.0 109.783 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.886 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -95.1 121.53 36.83 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.159 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.869 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -80.07 140.49 36.46 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.448 -0.783 . . . . 0.0 109.491 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.824 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 25.7 p90 -145.39 156.95 44.09 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.163 -0.961 . . . . 0.0 108.676 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.637 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -110.64 173.32 6.39 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.151 -0.968 . . . . 0.0 109.596 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.555 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -67.26 151.49 47.41 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.186 -0.946 . . . . 0.0 109.322 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 71.51 -8.19 5.8 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.69 142.93 42.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.934 -1.333 . . . . 0.0 109.839 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.0 138.94 33.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 109.456 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.609 ' CE ' HG11 ' A' ' 63' ' ' VAL . 2.5 mpp? -135.49 151.62 50.54 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.577 -0.702 . . . . 0.0 109.82 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 82.4 tttt -105.29 123.24 47.52 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.424 -0.798 . . . . 0.0 109.428 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.846 HG11 ' OE2' ' A' ' 40' ' ' GLU . 2.0 t -81.82 115.96 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.362 -0.836 . . . . 0.0 109.052 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 38' ' ' LEU . 9.3 mp -92.01 -39.65 11.54 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.085 -1.01 . . . . 0.0 109.887 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -142.29 102.65 4.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.102 -0.999 . . . . 0.0 109.06 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.846 ' OE2' HG11 ' A' ' 37' ' ' VAL . 1.0 OUTLIER -85.41 118.53 25.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.391 -0.818 . . . . 0.0 109.498 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.651 ' HB2' HD21 ' B' ' 186' ' ' LEU . 68.3 m-70 -89.26 -103.13 0.09 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.287 -0.883 . . . . 0.0 109.367 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.44 ' O ' ' CD ' ' A' ' 43' ' ' GLU . . . -138.71 -13.71 0.71 Allowed Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.426 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.561 ' HG2' ' HD2' ' B' ' 181' ' ' PRO . 0.6 OUTLIER -155.57 -20.95 0.11 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.832 -1.393 . . . . 0.0 110.584 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.818 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 58.9 m95 -136.47 95.27 3.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.874 -1.142 . . . . 0.0 109.047 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.589 ' CG ' ' HG3' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -87.03 141.46 28.65 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.992 -1.067 . . . . 0.0 110.492 -179.184 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.8 OUTLIER -87.1 106.74 18.07 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -104.32 -173.23 2.26 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.287 -0.883 . . . . 0.0 110.179 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 4.3 tttp -127.28 131.37 50.53 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.5 -0.75 . . . . 0.0 109.452 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.668 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 1.3 t -77.17 128.09 33.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.002 -1.061 . . . . 0.0 109.885 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.87 -7.68 49.87 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 51' ' ' LEU . 9.4 tp -53.7 -55.8 22.95 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.35 -0.844 . . . . 0.0 109.348 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.623 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.4 t -160.69 28.42 0.15 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.229 -0.92 . . . . 0.0 110.149 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.623 ' CB ' ' O ' ' A' ' 52' ' ' THR . 31.0 mtmt 86.8 44.5 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.444 -0.785 . . . . 0.0 111.122 178.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.758 ' HB3' HD23 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -87.67 131.95 34.27 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 8.9 pt-20 -121.83 120.66 35.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.932 -1.105 . . . . 0.0 109.641 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.688 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -158.37 168.94 34.82 Favored Glycine 0 N--CA 1.487 2.1 0 C-N-CA 119.539 -1.315 . . . . 0.0 109.887 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.79 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 11.5 m-85 -71.27 133.71 46.27 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.546 -0.973 . . . . 0.0 109.884 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.562 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 2.9 pt -122.31 142.37 36.8 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.696 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 47.8 Cg_endo -70.85 159.41 52.69 Favored 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 121.562 1.508 . . . . 0.0 111.818 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.513 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 90.3 p -87.31 7.2 29.78 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 110.073 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' B' ' 178' ' ' PRO . 0.3 OUTLIER -107.97 -54.86 2.44 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.006 -1.059 . . . . 0.0 110.351 -179.369 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.703 ' HE2' HD23 ' B' ' 179' ' ' LEU . 3.5 m-85 -48.6 -63.28 1.13 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.167 -0.958 . . . . 0.0 111.151 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.609 HG11 ' CE ' ' A' ' 35' ' ' MET . 2.9 m -79.8 155.9 4.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.995 0.902 . . . . 0.0 111.133 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.801 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -132.3 160.47 36.15 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.439 ' HA ' HG12 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -75.83 152.31 37.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.999 -1.063 . . . . 0.0 109.463 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.89 72.02 4.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.888 . . . . 0.0 109.569 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -163.99 123.16 1.97 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.413 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . 0.406 ' O ' ' OD2' ' B' ' 171' ' ' ASP . 14.9 m0 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . 0.604 ' N ' ' HD3' ' B' ' 172' ' ' PRO . 0.6 OUTLIER 174.18 58.02 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.269 -0.894 . . . . 0.0 109.061 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . 0.604 ' HD3' ' N ' ' B' ' 171' ' ' ASP . 51.7 Cg_endo -93.65 -78.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.234 2.623 . . . . 0.0 111.843 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' GLY . . . . . 0.536 ' O ' ' CG ' ' B' ' 174' ' ' MET . . . 153.49 -20.88 0.72 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' MET . . . . . 0.553 ' N ' ' HD3' ' B' ' 175' ' ' PRO . 5.9 ptm 39.69 51.37 3.77 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.482 -1.011 . . . . 0.0 109.661 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . 0.635 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 54.7 Cg_endo -78.95 -161.88 0.16 Allowed 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 122.524 2.149 . . . . 0.0 111.639 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 176' ' ' THR . . . . . 0.916 HG22 ' HB3' ' A' ' 17' ' ' TYR . 5.6 p -152.41 91.94 3.52 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.402 -0.811 . . . . 0.0 109.202 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 177' ' ' PRO . . . . . 0.595 ' HD2' ' CD2' ' A' ' 17' ' ' TYR . 50.3 Cg_endo -69.19 173.99 9.66 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.759 2.306 . . . . 0.0 111.789 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . 0.523 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 49.4 Cg_endo -70.13 158.82 55.24 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.6 2.2 . . . . 0.0 111.313 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 0.703 HD23 ' HE2' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -97.56 176.81 1.87 Allowed Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 121.077 -1.015 . . . . 0.0 109.589 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.818 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 39.3 Cg_endo -67.96 -174.48 0.62 Allowed 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 123.042 2.494 . . . . 0.0 112.075 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . 0.638 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.6 Cg_endo -92.78 -29.0 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 123.252 2.635 . . . . 0.0 114.213 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.757 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.1 OUTLIER 84.23 104.95 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.162 -0.961 . . . . 0.0 109.877 -179.323 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.715 ' CG ' HD22 ' B' ' 186' ' ' LEU . 44.7 Cg_endo -69.29 124.94 11.79 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 123.022 2.481 . . . . 0.0 111.998 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 40.44 69.27 0.33 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.36 -0.838 . . . . 0.0 109.567 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . 0.534 ' HA ' ' HB3' ' B' ' 188' ' ' GLU . 0.0 OUTLIER 42.06 47.22 3.83 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.289 -0.882 . . . . 0.0 109.413 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . 0.737 HD23 ' HB2' ' A' ' 44' ' ' TRP . 31.6 tp -56.19 -94.81 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . 0.79 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -78.49 0.48 75.61 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.643 ' HG3' ' CE1' ' A' ' 23' ' ' HIS . 0.7 OUTLIER -69.77 -72.47 0.19 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.571 -0.958 . . . . 0.0 109.44 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 189' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' B' ' 185' ' ' ASN . 0.0 OUTLIER -169.04 134.24 1.57 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.415 -0.803 . . . . 0.0 109.315 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -130.65 175.0 9.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.284 -0.885 . . . . 0.0 109.502 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.526 -179.965 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.9 139.05 5.26 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -166.04 -178.96 4.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.343 -1.092 . . . . 0.0 109.416 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.697 HD13 ' HA ' ' A' ' 36' ' ' LYS . 21.6 mm -119.03 138.32 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.18 -0.95 . . . . 0.0 109.587 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.8 HG12 ' HA ' ' A' ' 65' ' ' LYS . 0.8 OUTLIER -132.21 161.91 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 p -120.83 140.45 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.936 -1.102 . . . . 0.0 109.463 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -72.79 133.87 44.69 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.336 -0.853 . . . . 0.0 109.566 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.995 HD11 ' HB2' ' A' ' 64' ' ' ALA . 84.3 mt -99.88 -15.51 18.35 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.628 ' CD2' ' HD3' ' B' ' 177' ' ' PRO . 3.5 m-85 -156.32 154.71 27.78 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.729 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.2 Cg_endo -63.45 149.05 92.13 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 121.903 1.735 . . . . 0.0 110.448 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.831 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 50.9 t80 -98.46 178.7 4.94 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.438 -1.305 . . . . 0.0 110.367 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.694 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 0.5 OUTLIER -109.66 80.65 1.34 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.631 -0.668 . . . . 0.0 109.291 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.95 94.58 0.05 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 20' ' ' ASP . 17.1 mm -108.28 -41.92 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.089 -1.242 . . . . 0.0 108.902 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.602 ' CG ' ' O ' ' B' ' 188' ' ' GLU . 20.5 m-70 -77.54 157.75 79.62 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.54 -13.32 35.03 Favored 'Trans proline' 0 C--O 1.213 -0.75 0 C-N-CA 122.271 1.981 . . . . 0.0 111.921 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 1.0 OUTLIER -112.11 -13.9 13.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.253 -0.904 . . . . 0.0 110.673 -179.069 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.449 ' CG ' ' HB2' ' A' ' 23' ' ' HIS . 84.4 m-20 -57.97 139.74 53.77 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.819 -1.176 . . . . 0.0 109.94 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.948 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -94.74 120.9 35.71 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.872 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -79.19 140.25 37.77 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.263 -0.898 . . . . 0.0 109.277 179.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.831 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 23.5 p90 -145.2 156.8 44.07 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.098 -1.001 . . . . 0.0 108.701 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.621 ' HG2' ' HB2' ' A' ' 33' ' ' GLU . 5.6 ptmt -110.81 173.24 6.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 109.319 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -66.59 151.96 46.27 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.983 -1.073 . . . . 0.0 109.482 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 71.76 -7.39 7.2 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.621 ' HB2' ' HG2' ' A' ' 30' ' ' LYS . 5.0 tp10 -76.15 142.62 41.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.892 -1.357 . . . . 0.0 109.944 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.481 ' HD2' HG21 ' A' ' 12' ' ' ILE . 1.4 ttpt -97.28 139.52 33.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.886 . . . . 0.0 109.382 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.673 ' CE ' HG11 ' A' ' 63' ' ' VAL . 2.0 mpp? -135.1 151.48 50.77 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.441 0.639 . . . . 0.0 109.735 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.697 ' HA ' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -104.39 123.47 47.49 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.546 -0.722 . . . . 0.0 109.163 179.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.607 ' CG2' HG22 ' A' ' 13' ' ' VAL . 2.2 t -81.43 114.1 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.29 -0.881 . . . . 0.0 109.088 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 38' ' ' LEU . 6.3 mp -90.23 -44.17 9.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 109.656 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -143.08 97.46 3.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.932 . . . . 0.0 108.921 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.565 ' HG3' ' CD1' ' A' ' 45' ' ' TRP . 3.3 tt0 -83.72 116.67 22.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.34 -0.85 . . . . 0.0 109.588 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.696 ' HB2' HD21 ' B' ' 186' ' ' LEU . 4.0 m-70 -78.27 -95.83 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.319 -0.863 . . . . 0.0 109.228 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.46 ' O ' ' CD ' ' A' ' 43' ' ' GLU . . . -148.38 -13.05 0.13 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.383 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.602 ' HB3' ' HD2' ' B' ' 181' ' ' PRO . 6.5 mm-40 -148.69 -26.38 0.31 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.969 -1.312 . . . . 0.0 110.008 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.933 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 47.8 m95 -134.02 102.26 5.35 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.17 -0.956 . . . . 0.0 108.768 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.636 ' CZ2' ' CB ' ' A' ' 60' ' ' SER . 0.1 OUTLIER -90.02 147.17 23.83 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.092 -1.005 . . . . 0.0 110.398 -179.129 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -96.06 108.2 20.6 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -105.65 -172.89 2.18 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 110.346 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -125.56 127.11 45.86 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.609 -0.682 . . . . 0.0 109.266 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.65 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -70.82 126.06 28.54 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.183 -0.948 . . . . 0.0 109.835 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.6 mp -72.18 -7.97 52.14 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.4 tp -54.25 -54.83 34.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.528 -0.733 . . . . 0.0 109.17 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.587 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 1.3 t -161.06 30.08 0.14 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.173 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 52' ' ' THR . 38.3 mmtt 85.78 45.49 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.499 -0.751 . . . . 0.0 110.661 178.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.65 ' HB2' ' HB3' ' A' ' 49' ' ' SER . 0.8 OUTLIER -87.05 132.29 33.85 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.137 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.501 ' CG ' ' HE3' ' A' ' 46' ' ' LYS . 15.4 tt0 -121.72 117.35 26.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.876 -1.14 . . . . 0.0 109.57 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.651 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -158.42 168.62 34.78 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.44 -1.362 . . . . 0.0 110.015 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.871 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 12.5 m-85 -73.66 135.15 43.72 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.679 -0.895 . . . . 0.0 110.16 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.588 HD12 HG21 ' A' ' 63' ' ' VAL . 7.4 pt -122.39 139.34 30.61 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.596 ' HB2' ' CD ' ' B' ' 180' ' ' PRO . 52.3 Cg_endo -72.6 131.96 18.14 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 121.519 1.479 . . . . 0.0 112.014 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.636 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 53.7 p -62.88 3.68 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.39 -0.819 . . . . 0.0 110.542 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.637 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 6.5 p-10 -98.36 -52.42 3.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.797 -1.189 . . . . 0.0 110.62 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 1.18 ' CE2' HD21 ' B' ' 179' ' ' LEU . 4.0 m-85 -57.28 -59.25 5.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.113 -0.992 . . . . 0.0 111.176 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.673 HG11 ' CE ' ' A' ' 35' ' ' MET . 3.2 m -79.78 159.9 4.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 122.024 0.916 . . . . 0.0 111.235 -177.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.995 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -133.93 157.83 45.01 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.8 ' HA ' HG12 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -74.34 152.2 39.63 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.053 -1.029 . . . . 0.0 109.562 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.429 ' O ' HG23 ' A' ' 68' ' ' THR . 6.9 tp -103.74 -80.31 0.53 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.518 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.409 ' C ' ' O ' ' A' ' 66' ' ' LEU . 2.0 p-10 -44.61 152.94 0.18 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.313 -0.867 . . . . 0.0 109.575 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 66' ' ' LEU . 11.2 p . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.56 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 1.5 m-90 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.246 0.546 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . 0.603 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 0.2 OUTLIER -170.83 -55.55 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.4 0 O-C-N 121.196 -0.94 . . . . 0.0 109.001 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 46.3 Cg_endo -67.42 -89.93 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.682 2.255 . . . . 0.0 111.996 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' GLY . . . . . . . . . . . . . . . 163.27 73.13 0.02 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' MET . . . . . 0.626 ' N ' ' CD ' ' B' ' 175' ' ' PRO . 0.1 OUTLIER -74.78 -40.79 4.12 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.399 -1.059 . . . . 0.0 109.94 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . 0.756 ' O ' HG23 ' B' ' 176' ' ' THR . 49.3 Cg_endo -92.76 166.77 2.66 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.073 2.515 . . . . 0.0 112.075 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 176' ' ' THR . . . . . 0.756 HG23 ' O ' ' B' ' 175' ' ' PRO . 0.1 OUTLIER 161.8 116.6 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.508 -0.745 . . . . 0.0 109.152 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 177' ' ' PRO . . . . . 0.628 ' HD3' ' CD2' ' A' ' 17' ' ' TYR . 49.9 Cg_endo -87.14 172.94 5.97 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.91 2.407 . . . . 0.0 111.986 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.08 120.96 7.79 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.745 2.297 . . . . 0.0 111.975 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 1.18 HD21 ' CE2' ' A' ' 62' ' ' TYR . 74.5 mt -60.25 153.33 58.64 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.468 -0.77 . . . . 0.0 109.88 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.933 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.8 Cg_endo -67.67 176.91 4.54 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.566 2.178 . . . . 0.0 111.5 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . 0.619 ' O ' ' CB ' ' B' ' 182' ' ' ARG . 56.1 Cg_endo -81.36 -37.57 0.28 Allowed 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.822 2.348 . . . . 0.0 114.029 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.718 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.4 OUTLIER 82.22 98.02 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 120.997 -1.065 . . . . 0.0 109.295 -179.006 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.71 ' CG ' HD22 ' B' ' 186' ' ' LEU . 45.4 Cg_endo -69.61 130.76 20.09 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 123.206 2.604 . . . . 0.0 112.329 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . 0.509 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 35.63 72.89 0.09 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.436 -0.79 . . . . 0.0 109.821 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . 0.508 ' OD1' ' NE2' ' B' ' 190' ' ' GLN . 0.7 OUTLIER 40.59 45.34 1.96 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.37 -0.831 . . . . 0.0 109.438 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . 0.715 HD23 ' HB2' ' A' ' 44' ' ' TRP . 34.4 tp -54.6 -94.54 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . 0.871 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -76.95 -4.06 82.13 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.602 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 0.1 OUTLIER -77.52 -74.05 0.27 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.475 -1.015 . . . . 0.0 109.268 179.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 189' ' ' ARG . . . . . 0.558 ' O ' ' CE1' ' A' ' 23' ' ' HIS . 6.9 ttt180 71.77 101.31 0.07 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.347 -0.846 . . . . 0.0 109.385 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . 0.508 ' NE2' ' OD1' ' B' ' 185' ' ' ASN . 0.0 OUTLIER -89.36 156.18 18.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.92 . . . . 0.0 109.529 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.917 -1.04 . . . . 0.0 109.579 179.935 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.321 0.582 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.15 142.08 3.29 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.566 ' O ' HG23 ' A' ' 37' ' ' VAL . 2.6 m-20 -127.7 142.5 51.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -1.126 . . . . 0.0 109.283 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.557 ' CD1' ' HG2' ' A' ' 36' ' ' LYS . 2.5 tp -91.02 138.64 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 0.0 109.663 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 65' ' ' LYS . 1.9 m -131.01 160.75 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.407 -0.808 . . . . 0.0 108.908 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.8 p -120.39 138.62 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.079 -1.013 . . . . 0.0 109.283 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.4 133.35 45.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.41 -0.806 . . . . 0.0 110.101 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.956 HD11 ' HB2' ' A' ' 64' ' ' ALA . 14.7 mt -98.59 -15.2 19.57 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.648 ' CD2' ' CD ' ' B' ' 177' ' ' PRO . 53.3 m-85 -155.0 153.87 27.99 Favored Pre-proline 0 N--CA 1.486 1.374 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.698 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 41.4 Cg_endo -64.48 149.59 89.72 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 121.75 1.633 . . . . 0.0 109.805 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.81 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 59.1 t80 -98.89 179.25 4.7 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.102 -1.439 . . . . 0.0 110.346 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.682 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 73.5 m-20 -110.37 80.78 1.34 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.525 -0.735 . . . . 0.0 109.303 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.82 94.95 0.05 OUTLIER Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 20' ' ' ASP . 69.0 mt -108.74 -41.54 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -1.173 . . . . 0.0 108.895 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.593 ' CD2' ' O ' ' B' ' 188' ' ' GLU . 0.2 OUTLIER -78.14 158.81 76.7 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.103 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.579 ' HD2' ' CD2' ' A' ' 23' ' ' HIS . 48.5 Cg_endo -69.67 -13.85 35.51 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.24 1.96 . . . . 0.0 111.91 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 4.4 t70 -112.28 -13.86 13.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 110.799 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.486 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.5 OUTLIER -57.84 139.6 53.75 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.74 -1.225 . . . . 0.0 109.817 -179.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.929 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -95.33 121.37 36.91 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.148 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.876 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -79.44 139.98 37.5 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.338 -0.851 . . . . 0.0 109.439 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.81 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 32.6 p90 -145.2 157.09 44.17 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.19 -0.944 . . . . 0.0 108.711 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.665 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 1.4 tttt -110.56 172.95 6.56 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.492 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.539 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -66.77 151.88 46.59 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.216 -0.927 . . . . 0.0 109.343 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.7 -7.95 4.77 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -75.88 143.6 41.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.957 -1.32 . . . . 0.0 109.765 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.76 ' HD2' HD13 ' A' ' 50' ' ' LEU . 1.1 ptpt -96.97 139.63 32.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.307 -0.871 . . . . 0.0 109.398 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.59 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 3.4 mpp? -134.52 150.89 50.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.627 -0.671 . . . . 0.0 109.841 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.557 ' HG2' ' CD1' ' A' ' 12' ' ' ILE . 30.5 mtpt -102.55 123.08 45.64 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.455 -0.778 . . . . 0.0 109.42 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 11' ' ' ASP . 3.1 t -81.14 134.71 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.166 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.4 mt -110.99 -43.3 3.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.144 -0.973 . . . . 0.0 109.703 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -149.2 93.13 2.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.178 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.646 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.1 tt0 -78.24 116.24 18.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.331 -0.855 . . . . 0.0 109.326 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.739 ' HB2' HD21 ' B' ' 186' ' ' LEU . 5.7 m-70 -79.81 -100.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.301 -0.874 . . . . 0.0 109.481 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.06 -11.63 1.04 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.693 -1.242 . . . . 0.0 110.114 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.546 ' O ' ' HG3' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -156.48 -19.15 0.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.061 -1.258 . . . . 0.0 110.594 -179.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.797 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 66.2 m95 -136.49 99.02 3.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.882 -1.136 . . . . 0.0 109.427 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.646 ' CD1' ' CG ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -89.17 142.14 27.91 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.005 -1.059 . . . . 0.0 110.037 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -92.03 107.0 18.89 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.121 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.29 -174.78 2.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.858 . . . . 0.0 110.238 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 27.1 ttmt -124.98 111.4 15.36 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.675 -0.641 . . . . 0.0 109.277 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.627 ' N ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -56.01 126.35 25.52 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.23 -0.919 . . . . 0.0 109.776 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.76 HD13 ' HD2' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -75.66 -11.25 59.97 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.129 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.515 ' C ' HG22 ' A' ' 52' ' ' THR . 1.5 tp -46.19 -20.9 0.12 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.724 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 0.5 OUTLIER 168.02 -21.87 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.009 179.148 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.724 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 140.93 41.89 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.431 -0.793 . . . . 0.0 110.18 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.735 ' HB3' HD23 ' A' ' 27' ' ' LEU . 3.6 mtmt -87.22 134.4 33.54 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.046 -1.034 . . . . 0.0 108.375 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -122.45 119.1 29.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.95 -1.093 . . . . 0.0 109.48 -179.609 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.669 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -159.87 168.92 35.73 Favored Glycine 0 N--CA 1.486 2.027 0 C-N-CA 119.365 -1.398 . . . . 0.0 110.124 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.744 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 10.4 m-85 -72.92 133.66 44.45 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.636 -0.92 . . . . 0.0 109.929 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.551 HD12 HG21 ' A' ' 63' ' ' VAL . 7.8 pt -121.89 140.8 32.7 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.738 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 48.4 Cg_endo -69.56 140.53 43.67 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 121.676 1.584 . . . . 0.0 111.976 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.612 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 32.6 p -71.43 5.42 2.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.344 -0.847 . . . . 0.0 110.68 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' B' ' 178' ' ' PRO . 0.1 OUTLIER -106.34 -53.28 2.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.794 -1.192 . . . . 0.0 110.58 -179.134 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.576 ' CE2' HD23 ' B' ' 179' ' ' LEU . 3.4 m-85 -50.99 -61.76 2.03 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.09 -1.006 . . . . 0.0 111.012 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.59 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 3.4 m -78.04 156.22 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.948 0.88 . . . . 0.0 111.235 -177.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.956 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -131.22 160.05 36.0 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.556 ' HA ' HG12 ' A' ' 13' ' ' VAL . 9.1 mttt -76.31 95.96 3.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.994 -1.066 . . . . 0.0 109.792 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.55 ' O ' HD23 ' A' ' 66' ' ' LEU . 6.0 tt -45.89 97.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 0.0 109.441 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 65' ' ' LYS . 38.6 t-20 -141.9 119.19 11.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.313 -0.867 . . . . 0.0 109.512 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 58.4 m . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.43 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . 0.594 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 2.2 t0 -170.75 -55.63 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.289 -0.882 . . . . 0.0 108.921 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 47.9 Cg_endo -68.1 -90.54 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.632 2.221 . . . . 0.0 111.956 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' B' ' 174' ' ' MET . . . 60.83 27.4 66.67 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' MET . . . . . 0.547 ' CB ' ' O ' ' B' ' 173' ' ' GLY . 1.1 ptp 160.5 117.03 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.331 -1.1 . . . . 0.0 109.307 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . 0.506 ' O ' HG23 ' B' ' 176' ' ' THR . 50.6 Cg_endo -90.76 171.37 3.38 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.144 2.563 . . . . 0.0 111.724 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 176' ' ' THR . . . . . 0.588 ' CG2' ' HB3' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 172.45 104.47 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.477 -0.764 . . . . 0.0 109.268 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 177' ' ' PRO . . . . . 0.648 ' CD ' ' CD2' ' A' ' 17' ' ' TYR . 46.4 Cg_endo -69.89 163.3 38.88 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.594 2.196 . . . . 0.0 111.478 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . 0.41 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 45.5 Cg_endo -67.77 141.49 54.53 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.668 2.245 . . . . 0.0 111.388 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 0.614 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -83.89 174.49 5.85 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.172 -0.955 . . . . 0.0 109.628 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.797 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 39.1 Cg_endo -69.58 -176.04 1.31 Allowed 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.111 2.54 . . . . 0.0 111.917 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . 0.638 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 53.7 Cg_endo -90.33 -22.54 0.74 Allowed 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 123.075 2.517 . . . . 0.0 114.697 -177.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.738 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.8 OUTLIER 77.5 91.26 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 120.772 -1.205 . . . . 0.0 109.237 -179.331 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.513 ' HD3' ' HB2' ' A' ' 43' ' ' GLU . 50.7 Cg_endo -70.79 134.99 26.98 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.907 2.404 . . . . 0.0 112.029 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 39.27 64.81 0.76 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.328 -0.858 . . . . 0.0 109.625 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . 0.514 ' HA ' ' HB2' ' B' ' 188' ' ' GLU . 3.1 m-80 43.86 49.73 7.01 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.34 -0.85 . . . . 0.0 109.476 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . 0.739 HD21 ' HB2' ' A' ' 41' ' ' HIS . 35.3 tp -66.32 -87.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.321 -0.862 . . . . 0.0 109.34 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . 0.744 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -65.16 -7.86 33.54 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.816 -1.713 . . . . 0.0 108.816 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.593 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 3.8 mt-10 -72.1 -90.35 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.335 -1.097 . . . . 0.0 109.377 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 189' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' B' ' 188' ' ' GLU . 0.0 OUTLIER 78.44 102.82 0.07 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.367 -0.833 . . . . 0.0 109.576 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . 0.478 ' HG2' ' NE2' ' A' ' 23' ' ' HIS . 6.1 mt-30 -137.36 72.13 1.41 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -0.929 . . . . 0.0 109.415 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.049 -0.976 . . . . 0.0 109.501 -179.997 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.363 0.601 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.3 171.81 50.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -158.66 -174.62 4.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.375 -1.074 . . . . 0.0 109.286 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.736 HD12 ' HD3' ' A' ' 36' ' ' LYS . 2.6 tp -111.99 137.08 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 109.529 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.576 HG22 HG23 ' A' ' 37' ' ' VAL . 1.4 m -132.83 161.79 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.385 -0.822 . . . . 0.0 109.161 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.7 p -120.26 138.84 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.97 -1.081 . . . . 0.0 109.219 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.64 133.65 45.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.327 -0.858 . . . . 0.0 109.896 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.979 HD11 ' HB2' ' A' ' 64' ' ' ALA . 25.4 mt -99.09 -12.1 20.83 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.815 ' HB3' HG23 ' B' ' 176' ' ' THR . 39.5 m-85 -158.63 155.07 24.4 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.7 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 42.2 Cg_endo -64.71 149.04 90.35 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 121.761 1.641 . . . . 0.0 109.887 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.826 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 59.9 t80 -98.82 178.86 4.84 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 118.373 -1.331 . . . . 0.0 110.415 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.758 ' OD2' HD21 ' B' ' 179' ' ' LEU . 6.2 p30 -110.21 80.29 1.3 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.584 -0.698 . . . . 0.0 109.522 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.61 95.86 0.05 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 20' ' ' ASP . 0.5 OUTLIER -108.96 -41.78 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.243 -1.151 . . . . 0.0 108.859 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.648 ' CD2' ' HA ' ' B' ' 188' ' ' GLU . 34.6 m-70 -77.72 159.41 76.69 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.33 -13.79 33.62 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.195 1.93 . . . . 0.0 111.804 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -112.37 -14.29 13.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.143 -0.973 . . . . 0.0 110.758 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.434 ' OD2' ' NH2' ' B' ' 182' ' ' ARG . 2.1 m-20 -57.32 139.06 53.99 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.825 -1.172 . . . . 0.0 109.646 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.951 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -94.66 121.26 36.05 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.113 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.892 ' N ' HD22 ' A' ' 27' ' ' LEU . 55.9 p -80.26 140.59 36.15 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.265 -0.897 . . . . 0.0 109.427 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.826 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 23.4 p90 -146.06 157.87 43.86 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.145 -0.972 . . . . 0.0 108.875 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.61 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -111.07 168.06 9.78 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.122 -0.987 . . . . 0.0 109.453 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.567 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -62.23 153.63 29.92 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.135 -0.978 . . . . 0.0 109.628 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.69 -8.11 3.5 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 5.2 tt0 -75.65 142.61 42.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.979 -1.307 . . . . 0.0 109.912 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.483 ' HB3' HD13 ' A' ' 50' ' ' LEU . 0.7 OUTLIER -96.2 139.28 32.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.227 -0.921 . . . . 0.0 109.312 179.701 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.603 ' CE ' HG11 ' A' ' 63' ' ' VAL . 2.6 mpp? -135.28 151.44 50.57 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.606 -0.684 . . . . 0.0 109.919 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.736 ' HD3' HD12 ' A' ' 12' ' ' ILE . 5.8 tppp? -105.07 124.13 49.0 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.533 -0.729 . . . . 0.0 109.186 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.576 HG23 HG22 ' A' ' 13' ' ' VAL . 6.7 t -81.03 132.73 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.855 . . . . 0.0 109.291 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.7 mt -107.7 -47.43 3.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.152 -0.968 . . . . 0.0 109.63 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -142.42 97.47 3.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.943 . . . . 0.0 108.936 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.616 ' HG2' ' CD1' ' A' ' 45' ' ' TRP . 2.3 tm-20 -84.17 116.66 23.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.359 -0.838 . . . . 0.0 109.653 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.809 ' HB2' HD21 ' B' ' 186' ' ' LEU . 7.1 m-70 -80.58 -98.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.433 -0.792 . . . . 0.0 109.458 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.26 -11.36 0.67 Allowed Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.32 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.566 ' O ' ' HG3' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -156.85 -18.78 0.09 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.879 -1.365 . . . . 0.0 110.413 -179.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.86 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 67.2 m95 -135.78 96.17 3.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.902 -1.124 . . . . 0.0 109.124 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.622 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -88.21 145.27 25.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.022 -1.049 . . . . 0.0 110.119 -179.253 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.6 OUTLIER -93.7 107.43 19.31 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.219 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -104.55 -173.96 2.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.296 -0.878 . . . . 0.0 110.094 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 2.7 ttpm? -125.46 126.84 45.56 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.59 -0.694 . . . . 0.0 109.459 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.657 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -70.92 126.5 29.74 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.111 -0.993 . . . . 0.0 110.03 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.483 HD13 ' HB3' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -72.24 -7.47 49.52 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 51' ' ' LEU . 27.8 tp -54.49 -55.05 33.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.503 -0.748 . . . . 0.0 109.253 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.5 t -161.16 29.69 0.14 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.122 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.587 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 86.36 45.85 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.482 -0.761 . . . . 0.0 110.671 178.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.657 ' HB2' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER -86.94 132.3 33.84 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.068 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.454 ' HG2' ' CE ' ' A' ' 46' ' ' LYS . 20.2 tt0 -121.59 116.38 24.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.942 -1.099 . . . . 0.0 109.353 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.635 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -157.13 169.26 34.19 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 119.385 -1.388 . . . . 0.0 110.032 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.724 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 11.0 m-85 -73.55 133.91 43.67 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.625 -0.926 . . . . 0.0 109.958 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 45' ' ' TRP . 2.6 pt -121.68 142.51 36.04 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.677 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 49.6 Cg_endo -69.93 152.0 68.3 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 121.792 1.661 . . . . 0.0 111.816 -178.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.543 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 66.1 p -80.81 5.67 15.27 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 110.006 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 4.4 p-10 -106.01 -52.48 2.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.997 -1.065 . . . . 0.0 110.941 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.882 ' CE1' HG22 ' B' ' 176' ' ' THR . 4.5 m-85 -52.63 -61.28 2.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.099 -1.001 . . . . 0.0 111.263 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.603 HG11 ' CE ' ' A' ' 35' ' ' MET . 2.6 m -79.83 155.49 4.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 122.069 0.938 . . . . 0.0 111.092 -177.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.979 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -133.61 161.05 35.68 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.61 150.53 37.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.0 -1.063 . . . . 0.0 109.537 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.501 ' O ' ' HB2' ' A' ' 67' ' ' ASN . 0.6 OUTLIER -126.2 -24.4 3.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.103 -0.998 . . . . 0.0 109.638 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER 75.59 -81.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.912 . . . . 0.0 109.516 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.437 -179.961 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . 0.5 ' O ' ' HB2' ' B' ' 171' ' ' ASP . 1.6 m-90 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . 0.562 ' N ' ' HD3' ' B' ' 172' ' ' PRO . 4.3 t0 172.68 59.62 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.295 -0.878 . . . . 0.0 108.637 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' B' ' 171' ' ' ASP . 54.8 Cg_endo -88.68 -88.42 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.855 2.37 . . . . 0.0 112.009 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' GLY . . . . . . . . . . . . . . . 133.0 -36.3 2.17 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 178.43 109.0 0.15 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.284 -1.127 . . . . 0.0 109.398 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . 0.533 ' HG2' ' CE1' ' A' ' 17' ' ' TYR . 50.8 Cg_endo -91.0 174.25 2.69 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.135 2.557 . . . . 0.0 111.819 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 176' ' ' THR . . . . . 0.882 HG22 ' CE1' ' A' ' 62' ' ' TYR . 0.0 OUTLIER 178.37 105.31 0.14 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 109.496 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 177' ' ' PRO . . . . . 0.633 ' CD ' ' CD2' ' A' ' 17' ' ' TYR . 50.8 Cg_endo -75.64 174.58 12.56 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.446 2.097 . . . . 0.0 111.656 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . 0.507 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 46.6 Cg_endo -68.24 137.69 40.98 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.613 2.208 . . . . 0.0 111.667 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 0.758 HD21 ' OD2' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -87.96 177.33 2.73 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.281 -0.887 . . . . 0.0 109.797 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.86 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 39.5 Cg_endo -68.92 -176.02 1.13 Allowed 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 123.03 2.487 . . . . 0.0 111.991 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . 0.739 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 52.0 Cg_endo -92.74 -20.57 0.49 Allowed 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 123.28 2.653 . . . . 0.0 114.661 -177.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.756 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.0 OUTLIER 78.75 89.9 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 120.873 -1.142 . . . . 0.0 109.175 -179.106 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.576 ' HG2' HD22 ' B' ' 186' ' ' LEU . 49.1 Cg_endo -70.41 137.43 33.55 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.804 2.336 . . . . 0.0 112.039 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 37.26 60.87 1.0 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.424 -0.797 . . . . 0.0 109.562 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 46.91 47.71 15.44 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.154 -0.966 . . . . 0.0 109.125 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . 0.809 HD21 ' HB2' ' A' ' 41' ' ' HIS . 20.5 tp -61.18 -84.93 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.517 -0.739 . . . . 0.0 109.427 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . 0.724 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -76.55 32.79 1.39 Allowed Glycine 0 N--CA 1.486 1.988 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.648 ' HA ' ' CD2' ' A' ' 23' ' ' HIS . 31.0 mt-10 -103.98 -73.18 0.68 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.282 -1.128 . . . . 0.0 109.466 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 189' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.38 165.83 5.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.391 -0.818 . . . . 0.0 109.413 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -101.57 31.2 3.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.472 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.461 -179.984 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.471 ' HA ' ' OE1' ' A' ' 9' ' ' GLN . 44.4 mm-40 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.89 -99.29 0.43 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.24 -176.12 5.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -1.181 . . . . 0.0 109.444 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.16 137.55 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.296 -0.877 . . . . 0.0 109.523 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 m -131.79 161.3 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 0.0 109.279 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.5 p -120.13 139.99 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.126 -0.984 . . . . 0.0 109.186 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -73.1 133.06 44.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.475 -0.765 . . . . 0.0 110.122 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.044 HD11 ' HB2' ' A' ' 64' ' ' ALA . 8.7 mt -100.1 -14.01 18.75 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 1.027 ' HB3' HG22 ' B' ' 176' ' ' THR . 34.1 m-85 -155.84 150.47 20.31 Favored Pre-proline 0 N--CA 1.489 1.476 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.722 ' HD3' ' HG3' ' A' ' 31' ' ' LYS . 39.6 Cg_endo -61.09 149.03 91.11 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 121.718 1.612 . . . . 0.0 109.742 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.793 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 60.9 t80 -97.95 178.23 5.18 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.041 -1.464 . . . . 0.0 110.525 -177.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.679 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 30.6 t0 -109.75 80.46 1.32 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.673 -0.642 . . . . 0.0 109.408 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.63 93.22 0.03 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.524 HG12 ' O ' ' A' ' 20' ' ' ASP . 0.6 OUTLIER -107.26 -42.81 6.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.142 -1.21 . . . . 0.0 108.675 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.655 ' CD2' ' HA ' ' B' ' 188' ' ' GLU . 59.0 m-70 -76.86 156.43 82.54 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.97 -13.94 37.61 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.287 1.991 . . . . 0.0 111.998 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -111.71 -13.72 13.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.341 -0.85 . . . . 0.0 110.493 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.481 ' OD2' ' OH ' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -57.97 140.52 52.09 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.827 -1.171 . . . . 0.0 109.989 -179.316 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.96 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -95.62 122.11 38.03 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.077 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.879 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -80.54 140.48 35.81 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.203 -0.935 . . . . 0.0 109.282 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.793 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 29.9 p90 -146.99 158.27 43.87 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.124 -0.985 . . . . 0.0 109.042 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.667 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 16.4 mttp -111.69 174.61 5.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.165 -0.959 . . . . 0.0 109.41 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.722 ' HG3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -66.54 155.88 36.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.875 -1.141 . . . . 0.0 109.428 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 67.71 -6.75 2.51 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -75.24 140.51 43.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.86 -1.377 . . . . 0.0 109.573 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.9 138.99 32.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.532 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.581 ' CE ' HG11 ' A' ' 63' ' ' VAL . 3.5 mpp? -135.83 152.14 50.77 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.473 0.654 . . . . 0.0 109.753 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.9 OUTLIER -108.6 126.14 52.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.459 -0.776 . . . . 0.0 109.313 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.554 HG11 ' HG3' ' A' ' 40' ' ' GLU . 3.9 t -82.14 126.31 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.357 -0.839 . . . . 0.0 109.37 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.496 HD11 ' OE2' ' A' ' 55' ' ' GLU . 36.8 mt -99.33 -46.57 5.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.924 . . . . 0.0 109.429 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.5 90.62 2.58 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.596 ' HG2' ' CD1' ' A' ' 45' ' ' TRP . 1.4 tt0 -76.55 117.67 18.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.4 -0.812 . . . . 0.0 109.965 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.464 ' CD2' HD11 ' B' ' 186' ' ' LEU . 14.2 m-70 -87.34 -98.8 0.08 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.336 -0.853 . . . . 0.0 109.074 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.07 -7.52 0.11 Allowed Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.328 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.565 ' HB2' ' HD3' ' B' ' 183' ' ' PRO . 3.0 mp0 -149.43 -29.52 0.25 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.957 -1.32 . . . . 0.0 110.098 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.819 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 67.7 m95 -137.7 97.32 3.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 109.328 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.596 ' CD1' ' HG2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -88.42 146.64 25.12 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.976 -1.078 . . . . 0.0 110.147 -179.718 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.572 ' HG3' ' CD1' ' A' ' 57' ' ' PHE . 0.7 OUTLIER -93.15 107.07 18.94 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -104.75 -173.39 2.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.211 -0.931 . . . . 0.0 110.045 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.606 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -125.73 129.27 49.16 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.57 -0.706 . . . . 0.0 109.664 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.62 ' HB2' ' HB3' ' A' ' 54' ' ' LYS . 1.2 t -74.07 128.08 34.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.0 109.882 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.63 -8.88 57.49 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 51' ' ' LEU . 15.3 tp -53.08 -55.11 26.39 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.41 -0.806 . . . . 0.0 109.329 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.596 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.8 t -161.24 29.61 0.14 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.094 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.596 ' CB ' ' O ' ' A' ' 52' ' ' THR . 3.9 mttm 86.59 45.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.356 -0.84 . . . . 0.0 110.607 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.62 ' HB3' ' HB2' ' A' ' 49' ' ' SER . 8.1 tttt -85.79 132.67 34.07 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.496 ' OE2' HD11 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -122.52 116.7 24.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.939 -1.101 . . . . 0.0 109.412 -179.696 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.636 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -157.62 169.09 34.44 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 119.459 -1.353 . . . . 0.0 109.972 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.855 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 6.3 m-85 -72.65 133.76 44.79 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.72 -0.871 . . . . 0.0 109.874 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.45 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 6.5 pt -121.97 143.6 39.13 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.754 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 50.1 Cg_endo -71.41 152.0 60.13 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 121.778 1.652 . . . . 0.0 112.176 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.477 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 28.1 t -80.32 6.26 12.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.314 -0.866 . . . . 0.0 110.81 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.554 ' ND2' ' O ' ' B' ' 178' ' ' PRO . 0.1 OUTLIER -108.99 -52.51 2.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.795 -1.19 . . . . 0.0 110.709 -179.147 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.62 ' HE2' HD23 ' B' ' 179' ' ' LEU . 3.9 m-85 -50.04 -62.59 1.49 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.043 -1.036 . . . . 0.0 110.9 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.581 HG11 ' CE ' ' A' ' 35' ' ' MET . 3.1 m -79.14 155.31 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 121.925 0.869 . . . . 0.0 111.086 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.044 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -130.76 159.56 36.94 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.429 ' O ' HD12 ' A' ' 66' ' ' LEU . 11.1 mtpt -75.96 94.33 3.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.037 -1.04 . . . . 0.0 109.57 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -138.78 151.3 46.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.636 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -172.61 157.65 3.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.322 -0.861 . . . . 0.0 109.43 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.104 -0.997 . . . . 0.0 109.443 -179.931 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 63.8 m95 . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . 0.592 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 4.9 m-20 -169.61 -56.43 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.251 -0.905 . . . . 0.0 108.845 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 48.0 Cg_endo -67.88 -90.28 0.0 OUTLIER 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.724 2.282 . . . . 0.0 111.841 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' GLY . . . . . . . . . . . . . . . 175.76 42.43 0.05 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' MET . . . . . 0.553 ' N ' ' CD ' ' B' ' 175' ' ' PRO . 0.5 OUTLIER -50.27 -47.45 82.58 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.193 -1.181 . . . . 0.0 109.459 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . 0.908 ' O ' HG23 ' B' ' 176' ' ' THR . 55.2 Cg_endo -81.59 -164.75 0.29 Allowed 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.733 2.289 . . . . 0.0 111.859 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 176' ' ' THR . . . . . 1.027 HG22 ' HB3' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -173.18 100.83 0.33 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.429 -0.795 . . . . 0.0 109.198 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 177' ' ' PRO . . . . . 0.602 ' HD2' ' CD2' ' A' ' 17' ' ' TYR . 50.9 Cg_endo -69.71 161.57 45.42 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.801 2.334 . . . . 0.0 111.965 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . 0.554 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 51.4 Cg_endo -70.07 159.83 51.76 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.717 2.278 . . . . 0.0 111.066 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 0.642 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -91.77 175.42 3.45 Favored Pre-proline 0 C--N 1.303 -1.421 0 O-C-N 121.007 -1.058 . . . . 0.0 109.778 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.819 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 40.2 Cg_endo -69.13 -172.15 0.48 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.268 2.645 . . . . 0.0 111.652 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . 0.686 ' O ' ' CB ' ' B' ' 182' ' ' ARG . 53.3 Cg_endo -88.54 -40.96 0.05 OUTLIER 'Trans proline' 0 C--O 1.214 -0.721 0 C-N-CA 122.679 2.253 . . . . 0.0 114.025 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.755 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 2.7 ttm180 91.49 92.92 0.03 OUTLIER Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.299 -0.875 . . . . 0.0 109.39 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.565 ' HD3' ' HB2' ' A' ' 43' ' ' GLU . 48.8 Cg_endo -71.99 133.99 22.59 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.996 2.464 . . . . 0.0 112.144 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 36.66 69.81 0.19 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.49 -0.757 . . . . 0.0 109.725 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . 0.453 ' C ' ' O ' ' B' ' 184' ' ' ALA . 2.9 p-10 39.46 45.42 1.27 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.417 -0.802 . . . . 0.0 109.44 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . 0.597 ' CG ' ' HB2' ' A' ' 44' ' ' TRP . 18.1 tp -53.82 -89.0 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.458 -0.776 . . . . 0.0 109.046 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . 0.855 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -82.02 26.05 3.94 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.655 ' HA ' ' CD2' ' A' ' 23' ' ' HIS . 1.5 tt0 -99.51 -30.85 11.92 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.251 -1.147 . . . . 0.0 109.423 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 189' ' ' ARG . . . . . 0.451 ' C ' ' HG2' ' B' ' 190' ' ' GLN . 0.0 OUTLIER 47.31 40.2 10.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 109.536 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' B' ' 188' ' ' GLU . 13.9 mm100 -145.42 84.95 1.7 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.94 . . . . 0.0 109.55 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.501 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.317 0.579 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.41 112.92 3.62 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.74 162.92 13.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.347 -1.09 . . . . 0.0 109.405 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.7 tp -107.9 137.87 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.142 -0.974 . . . . 0.0 109.59 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 65' ' ' LYS . 1.5 m -132.0 161.76 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.44 HG12 ' HB2' ' A' ' 66' ' ' LEU . 8.0 p -120.94 139.18 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.024 -1.047 . . . . 0.0 109.279 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.53 134.55 46.57 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.395 -0.816 . . . . 0.0 109.731 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.712 ' CD1' ' HB2' ' A' ' 64' ' ' ALA . 19.2 mt -99.41 -21.72 15.86 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.68 ' CE1' ' HB2' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -148.68 152.55 37.93 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.439 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.697 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 39.8 Cg_endo -62.92 149.63 90.93 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 121.931 1.754 . . . . 0.0 110.185 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.811 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 55.9 t80 -98.84 179.13 4.75 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.153 -1.419 . . . . 0.0 110.432 -177.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.69 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 57.7 m-20 -110.84 79.86 1.25 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.682 -0.636 . . . . 0.0 109.356 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.8 95.15 0.04 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 20' ' ' ASP . 15.2 mm -108.42 -41.97 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -1.13 . . . . 0.0 108.893 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.516 ' CD2' ' O ' ' B' ' 188' ' ' GLU . 36.2 m80 -77.56 158.88 78.15 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.53 -14.17 36.39 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.284 1.989 . . . . 0.0 111.869 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.0 -13.51 13.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.0 110.416 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.66 138.08 55.76 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.821 -1.174 . . . . 0.0 109.809 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.929 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -95.53 121.22 36.99 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.874 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.1 m -79.99 141.3 36.08 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.355 -0.84 . . . . 0.0 109.475 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.811 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 28.3 p90 -145.84 157.54 43.91 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.201 -0.937 . . . . 0.0 108.588 178.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.665 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 40.6 mttm -110.65 173.82 6.15 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.087 -1.008 . . . . 0.0 109.585 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.506 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -67.52 151.54 47.19 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.111 -0.993 . . . . 0.0 109.314 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.87 -8.09 4.83 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -75.43 140.46 42.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.928 -1.336 . . . . 0.0 109.788 -179.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -93.54 138.66 31.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.862 . . . . 0.0 109.263 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.629 ' CE ' HG11 ' A' ' 63' ' ' VAL . 1.9 mpp? -135.24 151.66 50.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.622 -0.674 . . . . 0.0 109.796 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.739 ' HD3' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -106.16 124.61 49.85 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.469 -0.769 . . . . 0.0 109.62 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.628 HG11 ' HG3' ' A' ' 40' ' ' GLU . 1.4 t -82.21 132.32 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.34 -0.85 . . . . 0.0 108.846 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.739 HD23 ' HD3' ' A' ' 36' ' ' LYS . 3.7 mt -110.37 -42.51 4.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.006 -1.059 . . . . 0.0 109.849 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -138.8 84.47 2.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.178 -0.951 . . . . 0.0 109.215 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.628 ' HG3' HG11 ' A' ' 37' ' ' VAL . 1.4 tt0 -67.96 116.14 8.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.861 . . . . 0.0 109.274 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.746 ' HB2' HD21 ' B' ' 186' ' ' LEU . 46.1 m-70 -86.04 -103.32 0.06 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.235 -0.916 . . . . 0.0 109.398 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.425 ' O ' ' HG3' ' A' ' 43' ' ' GLU . . . -136.4 -15.39 0.88 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.304 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.582 ' CG ' ' HD2' ' B' ' 181' ' ' PRO . 1.3 mt-10 -158.0 -20.24 0.08 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.944 -1.327 . . . . 0.0 110.525 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.939 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 57.1 m95 -133.51 93.81 3.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.919 -1.113 . . . . 0.0 108.676 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.63 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -85.85 146.57 26.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.074 -1.016 . . . . 0.0 110.796 -178.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 1.1 ttpt -94.21 105.85 17.83 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.41 -174.05 2.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.32 -0.862 . . . . 0.0 110.125 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.9 mttp -125.72 126.85 45.29 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.542 -0.724 . . . . 0.0 109.496 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.601 ' HB2' ' HB3' ' A' ' 54' ' ' LYS . 1.8 t -70.94 125.62 27.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.136 -0.978 . . . . 0.0 109.875 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.75 -8.69 54.09 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.656 HD13 ' O ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -53.4 -55.27 26.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.508 -0.745 . . . . 0.0 109.352 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.633 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 1.5 t -161.16 30.11 0.14 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.267 -0.896 . . . . 0.0 110.186 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.633 ' HB2' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 85.58 45.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.499 -0.751 . . . . 0.0 110.651 178.547 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -86.8 132.18 33.91 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.122 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 1.4 pt-20 -121.82 117.56 26.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.89 -1.131 . . . . 0.0 109.455 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.642 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -157.67 168.67 34.38 Favored Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.346 -1.407 . . . . 0.0 110.158 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.75 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 15.5 m-85 -73.54 134.33 43.78 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.686 -0.89 . . . . 0.0 109.954 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.463 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 4.1 pt -122.37 141.16 34.09 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.59 ' HG3' ' CD2' ' B' ' 179' ' ' LEU . 53.4 Cg_endo -72.48 134.43 22.48 Favored 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 121.673 1.582 . . . . 0.0 111.997 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.623 ' HB3' ' CE2' ' A' ' 45' ' ' TRP . 24.3 p -65.2 4.69 0.45 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 110.422 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.67 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 5.9 p-10 -102.01 -51.64 3.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.871 -1.143 . . . . 0.0 110.86 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 1.182 ' CE2' HD21 ' B' ' 179' ' ' LEU . 3.1 m-85 -55.27 -59.99 4.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.142 -0.974 . . . . 0.0 111.304 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.629 HG11 ' CE ' ' A' ' 35' ' ' MET . 4.2 m -78.74 157.61 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 122.054 0.931 . . . . 0.0 111.41 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.712 ' HB2' ' CD1' ' A' ' 16' ' ' LEU . . . -135.63 161.88 34.29 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.509 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -75.55 93.28 2.99 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.046 -1.033 . . . . 0.0 109.265 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -146.62 147.4 31.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.448 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.516 ' ND2' ' N ' ' A' ' 68' ' ' THR . 1.0 OUTLIER 171.06 157.95 0.08 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -0.873 . . . . 0.0 109.496 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.516 ' N ' ' ND2' ' A' ' 67' ' ' ASN . 1.6 t . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.487 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 12.5 m95 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.326 0.584 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . 0.606 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 1.9 m-20 -170.18 -56.15 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.209 -0.932 . . . . 0.0 108.809 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 47.8 Cg_endo -67.9 -90.36 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.678 2.252 . . . . 0.0 111.868 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' B' ' 174' ' ' MET . . . 80.09 32.16 36.6 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' MET . . . . . 0.475 ' HB2' ' O ' ' B' ' 173' ' ' GLY . 32.0 mtm 65.31 87.39 0.12 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.398 -1.06 . . . . 0.0 109.552 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . 0.765 ' O ' HG23 ' B' ' 176' ' ' THR . 53.8 Cg_endo -83.07 -167.13 0.43 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.677 2.252 . . . . 0.0 111.842 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 176' ' ' THR . . . . . 0.765 HG23 ' O ' ' B' ' 175' ' ' PRO . 0.2 OUTLIER 160.59 117.56 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 177' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -86.69 168.21 8.37 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.847 2.365 . . . . 0.0 111.959 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.81 114.82 3.67 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.754 2.302 . . . . 0.0 111.789 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 1.182 HD21 ' CE2' ' A' ' 62' ' ' TYR . 46.2 mt -51.2 158.41 1.3 Allowed Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.328 -0.857 . . . . 0.0 109.955 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.939 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 39.6 Cg_endo -68.79 176.32 6.16 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.755 2.303 . . . . 0.0 111.648 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . 0.61 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 55.5 Cg_endo -86.82 -26.85 0.82 Allowed 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.885 2.39 . . . . 0.0 114.51 -177.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.727 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.0 OUTLIER 79.41 95.67 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 120.818 -1.176 . . . . 0.0 109.458 -179.213 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.752 ' CG ' HD22 ' B' ' 186' ' ' LEU . 48.0 Cg_endo -69.68 131.19 20.83 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 123.064 2.509 . . . . 0.0 112.269 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . 0.506 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 35.64 69.13 0.19 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.448 -0.782 . . . . 0.0 109.874 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . 0.447 ' HA ' ' HB3' ' B' ' 188' ' ' GLU . 0.2 OUTLIER 43.34 45.33 5.13 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.377 -0.827 . . . . 0.0 109.537 -179.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . 0.753 HD23 ' HB2' ' A' ' 44' ' ' TRP . 28.4 tp -55.7 -94.96 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . 0.75 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -71.58 -8.25 66.69 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 107.859 -2.097 . . . . 0.0 107.859 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.544 ' CA ' ' HD3' ' B' ' 182' ' ' ARG . 6.3 tt0 -74.62 -6.31 47.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.617 -0.931 . . . . 0.0 109.412 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 189' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -177.63 -78.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.177 -0.952 . . . . 0.0 109.52 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . 0.454 ' O ' ' O ' ' B' ' 191' ' ' ALA . 0.0 OUTLIER -157.75 113.43 2.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.521 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 191' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' B' ' 184' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.43 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.246 0.546 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.22 118.15 5.46 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.88 170.4 7.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -1.141 . . . . 0.0 109.424 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 36.0 mm -102.86 133.93 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.195 -0.941 . . . . 0.0 109.366 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 1.001 HG12 ' HA ' ' A' ' 65' ' ' LYS . 1.0 OUTLIER -132.36 159.57 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.508 -0.745 . . . . 0.0 109.171 -179.424 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 p -119.45 135.51 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.878 -1.139 . . . . 0.0 108.95 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.612 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -70.21 131.62 44.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.409 -0.807 . . . . 0.0 110.594 -178.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.024 HD11 ' HB2' ' A' ' 64' ' ' ALA . 95.2 mt -98.79 -39.31 8.69 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' B' ' 175' ' ' PRO . 16.4 m-85 -122.33 139.28 30.44 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -63.0 150.61 88.15 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.625 2.217 . . . . 0.0 113.015 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.786 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 25.1 t80 -130.25 115.97 17.72 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.417 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.5 OUTLIER -94.72 119.11 32.8 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 116.294 -2.162 . . . . 0.0 108.922 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -41.92 99.19 0.01 OUTLIER Glycine 0 N--CA 1.487 2.077 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 20' ' ' ASP . 12.9 mm -88.64 -54.03 8.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.608 ' CG ' ' HD3' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -66.39 -171.02 0.07 OUTLIER Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.608 ' HD3' ' CG ' ' A' ' 23' ' ' HIS . 52.2 Cg_endo -92.26 -13.48 1.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.54 2.16 . . . . 0.0 112.333 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -117.8 -11.14 10.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 0.0 110.779 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.488 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 99.5 m-20 -57.64 140.4 51.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.001 -1.062 . . . . 0.0 110.413 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.01 HD22 ' N ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -97.64 126.43 42.94 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 1.01 ' N ' HD22 ' A' ' 27' ' ' LEU . 9.4 m -81.62 138.02 35.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.149 -0.969 . . . . 0.0 110.693 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.786 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 18.5 p90 -145.84 156.66 43.71 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -112.09 163.19 14.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.015 -1.053 . . . . 0.0 109.618 -179.368 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.41 151.6 12.87 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.218 -0.926 . . . . 0.0 108.99 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.49 -8.42 3.07 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 3.2 tm-20 -73.66 144.41 45.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.93 -1.336 . . . . 0.0 109.997 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.712 ' HB2' HD12 ' A' ' 50' ' ' LEU . 4.0 mtmp? -96.03 135.98 37.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.91 . . . . 0.0 109.336 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.583 ' CE ' HG11 ' A' ' 63' ' ' VAL . 1.4 mpp? -134.52 150.67 50.8 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.518 -0.739 . . . . 0.0 110.02 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 13.0 tttt -105.74 117.52 34.24 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.529 -0.732 . . . . 0.0 109.182 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.677 HG23 HG22 ' A' ' 13' ' ' VAL . 2.5 t -76.92 132.42 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.386 -0.821 . . . . 0.0 109.185 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 98.2 mt -103.47 -50.53 3.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.722 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -140.89 103.94 4.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 108.913 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.653 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.2 tm-20 -87.54 119.22 27.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.459 -0.776 . . . . 0.0 109.784 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.704 ' HB2' HD21 ' B' ' 186' ' ' LEU . 3.0 m-70 -83.85 -98.39 0.05 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.379 -0.826 . . . . 0.0 109.206 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.483 ' O ' ' HG2' ' A' ' 43' ' ' GLU . . . -138.98 -13.1 0.71 Allowed Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.654 -1.26 . . . . 0.0 110.318 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' B' ' 180' ' ' PRO . 12.0 mt-10 -153.24 -16.43 0.15 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.918 -1.343 . . . . 0.0 110.412 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.784 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 65.3 m95 -140.21 100.1 3.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.939 -1.101 . . . . 0.0 109.53 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.662 ' CZ2' ' CB ' ' A' ' 60' ' ' SER . 0.1 OUTLIER -92.51 144.41 25.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.135 -0.978 . . . . 0.0 109.809 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -85.66 108.92 18.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.267 -0.895 . . . . 0.0 108.642 179.234 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.51 -177.87 3.5 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.264 -0.897 . . . . 0.0 110.01 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 8.5 mtpt -125.0 132.02 53.32 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.586 -0.697 . . . . 0.0 109.608 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.629 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 4.4 t -79.87 129.1 34.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.927 . . . . 0.0 109.717 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.712 HD12 ' HB2' ' A' ' 34' ' ' LYS . 19.6 mt -74.14 -5.24 40.56 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.7 tp -55.91 -54.76 40.77 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.334 -0.854 . . . . 0.0 109.132 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.624 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -160.4 27.56 0.16 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.33 -0.857 . . . . 0.0 110.04 179.323 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.624 ' HB2' ' O ' ' A' ' 52' ' ' THR . 5.0 mtpm? 87.2 43.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.586 -0.696 . . . . 0.0 110.805 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.629 ' HB2' ' CB ' ' A' ' 49' ' ' SER . 3.0 mmtp -85.27 132.57 34.24 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -122.63 116.54 23.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.955 -1.091 . . . . 0.0 109.424 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.649 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -152.67 170.62 31.8 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.67 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 5.1 m-85 -73.0 132.05 42.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.449 -1.03 . . . . 0.0 109.52 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.536 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 7.2 pt -121.14 140.17 30.64 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 108.965 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.675 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 49.3 Cg_endo -68.87 153.38 72.87 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.42 2.08 . . . . 0.0 112.022 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.662 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 77.4 p -85.61 6.55 26.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 109.948 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.574 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 3.4 p-10 -105.95 -47.58 3.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.145 -0.972 . . . . 0.0 110.158 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.783 ' CE2' HD23 ' B' ' 179' ' ' LEU . 10.4 m-30 -56.76 -59.97 4.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.495 -0.753 . . . . 0.0 110.956 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 15' ' ' ALA . 3.1 m -80.11 163.28 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 111.296 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.024 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -137.24 130.59 31.16 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 1.001 ' HA ' HG12 ' A' ' 13' ' ' VAL . 0.7 OUTLIER -48.37 179.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.154 -0.966 . . . . 0.0 109.849 -179.441 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.502 ' HA ' HD23 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -126.9 24.37 6.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.292 -0.88 . . . . 0.0 109.602 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -78.29 -154.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.895 . . . . 0.0 109.44 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.3 p . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.507 -179.987 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 5.0 p90 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . 0.583 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 0.9 OUTLIER -167.53 -57.14 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.28 -0.888 . . . . 0.0 108.865 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 45.5 Cg_endo -67.42 -89.35 0.0 OUTLIER 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.719 2.279 . . . . 0.0 111.821 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 173' ' ' GLY . . . . . 0.469 ' O ' ' HG2' ' B' ' 174' ' ' MET . . . -168.53 38.01 0.21 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 174' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' B' ' 173' ' ' GLY . 0.6 OUTLIER -144.22 91.54 6.4 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.317 -1.108 . . . . 0.0 109.399 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . 0.602 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 55.1 Cg_endo -77.81 -160.5 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.654 2.236 . . . . 0.0 111.705 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 176' ' ' THR . . . . . 0.585 HG22 ' HB3' ' A' ' 17' ' ' TYR . 21.1 p -150.27 93.22 3.89 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.429 -0.795 . . . . 0.0 109.316 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 177' ' ' PRO . . . . . 0.573 ' HD2' ' CD2' ' A' ' 17' ' ' TYR . 52.9 Cg_endo -74.08 174.17 12.87 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.683 2.255 . . . . 0.0 111.702 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' B' ' 177' ' ' PRO . 49.8 Cg_endo -71.03 110.38 2.8 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.547 2.164 . . . . 0.0 111.831 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 0.783 HD23 ' CE2' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -49.94 177.05 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.342 -0.849 . . . . 0.0 109.258 179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.784 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.4 Cg_endo -67.36 -175.84 0.75 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.872 2.382 . . . . 0.0 111.797 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . 0.738 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 53.5 Cg_endo -91.88 -22.58 0.48 Allowed 'Trans proline' 0 C--O 1.213 -0.775 0 C-N-CA 123.062 2.508 . . . . 0.0 114.709 -177.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.738 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 20.7 mtt180 77.0 93.07 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.892 -1.13 . . . . 0.0 109.063 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 47.0 Cg_endo -68.38 130.89 22.0 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.666 2.244 . . . . 0.0 111.848 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 43.53 61.82 2.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.367 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 47.18 50.27 14.4 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.267 -0.895 . . . . 0.0 109.274 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . 0.704 HD21 ' HB2' ' A' ' 41' ' ' HIS . 49.9 tp -68.51 -83.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.412 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . 0.67 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -68.18 -8.51 54.81 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.518 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -81.78 -86.73 0.09 Allowed 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.472 -1.017 . . . . 0.0 109.31 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 189' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.89 119.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.556 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -157.13 27.87 0.3 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.518 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.51 179.951 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.46 -118.66 0.67 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.439 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -159.64 155.83 26.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -1.126 . . . . 0.0 109.43 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.403 HD12 ' HG3' ' A' ' 36' ' ' LYS . 2.6 tp -106.3 142.13 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.233 -0.917 . . . . 0.0 109.648 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.5 m -132.33 162.46 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.443 -0.786 . . . . 0.0 109.175 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 9.7 p -121.78 138.64 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.123 -0.985 . . . . 0.0 109.209 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.2 136.85 48.26 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.469 -0.769 . . . . 0.0 109.829 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.649 HD11 ' HB2' ' A' ' 64' ' ' ALA . 55.6 mt -98.97 -25.46 14.57 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.807 ' HB3' HG22 ' B' ' 176' ' ' THR . 23.1 m-85 -144.66 154.85 56.46 Favored Pre-proline 0 N--CA 1.486 1.373 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.704 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 41.5 Cg_endo -63.99 149.36 90.7 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 121.941 1.761 . . . . 0.0 110.192 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.844 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 58.8 t80 -99.65 178.38 4.87 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 118.01 -1.476 . . . . 0.0 110.552 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.679 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -110.63 80.0 1.26 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.655 -0.653 . . . . 0.0 109.377 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.27 95.26 0.03 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.701 -1.759 . . . . 0.0 108.701 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.417 ' N ' ' O ' ' A' ' 20' ' ' ASP . 28.9 mt -109.89 -40.2 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.14 -1.212 . . . . 0.0 109.167 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.495 ' NE2' ' HG2' ' B' ' 188' ' ' GLU . 35.9 m-70 -80.18 158.91 71.53 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.88 -14.95 39.84 Favored 'Trans proline' 0 C--O 1.216 -0.586 0 C-N-CA 122.314 2.009 . . . . 0.0 112.159 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.454 ' OD1' ' HD2' ' B' ' 189' ' ' ARG . 5.1 m-20 -110.61 -11.46 14.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.022 -1.049 . . . . 0.0 110.488 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -59.95 143.2 52.25 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.857 -1.152 . . . . 0.0 109.655 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.948 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -102.42 122.92 45.25 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.913 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -77.35 138.94 39.62 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 109.568 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.844 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 19.8 p90 -143.66 155.4 44.23 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 108.542 178.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.654 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 1.8 ptpt -110.15 173.16 6.45 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.204 -0.935 . . . . 0.0 109.486 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.512 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -66.34 152.48 44.92 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.198 -0.939 . . . . 0.0 109.304 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.47 -7.76 3.49 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.5 OUTLIER -74.95 143.67 43.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.843 -1.386 . . . . 0.0 109.564 -179.677 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -96.42 138.83 33.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.901 . . . . 0.0 109.556 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.544 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 2.1 mpp? -134.86 151.58 51.03 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.594 -0.691 . . . . 0.0 109.657 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.592 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 2.6 tttt -104.99 128.82 53.45 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.406 -0.809 . . . . 0.0 109.179 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.492 ' O ' HD12 ' A' ' 38' ' ' LEU . 1.7 t -81.58 135.11 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.416 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 37' ' ' VAL . 6.8 mp -113.43 -41.13 3.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.313 -0.867 . . . . 0.0 109.513 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -149.91 88.38 1.53 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 109.233 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.628 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -74.76 114.49 13.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.378 -0.826 . . . . 0.0 109.438 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.812 ' HB2' HD21 ' B' ' 186' ' ' LEU . 3.2 m-70 -80.6 -101.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.518 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.411 ' C ' ' CD ' ' A' ' 43' ' ' GLU . . . -127.28 -14.91 2.59 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.048 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.571 ' CG ' ' HD3' ' B' ' 183' ' ' PRO . 0.0 OUTLIER -165.8 -10.87 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.022 -1.281 . . . . 0.0 110.3 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.84 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 71.2 m95 -131.1 89.2 2.7 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.859 -1.151 . . . . 0.0 108.701 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.628 ' CD1' ' CG ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -83.7 140.97 31.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.798 -1.189 . . . . 0.0 110.312 -179.064 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 4.3 tttt -91.42 103.54 16.16 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.592 ' HB1' ' O ' ' A' ' 36' ' ' LYS . . . -101.92 -177.21 3.35 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.351 -0.843 . . . . 0.0 110.336 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.489 ' HE2' HD21 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -123.72 109.5 13.77 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.855 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.614 ' OG ' ' CB ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -57.45 129.53 42.25 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.807 -179.606 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.436 ' O ' ' N ' ' A' ' 52' ' ' THR . 0.3 OUTLIER -76.88 -8.61 57.67 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.318 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.474 ' O ' ' HB ' ' A' ' 52' ' ' THR . 55.5 tp -46.55 -22.68 0.3 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.738 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER 169.42 -21.94 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.38 -0.825 . . . . 0.0 110.115 178.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.738 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.1 OUTLIER 140.33 39.23 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.47 -0.769 . . . . 0.0 110.105 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.646 ' HB3' HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -87.86 135.24 33.48 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -122.43 127.82 50.14 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.914 -1.117 . . . . 0.0 109.274 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.691 ' HA3' ' CB ' ' A' ' 27' ' ' LEU . . . -166.93 168.81 40.51 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.235 -1.46 . . . . 0.0 110.41 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.717 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 14.2 m-85 -71.62 132.89 45.26 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.754 -0.851 . . . . 0.0 109.898 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.513 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 8.1 pt -123.18 129.48 24.92 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.668 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 56.2 Cg_endo -75.1 126.49 9.94 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 121.634 1.556 . . . . 0.0 112.591 -178.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.612 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 32.2 t -55.28 -10.85 0.64 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.522 -0.736 . . . . 0.0 109.997 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.572 ' ND2' ' O ' ' B' ' 178' ' ' PRO . 5.3 t30 -88.35 0.81 55.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.034 -1.041 . . . . 0.0 110.383 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.619 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -117.08 -41.34 3.02 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.864 -1.148 . . . . 0.0 110.045 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.544 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.5 m -96.62 159.09 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.104 -0.997 . . . . 0.0 110.567 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.649 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -136.87 161.89 34.77 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -75.94 146.84 39.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.087 -1.008 . . . . 0.0 109.4 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.478 ' O ' ' ND2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -47.84 164.0 0.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.9 . . . . 0.0 109.596 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -153.72 102.14 2.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.352 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.508 -179.896 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . 0.409 ' CD1' ' C ' ' B' ' 170' ' ' TRP . 1.4 p90 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . 0.579 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 0.4 OUTLIER -166.5 -57.48 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.253 -0.904 . . . . 0.0 108.719 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 48.2 Cg_endo -67.91 -90.23 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.689 2.259 . . . . 0.0 111.803 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 173' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' B' ' 174' ' ' MET . . . 165.5 -35.69 0.26 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 174' ' ' MET . . . . . 0.41 ' C ' ' O ' ' B' ' 173' ' ' GLY . 0.0 OUTLIER 43.8 82.91 0.22 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.251 -1.147 . . . . 0.0 109.686 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . 0.639 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 55.5 Cg_endo -79.15 -161.69 0.16 Allowed 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 122.632 2.222 . . . . 0.0 111.72 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 176' ' ' THR . . . . . 0.807 HG22 ' HB3' ' A' ' 17' ' ' TYR . 11.8 p -149.03 91.06 4.62 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.359 -0.838 . . . . 0.0 109.301 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 177' ' ' PRO . . . . . 0.599 ' HD2' ' CD2' ' A' ' 17' ' ' TYR . 47.5 Cg_endo -68.91 172.81 11.17 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.784 2.323 . . . . 0.0 112.004 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . 0.572 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 50.7 Cg_endo -69.21 137.23 36.52 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.854 2.369 . . . . 0.0 111.676 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 0.643 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -78.77 176.42 3.7 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.172 -0.955 . . . . 0.0 109.598 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.84 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.5 Cg_endo -68.79 -176.57 1.26 Allowed 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 123.031 2.487 . . . . 0.0 111.647 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . 0.719 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.6 Cg_endo -89.82 -26.75 0.38 Allowed 'Trans proline' 0 C--O 1.213 -0.739 0 C-N-CA 122.886 2.391 . . . . 0.0 114.937 -177.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.719 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 39.4 mtt180 78.14 91.56 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 120.879 -1.138 . . . . 0.0 109.13 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.59 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 50.2 Cg_endo -70.0 135.59 30.27 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.689 2.26 . . . . 0.0 111.787 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 42.38 55.38 4.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.884 . . . . 0.0 109.5 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . 0.52 ' N ' ' ND2' ' B' ' 185' ' ' ASN . 0.7 OUTLIER 51.68 50.54 18.52 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.26 -0.9 . . . . 0.0 109.281 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . 0.812 HD21 ' HB2' ' A' ' 41' ' ' HIS . 60.9 tp -70.48 -81.88 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.362 -0.836 . . . . 0.0 109.418 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . 0.717 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -69.86 -5.72 53.16 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 108.924 -1.671 . . . . 0.0 108.924 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.556 ' N ' ' HD3' ' B' ' 182' ' ' ARG . 4.6 mt-10 -73.6 -81.4 0.06 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.393 -1.063 . . . . 0.0 109.242 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 189' ' ' ARG . . . . . 0.462 ' CB ' ' O ' ' B' ' 188' ' ' GLU . 0.0 OUTLIER 72.11 85.02 0.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.407 -0.808 . . . . 0.0 109.573 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -100.62 156.25 17.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.882 . . . . 0.0 109.468 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.44 179.989 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.407 ' O ' ' OD1' ' A' ' 11' ' ' ASP . . . -150.92 116.5 0.77 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -150.8 162.17 41.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -1.121 . . . . 0.0 109.266 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.7 mm -107.98 136.8 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.099 -1.0 . . . . 0.0 109.594 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.496 HG22 HG12 ' A' ' 37' ' ' VAL . 1.0 OUTLIER -131.34 160.68 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.505 -0.747 . . . . 0.0 109.036 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 p -120.66 139.23 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.054 -1.029 . . . . 0.0 109.372 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.86 133.3 45.37 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.379 -0.826 . . . . 0.0 109.744 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.983 HD11 ' CB ' ' A' ' 64' ' ' ALA . 23.4 mt -99.13 -17.25 18.28 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.672 ' HA ' ' CG ' ' A' ' 31' ' ' LYS . 7.2 m-85 -152.62 151.61 27.21 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.731 ' HD3' ' HG3' ' A' ' 31' ' ' LYS . 40.7 Cg_endo -61.53 148.93 91.8 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 121.53 1.487 . . . . 0.0 109.655 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.828 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 36.6 t80 -89.29 -34.3 16.63 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 117.947 -1.501 . . . . 0.0 110.224 -177.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.756 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 30.3 t70 106.84 -53.52 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.26 93.31 0.2 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.423 ' H ' HD12 ' A' ' 22' ' ' ILE . 0.5 OUTLIER -109.42 -42.96 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.385 -1.067 . . . . 0.0 108.433 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.636 ' CE1' ' CG ' ' B' ' 188' ' ' GLU . 1.9 m80 -74.74 153.35 87.22 Favored Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.79 -9.69 26.71 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.075 1.85 . . . . 0.0 111.417 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.8 -17.4 11.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.368 -0.833 . . . . 0.0 110.545 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.513 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.5 OUTLIER -57.18 141.28 46.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.856 -1.152 . . . . 0.0 109.956 -178.838 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.951 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -90.03 119.14 30.12 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.867 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.879 ' N ' HD22 ' A' ' 27' ' ' LEU . 93.9 p -77.08 138.51 39.59 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.333 -0.855 . . . . 0.0 109.734 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.828 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 17.6 p90 -143.68 155.56 44.26 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.238 -0.914 . . . . 0.0 108.772 178.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.692 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -112.36 175.47 5.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.242 -0.911 . . . . 0.0 109.434 -179.356 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.731 ' HG3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -66.13 155.8 35.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.95 -1.093 . . . . 0.0 109.423 179.576 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 66.01 -6.94 1.32 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.418 ' H ' ' C ' ' A' ' 31' ' ' LYS . 0.5 OUTLIER -74.79 141.31 44.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.839 -1.389 . . . . 0.0 109.687 -179.602 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -94.87 136.97 34.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.324 -0.86 . . . . 0.0 109.415 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.587 ' CE ' HG11 ' A' ' 63' ' ' VAL . 1.1 mpp? -137.23 153.1 50.45 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.421 0.629 . . . . 0.0 109.758 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.635 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 13.7 tttm -110.31 123.67 50.24 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.472 -0.768 . . . . 0.0 109.26 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.57 HG21 ' CD ' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -88.71 115.66 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -82.88 -41.09 19.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.196 -0.94 . . . . 0.0 110.038 -179.365 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.54 126.02 11.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.147 -0.971 . . . . 0.0 109.505 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.64 ' HG2' ' CD2' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -95.19 131.44 41.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.451 -0.78 . . . . 0.0 109.406 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.791 ' HB2' HD21 ' B' ' 186' ' ' LEU . 78.5 m-70 -98.72 -122.84 0.14 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.266 -0.896 . . . . 0.0 108.997 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.23 -28.96 21.28 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.574 ' CB ' ' HD2' ' B' ' 181' ' ' PRO . 2.1 tp10 -172.44 5.28 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.039 -1.271 . . . . 0.0 110.672 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 1.025 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 64.4 m95 -136.26 97.29 3.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.834 -1.166 . . . . 0.0 108.372 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.64 ' CD2' ' HG2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -93.23 145.89 24.1 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.921 -1.112 . . . . 0.0 110.337 -178.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -84.97 107.98 17.36 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.635 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -99.9 -179.62 4.22 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.363 -0.835 . . . . 0.0 109.909 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -122.76 129.97 52.36 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.62 -0.675 . . . . 0.0 109.493 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.574 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -76.75 126.79 31.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.75 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.64 -9.49 58.32 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.8 tp -52.11 -54.8 26.05 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.511 -0.743 . . . . 0.0 109.368 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.621 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.2 t -161.54 28.72 0.13 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.229 -0.92 . . . . 0.0 110.146 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.621 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.5 OUTLIER 87.09 44.33 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.47 -0.769 . . . . 0.0 110.715 178.726 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -85.46 132.64 34.18 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.077 -1.015 . . . . 0.0 108.337 178.517 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -122.4 114.75 21.17 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.859 -1.151 . . . . 0.0 109.483 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.627 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -152.22 171.84 31.49 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.666 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 8.1 m-85 -75.27 132.41 41.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.351 -1.088 . . . . 0.0 109.689 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.509 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 9.2 pt -121.93 137.42 27.3 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 108.605 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.603 ' HB2' ' CD ' ' B' ' 180' ' ' PRO . 50.9 Cg_endo -74.1 137.62 24.18 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.975 1.783 . . . . 0.0 112.763 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.578 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 28.3 t -67.93 4.3 1.23 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.583 -0.698 . . . . 0.0 110.317 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.598 HD22 ' HA ' ' B' ' 179' ' ' LEU . 0.8 OUTLIER -100.91 -55.34 2.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.022 -1.049 . . . . 0.0 110.063 -179.391 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 1.183 ' CE2' HD21 ' B' ' 179' ' ' LEU . 2.4 m-85 -51.81 -60.87 2.67 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.261 -0.899 . . . . 0.0 110.872 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.587 HG11 ' CE ' ' A' ' 35' ' ' MET . 4.0 m -78.61 154.8 4.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 122.004 0.906 . . . . 0.0 111.182 -177.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.983 ' CB ' HD11 ' A' ' 16' ' ' LEU . . . -130.07 159.55 36.4 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.481 ' HA ' HG12 ' A' ' 13' ' ' VAL . 2.1 ttpm? -74.72 149.81 39.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.974 -1.078 . . . . 0.0 109.552 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.488 ' O ' ' CB ' ' A' ' 67' ' ' ASN . 15.7 tp -135.6 -18.99 1.64 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.337 -0.852 . . . . 0.0 109.749 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' A' ' 66' ' ' LEU . 5.2 m120 74.69 -152.58 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -0.953 . . . . 0.0 109.38 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.483 -179.947 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . 0.435 ' O ' ' CB ' ' B' ' 171' ' ' ASP . 27.9 m95 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . 0.566 ' N ' ' HD3' ' B' ' 172' ' ' PRO . 0.6 OUTLIER 167.3 60.49 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.219 -0.926 . . . . 0.0 108.948 179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . 0.566 ' HD3' ' N ' ' B' ' 171' ' ' ASP . 52.0 Cg_endo -92.84 -82.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.171 2.581 . . . . 0.0 111.933 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 173' ' ' GLY . . . . . . . . . . . . . . . -113.37 32.41 6.1 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.99 105.65 0.36 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.186 -1.185 . . . . 0.0 109.48 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . 0.785 ' O ' HG23 ' B' ' 176' ' ' THR . 52.0 Cg_endo -89.52 -178.96 1.83 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.083 2.522 . . . . 0.0 111.776 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 176' ' ' THR . . . . . 0.8 HG22 ' CE1' ' A' ' 62' ' ' TYR . 0.1 OUTLIER 168.24 107.16 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.491 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 177' ' ' PRO . . . . . 0.655 ' CD ' ' CD2' ' A' ' 17' ' ' TYR . 49.2 Cg_endo -69.98 176.55 6.78 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.832 2.355 . . . . 0.0 111.83 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' B' ' 177' ' ' PRO . 48.6 Cg_endo -68.29 118.51 5.68 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.767 2.311 . . . . 0.0 111.991 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 1.183 HD21 ' CE2' ' A' ' 62' ' ' TYR . 33.4 mt -68.97 163.52 55.79 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.37 -0.831 . . . . 0.0 109.65 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 1.025 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 39.1 Cg_endo -70.56 176.12 7.81 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.483 2.122 . . . . 0.0 111.638 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . 0.578 ' O ' ' CB ' ' B' ' 182' ' ' ARG . 55.7 Cg_endo -76.47 -42.63 0.34 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.823 2.349 . . . . 0.0 113.916 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.659 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.0 OUTLIER 78.94 81.44 0.1 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.039 -1.038 . . . . 0.0 108.49 -178.583 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.485 ' O ' ' C ' ' B' ' 184' ' ' ALA . 51.5 Cg_endo -72.95 146.21 41.48 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.939 2.426 . . . . 0.0 112.33 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 36.35 61.93 0.76 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.607 -0.683 . . . . 0.0 109.616 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . 0.5 ' HA ' ' HB2' ' B' ' 188' ' ' GLU . 0.7 OUTLIER 42.95 46.2 4.6 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.308 -0.87 . . . . 0.0 109.05 -179.65 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . 0.791 HD21 ' HB2' ' A' ' 41' ' ' HIS . 68.0 tp -61.85 -86.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.435 -0.79 . . . . 0.0 109.447 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . 0.666 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -66.16 -11.4 55.34 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.636 ' CG ' ' CE1' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -69.66 -83.83 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.522 -0.987 . . . . 0.0 109.498 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 189' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.29 148.38 51.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.496 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . 0.411 ' O ' ' HB3' ' B' ' 191' ' ' ALA . 2.6 mp0 -58.83 -70.4 0.15 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.237 -0.914 . . . . 0.0 109.456 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 191' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' B' ' 190' ' ' GLN . . . . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.483 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.23 172.83 30.91 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.475 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -144.74 127.47 16.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -1.137 . . . . 0.0 109.45 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.498 ' CD1' ' HG3' ' A' ' 36' ' ' LYS . 1.0 OUTLIER -101.43 137.79 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.884 . . . . 0.0 109.407 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.493 HG11 ' HZ3' ' A' ' 45' ' ' TRP . 0.8 OUTLIER -130.99 159.93 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.474 HG12 ' HB2' ' A' ' 66' ' ' LEU . 14.6 p -120.55 138.46 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.981 -1.074 . . . . 0.0 109.482 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -72.29 134.58 45.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.465 -0.772 . . . . 0.0 110.111 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.038 HD11 ' HB2' ' A' ' 64' ' ' ALA . 16.5 mt -99.26 -17.81 17.91 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.593 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 43.1 m-85 -152.55 153.87 31.02 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.689 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.6 Cg_endo -63.66 149.64 90.4 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 121.812 1.675 . . . . 0.0 110.042 179.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.823 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 65.7 t80 -97.58 179.14 4.95 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 118.219 -1.392 . . . . 0.0 110.224 -177.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.67 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 9.8 p-10 -110.15 80.93 1.36 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.569 -0.707 . . . . 0.0 109.313 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.5 91.92 0.03 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.577 HD12 ' OD2' ' A' ' 20' ' ' ASP . 67.1 mt -106.67 -43.17 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.265 -1.138 . . . . 0.0 108.765 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.619 ' CE1' ' HA ' ' B' ' 188' ' ' GLU . 41.1 m80 -75.86 156.14 84.59 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.01 -13.27 36.23 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.225 1.95 . . . . 0.0 111.799 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -111.86 -13.99 13.59 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.24 -0.913 . . . . 0.0 110.363 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.74 141.83 47.4 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.825 -1.172 . . . . 0.0 109.798 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.93 HD22 ' N ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -98.64 124.06 43.2 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.93 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -81.08 140.26 35.2 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.322 -0.861 . . . . 0.0 109.81 -179.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.823 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 28.2 p90 -145.79 157.97 43.89 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.654 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 10.5 mtmm -111.27 174.03 6.06 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.047 -1.033 . . . . 0.0 109.557 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.553 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -67.38 151.9 46.64 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.186 -0.946 . . . . 0.0 109.314 179.803 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.39 -7.94 4.42 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 3.8 tt0 -75.55 143.43 42.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.917 -1.343 . . . . 0.0 109.838 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -96.3 138.18 34.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 0.0 109.273 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.623 ' CE ' HG11 ' A' ' 63' ' ' VAL . 1.7 mpp? -135.97 151.82 50.32 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.628 -0.67 . . . . 0.0 109.932 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 7.7 ttpt -109.02 122.37 47.11 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -89.93 119.0 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.296 -0.877 . . . . 0.0 108.758 178.832 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.732 HD12 ' O ' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -89.01 -40.79 12.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.159 -0.963 . . . . 0.0 110.191 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.28 119.42 15.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.049 -1.032 . . . . 0.0 109.268 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.636 ' HG3' ' CG ' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -99.35 122.17 42.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.823 . . . . 0.0 109.453 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.633 ' HB2' HD21 ' B' ' 186' ' ' LEU . 5.2 m-70 -90.25 -103.86 0.1 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.957 . . . . 0.0 109.116 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.69 -14.06 1.55 Allowed Glycine 0 N--CA 1.489 2.174 0 C-N-CA 119.548 -1.31 . . . . 0.0 110.177 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.593 ' CG ' ' HD2' ' B' ' 181' ' ' PRO . 0.3 OUTLIER -158.77 -15.1 0.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.963 -1.316 . . . . 0.0 110.972 -179.506 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.843 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 62.7 m95 -138.92 99.52 3.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.725 -1.234 . . . . 0.0 109.608 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.671 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -93.18 142.98 26.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.881 -1.137 . . . . 0.0 109.511 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.732 ' O ' HD12 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -85.91 109.11 18.51 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.29 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -101.3 -174.62 2.65 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.333 -0.855 . . . . 0.0 109.818 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -126.97 129.39 48.05 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.478 -0.764 . . . . 0.0 109.298 -179.729 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.589 ' HB2' ' HB2' ' A' ' 54' ' ' LYS . 7.6 t -74.9 126.75 31.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.064 -1.023 . . . . 0.0 109.795 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.3 -7.43 46.96 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.151 -0.968 . . . . 0.0 108.521 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.67 -55.6 27.96 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.374 -0.829 . . . . 0.0 109.227 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.634 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.1 t -160.62 27.51 0.15 Allowed 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.136 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.634 ' CB ' ' O ' ' A' ' 52' ' ' THR . 5.1 mmtt 87.83 45.17 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.495 -0.753 . . . . 0.0 110.898 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.589 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 0.1 OUTLIER -87.0 130.67 34.36 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 177.752 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 10.1 pt-20 -120.31 117.87 28.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.79 -1.194 . . . . 0.0 109.508 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.656 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -154.77 179.12 31.09 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.742 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 9.3 m-85 -80.07 132.56 35.99 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.454 -1.027 . . . . 0.0 109.954 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.484 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 8.8 pt -120.27 136.61 25.26 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.693 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 55.3 Cg_endo -73.95 135.16 20.8 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 121.827 1.685 . . . . 0.0 112.536 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.598 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 23.1 t -65.97 5.24 0.52 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.512 -0.743 . . . . 0.0 110.565 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.552 ' CG ' ' N ' ' A' ' 62' ' ' TYR . 1.2 p-10 -101.21 -51.81 3.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.765 -1.209 . . . . 0.0 110.458 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.686 ' CE2' HD23 ' B' ' 179' ' ' LEU . 4.8 m-85 -57.06 -59.01 5.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.117 -0.989 . . . . 0.0 110.947 -178.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.623 HG11 ' CE ' ' A' ' 35' ' ' MET . 3.1 m -79.79 156.8 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.988 0.899 . . . . 0.0 111.272 -177.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.038 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -131.54 159.47 38.08 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.437 ' HA ' HG12 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -76.43 97.08 4.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.933 -1.105 . . . . 0.0 109.568 -179.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.474 ' HB2' HG12 ' A' ' 14' ' ' VAL . 1.4 mt -147.14 123.94 11.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.173 -0.954 . . . . 0.0 109.598 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -154.55 165.3 36.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.926 . . . . 0.0 109.307 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.459 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . 0.479 ' O ' ' CB ' ' B' ' 171' ' ' ASP . 41.8 m0 . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . 0.546 ' N ' ' HD3' ' B' ' 172' ' ' PRO . 0.2 OUTLIER 165.89 61.31 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.228 -0.92 . . . . 0.0 108.953 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . 0.546 ' HD3' ' N ' ' B' ' 171' ' ' ASP . 51.9 Cg_endo -92.48 -91.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.222 2.615 . . . . 0.0 111.998 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 173' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' B' ' 174' ' ' MET . . . -131.48 19.23 4.83 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 174' ' ' MET . . . . . 0.436 ' HB3' ' O ' ' B' ' 173' ' ' GLY . 0.0 OUTLIER 176.41 69.65 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.36 -1.082 . . . . 0.0 109.179 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . 0.528 ' O ' HG23 ' B' ' 176' ' ' THR . 55.2 Cg_endo -79.19 -162.34 0.18 Allowed 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.733 2.289 . . . . 0.0 112.16 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 176' ' ' THR . . . . . 0.573 ' CG2' ' HB3' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -174.33 102.79 0.28 Allowed Pre-proline 0 N--CA 1.49 1.54 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 177' ' ' PRO . . . . . 0.568 ' HD2' ' CD2' ' A' ' 17' ' ' TYR . 48.5 Cg_endo -71.51 164.84 34.37 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.589 2.193 . . . . 0.0 111.75 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -67.9 136.09 37.29 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.522 2.148 . . . . 0.0 111.446 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 0.686 HD23 ' CE2' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -80.16 176.23 3.99 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.203 -0.935 . . . . 0.0 109.568 -179.769 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.843 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.1 Cg_endo -68.68 178.51 3.84 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.903 2.402 . . . . 0.0 111.531 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . 0.727 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.3 Cg_endo -88.21 -21.59 1.54 Allowed 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 122.982 2.455 . . . . 0.0 114.411 -177.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.727 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 24.6 mtt180 76.34 91.25 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.956 -1.09 . . . . 0.0 108.974 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' B' ' 186' ' ' LEU . 50.9 Cg_endo -70.68 136.42 30.54 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.84 2.36 . . . . 0.0 112.017 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 41.0 63.73 1.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.834 . . . . 0.0 109.492 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . 0.425 ' CA ' ' HB2' ' B' ' 188' ' ' GLU . 0.0 OUTLIER 44.73 48.86 8.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.205 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . 0.633 HD21 ' HB2' ' A' ' 41' ' ' HIS . 42.6 tp -67.77 -87.15 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.441 -0.787 . . . . 0.0 109.413 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . 0.742 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -64.67 -8.38 33.02 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.619 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 6.9 mt-10 -51.13 -90.67 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.361 -1.082 . . . . 0.0 109.5 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 189' ' ' ARG . . . . . . . . . . . . . 10.1 ptt85 -164.79 -169.02 1.6 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.161 -0.962 . . . . 0.0 109.584 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -100.49 161.17 13.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.26 -0.9 . . . . 0.0 109.497 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.092 -0.956 . . . . 0.0 109.404 179.96 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.46 168.94 18.62 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -143.1 161.72 37.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -1.147 . . . . 0.0 109.347 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.431 ' HB ' ' OD1' ' A' ' 67' ' ' ASN . 34.4 mm -111.8 136.79 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.119 -0.988 . . . . 0.0 109.729 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.497 HG12 ' HA ' ' A' ' 65' ' ' LYS . 1.3 m -133.09 162.92 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -118.65 139.17 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.84 -1.162 . . . . 0.0 109.069 179.176 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.707 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -72.09 95.42 1.63 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.44 -0.788 . . . . 0.0 110.695 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.024 HD11 ' CB ' ' A' ' 64' ' ' ALA . 37.3 mt -60.99 -34.08 74.24 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.743 ' HB3' HG22 ' B' ' 176' ' ' THR . 29.1 m-85 -134.1 152.95 79.3 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.589 ' HD2' HG22 ' B' ' 176' ' ' THR . 50.8 Cg_endo -70.27 150.9 65.79 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 122.409 2.073 . . . . 0.0 111.677 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.92 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 60.6 t80 -114.44 105.62 13.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.979 -1.075 . . . . 0.0 109.756 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 19' ' ' TYR . 40.3 m-20 -27.49 -37.75 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 19' ' ' TYR . . . 66.74 96.3 0.03 OUTLIER Glycine 0 N--CA 1.496 2.664 0 N-CA-C 106.206 -2.758 . . . . 0.0 106.206 -175.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.6 mt -115.04 -38.18 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.447 -1.031 . . . . 0.0 109.809 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.607 ' CG ' ' O ' ' B' ' 188' ' ' GLU . 0.9 OUTLIER -77.41 151.76 80.87 Favored Pre-proline 0 C--N 1.298 -1.64 0 O-C-N 121.346 -0.846 . . . . 0.0 108.753 179.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.34 -10.17 26.55 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.211 1.941 . . . . 0.0 110.774 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -114.9 -17.22 11.59 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.459 -0.776 . . . . 0.0 110.279 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.477 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -57.51 139.24 53.89 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.888 -1.133 . . . . 0.0 109.91 -178.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.948 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -88.19 115.06 25.41 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.841 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.758 ' N ' HD22 ' A' ' 27' ' ' LEU . 84.6 p -76.3 141.22 41.69 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.369 -0.832 . . . . 0.0 109.404 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.92 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 24.6 p90 -145.81 156.74 43.77 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.31 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.581 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -110.21 174.52 5.82 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.198 -0.939 . . . . 0.0 109.321 -179.704 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -67.4 151.09 48.03 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.093 -1.004 . . . . 0.0 109.315 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 71.38 -7.4 6.4 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -74.77 143.42 44.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.965 -1.314 . . . . 0.0 109.68 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -97.52 139.48 33.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.749 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.658 ' HE3' HG11 ' A' ' 63' ' ' VAL . 3.9 mtm -135.89 152.44 51.02 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.588 0.709 . . . . 0.0 109.744 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.608 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 17.2 ttmt -104.81 125.75 51.18 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 11' ' ' ASP . 2.7 t -75.72 132.18 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.192 -0.943 . . . . 0.0 109.431 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 46' ' ' LYS . 12.3 mt -110.94 -48.54 3.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.199 -0.938 . . . . 0.0 109.649 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 1.8 pt-20 -143.27 91.94 2.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.161 -0.962 . . . . 0.0 109.051 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.588 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 0.8 OUTLIER -78.68 114.89 18.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.697 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.626 ' HB2' HD21 ' B' ' 186' ' ' LEU . 4.2 m-70 -82.47 -101.71 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.372 -0.83 . . . . 0.0 109.113 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -136.33 -12.87 1.05 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.555 ' HB2' ' HD3' ' B' ' 183' ' ' PRO . 0.8 OUTLIER -153.15 -19.76 0.15 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.026 -1.279 . . . . 0.0 110.544 -179.668 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.873 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 66.8 m95 -137.43 99.93 4.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.868 -1.145 . . . . 0.0 109.395 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.623 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -88.22 146.97 25.08 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.133 -0.979 . . . . 0.0 109.851 -179.879 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -93.81 105.67 17.69 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.171 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -103.79 -177.96 3.52 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.298 -0.876 . . . . 0.0 110.281 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.631 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -123.73 128.07 49.07 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.644 -0.66 . . . . 0.0 109.684 -179.49 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.597 ' HB2' ' HB3' ' A' ' 54' ' ' LYS . 1.1 t -74.45 126.95 31.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.124 -0.985 . . . . 0.0 109.884 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 50' ' ' LEU . 32.9 mt -72.23 -7.43 49.26 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.5 tp -53.58 -54.92 30.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.529 -0.732 . . . . 0.0 109.287 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.596 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 2.6 t -161.08 29.08 0.14 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.278 -0.889 . . . . 0.0 109.955 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 52' ' ' THR . 12.6 mttm 86.93 45.46 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.552 -0.718 . . . . 0.0 110.585 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.631 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 3.6 tttm -85.17 132.29 34.31 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -123.22 117.01 24.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.929 -1.107 . . . . 0.0 109.17 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.661 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -159.27 166.03 34.55 Favored Glycine 0 N--CA 1.486 1.988 0 C-N-CA 118.966 -1.588 . . . . 0.0 110.55 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.782 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 8.1 m-85 -71.97 134.1 45.74 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.752 -0.852 . . . . 0.0 109.714 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.593 HD12 HG21 ' A' ' 63' ' ' VAL . 13.7 pt -123.29 144.53 43.96 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.304 -0.873 . . . . 0.0 108.841 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.632 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 43.2 Cg_endo -67.54 142.92 60.8 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.915 1.743 . . . . 0.0 111.597 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.525 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 32.4 p -74.67 6.05 4.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.189 -0.944 . . . . 0.0 110.737 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' B' ' 178' ' ' PRO . 0.1 OUTLIER -108.41 -51.72 2.86 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.808 -1.183 . . . . 0.0 110.484 -179.208 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.602 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 5.8 m-30 -49.68 -61.26 2.22 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.19 -0.944 . . . . 0.0 111.271 -178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.707 HG12 ' HA ' ' A' ' 15' ' ' ALA . 13.3 m -78.32 156.32 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.096 -1.002 . . . . 0.0 111.321 -177.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.024 ' CB ' HD11 ' A' ' 16' ' ' LEU . . . -135.74 163.5 30.03 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.497 ' HA ' HG12 ' A' ' 13' ' ' VAL . 3.7 ptpt -76.59 148.98 36.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.977 -1.077 . . . . 0.0 109.373 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER 171.93 113.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 109.699 179.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.431 ' OD1' ' HB ' ' A' ' 12' ' ' ILE . 0.1 OUTLIER -129.31 154.06 47.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.901 . . . . 0.0 109.144 179.697 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.5 m . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.451 -179.891 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . 0.486 ' O ' ' HB2' ' B' ' 171' ' ' ASP . 17.7 m95 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . 0.62 ' N ' ' HD3' ' B' ' 172' ' ' PRO . 24.6 t70 176.84 57.75 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.285 -0.884 . . . . 0.0 108.955 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . 0.62 ' HD3' ' N ' ' B' ' 171' ' ' ASP . 52.6 Cg_endo -92.29 -82.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.112 2.542 . . . . 0.0 111.857 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 173' ' ' GLY . . . . . . . . . . . . . . . -143.45 27.07 2.11 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.15 73.05 11.13 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.305 -1.115 . . . . 0.0 109.492 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . 0.611 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 55.1 Cg_endo -77.05 -159.73 0.1 Allowed 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.638 2.226 . . . . 0.0 111.626 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 176' ' ' THR . . . . . 0.743 HG22 ' HB3' ' A' ' 17' ' ' TYR . 14.7 p -157.46 93.73 2.19 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.464 -0.773 . . . . 0.0 109.497 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 177' ' ' PRO . . . . . 0.525 ' HD2' ' CD2' ' A' ' 17' ' ' TYR . 51.3 Cg_endo -69.94 175.1 8.71 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.768 2.312 . . . . 0.0 111.825 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . 0.534 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 50.4 Cg_endo -70.67 163.34 39.35 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.589 2.192 . . . . 0.0 111.425 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 0.604 HD22 ' HE1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -98.31 175.24 2.61 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.244 -0.91 . . . . 0.0 109.519 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.873 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.3 Cg_endo -69.14 -175.29 0.96 Allowed 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.944 2.429 . . . . 0.0 111.568 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . 0.756 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.1 Cg_endo -90.36 -29.75 0.17 Allowed 'Trans proline' 0 C--O 1.213 -0.742 0 C-N-CA 122.928 2.419 . . . . 0.0 114.471 -177.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.756 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 51.1 mtt180 81.97 95.34 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.227 -0.921 . . . . 0.0 109.212 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.62 ' CG ' HD22 ' B' ' 186' ' ' LEU . 43.6 Cg_endo -67.41 128.41 18.24 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.852 2.368 . . . . 0.0 111.806 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 42.47 66.87 0.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.182 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . 0.483 ' HB3' ' HB2' ' B' ' 189' ' ' ARG . 0.6 OUTLIER 43.08 43.91 3.96 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.368 -0.833 . . . . 0.0 109.137 -179.465 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . 0.626 HD21 ' HB2' ' A' ' 41' ' ' HIS . 59.9 tp -55.67 -93.81 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . 0.782 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -68.69 -8.62 57.24 Favored Glycine 0 N--CA 1.483 1.767 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.607 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 0.1 OUTLIER -71.98 -86.63 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.543 -0.975 . . . . 0.0 109.278 179.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 189' ' ' ARG . . . . . 0.483 ' HB2' ' HB3' ' B' ' 185' ' ' ASN . 0.3 OUTLIER -81.99 -169.0 2.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.072 -1.017 . . . . 0.0 109.433 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' B' ' 189' ' ' ARG . 1.0 OUTLIER -44.12 -72.92 0.05 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.923 . . . . 0.0 109.426 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.44 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 11' ' ' ASP . . . -106.92 100.97 1.65 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.501 ' O ' HG23 ' A' ' 37' ' ' VAL . 3.3 m-20 -150.59 149.49 29.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -1.107 . . . . 0.0 109.376 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.564 HD12 ' HG3' ' A' ' 36' ' ' LYS . 35.0 mm -105.27 136.09 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.927 . . . . 0.0 109.655 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.529 HG22 ' CG2' ' A' ' 37' ' ' VAL . 1.5 m -132.64 161.79 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 p -120.09 137.75 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.982 -1.074 . . . . 0.0 109.071 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.605 ' O ' ' N ' ' A' ' 32' ' ' GLY . . . -69.22 131.77 45.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.395 -0.816 . . . . 0.0 109.976 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.062 HD11 ' CB ' ' A' ' 64' ' ' ALA . 62.5 mt -97.77 -30.21 12.92 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.653 ' CD2' ' CD ' ' B' ' 177' ' ' PRO . 47.7 m-85 -131.74 143.32 48.63 Favored Pre-proline 0 N--CA 1.486 1.373 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.8 Cg_endo -62.34 149.39 90.94 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.692 2.261 . . . . 0.0 112.699 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.824 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 21.6 t80 -129.29 113.3 14.83 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -98.2 118.0 33.85 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 116.75 -1.98 . . . . 0.0 108.546 179.434 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -40.44 90.25 0.01 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.593 HG22 ' O ' ' A' ' 22' ' ' ILE . 2.4 mp -82.49 0.11 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 121.142 -1.211 . . . . 0.0 107.815 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.549 ' HB3' ' CD ' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -121.66 -172.55 0.24 Allowed Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.372 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.549 ' CD ' ' HB3' ' A' ' 23' ' ' HIS . 52.0 Cg_endo -90.86 -17.89 1.22 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.218 1.945 . . . . 0.0 112.602 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.462 ' CG ' ' CG ' ' B' ' 190' ' ' GLN . 30.6 m-20 -117.53 -12.09 10.4 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.389 -0.819 . . . . 0.0 111.09 -178.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.48 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 9.5 m-20 -58.52 142.56 48.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.927 -1.108 . . . . 0.0 110.708 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.018 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -98.93 122.68 42.5 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.959 ' N ' HD22 ' A' ' 27' ' ' LEU . 15.9 m -76.92 137.53 39.15 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -0.925 . . . . 0.0 110.655 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.824 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 30.5 p90 -143.75 154.74 43.77 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.555 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -111.54 166.04 11.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.979 -1.076 . . . . 0.0 109.656 -179.35 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.23 151.37 15.88 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.248 -0.907 . . . . 0.0 108.792 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.17 -7.69 3.18 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 9.0 tt0 -73.47 144.41 46.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.931 -1.335 . . . . 0.0 109.798 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.891 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -98.13 139.07 34.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 0.0 109.894 -179.708 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.608 ' SD ' HG21 ' A' ' 58' ' ' ILE . 4.6 mtm -134.89 151.08 50.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.578 -0.701 . . . . 0.0 109.662 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -103.05 121.05 41.77 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.504 -0.748 . . . . 0.0 109.252 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.529 ' CG2' HG22 ' A' ' 13' ' ' VAL . 1.8 t -82.7 124.1 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.369 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.2 mt -99.4 -44.88 6.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.137 -0.977 . . . . 0.0 109.608 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -148.25 97.22 2.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.891 . . . . 0.0 109.157 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.637 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -78.72 122.76 26.41 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.38 -0.825 . . . . 0.0 109.618 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.696 ' HB2' HD21 ' B' ' 186' ' ' LEU . 43.4 m-70 -83.01 -101.77 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.342 -0.849 . . . . 0.0 109.223 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.34 -16.28 1.37 Allowed Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.366 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.581 ' CG ' ' HD2' ' B' ' 181' ' ' PRO . 0.0 OUTLIER -158.43 -16.99 0.07 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.913 -1.345 . . . . 0.0 110.755 -179.531 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 1.019 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 64.3 m95 -132.74 94.86 3.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.942 -1.099 . . . . 0.0 108.601 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.637 ' CD1' ' CG ' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -88.47 147.55 24.61 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.028 -1.045 . . . . 0.0 110.096 -179.114 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.7 OUTLIER -94.46 107.39 19.36 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.601 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -105.41 -175.41 2.79 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.273 -0.892 . . . . 0.0 110.23 -179.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -126.18 130.98 52.06 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.667 -0.645 . . . . 0.0 109.905 -179.207 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.64 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -77.06 128.34 34.29 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.157 -0.964 . . . . 0.0 109.698 179.476 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.891 HD12 ' O ' ' A' ' 34' ' ' LYS . 1.2 mp -73.95 -7.21 51.52 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 49.2 tp -53.89 -54.46 38.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.399 -0.813 . . . . 0.0 109.32 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 2.8 t -160.88 29.16 0.15 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.267 -0.896 . . . . 0.0 110.036 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.587 ' CB ' ' O ' ' A' ' 52' ' ' THR . 17.4 mttp 85.91 42.98 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.528 -0.733 . . . . 0.0 110.879 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.681 ' HB3' HD23 ' A' ' 27' ' ' LEU . 7.4 mmtt -85.41 133.0 34.13 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -123.36 120.8 34.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.976 -1.078 . . . . 0.0 109.332 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.666 ' HA3' ' CB ' ' A' ' 27' ' ' LEU . . . -159.72 166.11 34.81 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.27 -1.443 . . . . 0.0 110.133 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.732 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 9.2 m-85 -70.19 133.3 46.94 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.64 -0.918 . . . . 0.0 109.437 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.608 HG21 ' SD ' ' A' ' 35' ' ' MET . 6.1 pt -121.97 136.68 26.46 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.311 -0.868 . . . . 0.0 108.717 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.6 ' HG3' ' CD2' ' B' ' 179' ' ' LEU . 50.0 Cg_endo -69.39 138.62 39.44 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.269 1.98 . . . . 0.0 112.325 -178.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.55 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 23.6 t -71.46 0.97 7.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 110.202 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.681 ' OD1' ' N ' ' A' ' 62' ' ' TYR . 6.5 p-10 -95.45 -49.66 5.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.964 -1.085 . . . . 0.0 110.233 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 1.174 ' CE2' HD21 ' B' ' 179' ' ' LEU . 11.6 m-30 -61.11 -56.94 15.0 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.337 -0.852 . . . . 0.0 111.211 -178.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 15' ' ' ALA . 3.7 m -79.19 157.29 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 122.175 0.988 . . . . 0.0 111.443 -177.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.062 ' CB ' HD11 ' A' ' 16' ' ' LEU . . . -138.05 163.0 32.69 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.519 ' HA ' HG12 ' A' ' 13' ' ' VAL . 19.0 ttmm -74.85 147.31 41.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.036 -1.04 . . . . 0.0 109.17 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.21 -75.37 0.1 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.221 -0.924 . . . . 0.0 109.623 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -142.17 -140.9 0.13 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 109.461 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.479 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 1.3 p90 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . 0.594 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 0.3 OUTLIER -168.53 -56.58 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.249 -0.907 . . . . 0.0 108.886 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 47.7 Cg_endo -67.78 -90.25 0.0 OUTLIER 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.691 2.261 . . . . 0.0 111.861 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 173' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' B' ' 174' ' ' MET . . . -140.13 -38.75 0.09 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 174' ' ' MET . . . . . 0.508 ' N ' ' HD3' ' B' ' 175' ' ' PRO . 0.4 OUTLIER 42.24 62.24 7.99 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.385 -1.068 . . . . 0.0 109.468 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . 0.597 ' O ' HG23 ' B' ' 176' ' ' THR . 50.5 Cg_endo -92.24 171.91 2.49 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.195 2.596 . . . . 0.0 111.81 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 176' ' ' THR . . . . . 0.647 HG22 ' CE1' ' A' ' 62' ' ' TYR . 0.0 OUTLIER 172.15 107.47 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.412 -0.805 . . . . 0.0 109.319 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 177' ' ' PRO . . . . . 0.653 ' CD ' ' CD2' ' A' ' 17' ' ' TYR . 48.0 Cg_endo -71.17 176.65 7.53 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.701 2.267 . . . . 0.0 111.675 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' B' ' 177' ' ' PRO . 45.5 Cg_endo -67.33 97.24 0.42 Allowed 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.569 2.18 . . . . 0.0 111.752 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 1.174 HD21 ' CE2' ' A' ' 62' ' ' TYR . 25.0 mt -39.24 162.42 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.487 -0.758 . . . . 0.0 109.689 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 1.019 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.1 Cg_endo -66.29 170.94 11.14 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.508 2.139 . . . . 0.0 111.254 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . 0.592 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 56.1 Cg_endo -79.05 -34.29 1.22 Allowed 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 122.903 2.402 . . . . 0.0 114.154 -177.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.711 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.1 OUTLIER 78.27 84.26 0.09 OUTLIER Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 120.982 -1.074 . . . . 0.0 108.711 -178.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 51.1 Cg_endo -71.65 139.27 33.68 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.791 2.328 . . . . 0.0 112.125 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . 0.483 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 38.6 62.23 1.06 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.504 -0.747 . . . . 0.0 109.582 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . 0.496 ' CA ' ' HB3' ' B' ' 188' ' ' GLU . 0.6 OUTLIER 44.68 48.58 8.78 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.273 -0.892 . . . . 0.0 109.157 -179.699 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . 0.696 HD21 ' HB2' ' A' ' 41' ' ' HIS . 56.2 tp -64.92 -83.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.413 -0.804 . . . . 0.0 109.352 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . 0.732 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -64.83 -9.97 42.69 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.518 ' HG3' ' NE2' ' A' ' 23' ' ' HIS . 4.6 tt0 -70.93 -87.26 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.547 -0.972 . . . . 0.0 109.386 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 189' ' ' ARG . . . . . 0.491 ' HG3' ' HG2' ' B' ' 188' ' ' GLU . 9.6 mtt-85 -72.79 -164.17 0.15 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 109.301 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . 0.462 ' CG ' ' CG ' ' A' ' 25' ' ' ASP . 50.5 mt-30 -105.88 44.64 1.03 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -0.928 . . . . 0.0 109.498 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.437 179.958 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.97 -152.81 23.53 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.544 ' O ' HG13 ' A' ' 37' ' ' VAL . 73.4 m-20 -89.48 121.27 31.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -1.159 . . . . 0.0 109.276 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 19.9 mm -92.4 137.23 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.565 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.605 HG22 HG12 ' A' ' 37' ' ' VAL . 2.1 m -131.44 160.2 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.459 -0.776 . . . . 0.0 109.097 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.2 p -121.64 138.43 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 109.346 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.708 ' HB2' ' HE3' ' A' ' 35' ' ' MET . . . -70.04 132.03 45.25 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.26 -0.9 . . . . 0.0 109.747 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.075 HD11 ' CB ' ' A' ' 64' ' ' ALA . 28.3 mt -98.03 -13.61 20.97 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.992 ' HB3' HG22 ' B' ' 176' ' ' THR . 56.2 m-85 -155.46 152.7 25.16 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.579 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 42.6 Cg_endo -66.04 149.42 85.98 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 121.554 1.502 . . . . 0.0 109.589 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.866 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 20.6 t80 -102.34 -175.85 2.94 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.176 -1.41 . . . . 0.0 110.535 -178.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.735 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 31.2 m-20 -112.99 85.92 2.27 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.572 -0.705 . . . . 0.0 110.065 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.19 92.03 0.05 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.519 -1.832 . . . . 0.0 108.519 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.751 HD11 ' NH2' ' B' ' 182' ' ' ARG . 0.4 OUTLIER -107.75 -42.94 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.262 -1.14 . . . . 0.0 108.767 179.604 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.654 ' CE1' ' HA ' ' B' ' 188' ' ' GLU . 56.3 m80 -76.09 156.93 83.81 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.4 -13.23 35.23 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.156 1.904 . . . . 0.0 111.859 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.514 ' OD2' ' NE ' ' B' ' 189' ' ' ARG . 4.9 m-20 -112.65 -13.78 13.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 110.462 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.468 ' OD2' ' OH ' ' A' ' 19' ' ' TYR . 43.2 m-20 -57.39 138.9 54.41 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.764 -1.21 . . . . 0.0 109.793 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.943 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -94.95 121.99 37.14 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.9 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.1 m -78.77 139.25 38.44 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.153 -0.967 . . . . 0.0 109.598 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.866 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 17.5 p90 -146.87 158.1 43.83 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.242 -0.911 . . . . 0.0 108.918 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.659 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 21.4 mtmm -111.79 174.33 5.93 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.138 -0.976 . . . . 0.0 109.41 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.512 ' HD3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -66.73 153.02 44.32 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.12 -0.988 . . . . 0.0 109.305 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.27 -7.96 4.27 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 15' ' ' ALA . 3.4 tt0 -74.53 144.03 44.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.918 -1.342 . . . . 0.0 109.615 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.484 ' HD3' HD13 ' A' ' 50' ' ' LEU . 2.6 ptpt -96.67 136.12 37.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.517 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.708 ' HE3' ' HB2' ' A' ' 15' ' ' ALA . 1.7 mpp? -137.85 153.69 49.57 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.415 0.626 . . . . 0.0 109.528 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.68 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 2.2 ttpt -110.87 125.42 53.61 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.377 -0.827 . . . . 0.0 109.004 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.605 HG12 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -87.65 128.43 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.9 . . . . 0.0 108.753 178.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 26.1 mt -88.58 -29.7 19.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 109.945 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -176.99 130.99 0.18 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.147 -0.971 . . . . 0.0 109.834 -179.444 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.654 ' HA ' ' CD1' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -78.53 132.44 37.2 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.441 -0.787 . . . . 0.0 109.162 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.656 ' CB ' HD11 ' B' ' 186' ' ' LEU . 18.7 m-70 -111.57 30.78 6.66 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.223 -0.923 . . . . 0.0 110.543 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.416 ' N ' ' OE2' ' A' ' 40' ' ' GLU . . . 108.73 -47.25 1.06 Allowed Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.516 -1.325 . . . . 0.0 110.744 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.444 ' HB2' ' HD3' ' B' ' 183' ' ' PRO . 0.0 OUTLIER -159.2 -5.9 0.07 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.023 -1.281 . . . . 0.0 110.388 -179.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.783 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 65.4 m95 -141.68 99.87 3.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.038 -1.039 . . . . 0.0 109.276 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.679 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -94.68 148.66 22.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.031 -1.043 . . . . 0.0 109.454 -179.621 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 17.7 tttt -88.56 109.11 19.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.256 -0.903 . . . . 0.0 108.973 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.68 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -100.97 178.6 4.62 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.449 -0.782 . . . . 0.0 109.863 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 2.7 mttt -121.1 129.78 53.45 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.647 -0.658 . . . . 0.0 109.588 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.609 ' HB2' ' HB3' ' A' ' 54' ' ' LYS . 1.1 t -77.6 128.41 34.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 110.056 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.484 HD13 ' HD3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -72.92 -9.25 58.5 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 tp -52.32 -54.92 25.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.407 -0.808 . . . . 0.0 109.383 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.611 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 2.6 t -161.5 29.35 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 110.041 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.611 ' CB ' ' O ' ' A' ' 52' ' ' THR . 8.7 mmtm 86.68 44.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.502 -0.749 . . . . 0.0 110.488 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.609 ' HB3' ' HB2' ' A' ' 49' ' ' SER . 0.5 OUTLIER -85.0 133.25 34.26 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.183 -0.948 . . . . 0.0 108.488 178.61 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.93 114.34 20.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.923 -1.111 . . . . 0.0 109.215 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.618 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -152.57 169.21 31.69 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.366 -1.397 . . . . 0.0 109.89 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.711 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 7.7 m-85 -73.4 132.0 42.49 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.546 -0.973 . . . . 0.0 109.57 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 58' ' ' ILE . 11.0 pt -121.96 140.98 33.13 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.875 . . . . 0.0 109.069 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.597 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 49.2 Cg_endo -69.54 149.42 68.25 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.176 1.918 . . . . 0.0 112.094 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.523 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 21.2 t -77.57 7.78 5.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.328 -0.857 . . . . 0.0 110.656 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.536 ' ND2' ' O ' ' B' ' 178' ' ' PRO . 0.1 OUTLIER -111.74 -51.8 2.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.824 -1.173 . . . . 0.0 110.672 -179.143 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.7 ' CE2' ' HA ' ' A' ' 19' ' ' TYR . 2.6 m-30 -48.96 -52.16 26.32 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.105 -0.997 . . . . 0.0 110.83 -178.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.561 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.7 m -88.91 155.52 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -0.972 . . . . 0.0 111.19 -178.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.075 ' CB ' HD11 ' A' ' 16' ' ' LEU . . . -134.09 162.38 32.25 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.505 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 3.2 ptmt -77.12 94.57 4.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.954 -1.091 . . . . 0.0 109.344 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.458 ' C ' ' O ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER 39.88 55.39 2.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.235 -0.915 . . . . 0.0 109.63 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 64' ' ' ALA . 1.2 t30 -74.55 108.45 7.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 109.556 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.465 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . 0.468 ' CD1' ' N ' ' B' ' 170' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.3 0.571 . . . . 0.0 109.464 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . 0.601 ' N ' ' HD2' ' B' ' 172' ' ' PRO . 0.4 OUTLIER -170.5 -56.25 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.225 -0.922 . . . . 0.0 108.781 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' B' ' 171' ' ' ASP . 46.5 Cg_endo -67.92 -89.88 0.0 OUTLIER 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.7 2.266 . . . . 0.0 111.837 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 173' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' B' ' 174' ' ' MET . . . 72.63 38.78 57.09 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 174' ' ' MET . . . . . 0.435 ' O ' ' O ' ' B' ' 173' ' ' GLY . 5.1 mtt 59.23 112.07 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.204 -1.174 . . . . 0.0 109.409 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . 0.771 ' O ' HG23 ' B' ' 176' ' ' THR . 53.8 Cg_endo -78.94 -161.88 0.16 Allowed 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.601 2.201 . . . . 0.0 111.632 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 176' ' ' THR . . . . . 0.992 HG22 ' HB3' ' A' ' 17' ' ' TYR . 2.0 p -164.77 97.58 0.87 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.444 -0.785 . . . . 0.0 109.323 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 177' ' ' PRO . . . . . 0.671 ' HD2' ' CD2' ' A' ' 17' ' ' TYR . 50.2 Cg_endo -69.21 164.88 32.29 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.939 2.426 . . . . 0.0 112.046 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . 0.536 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 50.0 Cg_endo -70.31 157.3 59.74 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.721 2.281 . . . . 0.0 111.466 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 0.628 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -92.81 175.72 3.04 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.148 -0.97 . . . . 0.0 109.802 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.783 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.4 Cg_endo -68.96 -172.3 0.48 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.068 2.512 . . . . 0.0 111.326 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . 0.804 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 52.7 Cg_endo -91.48 -35.17 0.06 OUTLIER 'Trans proline' 0 C--O 1.212 -0.783 0 C-N-CA 122.788 2.325 . . . . 0.0 114.694 -177.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.804 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 32.4 mtt180 87.83 96.27 0.03 OUTLIER Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.314 -0.866 . . . . 0.0 109.013 -178.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 47.4 Cg_endo -68.78 124.56 11.62 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.76 2.306 . . . . 0.0 111.904 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' B' ' 185' ' ' ASN . . . 45.69 67.4 0.74 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.862 . . . . 0.0 109.495 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . 0.466 ' CA ' ' HB3' ' B' ' 188' ' ' GLU . 14.9 m-20 43.08 50.5 5.5 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.354 -0.841 . . . . 0.0 109.535 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . 0.656 HD11 ' CB ' ' A' ' 41' ' ' HIS . 47.7 tp -67.6 -83.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.296 -0.877 . . . . 0.0 109.507 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . 0.711 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -66.01 -8.18 41.02 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.654 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 33.5 tt0 -69.91 -86.04 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.469 -1.019 . . . . 0.0 109.421 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 189' ' ' ARG . . . . . 0.514 ' NE ' ' OD2' ' A' ' 25' ' ' ASP . 0.0 OUTLIER 73.05 140.52 0.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.308 -0.87 . . . . 0.0 109.533 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -139.14 -40.93 0.47 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.26 -0.9 . . . . 0.0 109.405 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.448 179.994 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.3 0.571 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.45 -117.31 0.76 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -134.98 157.72 46.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.164 -1.198 . . . . 0.0 109.505 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.709 HD12 ' HA ' ' A' ' 36' ' ' LYS . 5.2 tp -109.61 136.64 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.183 -0.948 . . . . 0.0 109.46 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.0 m -131.77 160.2 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.35 -0.844 . . . . 0.0 109.186 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' HG3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -119.64 138.7 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.068 -1.02 . . . . 0.0 109.302 179.121 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.768 ' HB2' ' HE3' ' A' ' 35' ' ' MET . . . -72.14 133.67 45.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.451 -0.781 . . . . 0.0 109.946 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.053 HD11 ' HB2' ' A' ' 64' ' ' ALA . 7.6 mt -99.79 -8.31 24.35 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.92 ' HB3' HG22 ' B' ' 176' ' ' THR . 27.6 m-85 -162.29 151.94 13.49 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.771 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 39.2 Cg_endo -62.19 149.16 91.58 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 121.733 1.622 . . . . 0.0 110.05 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.848 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 57.0 t80 -98.63 178.23 5.06 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 118.364 -1.335 . . . . 0.0 110.764 -177.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.68 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 6.4 m-20 -109.22 79.95 1.27 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.47 94.44 0.04 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.409 ' N ' ' O ' ' A' ' 20' ' ' ASP . 21.2 mt -107.17 -42.93 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.108 -1.231 . . . . 0.0 108.803 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.574 ' ND1' ' O ' ' B' ' 188' ' ' GLU . 0.2 OUTLIER -76.04 152.69 84.47 Favored Pre-proline 0 C--N 1.3 -1.563 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.53 ' HD2' ' ND1' ' A' ' 23' ' ' HIS . 43.9 Cg_endo -66.68 -11.42 31.8 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.299 1.999 . . . . 0.0 111.567 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.87 -14.68 13.49 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.89 . . . . 0.0 110.215 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' B' ' 187' ' ' GLY . 26.4 m-20 -58.07 142.17 47.73 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.883 -1.135 . . . . 0.0 109.784 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.908 HD22 ' N ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -98.55 122.21 41.46 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.908 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -78.03 139.77 39.12 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.327 -0.858 . . . . 0.0 109.449 179.669 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.848 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 24.3 p90 -145.29 156.74 44.0 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.232 -0.917 . . . . 0.0 108.74 178.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.691 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 3.2 tttp -111.18 174.28 5.94 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.172 -0.955 . . . . 0.0 109.539 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.584 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -67.37 151.85 46.72 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.108 -0.995 . . . . 0.0 109.346 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 69.96 -7.65 4.15 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -74.79 141.89 44.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.04 -1.271 . . . . 0.0 109.611 -179.735 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.634 ' HG3' HG13 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -95.86 138.61 33.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.89 . . . . 0.0 109.298 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.768 ' HE3' ' HB2' ' A' ' 15' ' ' ALA . 3.7 mpp? -133.2 149.63 52.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.53 -0.731 . . . . 0.0 109.88 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.709 ' HA ' HD12 ' A' ' 12' ' ' ILE . 12.2 mtpt -104.78 119.77 39.8 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.463 -0.773 . . . . 0.0 109.256 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -78.05 109.43 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.342 -0.849 . . . . 0.0 108.887 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 mt -88.15 -40.22 13.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.905 . . . . 0.0 109.991 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -134.99 97.47 3.75 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.032 -1.043 . . . . 0.0 109.158 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.7 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 0.7 OUTLIER -79.89 113.62 18.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.245 -0.91 . . . . 0.0 109.298 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -106.33 -121.1 0.23 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.499 ' HA3' ' HG3' ' B' ' 183' ' ' PRO . . . -85.5 -124.58 1.43 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' B' ' 180' ' ' PRO . 7.0 mt-10 -78.46 10.33 3.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -1.104 . . . . 0.0 111.102 -178.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.866 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 64.6 m95 -141.1 98.1 3.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.528 -1.357 . . . . 0.0 109.824 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.7 ' HB3' ' HA ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -92.97 145.24 24.52 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.826 -1.171 . . . . 0.0 110.197 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -85.77 108.06 17.91 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.754 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -100.54 -177.16 3.41 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.264 -0.898 . . . . 0.0 109.97 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -123.94 109.03 13.06 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.648 -0.658 . . . . 0.0 109.394 -179.663 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.617 ' N ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -54.77 127.84 30.18 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.167 -0.958 . . . . 0.0 109.861 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 52' ' ' THR . 0.1 OUTLIER -76.76 -11.46 59.84 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.222 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.512 ' C ' HG22 ' A' ' 52' ' ' THR . 4.5 tp -46.06 -20.9 0.11 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.722 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 0.5 OUTLIER 168.1 -21.72 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.371 -0.831 . . . . 0.0 109.935 179.123 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.722 ' CB ' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 140.84 42.48 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.528 -0.733 . . . . 0.0 110.046 179.595 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.683 ' HB3' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -85.67 134.36 33.98 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.131 -0.98 . . . . 0.0 108.424 178.4 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -121.67 114.16 20.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.909 -1.12 . . . . 0.0 109.439 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.625 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -152.49 172.46 31.65 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.677 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 6.8 m-85 -74.49 132.17 41.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.431 -1.04 . . . . 0.0 109.859 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.551 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 7.3 pt -121.42 138.24 27.97 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.667 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 48.6 Cg_endo -69.93 163.06 39.81 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 121.64 1.56 . . . . 0.0 112.01 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.564 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 82.8 p -90.89 8.25 35.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.389 -0.819 . . . . 0.0 110.095 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' B' ' 178' ' ' PRO . 0.4 OUTLIER -108.91 -54.9 2.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.028 -1.045 . . . . 0.0 110.109 -179.553 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.747 ' HE2' HD23 ' B' ' 179' ' ' LEU . 2.3 m-85 -47.24 -63.56 1.01 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.201 -0.937 . . . . 0.0 110.648 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.608 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.5 m -78.73 155.77 4.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.945 0.878 . . . . 0.0 110.96 -177.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.053 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -128.46 157.66 40.5 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp -75.64 154.88 36.33 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.948 -1.095 . . . . 0.0 109.583 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 67' ' ' ASN . 19.7 tp -126.91 90.95 3.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.923 . . . . 0.0 109.374 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 66' ' ' LEU . 0.7 OUTLIER -43.41 -81.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.558 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.488 179.974 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . 0.431 ' O ' ' HB3' ' B' ' 171' ' ' ASP . 6.0 m-90 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . 0.595 ' N ' ' HD3' ' B' ' 172' ' ' PRO . 1.5 p30 172.71 58.8 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.859 . . . . 0.0 109.005 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . 0.595 ' HD3' ' N ' ' B' ' 171' ' ' ASP . 52.5 Cg_endo -93.76 -77.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.271 2.647 . . . . 0.0 112.053 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 173' ' ' GLY . . . . . . . . . . . . . . . 87.5 35.29 9.52 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 174' ' ' MET . . . . . 0.586 ' N ' ' CD ' ' B' ' 175' ' ' PRO . 0.0 OUTLIER -83.75 -44.39 0.8 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.301 -1.117 . . . . 0.0 109.703 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . 0.931 ' O ' HG23 ' B' ' 176' ' ' THR . 54.2 Cg_endo -81.0 -165.13 0.32 Allowed 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 122.525 2.15 . . . . 0.0 111.812 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 176' ' ' THR . . . . . 0.931 HG23 ' O ' ' B' ' 175' ' ' PRO . 2.9 p -171.12 100.14 0.41 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.588 -0.695 . . . . 0.0 109.176 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 177' ' ' PRO . . . . . 0.63 ' HD2' ' CG ' ' A' ' 17' ' ' TYR . 50.7 Cg_endo -68.94 165.0 31.49 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.777 2.318 . . . . 0.0 111.703 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . 0.585 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 48.6 Cg_endo -69.13 -165.52 0.14 Allowed 'Trans proline' 0 C--O 1.213 -0.761 0 C-N-CA 122.607 2.205 . . . . 0.0 110.893 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 0.747 HD23 ' HE2' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -126.53 175.16 3.45 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.094 -1.004 . . . . 0.0 109.481 179.693 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.866 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 37.9 Cg_endo -67.24 -174.65 0.54 Allowed 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.922 2.415 . . . . 0.0 111.648 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . 0.751 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 54.8 Cg_endo -92.62 -23.69 0.33 Allowed 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 123.022 2.482 . . . . 0.0 114.617 -177.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.751 ' HB2' ' O ' ' B' ' 181' ' ' PRO . 27.6 mtt180 76.47 96.73 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.876 -1.14 . . . . 0.0 109.048 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' B' ' 186' ' ' LEU . 45.3 Cg_endo -67.0 107.24 1.29 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.6 2.2 . . . . 0.0 111.408 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' B' ' 185' ' ' ASN . . . 60.65 68.56 0.74 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.306 -0.871 . . . . 0.0 108.864 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . 0.48 ' HA ' ' HB2' ' B' ' 188' ' ' GLU . 2.9 p30 41.15 49.18 3.14 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.46 -0.775 . . . . 0.0 109.468 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . 0.619 HD23 ' HB2' ' A' ' 44' ' ' TRP . 64.5 tp -68.67 -75.33 0.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.357 -0.84 . . . . 0.0 109.278 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . 0.677 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -65.64 -10.79 51.3 Favored Glycine 0 N--CA 1.484 1.838 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.574 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 1.6 mt-10 -81.98 -58.14 3.1 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.529 -0.983 . . . . 0.0 109.126 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 189' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.48 -156.84 0.76 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.428 -0.795 . . . . 0.0 109.427 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . 0.658 ' O ' ' HB2' ' B' ' 191' ' ' ALA . 0.0 OUTLIER -153.49 30.06 0.48 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 109.421 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 191' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' B' ' 190' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.463 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.62 89.6 2.01 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.558 ' O ' HG23 ' A' ' 37' ' ' VAL . 79.9 m-20 -126.84 140.7 52.16 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.333 -1.098 . . . . 0.0 109.309 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.679 HD11 ' HG3' ' A' ' 36' ' ' LYS . 24.2 mm -101.82 136.39 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.134 -0.979 . . . . 0.0 109.553 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.07 160.69 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.8 p -121.24 137.15 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.001 -1.062 . . . . 0.0 109.341 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -70.44 135.21 48.5 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.414 -0.804 . . . . 0.0 109.886 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.03 HD11 ' HB2' ' A' ' 64' ' ' ALA . 18.1 mt -97.73 -28.36 13.92 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.666 ' HB2' ' CD1' ' A' ' 62' ' ' TYR . 4.3 m-85 -141.27 155.79 67.78 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 39.7 Cg_endo -62.13 145.39 96.41 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 121.692 1.594 . . . . 0.0 110.73 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.72 ' O ' ' CB ' ' A' ' 20' ' ' ASP . 23.7 t80 -70.36 -76.45 0.1 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.448 -0.782 . . . . 0.0 112.102 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.72 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 6.0 m-20 127.03 72.46 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -178.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.57 82.77 0.01 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.189 -1.165 . . . . 0.0 110.189 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.55 ' N ' ' O ' ' A' ' 20' ' ' ASP . 9.4 mm -99.56 0.96 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.979 -1.306 . . . . 0.0 108.226 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.624 ' CD2' ' O ' ' B' ' 188' ' ' GLU . 0.7 OUTLIER -122.64 152.6 62.14 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.753 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.25 -14.49 34.6 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.838 1.692 . . . . 0.0 111.986 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.73 -19.11 11.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.401 -0.812 . . . . 0.0 110.875 -178.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.498 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.8 OUTLIER -55.72 139.34 45.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.872 -1.142 . . . . 0.0 110.103 -178.773 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.967 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -87.79 117.32 26.55 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.315 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.887 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.8 m -76.87 138.7 39.93 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.331 -0.856 . . . . 0.0 110.216 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.705 ' CE2' ' HB2' ' A' ' 19' ' ' TYR . 10.6 p90 -143.38 154.77 44.07 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.683 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.8 OUTLIER -111.18 171.28 7.57 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.006 -1.058 . . . . 0.0 109.652 -179.291 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -63.15 152.19 38.04 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.201 -0.937 . . . . 0.0 109.081 179.792 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 68.02 -7.59 2.32 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.4 ' H ' ' C ' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -74.15 143.4 45.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.827 -1.396 . . . . 0.0 110.009 -179.461 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HE2' ' HB2' ' A' ' 34' ' ' LYS . 3.9 mppt? -95.22 137.14 34.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.34 -0.85 . . . . 0.0 109.457 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.571 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -136.13 151.88 50.24 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.611 -0.68 . . . . 0.0 109.813 -179.448 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.679 ' HG3' HD11 ' A' ' 12' ' ' ILE . 4.5 ttmt -109.87 126.79 54.21 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.455 -0.778 . . . . 0.0 109.776 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 11' ' ' ASP . 1.4 t -82.68 138.28 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.386 -0.821 . . . . 0.0 108.942 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.604 HD12 ' N ' ' A' ' 38' ' ' LEU . 6.3 mp -112.54 -31.0 6.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.07 -1.019 . . . . 0.0 109.927 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.03 96.08 1.2 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.184 -0.948 . . . . 0.0 109.303 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.579 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 1.0 OUTLIER -49.93 130.52 21.9 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.477 -0.764 . . . . 0.0 108.993 179.646 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.921 ' HB3' HD21 ' B' ' 186' ' ' LEU . 1.8 m-70 -128.51 102.12 6.48 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.486 ' C ' ' O ' ' A' ' 41' ' ' HIS . . . 41.18 -142.37 0.93 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.616 ' CB ' ' HD2' ' B' ' 181' ' ' PRO . 4.7 mt-10 -77.1 11.04 1.99 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -1.137 . . . . 0.0 110.707 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 1.053 ' CE2' ' HG2' ' B' ' 180' ' ' PRO . 64.5 m95 -137.4 100.36 4.21 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.668 -1.27 . . . . 0.0 109.67 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.58 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -94.44 149.27 21.41 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.817 -1.177 . . . . 0.0 110.215 -179.616 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -95.52 110.96 22.96 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.112 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -107.33 -175.3 2.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.177 -0.952 . . . . 0.0 110.297 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 9.9 ttpt -125.14 130.75 52.83 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.646 -0.659 . . . . 0.0 109.595 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.626 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -76.35 128.21 34.4 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 109.735 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.48 -6.11 46.46 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.8 tp -55.9 -54.73 41.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.455 -0.778 . . . . 0.0 109.259 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.606 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 1.3 t -160.45 29.68 0.16 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.143 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.606 ' HB2' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER 85.25 43.03 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.466 -0.771 . . . . 0.0 111.09 178.199 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.76 ' HB3' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -86.42 132.5 33.93 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.474 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 12.9 pt-20 -122.62 118.91 29.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.937 -1.102 . . . . 0.0 109.387 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.678 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -155.6 166.57 32.85 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.013 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.745 ' CG ' ' HA2' ' B' ' 187' ' ' GLY . 7.0 m-85 -71.87 134.97 46.4 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.7 -0.883 . . . . 0.0 109.695 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.517 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 3.0 pt -124.55 144.89 47.53 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.406 -0.809 . . . . 0.0 109.148 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.613 ' HG3' ' CD2' ' B' ' 179' ' ' LEU . 47.1 Cg_endo -69.31 162.67 40.91 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 121.977 1.785 . . . . 0.0 111.393 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.531 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 98.2 p -92.13 8.98 35.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.016 -1.052 . . . . 0.0 110.894 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.575 ' OD1' ' C ' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -112.08 -51.7 2.83 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.765 -1.209 . . . . 0.0 110.153 -179.581 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 1.141 ' CE2' HD21 ' B' ' 179' ' ' LEU . 1.3 m-85 -44.66 -62.22 1.28 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.163 -0.961 . . . . 0.0 110.787 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.571 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 2.9 m -79.64 156.7 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 122.104 0.954 . . . . 0.0 111.486 -177.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.03 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -133.35 161.22 35.1 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.9 tttp -75.96 151.0 37.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.995 -1.066 . . . . 0.0 109.395 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.38 -81.28 0.33 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.152 -0.967 . . . . 0.0 109.498 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -49.25 147.06 3.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.345 -0.847 . . . . 0.0 109.522 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.2 p . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.043 -0.98 . . . . 0.0 109.514 -179.918 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . 0.524 ' CD1' ' C ' ' B' ' 170' ' ' TRP . 1.8 p90 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.258 0.551 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . 0.589 ' H ' ' HD2' ' B' ' 172' ' ' PRO . 0.1 OUTLIER -161.77 -58.73 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.828 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . 0.589 ' HD2' ' H ' ' B' ' 171' ' ' ASP . 48.1 Cg_endo -68.25 -90.62 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.756 2.304 . . . . 0.0 111.778 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 173' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' B' ' 174' ' ' MET . . . 120.86 7.84 8.44 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 174' ' ' MET . . . . . 0.432 ' O ' ' O ' ' B' ' 173' ' ' GLY . 37.1 mmt 43.19 89.58 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.223 -1.163 . . . . 0.0 109.432 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . 0.56 ' HD2' ' CE1' ' A' ' 17' ' ' TYR . 55.3 Cg_endo -77.77 -160.67 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.615 2.21 . . . . 0.0 111.882 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 176' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 17' ' ' TYR . 3.1 p -156.38 96.16 2.26 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 177' ' ' PRO . . . . . 0.558 ' HG2' ' OD1' ' A' ' 61' ' ' ASN . 48.5 Cg_endo -70.24 174.77 9.43 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.779 2.319 . . . . 0.0 111.783 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' B' ' 179' ' ' LEU . 46.5 Cg_endo -68.18 108.6 1.79 Allowed 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.599 2.2 . . . . 0.0 111.743 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 1.141 HD21 ' CE2' ' A' ' 62' ' ' TYR . 30.1 mt -40.38 163.54 0.08 OUTLIER Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.44 -0.787 . . . . 0.0 109.657 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 1.053 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 38.3 Cg_endo -65.92 177.08 3.18 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.781 2.321 . . . . 0.0 111.83 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . 0.617 ' O ' ' CB ' ' B' ' 182' ' ' ARG . 53.9 Cg_endo -73.65 -48.01 0.26 Allowed 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.933 2.422 . . . . 0.0 113.873 -177.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.709 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.0 OUTLIER 84.81 91.78 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.151 -0.968 . . . . 0.0 108.946 -178.724 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.692 ' HG2' ' HB2' ' B' ' 186' ' ' LEU . 43.9 Cg_endo -69.07 129.66 18.74 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 123.085 2.523 . . . . 0.0 112.326 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 38.21 67.03 0.43 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.477 -0.764 . . . . 0.0 109.464 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . 0.499 ' HA ' ' CB ' ' B' ' 188' ' ' GLU . 0.5 OUTLIER 42.93 43.47 3.56 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.357 -0.84 . . . . 0.0 109.026 -179.55 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . 0.98 HD23 ' HB2' ' A' ' 44' ' ' TRP . 42.4 tp -54.27 -94.54 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . 0.745 ' HA2' ' CG ' ' A' ' 57' ' ' PHE . . . -64.2 -12.43 50.11 Favored Glycine 0 N--CA 1.482 1.729 0 N-CA-C 107.474 -2.25 . . . . 0.0 107.474 178.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.624 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 0.1 OUTLIER -67.64 -73.17 0.15 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.688 -0.89 . . . . 0.0 109.094 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 189' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' B' ' 188' ' ' GLU . 0.0 OUTLIER 74.25 158.35 0.2 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.442 -0.786 . . . . 0.0 109.576 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . 0.459 ' O ' ' HB3' ' B' ' 191' ' ' ALA . 0.0 OUTLIER -143.44 23.45 1.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 109.529 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 191' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' B' ' 190' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.432 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.93 100.93 0.17 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.571 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.3 OUTLIER -114.65 139.02 49.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -1.13 . . . . 0.0 109.326 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 36' ' ' LYS . 17.6 mm -92.93 136.67 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 109.618 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.87 HG12 ' HD3' ' A' ' 65' ' ' LYS . 1.1 m -132.14 161.8 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.6 p -120.97 139.2 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.137 -0.977 . . . . 0.0 109.075 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.671 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . -71.05 132.92 45.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.346 -0.846 . . . . 0.0 109.807 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.081 HD11 ' CB ' ' A' ' 64' ' ' ALA . 24.4 mt -98.66 -11.97 21.51 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.938 ' HB3' HG22 ' B' ' 176' ' ' THR . 54.8 m-85 -159.55 153.69 19.96 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.701 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 42.0 Cg_endo -64.55 149.09 90.49 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 121.672 1.582 . . . . 0.0 109.983 179.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.816 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 56.4 t80 -97.79 178.6 5.09 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 118.303 -1.359 . . . . 0.0 110.265 -177.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.682 ' N ' ' CG ' ' A' ' 19' ' ' TYR . 12.2 m-20 -109.47 80.66 1.34 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.56 -0.713 . . . . 0.0 109.322 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.51 95.38 0.06 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.6 mt -108.5 -42.24 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.157 -1.202 . . . . 0.0 108.896 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.657 ' CG ' ' O ' ' B' ' 188' ' ' GLU . 3.4 m-70 -76.98 159.6 78.19 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -71.11 -12.12 29.89 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.141 1.894 . . . . 0.0 111.778 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -113.86 -14.94 12.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 110.869 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.48 ' CG ' ' HB2' ' A' ' 23' ' ' HIS . 90.7 m-20 -57.19 139.47 52.54 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.719 -1.238 . . . . 0.0 109.955 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.896 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -93.77 120.86 34.58 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.005 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.855 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -80.68 141.41 34.93 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.351 -0.843 . . . . 0.0 109.595 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.816 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 30.5 p90 -146.05 157.79 43.86 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.181 -0.949 . . . . 0.0 108.599 178.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.671 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 6.4 mttt -110.7 173.7 6.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.147 -0.97 . . . . 0.0 109.594 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.552 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -67.43 151.43 47.42 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.141 -0.975 . . . . 0.0 109.314 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 70.96 -8.25 4.79 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -75.84 143.63 41.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.953 -1.322 . . . . 0.0 109.755 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.31 138.95 33.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 109.509 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.576 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 2.5 mpp? -134.91 151.47 50.91 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.564 -0.71 . . . . 0.0 109.761 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 8.3 ttpp -105.15 124.13 49.0 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.507 -0.745 . . . . 0.0 109.53 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.808 ' C ' HD12 ' A' ' 38' ' ' LEU . 2.2 t -81.13 136.97 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.297 -0.877 . . . . 0.0 109.216 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.808 HD12 ' C ' ' A' ' 37' ' ' VAL . 7.1 mp -111.85 -43.36 3.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 109.648 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.05 106.35 3.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.124 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.654 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 0.7 OUTLIER -89.98 118.03 29.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.333 -0.855 . . . . 0.0 109.539 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.615 ' CG ' HD12 ' B' ' 186' ' ' LEU . 1.8 m-70 -81.83 -100.31 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.314 -0.866 . . . . 0.0 109.382 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.465 ' O ' ' HG2' ' A' ' 43' ' ' GLU . . . -133.34 -14.31 1.4 Allowed Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.664 -1.255 . . . . 0.0 110.065 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 42' ' ' GLY . 6.0 mm-40 -157.52 -16.0 0.08 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.972 -1.31 . . . . 0.0 110.623 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.94 ' CD1' ' HA ' ' B' ' 182' ' ' ARG . 56.3 m95 -137.6 101.65 4.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.673 -1.267 . . . . 0.0 109.485 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.654 ' CD1' ' CG ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -93.32 144.4 25.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.206 -0.934 . . . . 0.0 110.211 -179.313 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 11.4 ttpt -90.08 108.08 19.51 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -102.8 -175.3 2.77 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.354 -0.841 . . . . 0.0 109.931 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 17.7 ttpt -125.88 130.43 51.31 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.605 -0.684 . . . . 0.0 109.31 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.595 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 6.9 t -75.84 126.78 31.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.072 -1.017 . . . . 0.0 109.963 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 50' ' ' LEU . 14.4 mt -70.81 -7.99 49.3 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.3 tp -53.94 -55.6 25.51 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.53 -0.731 . . . . 0.0 109.445 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.629 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.7 t -161.04 28.14 0.14 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 110.119 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.629 ' CB ' ' O ' ' A' ' 52' ' ' THR . 14.1 mtmm 87.38 44.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.414 -0.804 . . . . 0.0 110.687 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.595 ' HB2' ' CB ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -86.77 131.58 34.09 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.042 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.456 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 2.5 pt-20 -122.01 118.46 28.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.879 -1.138 . . . . 0.0 109.625 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.658 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -157.66 168.36 34.32 Favored Glycine 0 N--CA 1.487 2.068 0 C-N-CA 119.427 -1.368 . . . . 0.0 109.904 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.963 ' CD1' HD21 ' B' ' 186' ' ' LEU . 27.1 m-85 -70.98 132.39 45.1 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.57 -0.959 . . . . 0.0 109.883 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 58' ' ' ILE . 6.6 pt -121.08 141.64 33.26 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.654 ' HB3' ' HD2' ' B' ' 180' ' ' PRO . 46.6 Cg_endo -69.18 154.86 69.38 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 121.721 1.614 . . . . 0.0 111.836 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.621 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 73.7 p -83.96 7.12 19.35 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.364 -0.835 . . . . 0.0 110.252 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.13 -53.28 2.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.936 -1.102 . . . . 0.0 110.515 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.584 ' CD1' ' HB2' ' A' ' 17' ' ' TYR . 2.6 m-85 -48.44 -62.72 1.35 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.075 -1.016 . . . . 0.0 111.173 -178.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.576 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 3.0 m -78.11 155.5 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 122.079 0.942 . . . . 0.0 111.18 -177.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.081 ' CB ' HD11 ' A' ' 16' ' ' LEU . . . -136.02 163.29 30.64 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.87 ' HD3' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -75.73 148.66 38.4 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.046 -1.034 . . . . 0.0 109.228 179.615 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.0 mp -80.18 78.06 6.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.17 -0.956 . . . . 0.0 109.772 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -149.04 12.77 0.86 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 109.675 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.413 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . 0.597 ' CZ3' ' HA2' ' B' ' 173' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . 0.572 ' H ' ' HD2' ' B' ' 172' ' ' PRO . 0.4 OUTLIER -164.0 -58.49 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.238 -0.914 . . . . 0.0 108.714 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . 0.572 ' HD2' ' H ' ' B' ' 171' ' ' ASP . 46.8 Cg_endo -67.67 -89.33 0.0 OUTLIER 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.817 2.344 . . . . 0.0 111.773 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 173' ' ' GLY . . . . . 0.597 ' HA2' ' CZ3' ' B' ' 170' ' ' TRP . . . 110.56 75.6 0.82 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 174' ' ' MET . . . . . 0.476 ' O ' ' O ' ' B' ' 173' ' ' GLY . 43.5 mtm 59.07 118.82 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.306 -1.114 . . . . 0.0 109.476 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . 0.926 ' O ' HG23 ' B' ' 176' ' ' THR . 54.4 Cg_endo -79.61 -163.66 0.24 Allowed 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 122.556 2.171 . . . . 0.0 111.493 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 176' ' ' THR . . . . . 0.938 HG22 ' HB3' ' A' ' 17' ' ' TYR . 0.7 OUTLIER -176.16 102.62 0.24 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.474 -0.766 . . . . 0.0 109.142 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 177' ' ' PRO . . . . . 0.625 ' HD2' ' CD2' ' A' ' 17' ' ' TYR . 48.0 Cg_endo -69.66 157.32 61.0 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.716 2.277 . . . . 0.0 111.709 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.63 144.21 59.44 Favored 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 122.598 2.199 . . . . 0.0 111.478 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 0.608 ' CB ' ' HD2' ' B' ' 180' ' ' PRO . 0.0 OUTLIER -83.77 174.52 5.81 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.135 -0.978 . . . . 0.0 109.875 -179.705 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.717 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 42.9 Cg_endo -72.44 -170.66 0.61 Allowed 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.976 2.451 . . . . 0.0 110.211 178.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . 0.766 ' O ' ' HB2' ' B' ' 182' ' ' ARG . 51.6 Cg_endo -87.06 -67.54 0.01 OUTLIER 'Trans proline' 0 C--O 1.212 -0.79 0 C-N-CA 121.991 1.794 . . . . 0.0 112.198 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.94 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 0.8 OUTLIER 141.05 112.78 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.078 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.581 ' HG2' ' CB ' ' B' ' 186' ' ' LEU . 44.1 Cg_endo -67.45 127.14 15.97 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 123.04 2.493 . . . . 0.0 112.087 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . 0.491 ' C ' ' O ' ' B' ' 183' ' ' PRO . . . 37.99 52.88 1.57 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.378 -0.826 . . . . 0.0 109.375 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . 0.492 ' N ' ' ND2' ' B' ' 185' ' ' ASN . 0.2 OUTLIER 46.28 44.33 12.32 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.369 -0.832 . . . . 0.0 109.104 -179.526 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . 1.053 HD23 ' N ' ' B' ' 187' ' ' GLY . 7.8 tt -72.8 -82.83 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.479 -0.763 . . . . 0.0 108.97 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . 1.053 ' N ' HD23 ' B' ' 186' ' ' LEU . . . -62.17 -11.99 35.37 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 108.161 -1.976 . . . . 0.0 108.161 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.657 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 64.0 tt0 -72.89 -102.45 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.506 -0.996 . . . . 0.0 109.156 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 189' ' ' ARG . . . . . 0.498 ' N ' ' HG2' ' B' ' 188' ' ' GLU . 0.0 OUTLIER -96.94 157.63 15.81 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.057 -1.027 . . . . 0.0 109.433 179.656 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -83.09 164.5 20.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.919 . . . . 0.0 109.504 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.427 -179.957 . . . . . . . . 0 0 . 1 stop_ save_